02-32503. Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2003 and Inclusion of Registered Nurses in the Personnel Provision of the Critical Access Hospital Emergency Services Requirement for ...

AGENCY:

Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION:

Final rule with comment period.

SUMMARY:

This final rule with comment period refines the resource-based practice expense relative value units (RVUs) and makes other changes to Medicare Part B payment policy. In addition, as required by statute, we are announcing the physician fee schedule update for CY 2003.

The update to the physician fee schedule occurs as a result of a calculation methodology specified by law. That law required the Department to set annual updates based in part on estimates of several factors. Although subsequent after-the-fact data indicate that actual increases were different to some degree from earlier estimates, the law does not permit those estimates to be revised. A subsequent law required estimates to be revised for FY 2000 and beyond.

Although we have exhaustively examined opportunities for a different interpretation of law that would allow us to correct the flaw in the formula administratively, current law does not permit such an interpretation. Accordingly, without Congressional action to address the current legal framework, the Department is compelled to announce herein a physician fee schedule update for CY 2003 of −4.4 percent.

Because the Department would adopt a change in the formula that determines the physician update if the law permitted it, we have examined how proper adjustments to past data could result in a positive update. The Department believes that revisions of estimates used to establish the sustainable growth rates (SGR) for fiscal years (FY) 1998 and 1999 and Medicare volume performance standards (MVPS) for 1990-1996 would, under present calculations, result in a positive update.

The Department intends to work closely with Congress to develop legislation that could permit a positive update, and hopes that such legislation can be passed before the negative update takes effect. Because the Department wishes to change the update promptly in the event that Congress provides the Department legal authority to do so, we are requesting comments regarding how physician fee schedule rates could and should be recalculated prospectively in the event that Congress provides the Department with legal authority to revise estimates used to establish the sustainable growth rates (SGR) and for 1998 and 1999 and the NVPS for 1990-1996.

The other policy changes concern: the pricing of the technical component for positron emission tomography (PET) scans, Medicare qualifications for clinical nurse specialists, a process to add or delete services to the definition of telehealth, the definition for ZZZ global periods, global period for surface radiation, and an endoscopic base for urology codes. In addition, this rule updates the codes subject to physician self-referral prohibitions. We are expanding the definition of a screening fecal-occult blood test and are modifying our regulations to expand coverage for additional colorectal cancer screening tests through our national coverage determination process. We also make revisions to the sustainable growth rate, the anesthesia conversion factor, and the work values for some gastroenterologic services.

We are making these changes to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services.

This final rule also clarifies the enrollment of physical and occupational therapists as therapists in private practice and clarifies the policy regarding services and supplies incident to a physician's professional services. In addition, this final rule discusses physical and occupational therapy payment caps and makes technical changes to the definition of outpatient rehabilitation services.

In addition, we are finalizing the calendar year (CY) 2002 interim RVUs and are issuing interim RVUs for new and revised procedure codes for calendar year (CY) 2003.

As required by the statute, we are announcing that the physician fee schedule update for CY 2003 is −4.4 percent, the initial estimate of the sustainable growth rate for CY 2003 is 7.6 percent, and the conversion factor for CY 2003 is $34.5920.

This final rule will also allow registered nurses (RNs) to provide emergency care in certain critical access hospitals (CAHs) in frontier areas (an area with fewer than six residents per square mile) or remote locations (locations designated in a State's rural health plan that we have approved.) This policy applies if the State, following consultation with the State Boards of Medicine and Nursing, and in accordance with State law, requests that RNs be included, along with a doctor of medicine or osteopathy, a physician's assistant, or a nurse practitioner with training or experience in emergency care, as personnel authorized to provide emergency services in CAHs in frontier areas or remote locations.

DATES:

Effective date: This rule is effective on March 1, 2003.

Comment date: We will consider comments on the definition of a screening fecal-occult blood test, the critical access hospital emergency services requirement, the physician self-referral designated health services identified in Table 10, the interim work RVUs for selected procedure codes identified in Addendum C, the practice expense direct cost inputs, and on how physician fee schedule rates could and should be recalculated prospectively in the event that Congress provides the Department with legal authority to revise estimates used to establish SGRs for 1998 and 1999 and the MVPS for 1990-1996, if we receive them at the appropriate address, as provided in the addresses section, no later than 5 p.m. on March 3, 2003.

ADDRESSES:

In commenting, please refer to file code CMS-1204-FC. Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission. Mail written comments (one original and two copies) to the following address ONLY: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS-1204-FC, P.O. Box 8013, Baltimore, MD 21244-8013.

Please allow sufficient time for us to receive mailed comments on time in the event of delivery delays.

If you prefer, you may deliver (by hand or courier) your written comments (one original and two copies) to one of the following addresses: Room 445-G, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201, or Room C5-14-03, 7500 Security Boulevard, Baltimore, MD 21244-8013.

(Because access to the interior of the HHH Building is not readily available to persons without Federal Government identification, commenters are encouraged to leave their comments in the CMS drop slots located in the main lobby of the building. A stamp-in clock is available if you wish to retain proof of filing by stamping in and retaining an extra copy of the comments being filed.)

Comments mailed to the addresses indicated as appropriate for hand or courier delivery may be delayed and could be considered late.

For information on viewing public comments, see the beginning of the SUPPLEMENTARY INFORMATION section.

FOR FURTHER INFORMATION CONTACT:

Marc Hartstein, [phone], or Stephanie Monroe [phone] (for issues related to resource-based practice expense relative value units).

Jim Menas, [phone] (for issues related to anesthesia).

Marc Hartstein, [phone] (for issues related to the sustainable growth rate).

Gail Addis, [phone] (for issues related to PET scans).

Craig Dobyski, [phone] (for issues related to telehealth).

Terri Harris, [phone] or Pam West, [phone] (for issues related to physical and occupational therapy).

William Larson, [phone] (for issues related to fecal-occult blood test).

Regina Walker-Wren, [phone] (for issues related to clinical nurse specialists).

Dorothy Shannon, [phone] (for issues related to services and supplies incident to a physician's professional services).

Joanne Sinsheimer, [phone] (for issues related to updates to the list of certain services subject to the physician self-referral prohibitions).

Mary Collins, [phone] (for issues related to the critical access hospital emergency services requirement).

Diane Milstead, [phone] (for all other issues).

SUPPLEMENTARY INFORMATION:

Inspection of Public Comments: Comments received timely will be available for public inspection as they are recorded and processed, generally beginning approximately 4 weeks after the publication of the document, at the headquarters of the Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Baltimore, Maryland 21244, Monday through Friday of each week from 8:30 a.m. to 4 p.m. To schedule an appointment to view public comments, phone [phone].

Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at [phone] (or toll-free at 1-888-293-6498) or by faxing to [phone]. The cost for each copy is $10. As an alternative, you can view and photocopy the Federal Register document at most libraries designated as Federal Depository Libraries and at many other public and academic libraries throughout the country that receive the Federal Register.

This Federal Register document is also available from the Federal Register online database through GPO Access, a service of the U.S. Government Printing Office. The Web site address is: http://www.access.gpo.gov/​nara/​index.html.

Information on the physician fee schedule can be found on our homepage. You can access this data by using the following directions:

1. Go to the CMS homepage (http://www.cms.hhs.gov).

2. Click on “Medicare.”

3. Select Medicare Payment Systems.

4. Select Physician Fee Schedule.

To assist readers in referencing sections contained in this preamble, we are providing the following table of contents. Some of the issues discussed in this preamble affect the payment policies but do not require changes to the regulations in the Code of Federal Regulations. Information on the regulation's impact appears throughout the preamble and is not exclusively in section XIII.

Table of Contents

I. Background

A. Legislative History

B. Published Changes to the Fee Schedule

C. Components of the Fee Schedule Payment Amounts

D. Development of the Relative Value Units

E. Delay in the Effective Date

II. Specific Provisions for Calendar Year 2003

A. Resource-Based Practice Expense Relative Value Units

B. Anesthesia Issues

C. Pricing of Technical Components (TC) for Positron Emissions Tomography (PET) Scans

D. Enrollment of Physical and Occupational Therapists as Therapists in Private Practice

E. Clinical Social Worker Services

F. Medicare Qualifications for Clinical Nurse Specialists

G. Process to Add or Delete Services to the Definition of Telehealth

H. Definition for ZZZ Global Periods

I. Change in Global Period for CPT Code 77789 (Surface Application of Radiation Source)

J. Technical Change for § 410.61(d)(1)(iii) Outpatient Rehabilitation Services

K. New HCPCS G-Codes From June 28, 2002 Proposed Rule

L. Endoscopic Base for Urology Codes

M. Physical Therapy and Occupational Therapy Caps

III. Other Issues

A. Definition of a Screening Fecal-Occult Blood Test

B. Clarification of Services and Supplies Incident To a Physician's Professional Services: Conditions

C. Five-Year Review of Gastroenterology Codes

D. Critical Access Hospital Emergency Services Requirements

IV. Refinement of Relative Value Units for Calendar Year 2003 and Response to Public Comments on Interim Relative Value Units for 2002

V. Update to the Codes for Physician Self-Referral Prohibition

VI. Physician Fee Schedule Update for Calendar Year 2003

VII. Allowed Expenditures for Physicians' Services and the Sustainable Growth Rate

A. Medicare Sustainable Growth Rate

B. Physicians' Services

C. Provisions Related to the Sustainable Growth Rate

D. Preliminary Estimate of the Sustainable Growth Rate for 2003

E. Sustainable Growth Rate for 2002

F. Sustainable Growth Rate for 2001

G. Calculation of 2003, 2002, and 2001 Sustainable Growth Rates

VIII. Anesthesia and Physician Fee Schedule Conversion Factors for CY 2003

IX. Provisions of the Final Rule

X. Waiver of Proposed Rulemaking for Definition of a Screening Fecal-Occult Blood Test and Critical Access Hospital Emergency Services Requirement

XI. Collection of Information Requirements

XII. Response to Comments

XIII. Regulatory Impact Analysis

Addendum A—Explanation and Use of Addendum B

Addendum B—2003 Relative Value Units and Related Information Used in Determining Medicare Payments for 2003

Addendum C—Codes with Interim RVUs

Addendum D—2003 Geographic Practice Cost Indices by Medicare Carrier and Locality

Addendum E—Updated List of CPT/HCPCS Codes Used to Describe Certain Designated Health Services Under the Physician Self-Referral Provision

Addendum F—Codes Refined by the PEAC for 2003

In addition, because of the many organizations and terms to which we refer by acronym in this proposed rule, we are listing these acronyms and their corresponding terms in alphabetical order below:

AMA	American Medical Association
BBA	Balanced Budget Act of 1997
BBRA	Balanced Budget Refinement Act of 1999
CAH	Critical Access Hospitals
CF	Conversion factor
CFR	Code of Federal Regulations
CMS	Centers for Medicare & Medicaid Services
CNS	Clinical Nurse Specialist
CPT	[Physicians'] Current Procedural Terminology [4th Edition, 2002, copyrighted by the American Medical Association]
CPEP	Clinical Practice Expert Panel
CRNA	Certified Registered Nurse Anesthetist
E/M	Evaluation and management
GPCI	Geographic practice cost index
HCPCS	Healthcare Common Procedure Coding System
HHA	Home health agency
HHS	[Department of] Health and Human Services
IDTFs	Independent Diagnostic Testing Facilities
MCM	Medicare Carrier Manual
MedPAC	Medicare Payment Advisory Commission
MEI	Medicare Economic Index
MSA	Metropolitan Statistical Area
NCD	National Coverage Decision
PC	Professional Component
PEAC	Practice Expense Advisory Committee
PET	Positron Emission Tomography
PPS	Prospective payment system
RUC	[AMA's Specialty Society] Relative [Value] Update Committee
RVU	Relative value unit
SGR	Sustainable growth rate
SMS	[AMA's] Socioeconomic Monitoring System
SNF	Skilled Nursing Facility
TC	Technical Component

I. Background

A. Legislative History

Since January 1, 1992, Medicare has paid for physicians' services under section 1848 of the Social Security Act (the Act), “Payment for Physicians” Services.” This section provides for three major elements—(1) A fee schedule for the payment of physicians' services; (2) limits on the amounts that nonparticipating physicians can charge beneficiaries; and (3) a sustainable growth rate for the rates of increase in Medicare expenditures for physicians' services. The Act requires that payments under the fee schedule be based on national uniform relative value units (RVUs) based on the resources used in furnishing a service. Section 1848(c) of the Act requires that national RVUs be established for physician work, practice expense, and malpractice expense. Section 1848(c)(2)(B)(ii)(II) of the Act provides that adjustments in RVUs may not cause total physician fee schedule payments to differ by more than $20 million from what they would have been had the adjustments not been made. If adjustments to RVUs cause expenditures to change by more than $20 million, we must make adjustments to preserve budget neutrality.

B. Published Changes to the Fee Schedule

In the July 2000 proposed rule, (65 FR 44177), we listed all of the final rules published through November 1999. In the August 2001 proposed rule (66 FR 40372) we discussed the November 2000 final rule relating to the updates to the RVUs and revisions to payment policies under the physician fee schedule.

In the November 2001 final rule with comment period (66 FR 55246), we revised the policy for—resource-based practice expense RVUs; services and supplies incident to a physician's professional service; anesthesia base unit variations; recognition of CPT tracking codes; and nurse practitioners, physician assistants, and clinical nurse specialists performing screening sigmoidoscopies. We also addressed comments received on the June 8, 2001 proposed notice (66 FR 31028) for the 5-year review of work RVUs and finalized these work RVUs. In addition, we acknowledged comments received in response to a discussion of modifier-62, which is used to report the work of co-surgeons. The November 2001 final rule also updated the list of services that are subject to the physician self-referral prohibitions in order to reflect CPT and Healthcare Common Procedure Coding System (HCPCS) code changes that were effective January 1, 2002. These revisions ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services.

The Medicare, Medicaid, and State Child Health Insurance Program (SCHIP) Benefits Improvement and Protection Act of 2000 (Pub. L. 106-554) (BIPA) modernized the mammography screening benefit and authorized payment under the physician fee schedule effective January 1, 2002. It provided for biennial screening pelvic examinations for certain beneficiaries and expanded coverage for screening colonoscopies to all beneficiaries effective July 1, 2001. It provided for annual glaucoma screenings for high-risk beneficiaries and established coverage for medical nutrition therapy services for certain beneficiaries effective January 1, 2002. It expanded payment for telehealth services effective October 1, 2001; required certain Indian Health Service providers to be paid for some services under the physician fee schedule effective July 1, 2001; and revised the payment for certain physician pathology services effective January 1, 2001. This final rule conformed our regulations to reflect these statutory provisions.

The final rule also announced the calendar year 2002 physician fee schedule conversion factor (CF) of $36.1992.

C. Components of the Fee Schedule Payment Amounts

Under the formula set forth in section 1848(b)(1) of the Act, the payment amount for each service paid under the physician fee schedule is the product of three factors—(1) A nationally uniform relative value for the service; (2) a geographic adjustment factor (GAF) for each physician fee schedule area; and (3) a nationally uniform conversion factor (CF) for the service. The CF converts the relative values into payment amounts.

For each physician fee schedule service, there are three relative values—(1) An RVU for physician work; (2) an RVU for practice expense; and (3) an RVU for malpractice expense. For each of these components of the fee schedule, there is a geographic practice cost index (GPCI) for each fee schedule area. The GPCIs reflect the relative costs of practice expenses, malpractice insurance, and physician work in an area compared to the national average for each component.

The general formula for calculating the Medicare fee schedule amount for a given service in a given fee schedule area can be expressed as:

Payment = [(RVU work × GPCI work) + (RVU practice expense × GPCI practice expense) + (RVU malpractice × GPCI malpractice)] × CF

The CF for calendar year (CY) 2003 appears in section VIII. The RVUs for CY 2003 are in Addendum B. The GPCIs for CY 2003 can be found in Addendum D.

Section 1848(e) of the Act requires us to develop GAFs for all physician fee schedule areas. The total GAF for a fee schedule area is equal to a weighted average of the individual GPCIs for each of the three components of the service. In accordance with the statute, however, the GAF for the physician's work reflects one-quarter of the relative cost of physician's work compared to the national average.

D. Development of the Relative Value System

1. Work Relative Value Units

Approximately 7,500 codes represent services included in the physician fee schedule. The work RVUs established for the implementation of the fee schedule in January 1992 were developed with extensive input from the physician community. A research team at the Harvard School of Public Health developed the original work RVUs for most codes in a cooperative agreement with us. In constructing the vignettes for the original RVUs, Harvard worked with expert panels of physicians and obtained input from physicians from numerous specialties.

The RVUs for radiology services were based on the American College of Radiology (ACR) relative value scale, which we integrated into the overall physician fee schedule. The RVUs for anesthesia services were based on RVUs from a uniform relative value guide. We established a separate CF for anesthesia services, and we continue to recognize time as a factor in determining payment for these services. As a result, there is a separate payment system for anesthesia services.

2. Practice Expense and Malpractice Expense Relative Value Units

Section 1848(c)(2)(C) of the Act required that the practice expense and malpractice expense RVUs equal the product of the base allowed charges and the practice expense and malpractice percentages for the service. Base allowed charges are defined as the national average allowed charges for the service furnished during 1991, as estimated using the most recent data available. For most services, we used 1989 charge data aged to reflect the 1991 payment rules, since those were the most recent data available for the 1992 fee schedule.

Section 121 of the Social Security Act Amendments of 1994 (Pub. L. 103-432), enacted on October 31, 1994, required us to develop a methodology for a resource-based system for determining practice expense RVUs for each physician service. As amended by the BBA, section 1848(c) required the new payment methodology to be phased in over 4 years, effective for services furnished in 1999, with resource-based practice expense RVUs becoming fully effective in 2002. The BBA also required us to implement resource-based malpractice RVUs for services furnished beginning in 2000.

E. Delay in the Effective Date

On November 5, 2002 we published a notice (67 FR 67319), delaying the publication of this final rule due to concerns about the data used to establish the physician fees and the need to further assess the accuracy of the data. We have concluded our review and are moving forward with our proposals unless otherwise indicated in this preamble. This rule is effective on March 3, 2003.

II. Specific Provisions for Calendar Year 2003

In response to the publication of the June 28, 2002 proposed rule, (67 FR 43846), and the interim final rule, (67 FR 43555), we received approximately 236 comments. We received comments from individual physicians, health care workers, and professional associations and societies. The majority of comments addressed the proposals related to the enrollment of therapists, anesthesia services and the SGR.

The proposed rule discussed policies that affected the number of RVUs on which payment for certain services would be based. Certain changes implemented through this final rule are subject to the $20 million limitation on annual adjustments contained in section 1848(c)(2)(B)(ii)(II) of the Act.

After reviewing the comments and determining the policies we would implement, we have estimated the costs and savings of these policies and added those costs and savings to the estimated costs associated with any other changes in RVUs for 2003. We discuss in detail the effects of these changes in the Regulatory Impact Analysis in section XIII.

For the convenience of the reader, the headings for the policy issues correspond to the headings used in the June 28, 2002 proposed rule. More detailed background information for each issue can be found in the June 2002 interim final rule with comment period and the June 2002 proposed rule.

A. Resource-Based Practice Expense Relative Value Units

1. Resource-Based Practice Expense Legislation

Section 121 of the Social Security Act Amendments of 1994 (Pub. L. 103-432), enacted on October 31, 1994, required us to develop a methodology for a resource-based system for determining practice expense RVUs for each physician's service beginning in 1998. In developing the methodology, we were to consider the staff, equipment, and supplies used in providing medical and surgical services in various settings. The legislation specifically required that, in implementing the new system of practice expense RVUs, we apply the same budget-neutrality provisions that we apply to other adjustments under the physician fee schedule.

Section 4505(a) of the Balanced Budget Act of 1997 (BBA) (Pub. L. 105-33), enacted on August 5, 1997, amended section 1848(c)(2)(ii) of the Act and delayed the effective date of the resource-based practice expense RVU system until January 1, 1999. In addition, section 4505(b) of the BBA provided for a 4-year transition period from charge-based practice expense RVUs to resource-based RVUs. Further legislation affecting resource-based practice expense RVUs was included in the Medicare, Medicaid and State Child Health Insurance Program (SCHIP) Balanced Budget Refinement Act of 1999 (BBRA) (Pub. L. 106-113), enacted on November 29, 1999. Section 212 of the BBRA amended section 1848(c)(2)(ii) of the Act by directing us to establish a process under which we accept and use, to the maximum extent practicable and consistent with sound data practices, data collected or developed by entities and organizations. These data would supplement the data we normally collect in determining the practice expense component of the physician fee schedule for payments in CY 2001 and CY 2002. (In the 1999 final rule (64 FR 59380), we extended, for an additional 2 years, the period during which we would accept supplementary data.)

2. Current Methodology for Computing the Practice Expense Relative Value Unit System

Effective with services furnished on or after January 1, 1999, we established a new methodology for computing resource-based practice expense RVUs that used the two significant sources of actual practice expense data we have available—the Clinical Practice Expert Panel (CPEP) data and the American Medical Association's (AMA) Socioeconomic Monitoring System (SMS) data. The methodology was based on an assumption that current aggregate specialty practice costs are a reasonable way to establish initial estimates of relative resource costs for physicians' services across specialties. The methodology allocated these aggregate specialty practice costs to specific procedures and, thus, is commonly called a “top-down” approach.

a. Major Steps

A brief discussion of the major steps involved in the determination of the practice expense RVUs follows. (Please see the November 1, 2001 final rule (66 FR 55249) for a more detailed explanation of the top-down methodology.)

Step 1—Determine the specialty specific practice expense per hour of physician direct patient care. We used the AMA's SMS survey of actual aggregate cost data by specialty to determine the practice expenses per hour for each specialty. We calculated the practice expenses per hour for the specialty by dividing the aggregate practice expenses for the specialty by the total number of hours spent in patient care activities. For the CY 2000 physician fee schedule, we also used data from a survey submitted by the Society of Thoracic Surgeons (STS) in calculating thoracic and cardiac surgeons' practice expenses per hour. (Please see the November 1999 final rule (64 FR 59391) for additional information concerning acceptance of these data.) For 2001, we used these STS data, as well as survey data submitted by the American Society of Vascular Surgery and the Society of Vascular Surgery. (Please see the November 2000 final rule (65 FR 65385) for additional information on the acceptance of these data.)

Step 2—Create a specialty specific practice expense pool of practice expense costs for treating Medicare patients. To calculate the total number of hours spent treating Medicare patients for each specialty, we used the physician time assigned to each procedure code and the Medicare utilization data. We then calculated the specialty specific practice expense pools by multiplying the specialty practice expenses per hour by the total physician hours.

Step 3—Allocate the specialty specific practice expense pool to the specific services performed by each specialty. For each specialty, we divided the practice expense pool into two groups based on whether direct or indirect costs were involved and used a different allocation basis for each group.

(i) Direct costs—For direct costs (which include clinical labor, medical supplies, and medical equipment), we used the procedure specific CPEP data on the staff time, supplies, and equipment as the allocation basis.

(ii) Indirect costs—To allocate the cost pools for indirect costs, including administrative labor, office expenses, and all other expenses, we used the total direct costs combined with the physician fee schedule work RVUs. We converted the work RVUs to dollars using the Medicare CF (expressed in 1995 dollars for consistency with the SMS survey years).

Step 4—For procedures performed by more than one specialty, the final procedure code allocation was a weighted average of allocations for the specialties that perform the procedure, with the weights being the frequency with which each specialty performs the procedure on Medicare patients.

b. Other Methodological Issues

(i) Non-Physician Work Pool—For services with physician work RVUs equal to zero (including those services with a technical and professional component), we created a separate practice expense pool using the average clinical staff time from the CPEP data and the “all physicians” practice expense per hour.

We then used the adjusted 1998 practice expense RVUs to allocate this pool to each service. Also, for all radiology services that are assigned physician work RVUs, we used the adjusted 1998 practice expense RVUs for radiology services as an interim measure to allocate the direct practice expense cost pool for radiology.

(ii) Crosswalks for Specialties Without Practice Expense Survey Data—Since many specialties identified in our claims data did not correspond exactly to the specialties included in the SMS survey data, it was necessary to crosswalk these specialties to the most appropriate SMS specialty.

Because we believe that most physical therapy services furnished in physicians' offices are performed by physical therapists, we cross-walked all utilization for therapy services in the CPT 97000 series to the physical and occupational therapy practice expense pool.

Comment: We received several comments objecting to our policy of cross-walking all utilization for therapy services in the CPT 97000 series to the physical and occupational therapy practice expense pool. One commenter stated that we are currently employing an arbitrary utilization crosswalk methodology to determine the resource-based practice expense RVUs for physical and occupational therapy. Commenters also indicated that this departure from the standard methodology has not been previously published for review and comment. In addition, one commenter challenged our assumption that most therapy services billed by physicians are furnished by therapists and stated that it is neither supported by explanatory text nor accompanying data. The commenter indicates that if we did not employ this assumption to change the resource-based practice expense methodology only for therapy services, payments for these services would be as much as 18 percent higher. Other commenters stated that use of the “altered methodology” has resulted in inappropriate reductions in payments for physical and occupational therapy services. One commenter expressed concern that the adjustment affects SNFs, home health agencies, outpatient hospital departments and CORFs in addition to therapists in private practice. Other commenters also objected to use of a crosswalk for physical and occupational therapy services stating that the policy is inconsistent with the “top-down” methodology that bases the final RVUs for a service on a weighted average of the practice expenses of the specialties that bill Medicare. Another commenter indicated that there is no evidence to suggest that practice expenses for therapy services provided by physicians are any different from the practice expenses of all other services they provide. This commenter indicated that physician specialties were also disadvantaged because all therapy services that a specialty billed were not included in calculating the practice expense pool for that specialty, thus decreasing the dollars that could be allocated to the services performed by that specialty. The commenters strongly recommended that we discontinue use of the crosswalk and employ the standard top down methodology for computing the 2003 PERVUs for the 97000 CPT code series.

Response: We carefully reviewed comments on this issue. As indicated in our proposed rule, we do not believe that physicians provide most therapy services that are billed by physicians. We believe that the practice expenses for therapy services provided in physicians' offices by therapists are more likely to be comparable to those of therapists than physicians. For this reason, we crosswalked utilization for the therapy codes (CPT codes 97010 through 97750) to the physical and occupational therapy practice cost pools. We used the physician utilization data for the therapy evaluation codes (CPT codes 97001 through 97004) since we believe these services would be much more likely to be performed by the billing physician. In the meantime, we welcome further public comments on this issue. We note that physical therapy was the only specialty for which we used their supplemental survey data (as noted below). Use of such survey data increases payments for physical therapy by 2 percent.

3. Practice Expense Provisions for Calendar Year 2003

a. Supplemental Practice Expense Surveys Criteria for Acceptance of Supplemental Practice Expense Surveys From the June 28, 2002 Interim Final Rule with Comment Period

On June 28, 2002 we published an interim final rule with comment period (67 FR 43555) in the Federal Register, which made revisions to the criteria that we apply to supplemental survey information supplied by physician, non-physician, and supplier groups for use in determining practice expense RVUs under the physician fee schedule. While this rule was effective upon publication, we provided a comment period on the revision to the criteria and are responding to the comments received in this final rule.

The following criteria had been in effect:

• Physician groups must draw their sample from the AMA Physician Masterfile to ensure a nationally representative sample that includes both members and non-members of a physician specialty group. Physician groups must arrange for the AMA to send the sample directly to their survey contractor to ensure confidentiality of the sample; that is, to ensure comparability in the methods and data collected, specialties must not know the names of the specific individuals in the sample.
• Non-physician specialties not included in the AMA's SMS must develop a method to draw a nationally representative sample of members and non-members. At a minimum, these groups must include former members in their survey sample. The sample must be drawn by the non-physician group's survey contractor, or another independent party, in a way that ensures the confidentiality of the sample; that is, to ensure comparability in the methods and data collected, specialties must not know the names of the specific individuals in the sample.
• A group (or its contractors) must conduct the survey based on the SMS survey instruments and protocols, including administration and follow-up efforts and definitions of practice expense and hours of direct patient care. In addition, any cover letters or other information furnished to survey sample participants must be comparable to the information previously supplied by the SMS contractor to its sample participants.
• Physician groups must use a contractor that has experience with the SMS or a survey firm with experience successfully conducting national multi-specialty surveys of physicians using nationally representative random samples.
• Physician groups or their contractors must submit raw survey data to us, including all complete and incomplete survey responses as well as any cover letters and instructions that accompanied the survey, by August 1, 2002 for data analysis and editing to ensure consistency. All personal identifiers in the raw data must be eliminated.
• The physician practice expense data from surveys that we use in our code-level practice expense calculations are the practice expenses per physician hour in the six practice expense categories—clinical labor, medical supplies, medical equipment, administrative labor, office overhead, and other. Supplemental survey data must include data for these categories.

In addition to the above survey criteria, we required a 90-percent confidence interval with a range of plus or minus 10 percent of the mean (that is, 1.645 times the standard error of the mean, divided by the mean should be equal to or less than 10 percent of the mean).

Based on a review of these criteria and concern that the this language had created confusion, in the June 2002 interim final rule we revised this language to indicate that we will accept surveys that achieve a sampling error of 0.15 or less at a confidence level of 90 percent. We noted that this change refines both the measurement of precision and the level of precision we will accept and could result in our acceptance of more surveys than the past criteria. In addition, we stated that we would allow specialties that have submitted surveys previously rejected under the present criteria to resubmit these surveys to be evaluated under the revised criterion.

We also amended § 414.22(b)(6) to reflect the 2-year extension in the deadline for submitting supplemental data. Specifically, we will accept supplemental data that meet the established criteria that we received by August 1, 2002 to determine CY 2003 practice expense RVUs and by August 1, 2003 to determine CY 2004 practice expense RVUs.

Comment: We received comments from several specialty organizations on the change in the precision criteria for supplemental surveys. Specialty organizations representing audiologists, physical therapists and radiologists expressed support for the revised precision criterion. The American Academy of Audiology indicated that the revised rule makes it easier for specialty groups to submit information for our consideration. The American College of Radiology (ACR) supported the proposed change by suggesting that the previous requirements were not reasonable. The ACR indicated that radiology and radiation oncology did not conduct surveys previously because of concerns about the strictness of the original criteria. The ACR also indicated concerns about averaging the supplemental survey data with existing SMS survey data and the requirement that the survey sample would have to be selected from the AMA Masterfile. According to the ACR, the AMA Masterfile does not adequately represent radiologists and radiation oncologists that own and operate their own centers and equipment. The American Physical Therapy Association (APTA) supported the new criterion and our decision to allow previously completed surveys to be resubmitted and considered using the new precision standard. The American Society Clinical Oncology (ASCO) objected to the use of any precision criteria and outlined a number of reasons why they opposed the use of this test. The ASCO indicated that there may be wide variation in oncology practice patterns (for example, hospital based versus non-hospital based, or differentials in provision of chemotherapy) that could lead to wide variation in practice expenses among surveyed practices. They suggested that “at least in the case of oncologists, a survey that is conducted in accordance with the CMS rules should not be excluded from consideration because of failure to meet the precision criteria.”

Response: If the data from physician and practitioner surveys is to be used as the basis for physician payment, it is necessary that we have assurance that the survey is both representative and reliable. Applying numerical criteria for the statistical concepts of confidence and precision give some basis for believing that the data accurately represent practice costs for the specialty nationwide. We set the criteria for precision and confidence after lengthy consultation with our contractor, the Lewin Group, and agency experts on statistical surveys. We believe the levels set are both fair and reasonable. In addition, as indicated in the proposed rule, we are attempting to be as flexible as possible consistent with our goal of obtaining new surveys of practice expense that are scientifically sound and methodologically consistent with our existing estimates. We indicated that a specialty may include different types of physician practices that exhibit different patterns of practice expenses. We welcome stratified sampling of these different types of practices and, would, as appropriate, apply the precision criteria to subgroups of surveyed practices.

We considered the comment that suggests the AMA Masterfile may not adequately represent radiologists and radiation oncologists that own and operate their own equipment. However, since the AMA Masterfile is the most comprehensive listing of physicians that practice in the United States, we still believe it should be the best source of information for selecting a representative sample of physicians. We do acknowledge that there may be special issues related to diagnostic and radiation oncology services. For instance, radiologists and radiation oncologists that predominantly practice in hospitals may have fundamentally different practice expenses than those providing services in free-standing clinics and private offices where they likely incur far higher costs for staff, supplies, equipment and indirect costs. In addition, office-based radiologists and radiation oncologists may have substantial but irregular expenses associated with medical equipment. That is, they may purchase equipment one year and amortize the costs over several years. It is possible that modification to the survey instrument may be necessary to accurately identify annual equipment costs for some specialties. Further, independent diagnostic testing facilities also bill Medicare for diagnostic services affected by the non-physician work pool calculations. A sample of physicians selected from the AMA Masterfile is unlikely to include independent diagnostic testing facilities. We believe that all of these issues can be addressed in a supplemental survey with stratified sampling, relevant modifications to the survey instrument and augmentation of the AMA Masterfile with a listing of independent diagnostic testing facilities. As we indicated in our supplemental survey interim final rule, we are attempting to be flexible to achieve our goal of incorporating the best possible practice expense survey information into our methodology. We believe all of these issues should be considered carefully. We advise any party interested in conducting a supplemental survey to consult the Lewin Group and us before proceeding with a survey.

Comment: We also received comments from two organizations representing emergency medicine. The Emergency Department Practice Management Association (EDPMA) is concerned that the requirement that supplemental surveys be based on the SMS survey instrument will preclude us from obtaining data on uncompensated care and emergency physician practice expenses. The EDPMA suggests that we extend the criteria to include data regarding indirect emergency medicine practice expense or uncompensated care cost. The American College of Emergency Physicians (ACEP) stated that we have failed to recognize the legitimate practice costs associated with uncompensated care pursuant to requirements imposed by the Emergency Medical Treatment and Active Labor Act (EMTALA) and that these costs should be recognized by us. Despite our acknowledgement of these costs, the commenter argues that we have not made any movement in making payment for EMTALA's uncompensated care costs.

Response: As we indicated in the November 2, 1998 final rule (63 FR 58821), we made an adjustment in the practice expense per hour for emergency medicine because of our concern that emergency medicine physicians could spend a significantly higher proportion of time than other physicians providing uncompensated care to patients. We are currently using a practice expense per hour of $33.00 for emergency medicine. If we had not made the adjustment for uncompensated care, the practice expense per hour for emergency medicine would be $14.90. Our adjustment assumes that 55 percent ($14.9/(1−0.55)=$33.00) of emergency physicians' time spent treating patients is uncompensated. This has the effect of raising the practice expense per hour to reflect only the physician's time spent in revenue-generating activities. If emergency physicians believe that they spend more than 55 percent of their time treating patients for which they are not compensated, we would welcome specific data on this subject from a supplemental survey.

Comment: The American College of Cardiology (ACC) and the AMA, who wrote in support of the ACC, indicated they are aware that we would like data on practice expenses that shows the six categories of practice expenses used in the practice expense methodology. However, the ACC indicated that the AMA no longer collects data in this disaggregated fashion and suggested that this data limitation can be overcome by simply apportioning practice expense reported in the most recent survey to the separate pools based on historical distribution patterns.

Response: We will continue to require disaggregated data from supplemental surveys because apportionment based on historical distribution patterns might not reflect actual or current cost patterns. Further, to accept this data would be inconsistent with our clearly stated rule. In both the original interim final rule published on May 3, 2000 (65 FR 25666) and in the interim final rule published on June 28, 2002 (67 FR 43556), we indicated that “* * * code-level practice expense calculations are the practice expense per physician hour in the six practice expense categories-clinical labor, medical supplies, medical equipment, administrative labor, office overhead and other. Supplemental survey data must include data for these categories.”

Result of Evaluation of Comments

We are retaining the change to the precision and confidence levels for supplemental surveys to reflect a confidence level of 90 percent and a precision level of 0.15, as stated in our interim final rule.

(ii) Submission of Supplemental Surveys—We received surveys from the American Physical Therapy Association (APTA), the American Society of Clinical Oncology (ASCO), the American College of Cardiology (ACC), and the American Academy of Pediatrics (AAP). The National Association of Portable X-Ray Providers (NAPXP) also provided us with cost data for their industry. Our contractor, the Lewin Group, has evaluated the data submitted by each organization and recommends that we use the survey information from APTA. We reviewed and agree with their analysis; therefore, we are using the APTA survey to determine practice expense RVUs for CY 2003 and subsequent years. The data supplied to the Lewin Group reflects a 1999 cost year. As indicated in our June 2002 interim final rule (67 FR 43556), we are deflating the figures by the MEI to reflect a 1995 cost year. The revised practice expense per hour figures that we are using for physical therapy (specialty code 65) and occupational therapy (specialty code 67) are as follows:

Table 1

Clinical staff	Admin. staff	Office expense	Supplies	Equipment	Other	Total
10.4	6.5	13.4	2.4	2.2	7.7	42.5

The Lewin Group raised significant concerns about the data received from ASCO. Specifically, the Lewin Group is concerned about extraordinarily high expenses associated with clinical and clerical staff and a more than 300 percent increase in “other” practice expenses compared to the SMS value for oncology. As a result, the Lewin Group carefully examined the underlying data. They report that compensation (including salaries and fringe benefits) would average out to $71,014 for clinical staff and $87,253 for clerical staff. They believe it is unlikely that the average annual salary for clerical staff would be higher than for clinical staff. Further, the Lewin Group indicates that the average clerical compensation from the ASCO survey is approximately 400 percent higher than the figure reported by the Bureau of Labor Statistics for “Office Clerks, General.” While the Lewin Group indicates that the high payroll expense for clinical staff may be explained, in part, by recent changes in labor markets, we remain concerned that the compensation reported in the survey is far higher than independent information on oncology nursing salaries provided to us by the Oncology Nursing Society. The Lewin Group also indicated that “other professional expenses” increased more than 349 percent from the SMS to the supplemental survey and the contribution of this category to total practice expenses increased from 9.4 percent to 22.3 percent. They believe that such a large increase in practice expense per hour needs further examination. The Lewin Group believes that we should confer with ASCO and request a rationale for the high values found in the survey results or validate the data in some other fashion. Therefore, at this time, we are not using the supplemental survey received from ASCO. However, we would like to further examine the data with the Lewin Group and discuss the survey results with ASCO and will consider using the data in the future if our concerns are addressed.

In the June 2002 proposed rule (67 FR 43850), we discussed an adjustment made to the medical supplies practice expense per hour for oncology. We made this adjustment because of a concern that the inordinately high practice expense per hour includes expenses associated with separately billable drugs. We expressed an interest in reconsidering the adjustment consistent with a recommendation made by the GAO in their October 2001 report. If we resolve concerns about the oncology survey data, the adjustment for medical supplies will no longer be necessary since the supplemental survey collects information on medical supplies practice expenses net of separately billable drugs.

The Lewin Group indicated that the surveys from the ACC and the AAP do not meet requirements established in regulations for supplemental surveys. As a result, we will not be incorporating data from the ACC or the AAP into the practice expense methodology. We will be making the Lewin Group's full recommendations available on our website. The National Association of Portable X-ray Providers (NAPXP) did not provide us with data as part of the supplemental survey process. However, they requested that we use their data to develop practice expense RVUs for the physician fee schedule services they provide. Since we were provided with survey information, we asked the Lewin Group to evaluate the data using the same standards of review applied to other specialty survey data. The Lewin Group evaluated whether the cost information supplied by NAPXP meets our criteria for acceptance of supplemental surveys. The Lewin Group found that (1) More information is required to determine if the data are broadly representative of the portable x-ray industry and (2) the data as presented are not adequately detailed to support a practice expense per hour based on the current practice expense methodology.

Comment: Health Trac, a supplier of portable x-rays and other imaging services, commented that the practice costs associated with set-up of portable x-ray equipment are not included in the SMS and there are sufficient differences among geographic regions in the performance of this procedure that warrant reclassifying this service as carrier-priced.

Response: At this time, we are not making portable x-ray set-up (Q0092) a carrier-priced service. However, we will continue to work with the suppliers of portable x-ray services to find the best ways of developing payment rates for these services.

b. CPEP Data

(i) 2001 PEAC/RUC Recommendations on CPEP inputs

In the November 2001 final rule (66 FR 55256), we responded to the PEAC/RUC recommendations for the refinement to all or part of the CPEP inputs for over 1,100 codes. These included refinements of large numbers of orthopedic, dermatology, pathology, physical medicine, and ophthalmology services. In addition, these recommendations confirmed that there were no inputs for over 150 ZZZ-global procedures that are performed only in a facility and no supply or equipment inputs for almost 700 facility-only services with an XXX or 0-day global period.

We accepted almost all of the recommendations with only minor revisions. We received the following comments on our responses and modifications to the RUC recommendations on the CPEP inputs.

Comment: Specialty societies representing radiology and orthopedic surgery both expressed appreciation about our willingness to work with the RUC and PEAC on practice expense refinement, as well as for our implementation of the refinements already submitted by the PEAC. Both societies agreed with our establishment of revised practice expense values as “interim” until the refinement process is complete.

Response: We are also pleased with the progress of the refinement of the CPEP inputs and thank the PEAC, RUC and all the involved specialty societies for the hard work and dedicated commitment that has led to a successful refinement process.

Comment: A specialty society representing surgeons expressed support for our decisions on CPEP revisions in general and commended our staff for our efforts to develop appropriate and acceptable inputs for a large number of codes. The commenter also agreed with the use of the refined evaluation and management (E/M) inputs to refine post-surgical visits, but recommended that the process should allow for exceptions.

Response: We understand that the PEAC has developed a standard approach to estimating the clinical staff time involved in post-surgical visits in which the times associated with the assigned E/M visits are applied to the post-surgical clinical staff times. It is also our understanding that, as with all the standards and packages that the PEAC has developed, a specialty would be free to argue that something other than the standard should be applied to a given service.

Comment: One commenter representing family physicians noted that we had accepted most of the practice expense recommendations submitted by the PEAC/RUC and commended us for our willingness to accept these recommendations. The commenter also suggested that the PEAC recommendations for the fine needle aspiration CPT codes 88170 and 88171, which were deleted CPT codes for 2002, should be applied to CPT codes 10021 and 10022 that replace these deleted codes.

Response: We agree with this suggestion. When CPT codes 10021 and 10022 were originally valued by the RUC, the practice expense inputs were crosswalked from the then unrefined inputs for CPT codes 88170 and 88171. Now that these inputs have been refined, it is appropriate for us to crosswalk the inputs for CPT codes 10021 and 10022 from this updated CPEP data.

Comment: A commenter representing dermatologists was pleased with our acceptance of PEAC revisions for the phototherapy codes. However, the commenter expressed concern about the decrease in the practice expense RVUs for the code for the application of an Unna boot, CPT code 29580, and for the cryotherapy code, CPT code 17340 and requested that we explain the decrease. A specialty society representing podiatrists agreed with decision to retain the Unna boot in the list of supplies for CPT code 29580.

Response: Both CPT codes 29580 and 17340 were refined by the PEAC in October 2001 and were included in the PEAC/RUC recommendations for 2002. We accepted these recommendations without change, except that we retained an Unna boot in the supply list for CPT code 29580. The recommendations contained lower direct cost inputs than the original CPEP panel data, which explains the decrease in payment for these services.

Comment: A specialty society representing urologists requested an explanation of why the bougie a boule was deleted from the equipment list for the cystourethroscopy code, CPT code 52281 and requested that it be added as a supply.

Response: Since the inception of resource-based practice expense, the supply list has been used for disposable items and we have only included as equipment those items that are more than $500. The bougie a boule is not a disposable item, and at a cost of $105 it does not meet the definition of equipment. These definitions have applied across the spectrum of physician fee schedule services and, therefore, we do not believe that any specialty has been disadvantaged. If we did include a $100 item in our equipment list with a five-year expected life, it would add only $0.0004 per minute of use to the input costs of any associated procedure and, thus, would have no effect on the practice expense RVUs for that service.

Comment: Two organizations representing physical and occupational therapists argued strongly that the revisions we made to the PEAC recommendations on the practice expense inputs for the physical medicine and rehabilitation (PM&R) codes were inappropriate. The physical therapy comment commended the specialty societies participating in the PEAC, as well as AMA and our staff, for their time and assistance as the clinical inputs for the therapy codes were developed. However, the commenter also expressed concern that we did not accept the PEAC's recommendations in their entirety despite the fact that we state in the rule that the PEAC refinement process is working. The comment from the occupational therapists shared this concern and both commenters urged us to revisit our decision and accept the PEAC recommendations for the CPT codes in the 97000 series without revisions.

Specifically, both commenters objected to the deletion of the PEAC approved clinical staff time for obtaining vital signs and measurements, patient education and phone calls. One commenter contended that our decision is contrary to the standardized times that we have allowed for physicians' clinical staff and to the survey data presented which demonstrated that clinical staff do perform these services in therapy practices. The other commenter argued that, because we have allowed such clinical staff time for other specialties, our revisions disrupt the resource-based relative value scale on which the physician fee schedule is based. Further, the occupational therapy comment states that the addition of 7 minutes only in the evaluation and reevaluation codes for aide services is insufficient to counteract the deletion of the physical therapy assistant time, and that this has created anomalies in the practice expense RVUs within the PM&R family of services.

Response: We deleted the times assigned to the physical therapy assistant for taking vital signs, and for phone calls and patient education because we were concerned that there could be an overlap between the work of the physical therapist, which is reflected in the work RVUs, and the work of the assistant, which is considered as practice expense. However, the commenters are correct that we have allowed such tasks to be considered as practice expense for other services, even though there could also be some potential overlap between practitioner and clinical staff work. We still believe that this can be more problematic with therapy services because of the broad range of clinical activities that the physical therapy assistant can share with the therapist, but also believe that this issue might be better addressed as a general issue across all specialties. Therefore, we are revising the clinical staff times for all codes in the CPT 97000 series to reflect the 2001 PEAC recommendations for these services.

Comment: The specialty society representing physical therapy commented that the relatively high practice expense of 0.45 RVUs for CPT code 97530, therapeutic activities, cause a rank order anomaly with other codes in the CPT 97000 series. For example, therapeutic exercise (CPT code 97110) only has a PE value of 0.25. The commenter speculated that this might be due to inclusion of the environmental module in the equipment list for this code.

Response: On analyzing the differences in CPEP inputs between these two codes, it became apparent that the major contributor to the possible anomalous practice expense values lies not with the equipment for CPT code 97530, but with the supplies. For the timed codes that are billed in 15-minute increments, the PEAC recommendations generally assumed that two 15-minute sessions would be performed during one visit. Therefore, for all of these codes, including CPT code 97110, the PEAC recommendations divided the supplies by half because they would not have to be replaced for the second 15-minute session. However, inadvertently, the recommendation for the therapeutic activities code, CPT code 97530, did not make this adjustment, and the full cost of the relatively expensive woodworking kit was assigned to the code. In addition, it seems unlikely that a supply like a $13 woodworking kit would necessarily be discarded after one visit. Therefore, we are apportioning the cost of this kit over four sessions, and are assigning one-fourth of a kit to CPT code 97530.

Comment: The comment from the physical therapy specialty society raised the concern that there may be an inadvertent error in the printing of the values of physical therapy and occupational therapy evaluation and reevaluation CPT codes in the final rule. First, the values for the occupational therapy codes are significantly higher than values for the physical therapy codes, which did not change from the 2001 values, despite the refinement of these codes. Second, the practice expense RVUs for the occupational therapy evaluation and re-evaluation codes are the same, which appears inappropriate.

Response: The practice expense RVUs for the occupational therapy evaluation and re-evaluation codes are higher than those for physical therapy because the PEAC recommendations, which were based on the specialty societies' presentation and which we later accepted, assigned higher cost supplies and equipment to the occupational therapy codes than to the physical therapy evaluation and re-evaluation services. In addition, although the occupational therapy evaluation code had higher cost equipment than the re-evaluation code, the opposite was true for supplies. We would certainly consider information that might point to specific problems in any inputs assigned to these codes, but, at this point, have no basis for making any changes in the direct cost inputs.

Comment: A medical electronics manufacturer commented that the practice expense RVUs assigned to short wave diathermy treatment (CPT code 97024) may not take into account all of the resources required to provide the service, because the cost of the equipment alone is not covered by the practice expense reimbursement. The commenter suggested that the cost of the diathermy machine has increased greatly since 1995, when the equipment was last priced, and stated that the current price is between $18,000 and $30,000. The commenter urged us to reevaluate and increase the 2002 fee schedule reimbursement to ensure that diathermy continues to be available for beneficiaries.

Response: We accepted the PEAC recommendations for the direct cost inputs for CPT code 97024, except for the deletion of one minute of physical therapy assistant time. The PEAC recommendation was based on a presentation that was made by the physical therapy specialty society. The current CPEP inputs consist of 2 minutes for a physical therapy aide and 3 minutes of physical therapy assistant time and 15 minutes of a low mat table and diathermy machine. There were no supplies assigned because the supplies are included in the procedures that are typically delivered with this modality. We have seen no evidence that would indicate that any of these inputs are incorrect. Therefore, we will make no revisions to the inputs at this time. However, we have two diathermy machines in our CPEP input database. We currently have assigned the machine priced at $2850 to the diathermy code, but will substitute the higher priced machine, which we have priced at $3120, until we have more definitive information regarding the typical cost of the equipment. We have a contractor who is currently updating the prices of all the supplies and equipment listed in the CPEP database, and will soon be proposing updated prices for all the CPEP inputs, including the diathermy equipment.

(ii) PEAC/RUC Recommendations on CPEP Inputs for 2003

We have received recommendations from the PEAC on the refinement to the CPEP direct practice expense inputs for over 1200 codes. (A list of these codes can be found in Addendum F.) These include refinements to codes from almost every major specialty. In addition, the PEAC has continued to standardize inputs to streamline the refinement process. Previously, the PEAC created standardized inputs for 90-day global services as well as supply packages for evaluation and management, neurosurgery, gynecology services, ophthalmology and postoperative services. The PEAC has also established standard times for certain clinical staff tasks, such as greeting and gowning the patient, the taking of vital signs and post-service phone calls. These current recommendations include standardized times for office-based clinical staff for services provided during a patient's hospitalization and for discharge day management services, as well as pre-service clinical staff time data for 323 neurosurgery procedures. At an early PEAC meeting a list was drawn up of the codes most in need of refining. Of the 122 codes on this list, only seven have not yet been refined, which is one important measure of the success of the PEAC's efforts.

As stated above, we are very pleased with the progress that the PEAC has made so far and appreciate greatly the contributions that have been made to our refinement effort by the PEAC members, as well as by the staff from the AMA and the specialty societies. We have reviewed the submitted PEAC recommendations and are also pleased that, because of the expertise gained by the PEAC in evaluating the practice expense inputs, we are able to accept all of the recommendations without any revision. The complete PEAC recommendations and the revised CPEP database can be found on our Web site. (See the SUPPLEMENTARY INFORMATION section of this rule for directions on accessing our Web site.)

(iii) Other Comments on the Refinement of the CPEP Inputs

Comment: We received comments from specialty societies representing vascular surgery, radiation oncology, rheumatology, physical therapy and internal medicine agreeing with the update we made to the clinical staff categories and to the revised salary data. Several of these commenters also thanked us for our analysis and use of the additional data that was supplied by the specialty societies.

Response: We appreciate the positive response to our repricing of clinical staff salaries.

Comment: The specialty society representing radiology expressed appreciation for the establishment of new clinical wage rates for CT technologist, MRI technologist, medical physicist, and dosimetrist. However, the comment expressed disagreement with our decision to merge the x-ray technician and radiation technologist staff types under the title of “radiologic technologist,” because the education and scope of practice for these staff types are different and merging them will reduce the radiation technologists wage rate. The specialty society also opposed the decision to blend the staff types of RN and sonographers because they are trained to provide different services and are not interchangeable.

Response: The original CPEP data listed both “x-ray technician” and “radiation technologist” and seemingly made no distinction between these two staff types because the same wage rate was assigned to both. We used the Bureau of Labor Statistics' salary data to determine the wage rate for the “radiologic technologist.” Therefore, we do not believe that the salary assigned has been reduced in any way. If some of the radiology procedures typically use staff that are paid at a lower rate than the radiologic technologist, this information should be provided by the specialty society when the practice expense inputs for the services are refined. Regarding the second concern, we did not make a decision to blend the staff types, “RN” and “diagnostic medical sonographer.” This blend currently exists in the original CPEP data and has also been contained in several PEAC recommendations. Both staff types are priced separately and we were merely listing what the pricing would be when such a blend was applied to any service.

Comment: Three specialty societies, representing surgeons, thoracic surgeons and ophthalmologists, commented on the issue of our previous exclusion from the CPEP data of all claimed time associated with staff brought to the hospital by the physician. The commenters from the surgical and the thoracic surgery specialty societies claimed that a recent report by the Office of the Inspector General (OIG) confirms that over 70 percent of cardiac surgeons bring staff to the hospital, but that only 19 percent are being reimbursed by the hospital. The commenters further argued that this is an inequitable arrangement that requires corrective action by us. The commenter from the ophthalmology society claimed that ophthalmologists bring their staff to the facility setting 50 percent of the time and some cost for this should be built into their practice expense.

Response: In the November 2, 1999 final rule (64 FR 59399), we adopted a policy to exclude all clinical staff time in the facility setting from the input data used to develop practice expense RVUs. Among other arguments, we indicated that Medicare should not pay twice for the same service. That is, Medicare's payment to the hospital includes payment for clinical staff and we should not also compensate a physician for using their own staff in the hospital. In addition, we argued that we also pay for physician-extender staff used in the facility setting, such as physician assistants and nurse practitioners, through the physician work RVUs, and we pay physician assistants directly when performing as an assistant-at-surgery. In response to this argument, thoracic surgeons contended that hospitals are no longer providing the staff to furnish adequate care. While we did not change our policy, we asked the Office of Inspector General (OIG) to conduct an independent assessment of staffing arrangements between hospitals and thoracic surgeons (see November 1, 2000 final rule 65 FR 65395). In April, 2002 (OEI-09-01-00130, page ii), OIG concluded:

Medicare pays for non-physician staff even though surgeons do not receive additional payment for some of the staff they bring to the hospital. Instead, services of these staff are paid to either physicians through the work relative value units, to the mid-level practitioners directly, or to the hospital through Part A or the Ambulatory Payment Classification system for outpatient services. Recognizing this, some hospitals and cardiothoracic surgeons have entered into arrangements whereby hospitals provide some compensation to surgeons who bring their own staff.

We believe the OIG report clearly supports our position to exclude the costs of clinical staff brought to the hospital from the practice expense calculations. While it may be common for thoracic surgeons to bring staff to hospitals, the OIG report makes clear that Medicare pays for these costs either directly to physicians or the hospital. Since the OIG report supports our position, we are not making any revisions to our policy to exclude practice expense inputs associated with bringing clinical staff to hospitals.

Comment: One commenter representing an independent diagnostic testing facility commented that a review of the practice expense inputs for the 24-hour cardiac monitoring HCPCS codes G0005, G0006 and G0007 and the corresponding CPT codes 93270, 93271, and 93272 revealed the CPEP input lists contain items that are not needed to perform these services. The commenter suggested the following deletions: G0005 and CPT code 93270 (for the hookup of the equipment)—delete the ECG electrodes, laser paper, king of hearts-20, computer, life receiving center; G0006 and CPT code 93721 (for the monitoring and transmission of data)-delete the razor, gloves, alcohol swab, and tape and exam table; G0007 (interpretation and report)-delete all the supplies (G0007 currently has no equipment and CPT code 93272 currently has no equipment or supplies assigned.

Response: We agree that the changes to the practice expense inputs suggested above divide the inputs more appropriately between the two TC codes and the PC code for this cardiac monitoring service. However, as discussed in section IV, we are deleting the referenced G-codes for CY 2003 and these services will be reported using the CPT codes. On an interim basis, until these codes are refined, we will make the recommended revisions to the CPEP data for the CPT codes for these services. It should be noted, however, that the TC codes are currently in the non-physician work pool and that the CPEP data is not currently used to calculate their practice expense RVUs. In addition, we do not assign direct cost inputs to PC codes. Therefore, these changes will not at this time have any effect on the payment for these codes.

Comment: A specialty society representing radiology commented that the review cycle for pricing “high tech” equipment and supplies may need to be reviewed more frequently than every 5 years and suggested a 3-year cycle.

Response: We plan to propose current pricing for all the supplies and equipment in our CPEP database in next year's proposed rule. We have made no final decision on how often this pricing update should be done and will consult with the medical community on how best to ensure that we have appropriate pricing for all of our direct cost inputs.

(iv) Proposed Changes from June 28, 2002 Proposed Rule

(A) Ophthalmology Services—Rank Order Anomalies

Based on a request from the American Academy of Ophthalmology we proposed revisions to the CPEP data for five ophthalmology services: For CPT code 67820, Revise eyelashes, we proposed to remove ophthane from the supply list. For CPT code 67825, Revise eyelashes, we proposed to remove the bipolar handpiece from the supply list. For CPT code 65220, Removal foreign body from eye, we proposed using the supply list and clinical staff time assigned to CPT code 65222. The exam lane is the only equipment assigned. For CPT codes 92081 and 92083, Visual field examination(s), we proposed to assign the same supplies and equipment as CPT code 92082 and to assign 35 minutes of clinical staff time to 92081 and 70 minutes to 92083.

Comment and Response: Commenters were supportive of the proposed revision to the CPEP inputs for the ophthalmology codes and we are finalizing the revisions as proposed.

(B) Practice Expense Inputs for Thermotherapy Procedures

There are three CPT codes for transurethral destruction of prostate tissue: CPT 53850, by microwave therapy, CPT 53852, by radiofrequency thermotherapy, and CPT 53853, by water-induced thermotherapy (WIT). Based on concerns expressed by a manufacturer of WIT equipment that practice expense inputs were underestimated for CPT code 53853 relative to the other two codes, we made a comparison and agreed that the WIT procedure had not been assigned many of the basic supply and equipment inputs that were included in the CPEP inputs for the other two procedures. Therefore, we proposed to add, on an interim basis, the following inputs: Power table, ultrasound unit, mayo stand, endoscopy stretcher, light source, chux, sani-wipe, patient education book, sterile towel, sterile gloves, specimen cup, alcohol swab, gauze, tape, lidocaine, betadine, 10 cc syringe, 30 cc syringe, sterile water, leg bag.

We also proposed to change on an interim basis the staff type for CPT code 53853 from the RN/LPN/MTA blend to RN in order to make the staff type consistent among these three similar procedures. In addition, we corrected, for all three procedures, the minutes assigned to each piece of equipment to reflect the intra- and post-clinical staff times only, rather than the total clinical staff times.

We have also requested that these three procedures be reexamined by the PEAC at the same time in order to ensure that there is a consistent approach to the assignment of direct cost inputs.

Based on questions we received regarding the large disparity in prices used for the three different thermotherapy machines and indications that the prices have decreased dramatically since these were initially priced in 1999, we proposed to set the price for thermotherapy equipment at $60,000 for CPT code 53850 and $30,000 for CPT code 53852. We also requested any additional available price documentation that would assist us in ensuring assigned prices accurately reflect actual costs.

Comment: Commenters were generally supportive of the proposed revisions and in agreement that the PEAC should review the CPEP inputs for these procedures. A specialty society representing urology agreed that the best way to handle the CPEP inputs for these services is to have the PEAC review the direct cost inputs for all the heat therapy procedures concurrently and the comment from the RUC stated that it plans to review these codes in time for inclusion in the physician fee schedule for 2004. However, a few commenters also suggested that the review be extended to other codes for treatment for benign prostatic hypertrophy, such as the code for transurethral resection of the prostate, CPT code 52612, and for laser coagulation of the prostate, CPT code 52647.

Response: We agree that it would be advantageous to have the PEAC review the CPEP inputs for all codes pertaining to the treatment of benign prostatic hypertrophy at the same time. This would help ensure that the same standards are applied to developing the direct cost inputs for these codes so that the resulting practice expense RVUs appropriately reflect the relative costs of each service. We will request that the PEAC include for review all the codes suggested by the commenters.

Comment: One commenter, representing a manufacturer, also indicated that, as part of any review, it is imperative that cost data for all medical devices that fall within the CPT code should be evaluated. The commenter suggested that we work with the specialty groups to obtain pricing information rather than using invoices for pricing. The comment from the specialty society argued that we should maintain all the proposed input changes unless we receive compelling data from urologists or manufacturers that varies from the proposed inputs. Another commenter stated that, while there has been a reduction in the price of the thermotherapy control unit over the past few years, the proposed price of $60,000 for thermotherapy equipment for CPT code 53850 was not representative. The commenter included an invoice that indicated that the current price is closer to $80,000, after the application of discounts.

Response: We will finalize the revisions to the CPEP inputs as proposed with the exception of the price for the thermotherapy equipment that we will increase to $80,000 on an interim basis. As part of the practice expense refinement process we have awarded a contract to update the pricing for both the supplies and equipment represented in the CPEP inputs and we anticipate that the proposed pricing revisions to the inputs will be included in next year's proposed rule. Pricing of the thermotherapy equipment will be included in these proposed changes and we will be seeking input from the specialty society to help us in this endeavor.

(C) Revision to Inputs for Iontophoresis

It had been brought to our attention that the electrodes assigned to the supply list for CPT code 97033, Iontophoresis, were not the type required for this procedure. We proposed to substitute two electrodes with a medication vesicle as the appropriate supply for iontophoresis.

(D) Correction to Price for Sterile Water

We proposed to change the price for 1000 ml of sterile water from $40.00 to $3.00.

Comments and Responses: No comments were received on our proposals to substitute two electrodes with a medication vesicle as the appropriate supply for iontophoresis or to correct the price of sterile water. Therefore, we are finalizing these as proposed.

b. Non-Physician Work Pool For Practice Expense

Comment: We received a comment objecting to use of the phrase “zero work pool.” The comment acknowledges that our preamble refers to “zero physician work pool” but stated that the vernacular used by the agency, Congressional staff and other stakeholders is “zero work pool.” While acknowledging that we do not intend to connote a zero value for oncology nurses' contributions, oncology nurses, social workers, radiology technicians and others take offense to the use of “zero work pool” because it suggests that the work done by oncology nurses and other clinical staff is without value. The comment suggested four appropriate alternative titles: Non-physician clinical staff time, Non-physician work components, Non-physician work pool or Non-physician health professional pool.

Response: We did not intend to devalue the contribution of clinical staff involved in providing physician fee schedule services. In fact, we created the special methodology to value services that are provided by clinical staff without a physician because of our concern that these services could be valued inappropriately low under the top down methodology. Nevertheless, it is clear that there are objections to the nomenclature we have used. We appreciate the suggestions for alternative nomenclature and will refer to the special methodology as the “Non-physician work pool.”

(i) Discussion of Alternatives to the Non-Physician Work Pool

In our June 2002 proposed rule (67 FR 43850) we summarized alternatives to the non-physician work pool that have been included in reports prepared by our contractor, the Lewin Group. Included in the alternatives were: elimination of the non-physician work pool; development of specialty specific non-physician work pools; making the TC equal to the global less the PC RVUs; and, development of proxy physician work RVUs for physician fee schedule services provided by clinical staff without physicians. While we included a discussion of each alternative and their feasibility, we did not propose eliminating or replacing the non-physician work pool. We indicated that specialties whose services are affected by the non-physician work pool may conduct supplemental practice expense surveys if they believe there are shortcomings in the practice expense per hour information that we use as part of the basic methodology. We referenced the interim final rule also published June 28, 2002 in the Federal Register. The interim final rule modified the criteria for acceptance of supplemental data. (See section II.A.3.(a) of this rule for a summary of the interim final rule, the public comments, and our responses.) We also noted that while the non-physician work pool is of benefit to many of the services that were originally included, we have allowed specialties to request that their services be removed.

As part of our analysis of alternatives to the non-physician work pool, we proposed a change in the computation of practice expense RVUs for some PC and TC services. Since it is far more common to receive a global bill than a TC only bill, we believe that using the global to value the TC service will result in a payment that is more typical of the relative actual practice expense associated with the service. Therefore, we proposed to make the TC value equal the difference between the global and the PC for procedure codes that are not included in the non-physician work pool. That is, we used the practice expense value produced by the methodology for the global and subtracted the PC to derive the TC practice expense RVU. As a result of concerns that we had about the impact of this change on services that are affected by the non-physician work pool calculations, we proposed continuing to make the global value equal to the sum of the professional and the TC values for non-physician work pool services.

Comment: One commenter, representing oncologists, argued that the “normal top-down methodology discriminates against [non-physician work pool] services * * * by assuming, without any basis, that indirect costs are lower than comparable services that do involve physician work.” The commenter stated that both the GAO and Lewin reports provide support for the conclusion that the indirect cost allocation is biased against non-physician work services. According to the commenter, our assertion that “the indirect cost allocation must be correct because not all of the services without a physician work component are disadvantaged by its use is not a sound basis for maintaining the current methodology.” The commenter argues that estimates of practice expense per hour and physician time may be overstated for some non-physician work services resulting in an advantage outside of the non-physician work pool. Furthermore, the comment argues that an increase in payment resulting from services being “withdrawn from the [non-physician work pool] does not demonstrate that the normal top-down methodology results in an appropriate payment amount for services that do not have physician work components.” The commenter also objected to our rejection of the Lewin Group's idea to develop specialty-specific non-physician work pools on the basis that a single methodology must apply to all services. According to the commenter, our refusal would only be appropriate if the methodology was not biased against non-physician work pool services. Another comment suggested that we allocated indirect costs by deeming direct costs as 33.2 percent of total costs. Indirect costs would then be added to direct costs to determine a total practice expense RVU.

Response: We do not believe the practice expense methodology is biased against non-physician work services. The methodology allocates indirect costs based on physician work and direct costs. While the comment suggests the use of physician work in the indirect cost allocation is biased against services that do not have physician work, it ignores that direct costs are also used. Most services that do not have physician work have significant direct expenses. Thus, any bias against non-physician work services in the indirect cost allocation is offset by the use of direct costs. Similarly, the use of physician work in the indirect cost allocation will offset any bias against services predominantly performed in facilities where the physician will have few, if any, direct costs associated with the services. For example, surgical services furnished in a hospital have few direct expenses, thus the allocation of indirect expenses according to both work and direct expenses helps offset any bias against surgical services.

We also disagree with the comment that suggests “deeming” direct costs to be 33.2 percent of total costs for purposes of developing practice expense RVUs. The proportion of costs attributable to direct and indirect costs will be different for each service. Such a proposal would be inherently unfair to services that have few direct costs (and impossible to use for services that have no direct costs) and would create a significant bias in favor of services that have high direct expenses.

We further examined the assertion in the comment and in the Lewin Group and GAO reports that the indirect cost allocation is a possible explanation for the adverse payment impact that would occur under the top-down methodology for some non-physician work pool services. It is important to distinguish between the different types of services that are affected by the non-physician work pool calculations. Professional/TC services are the largest category of services included in the non-physician work pool. While many professional/TC services were not adversely affected by the adoption of the top-down methodology, the ones remaining in the pool are the services that would be most adversely affected by its elimination. Some “Incident to” services are also included in the non-physician work pool. Elimination of the non-physician work pool may cause payments for these services to go up or down depending on the specialty that provides them.

Based on 2000 utilization data, the specialties with the largest amount of Medicare allowed charges affected by the non-physician work pool calculations are: radiology ($2.8 billion), cardiology ($2.1 billion), internal medicine ($568 million), radiation oncology ($465 million), multi-specialty clinics ($313 million), independent diagnostic testing facilities ($309 million) and oncology ($226 million). Radiology receives 87 percent of its Medicare revenues from services that are affected by the non-physician work pool calculations. The figures are 47 percent for cardiology, 9 percent for internal medicine, 65 percent for radiation oncology, 17 percent for multi-specialty clinics, 86 percent for independent diagnostic testing facilities and 26 percent for oncology. There are other smaller specialties that also receive a significant proportion of their revenues from services in the non-physician work pool (portable x-ray suppliers, 100 percent, interventional radiology, 63 percent, allergy/immunology 35 percent). The specialties that receive the highest proportion of their revenues from professional/TC services remaining in the non-physician work pool would be most adversely affected by its elimination (independent diagnostic testing facilities, portable x-ray suppliers, radiology, radiation oncology and interventional radiology). Cardiology also receives substantial Medicare revenues from professional/TC services remaining in the non-physician work pool but would be less adversely affected by its elimination. Allergy/immunology receives substantial revenues from “incident to” services in the non-physician work pool and would experience a more modest decline in payment under the top-down methodology. Payments to oncology for “incident to” services would increase if the non-physician work pool were eliminated.

Radiology, radiation oncology and certain other diagnostic services with professional and technical components are likely to be the services most adversely affected by elimination of the non-physician work pool. We do not believe the allocation of either direct or indirect costs explains the effect of the top-down methodology on these services. We examined this issue further by modifying the indirect cost allocation using an idea suggested by the Lewin Group that would retain work and direct expenses to allocate indirect costs but create proxy physician work values for services that do not have physician work (the Lewin Group, pages 22-23). As indicated earlier, we proposed to modify the practice expense methodology to calculate the TC practice expense RVU as the difference between the global and the PC RVU for services unaffected by the non-physician work pool. To analyze the Lewin idea, we followed this same approach for all services. However, we further modified the methodology to use proxy work RVUs for the TC (or non-physician work portion) of the global service for the allocation of indirect costs. (We did this for TC services as well, but it makes no difference whether a proxy physician work RVU is used for the indirect cost allocation since the RVU produced by the practice expense methodology for the TC is not used). By developing a proxy work RVU for the global, in effect, we imputed physician work RVUs for the technical portion of the global service and added it to the existing work RVUs for the physician interpretation. If such an approach were adopted, the indirect cost allocation would favor the global service at the expense of professional component. That is, the practice expense RVUs would increase for the global and decrease for the PC but the overall impact for the specialty would be about the same. Modifying the indirect cost allocation in this way would not offset large decreases in payment for radiology, radiation oncology and other specialties most adversely affected by elimination of the non-physician work pool. In fact, such a methodological change would not even raise payments to these specialties.

As we indicated in the June 2002 proposed rule, we believe a relatively low practice expense per hour, and not the indirect cost allocation, explains the adverse impact on diagnostic services that would occur from eliminating the non-physician work pool. We encourage radiology, radiology oncology and other diagnostic service providers affected by the non-physician work pool to undertake a survey of the practice expenses. Since practice expense methodology uses a weighted average of the practice expenses of the specialties that bill Medicare, we believe there are significant advantages to the survey being undertaken with collaboration among the different providers of diagnostic services. As indicated earlier, we advise any party interested in conducting a supplemental survey to consult the Lewin Group and us before proceeding.

Comment: Most comments we received supported making the TC practice expense RVUs equal to the difference between the global and PC practice expense RVUs. We received a number of comments from pathologists and organizations representing independent laboratories, pathologists, dermatologists, and others expressing concern about the effect of the proposal on payment for pathology services. Some of the commenters indicated that we did not provide an explanation of the necessity for the change or indicate why a simple arithmetic change should result in such a large difference in the proposed fee for TC services. Several of these commenters stated that practice expenses for physician pathology services are increasing, not decreasing. According to some of these commenters, it is inequitable to apply the methodology to certain specialties or groups of services that would experience significant reductions while sparing other specialties or services that would experience reductions under the same change. There were also comments indicating that the reduction in payment for pathology services was related to the mix of specialties that bill for global services; specifically, there is concern that independent laboratories bill for a higher proportion of global than TC services. The commenters noted that we do not have a practice expense per hour for independent laboratories and use a crosswalk practice expense per hour from “all physicians.” While this comment acknowledges our need to use a crosswalk when we do not have a practice expense per hour, the comment indicated that there is no reason to conclude that independent laboratories that provide pathology services have practice expenses per hour similar to the all physician average. The comments expressing concern about the impact of the proposal on pathology services requested a one-year moratorium on its implementation to allow for a survey of independent laboratory practice expenses under the supplemental survey process. There were a number of comments indicating that organizations representing pathologists would undertake a survey of practice expenses for independent laboratories that could be used to develop 2004 physician fee schedule rates.

Response: We agree with the comments that suggest a one-year moratorium on implementation of the proposed change for pathology services paid under the physician fee schedule. Based on a consultation with the College of American Pathologists, we will continue to determine the global practice expense RVUs as the sum of the professional plus TC for all of the global codes in the CPT 80000 series that are paid using the physician fee schedule, as well as the following HCPCS and CPT codes:

Table 2

CPT/HCPCS	Description
G0141	Screening c/v, autosys, interp
P3001	Screening c/v, interp
10021	FNA w/o image
10022	FNA w/image
36430	Blood transfusion service
36440	Blood transfusion service
36450	Blood transfusion service
36455	Exchange transfusion service
36460	Transfusion service, fetal
36520	Plasma and/or cell exchange
38220	Bone marrow aspiration
38221	Bone marrow biopsy
38230	Bone marrow collection
38231	Stem cell collection

CPT codes and descriptions only are copyright 2002 American Medical Association.

As we indicate in the background part of this preamble, the practice expense methodology essentially takes a weighted average of different specialty practice expenses to determine a practice expense RVU. The methodology will independently produce a value for the global, professional and technical components. For instance, CPT code 88305 (Tissue exam by pathologist) is a commonly provided pathology service. The methodology produces a value of 1.60 for the global, 0.34 for the PC and 1.39 for the technical component. The sum of the professional and TC RVUs (0.34 + 1.39 = 1.73) is not equal to the global RVU (1.60). The values are not equal because the mix of specialties that provide the global and the TC are different and each specialty has a different practice expense per hour. The specialties that bill CPT code 88305 to Medicare for the global service most frequently have the following practice expense per hour:

Table 3

Specialty	Practice expense per hour	Percent of total volume
Independent Lab	$69.00	56
Pathology	66.30	29
Dermatology	119.40	13

The specialties that bill Medicare most frequently for the TC are:

Table 4

Specialty	Practice expense per hour	Percent of total volume
Independent Lab	$69.00	47
Dermatology	119.40	33
Pathology	66.30	16

As shown in the tables above, dermatology has a very high practice expense per hour relative to independent laboratories and pathology. However, dermatologists bill Medicare for a smaller portion of the global services. As a result, dermatology contributes less weight to the global value than the TC value. Our practice has been to make the global RVUs equal the sum of the PC and TC values. If the methodology results in PC and TC values that do not sum to the global value, we must change either the global or TC value. To date, we have used the PC (0.34) and the TC value (1.39) to determine the global value (1.74). However, in the proposed rule, we used the global value (1.60) minus the PC (0.34) to obtain the TC (1.26). Using the TC to value the global component for this code (88305) produces a higher RVU for both the technical and the global components than using the global component to value the TC.

As we have previously indicated, it is far more common for Medicare to receive a global than technical-component-only bill. For this reason, we believe it is valid to rely on the global to produce a value for the technical rather than use the technical to value the global. Nevertheless, since independent laboratories predominantly bill the global for pathology services and we are using a crosswalk for the practice expense per hour, we believe it makes sense to allow for a one-year moratorium on implementation of this provision for pathology services to allow for use of a supplemental survey that provides us with specific data on practice expenses for independent laboratories.

Final Decision: We are not adopting the proposed change for pathology services paid using the physician fee schedule at this time. For all professional/TC services not included in the non-physician work pool, excluding pathology services, we will make the TC value equal the difference between the global and the professional component. We will continue with the current practice for pathology services and non-physician work pool services and sum the professional and TC values to determine the global.

(ii) Other Proposals for Changes to the Non-Physician Work Pool

(A). Change to Staff Time Used To Create the Pool

In the November 2, 1998 final rule (63 FR 58841), we indicated that average clinical staff time was used in the creation of the non-physician work pool. Since the cost pools are created using physician time and, by definition, services provided by clinical staff have no physician time, we need staff time to create the non-physician cost pool. If our database indicates that multiple staff types are typically involved in the service, we have used an average of the different clinical staff times. We proposed to create the non-physician cost pool using the highest staff time in place of average staff time.

Comment: We received many comments that supported using the highest staff time to create the non-physician work pool. Some comments suggested that we should consider using “total” staff time especially if we will use the clinical staff times being provided by the Practice Expense Advisory Committee (PEAC). The comment indicates that the PEAC has been particularly careful to avoid duplications of time. If the PEAC has limited or eliminates concurrent staff time, the comment suggests that “total” rather “maximum” staff time should be use to determine the non-physician work pool. A number of comments expressed concern about PEAC refinements of clinical staff times associated with codes included in the non-physician work pool. These comments requested that we not incorporate any PEAC revised clinical staff times for non-physician work services until there has been an opportunity for public notice and comment. There were two comments objecting to this proposal. One comment indicated that the maximum staff time is not the “typical” time associated with provision of the service and urged us not to implement the proposal. We received another comment that noted that physician times used to establish practice expense cost pools for physician work services use average or median times from RUC or Harvard surveys. The comment indicates that the proposal to use maximum staff time represents a step away from the stated goal of developing a consistent method for all services. According to this commenter, the proposal will penalize specialties that do not perform a large volume of services in the non-physician work pool.

Response: We disagree with the comment that suggests we are not using a time that is typical of the service and the one that implies our staff time proposal is inconsistent with how we determine physician time. For a physician's service, we develop time based on surveys. While the comment is correct that we generally use average or median time estimates from surveys to determine the typical time, the time reflects the service of a single physician. For non-physician work pool services, we are also using estimated average staff times to represent the typical service. However, multiple clinical staff are frequently involved in performing non-physician work pool services. The staff may be working concurrently, consecutively or overlapping time. Given the special circumstances associated with non-physician work pool services that do not apply to physicians' services, it was necessary for us to select among multiple time estimates to develop the pool. We are currently using an average of the estimated staff times but proposed to use the maximum. Once we address issues related to the non-physician work pool, this will no longer be an issue since we will use a single methodology for all physician fee schedule services and staff time will not be used to create cost pools.

In response to the comment that refined clinical staff times not be used at this time for non-physician work pool services, we agree that there are special circumstances that apply to these services. Because the clinical staff times are used to create the pool and can result in RVU changes across all services, even those where no refinements have been made, we are not using the revised clinical staff time to create the non-physician work pool at this time. However, as indicated above, this will no longer be an issue once we address other issues related to the non-physician work pool.

(B). Removal of Non-Invasive Vascular Diagnostic Study Codes From the Non-Physician Work Pool

We proposed to remove the non-invasive vascular diagnostic study codes (CPT codes 93875-93990) from the non-physician work pool based on a request from the American Association for Vascular Surgery (AAVS) and the Society for Vascular Surgery (SVS).

Comment: We received support from vascular surgeons and others for removing the non-invasive vascular diagnostic studies from the non-physician work pool. These comments requested that AAVS/SVS should be able to modify the request if CMS does not finalize its proposal to calculate the TC practice expense RVU as the difference between the global and professional components. We also received a number of comments requesting that we remove other codes from the non-physician work pool. The Society of Vascular Technology and Society of Diagnostic Medical Sonography) requested that we remove 26 ultrasound codes in the CPT code range 76506 through 76977. The American Society of Neuroimaging also requested that some of these codes be removed. The American Urological Association (AUA) also requested that we remove CPT codes 76857, 76872, 76942 and 96400 from the non-physician work pool. While there were no objections to removing the non-invasive vascular diagnostic study codes, we received many comments that suggested limiting the financial impact that removing codes from the non-physician work pool have on the remaining codes. In particular, many of these commenters expressed concern about the impact of removing chemotherapy administration codes from the non-physician work pool. Some comments provided suggestions for modifications to the non-physician work pool (for example, using a different practice expense per hour) that could be used if adverse impacts result from codes being removed. One commenter suggested that we maintain the existing RVUs and provide a downward adjustment to the CF to ensure no increase in aggregate payment results from removing chemotherapy administration services from the non-physician work pool.

Response: At this time, we have not received any requests to remove chemotherapy administration from the non-physician work pool. Nevertheless, if there are sound suggestions that could be adopted consistent with changes in the composition of the non-physician work pool that will improve the practice expense methodology, we may consider adopting them in the future. Of course, as stated elsewhere, our goal is to eliminate the non-physician work pool and apply a single methodology to all physician fee schedule services so further adjustments will be unnecessary. We expect this to be a top priority in CY 2003 for determining CY 2004 physician fee schedule rates.

We have reviewed the comments to remove specific services from the non-physician work pool. While our general policy has been that “families” of procedure codes should be removed from the non-physician work pool (see the July 22, 1999 proposed rule (64 FR 39620)), we will allow individual codes to be removed if the requesting specialty predominantly performs the requested code and other specialties predominantly perform the other codes in the family. We have reviewed 2001 utilization for the codes requested by the AUA. Since urologists predominantly perform the requested codes and other codes in the family are predominantly performed by other specialties, we are removing the following codes from the non-physician work pool: CPT codes 76857, 76872, 76942 and 96400. We are not removing other codes requested in the comments because they are predominantly performed by radiology, neurology or obstetrics-gynecology and the specialty societies representing these physicians have not requested that the codes be removed from the non-physician work pool.

Comment: The American College of Rheumatology (ACR) acknowledged that the current average wholesale price (AWP) methodology provides for a “healthy margin overall” in the provision of these services [infusion agents and infusion therapy] through “cross-subsidization.” However, they indicated that payments for infusion therapy services are “woefully insufficient.” The comments from ACR and many rheumatologists expressed concern about reductions in payment for infusion agents in combination with maintaining the current payment amounts for infusion therapy (CPT codes 90780 and 90781). The comments indicated that a reduction in payment for infusion agents without an increase in the payment for infusion therapy services will likely result in Medicare beneficiaries being unable to receive infusion services in physicians' offices. One commenter from a society representing gastroenterologists indicated that we should consider increasing the payment for non-chemotherapy infusion services. Other comments suggested that we should use the rulemaking process to establish HCPCS G codes to increase payment for non-chemotherapy drug administration to a more appropriate level.

Response: We currently determine the practice expense RVUs for CPT codes 90780 and 90781 using the non-physician work pool methodology. One commenter suggested establishing a G code for non-chemotherapy infusion services. While this option would allow infusion therapy to be valued outside of the non-physician work pool, we want to avoid establishment of G codes for services that are already described by existing CPT codes. Another option for addressing these comments would be to remove infusion therapy from the non-physician work pool and allow for resource-based pricing under the top-down methodology. However, oncologists predominantly perform these services and have not requested removing the codes from the non-physician work pool. We are reluctant to remove infusion therapy services from the non-physician work pool without a request from the specialty that predominates the data. As we previously noted, oncologists provided us with a supplemental practice expense survey. At this time, we are not incorporating the survey into the practice expense methodology because of concerns raised by our contractor, the Lewin Group, about the validity of some of the data. However, we hope to work with the Lewin Group and ASCO to either get an explanation of the survey results or use alternative data to validate the results. As we work to resolve issues related to the ASCO survey, we will consider removing the infusion therapy codes from the non-physician work pool.

In the interim, we note that Medicare pays for drugs based on 95 percent of AWP. This system has been widely criticized for paying physicians for drugs at far higher rates than prices paid to obtain them. Oncologists receive more than 70 percent of their Medicare revenues from drugs. While we would prefer a statutory change to address Medicare's drug pricing methodology, we are contemplating administrative actions that may be taken under current law to address this issue. As we consider options for changing Medicare's drug payment methodology, we will continue examining the ASCO survey to determine whether the data can be used to calculate the practice expense per hour for oncology.

(C). Removal of Immunization CPT Codes 90471 and 90472 From the Non-Physician Work Pool

We proposed to remove immunization administration services from the non-physician work pool. We indicated this change would nearly double payment for CPT code 90471 and slightly reduce payment for CPT code 90472. Procedure CPT code 90471 is used for immunization administration of one vaccine and CPT code 90472 is used for the administration of each additional vaccine. Since CPT code 90472 must be billed in conjunction with CPT code 90471, the total payment for these procedures would increase when billed together.

We also explained that we have not assigned immunization administration physician work RVUs because this service does not typically involve a physician. The nurse that administers the vaccine typically provides the necessary counseling to the patient and this time is accounted for in the practice expense RVU.

In addition, we noted that not all services represented by CPT codes 90471 and 90472 are covered by Medicare. For example, medically necessary administrations of tetanus toxoid (such as following a severe injury) would be covered whereas preventive administration of this vaccine would not be covered. We also indicated we would consider whether coding changes might be appropriate to reflect the differences in counseling of the patient and/or family for childhood immunizations.

Comment: Commenters supported our proposal to remove CPT codes 90471 and 90472 from the non-physician work pool. However, commenters indicated elderly patients are at higher risk to acquire pathogens and viruses and are in greater need of vaccinations. Medicare must recognize that as part of their practice of medicine, physicians take the time and responsibility to explain to their patients the benefits of vaccination and the potential side effects. Physicians question the patient about previous reactions to the vaccine and provide information material. These comments indicated that we should assign work RVUs of 0.17 for the administration of vaccines as recommended by the RUC.

Response: The RUC has recommended that we both establish a work RVU for CPT code 90471 and include 13 minutes of clinical staff time to value the practice expense RVU. Further, our understanding from the RUC is that these immunization services are also provided in conjunction with a separately billable visit. We believe the clinical staff time for these services is intended to account for patient counseling and some of the activities described in the comment. Other activities attributed to the physicians are likely being provided as part of a separately billable office visit. For these reasons, we continue to believe that these codes should not be assigned physician work RVUs.

Comment: Several commenters expressed concern that we did not propose any change in the payment rate for the administration of influenza (G0008), pneumonia (G0009), and hepatitis B (G0010) vaccines. The commenters are concerned that we continue to link payment for the administration of Medicare covered vaccines to a therapeutic injection CPT code (90782) that pays at half of the proposed rate for CPT code 90471. Other commenters recommended that Medicare use the CPT codes 90471 and 90472 in place of the Medicare-only alphanumeric codes (G0008, G0009, G0010). These comments indicated that if we are to retain the G codes, we should publish RVUs for them that match CPT code 90471.

Response: We considered the comment to eliminate use of the G codes and allow use of the CPT codes for the administration of Medicare covered vaccines. However, we have decided that we will maintain these G codes at this time. It is important that we be able to closely monitor patient access to these important preventive services. However, since CPT has established similar codes for immunization administration that can be covered by Medicare, we will consider this issue further in 2003.

With respect to payment, we agree with the commenters. Rather than link payment for procedures codes G0008, G0009, and G0010 to a service paid under the physician fee schedule, we will develop practice expense RVUs for these codes. Using the top-down methodology to develop practice expense RVUs will nearly double payment for these codes and make Medicare's payment for vaccine administration using the G codes more consistent with the rates paid for the CPT codes. Since the statute does not include the administration of pneumonia, influenza, and hepatitis B vaccines within the definition of physicians' services in section 1848(j) of the Act, the increased payment for these services will not result in reductions to the practice expense RVUs associated with physician fee schedule services. That is, there is no budget-neutrality adjustment to be made for revisions in payments for the administration of pneumonia, influenza, and hepatitis B vaccines.

Comment: One commenter indicated that Medicare does not pay for the administration of influenza and pneumonia vaccines provided on the same day as another physician's service.

Response: The commenter is incorrect. Medicare will pay separately for the administration of these vaccines and other physicians' services on the same day.

(D) Utilization Data

Medicare utilization is an important data source used in determining the practice expense RVUs. Our current policy has been to use the latest utilization data to develop each successive year's fully implemented practice expense RVUs during each year of the transition. While substituting the latest year's utilization data into the practice expense methodology generally made little difference on total Medicare payments per specialty, there has been a larger impact on services affected by the non-physician work pool. Based on suggestions made by specialty organizations, we proposed to use the CYs 1997 through 2000 utilization data to develop the CY 2003 practice expense RVUs and not to update further the utilization data in this year's final rule to incorporate the CY 2001 utilization data. Further, we proposed to continue using the CYs 1997 through 2000 utilization data in the practice expense methodology until we undertake the 5-year review of practice expense RVUs.

Comment: We received comments both supporting and opposing use of multi-year utilization data in the practice expense methodology. The comments that “applauded CMS's efforts to ensure the stability” of the practice expense RVUs largely came from organizations affected by the non-physician work pool methodology. We also received support from specialties that are largely unaffected by the proposal because of its potential to provide more year-to-year stability in the practice expense RVUs. Other commenters indicated that use of new utilization data with a different “mix” of services produces unpredictable changes in RVUs even though resource costs have not changed. There were comments that indicated use of multi-year utilization data will restore the unanticipated and extraordinary reductions experienced by diagnostic imaging centers in CY 2002. These commenters urged that we adopt our proposal in the final rule. One comment stated that “utilization data adjustments should not change annually until the [non-physician work pool] is eliminated and/or CMS undertakes the 5-year review of practice expense RVUs.”

One commenter stated that it is unclear whether the multi-year utilization will be used to develop practice expense RVUs for all services or only those in the non-physician work pool. Another commenter stated it is difficult to assess the impact of the proposal and urged the agency “not to make such a change, at least until it has conducted extensive impact comparisons” that can be evaluated by physicians and other stakeholders. Other commenters suggested that we should not update the practice expense methodology with new utilization data without giving an opportunity for public notice and comment. A number of commenters argued that application of a 10-percent payment reduction in CY 1998 and the per beneficiary per facility payment cap of $1500 cap in CY 1999 (in settings other than outpatient hospital departments) make utilization data unreliable for therapy services during the CYs 1997 through 2000 period. Commenters also noted that outpatient physical and occupational therapy services provided in facility settings were paid under cost-based reimbursement before CY 1999. The commenters questioned the accuracy of the utilization data for Part B therapy services from CYs 1997 through 2000 and suggested that the utilization data during this period would be biased by the implementation of policy changes. One commenter recommended that we use the most current available data as the base for examining therapy utilization and should commit to an annual review of the data until it can be established that a longer time horizon accurately reflects utilization. Other comments requested clarification of how we use data from this period for physical and occupational therapy.

Response: With respect to therapy services, we do not use claims of institutional providers (rehabilitation agencies and comprehensive outpatient rehabilitation facilities) in developing payment rates for therapy services paid using the physician fee schedule. We only use the claims for therapy services from physical and occupational therapists in private practice. The proposal was intended to apply to all physician fee schedule services, not just those in the non-physician work pool. We are finalizing our proposal to use the CYs 1997 through 2000 utilization data to develop the practice expense RVUs for all services. However, we believe the comments raise important issues about policy changes that were occurring from CYs 1997 through 2000 that could lead to changes in utilization patterns during this time. We may analyze this issue further. In the interim, we welcome public comment about using the latest utilization data in the practice expense methodology.

(E) Site of Service

As part of our resource-based practice expense methodology, we make a distinction between the practice expense RVUs for the non-facility and the facility setting. This distinction is needed because of the higher resource costs to the physician in the non-facility setting where the practitioner typically bears the cost of the resources associated with the service. In addition, the distinction ensures that we do not make a duplicate payment for any of the practice expenses incurred in performing a service for a Medicare beneficiary. Currently, we have designated only hospitals, skilled nursing facilities (SNFs), and community mental health centers (CMHCs) as facilities for purposes of calculating practice expense. An ambulatory surgical center (ASC) is designated as a facility if it is the place of service for a procedure on the ASC list. All other places of service are currently considered non-facility.

We proposed site-of-service designations for several new places of service as well as revisions to the site-of-service designation for several existing places of service. We proposed to assign a facility site-of-service when a facility or other payment will be made, in addition to the physician fee schedule payment to the practitioner, to reflect the practice expenses incurred in providing a service to a Medicare patient. We proposed to designate all other places of service as non-facilities.

The following lists the place of service numerical code, the place of service and the proposed site of service designations:

04 Homeless Shelter—Non-facility

15 Mobile Unit—Non-facility, however, if a mobile unit provides a service to a facility patient, the appropriate place-of-service code for the facility should be used.)

20 Urgent Care Facility—Non-facility

26 Military Treatment Facility—Facility

41 Ambulance-Land—Facility

42 Ambulance Air or Water—Facility

52 Psychiatric Facility Partial Hospitalization—Facility

56 Psychiatric Residential Treatment Facility—Facility (NOTE: the chart included in the June 28, 2002 proposed rule at 67 FR 43854 incorrectly listed this as “NF”—nonfacility)

We would also clarify two items in the chart published at 67 FR 43854:

61 Comprehensive Inpatient Rehabilitation Facility was listed as a non-facility. This is currently considered a facility setting and we did not propose changing this designation. The reference to non-facility was in error.

We also made reference to four place of service codes for Indian Health Service and Tribal 638 facilities and clinics. We were considering these place of service codes to implement section 432 of the BIPA that authorizes physician fee schedule payments to Indian Health Service and Tribal 638 facilities and clinics. At this time, we do not believe these place of service codes will be needed for implementation of these provisions and do not expect them to be in use. We are implementing section 432 of BIPA by using specialty codes, not place of service codes to identify HIS providers.

Comment: One organization expressed appreciation for our efforts to update the list and had no comments. Others commented requesting clarification of site-of-service designations for the provision of Part B therapy services in nursing facilities. One commenter expressed particular concern about the use of place of service code 32 (Nursing facility) in conjunction with outpatient therapy services in nursing facilities. This commenter suggested we reiterate in the final rule the current policy that fee schedule payments for Part B therapy services delivered in a nursing home are classified as “non-facility.” They also suggested we redefine “site-of-service” for physicians services to non-Part A patients in nursing centers as “non-facility,” thereby applying the higher PERVUs to those services. We received one comment from a carrier medical director that indicated that physician practice costs for treating patients in skilled nursing facilities (POS 31) and nursing facilities (POS 32) are the same and that both should be designated as either facility or non-facility. This comment also suggested deleting the POS 32 designation (NH), or changing its meaning to a “SNF or NF stay not covered by Medicare.” A physician who practices in nursing facilities also argued that our current policy makes no sense because physician practice costs are the same regardless of whether Medicare makes a payment to the SNF for institutional services. This physician would like us to pay at the higher non-facility rate for physicians' services in both entities, but acknowledged that using the lower facility rate would be more consistent with the practice expense methodology.

Response: We regret any ambiguity or concern that we may have created in our proposed rule. In general, for purposes of the physician fee schedule, we will consider a site to be a facility if the site also receives a Medicare payment for institutional services (that is, a payment under the inpatient prospective payment system (PPS), outpatient PPS, and SNF PPS). Thus, since there is a payment for institutional services to a hospital when a beneficiary receives care in an inpatient or outpatient setting, we consider the site to be a facility site and make a payment under the physician fee schedule using the facility rate. For entities other than those that receive a payment for institutional services, we consider the site a non-facility site and pay under the physician fee schedule using the higher non-facility rate. However, there are special provisions with respect to outpatient physical and occupational therapy services. These services are paid under the physician fee schedule even when provided in institutional sites like skilled nursing facilities. For this reason, for these services we calculate only a non-facility rate. Since there is no facility payment under Medicare, we use a non-facility rate to determine payment.

Place of service code 32—Nursing facility—was designated as non-facility in our June 2002 proposed rule. Place of service code 31—Skilled nursing facility—is designated as facility. We have instructed physicians to use place of service code 31 for patients who are in an inpatient stay in a skilled nursing facility. Since Medicare is making a payment for institutional services that includes compensation for staff, supplies, and equipment, we are paying physicians using the lower facility rate when place of service code 31 is used. If the patient exhausts eligibility for SNF benefits and Medicare is no longer making payment to the SNF for institutional services, we have instructed physicians to use place of service code 32—Nursing facility, to allow Medicare to provide compensation to the physician for the costs of staff, supplies and equipment that would otherwise not be included in our payment. However, since it may be burdensome to the physician to determine when a patient is entitled to SNF Part A benefits, we always allow the physician to use place of service 31 and receive the lower facility payment for physicians' services.

While we acknowledge the arguments of those who have written and contacted us both prior to and as part of the rulemaking process, we are reluctant to make any further changes in our policy at this time. We believe existing policy is equitable in that it does not overly burden physicians to have to determine whether a patient is in a Part A SNF inpatient stay. Physicians can always bill using place of service code 31 and be paid at the facility rate. Further, we allow use of place of service code 32 and our payment will be at the higher non-facility rate that includes compensation for staff, equipment, and supplies that would not otherwise be paid since there is no payment for the institutional services. In response to the request that we change the nomenclature describing place of service code 32, we will consider this further as updates are made to place of service coding. However, we note that Medicaid uses the place of service codes as well and the needs of this program will also need to be considered.

Comment: One commenter suggested the descriptor for place of service code 23, “emergency room-hospital,” should be changed to “emergency department.”

Response: We will consider this comment when further updates are made to place of service codes.

Comment: One commenter expressed concern about the proposed designation change of site of service from non-facility to facility for both psychiatric facility partial hospitalization and psychiatric residential treatment facility. The commenter felt this would negatively impact physician reimbursement and could provide disincentive for psychiatrists to treat patients in these settings.

Response: By developing practice expense RVUs that differ by site, we intend to reflect the relativity of resource costs incurred by physicians between sites. Our policies are not intended to provide financial incentives for a physician to select one site over another. Physicians should make these decisions based on the clinical needs of the patient. We believe that both psychiatric residential treatment facilities and psychiatric partial hospitalization programs are institutional sites that provide staff, equipment and supplies used in providing medical services and physicians will not incur these resource costs when providing services in these settings.

(F). Other Practice Expense Issues

(1) Budget Neutrality

We received several comments suggesting that budget neutrality for changes in practice expense RVUs be applied to the physician fee schedule conversion factor. The comments indicated that payment for CPT codes with significant practice expense RVUs are reduced when there are aggregate increases in work RVUs but services that are predominantly composed of work RVUs are not significantly affected by aggregate increases in practice expense RVUs. According to the comments, such a modification would “help assure more year-to-year stability in the practice expense RVUs.” Since affected professional groups have not had an opportunity to consider and comment on this important issue, one comment suggests that we include this issue in the proposed notice for the CY 2004 physician fee schedule.

Response: We will consider this idea for the future.

(2) Computerized Tomographic Angiography

Comment: We received a number of comments about Computed Tomographic Angiography (CTA). The comments indicated that, before CY 2001, CTA services were billed as a CT scan of an anatomical region plus an add-on code for 3-D image reconstruction. New codes specifically for CTA that incorporated the image reconstruction were developed for use in 2001. The comments indicated that the TC RVUs for CTA established in the November 1, 2000 final rule appear as though they were calculated by cross-walking the RVUs from the anatomically analogous existing CT procedure codes without accounting for the 3-D image reconstruction.

Response: Based on this comment, we have adjusted the current CTA codes to incorporate image reconstruction.

(3) TC for Cardiac Catheterization

Comment: We received several comments that noted the TC RVU for cardiac catheterization declined in the notice of proposed rulemaking even though the codes are included in the non-physician work pool. These comments noted that the practice expense RVUs for all other non-physician work pool services increased in the proposed rule. One comment expressed concern over our proposal to derive the TC RVU from the global RVU service. The comment indicated that we currently have no direct cost inputs for these services and it is unlikely that the PEAC will be able to provide them since cardiac catheterization is generally provided in hospital settings. According to the commenter, there are only 80-100 non-hospital facilities that provide cardiac catheterization services. It is unlikely that we will have physician survey information that reflects the costs of these providers since they normally bill for the TC service and not the global service. The comment stated the cardiologist normally bills independently for professional services.

Response: We have addressed the comment regarding the TC for the cardiac catheterization. The TC RVUs for these services are changing by the same percentage as all other non-physician work pool services. We understand that the PEAC may consider providing inputs for cardiac catheterization services. This will address one aspect of the commenter's concern. With respect to valid SMS data for cardiac catheterization services, we will consider this issue along with others as we address issues related to the non-physician work pool in CY 2003.

B. Anesthesia Issues

1. Five-Year Review of Anesthesia Work

Section 1848(b)(2)(B) of the Act indicates that, to the extent practicable, we will use the anesthesia relative value guide with appropriate adjustment of the anesthesia conversion factor (CF) in a manner to assure that the fee schedule amounts for anesthesia services are consistent with the fee schedule amounts for other services. The statute also requires us to adjust the CF by geographic adjustment factors in the same manner as for other physician fee schedule services. Unlike other physician fee schedule services, anesthesia services are paid using a system of base and time units. The base and time units are summed and multiplied by a CF. The base unit is fixed depending on the type of anesthesia procedure performed, and the time units vary based on the length of the anesthesia time associated with the surgical procedure. Thus, our payment will increase as anesthesia time lengthens. The same anesthesia service provided in two different surgeries will be paid different amounts if the associated anesthesia time is different. This system differs from other physician fee schedule services for which RVUs for physician work, practice expense, and malpractice are summed and multiplied by a CF to determine payment. Payment for these non-anesthesia procedures will not vary based on the length of time it takes to perform the procedure in a specific instance.

In the June 2002 proposed rule (67 FR 43855) we explained that the law requires that we review RVUs no less often than every 5 years. There is a fundamental difference in how the 5-year review applies to anesthesia services versus medical and surgical services. In general, for medical and surgical services, the relevant physician specialty society and the AMA's RUC review the current and proposed work RVUs on a code-by-code basis. The RUC will make recommendations to us on work values for specific codes and, if we accept or modify them, the new physician work RVUs will be used to determine payment. However, each anesthesia service does not have a work RVU. Therefore, adjustments for anesthesia work (and practice expense) are made to the anesthesia CF and payment for all anesthesia services is affected.

The second 5-year review (with the exception of anesthesia services) was completed and revised work RVUs were implemented in 2002. For the second 5-year review, the American Society of Anesthesiologists (ASA) contended that the work of anesthesia services remained undervalued by almost 31 percent. They subsequently argued for a 26 percent increase in work RVUs based on additional discussions with the RUC. More recently, based on their further analysis and discussion with the RUC, the ASA asked for a 13.6 percent increase in work.

The ASA derived a work value for an anesthesia code by dividing the anesthesia service into five uniform components. The five components are preoperative evaluation, equipment and supply preparation, induction period, postinduction period, and postoperative care and visits. These components were assigned work RVUs based on a comparison to non-anesthesia services paid under the physician fee schedule. The work of these components is then summed. Using this method, the ASA proposed new work values for 19 high volume anesthesia codes. These work values can be compared to imputed work values derived from current anesthesia payments for these services.

Under the CPT coding system, anesthesia for various common surgical procedures is reported under a single anesthesia code. For example, CPT code 00790 is used to report anesthesia for over 250 intraperitoneal procedures in the upper abdomen.

The ASA studied one surgical procedure for each of the anesthesia codes. The 19 codes represent a range of surgical procedure types, including general surgery, vascular surgery, neurosurgery, urology, orthopedics, cardiac surgery, and ophthalmology. The 19 procedures reviewed account for about 35 percent of Medicare allowed charges for anesthesia services.

During the second 5-year review of work, several RUC workgroups reviewed the ASA comments and received supplemental information from them through presentations. Most of these workgroups expressed concerns about some of the work intensity values the ASA assigned to the individual anesthesia components, most notably, the induction and post induction time periods. For about 50 percent of the codes, the RUC was confident that the anesthesia work value of the surveyed service was similar to the anesthesia work values for all of the other surgical services assigned to the given anesthesia code. For the remaining codes, the RUC was not confident that the work values of the surveyed code could be applied to other anesthesia services that would be reported under that anesthesia code.

The workgroups also expressed concern about extrapolating the results from the 19 surveyed codes to all anesthesia services. At its April 2002 meeting, the final meeting addressing anesthesia work values for the second 5-year review, the RUC concluded it was unable to make a recommendation regarding modification to the physician work values for anesthesia services. Specifically, the RUC stated:

The RUC, having carefully considered the information presented, and having a reasonable level of confidence in the data, which was presented and developed by the ASA, is unable to make a recommendation to CMS regarding modification to the physician work valuation of anesthesia services.

While the RUC did not make a recommendation to us regarding extrapolation, it forwarded its analysis to us for review.

In the June 2002 proposed rule (67 FR 43856), we indicated our intent to review the information forwarded by the RUC and all comments we received during the comment period.

Comment: The ASA commented that, based on work values accepted by the RUC anesthesia workgroup, the final RUC data show that anesthesia services are undervalued by a weighted average of 13.57 percent. The ASA urged us to adjust the anesthesia CF accordingly. The American Association of Nurse Anesthetists (AANA) endorsed the ASA's comments and provided similar comments. Several certified registered nurse anesthetists and anesthesiologists also wrote in support of an increase in the anesthesia CF. We also received several comments alleging that the ratio of Medicare payment to private payer payments for anesthesia services is considerably less than the analogous ratio for medical and surgical services.

Response: The ASA and the AANA have requested that we apply the RUC's analysis of the 19 codes to all anesthesia codes. They believe that the weighted average increase in anesthesia work values that results from the RUC's analysis is representative of work values for all other anesthesia codes.

For some codes, the RUC seemed confident that the anesthesia work value of the surveyed code was similar to the anesthesia work values for all of the other surgical services assigned to the given anesthesia code. However, for almost half of the surveyed codes, the RUC did not have confidence that the work values of the surveyed code could be applied to any other anesthesia services that would be reported under that anesthesia code.

Due to the uncertainty of the RUC with regard to extrapolation, even within the family of surgical procedures assigned to a single anesthesia code, we have weighted each of the 19 anesthesia codes only by the anesthesia allowed charges associated with the single surveyed surgical procedure. Using this methodology, anesthesia for the surveyed surgical codes account for approximately 23 percent of all anesthesia allowed charges. This results in an increase in anesthesia work for the 19 codes of 9.13 percent. However, because we will apply a payment increase only to these codes, we are increasing the physician work portion of the anesthesia conversion factor by 2.10 percent which reflects a 9.13 percent increase in payment applied to the 23 percent of total anesthesia charges represented by the 19 codes. We provide more detail on how this increase is applied to the anesthesia conversion factor in the section VIII of this final rule.

Final Decision

We are increasing the physician work component of the anesthesia conversion factor by 2.10 percent to reflect a 9.13 percent increase in payment applied to 23 percent of anesthesia allowed charges. This as an interim adjustment that is subject to comment.

2. Add-On Anesthesia Codes

Payment for anesthesia services is based on the sum of an anesthesia code-specific base unit value plus anesthesia time units multiplied by an anesthesia CF. Under our current policy at § 414.46(g), if the physician is involved in multiple anesthesia services for the same patient during the same operative session, payment is based on the base unit assigned to the anesthesia service having the highest base unit value and anesthesia time that encompasses the multiple services.

Claims processing manuals instruct the carrier on the method for handling anesthesia associated with multiple or bilateral surgical procedures. Under the Medicare Carrier Manual (MCM) 4830 D, the physician reports the anesthesia procedure with the highest base unit value with the multiple procedures modifier-51 and total time of anesthesia for all surgical procedures. Thus, the carrier is recognizing payment for one anesthesia code.

In CYs 2001 and 2002, the CPT included new add-on anesthesia codes. The objective is that the add-on code would be billed with a primary code, each code having base units. We believe that anesthesia add-on codes should be priced differently from other multiple anesthesia codes. We proposed to revise the regulations at § 414.46(g) to include an exception to the usual multiple anesthesia services policy for add-on codes.

Comment: The ASA, AANA and the AMA expressed support for our adopting a payment policy for add-on anesthesia codes. The ASA asked that we clarify the policy for recognition of base or time units or both for add-on anesthesia codes.

Response: Of the 259 anesthesia codes, there are two codes, called primary codes that may have add on codes, under certain circumstances. These are:

Primary code: CPT code 01967

Add-on code: CPT code 01968 or 01969

Primary code: CPT code 01952

Add-on code: CPT code 01953

Based on comments received, we understand that the ASA is seeking to bill only the base unit of the add-on code (01953) when it is billed with the primary code 01952. The time of the add-on code is to be included in the time of the primary code. Thus, all anesthesia time is attributable to the primary code.

The ASA is seeking to bill both the base and time of the add-on code, 01968 or 01969, when either is billed with the primary code 01967. Thus, the anesthesia provider would report the base and time units of both the primary and the add-on code.

We recognize that the general policy for add-on codes is that the carrier should allow only the base unit of the add-on code. As with multiple anesthesia services, the anesthesia time of the add-on code would be reported with the time of the primary code. In other words, anesthesia time is reported for all the underlying surgical services.

However, in discussions with the ASA, we have learned that many third party payors have more restrictive time units policies for obstetrical anesthesia codes than for other anesthesia codes. If the time of the add-on code, such as 01968 or 01969, were reported with the primary code, the time units of the add-on code might be undervalued. To prevent this result, we are requiring that (for the two obstetrical anesthesia add-on codes) the anesthesia time be separately reported with each of the primary and the add-on code based on the amount of time appropriately associated with either code.

Further, we think the policy on multiple procedure codes as well as add-on codes is an operational policy and should be addressed only in program operating instructions. As a result, we are revising the regulation text at § 414.46(g) accordingly.

Final Decision

We are allowing the carriers to recognize the base unit of the add-on codes. However, for the obstetrical add-on codes, the carrier may recognize both the base unit and the anesthesia time associated with the add-on code.

C. Pricing of Technical Components (TC) for Positron Emission Tomography (PET) Scans

Currently, all components of HCPCS code G0125, Lung image PET scan, are nationally priced. However, the TC and the global value for all other PET scans are carrier-priced. To keep pricing consistent with other PET scans, we proposed to have carriers price the TC and global values of HCPCS code G0125.

Comment: We received comments from one specialty organization in support of carrier pricing. We received comments from another specialty organization and a few providers stating that they were concerned that, contrary to our stated purpose, this change would lead to inconsistent payment by carriers. The commenters believe that some carriers use the nationally-established TC RVUs for G0125 as a reference for payment for the other PET scans.

Response: While we understand the commenter's concerns, we believe the RVUs assigned before CY 2003 for the TC of G0125 do not accurately reflect the resources used for furnishing this service, which is why we proposed carrier pricing. Thus, using G0125 as a reference code for pricing could lead to inappropriate pricing for all services. We believe that adopting carrier-pricing, instead of a national fee schedule amount, for the TC of G0125 will result in more appropriate pricing for the TC of all PET scans. Carriers have a variety of methods that they use to establish payment for codes. We believe using some of these alternative methods will lead to more accurate pricing for this service.

Final Decision

We will finalize our proposal to allow carriers to price the TC and global values of code G0125.

D. Enrollment of Physical and Occupational Therapists as Therapists in Private Practice

In the November 2, 1998 final rule (63 FR 58814), we defined private practice for physical therapists (PTs) or occupational therapists (OTs) to include a therapist whose practice is in an—

• Unincorporated solo practice;
• Unincorporated partnership; or
• Unincorporated group practice.

The term “private practice” also includes an individual who is furnishing therapy services as an employee of one of the above, a professional corporation, or other incorporated therapy practice. Some carriers and fiscal intermediaries have interpreted the regulation to mean that OTs and PTs employed by physicians cannot be enrolled as therapists in private practice. In these carrier areas, therapy services provided in a physician's office must instead be billed as incident to a physician's service.

A specialty society representing OTs has requested that carriers be able to enroll OTs in physician-directed groups as OTs in private practice. A group representing PTs believes that provider numbers should be issued only to PTs working as employees in practices owned and operated by therapists.

We proposed to clarify national policy and revise §§ 410.59 and 410.60 to state we would allow enrollment of therapists as PTs or OTs in private practice when employed by physician groups. We believe that this reflects actual practice patterns, will permit more flexible employment opportunities for therapists and will also increase beneficiaries' access to therapy services, particularly in rural areas.

Comments: We received many comments from associations, specialty groups, therapists, and the public that strongly support the proposed clarification that would allow carriers and fiscal intermediaries to enroll therapists as PTs or OTs in private practice when they are employed by physician groups. However, one association urged us to confirm that this policy extends to therapists employed by a non-professional corporation.

Response: We agree and will change the regulation to reflect that carriers and fiscal intermediaries can enroll therapists as PTs or OTs in private practice when the therapist is employed by physician groups or groups that are not professional corporations, if allowed by State law.

Comments: Several commenters suggested that we state clearly that carriers and fiscal intermediaries are required to enroll physician-employed therapists, who are otherwise qualified, and that carriers and fiscal intermediaries may not refuse to enroll therapists simply on the basis of employment. They requested that the regulation state specifically that Medicare contractors must enroll therapists as PTs or OTs in private practice when they are employed or under contractual relationships with physician groups or groups that are not professional corporations.

Response: We agree and will change the Medicare Carriers and Fiscal Intermediaries Manuals' to reflect that carriers and fiscal intermediaries “will” enroll Medicare therapists as PTs or OTs in private practice for purposes of Medicare when the therapists are employed by physician groups or groups that are not professional corporations. However, we do not believe that we need to specify further employee-employer relationships, which are detailed in the Medicare Carriers Manual, Part 3, Chapter III.

Comment: One commenter believed that we should not enroll PTs who are employees of physicians' offices as PTs or OTs in private practice but, instead, should establish a separate section of the regulations that would govern the issuance of provider numbers to PTs who are employees in physicians' offices, and give these therapists a different designation. The commenter suggested we also include protections that currently exist when a non-physician practitioner provides services in a physician's office and the physician bills for these services under the physician's Medicare provider number.

Response: We disagree with this comment. We have established procedures for issuing provider numbers that we believe are adequate. The proposed changes to the regulations reflect actual practice patterns, will permit more flexible employment opportunities for all therapists, and also increase beneficiary access to therapy services, particularly in rural areas. Therapists still have the flexibility of providing outpatient therapy services incident to a physicians service if they so choose. However, the services must meet the incident to requirements at § 410.26.

Final Decision

We will finalize our proposal to revise §§ 410.59 and 410.60 with the modifications noted above.

E. Clinical Social Worker Services

In the June 28, 2002 proposed rule, (67 FR 43846), we indicated we would be addressing comments received on the October 19, 2000 proposed rule entitled, “Clinical Social Worker Services,” (65 FR 62681), in this final rule. Upon further review, we have determined that we will not include this issue in this final rule, but will address it in future rulemaking.

F. Medicare Qualifications For Clinical Nurse Specialists

Currently, the qualifications for a clinical nurse specialist (CNS) include a requirement that a CNS must be certified by the American Nurses Credentialing Center (ANCC). We proposed to revise this particular requirement under the CNS qualifications because of concerns expressed that the ANCC does not provide certification for CNSs who specialize in fields such as oncology, critical care, and rehabilitation. Additionally, we noted that the proposed revision of the certification requirement for CNSs is consistent with the certification requirement under the nurse practitioner (NP) qualifications. Accordingly, we proposed specifically to revise section § 410.76(b)(3) to read as follows:

“Be certified as a clinical nurse specialist by a national certifying body that has established standards for clinical nurse specialists and that is approved by the Secretary.”

Comments and Responses

We received comments on the proposed revision to the CNS certification requirement from professional nursing societies, a specialty nursing certification corporation, a college of radiology, a major nurses association, a provider of health care and elder care and, several independent clinical nurse specialists.

Comment: We received comments indicating that the current CNS certification requirement poses a serious threat to ensuring Medicare beneficiary access to quality care because it restricts CNSs who are not certified by the ANCC from qualifying for Medicare payment. The ANCC does not certify CNSs in oncology, rehabilitation, acute care or critical care. Since the current CNS certification requirement inherently precludes CNSs who are certified in oncology from Medicare payment, the number of nurses available to care for Medicare beneficiaries with cancer is limited. The proposed change to the CNS qualifications is more inclusive, and it will enable the 415 oncology CNSs who hold Advanced Oncology Nursing Certification (AOCN) provided by the Oncology Nursing Certification Corporation (ONCC) to meet the certification criteria for CNSs and therefore, qualify for Medicare payment. An independent CNS stated that as a palliative care CNS, her institution required advanced certification that is not offered by the ANCC in many specialty areas of practice. However, the American Board of Nursing Specialties is the credentialing board for the ONCC, which is the only national certification that an advanced practice nurse can obtain specific to his or her field of expertise. All of the commenters support the proposed revision to the CNS certification requirement because they stated that overall, the certification criteria for CNSs will be consistent with the certification criteria for NPs and the requirement will ensure that Medicare beneficiaries receive services from advanced practice nurses who are certified by a national certifying body.

Response: It has not been our intention to be overly restrictive in our program requirements and consequently prevent qualified CNSs who specialize in areas of medicine other than those certified by the ANCC from participating under the Medicare program's CNS benefit and rendering care to patients in need of specialized services. The intent of the revised CNS certification requirement is to recognize all appropriate national certifying bodies for CNSs as the program does for NPs.

Result of Evaluation of Comments

We are implementing the proposed revision to the CNS certification requirement under the CNS qualifications at § 410.76.

G. Process To Add or Delete Services to the Definition of Telehealth

In the June 2002 proposed rule (67 FR 43862), we proposed to establish a process for adding or deleting services from the list of telehealth services, and to add specific services to the list of telehealth services for CY 2003.

We stated that we would accept proposals from any interested individuals or organizations from either the public or the private sectors, for example, from medical specialty societies, individual physicians or practitioners, hospitals, and State or Federal agencies. We also mentioned that we might internally generate proposals for additions or deletions of services.

We stated that we would post instructions on our website outlining the steps necessary to submit a proposal. Please see the June 2002 proposed rule for the items that were to be addressed, the assignment of categories, and the outcomes.

We proposed to remove a service from the telehealth list of services if, upon review of the available evidence, we determine that a telehealth service is not safe, effective, or medically beneficial when performed as a telehealth service.

We proposed to make additions or deletions to the list of telehealth services effective on a CY basis. We proposed to use the annual physician fee schedule proposed rule published in the summer and the final rule published by November 1 each year as the vehicle for making these changes. Requests must be received no later than December 31 of each CY to be considered for the next proposed rule.

Based upon further review of the comments submitted in response to the proposed rule for CY 2002, we believe that the psychiatric diagnostic interview is similar to the telehealth services listed in the statute. Specifically, we believe this service would meet the criteria set forth in Category 1 of the proposed process for adding services. Therefore, we proposed to add psychiatric diagnostic interview examination as represented by CPT code 90801 to the list of telehealth services and proposed to revise §§ 410.78 and 414.65 to reflect the proposed addition to the list of telehealth services.

Comment: We received many comments expressing support for our proposed process for adding and deleting telehealth services. The commenters indicated that our proposed criteria for reviewing submitted requests are reasonable and provide a viable mechanism for adding existing services to the list of telehealth services. However, as part of our review, one specialty college suggested that the CPT editorial panel be an integral part of our process. The commenter stressed that reviewing codes and determining how these services can be furnished is the CPT editorial panel's area of expertise. With regard to deletion of services, one association urged us to consult with the appropriate medical society members to obtain clinical evidence based on peer-reviewed information and medical journal articles before deleting services from the list of telehealth services.

Response: Section 1834(m) of the Act requires us to develop a process specifically for adding or deleting telehealth services on an annual basis. The mandate for this statutory provision is separate and distinct from the role of the AMA CPT editorial panels in developing new codes and/or defining services for the CPT compendia. It would not be appropriate to make the CPT editorial panel an integral part of the process to add or delete services from the list of telehealth services. We will review submitted requests for addition and deletion based on the criteria discussed in this final rule and welcome input from medical professionals with expertise in the service being reviewed as part of the rulemaking process.

We are clarifying from the proposed rule that a decision to remove a service from the list of telehealth services would be made using evidence-based, peer-reviewed data which indicate that a specific telehealth service is not safe, effective, or medically beneficial. Such determination would not be made under section 1862(a)(1)(A) of the Act. Therefore, a decision to delete a service under this process would only apply to the list of Medicare telehealth services.

Comment: One commenter suggested that we publish a summary of any requests that are rejected.

Response: As stated in the proposed rule, we will use the annual physician fee schedule as a vehicle to make changes to the list of telehealth services. As part of the rulemaking process, we will publish a summary in the proposed rule of the requests that we receive with an explanation as to why a service is added, deleted, or a request is rejected.

Comment: One commenter requested that, if possible, we look for ways to shorten the time frame between the submittal of a request and the actual implementation. The commenter stated that actual implementation of an additional telehealth service could take a year or more from the date of the request.

Response: The statute requires us to establish a process that provides for the addition or deletion of telehealth services on an annual basis. We understand that in some cases our review and subsequent implementation of a decision to accept a request may take up to and possibly more than a full year. However, we believe that using the annual physician fee schedule rulemaking schedule would be the most efficient and time sensitive mechanism for publishing changes to the list of telehealth services.

A national coverage determination (NCD) is a possible alternative to the rulemaking process for adding or deleting telehealth services. In formulating the proposed process to add services to the list of telehealth services, we considered using the NCD process. For instance, under this option, all requests for addition, whether the request is considered an existing or new service, would be required to complete the requirements for an NCD. We rejected this option because we believe that many telehealth applications are existing services provided through a different delivery mechanism. We believe that subjecting all requests for addition to the evidence-based requirements of an NCD would be unnecessary, and would be contrary to the public interest.

Comment: A large number of commenters applauded the addition of the psychiatric diagnostic interview examination to the list of telehealth services. Commenters generally agreed that the psychiatric diagnostic interview includes components that are comparable to an initial office visit or consultation, which are currently telehealth services.

Response: We agree with the comment.

Comment: We received two comments regarding general telehealth policy. One commenter urged us to expand the definition of an originating site. For example, the commenter believes that hospitals with inadequate physician ratios relative to the treatment of acute ischemic stroke patients should be considered as an originating site, regardless of geographic location or whether the hospital is located in a designated health professional shortage area. The other comment pertained to the physician or practitioner who provides the telehealth service at the distant site. In this regard, one association encouraged us to support the addition of speech language pathologists and audiologists to the list of practitioners that may provide and receive payment for telehealth services.

Response: The statute permits hospitals to serve as originating sites for any Medicare telehealth service as long as the hospital is located in a rural HPSA or in a non-MSA county. Thus, the commenter would be able to serve as an originating site for the treatment of acute ischemic stroke patients if the hospital is located in these geographic areas. The statute is explicit regarding the types of practitioners who can provide and receive payment for telehealth services. Speech language pathologists and audiologists are not included within the list of medical professionals that may provide and or receive payment for telehealth services at the distant site. We are reviewing these issues as part of a report to the Congress as required by the BIPA.

Result of Evaluation of Comments

We are adopting the process to add or delete telehealth services and adding the psychiatric diagnostic interview examination to the list of telehealth services as stated in the proposed rule. Additionally, we are referencing the process to add or delete services at new § 410.78(f).

H. Definition for ZZZ Global Periods

Services with ZZZ global periods are add-on services that can be billed only with another service. Before CY 2003, we paid only the incremental intraservice work and practice expense RVUs associated with the add-on service for a code with a global indicator of ZZZ. Any pre-service or post-service work associated with a service with a global indicator of ZZZ is considered accounted for in the base procedure with which these add-on services must be billed. However, based on comments from the RUC and specialty societies that some add-on services contain separately identifiable post-service work and practice expense RVUs, we proposed to revise the current definition of a ZZZ global period as follows:

“ZZZ = Code related to another service and is always included in the global period of the other service (Note: Physician work is associated with intra-service time and in some instances the post-service time).”

Comments: The commenters supported this change. However, several specialty organizations, as well as the RUC, stated that there are instances when pre-service time should be considered, and they recommended that we amend the definition to include pre- and post-service time.

Response: We agree with the commenters and will revise the definition to consider pre-service time as well post-service time. However, when a code with a ZZZ global indicator is considered by the RUC or PEAC, we will require that all base codes with which the ZZZ codes are billed are also considered by the RUC and PEAC to assure that both physician work and practice expense RVUs are appropriate for the base and add-on codes and to assure that no duplicate payment is made.

Result of Evaluation of Comments

The definition of a ZZZ global period will be revised as follows:

“ZZZ = Code related to another service and is always included in the global period of the other service (Note: Physician work is associated with intra-service time and in some instances the pre- and post-service time).”

I. Change in Global Period for CPT Code 77789 (Surface Application of Radiation Source)

Based on a suggestion from the RUC, we proposed to change the global period for CPT code 77789 (surface application of radiation source) from a 90-day global period to a 000-day global period. We stated that we did not need to adjust the current work values or the practice expense inputs for supplies and equipment, but we would adjust the clinical staff practice expense inputs to reflect that there is no post-procedure visit.

Comment: The commenters supported this change and noted that the PEAC attributed clinical times for this CPT code of 34 minutes for the registered nurse and 6 minutes for the physicist. The commenters did not believe the practice expense RVUs should change significantly, if at all, as a result of this adjustment in the global period.

Response: We had not received the PEAC recommendations at the time the proposed rule was written, and we proposed a change to the original CPEP inputs that included time for a post-procedure visit. We have reviewed and accepted the above PEAC recommended clinical staff times.

Result of Evaluation of Comments

We are changing the global period for CPT code 77789 (surface application of radiation source) from a 90-day global period to a 000-day global period as proposed.

J. Technical Change for § 410.61(d)(1)(iii) Outpatient Rehabilitation Services

Based on comments received that § 410.61(d)(1)(iii) incorrectly references “physical” therapy when it should reference “occupational” therapy, we proposed to revise § 410.61(d)(1)(iii) to correct this error.

Final Decision

No comments were received on this proposed technical correction. We will correct § 410.61(d)(1)(iii) by replacing the word “physical” with “occupational” as proposed.

K. HCPCS G-Codes From June 28, 2002 Proposed Rule

In the June 28, 2002 rule we proposed the following new HCPCS G codes.

1. Codes for Treatment of Peripheral Neuropathy

Effective for services furnished on or after July 1, 2002, Medicare will cover an evaluation (examination and treatment) of the feet every six months for individuals with a documented diagnosis. This policy is a national coverage determination.

G0245: Initial physician evaluation of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (LOPS) which must include the procedure used to diagnose LOPS; a patient history; and a physical examination that consists of at least the following elements—

(a) Visual inspection of the forefoot, hindfoot and toe-web spaces;

(b) Evaluation of protective sensation;

(c) Evaluation of foot structure and biomechanics;

(d) Evaluation of vascular status and skin integrity;

(e) Evaluation and recommendation of footwear; and

(f) Patient education.

We proposed to crosswalk work and malpractice RVUs and the practice expense inputs from CPT code 99202, a level two, new patient office visit code. We proposed to revalue the practice expense RVUs using the practice expense methodology once we have utilization data for these codes.

G0246: Follow-up evaluation of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (LOPS) to include at least the following, a patient history and physical examination that includes—

(a) Visual inspection of the forefoot, hindfoot and toe-web spaces;

(b) Evaluation of protective sensation;

(c) Evaluation of foot structure and biomechanics;

(d) Evaluation of vascular status and skin integrity;

(e) Evaluation and recommendation of footwear; and

(f) Patient education.

We proposed to crosswalk the work and malpractice RVUs from CPT code 99212, a level two, established-patient office visit code. We also proposed to crosswalk the practice expense inputs from CPT code 99212 and to revalue the practice expense RVUs using the practice expense methodology once we have utilization data for these codes.

G0247: Routine foot care of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (LOPS) to include if present, at least the following—

(a) Local care of superficial wounds;

(b) Debridement of corns and calluses; and

(c) Trimming and debridement of nails.

We proposed to crosswalk the work and malpractice RVUs and the practice expense inputs from CPT code 11040, Debridement; skin; partial thickness. We would revalue the practice expense RVUs using the practice expense methodology once we have utilization data for this code.

Comment: The American Podiatric Medical Association (APMA) believes that the RVUs assigned to HCPCS codes G0245 and G0246 are too low. They do not believe that the assigned RVUs account for the physician work and practice expense required to perform those services. They recommended that we crosswalk the RVUs from CPT codes 99203 and 99213 to these codes instead of the crosswalk we actually used, from CPT codes 99202 and 99212. They also commented that the RVUs assigned for G0247 were too low and should be increased as the assigned RVUs did not account for the required physician work. Alternatively, they recommended that we delete G0247 and allow a physician to report CPT codes that described similar services. A large medical clinic commented that they were not sure why CMS had implemented these codes. They believe that if the only reason for creating codes was to permit us to track the services, this reason is insufficient because the codes cause significant administrative burden to physician practices. They believe that providers could use other CPT codes to report these services instead of the G codes. A carrier medical director familiar with these services commented that G0247 is overvalued because the most common service provided using this code will be toe nail trimming and debridement and that the CPT code for toe nail trimming and debridement is valued much lower then G0247.

Response: These G codes were created to implement a national coverage determination (NCD). The coverage determination was very specific with regard to the required components of each service. Furthermore, the NCD specifically allowed these services to be performed no more than every six months and allowed the initial visit to be performed only once per physician for the lifetime of a beneficiary. Creation of these G codes allows us to implement the coverage decision, especially with regard to the required frequency limitation and to track the utilization of these services while minimizing provider burden. Reporting these services with CPT evaluation and management (E/M) codes and procedure codes would have resulted in numerous post-pay audits while creation of a modifier to be used in conjunction with such CPT codes would have been quite burdensome and resulted in just as many post pay audits. Therefore, we plan to continue requiring these G codes for reporting of these services.

With regard to the valuation of these services we will finalize the proposed RVUs. This service is provided to those diabetic beneficiaries who are “at risk” for foot-care problems but who do not have an injury or illness of the foot. Any service provided to a diabetic beneficiary with an illness or injury to the foot (for example, foot pain, foot ulcer, foot infection) should be reported using the appropriate CPT codes (for example, E/M service, debridement service). Furthermore, the requirements for provision of care to LOPS patients are clearly set forth in the NCD. Nothing beyond those requirements need be performed in order to report a LOPS HCPCS code. Careful scrutiny of the requirements for provision of initial LOPS services shows that they are most similar to the requirements of a level 2 E/M service. The lack of illness, injury, or deformity in these patients and the requirements that the practitioners need only to take a history and to examine the foot are quite similar to the requirements of CPT code 99202: an expanded problem focused history, an expanded problem focused examination, and straightforward medical decision making. For follow-up patients who do not have an illness, injury, or deformity, the requirements of the NCD are quite similar to the requirements of CPT code 99212: a problem focused history, a problem focused examination, and straightforward medical decision making. With regard to G0247, we agree with the carrier medical director who stated that the most commonly performed procedure would be toenail trimming and or debridement. However, review of the work RVUs for CPT codes 11719 (0.17), 11720 (0.32), 11721 (0.54), 11055 (0.43), 11056 (0.61), 11057 (0.79), and 11040 (0.50) shows that we have properly valued this service. We believe that a work value of 0.50 RVUs appropriately accounts for what is likely to be the typical combination of services provided to eligible beneficiaries.

Result of Evaluation of Comments

We will continue requiring these G codes for reporting of these services and are finalizing the RVUs as proposed.

2. Current Perception Sensory Nerve Conduction Threshold Test (SNCT)

G0255: Current Perception Threshold/Sensory Nerve Conduction Test, (SNCT) per limb, any nerve

We proposed a G-code that represents SNCT as a diagnostic test used to diagnose sensory neuropathies. This test is noninvasive and uses a transcutaeous electrical stimulus to evoke a sensation. However, we determined that there is insufficient scientific or clinical evidence to consider the use of this device as reasonable and necessary within the meaning of section 1862(a)(1)(A) of the Act and indicated Medicare will not pay for this type of test.

Comment: One commenter requested that the descriptor for this code be revised, as the current descriptor “Current Perception Threshold/Sensory Nerve Conduction Test” is very similar to other codes for example, the short descriptor for CPT code 95904 is “Sense Nerve Conduction Test”. The commenter recommended changing the descriptor for this G code to “Current Perception Threshold Test”.

Response: We appreciate the commenters bringing this to our attention and have revised the short descriptor for this G code to address the concern they raised. The short descriptor for this G code will be “Current perception threshold test”.

Result of Evaluation of Comments: We will finalize our proposal for G0255 but will revise the short descriptor as discussed above.

3. Positron Emission Tomography (PET) Codes for Breast Imaging

Medicare has expanded the coverage indications for PET scanning to include imaging for breast cancer, and we have created codes that describe staging and restaging after or prior to the course of treatment of breast cancer. We also created a PET scan code to evaluate the response to treatment of breast cancer.

PET imaging for initial diagnosis of breast cancer and/or surgical planning for breast cancer are described by a CPT code, but Medicare will not cover the procedure for this diagnosis.

G0252: PET imaging for initial diagnosis of breast cancer and /or surgical planning for breast cancer (for example, initial staging of axillary lymph nodes), not covered by Medicare.

We stated that this code is not covered by Medicare because there is a national non-coverage determination for the use of PET imagery for the initial diagnosis of breast cancer and initial staging of axillary lymph nodes.

G0253: PET imaging for breast cancer, full and partial-ring PET scanners only, staging/restaging after or prior to course of treatment.

G0254: PET imaging for breast cancer, full and partial-ring PET scanners only, evaluation of response to treatment, performed during course of treatment.

We proposed that the TC and global for both of these codes be carrier-priced. For the PC for codes G0253 and G0254, we proposed to make the PC work RVU equal to 1.87 and use practice expense RVUs of 0.58 and malpractice RVUs of 0.07 since there are no direct inputs for PC services.

Comments: Commenters expressed appreciation for creation of these G codes; however, one commenter was concerned that the TC and global component of these codes will be carrier-priced which, the commenter contended, could lead to widely varying and unjustifiably low payment rates, particularly if there is no national benchmark.

Response: Carriers use a variety of methods and resources when developing payment rates for services that they are responsible for pricing. We do not believe that having the carriers price these codes will lead to unjustifiably low payment rates.

Result of Evaluation of Comments: We are adopting the proposals for these G codes; however, we have made editorial revisions to the descriptors for G0252 and G0253 to more accurately describe the service provided. The revised descriptors are as follows:

G0252: PET imaging, full and partial-ring PET scanners only, for initial diagnosis of breast cancer and /or surgical planning for breast cancer (for example, initial staging of axillary lymph nodes).

G0253: PET imaging for breast cancer, full and partial-ring PET scanners only, staging/restaging of local regional recurrence or distant metastases (that is, staging/restaging after or prior to course of treatment).

4. Home Prothrombin Time International Normalized Ratio (INR) Monitoring for Anticoagulation Management

For services furnished on or after July 1, 2002, Medicare will cover the use of home prothrombin time or INR monitoring in a patient's home for anticoagulation management for patients with mechanical heart valves. A physician must prescribe the testing. The patient must have been anticoagulated for at least three months prior to use of the home INR device, and the patient must undergo an education program. The testing with the device is limited to a frequency of once per week.

G0248: Demonstration, at initial use, of home INR monitoring for a patient with mechanical heart valve(s) who meets Medicare coverage criteria, under the direction of a physician; includes: demonstration use and care of the INR monitor, obtaining at least one blood sample provision of instructions for reporting home INR test results and documentation of a patient's ability to perform testing.

We proposed that this code be assigned no work RVUs and .01 malpractice RVUs. For the practice expense inputs, we proposed 75 minutes of RN/LPN/MTA staff time; a supply list including four test strips, lancets and alcohol pads, a patient education booklet, and batteries for the monitor; and equipment consisting of a home INR monitor. These proposed inputs result in an estimated practice expense RVU of 2.92.

G0249: Provision of test materials and equipment for home INR monitoring to patient with mechanical heart valve(s) who meets Medicare coverage criteria. Includes provision of materials for use in the home and reporting of test results to physician; per 4 tests.

We proposed this code be assigned no work RVUs and .01 malpractice RVUs. For the practice expense inputs, we proposed 13 minutes of RN/LPN/MTA staff time; a supply list including four test strips, lancets and alcohol pads, and equipment consisting of a home INR monitor. These resulted in an estimated practice expense RVU of 2.08.

G0250: Physician review/interpretation and patient management of home INR test for a patient with mechanical heart valve(s) who meets other coverage criteria; per 4 tests (does not require face-to face service)

We proposed this code be assigned 0.18 work RVUs and .01 malpractice RVUs. We stated that there would be no direct practice expense inputs for this code, and the use of the practice expense methodology to develop the indirect practice expense of the physician performing this service resulted in an estimated practice expense RVU of 0.07. Note: Subsequent to the publication of the proposed rule, we updated the payment rates for home PT/INR monitoring via Program Memorandum AB-02-112 (July 31, 2002). Based on a correction in the practice expense methodology used to calculate the practice expense RVUs issued in the Program Memorandum AB-02-064 on May 2, 2002 and included in the June 28, 2002 proposed rule there was an increase in practice expense RVUS for G0248 to 3.06 and to 3.28 for G0249 effective for services performed after October 1, 2002.

Comment: A manufacturer of equipment used to perform INR monitoring at home was concerned that the proposed RVUs for the HCPCS codes used to report Home INR monitoring services were inconsistent with the RVUs published in Program Memorandum AB-02-112 issued on July 31, 2002. (This program memorandum was issued to correct an error that had resulted in the original RVUs for these codes being too low.) The commenter also requested that we clarify the descriptor for the HCPCS code used to report provision of Home INR materials to assure that Medicare only paid for properly controlled INR tests that were consistent with FDA labeling.

Response: The aforementioned program memorandum was issued after the Proposed Rule (NPRM) was published. We agree with the commenter that the physician fee schedule for 2003 should reflect the RVUs as published in the July 31, 2002 program memorandum and will make this change.

With regard to changing the descriptors for the HCPCS code used to report provision of home INR test materials, we will review this issue and, if appropriate, clarify the descriptor as requested for CY 2004.

Comment: Several commenters asked CMS to expand the covered indications for home INR monitoring.

Response: We direct these commenters to the published process for requesting a national coverage determination. In order for the covered indications to be expanded on a national level this process must be followed.

Comment: A manufacturer of equipment used for home INR monitoring pointed out that there were several companies who manufacture test strips. Producing a test result may require one or three test strips depending on the manufacturer. Additionally, the cost of test strips from each manufacturer is different and Medicare based its payment on the cost of a test strip from only one manufacturer.

Response: We agree that there are several types of test strips available. However, we also understand that not all manufacturers are currently providing new home INR monitoring equipment and that the market share for each product is in flux. We will review the appropriate payment for this service, including the appropriate amount to include for test strips, after we have sufficient experience paying for this service. The earliest time that we could consider proposing a change in payment rate would be for the 2005 physician fee schedule; at that time, we would have 18 months worth of payment data upon which we could base a proposal.

Result of Evaluation of Comments

As indicated above, payment for CY 2003 for these services will reflect the corrections made in the Program Memorandum AB-02-112 issued on July 31, 2002.

5. Bone Marrow Aspiration and Biopsy on the Same Date of Service

We proposed a new G code (GXXXX) that reflects a bone marrow biopsy and aspiration procedure that is performed on the same date, at the same encounter, through the same incision, based on our understanding that the typical case involves an aspiration and biopsy through the same incision.

We proposed physician work RVUs of 1.56 and malpractice RVUs of 0.04. We also proposed to crosswalk the practice expense inputs from CPT code 38220, Bone marrow aspiration, with the assignment of an additional five minutes of clinical staff time. These proposed inputs in the practice expense methodology resulted in an estimated practice expense RVU of 3.32 in the nonfacility setting and 0.60 in the facility setting.

We also noted that if the two procedures, aspiration and biopsy, are performed at different sites (for example, contralateral illiac crests, sternum/illiac crest, two separate incisions on the same iliac crest or two patient encounters on the same date of service), the CPT codes for aspiration and biopsy would each be used along with the -59 modifier.

Comment: Two commenters, one representing a provider and the other a specialty organization, agreed with the proposal to create a G code for bone marrow aspiration and biopsy on the same date of service. However, another specialty organization and the AMA did not agree with the creation of this new G code and felt its creation was unnecessary. These commenters indicated that CPT currently has sufficient and accurate coding for these services that is, CPT codes 38220 and 38221 which when performed through the same incision could both be reported with the modifier 51 (used in reporting of multiple procedures performed in the same incision) appended. In addition, the commenters stated that the descriptor for this code does not adequately describe the procedure for which it is intended as it does not specifically state “through the same incision.” This could lead to a denial of services of all bone marrow aspiration and biopsies performed on the same date of service.

Response: After review of the comments, we agree that this code should go through the CPT process. Therefore, we are withdrawing our proposal to create this code. We will submit a code for “Bone Marrow Biopsy and Aspiration performed in the same bone” to CPT in time for the 2004 CPT cycle.

Result of Evaluation of Comments

We will not proceed with a separate G code for bone marrow biopsy and aspiration procedure that is performed on the same date, at the same encounter.

Creation of G Codes

Comment: Several commenters expressed concern about the increasing frequency of G codes being issued by us. Commenters believed that, in the interest of coding standardization, accuracy, and clarity, G codes should only be developed as a last resort and should be temporary. Commenters believed that an annual meeting with us to discuss codes that may be necessary to accommodate new payment and coverage policies would help reduce the number of G codes. Some commenters also asked for greater physician involvement in the HCPCS editorial process (for example, direct representation of the physician community on the panel).

Response: We agree that, where appropriate, G codes should be temporary. Unfortunately, it is sometimes necessary to develop G codes to accommodate changes in legislation, regulation, coverage, and payment policy. The timetable for such changes is not necessarily consistent with the timetable for CPT publication and frequently these changes must be made on a quarterly basis.

In 2002 CMS and CPT staff, working together, reviewed all existing G codes and agreed to transition over 20 of them to CPT codes. Therefore, for 2003 many G codes are being deleted in favor of newly created CPT codes. (See section IV for a discussion of deleted G codes). We believe that an annual review of G codes by CMS and CPT staff is the best way to determine which G codes should be transitioned to CPT codes and the process to use for such a transition. Therefore, we plan to continue working with CPT staff on an annual basis to continue transitioning existing G codes to CPT codes. We believe such an annual comprehensive review will address the commenters' concerns. However, we do wish to emphasize that we, when appropriate, does consult with interested providers prior to the creation of G codes in order to facilitate coding clarity and minimize physician burden.

L. Endoscopic Base For Urology Codes

Cystoscopy and treatment CPT codes 52234, 52235, and 52240 were inadvertently identified in the Medicare Physician Fee Schedule Database as services subject to the reductions for multiple procedures as opposed to the procedural reduction rules specific to endoscopic services. This has resulted in our overpaying for these services. We proposed applying the endoscopic reduction rules to these services and identified CPT code 52000 as the endoscopic base code for these services.

Comment: The American Urological Association was in agreement with our proposal to apply the endoscopic reduction rules to CPT codes 52234, 52235, and 52240.

Final Decision: The endoscopic reduction rules will be applied to these three codes as proposed.

M. Physical Therapy and Occupational Therapy Caps

Section 4541(c) of the Balanced Budget Act of 1997 required application of a payment limitation to all rehabilitation services provided on or after January 1, 1999. The limitation was an annual per beneficiary limit of $1500 on all outpatient physical therapy (PT) services (including speech-language pathology services). A separate $1500 limit was applied to all occupational therapy (OT) services. (The limitation amounts were to be increased to reflect medical inflation.) The annual limitation did not apply to services furnished directly or under arrangement by a hospital to an outpatient or to an inpatient who is not in a covered Part A stay.

Section 221 of the Balanced Budget Refinement Act of 1999 (BBRA) (Pub. L. 106-113, enacted on November 29, 1999) placed a moratorium on the application of the payment limitation for two years from January 1, 2000 through December 31, 2001. Section 421 of the Medicare, Medicaid, and SCHIP Beneficiary Improvement and Protection Act of 2000 (BIPA) (Pub. L. 106-554, enacted on December 21, 2000), extended the moratorium on application of the limitation to claims for outpatient rehabilitation services with dates of service January 1, 2002 through December 31, 2002. As we explained in the June 28, 2002 proposed rule, outpatient rehabilitation claims for services rendered on or after January 1, 2003 will be subject to the payment limitation unless the Congress acts to extend the moratorium.

Comments: We received comments from associations and societies urging us to support the permanent repeal of the $1500 financial limitation on PT, including speech language pathology, and a separate $1500 financial limitation on OT. All commenters stated that this financial limitation would adversely affect nursing home beneficiaries who receive Part B therapy services.

Response: As stated before, we will implement the outpatient rehabilitation therapy financial limitation via a Program Memorandum to Carriers and Fiscal Intermediaries, unless the Congress acts to extend the moratorium or repeals the legislation.

III. Other Issues

A. Definition of a Screening Fecal-Occult Blood Test

One commenter suggested that the current definition of a screening fecal-occult blood test at § 410.37(a)(2) that limits coverage to guaiac-based tests should be expanded to permit coverage of another test. The commenter suggested that this change be made in the final rule because the June 2002 proposed rule added a variety of new HCPCS G codes similar to the G code for which the commenter has requested for its new fecal-occult blood test.

Based on our analysis of the preliminary information we have on the new test, we believe that it may have the potential for effective screening for colorectal cancer, and thus, we have agreed with the commenter to broaden the definition in § 410.37(a)(2) to permit coverage of non-guaiac based tests. However, in order to establish national coverage of the new test under the Medicare colorectal cancer screening benefit we must first compare the clinical utility of the test to the existing guaiac-based test. If, for instance, the test is not as effective as the currently covered test, it would not make sense to authorize coverage as permitted by section 1861(pp)(1)(D) of the Act.

To facilitate our consideration of future coverage of other new types of fecal-occult blood tests, we have decided to amend § 410.37(a)(2) to provide that in addition to the guaiac-based screening test, other types of fecal-occult blood tests may be covered under the screening benefit, if we determine that this is appropriate through a national coverage determination (NCD). This change will allow us to conduct a more timely assessment of other new types of fecal-occult blood tests that may have been approved or cleared for marketing by the Food and Drug Administration (FDA) than is possible under the standard rulemaking process. We intend to use the NCD process, which includes an opportunity for public comments, for evaluating the medical and scientific issues relating to the coverage of additional tests that may be brought to our attention in the future. Use of an NCD to establish a change in the scope of benefits is authorized by section 1871(a)(2) of the Act.

In accordance with section 1861(pp)(1)(D) of the Act, we have discretion to determine that additional tests or procedures are appropriate and can be used for the early detection of colorectal cancer. This authority is currently reflected in § 410.37(a)(1)(v). We are amending that section to announce that approval of any new tests or procedures for use in early detection of colorectal cancer will be made through an NCD. The use of an NCD, authorized by section 1871(a)(2) of the Act, will permit public participation. The NCD process, however will allow Medicare to expand coverage for additional tests or procedures when warranted more rapidly than the notice and comment procedures of the Administrative Procedure Act would normally permit.

B. Clarification of Services and Supplies Incident to a Physician's Professional Services: Conditions

In the November 2001 final rule (66 FR 55238) we revised regulations on services and supplies furnished incident to a physician's professional services. In the revised regulations at § 410.26(a)(7) we defined such services and supplies as “ * * * any services and supplies * * * that are included in section 1861(s)(2)(A) of the Act and are not specifically listed in the Act as a separate benefit included in the Medicare program.”

We are clarifying that services having their own statutory benefit category are covered under that category rather than as incident to services. This means that they are subject to manual and other program operating instructions pertaining to their specific statutory benefit category. In addition, they are not required to meet incident to implementing instructions such as those in section 2050 of Part III of the Medicare Carriers Manual (MCM). For example, diagnostic tests are covered under section 1861(s)(3) of the Act and are subject to the requirements for diagnostic tests in MCM section 2070. Depending on the particular test, the supervision requirement in section 2070 may be more or less stringent than that in section 2050 for incident to services. When diagnostic tests are furnished, the requirements for diagnostic tests apply, and not those for incident to services. Likewise, pneumococcal, influenza, and hepatitis B vaccines are covered under section 1861(s)(10) of the Act and do not need to meet incident to requirements.

While we believe our regulations are clear on this point, one of the comments and responses published in our November 2001 final rule has caused some confusion on this issue. The comment and response were as follows:

Comment: “Many commenters wanted us to re-emphasize that incident to services set forth in section 1861(s)(2)(A) of the Act do not include Medicare benefits separately and independently listed in the Act, such as diagnostic services set forth in section 1861(s)(3). Some requested that we not permit these separately and independently listed services to be furnished as incident to services.”

Response: “We realize, as did the Congress with the enactment of section 4541(b) of the BBA, that many services—even those that are separately and independently listed—can be furnished as incident to services. However, this fact of medical practice is not inconsistent with our policy. We maintain that a separately and independently listed service can be furnished as an incident to service but is not required to be furnished as an incident to service. Furthermore, even if a separately and independently listed services is provided as an incident to service, the specific requirements of that separately and independently listed service must be met. For instance, a diagnostic test under section 1861(s)(3) of the Act may be furnished as an incident to service. Nevertheless, it must also meet the requirements of the diagnostic test benefit set forth in § 410.32. Specifically, the test must be ordered by the treating practitioner, and it must be supervised by a physician. Thus, if a test requires a higher level of physician supervision than direct supervision, then that higher level of supervision must exist even if the test is furnished as an incident to service. Accordingly, we decline to prohibit a separately and independently listed service from being furnished as an incident to service. Instead, we reiterate that a separately and independently listed service need not meet the requirements of an incident to service.”

The intent of the above response was to state that for a service having its own separately and independently listed statutory benefit category, Medicare carriers should apply the requirements of that separately listed benefit category and not also apply the incident to requirements. We interpret § 410.26(a)(7) literally. That is, incident to services and supplies covered under 1861(s)(2)(A) of the Act means services and supplies not having their own independent and separately listed statutory benefit category.

Perhaps it could be argued that any service provided under the direct supervision of a physician could be considered an incident to service. However, the Congress specifically provided for the many separate benefit categories of medical and health services in the Act. We believe that the Congress intended for incident to services to be a catch-all category to allow payment for certain services and supplies commonly furnished in a physician's office and not having their own separate benefit category. The billing of services with their own separate and independent coverage benefit categories as incident to may circumvent the coverage and payment rules applicable to those other categories. Therefore, only services that do not have their own benefit category are appropriately billed as incident to a physician service. Examples of benefit categories are diagnostic X-ray tests (section 1861(s)(3) of the Act) and influenza vaccine and its administration (section 1861(s)(10)(A) of the Act).

However, since section 4541(b) of the BBA allows certain services with their own benefit category (that is, outpatient physical therapy services (including speech-language pathology services) and outpatient occupational therapy) to also be provided as incident to services, we cannot prohibit physicians and practitioners from billing these services as incident to. However, when these services are billed incident to, requirements in Medicare Carriers Manual section 2050 must also be met. Note that the personal (in-the-room) supervision requirements for physical and occupational therapy assistants apply only to the private practice setting. The services of nurse practitioners, clinical nurse specialists and physician's assistants may be billed as incident to a physician's service if the incident to requirements are met, or those practitioners may bill their services separately under their own benefit.

C. Five-Year Review of Gastroenterology Codes

In the November 2001 final rule, (66 FR 55246), we finalized work RVUs for several gastrointestinal endoscopy codes that were reviewed by the RUC during the five-year review of physician work. However, we asked the RUC to review several families of gastrointestinal endoscopy codes to ensure that no rank order anomalies existed within those families. The procedures for gastrointestinal stent placement were among those families. Although we have not received further RUC recommendations for any gastrointestinal endoscopy codes, several specialty societies have submitted further information regarding the physician work required to perform gastrointestinal stent placement services. We have reviewed this information and are making several adjustments to the RVUs for these services. These adjustments are interim and we will respond to comments concerning these adjustments in next year's final rule.

CPT code 43219 Esophagoscopy, rigid or flexible; with insertion of plastic tube or stent

Based on the information we have reviewed (including physician intraservice time data), there is no compelling evidence that the physician work of this procedure is inappropriate. The work increment (1.21 work RVUs) beyond the base procedure CPT code 43200, Esophagoscopy, rigid or flexible; with or without collection of specimen(s) by brushing or washing (separate procedure) is appropriate. Therefore we are maintaining 2.8 work RVUs for CPT code 43219.

CPT code 43256 Upper gastrointestinal endoscopy including esophagus, stomach, and either the duodenum and/or jejunum as appropriate; with transendoscopic stent placement (includes predilation)

This code currently has 4.60 work RVUs. We reviewed physician time data for this service and believe that it is overvalued compared to the value of other stent placement procedures. Therefore, to place it in the proper rank order to other stent placement codes, we are assigning it 4.35 work RVUs. This makes the incremental work (1.96 work RVUs) above the base procedure CPT code 43235, Upper gastrointestinal endoscopy including esophagus, stomach and either the duodenum and/ or jejunum as appropriate; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure), in line with other stent placement codes.

CPT code 44383 Ileoscopy, through stoma; with transendoscopic stent placement (includes predilation)

This code currently has 3.26 work RVUs. We reviewed physician time data for this code and compared it to other stent placement codes. The incremental work value (2.21 work RVUs) above the base procedure CPT code 44380, Ileoscopy, through stoma; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure), is high. Therefore, we are reducing the work RVUs to 2.94. This gives it an incremental work value of 1.89 work RVUs which is similar to the incremental work value of CPT code 44397, Colonoscopy through stoma; with transendoscopic stent placement (includes predilation), and places it in the proper rank order with other stent placement codes.

D. Critical Access Hospital Emergency Services Requirements

Section 1820 of the Act provides for a nationwide Medicare Rural Hospital Flexibility Program (MRHF). The Act also provides that certain rural providers may be designated as critical access hospitals (CAHs) under the MRHF program if they meet qualifying criteria and the conditions for designation specified in the statute. Implementing regulations for section 1820 of the Act are located at 42 CFR part 485, subpart F.

Section 1820(c)(2)(B) of the Act implements specific conditions of participation (CoPs) that a facility must meet to be designated a CAH. The statutory criteria for State designation as a CAH require, in part, that the facility makes available 24-hour emergency care services that a State determines are necessary for ensuring access to emergency care services in each area served by a CAH. To help protect the health and safety of Medicare patients who seek emergency medical care at a CAH, our regulations at § 485.618 require CAHs to provide emergency care necessary to meet the needs of its patients.

In 2002, we received letters requesting a special waiver from the current emergency services personnel requirement (specified in § 485.618(d)) for CAHs in frontier areas and remote locations. The requests included the following comments; (1) A number of remote CAHs have been struggling to comply with the current CAH requirement; (2) the personnel requirement places a hardship on isolated frontier communities that have only one medical practitioner; and (3) often these remote facilities have a very low volume of patients which makes it difficult to recover all of their costs and to recruit other practitioners.

As of September 2002, the Cecil G. Sheps Center for Health Services Research at Chapel Hill, North Carolina has identified approximately 173 CAHs that are located in frontier areas (identified as having six individuals per square mile). The average population for a frontier CAH community is 7,024. We have no empirical data to indicate which of these 173 CAHs are currently experiencing workforce issues that create a hardship for the facility or any sole provider. However, the University of Washington conducted a survey of CAHs in May 2001 and learned that, of the 388 CAHs that responded to the survey, 146 facilities are in an isolated small rural census tract. Of these facilities, 10 have no physicians, 24 have only 1 physician, 39 have 2 physicians, and 26 have 3 physicians. Of the CAHs with no doctors, 6 have only 1 mid-level provider (4 of these are in Montana), and 3 have 2 mid-level providers (1 apparently had no physician or mid-level provider at the time of the survey). Of the 39 CAHs that had 2 physicians, 3 had no mid-level providers, and 12 had only 1 mid-level provider.

The Rural Health Research Center at the University of Washington, through its CAH National Tracking Project, reported that CAHs frequently cite problems with recruitment and retention of emergency medical personnel. Based on 2002 data, more than half of the designated CAHs are serving counties dually designated as both a Medically Underserved Area (MUA) and a Health Professional Shortage Area (HPSA). Less than 1 in 10 CAHs are located in counties without a HPSA or an MUA designation.

The delicate balance of providing access to care in very rural and remote areas without jeopardizing quality of care continues to be challenging. We believe that if a small CAH is forced to close because of the lack of qualified personnel, adding RNs to the list of approved personnel would greatly help CAHs with nogreater than 10 beds, in frontier areas or remote locations to serve the emergency health care needs of residents of these areas. Often CAHs in frontier or remote areas are located 50 miles or farther from the nearest health care facility. We believe that allowing RNs, as needed on a temporary basis, to work in CAHs with no greater than 10 beds, with training or experience in emergency care to be included in the list of personnel to be on call and immediately available within 60 minutes is the best means of ensuring that patients in frontier or remote areas will continue to have access to high-quality emergency health care services. However, we are requesting comments on other viable alternatives on how CAHs that are currently experiencing workforce issues can provide emergency care in frontier and remote areas.

Our regulations at § 485.618(d) require a doctor of medicine or osteopathy, a physician's assistant, or a nurse practitioner with training or experience in emergency care to be on call and immediately available by telephone or radio and to be available on site within 30 minutes, or 60 minutes if the CAH is located in a designated frontier area or a remote location designated by the State in its rural health plan. In addition, § 485.618(e) requires that the CAH must coordinate with the emergency response system in the area and ensure the 24-hour telephone or radio availability of a doctor of medicine or osteopathy to receive emergency calls, provide information on treatment of patients, and refer patients to the CAH or other appropriate locations for treatment.

We understand that it may be difficult for small CAHs in frontier areas or remote locations to meet the personnel requirements set forth in § 485.618(d). However, section 1820(c)(2)(B)(ii) of the Act requires a qualifying CAH to make available the 24-hour emergency care services that a State determines are necessary for ensuring access to emergency care services in each area served by a CAH. Although the statute does not provide authority to waive the requirement for continuous emergency care services, we believe that the statute provides the flexibility for States to assess their emergency care service needs and permit small CAHs that experience the absence of emergency personnel required by § 485.618(d) to nonetheless provide emergency services. Accordingly, this final rule with comment provides a mechanism for States with CAHs with no greater than 10 beds, in frontier areas and remote locations to include registered nurses (RNs), with training or experience in emergency care, as authorized emergency services personnel under our current general emergency service personnel requirements at § 485.618(d). Therefore, in this final rule with comment we are revising § 485.618(d) to add the possibility for States to include RNs among authorized personnel, at § 485.618(d)(3). This will permit State Governors, following consultation on the issue of using RNs on a temporary basis as part of their State rural healthcare plan with the State Boards of Medicine and Nursing, and in accordance with State laws, to request in writing the inclusion of RNs to our current personnel requirements, so that RNs may fulfill the emergency personnel requirements of § 485.618 for frontier area or remote location CAHs with no greater than 10 beds. The letter from the Governor must attest that he or she has consulted with State Boards of Medicine and Nursing about issues related to access to and the quality of emergency services in the State. The letter from the Governor must also describe the circumstances and duration of the temporary request to include the RN on a list of emergency personnel specified in § 485.618(d)(1). The request for such inclusion, and any withdrawal of a request for this inclusion, may be submitted at any time, and will be effective on the date we receive the request. In addition, once a State submits a letter to us signed by the Governor requesting that an RN be included in the list of specified personnel for CAHs with no greater than 10 beds, a CAH must submit documentation to the State survey agency demonstrating that it has not been able, despite reasonable attempts, to hire a sufficient number of physicians, physician assistants, or nurse practitioners to provide 24-hour emergency services on-call coverage. In a frontier or remote area when a CAH has only one physician or mid-level provider, we would expect the facility to provide relief to the sole provider by using an RN with training or experience in emergency services to provide emergency on-call services.

IV. Refinement of Relative Value Units for Calendar Year 2003 and Response to Public Comments on Interim Relative Value Units for 2002

A. Summary of Issues Discussed Related to the Adjustment of Relative Value Units

Section IV.B of this final rule describes the methodology used to review the comments received on the RVUs for physician work and the process used to establish RVUs for new and revised CPT codes. Changes to codes on the physician fee schedule reflected in Addendum B are effective for services furnished beginning January 1, 2003.

B. Process for Establishing Work Relative Value Units for the 2003 Physician Fee Schedule

Our November 1, 2001 final rule (66 FR 55294) announced the final work RVUs for Medicare payment for existing procedure codes under the physician fee schedule and interim RVUs for new and revised codes. The RVUs contained in the final rule applied to physician services furnished beginning January 1, 2002. We announced that we considered the RVUs for the interim codes to be subject to public comment under the annual refinement process. In this section, we summarize the refinements to the interim work RVUs published in the November 2001 final rule and our establishment of the work RVUs for new and revised codes for the 2003 physician fee schedule.

Work Relative Value Unit Refinements of Interim and Related Relative Value Units

1. Methodology (Includes Table titled “Work Relative Value Unit Refinements of the 2002 Interim and Related Relative Value Units”)

Although the RVUs in the November 2001 final rule were used to calculate 2002 payment amounts, we considered the RVUs for the new or revised codes to be interim. We accepted comments for a period of 60 days. We received substantive comments from many individual physicians and several specialty societies on approximately 19 CPT codes with interim work RVUs. Only comments on codes listed in Addendum C of the November 2001 final rule were considered.

To evaluate these comments we used a process similar to the process used in 1997. (See the October 31, 1997 final rule (62 FR 59084) for the discussion of refinement of CPT codes with interim work RVUs.) We convened a multispecialty panel of physicians to assist us in the review of the comments. The comments that we did not submit to panel review are discussed at the end of this section, as well as those that were reviewed by the panel. We invited representatives from the organization from which we received substantive comments to attend a panel for discussion of the code on which they had commented. The panel was moderated by our medical staff, and consisted of the following voting members:

• One or two clinicians representing the commenting organization.
• Two primary care clinicians nominated by the American Academy of Family Physicians and the American College of Physicians/American Society of Internal Medicine.
• Four carrier medical directors.
• Four clinicians with practices in related specialties, who were expected to have knowledge of the service under review.

The panel discussed the work involved in the procedure under review in comparison to the work associated with other services under the physician fee schedule. We assembled a set of reference services and asked the panel members to compare the clinical aspects of the work of the service a commenter believed was incorrectly valued to one or more of the reference services. In compiling the set, we attempted to include—(1) Services that are commonly performed whose work RVUs are not controversial; (2) services that span the entire spectrum from the easiest to the most difficult; and (3) at least three services performed by each of the major specialties so that each specialty would be represented. The set listed approximately 300 services. Group members were encouraged to make comparisons to reference services. The intent of the panel process was to capture each participant's independent judgement based on the discussion and his or her clinical experience. Following the discussion, each participant rated the work for the procedure. Ratings were individual and confidential, and there was no attempt to achieve consensus among the panel members.

We then analyzed the ratings based on a presumption that the interim RVUs were correct. To overcome this presumption, the inaccuracy of the interim RVUs had to be apparent to the broad range of physicians participating in each panel.

Ratings of work were analyzed for consistency among the groups represented on each panel. In general, we used statistical tests to determine whether there was enough agreement among the groups of the panel and whether the agreed-upon RVUs were significantly different from the interim RVUs published in Addendum C of the November 2001 final rule. We did not modify the RVUs unless there was a clear indication for a change. If there was agreement across groups for change, but the groups did not agree on what the new RVUs should be, we eliminated the outlier group and looked for agreement among the remaining groups as the basis for new RVUs. We used the same methodology in analyzing the ratings that we first used in the refinement process for the 1993 physician fee schedule. The statistical tests were described in detail in the November 25, 1992 final rule (57 FR 55938).

Our decision to convene multispecialty panels of physicians and to apply the statistical tests described above was based on our need to balance the interests of those who commented on the work RVUs against the redistributive effects that would occur in other specialties.

We also received comments on RVUs that were interim for 2002, but which we did not submit to the panel for review for a variety of reasons. These comments and our decisions on those comments are discussed in further detail below.

The table below lists the interim code reviewed during the refinement process described in this section. This table includes the following information:

• CPT Code. This is the CPT code for a service.
• Description. This is an abbreviated version of the narrative description of the code.
• 2002 Work RVU. The work RVUs that appeared in the November 2001 rule are shown for each reviewed code.
• Requested Work RVU. This column identifies the work RVUs requested by commenters.
• 2003 Work RVU. This column contains the final RVUs for physician work.

Table 5.—Work RVU Refinement of 2002 Interim Codes and Related RVUs

CPT code 1	Description	2002 Work RVU	Requested work RVU	2003 Work RVU
53853	Transurethral destruction of prostate tissue; by water-induced thermotherapy	4.14	8.75	5.24
1 All CPT codes and descriptions copyright 2003 American Medical Association.

2. Interim 2002 Codes

CPT Code 00797 Anesthesia for Intraperitoneal Procedures in Upper Abdomen Including Laparoscopy; Gastric Restrictive Procedure for Morbid Obesity CPT Code 01968 Cesarean Delivery Following Neuraxial Labor Analgesia/Anesthesia (List Separately in Addition to Code for Primary Procedure

The RUC recommended that 9 base units be assigned to CPT code 00797 and 3 base units be assigned to the add-on code CPT code 01968. We did not accept the RUC recommended values for these two anesthesia services and assigned 8 base units to CPT code 00797 and 2 base units to the add-on code CPT code 01968.

The AMA and the RUC disagreed with the reductions we made to the base units and the reasoning as stated in the November 1, 2001 final rule behind these reductions. No other comments were received on these codes.

Final Decision: Given that the only comments received were from the AMA and RUC and these provided no additional information, we are maintaining the base units of 8 for CPT code 00797 and 2 base units for the CPT code 01968.

CPT code 47382 Ablation, one or more liver tumor(s), percutaneous, radiofrequency

We had not received recommendations from the RUC for this procedure and assigned work RVUs of 12.00 to this service.

Specialty organizations indicated that the value assigned was inappropriately low and that this would be revisited by the RUC in February 2002. They recommended that we take the RUC values into consideration for the 2003 Medicare fee schedule.

Final Decision: We did receive a RUC recommendation of 15.19 for CPT code 47382 and are in agreement with the recommended work RVU.

CPT code 52001 Cystourethroscopy with irrigation and evacuation of clots.

The RUC recommended 5.45 work RVUs based on a comparison to certain reference procedures. We had concerns about the descriptor associated with this code and based on the descriptor of this CPT code for 2002 assigned 2.37 RVUs to this procedure. We felt the time and intensity of the physician work for this procedure as described was comparable to CPT Code 52005. Commenters acknowledged that the descriptor was being revised and felt that this would enable us to accept the original RUC recommendation of 5.45.

Final decision: The descriptor for CPT code 52001 has been revised for 2003 and the RUC provided a new recommended work RVU of 5.45. We agree with the RUC recommended work RVU of 5.45 for CPT code 52001.

CPT code 53853 Transurethral destruction of prostatic tissue; by water induced thermotherapy).

The RUC recommended 6.41 work RVUs for this procedure. We did not agree with the RUC recommendation and based on an analysis of intraservice activities, we believed it more appropriate to compare CPT code 53853 to 90-day global procedures with less than 30 minutes of intraservice time. Based on this we assigned a work RVU of 4.14 to this code.

Commenters disagreed with the RVUs assigned. One commenter provided detailed information in support of an increase in work RVUs. Based on these comments we referred this code to the multispecialty validation panel for review.

Final decision: As a result of the statistical analysis of the 2002 multispecialty validation panel ratings, we have assigned 5.24 work RVUs to CPT code 53853.

CPT code 76490 Ultrasound guidance for, and monitoring of, tissue ablation

We did not receive a recommendation from the RUC for this procedure. We compared the time and intensity of this procedure to other radiologic guidance codes and to radiologic supervision and interpretation codes and assigned work RVUs of 2.00 to this code. Two specialty groups expressed concern that the assigned RVUs were not appropriate and indicated the RUC would be revisiting work RVUs for this service in February 2002. They recommended that we take the RUC values into consideration for the 2003 Medicare fee schedule.

Final Decision: We did receive a RUC work RVU recommendation of 4.00 for this service and are in agreement with this recommendation.

CPT code 90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, intramuscular and jet injections); one vaccine (single or combination vaccine/toxoid) and CPT code 90472 Immunization administration (includes percutaneous, intradermal, subcutaneous, intramuscular and jet injections); each additional vaccine/toxoid (List separately in addition to code for primary procedure) one vaccine

We disagreed with the RUC recommended work RVU of .17 for CPT code 90471 and .15 work RVUs for CPT code 90472. To the extent the physician performs any counseling related to this service, it is considered part of the work of the preventive medicine visit during which the immunization was administered. If the vaccine is administered during a visit other than a preventive medicine service, any physician counseling should be billed separately as an E/M service. Commenters disagreed that there is no physician work associated with this service particularly in light of the required counseling that must be provided by the physician concerning possible reactions to vaccines. Commenters also continue to be concerned that Medicaid and private payors will base their payment amounts on the “incomplete” RVUs established under the physician fee schedule, which do not include physician work for these services.

Final Decision: We have addressed the issue of immunization administration in a separate section of this rule. We continue to believe that there is no physician work associated with this service. Please see Section A.(3)(c) (Practice Expense provisions for CY 2003) for discussion of this issue.

CPT code 90473 Immunization administration by intranasal or oral route; one vaccine (single or combination vaccine/toxoid); and, CPT code 90474 Immunization administration by intranasal or oral route each additional vaccine/toxoid (List separately in addition to code for primary procedure)

The RUC recommended a work RVU of .17 for CPT code 90473 and .15 work RVUs for CPT code 90474. Medicare does not cover self-administered vaccines. We did not assign work RVUs to these services as these are noncovered services. Commenters disagreed with our assessment that there is no physician work associated with these codes.

Final Decision: As we had previously indicated, Medicare does not cover self-administered vaccines. Since these services are not covered under Medicare, RVUs are not listed under the physician fee schedule.

CPT code 93609 Intraventricular and/or intra-atrial mapping of tachycardia site(s) with catheter manipulation to record from multiple sites to identify origin of tachycardia

We did not receive a recommendation from the RUC for this service. The descriptor for this service did not change, but the AMA CPT editorial panel changed the global period for this service from a zero day global to a ZZZ global. This means that this is now an “add-on” code and the physician work RVUs no longer include any pre- or postservice work. (It previously had a work RVU of 10.07.) To appropriately value this add-on service, we compared it to several other electrophysiology services and assigned a work RVU of 4.81 to CPT code 93609. Commenters disagreed with the assigned work RVUs and stated that this code would be presented at the February 2002 RUC meeting. Commenters encouraged us to reconsider the work RVUs for this code based on the forthcoming RUC recommendation.

Final Decision: We have received a RUC recommendation of 5.00 for CPT code 93609 for 2003 and are in agreement with this recommendation.

CPT code 93613 Intracardiac electrophysiologic 3-dimensional mapping

This was a new add-on code for 2002 for which we did not receive a recommendation from the RUC. This is a service that does not include any pre-or postservice work. Based on a comparison to similar services, we believed the intraservice time and intensity of 93613 was slightly less than that of CPT code 93619 and therefore assigned 7.00 work RVUs to CPT code 93613. Commenters disagreed with our rationale and stated that this code would be presented at the February 2002 RUC meeting. Commenters encouraged us to reconsider the work RVUs for this code.

Final Decision: We have received a RUC recommendation of 7.00 for CPT code 93613 for 2003 and are in agreement with this recommendation.

CPT code 93701 Bioimpedence, thoracic, electrical

We did not accept the RUC recommendation of 0.00 work RVUS but assigned this service 0.17 work RVUs based on the value assigned to HCPCS code M0302 which is the code used to pay for this service in 2001. We did indicate that we would consider the RUC recommendation but that, if we considered revising the work RVUs, we would discuss any proposed change in a future proposed rule. Commenters expressed concern that we would revisit this issue as we had addressed valuing of this service through rulemaking in 2000. While we retained the work RVUs that had been assigned based on rulemaking in 2000 for this service, we did want to indicate that, in consideration of the RUC recommendation, should we determine that any revisions to the RVUs are necessary, we would address revisions in future rulemaking.

Final Decision: We are retaining the work RVU of 0.17.

CPT code 95250 Glucose monitoring for up to 72 hours by continuous recording and storage of glucose values from interstitial tissue fluid via a subcutaneous sensor (includes hook-up, calibration, patient initiation and training, recording, disconnection, downloading with printout of data)

We agreed with the RUC recommendation that the physician work value for this service was 0.00. Though the physician can bill an E/M code for the physician review and interpretation associated with this service, commenters believe that use of the E/M code to reflect the physician work is not adequate and that the present reimbursement for this code will discourage its use.

Final Decision: The CPT descriptor for this code indicates that it is for the “TC” only and that, to report the physician review, interpretation and written report associated with this code, the practitioner should use the E/M service codes. Based on this, we believe that the assignment of 0.00 work RVUs is appropriate.

CPT code 97602 Removal of devitalized tissue from wound(s); non-selective debridement, without anesthesia (e.g., wet-to-moist dressings, enzymatic, abrasion), including topical applications(s), wound assessment and instruction(s) for ongoing care, per session

The HCPAC recommended a work RVU of 0.32 for this service. We disagreed with this recommendation and stated that the services of this code are bundled into CPT code 97601 and did not establish work RVUs for this service. Commenters disagreed with our determination that this service should be bundled. Commenters felt that, despite the fact that there may be some elements of the service that are common to both codes, these codes describe distinct services that are not used simultaneously. We have re-examined our determination but have not changed our decision. As we explained in last year's final rule, CPT code 97602 describes services that typically involve placement of a wound covering, for example, wet-to-dry gauze or enzyme-treated dressing. It also includes nonspecific removal of devitalized tissue that is an inherent part of changing a dressing. This service is already included in the work and practice expenses of CPT code 97601. In the typical service described by CPT code 97601, the patient has a dressing placed over the wound. We would add that the services described by CPT code 97602 are also included in the work and practice expenses of the whirlpool code, CPT code 97022. For this reason, we consider this a bundled service that is not paid separately.

Final Decision: As discussed above we will continue to consider this a bundled service that is not paid separately.

CPT code 99091 Collection and interpretation of physiologic data (e.g., ECG, blood pressure, glucose monitoring) digitally stored and/or transmitted by the patient and/or caregiver to the physician or other qualified health care professional, requiring a minimum of 30 minutes of time

The RUC recommended work RVUs of 1.10 for this code. We disagreed since this work is considered part of the pre- and post-service work of an E/M service and payment for this code is bundled into payment for the E/M service. Commenters objected to our bundling of this code and believed that the work associated with this service is not captured in other services, as this is not a face-to-face service. Some commenters felt that the work involved in this code was similar to care plan oversight codes, for which we provide separate payment.

Final Decision: Some portion of both the pre- and post-service work of an evaluation and management visit will not be face-to-face. We still conclude, as discussed above, that this a bundled service that is not paid separately.

CPT codes 99289 Physician constant attention of the critically ill or injured patient during an interfacility transport; first 30-74 minutes, and 99290, each additional 30 minutes (List separately in addition to code for primary service)

We did not agree with the RUC recommended values of 4.8 work RVUs for CPT code 99289 and 2.4 work RVUs for CPT code 99290. We also had concerns as to whether the code descriptors for these two new codes, as written, met the requirements for critical care. Based on the concerns outlined in the November 1, 2001 rule, we decided not to recognize these codes for Medicare purposes and created two HCPCS Level II codes for use in CY 2002 to describe critical care services provided to patients during inter-facility transport. These codes (G0240—Critical Care Service delivered by a physician; face-to-face, during inter-facility transport of a critically ill or critically injured patient: first 30-74 minutes of active transport and G0241—each additional 30 minutes (list separately in addition to G0240) were valued at 4.00 work RVUs and 2.00 work RVUs, respectively. Commenters indicated that the descriptors for the CPT codes were being revised and requested that we reconsider the work relative values for these codes in light of the changes that CPT will be making to these codes.

Final Decision: Based on the changes the CPT Editorial Panel has made to the descriptors for CPT codes 99289 and 99290, we are in agreement with the RUC recommended work RVUs of 4.80 for 99289 and 2.40 for 99290 and will use these CPT codes for Medicare purposes. We are also eliminating HCPCS codes G0240 and G0241 that had previously been used to report these services.

RUC Recommendations on Practice Expense Inputs for 2002 New and Revised Codes

In the November 2001 final rule (66 FR 55310), we responded to the RUC recommendations on the practice expense inputs for the new and revised CPT codes for CY 2002. We have received two comments on this issue.

Comment: The AMA commented that it was pleased that we accepted nearly all of the RUC's recommendations for direct practice expense inputs for new and revised codes for CPT 2002.

Response: We are also pleased that we are receiving recommendations on the practice expense inputs that need no modification and thank the RUC for the time and effort expended on developing appropriate recommendations.

Comment: Two organizations representing radiation oncologists were opposed to the reduction of the recommended clinical staff time for a radiation therapist from 123 to 60 minutes for CPT code 77418, intensity modulated treatment delivery. One of the comments argued that there is no overlap of clinical staff time with other services and that the typical time is over 60 minutes for this procedure. Both comments contend that for quality of care purposes two therapists are required.

Response: In the November 2001 final rule (66 FR 55310), we accepted, as interim, the RUC's recommendations for practice expense inputs for CPT code 77418, except that we reduced the staff time from 120 minutes (60 minutes for each of two radiation technologists) to 60 minutes (for one radiation technologist). We still believe that this reduction in staff time is appropriate. IMRT is currently delivered in multiple fractions on a daily basis and is usually administered to patients with prostate cancer or tumors of the head and neck. Most of the treatments take considerably less than 60 minutes and only one technologist is required to actually deliver the treatment, as the parameters are preprogrammed into a computer. Further, any time spent adjusting the radiation fields using ultrasound or computed tomography is separately payable. We believe that 60 minutes of staff time adequately accounts for the pre-, intra-, and post-service staff resources used to provide this service.

We received the following comments on HCPCS codes established in the November 1, 2001 final rule.

• Respiratory Therapy Codes

G0237 Therapeutic Procedures To Increase Strength or Endurance of Respiratory Muscles, Face-to-Face, One-on-One, Each 15 Minutes (Includes Monitoring); G0238 Therapeutic Procedures To Improve Respiratory Function, Other Than Described by G0237, One-on-One, Face-to-Face, per 15 Minutes (Includes Monitoring); and G0239 Therapeutic Procedures To Improve Respiratory Function, Two or More Patients Treated During the Same Period, Face-to-Face (Includes Monitoring).

Note that we have revised the descriptor for G0239 for clarity, and discussed this in section IV(C).

While several organizations expressed appreciation for the establishment of these codes, they requested clarification on the following points:

Comment: Commenters asked whether nurses could also use these codes.

Response: Physicians can use these codes if nurses are providing services “incident to” a physician's service, with the physician in the suite in his or her office, and the codes may be used in a comprehensive outpatient rehabilitation facility (CORF) or a hospital outpatient department. Since there is no respiratory therapy or pulmonary rehabilitation benefit, respiratory therapists can provide these services only in a CORF or under the “incident to” provision in a physician's office or in the hospital outpatient setting.

Comment: Commers requested clarification of the term “monitoring” used in all three of these code descriptions.

Response: Monitoring provides physiologic or other data about the patient during the period before, during, and after the activities. It can represent, for example, pulse oximetry readings, electrocardiography data, pulmonary testing measurements, or measurements of strength or endurance performed to assess the status of the patient before, during, and after the activities. An example would be pursed-lip breathing which involves nasal inspiration followed by slow exhalations through partially closed pursed lips to create positive pressure in upper respiratory tract, and improve respiratory muscles action. If, after this training, the practitioner were to check the patient's oxygen saturation level (via pulse oximetry), peak respiratory flow, or other respiratory parameters, then this would be considered “monitoring.” Payment for this monitoring is bundled into G0237 and not paid separately as a diagnostic test.

Comment: Another asked about the differences between the G codes.

Response: G0237 involves therapeutic procedures specifically targeted at improving the strength and endurance of respiratory muscles. Examples include pursed-lip breathing, diaphragmatic breathing, and paced breathing (strengthening the diaphragm by breathing through tubes of progressively increasing resistance to flow). G0238 involves a variety of activities including teaching patients strategies for performing tasks with less respiratory effort and the performance of graded activity programs to increase endurance and strength of upper and lower extremities. G0238 does not include demonstration of the use of nebulizer or inhaler or chest percussions because these services are described by other CPT codes (94664 and 94667, respectively). G0239 represents situations in which two or more patients are receiving services simultaneously (such as those described above in G0237 or G0238) during the same time period. The practitioners must be in constant attendance but need not be providing one-on-one contact. For example, a therapist provides medically necessary therapeutic procedures to two patients (A and B) in the same gym, for a 30-minute period. Both are performing different graded activities (described by G0238) to increase endurance of their upper and lower extremities while the therapist divides his/her time—in intermittent, brief episodes—between patients A and B. In this scenario the therapist would bill each patient for group therapy (G0239) because the treatment was provided simultaneously to two patients, and not one-on-one, as required by G0238.

Comment: Commers requested clarification concerning use of G0237, G0238, and G0239 codes and whether these codes can be billed more than once a day.

Response: G0237 and G0238 are timed codes, reported for each 15 minutes of one-on-one face-to-face treatment. They can be reported with more than one unit per patient per day, depending upon the duration of treatment. G0239 is not a timed code and thus should be reported only once a day for each patient in the group.

Comment: Clarification was also requested about whether the physician must certify the services every 30 days.

Response: The 30-day certification and recertification of the plan of care requirement applies to the services of physical therapists, occupational therapists, and speech language pathologists as described in section 1861(p) of the Act. Since we expected G0237, G0238, and G0239 typically to be provided by respiratory therapists, the 30-day certification and recertification of the plan of care requirement does not generally apply. If the services are performed by either a physical or occupational therapist (or by a therapy assistant under his or her direction), the requirement for the 30-day certification and recertification applies. Additionally, all services provided in the CORF setting including G0237, G0238, and G0239 require 60-day certification and recertification of the plan of care.

Comment: One commenter asked whether the “NA” in the facility total column indicated that these codes are not for use in the hospital outpatient setting.

Response: As stated above, these codes are appropriate for use in the hospital outpatient setting. The “NA” refers to the fact that in the hospital outpatient setting, these codes are paid under the hospital outpatient prospective payment system and are assigned to an APC, rather than being paid on the physician fee schedule.

Comment: Commenters also asked for the specific clinical situations in which the use of these codes is appropriate.

Response: All services must meet the test of being “reasonable and necessary” pursuant to section 1862(a)(1)(A) of the Act. Determinations of medical necessity have been made by carriers and intermediaries on a claim-by-claim basis in their local medical review policies. We believe that this is the appropriate manner to address these questions, and many of our contractors have already developed these policies. We note however, there is no explicit pulmonary rehabilitation benefit.

Comment: Commenters asked whether respiratory therapists would be precluded from using additional CPT codes to bill for their pulmonary-rehabilitation related services.

Response: We reiterate that codes G0237, G0238, and G0239 were developed to provide more specificity about the services being delivered. Thus, CPT codes 97000 to 97799 are not to be billed by professionals involved in treating respiratory conditions, unless these services are delivered by physical or occupational therapists and meet the other requirements for physical and occupational therapy services. Also CPT code 99211, (office or other outpatient visit for evaluation and management), should not be used by practitioners providing outpatient respiratory or pulmonary therapy services.

Revisions to Malpractice RVUs for New and Revised CPT Codes for 2002

Malpractice RVUs are calculated using the methodology described in detail at Addendum G of our November 1, 2000 final rule (65 FR 65589). Because of the timing of the release of new and revised CPT codes each year, the malpractice RVUs for the first year of these codes are extrapolated from existing similar codes based on the advice of our medical consultants and are considered interim subject to public comment and our revision. The following year, these codes are given values based on our malpractice RVU methodology and a review of any comments received.

The malpractice RVUs for new and revised codes for CY 2002 published in Addendum B of the November 2001 final rule, were extrapolated from existing similar codes. The malpractice RVUs for these codes in this year's Addendum B were calculated by our consultant, KPMG, using the same methodology used for all other codes. Likewise, the malpractice RVUs for new and revised codes for CY 2003 are being extrapolated from existing similar codes and will be calculated using the malpractice RVU methodology next year.

Comment: The American College of Radiology continues to be concerned about the increasing liability costs for radiology and radiation oncology. They would like us to explore and ultimately implement a change in the malpractice methodology. They stated that radiologists and radiation oncologists bear the majority of costs for liability insurance; therefore, the larger proportion of malpractice value should be included in the PC and the smaller portion in the TC.

Response: While we can understand the concern about rising liability costs, we do not believe that radiology and radiation oncology are the only specialties facing such increases. We also do not agree that the larger proportion of malpractice values should be associated with the PC component of the service. As we have explained in previous physician fee schedule rules, the total TC RVUs (practice expense and malpractice) for the TC of radiology diagnostic tests represent the expenses required to perform the test—equipment, supplies, and technicians plus malpractice insurance. The total PC RVUs (work, practice expense and malpractice insurance) represent only the interpretation of the test by the physician. Generally, the TC RVUs for radiology services are significantly higher than the PC RVUs because of the very expensive equipment and supplies. The malpractice RVUs are generally split in similar proportion between PC and TC as are the practice expense RVUs. In cases when the physician or group provides both the TC and PC and bills for both components, the split is not a significant issue since the physician or group would receive the total payment. In many cases, the TC is provided by an entity—hospital or free standing imaging center—other than the physician providing the interpretation. The entity providing the TC, which includes a supervising physician who is most likely a radiologist, assumes the risk, such as excessive irradiation of the patient, of providing the TC. We can think of no reason to transfer any portion of malpractice RVUs from the entity (which would include a supervising physician) providing the majority of the service, the TC, to a physician who is providing only the interpretation. The malpractice liability associated with interpreting the test is reflected in the PC malpractice RVUs.

Comment: The American Occupational Therapy Association indicated that for computing malpractice RVUs, occupational therapy was incorrectly crosswalked to occupational medicine (Insurance Service Office (ISO) code 80233). They suggested the appropriate crosswalk is to physical medicine and rehabilitation (ISO 80235).

Response: We agree with the commenter that a more appropriate crosswalk for occupational therapy is to physical medicine and rehabilitation as opposed to occupational medicine. The original data that were used to calculate malpractice RVUs were based upon 1993 to 1995 malpractice premium data. These data were replaced with more recent premium data (1996 to 1998). The resulting risk factors are published in the November 2000 final rule (65 FR 65594). These more recent premium data place occupation medicine, occupational therapy, and physical medicine and rehabilitation into the same risk classification. Due to this update to the risk classifications, revising the crosswalk for occupational therapy will have no effect; nonetheless, for purposes of accuracy, we will change the occupational therapy crosswalk at the next scheduled update to malpractice premium data in CY 2005.

Establishment of Interim Work Relative Value Units for New and Revised Physician's Current Procedural Terminology (CPT) Codes and New Healthcare Common Procedure Coding System Codes (HCPCS) for 2003 (Includes Table titled American Medical Association Specialty Relative Value Update Committee and Health Care Professionals Advisory Committee Recommendations and CMS's Decisions for New and Revised 2003 CPT Codes)

One aspect of establishing RVUs for 2003 was related to the assignment of interim work RVUs for all new and revised CPT codes. As described in our November 25, 1992 notice on the 1993 physician fee schedule (57 FR 55983) and in section III.B. of the November 22, 1996 final rule (61 FR 59505 through 59506), we established a process, based on recommendations received from the AMA's RUC, for establishing interim work RVUs for new and revised codes.

This year we received work RVU recommendations for approximately 249 new and revised CPT codes from the RUC. Our staff and medical officers reviewed the RUC recommendations by comparing them to our reference set or to other comparable services for which work RVUs had previously been established, or to both of these criteria. We also considered the relationships among the new and revised codes for which we received RUC recommendations. We agreed with the majority of the relative relationships reflected in the RUC values. In some instances, when we agreed with the relationships, we nonetheless revised the work RVUs to achieve work neutrality within families of codes, that is, the work RVUs have been adjusted so that the sum of the new or revised work RVUs (weighted by projected frequency of use) for a family will be the same as the sum of the current work RVUs (weighted by projected frequency of use). For approximately 96 percent of the RUC recommendations, proposed work RVUs were reviewed and accepted, and, for approximately 4 percent, we disagreed with the RUC recommended values. In the majority of these instances, we agreed with the relativity established by the RUC, but needed to adjust work RVUs to retain budget neutrality.

There were also 22 CPT codes for which we did not receive a RUC recommendation. After a review of these CPT codes by our staff and medical officers, we established interim work RVUs for the majority of these services. For those services for which we could not arrive at interim work RVUs, we have assigned a carrier-priced status until such time as the RUC provides work RVU recommendations.

We received 22 recommendations from the Health Care Professionals Advisory Committee (HCPAC). We agreed with approximately 86 percent of the HCPAC recommendations and disagreed with approximately 14 percent of the HCPAC recommendations.

We have also included, in Table 6, 34 codes for which the RUC has submitted revisions to their original 2002 recommendations. These CPT codes are identified with an “L” in Table 6.

Table 6, titled “AMA RUC and HCPAC Recommendations and CMS Decisions for New and Revised 2003 CPT Codes”, lists the new or revised CPT codes, and their associated work RVUs, that will be interim in 2003. This table includes the following information:

• A “#” identifies a new code for 2003.
• CPT code. This is the CPT code for a service.
• Modifier. A “26” in this column indicates that the work RVUs are for the professional component of the code.
• Description. This is an abbreviated version of the narrative description of the code.
• RUC recommendations. This column identifies the work RVUs recommended by the RUC.
• HCPAC recommendations. This column identifies the work RVUs recommended by the HCPAC.
• CMS decision. This column indicates whether we agreed with the RUC recommendation (“agree”) or we disagreed with the RUC recommendation (“disagree”). Codes for which we did not accept the RUC recommendation are discussed in greater detail following this table. An “(a)” indicates that no RUC recommendation was provided.
• 2003 Work RVUs. This column establishes the 2003 work RVUs for physician work.

Table 6

*CPT code	Mod	Description	RUC recommendation	HCPAC recommendation	CMS decision	2003 Work RVU
11400		Exc tr-ext b9+marg 0.5 < cm	0.85		Agree	0.85
11401		Exc tr-ext b9+marg 0.6-1 cm	1.23		Agree	1.23
11402		Exc tr-ext b9+marg 1.1-2 cm	1.51		Agree	1.51
11403		Exc tr-ext b9+marg 2.1-3 cm	1.79		Agree	1.79
11404		Exc tr-ext b9+marg 3.1-4cm	2.06		Agree	2.06
11406		Exc tr-ext b9+marg > 4.0 cm	2.76		Agree	2.76
11420		Exc h-f-nk-sp b9+marg 0.5 <	0.98		Agree	0.98
11421		Exc h-f-nk-sp b9+marg 0.6-1	1.42		Agree	1.42
11422		Exc h-f-nk-sp b9+marg 1.1-2	1.63		Agree	1.63
11423		Exc h-f-nk-sp b9+marg 2.1-3	2.01		Agree	2.01
11424		Exc h-f-nk-sp b9+marg 3.1-4	2.43		Agree	2.43
11426		Exc h-f-nk-sp b9+marg > 4 cm	3.78		Agree	3.78
11440		Exc face-mm b9+marg 0.5 < cm	1.06		Agree	1.06
11441		Exc face-mm b9+marg 0.6-1 cm	1.48		Agree	1.48
11442		Exc face-mm b9+marg 1.1-2 cm	1.72		Agree	1.72
11443		Exc face-mm b9+marg 2.1-3 cm	2.29		Agree	2.29
11444		Exc face-mm b9+marg 3.1-4 cm	3.14		Agree	3.14
11446		Exc face-mm b9+marg > 4 cm	4.49		Agree	4.49
11600		Exc tr-ext mlg+marg 0.5 < cm	1.31		Agree	1.31
11601		Exc tr-ext mlg+marg 0.6-1 cm	1.80		Agree	1.80
11602		Exc tr-ext mlg+marg 1.1-2 cm	1.95		Agree	1.95
11603		Exc tr-ext mlg+marg 2.1-3 cm	2.19		Agree	2.19
11604		Exc tr-ext mlg+marg 3.1-4 cm	2.40		Agree	2.40
11606		Exc tr-ext mlg+marg > 4 cm	3.43		Agree	3.43
11620		Exc h-f-nk-sp mlg+marg 0.5 <	1.19		Agree	1.19
11621		Exc h-f-nk-sp mlg+marg 0.6-1	1.76		Agree	1.76
11622		Exc h-f-nk-sp mlg+marg 1.1-2	2.09		Agree	2.09
11623		Exc h-f-nk-sp mlg+marg 2.1-3	2.61		Agree	2.61
11624		Exc h-f-nk-sp mlg+marg 3.1-4	3.06		Agree	3.06
11626		Exc h-f-nk-sp mlg+mar > 4 cm	4.30		Agree	4.30
11640		Exc face-mm malig+marg 0.5 <	1.35		Agree	1.35
11641		Exc face-mm malig+marg 0.6-1	2.16		Agree	2.16
11642		Exc face-mm malig+marg 1.1-2	2.59		Agree	2.59
11643		Exc face-mm malig+marg 2.1-3	3.10		Agree	3.10
11644		Exc face-mm malig+marg 3.1-4	4.03		Agree	4.03
11646		Exc face-mm mlg+marg > 4 cm	5.95		Agree	5.95
L 11981		Insert drug implant device	1.48		Agree	1.48
L 11982		Remove drug implant device	1.78		Agree	1.78
L 11983		Remove/insert drug implant	3.30		Agree	3.30
17304		1 stage mohs, up to 5 spec	7.60		Agree	7.60
17305		2 stage mohs, up to 5 spec	2.85		Agree	2.85
17306		3 stage mohs, up to 5 spec	2.85		Agree	2.85
17307		Mohs addl stage up to 5 spec	2.85		Agree	2.85
17310		Mohs any stage > 5 spec each	0.95		Disagree	0.62
L 20526		Ther injection, carp tunnel	0.94		Agree	0.94
L 20550		Inj tendon sheath/ligament	0.75		Agree	0.75
L 20551		Inject tendon origin/insert	0.75		Agree	0.75
L 20552		Inject trigger point, 1 or 2	0.66		Agree	0.66
L 20553		Inject trigger points, =/> 3	0.75		Agree	0.75
L 20600		Drain/inject, joint/bursa	0.66		Agree	0.66
L 20605		Drain/inject, joint/bursa	0.68		Agree	0.68
# 20612		Aspirate/inj ganglion cyst	0.70		Agree	0.70
21030		Excise max/zygoma b9 tumor	(a)		(a)	3.89
21034		Excise max/zygoma mlg tumor	16.17		Agree	16.17
21040		Removal of jaw bone lesion	(a)		(a)	3.89
# 21046		Remove mandible cyst complex	13.00		Agree	13.00
# 21047		Excise lwr jaw cyst w/repair	18.75		Agree	18.75
# 21048		Remove maxilla cyst complex	13.50		Agree	13.50
# 21049		Excise uppr jaw cyst w/repair	18.00		Agree	18.00
21740		Reconstruction of sternum	16.50		Agree	16.50
# 21742		Repair sternum/nuss w/o scope	(a)		(a)	carrier
# 21743		Repair sternum/nuss w/scope	(a)		(a)	carrier
23410		Repair rotator cuff, acute	12.45		Agree	12.45
23412		Repair rotator cuff, chronic	13.31		Agree	13.31
L 24344		Reconstruct elbow lat ligmnt	14.00		Agree	14.00
L 24346		Reconstruct elbow med ligmnt	14.00		Agree	14.00
25320		Repair/revise wrist joint	10.77		Agree	10.77
27425		Lat retinacular release open	5.22		Agree	5.22
27730		Repair of tibia epiphysis	7.41		Agree	7.41
27732		Repair of fibula epiphysis	5.32		Agree	5.32
27734		Repair of lower leg epiphysis	8.48		Agree	8.48
27870		Fusion of ankle joint, open	13.91		Agree	13.91
29806		Shoulder arthroscopy/surgery	14.37		Agree	14.37
# 29827		Arthroscop rotator cuff repr	15.36		Agree	15.36
# 29873		Knee arthroscopy/surgery	6.00		Agree	6.00
# 29899		Ankle arthroscopy/surgery	13.91		Agree	13.91
# 33215		Reposition pacing-defib lead	4.44		Disagree	4.76
33216		Insert lead pace-defib, one	5.39		Disagree	5.78
33217		Insert lead pace-defib, dual	5.75		Agree	5.75
# 33224		Insert pacing lead & connect	9.05		Agree	9.05
# 33225		L ventric pacing lead add-on	8.34		Agree	8.34
# 33226		Reposition L ventric lead	8.69		Agree	8.69
# 33508		Endoscopic vein harvest	0.31		Agree	0.31
L 33979		Insert intracorporeal device	46.00		Agree	46.00
L 33980		Remove intracorporeal device	56.25		Agree	56.25
34812		Xpose for endoprosth, femorl	6.75		Agree	6.75
34825		Endovasc extend prosth, init	12.00		Agree	12.00
34826		Endovasc extend prosth, addl	4.13		Agree	4.13
# 34833		Xpose for endoprosth, iliac	12.00		Agree	12.00
# 34834		Xpose, endoprosth, brachial	5.35		Agree	5.35
# 34900		Endovasc iliac repr w/graft	16.38		Agree	16.38
# 35572		Harvest femoropopliteal vein	6.82		Agree	6.82
36415		Routine venipuncture	0.00		Agree	0.00
# 36416		Capillary blood draw	0.00		Agree	0.00
# 36511		Apheresis wbc	(a)		(a)	1.74
# 36512		Apheresis rbc	(a)		(a)	1.74
# 36513		Apheresis platelets	(a)		(a)	1.74
# 36514		Apheresis plasma	(a)		(a)	1.74
# 36515		Apheresis, adsorp/reinfuse	(a)		(a)	1.74
# 36516		Apheresis, selective	(a)		(a)	1.74
# 36536		Remove cva device obstruct	3.60		Agree	3.60
# 36537		Remove cva lumen obstruct	0.75		Agree	0.75
36540		Collect blood venous device	0.00		Agree	0.00
# 37182		Insert hepatic shunt (tips)	17.00		Agree	17.00
# 37183		Remove hepatic shunt (tips)	8.00		Agree	8.00
# 37500		Endoscopy ligate perf veins	11.00		Agree	11.00
37760		Ligation, leg veins, open	10.47		Agree	10.47
# 38204		Bl donor search management	2.00		Disagree	0.00
# 38205		Harvest allogenic stem cells	1.50		Agree	1.50
# 38206		Harvest auto stem cells	1.50		Agree	1.50
# 38207		Cryopreserve stem cells	(a)		(a)	0.00
# 38208		Thaw preserved stem cells	(a)		(a)	0.00
# 38209		Wash harvest stem cells	(a)		(a)	0.00
# 38210		T-cell depletion of harvest	(a)		(a)	0.00
# 38211		Tumor cell deplete of harvest	(a)		(a)	0.00
# 38212		Rbc depletion of harvest	(a)		(a)	0.00
# 38213		Platelet deplete of harvest	(a)		(a)	0.00
# 38214		Volume deplete of harvest	(a)		(a)	0.00
# 38215		Harvest stem cell concentrte	(a)		(a)	0.00
# 38242		Lymphocyte infuse transplant	1.71		Agree	1.71
# 43201		Esoph scope w/submucous inj	2.09		Agree	2.09
# 43236		Uppr gi scope w/submuc inj	2.92		Agree	2.92
43245		Uppr gi scope dilate strictr	3.18		Agree	3.18
# 44206		Lap part colectomy w/stoma	27.00		Agree	27.00
# 44207		L colectomy/coloproctostomy	30.00		Agree	30.00
# 44208		L colectomy/coloproctostomy	32.00		Agree	32.00
# 44210		Laparo total proctocolectomy	28.00		Agree	28.00
# 44211		Laparo total proctocolectomy	35.00		Agree	35.00
# 44212		Laparo total proctocolectomy	32.50		Agree	32.50
# 44701		Intraop colon lavage add-on	3.10		Agree	3.10
# 45335		Sigmoidoscope w/submuc inj	1.46		Disagree	1.36
# 45340		Sig w/balloon dilation	1.96		Disagree	1.66
# 45381		Colonoscope, submucous inj	4.30		Disagree	4.20
# 45386		Colonoscope dilate stricture	4.58		Agree	4.58
# 46706		Repr of anal fistula w/glue	2.95		Disagree	2.39
L 47370		Laparo ablate liver tumor rf	19.69		Agree	19.69
L 47371		Laparo ablate liver cryosurg	19.69		Agree	19.69
L 47380		Open ablate liver tumor rf	23.00		Agree	23.00
L 47381		Open ablate liver tumor cryo	23.27		Agree	23.27
L 47382		Percut ablate liver rf	15.19		Agree	15.19
# 49419		Insrt abdom cath for chemotx	6.65		Agree	6.65
# 49904		Omental flap, extra-abdom	20.00		Agree	20.00
49905		Omental flap, intra-abdom	6.55		Agree	6.55
# 50542		Laparo ablate renal mass	20.00		Agree	20.00
# 50543		Laparo partial nephrectomy	25.50		Agree	25.50
# 50562		Renal scope w/tumor resect	10.90		Agree	10.90
# 55866		Laparo radical prostatectomy	30.74		Agree	30.74
# 51701		Insert bladder catheter	0.50		Agree	0.50
# 51702		Insert temp bladder cath	0.50		Agree	0.50
# 51703		Insert bladder cath, complex	1.47		Agree	1.47
# 51798		Us urine capacity measure	0.38		Disagree	0.11
53440		Male sling procedure	13.62		Agree	13.62
53442		Remove/revise male sling	11.57		Agree	11.57
# 56820		Exam of vulva w/scope	1.50		Agree	1.50
# 56821		Exam/biopsy of vulva w/scope	2.05		Agree	2.05
# 57420		Exam of vagina w/scope	1.60		Agree	1.60
# 57421		Exam/biopsy of vag w/scope	2.20		Agree	2.20
# 57452		Exam of cervix w/scope	1.50		Agree	1.50
# 57454		Bx/curett of cervix w/scope	2.33		Agree	2.33
# 57455		Biopsy of cervix w/scope	1.99		Agree	1.99
# 57456		Endocerv curettage w/scope	1.85		Agree	1.85
# 57460		Bx of cervix w/scope, leep	2.83		Agree	2.83
# 57461		Conz of cervix w/scope, leep	3.44		Agree	3.44
58140		Myomectomy abdom method	14.60		Agree	14.60
58145		Myomectomy vag method	8.04		Agree	8.04
# 58146		Myomectomy abdom complex	19.00		Agree	19.00
58260		Vaginal hysterectomy	12.98		Agree	12.98
58262		Vag hyst including t/o	14.77		Agree	14.77
58263		Vag hyst w/t/o & vag repair	16.06		Agree	16.06
58267		Vag hyst w/urinary repair	17.04		Agree	17.04
58270		Vag hyst w/enterocele repair	14.26		Agree	14.26
# 58290		Vag hyst complex	19.00		Agree	19.00
# 58291		Vag hyst incl t/o, complex	20.79		Agree	20.79
# 58292		Vag hyst t/o & repair, compl	22.08		Agree	22.08
# 58293		Vag hyst w/uro repair, compl	23.06		Agree	23.06
# 58294		Vag hyst w/enterocele, compl	20.28		Agree	20.28
# 58545		Laparoscopic myomectomy	14.60		Agree	14.60
# 58546		Laparo-myomectomy, complex	19.00		Agree	19.00
58550		Laparo-asst vag hysterectomy	14.19		Agree	14.19
# 58552		Laparo-vag hyst incl t/o	14.19		Agree	14.19
# 58553		Laparo-vag hyst, complex	19.00		Agree	19.00
# 58554		Laparo-vag hyst w/t/o, compl	19.00		Agree	19.00
# 61316		Implt cran bone flap to abdo	1.39		Agree	1.39
# 61322		Decompressive craniotomy	29.50		Agree	29.50
# 61323		Decompressive lobectomy	31.00		Agree	31.00
61340		Subtemporal decompression	18.66		Agree	18.66
# 61517		Implt brain chemotx add-on	1.38		Agree	1.38
# 61623		Endovasc tempory vessel occl	9.96		Agree	9.96
61624		Transcath occlusion, cns	20.15		Agree	20.15
# 62148		Retr bone flap to fix skull	2.00		Agree	2.00
# 62160		Neuroendoscopy add-on	3.00		Agree	3.00
# 62161		Dissect brain w/scope	20.00		Agree	20.00
# 62162		Remove colloid cyst w/scope	25.25		Agree	25.25
# 62163		Neuroendoscopy w/fb removal	15.50		Agree	15.50
# 62164		Remove brain tumor w/scope	27.50		Agree	27.50
# 62165		Remove pituit tumor w/scope	22.00		Agree	22.00
62201		Brain cavity shunt w/scope	14.86		Agree	14.86
62263		Epidural lysis mult sessions	6.14		Agree	6.14
# 62264		Epidural lysis on single day	4.43		Agree	4.43
64415		N block inj, brachial plexus	1.48		Agree	1.48
# 64416		N block cont infuse, b plex	3.50		Agree	3.50
64445		N block inj, sciatic, sng	1.48		Agree	1.48
# 64446		N blk inj, sciatic, cont inf	3.25		Agree	3.25
# 64447		N block inj fem, single	1.50		Agree	1.50
# 64448		N block inj fem, cont inf	3.00		Agree	3.00
64450		N block, other peripheral	1.27		Agree	1.27
# 66990		Ophthalmic endoscope add-on	1.51		Agree	1.51
# 75901	26	Remove cva device obstruct	0.49		Agree	0.49
# 75902	26	Remove cva lumen obstruct	0.39		Agree	0.39
75953	26	Abdom aneurysm endovas rpr	1.36		Agree	1.36
# 75954	26	Iliac aneurysm endovas rpr	2.93		Disagree	1.36
76070	26	Ct bone density, axial	0.25		Agree	0.25
# 76071	26	Ct bone density, peripheral	0.22		Agree	0.22
L 76085	26	Computer mammogram add-on	0.06		Agree	0.06
L 76362E	26	CAT scan for tissue ablation	4.00		Agree	4.00
L 76394	26	MRI for tissue ablation	4.25		Agree	4.25
L 76490	26	US for tissue ablation	4.00		Agree	4.00
# 76801		Ob us < 14 wks, single fetus	0.99		Agree	0.99
# 76802		Ob us < 14 wks, addl fetus	0.83		Agree	0.83
76805		Ob us ≥ 14 wks, sngl fetus	0.99		Agree	0.99
76810		Ob us ≥ 14 wks, addl fetus	0.98		Agree	0.98
# 76811		Ob us, detailed, sngl fetus	1.90		Agree	1.90
# 76812		Ob us, detailed, addl fetus	1.78		Agree	1.78
76815		Ob us, limited, fetus(s)	0.65		Agree	0.65
76816		Ob us, follow-up, per fetus	0.85		Agree	0.85
# 76817		Transvaginal us, obstetric	0.75		Agree	0.75
# 92601		Cochlear implt f/up exam < 7		0.00	Agree	0.00
# 92602		Reprogram cochlear implt < 7		0.00	Agree	0.00
# 92603		Cochlear implt f/up exam 7 >		0.00	Agree	0.00
# 92604		Reprogram cochlear implt 7 >		0.00	Agree	0.00
# 92605		Eval for nonspeech device rx		0.00	Agree	0.00
# 92606		Non-speech device service		0.00	Agree	0.00
# 92607		Ex for speech device rx, 1hr		0.00	Agree	0.00
# 92608		Ex for speech device rx addl		0.00	Agree	0.00
# 92609		Use of speech device service		0.00	Agree	0.00
# 92610		Evaluate swallowing function		0.00	Agree	0.00
# 92611		Motion fluoroscopy/swallow		0.00	Agree	0.00
# 92612		Endoscopy swallow tst (fees)		1.27	Agree	1.27
# 92613		Endoscopy swallow tst (fees)		0.99	Disagree	0.00
# 92614		Laryngoscopic sensory test		1.27	Agree	1.27
# 92615		Eval laryngoscopy sense tst		0.88	Disagree	0.00
# 92616		Fees w/laryngeal sense test		1.88	Agree	1.88
# 92617		Interprt fees/laryngeal test		1.10	Disagree	0.00
# 93580		Transcath closure of asd	18.00		Agree	18.00
# 93581		Transcath closure of vsd	24.43		Agree	24.43
L 93609	26	Map tachycardia, add-on	5.00		Agree	5.00
L 93613		Electrophys map 3d, add-on	7.00		Agree	7.00
L 93619	26	Electrophysiology evaluation	7.32		Agree	7.32
L 93620	26	Electrophysiology evaluation	11.59		Agree	11.59
L 93621	26	Electrophysiology evaluation	2.10		Agree	2.10
L 93622	26	Electrophysiology evaluation	3.10		Agree	3.10
# 95990		Spin/brain pump refil & main	(a)		(a)	0.00
L 96000		Motion analysis, video/3d		1.80	Agree	1.80
L 96001		Motion test w/ft press meas		2.15	Agree	2.15
L 96002		Dynamic surface emg		0.41	Agree	0.41
L 96003		Dynamic fine wire emg		0.37	Agree	0.37
L 96004		Phys review of motion tests		2.14	Agree	2.14
96530		Syst pump refill & main	0.00		Agree	0.00
# 96920		Laser tx, skin < 250 sq cm	1.15		Agree	1.15
# 96921		Laser tx, skin 250-500 sq cm	1.17		Agree	1.17
# 96922		Laser tx, skin > 500 sq cm	2.10		Agree	2.10
# 99026		In-hospital on call service	(a)		(a)	0.00
# 99027		Out-of-hosp on call service	(a)		(a)	0.00
99289		Ped crit care transport	4.80		Agree	4.80
99290		Ped crit care transport addl	2.40		Agree	2.40
# 99293		Ped critical care, initial	16.00		Agree	16.00
# 99294		Ped critical care, subseq	8.00		Agree	8.00
99295		Neonate crit care, initial	18.49		Agree	18.49
99296		Neonate critical care subseq	8.00		Agree	8.00
99298		Neonatal critical care	2.75		Agree	2.75
# 99299		Ic, lbw infant 1500-2500 gm	2.50		Agree	2.50
(a) No Final RUC recommendation provided.
# New CPT codes.
*All CPT codes copyright 2002 American Medical Association.
L Revised 2002 RUC recommendations.

Table 7, which is titled “AMA RUC ANESTHESIA RECOMMENDATIONS AND CMS DECISIONS FOR NEW AND REVISED 2003 CPT CODES”, lists the new or revised CPT codes for anesthesia and their base units that will be interim in 2003. This table includes the following information:

• CPT code. This is the CPT code for a service.
• Description. This is an abbreviated version of the narrative description of the code.
• RUC recommendations. This column identifies the base units recommended by the RUC.
• CMS decision. This column indicates whether we agreed with the RUC recommendation (“agree”) or we disagreed with the RUC recommendation (“disagree”). Codes for which we did not accept the RUC recommendation are discussed in greater detail following this table.
• 2003 Base Units. This column establishes the 2003 base units for these services.

Table 7

*CPT code	Description	RUC recommendation	CMS decision	2003 base units
# 00326	Anesth, larynx/trach, < 1 yr	7	Agree	7
# 00539	Anesth, trach-bronch reconst	18	Agree	18
# 00540	Anesth, chest surgery	12	Agree	12
# 00541	Anesth, one lung ventiliation	15	Agree	15
# 00640	Anesth, spine manipulation	3	Agree	3
# 00834	Anesth, hernia repair < 1 yr	5	Agree	5
# 00836	Anesth hernia repair, preemie	6	Agree	6
# 00921	Anesth, vasectomy	3	Agree	3
# 01829	Anesth, dx wrist arthroscopy	3	Agree	3
# 01991	Anesth, nerve block/inj	3	Agree	3
# 01992	Anesth, nerve block/inj, prone	5	Agree	5
*All CPT codes copyright 2003 American Medical Association.# New CPT codes.

Discussion of Codes for Which There Were No RUC Recommendations or for Which the RUC Recommendations Were Not Accepted

The following is a summary of our rationale for not accepting particular RUC work RVU or base unit recommendations. It is arranged by type of service in CPT order. Additionally, we also discuss those CPT codes for which we received no RUC recommendations for physician work RVUs. This summary refers only to work RVUs or base units.

New and Revised Codes for 2003

CPT code 17310 Chemosurgery (Mohs micrographic technique) including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and complete histopathological preparation including the first routine stain (e.g., hematoxylin and eosin, toluidine blue); each additional specimen after the first 5 specimens, fixed or fresh tissue, any stage (List separately in addition to code for primary procedure).

This add-on code is used to report specimens generated during Mohs surgery. Prior to the changes made for 2003, the code was reported once for all specimens over five, generated during a particular stage of Mohs surgery. In 2003, the code will be used to report each specimen over five during a particular stage of Mohs surgery. The RUC recommended maintaining 0.95 work RVUs for this code as an interim value. We disagree. We share the concerns of the RUC that the specialty society recommendation was based on a survey that did not take into account the ZZZ global period of this code. Additionally, in order to determine whether the current work RVU for 17310 was appropriate, we analyzed the current work RVU for 17310 in the context of the work RVUs for other Mohs surgery CPT codes. Mohs surgery work RVUs are based on Harvard data which is depicted in Table 8 below (all codes have 000 global periods for 2002):

Table 8

CPT code	2002 Work RVUs	Total time (minutes)	Intra-service time (minutes)	Work intensity (work RVU/total time)	RN Time (minutes) (CPEP data)	Histotechnician Time (minutes) (CPEP data)
17304	7.6	89	50	.085	202	50
17305	2.85	62		.046	101	25
17306	2.85	62		.046	101	25
17307	2.85	62		.046	101	25
17310	0.95	31		.031	32	8

These data clearly show that the Harvard data appropriately rank these services in terms of intensity. We note that, because intra-service times are not given for all codes, it is impossible to calculate intra-service work intensity. The RUC recommendation of 0.95 work RVUs which is based on a median time of 20 minutes yields a work intensity of 0.047 which is higher than the work intensities for CPT codes 17305-17307. This would create a rank order anomaly in this family of codes.

We also note that the 2002 descriptor for CPT code 17310 says that this code should be reported only once for all specimens more than five for a given stage of Mohs. Therefore, we believe that the current work RVU represents the total work required for the typical number of specimens obtained (beyond five) per stage of Mohs.

We compared CPT code 17310 with CPT codes 88331 Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen, and 88332 Pathology consultation during surgery; each additional tissue block with frozen section(s). CPT code 88332 has a work RVU of 0.59 and total physician time of 15 minutes. We note that if the RUC survey time (20 minutes) for CPT code 17310 is multiplied by the Harvard intensity (.031) that a work value of 0.62 is obtained.

Therefore, we are assigning a work value of 0.62 work RVUs to CPT code 17310 pending further recommendations from the RUC. We believe this value is appropriate for the new descriptor, which allows reporting of CPT code 17310 for each specimen rather than once for all specimens. We also believe this work value places this code in correct rank order with CPT codes 17304-17307 and with CPT codes 88331 and 88332.

We also note that a work value of 0.62 RVUs will not require any work neutrality adjustment because it already takes our claims data for CPT code 17310 into account.

CPT Codes 21030, Excision of benign tumor or cyst of maxilla or zygoma, by enucleation and curettage, and 21040, Excision of benign tumor or cyst of mandible, by enucleation or curettage.

CPT changed the descriptors for these codes to make the procedure more specific, and we have not yet received RUC recommendations for these codes. We compared these services to CPT Codes 21555, Excision tumor, soft tissue of neck or thorax; subcutaneous (work RVU of 4.35), 28043, Excision, tumor, foot; subcutaneous tissue (work RVU 3.54), 28108, Excision or curettage of bone cyst or benign tumor, phalanges of foot (work RVU 4.16), 21501, Incision and drainage, deep abscess or hematoma, soft tissues of neck or thorax (work RVU 3.81), 26115 Excision, tumor or vascular malformation, soft tissue of hand or finger; subcutaneous (work RVU 3.86), and 24075 Excision, tumor, soft tissue of upper arm or elbow area; subcutaneous (work RVU 3.92). We believe that 21030 and 21040 are most similar to 24075 and 26115 in terms of physician work and are assigning interim RVUs of 3.89 for both of these procedures. We are crosswalking the malpractice RVUs from current CPT Code 21030 (0.60 RVUs) to these procedures.

CPT Codes 21740 Reconstructive repair of pectus excavatum or carinatum; open and 21742 Reconstructive repair of pectus excavatum or carinatum; minimally invasive approach (Nuss procedure) with thoracoscopy

We have not received the final recommendation from the RUC on these services and carriers will price these services in 2003.

CPT codes 33215 Repositioning of previously implanted transvenous pacemaker or pacing cardioverter-defibrillator (right atrial or right ventricular) electrode and 33216 Insertion of transvenous electrode; single chamber (one electrode) permanent pacemaker or single chamber pacing cardioverter-defibrillator

We received a RUC recommendation of 4.44 work RVUs for CPT code 33215 and a RUC recommendation of 5.39 work RVUs for CPT code 33216. Previously, both the insertion and repositioning of the electrodes were billed under CPT code 33216. Effective January 1, 2003, CPT code 33215 will be used to report the repositioning of a previously implanted transvenous pacemaker or pacing cardioverter-defibrillator electrode, while CPT 33216 will be used to report the insertion of a transvenous electrode. Although we agree with the relativity established by the RUC, in order to retain work neutrality between these two services, we have scaled the total relative values that will be paid in 2003 to what would have been paid in 2003 if CPT code 33215 had not been established. This results in work RVUs of 4.76 for CPT code 33215 and 5.78 work RVUs for CPT code 33216.

CPT Codes 36511 Therapeutic apheresis; for white blood cells, 36512 Therapeutic apheresis; for red blood cells, 36513 Therapeutic apheresis; for platelets, 36514 Therapeutic apheresis; for plasma pheresis, 36515 Therapeutic apheresis; with extracorporeal immunoadsorption and plasma reinfusion, and 36516 Therapeutic apheresis; with extracorporeal adsorption or selective filtration and plasma reinfusion

We have not yet received the RUC recommendations for these CPT codes. We are assigning 1.74 work RVUs to all these procedures. This is the work RVU for both CPT codes 36520 and 36521 (deleted for CPT 2003) which are currently being used to report these procedures. We are also crosswalking the malpractice RVUs for CPT code 36520 to these procedures (0.06 RVU).

CPT Codes 38204 Management of recipient hematopoietic progenitor cell donor search and cell acquisition, 38205 Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; allogenic, 38206 Blood-derived hematopoietic cell harvesting for transplantation, per collection; autologous, 38207 Transplant preparation of hematopoietic progenitor cells; cryopreservation and storage, 38208 Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, 38209 Transplant preparation of hematopoietic progenitor cells; washing of harvest, 38210 Transplant preparation of hematopoietic progenitor cells; specific cell depletion within harvest, T-cell depletion, 38211 Transplant preparation of hematopoietic progenitor cells; tumor cell depletion, 38212 Transplant preparation of hematopoietic progenitor cells; red blood cell removal, 38213 Transplant preparation of hematopoietic progenitor cells; platelet depletion, 38214 Transplant preparation of hematopoietic progenitor cells; plasma (volume) depletion, 38215 Transplant preparation of hematopoietic progenitor cells; cell concentration in plasma, mononuclear, or buffy coat layer, 38242 Bone marrow or blood-derived peripheral stem cell transplantation; allogeneic donor lymphocyte infusions

We agree with the RUC work recommendations for CPT codes 38205, 38206, and 38242. We disagree with the RUC recommendations for the CPT code 38204. CPT codes 38207 through 38215 were reviewed at the April RUC meeting but final work RVUs were not established. We did not receive final recommendations on work RVUs for these services in time for publication in this final rule, but will review any RUC recommendations for next year.

CPT code 38204 is reported by the physician managing a search for potential hematopoietic progenitor cell donors. We are giving this code a status indicator “B,” meaning that we will not make separate payment for this service. We believe we are already making payment for any physician work associated with this service as part of our payment for other bone marrow transplant codes (that is, CPT codes 38205, 38206, 38240, 38241, and 38242). Furthermore, we have significant concerns about how this code would be used in actual practice. Would beneficiaries be billed for failed donor searches, and, if so, how many? How would beneficiaries be able to determine whether one or more searches had actually been conducted? This problem is compounded by the fact that the beneficiary would probably never meet the physician conducting the search. Additionally, it is unclear from the specialty society vignette what is actually physician work and what is the work of clinical and administrative staff. It would seem most appropriate that any payment would be made to the physician who is performing the cell harvesting or bone marrow transplant services (that is, CPT codes 38205, 38206, 38240, 38241, and 38242). We welcome RUC's further review of these codes to determine whether any physician work associated with a cell donor search is already included. If the RUC determines that such work is not included, we would review recommendation for changing the RUC values of these codes to include such work.

CPT codes 38207, 38208, 38209. These codes represent an unbundling of CPT codes 88240 Cryopreservation, freezing and storage of cells, each cell line, and 88241 Thawing and expansion of frozen cells, each aliquot. Both codes 88240 and 88241 are paid under the laboratory fee schedule. We also note that CPT 2003 has added a parenthetical note under 88240 and 88241, which implies that, starting in January 2003, they should be used only for diagnostic services, and codes 38207, 38208, and 38209 should be used for therapeutic services.

• It is unclear from the specialty vignettes whether any physician work is typically required to perform these services. The descriptions of typical physician involvement in these procedures indicate that the only physician services are laboratory oversight or quality management services for which we do not make separate payment to physicians.
• We also believe these services will be reported on a “per aliquot” basis. However, even though blood-derived stem cells are usually stored in aliquots, the processes of freezing, thawing, and washing are done in batches. This means that the physician oversight of these processes does not occur on a “per aliquot” basis and therefore, it does not seem appropriate to pay for physician services on a “per aliquot” basis.
• We believe that the analysis the RUC was using to arrive at its interim recommendation for assigning physician work to CPT codes 38207, 38208, and 38209 was flawed. The RUC discussed assigning physician work to these services based on its review of 38210 which it compared to CPT code 86077 Blood bank physician services; difficult cross match and/or evaluation of irregular antibody(s), interpretation and written report (work RVU 0.94). The RUC then used the specialty societies' relative ranking of services 38207-38215 as the basis for recommending work values for CPT codes 38207-38209 and 38211-38215. With regard to this analysis, we note: (1) the descriptor for CPT code 86077 requires a physician service and an “interpretation and written report,” while CPT code 38210 is not described as a physician service, nor does it require an “interpretation and written report.” Therefore, we believe it is inappropriate to compare 38210 with 86077, (2) 38210 is currently reported as CPT code 86915, Bone Marrow or peripheral stem cell harvest, modification or treatment to eliminate cell types (e.g., T cells, metastatic carcinoma) which is paid under the laboratory fee schedule, and (3) 38207, 38208, and 38209 describe entirely different services from 38210, 86077, and 86915, thus making it difficult to understand how a work value for 38210 could be extrapolated to 38207-38209.

At this time we are assigning status indicator “I” to 38207-38209 making them not valid for Medicare purposes. We are creating two G codes, G0265 Cryopreservation, freezing and storage of cells for therapeutic use, each cell line, and G0266 Thawing and expansion of frozen cells for therapeutic use, each aliquot. These codes will be paid under the laboratory fee schedule at the same rate as CPT codes 88240 and 88241 respectively. The descriptors will allow us to continue to recognize CPT codes 88140 and 88141 as described in CPT 2003 for diagnostic use, thus making it unnecessary for us to change the status indicators for these services. The G codes will also enable us to track the utilization of these services. We believe that continuing the status quo with regard to these procedures will not affect beneficiary access to transplantation services and will give us more time to analyze the services and recommendations.

CPT codes 38210-38215. Currently CPT codes 38210-38213 are described by CPT code 86915, Bone Marrow or peripheral stem cell harvest, modification or treatment to eliminate cell types (for example, T cells, metastatic carcinoma). Currently, CPT code 86915 is paid under the laboratory fee schedule. With regard to CPT codes 38210-38215, we have many of the same concerns as we have for CPT codes 38207-38209.

• It is unclear from the specialty vignettes whether any physician work is typically required to perform these services. The descriptions of typical physician involvement in these procedures indicate that a significant portion of the physician work is procedure oversight or quality management services for which we do not make separate payment to physicians. In fact, the only references in the specialty society vignettes for these procedures to services paid under the physician fee schedule are references to performance of flow cytometry. Therefore, if there is any physician work associated with these services it is currently payable under the CPT code 88180 Flow cytometry; each cell surface, cytoplasmic or nuclear marker.
• We do not believe that unbundling of these services is warranted because CPT codes 38210, 38212, 38213, 38214, and 38215 may be performed together on a single harvest of stem cells during an allogeneic transplant. Further, when these services are performed together, if there is any physician work associated with these activities, it must be allocated to each service and it is not clear that this can be accomplished.
• As discussed above, we have concerns about the RUC's preliminary discussions for work RVUs for these codes. CPT code 86077 to which 38210 was compared requires physician services, an interpretation and report, and has forty minutes of intra-service time associated with it. In contrast 38210 has no requirement for physician work, and it is stated that the physician will only perform this service in an emergency. Further, there is no requirement for interpretation of data or a written report, and the intra-service time is 23 minutes. We do not believe the stress involved with these procedures is any greater than the stress involved with 86077 or other pathology services that require correct interpretation of clinical laboratory data or surgical specimens to make a correct diagnosis essential in determining appropriate treatment. Furthermore, we know the RUC is continuing to review these codes and we also require further time to review them.

Therefore, we are assigning status indicator “I” to CPT codes 38210-38215, making them invalid for Medicare purposes. We are creating G0267, Bone marrow or peripheral stem cell harvest, modification or treatment to eliminate cell type(s) (for example, T-cells, metastic carcinoma). This G code will replace deleted code CPT code 86915, and it will be paid under the laboratory fee schedule.

We welcome any comments from the RUC or other interested parties concerning these codes and ask that such comments specifically address the concerns discussed above. We will continue to review these codes internally, obtain payment and utilization data for CPT code 86915, and track utilization of all three G codes.

CPT code 45335 Sigmoidoscopy, flexible; with directed submucosal injection(s) any substance and 45381 Colonoscopy, flexible, proximal to splenic flexure; with directed submucosal injection(s) any substance

The RUC recommended work RVUs of 1.46 for CPT code 45335 and 4.30 for CPT code 45381. For CPT code 45335, the RUC used CPT code 45330 as the base code (0.96 work RVUs) and added an increment of 0.50 work RVUs based upon the increased pre-, intra-, and post-service work associated with CPT code 45335 as compared to CPT code 45330. For CPT code 45381, the RUC used CPT code 45378 (3.70 work RVUs) as the base code and added an increment of 0.60 work RVUs based upon the increased pre-, intra-, and post-service work associated with CPT code 45381 as compared to CPT code 45378.

In order to review the RUC recommended values for CPT code 45335 and 45381, we compared these services to the analysis and recommendations provided by the RUC for CPT codes 43201 and 43236. We agree with the RUC recommendations for CPT codes 43201 and 43236, which are also new submucosal injection codes. We further note that the intra-service intensities of CPT codes 43201 and 43236 should be higher than the intra-service intensities of CPT codes 45335 and 45381 because of the increased risk of complications, and the fact that several sites are being injected instead of one.

In reviewing the pre-, intra-, and post-service times for CPT codes 43201, 43236, 45335, and 45381, we are unsure why these times vary so much. The pre-service time for CPT code 45381 is 25 minutes longer than the pre-service time for CPT code 45378 and there is nothing in the RUC vignette to indicate the reason for the increased pre-service time. Moreover, it is unclear why the post-service time for CPT code 45381 is 9 minutes less than the post-service time for CPT code 45378. Interestingly, less than 10 minutes of extra pre- and post-service time (beyond the base codes) was allotted for the incremental work of CPT codes 43201 and 43236 that we believe are more intensive procedures than CPT codes 45335 and 45381. Therefore, we believe that the pre- and post-service time increment for CPT codes 45335 and 45381 should be less than for CPT codes 43201 and 43236. In short, we had a great deal of difficulty interpreting the RUC time data.

In assigning work values to CPT codes 45335 and 45381, we compared them to the incremental work values and times for CPT codes 43201 and 43236 because we agreed with the RUC recommendations and times for those codes. The intra-service intensities for CPT codes 43201 and 43236 are 0.05 RVU per minute and 0.035 RVU per minute, respectively. We believe the intra-service intensity of CPT code 45335 is less than the intensity of CPT code 43201. After accounting for a few minutes of extra post-service time and an intra-service intensity of 0.04 RVU per minute, we are left with an incremental work value of 0.4 work RVUs for CPT code 43201, which is what we will apply to CPT code 45335. We also believe the intensity of CPT code 45381 is less than the intensity of CPT code 43201. Therefore, accounting for approximately 10 minutes of extra pre- and post-service time, and assigning an intra-service intensity of 0.04 RVU per minute leaves an incremental work value of 0.5 work RVUs, which is what we will apply to CPT code 45381. Therefore, we are assigning work RVUs of 1.36 and 4.20 to CPT codes 45335 and 45381, respectively.

CPT code 45340 Sigmoidoscopy, flexible; with dilation by balloon, each stricture

The RUC recommended a work RVU of 1.96 for this CPT code. This includes 1.00 for the incremental work based on the need for conscious sedation to perform this procedure (other flexible sigmoidoscopies do not require conscious sedation). This means the incremental work for CPT code 45340 is greater than the incremental work for other endoscopic dilation codes (CPT codes 43245 and 45386) because those codes have base procedures that include use of conscious sedation. The RUC has been considering the issue of conscious sedation in general for some time and has not been able to conclude that there is any incremental physician work associated with conscious sedation. In the absence of a specific RUC recommendation affirmatively stating that specific physician work is associated with conscious sedation, we do not believe it is appropriate to assign a work RVU for CPT code 45340 that is based on the presumption that a portion of the work value is for using conscious sedation. Therefore, we compared the RUC recommendations for work and physician time for CPT code 45386 to the incremental times for CPT code 45340. We believe that the intra-service intensity of CPT code 45340 should be no greater than the intra-service intensity for CPT code 45386. Therefore, we calculated the increment in pre- and post-service work (.341 work RVUs) and the intra-service intensity (0.036 RVU per minute) of CPT code 45386. We multiplied this intensity by 10 minutes to arrive at an intra-service work of .36 RVU for CPT code 45340 and added .341 RVUs for pre- and post-service work to arrive at an RVU of 0.7 for the total incremental work of CPT code 45340. Therefore, we are assigning an interim work RVU of 1.66 to CPT code 45340.

CPT code 46706 Repair of Anal Fistula with fibrin glue. The RUC recommended 2.95 work RVUs for this service based on a comparison to CPT codes 46020, Placement of Seton (work RVU 2.90) and 46940, Curettage or Cautery of Anal Fissure, including dilation of anal sphincter (separate procedure); initial (work RVU 2.32). The intra-service time for CPT code 46706 is less than the intra-service time for CPT code 46940 and requires similar physician work to CPT code 46612, Anoscopy with removal of multiple tumors, polyps, or other lesions by hot biopsy forceps, bipolar cautery or snare technique (work RVU 2.34). The post-service work for CPT code 46706 is comparable to that of CPT code 46940. Therefore, we are assigning a work RVU of 2.39 to CPT code 46706. Malpractice RVUs are crosswalked from CPT code 46940 at 0.17 RVUs.

CPT code 51798 Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, nonimaging. The RUC recommended 0.38 work RVUs based on a comparison of this procedure to CPT code 76857, Ultrasound, pelvic (nonobstetric), B-scan and/or real time with image documentation; complete. The RUC recommended 0.38 work RVUs based on a urology survey that reported that this procedure is performed 75 percent of the time by the physician and based on a comparison of this procedure to CPT code 76857, Ultrasound, pelvic (nonobstetric, B-scan and/or real time with image documentation; complete. We disagree. This code has been a HCPCS level two code that was assigned 0.00 work RVUs because we believe that it is typically performed by a nurse or other clinical staff. We continue to believe that this is a non-physician service and are assigning 0.00 work RVUs to this service. We will accept the practice expense inputs recommended by the RUC and will crosswalk the malpractice RVUs from G0050. It is not appropriate to bill CPT code 51798 in a SNF, hospital, or other setting in which nursing care is provided by the facility, since it is a routine nursing service, not really a diagnostic test.

CPT code 75954 Endovascular graft placement for repair of iliac artery (for example, aneurysm, pseudoaneurysm, ateriovenous malformation, trauma) radiological supervision and interpretation.

The RUC agreed with the specialty societies and recommended a value of 2.93 work RVUs based on comparing this code to CPT code 75952, Endovascular repair of infrarenal abdominal aortic anuerysm or dissection, radiological supervision and interpretation (work RVU of 4.5) and CPT code 75953, Placement of proximal or distal extension prosthesis for endovascular repair of infra renal abdominal aortic aneurysm, radiological supervision and interpretation (work RVU or 1.36). The recommended RVUs are midway between the RVUs of the reference procedures. The specialty societies presented the following to the RUC: “Unlike many of the other radiological supervision and interpretation (S&I) codes, 75954 includes all routine supervision and interpretation of the endovascular iliac graft placement procedure with the only exception being that 75953 is added if an extension prosthesis is required. This more inclusive approach makes 75954 very similar in concept to the inclusive S&I for endovascular aortic aneurysm repair CPT 75952.” The specialties go on to say that survey respondents believed that the code should be valued less than CPT code 75952 but more than CPT code 75953. We disagree. First, we note that CPT code 75953, which was reviewed by the RUC in February of 2001, is not an “add-on” code. It is a stand-alone code that is billed with a stand-alone surgical procedure. Furthermore, total procedure time for CPT code 75954 (85 minutes) is less than the total procedure time for CPT code 75953 (95 minutes), and the intra-service times of CPT codes 75954 and 75953 are identical (45 minutes). This is consistent with the specialty societies' description of the work of CPT code 75954, which is virtually identical to the description of the work for CPT code 75953. Therefore, in order to maintain correct rank order in this family of codes we are assigning a work RVU of 1.36 to CPT code 75954.

CPT codes 92605 Evaluation for prescription of non-speech generating augmentative and alternative communication device and 92606 Therapeutic service(s) for the use of non-speech generating device, including programming and modification

We will consider CPT codes 92605 and 92606 bundled for Medicare payment purposes. The RUC's evaluation of these services implied that they are similar to the new CPT codes for speech generating devices. We believe that CPT codes 92605 and 92606 typically do not involve the same type of highly specialized equipment as the codes for speech generating devices. We believe that the work associated with these services is already contained in CPT codes 92506 Evaluation of speech, language, voice communication, auditory processing, and/or aural rehabilitation status and 92507 Treatment of speech, language, voice communication, auditory processing disorder (includes aural rehabilitation); individual, and will consider CPT codes 92605 and 92606 bundled.

We note that CPT also created new codes to describe programming and analysis of cochlear implants. These CPT codes are 92601 Diagnostic analysis of cochlear implant, patient under 7 years of age; with programming; 92602 Diagnostic analysis of cochlear implant, patient under 7 years of age; subsequent reprogramming; 92603 Diagnostic analysis of cochlear implant, age 7 years or older, with programming; and 92604 Diagnostic analysis of cochlear implant, age 7 years or older, subsequent reprogramming. Codes 92601 and 92603 describe post-operative analysis and fitting of previously placed external devices, connection to the cochlear implant, and programming of the stimulator. CPT Codes 92602 and 92604 describe subsequent sessions for measurements and adjustment of the external transmitter and re-programming of the internal stimulator.

An existing CPT code, 92510 Aural rehabilitation following cochlear implant (includes evaluation of aural rehabilitation status and hearing, therapeutic services) with or without speech processor programming, will no longer be used for Medicare services since it represents services which have considerable overlap with the services described by the new CPT codes, 92601, 92602, 93603, and 92604. For the remaining services that do not involve reprogramming of the cochlear implant, CPT code 92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder (includes aural rehabilitation); individual describes the services, so a code specific to cochlear implant patients is no longer needed. The use of CPT code 92507 for this service is consistent with the note in the CPT manual under CPT code 92602.

CPT codes 92613 Flexible fiberoptic endoscopic evaluation of swallowing by cine or video recording; physician interpretation and report only, 92615 Flexible fiberoptic endoscopic evaluation, laryngeal sensory testing by cine or video recording; physician interpretation and report only, and 92617 Flexible fiberoptic endoscopic evaluation of swallowing and laryngeal sensory testing by cine or video recording; physician interpretation and report only.

Effective January 1, 2003, CPT created several codes to describe fiberoptic endoscopic evaluation services that are currently described by temporary G-codes. For specific information related to both the former G-codes and the new CPT codes that will replace the deleted G-codes, refer to the end of this section. We agreed with the RUC recommended values for all of the fiberoptic endoscopic evaluation services (CPT codes 92612, 92614, and 92616) with the exception of CPT codes 92613, 92615, and 92617. For these three services that refer only to a separately identified physician review and interpretation of the fiberoptic endoscopic evaluation, we consider the physician interpretation and report bundled into an evaluation and management service. We believe the physician who does not perform the testing should only bill the patient when performing an evaluation and management service, not as the supervisor of another professional performing and reviewing the initial fiberoptic endoscopic evaluation. The interpretation of this test is an integral part of the testing itself. If a nonphysician professional has the credentials and experience to perform this testing, then that professional should also provide the interpretation of the findings.

CPT codes 93784 Ambulatory blood pressure monitoring, utilizing a system such as magnetic tape and/or computer disk, for 24 hours or longer; including recording, scanning analysis, interpretation and report, 93786 Ambulatory blood pressure monitoring, utilizing a system such as magnetic tape and/or computer disk, for 24 hours or longer; recording only, 93788 Ambulatory blood pressure monitoring, utilizing a system such as magnetic tape and/or computer disk, for 24 hours or longer; scanning analysis with report, and 93790 Ambulatory blood pressure monitoring, utilizing a system such as magnetic tape and/or computer disk, for 24 hours or longer; physician review with interpretation and report.

We have not yet received RUC recommendations for these codes. We established RVUs for these services during this past year in response to a national coverage determination. We will maintain these RVUs until we receive a RUC recommendation.

CPT code 95990 Refilling and maintenance of implantable pump or reservoir for drug delivery; spinal (intrathecal, epidural) or brain (intraventricular).

We understand that performance of CPT code 95990 requires the use of an expensive kit, the cost of which may not be reflected in the RVUs for CPT code 96530, the code under which it was previously reported. CPT code 96530 has practice expense RVUs of 1.01 and malpractice RVUs of 0.05. We are assigning 1.50 practice expense RVUs because we estimate that the practice expense for CPT code 95990 is 50 percent higher than it is for CPT code 96530. We are crosswalking the malpractice RVUs from CPT code 96530 to CPT code 95990.

We are not assigning work RVUs to CPT code 95990 for 2003 since we believe that this procedure is typically (greater than 50 percent of the time) performed by a nurse. We understand that there has been discussion with the CPT Editorial Committee about revising this code so that it would be billed only when performed in the presence of a physician. If the code were to be so revised, we would consider any RUC recommendations regarding work RVUs for this service.

These values are interim for 2003 and we will address comments about the RVUs for this code in next year's final rule.

CPT codes 99026 Mandated On-call service; in hospital and 99027 Mandated physician on call services

No RUC recommendation was received for these codes. Note that stand-by and on-call services are not covered by Medicare and we would not pay for these services billed using these codes.

Establishment of Interim Practice Expense RVUs for New and Revised Physician's Current Procedural Terminology (CPT) Codes and New Healthcare Common Procedure Coding System (HCPCS) Codes for 2003

We have developed a process for establishing interim practice expense RVUs for new and revised codes that is similar to that used for work RVUs. Under this process, the RUC recommends the practice expense direct inputs, that is, the staff time, supplies and equipment, associated with each new code. We then review the recommendations in a manner similar to our evaluation of the recommended work RVUs.

The RUC recommendations on the practice expense inputs for the new and revised 2003 codes were submitted to us as interim recommendations. We, therefore, consider that these recommendations are still subject to further refinement by the PEAC, or by us, if it is determined that such future review is needed. We may also revisit these inputs in light of future decisions of the PEAC regarding supply and equipment packages and standardized approaches to pre- and post-service clinical staff times.

We have accepted, in the interim, all of the practice expense recommendations submitted by the RUC for the codes listed in the following table titled “AMA RUC and HCPAC RVU Recommendations and CMS Decisions for New and Revised 2003 CPT Codes.”

C. Other Changes to the 2003 Physician Fee Schedule

We are establishing the following HCPCS codes for CY 2003.

GO262 Small intestinal imaging; intraluminal, from ligament of Treitz to the ileo cecal valve, includes physician interpretation and report

We are creating this code to describe a new diagnostic test for which we will make separate payment under the physician fee schedule and the Hospital Outpatient Prospective Payment System (OPPS). The procedure involves ingesting a small camera through the mouth. As the camera traverses the gastrointestinal tract, it produces two images per second and transmits those images to a receiver worn by the patient. After eight hours (the battery life of the camera) the belt containing the receiver is removed from the patient. The images are then developed and reviewed by a physician who interprets them and makes a written report. The capsule is excreted in the patient's stool and discarded. Images taken in the esophagus, stomach and large intestine (colon) are hard to interpret; therefore, current use of this imaging modality is limited to evaluation of the small intestine. The G-code descriptor is designed to ensure accurate reporting of this diagnostic test. Although this test has been referred to as “capsule endoscopy”, the term “endoscopy” is a misnomer because “endoscopy” refers to physician-controlled viewing the gastrointestinal tract through an endoscope.

Physician Work

We understand from recently published clinical studies that the average small intestine transit time was 257 minutes and the transit time from ingestion to the cecum was 302 minutes. Review of the images includes a first pass overview to mark areas of special interest, a review of the entire video recording, and a focused review of abnormalities, if any are found. The average time to review the capsule images in two recently published studies was 50 and 56 minutes. Therefore, we believe that, typically, 53 minutes of physician time will be spent reviewing the video. To assign a work value, we compared the work of this code to the work of other diagnostic tests and procedures that require review of significant amounts of data. Specifically, we reviewed the work RVUs and intra-service times for electroencephalography (EEG) reading and interpretation, magnetic resonance angiography (MRA), computed tomographic angiography (CTA), Holter monitor reading and interpretation, prolonged esophageal acid reflux testing, echocardiography, duplex scanning of the carotid arteries, and anorectal manometry. Based on these comparisons, we are assigning a work value of 2.12 RVUs. This results in an intensity of .04 RVU per minute and places it in correct rank order with the procedures to which it was compared. We note that this assumes that a complete study from the ligament of Treitz to the ileocecal valve was performed and that the camera functioned normally throughout the procedure and produced two images per second. If an incomplete evaluation of the small intestine is accomplished, this code should be billed with a CPT code 52-modifier indicating reduced services, and the payment amount would also be reduced. The amount of reduction is determined by the carrier. Until such time as we make a NCD for this service, coverage is at the discretion of carriers and intermediaries.

Malpractice

We are crosswalking the value from CPT code 74230 with the same PC/TC split because they have similar physician times and intensities.

Practice Expense

For the physician fee schedule we are assigning the following inputs for practice expense:

• Staff Time—RN/LPN/MA mix—90 minutes—includes pre-service education, attachment of the receiver, administration of the camera, removal of the receiver, and processing of the images
• Supplies—Single use camera; Razor
• Equipment—Workstation

GO268 Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing

This code was created in order to allow payment to a physician who removes impacted cerumen on the same date as his or her employed audiologist performs audiologic function testing. We will assign the same physician work RVUs, practice expense inputs, and malpractice RVUs to this code as are assigned to CPT code 69210, Removal impacted cerumen (separate procedure), one or both ears.

First, we emphasize that routine removal of cerumen is not paid separately. It is considered to be part of the procedure with which it is billed (for example, audiologic function testing). To assure the appropriate reporting of this code, we note that it should only be used in those unusual circumstances when an employed audiologist who bills under a physician UPIN number performs audiologic function testing on the same day as removal of impacted cerumen requiring physician expertise for removal. This code should not be used when the audiologist removes cerumen, because removal of cerumen is considered to be part of the diagnostic testing and is not paid separately.

GO269 Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (for example, angioseal plug, vascular plug)

We are creating this G code to assure proper reporting of this service. It has come to our attention that this service is being inappropriately reported with codes for such procedures as “blood vessel repair” and “repair of arterial pseudoaneurysm.” We are assigning a status indicator of “B” (payment bundled into payment for other services) to this service, as the work, practice expense, and malpractice risk of closing an arteriotomy or venotomy site at the conclusion of an invasive percutaneous procedure, whether by manual compression, suture, or use of a closure device, is included in the main invasive procedure. Therefore, there is no separate payment for this procedure.

GO270 Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), individual, face-to-face with the patient, each 15 minutes and

GO271 Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease) group (2 or more individuals), each 30 minutes

In our NCD dated May 1, 2002, we established basic coverage for medical nutrition therapy billed under CPT codes 97802 through 97804 as 3 hours per year for beneficiaries with either diabetes or renal disease. However, we also pay for additional hours if a physician makes a second referral in the same year based on a change in the beneficiary's medical condition, diagnosis, or treatment regimen. These new codes allow us to edit for basic coverage and reimburse for additional coverage when appropriate.

We are crosswalking the RVUs from CPT code 97803 to G0270 and CPT code 97804 to G0271 because these are the corresponding CPT medical nutrition codes.

GO272 Naso/oro gastric tube placement, requiring physician's skill and fluoroscopic guidance (includes fluoroscopy, image documentation and report)

We are creating this code for one year until an identical CPT code becomes effective.

Physician Work

We compared this code to other gastroenterology and radiologic procedures including CPT codes 91105 Gastric intubation, and aspiration or lavage for treatment (e.g, for ingested poisons) (work RVU of 0.37); 44500 Introduction of long gastrointestinal tube (e.g., Miller-Abbott) (separate procedure) (work RVU of 0.49); 74340 Introduction of long gastrointestinal tube (e.g., Miller-Abbott), including multiple fluoroscopies and films, radiological supervision and interpretation (work RVU of 0.54), and 76000 Fluoroscopy (separate procedure), up to one hour physician time, other than 71023 or 71034 (e.g., cardiac fluoroscopy) (work RVU of 0.17).

This procedure is most similar to CPT code 91105 (16 minutes of physician time), but requires less work because it is done in a controlled setting with fluoroscopy to aid in placement. It is not similar to CPT codes 44500 and 74340 because placement of Miller-Abbott tubes is a more lengthy and involved procedure than placement of naso/oro gastric tubes. In fact, the physician time for placement of Miller-Abbott tubes is over 30 minutes, while placement of a naso/oro gastric tube takes about 15 minutes. We are assigning this G code a work RVU of 0.32, which is the sum of the work RVU for CPT code 76000 and the work intensity of CPT code 44500 times 15 minutes.

Malpractice

We are assigning 0.02 malpractice RVUs to this procedure.

Practice Expense

We believe this procedure will only be performed in facilities, so we are not assigning any practice expense inputs to this code.

GO273 Radiopharmaceutical biodistribution, single or multiple scans on one or more days, pre-treatment planning for radiopharmaceutical therapy of non-Hodgkin's lymphoma, includes administration of radiopharmaceutical (e.g., radiolabeled antibodies).

We are creating this code to describe radionuclide scanning to determine the biodistribution of Zevalin. The procedure encompasses administration of Indium labeled Zevalin followed by whole body radionucliide scanning 2-24 hours and 48-72 hours after the administration of Zevalin. Rarely, a third scan is necessary. The purpose of the scanning is to ensure that the biodistribution of Zevalin is normal, thus decreasing the risk of toxic effects from the administration of a therapeutic dose. The published criteria for determining appropriate biodistribution involve making a qualitative comparison of isotope uptake in several organ systems between the two scans. Therefore, these scans cannot be read in isolation, and this code should only be reported once, no matter how many scans are performed.

Physician Work

We are assigning 0.86 work RVUs to this code which is equivalent to the work for CPT code 78802, Radiopharmaceutical localization of tumor; whole body. We believe the total physician time of 41 minutes for CPT code 78802, and the intensity are similar to the time and intensity required for this service.

Malpractice

We are assigning 0.28 RVU to the global procedure, 0.25 RVU to the technical component, and 0.03 RVU to the professional component. These are identical values to CPT code 78802.

Practice Expense

The TC of this code is being priced in the nonphysician work pool, where we crosswalked it to the charge-based practice expense RVUs for CPT code 78802, taking into account that the radiopharmaceutical is administered once, but that there are two scans obtained.

We wish to emphasize that this code is only reported once and includes the administration of the radiopharmaceutical and performance and interpretation of all scans. We also note that the infusion of rituxumab prior to the administration of Zevalin is separately payable.

GO274 Radiopharmaceutical therapy, non-Hodgkin's lymphoma, includes administration of radiopharmaceutical (e.g., radiolabeled antibodies)

We are establishing this code to allow appropriate reporting of this new service. Radiopharmaceutical therapy using radiolabeled monoclonal antibodies is a new form of treatment for non-Hodgkins lymphoma and is not currently described by any existing HCPCS code.

After review of information regarding this service, we are assigning the following RVUs:

Physician Work

We believe that physicians typically take 60 minutes to perform this service on the day of the procedure. Of this time, 45 minutes is spent counseling the patient and family, while 15 minutes are spent setting up and infusing the radiopharmaceutical. Additionally, there is post-procedure time spent reviewing platelet counts, which requires calling the patient or another physician 25 percent of the time. We compared this procedure to the physician work RVUs, physician times, and intensity (RVU per minute) of other nuclear medicine and radiation oncology procedures CPT codes 79400, 77790, 79030, 79035, and 79100; infusion procedures CPT codes 36520, 36521, 37201, and 37202; hemodialysis CPT codes 90935, and 90937; evaluation and management CPT codes 99214 and 99215.

Based on this comparison we are assigning a work RVU of 2.07 to this code. This represents the work of CPT code 99214 (counseling a complex patient), 15 minutes for infusion at an intensity of 0.05 RVU per minute (similar to the intensity of CPT code 77790), and 10 minutes of post service work (at an intensity of 0.022 RVU per minute). This also places the code in the correct rank order with all of the above procedures.

Malpractice

We are assigning malpractice RVUs of 0.20 to this procedure, with 0.12 assigned to the technical component and 0.08 assigned to the professional component. These are identical to the RVUs for CPT code 79400.

Practice Expense

The TC of this code is being priced in the nonphysician workpool where we crosswalked it to the charge-based practice expense RVUs for CPT code 79400.

GO275 Renal angiography (unilateral or bilateral) performed at the time of cardiac catheterization, includes catheter placement in the renal artery, injection of dye, flush aortogram and radiologic supervision and interpretation and production of images (List separately in addition to primary procedure) and

GO278 Iliac artery angiography performed at the same time of cardiac catheterization, includes catheter placement in the iliac artery, injection of dye, radiologic supervision and interpretation and production of images (List separately in addition to primary procedure)

We are creating these add-on codes to assure proper reporting of and payment for renal and iliac angiography performed at the time of cardiac angiography. These procedures are performed frequently on Medicare patients and are currently reported using codes that describe placement of a catheter in the renal and/or iliac artery(s) (CPT codes 36245 and 36246) and radiological supervision and interpretation of renal and/or iliac angiography (CPT codes 75710, 75716, 75722, and 75724).

Physician Work

Based on the information we reviewed, the typical performance of these procedures involves the use of a pigtail catheter positioned in the aorta (not the renal or iliac artery(s)), injection of a minimal dye load (because of the heavy dye load already used for cardiac angiography), and viewing the dye run off into the proximal main renal or iliac arteries under fluoroscopy. We determined work values for these procedures by using the work values for CPT codes 75625, Aortography, abdominal, by serialography, radiological supervision and interpretation (1.14 work RVUs with 22 minutes of physician time) and 93544, Injection procedure during cardiac catheterization; for aortography (0.25 work RVUs and 5 minutes of physician time) and adjusting for a procedure time of approximately two and one half minutes. This process yields a value of 0.25 work RVUs, which is what we are assigning to these two add-on procedures.

Malpractice

We are crosswalking the 0.01 malpractice RVUs for CPT code 93544 to these procedures.

Practice Expense

We are not assigning any practice expense inputs to these procedures because the incremental increase in staff and room time to perform these procedures is negligible.

GO279 Extracorporeal shock wave therapy; involving elbow epicondylitis.

GO280 Extracorporeal shock wave therapy; involving other than elbow epicondylitis or plantar fascitis.

CPT code 0020T Extracorporeal Shock Wave Therapy; involving plantar fascia

We are creating and establishing a national payment amount for two G-codes describing extracorporeal shock wave therapy for the musculoskeletal system and establishing a national payment amount for CPT code 0020T. We are doing this in response to multiple requests from our contractors to establish a national payment amount, though creation of these codes does not imply that services will be covered by Medicare. We also note that this form of therapy was recently approved by the Food and Drug Administration for treatment of lateral epicondylitis. Our staff has reviewed the method of treatment and we are establishing work, practice expense, and malpractice RVUs for these codes.

We believe these services are similar to other physical therapy modalities and are designating it to be paid on the therapy fee schedule. Based on the information we reviewed, these services are typically performed by a technician similar to a physical therapy aide and take about 20 minutes to perform.

Physician Work

We compared these services to other physical therapy services and believe they are most similar to unattended physical therapy modalities such as diathermy. We are assigning a work RVU of 0.06 for these procedures in order to place them in proper rank order with other unattended physical therapy services.

Malpractice

We are crosswalking the malpractice RVUs (0.01) from CPT code 97024, Application of a modality to one or more areas; diathermy, to these procedures.

Practice Expense

We are assigning the following practice expense inputs:

• Staff/Time: Physical therapy aide; 30 minutes.
• Supplies: Ultrasound Gel.
• Equipment: Shock wave machine.

We note that, for lateral epicondylitis, the typical treatment regimen is up to 3 total treatments at weekly intervals.

Electrical Stimulation for Wound Care

GO281 Electrical stimulation, (unattended), to one or more areas, for chronic stage III and stage IV pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care; and

GO282 Electrical stimulation, (unattended), to one or more areas, for wound care other than described in G0281 and

GO283 Electrical stimulation, (unattended), to one or more areas, for indication(s) other than wound care, as part of a therapy plan of care.

These three new G codes have been created to implement the coverage determination on use of electrical stimulation for wound care.

The work, practice expense, and malpractice values for CPT code 97014 Application of a modality to one or more areas; electrical stimulation (unattended) will be crosswalked to these new G codes, but G0282 will not be covered by Medicare. In addition, CPT code 97032, Application of a modality to one or more areas: electrical stimulation (manual), each 15 minutes, should not be utilized for any wound care.

The coverage determination that allowed coverage for the use of electrical stimulation for certain types of wound care also stated that another similar modality, electromagnetic stimulation, would not be covered. A G code, “G0295: Electromagnetic stimulation, to one or more areas” will be created to describe this service, since this service would otherwise have been coded using CPT code 97039 and would have required manual claims review. The new code, G0295, will be listed as non-covered by Medicare.

GO288 Reconstruction, computed tomographic angiography of aorta for surgical planning for vascular surgery.

We are creating this code to assure accurate reporting of this service by independent diagnostic testing facilities (IDTFs) that perform this service. Facilities that perform this service (either at the facility or under arrangement) report this service through the use of a “C” code specific to hospital reporting.

This code is a technical component code only since the service provided by the IDTF includes receipt of a Computed Tomographic Angiogram (CTA), post CTA processing using specialized software, and burning the 3D model onto a CD and returning it to the operating surgeon. This 3D model is used to assist vascular surgeons in planning for, or monitoring the results of, endovascular aneurysm repair. The service is a technical service provided under the general supervision of a physician according to the supervision requirements for IDTFs. We compared this procedure to CPT codes 74175, Computed tomagraphic angiography, abdomen, without contrast material(s), followed by contrast material(s) and further sections, including image post-processing and 76375, Coronal, sagital, multiplanar, oblique, 3-dimensional and/or holographic reconstruction of computerized axial tomography, magnetic resonance imaging, or other tomographic modality. Based on this review, we developed practice expense RVUs using the nonphysician workpool methodolgy. The malpractice RVUs will be crosswalked from CPT code 76375 directly and will be set at 0.15 RVUs.

GO289 Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chrondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee.

We are creating this code to permit appropriate reporting of arthroscopic procedures performed in different compartments of the same knee during the same operative session. This is an add-on code and should be added to the knee arthroscopy code for the major procedure being performed. This code is only to be reported once per extra compartment, even if both chondroplasty, loose body removal, and foreign body removal are performed. The code may be reported twice (or with a unit of two) if the physician performs these procedures in two compartments in addition to the compartment where the main procedure was performed.

This code should only be reported if the physician spends at least 15 minutes in the additional compartment performing the procedure. It should not be reported if the reason for performing the procedure is due to a problem caused by the arthroscopic procedure itself. This code is to be used when a procedure is performed in the lateral, medial, or patellar compartments in addition to the main procedure. However, CPT codes 29874, Arthroscopy, knee, surgical; for removal of loose body or foreign body (e.g., osteochrondritis dissecans fragmentation, chondral fragmentation) and 29877 Arthroscopy, knee, surgical; debridement/shaving of articular cartilage (chrondroplasty) may not be billed with other arthroscopic procedures on the same knee.

Physician Work

We examined the work RVUs, the intra-operative work intensity, and the intra-operative times for CPT codes 29874 and 29877. We also compared these intensities and times to those for CPT code 29870, the base procedure for this family. We determined a work value using the intra-operative intensity for CPT code 29874 (which is higher than for CPT code 29877) and the mean intra-operative times (for CPT codes 29874 and 29877) beyond the time required for CPT code 29870 (14 minutes for CPT code 29874 and 27 minutes for CPT code 29877). This code represents approximately 20 minutes of extra work at a high level of intensity. Therefore, the work value we are assigning to this code is 1.48 RVUs.

Malpractice

We are assigning 0.27 malpractice RVUs to this procedure. This is the sum of the malpractice RVUs for CPT codes 29874 and 29877 beyond the malpractice RVUs for CPT code 29870, divided by two.

Practice Expense

We are not assigning any practice expense inputs to this code because it is an add-on code that will only be performed in the facility setting.

Revisions to G Codes

We are also revising the descriptors for the following existing G codes as follows:

G0179 Physician recertification services for Medicare-covered services provided by a participating home health agency (patient not present) including review of subsequent reports of patient status, review of patient's responses to the OASIS assessment instrument, contact with the home health agency to ascertain the follow-up implementation plan of care, and documentation in the patient's office record, per certification period and

G0180 Physician certification services for Medicare-covered services provided by a participating home health agency (patient not present), including review of initial or subsequent reports of patient status, review of patient's responses to the OASIS assessment instrument, contact with the home health agency to ascertain the initial implementation plan of care, and documentation in the patient's office record, per certification period

Comment: Individuals have requested clarification as to whether a review of OASIS data is required when a physician bills for the certification and re-certification of home health plans of care.

Response: The review of OASIS data, although not required for the performance of either a certification or re-certification of a home health plan of care, is considered a valuable tool to be utilized in the performance of both a certification or re-certification of a home health plan of care. We agree that the current HCPCS code(s) descriptors are unclear and will revise the descriptors to identify the review of OASIS as an option as opposed to a requirement. The descriptors are being revised as follows:

G0179 Physician re-certification for Medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implementation of the plan of care that meets patient's needs, per re-certification period.

G0180: Physician certification for Medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implementation of the plan of care that meets patient's needs, per certification period.

G0236 Digitization of film radiographic images with computer analysis for lesion detection and further physician review for interpretation, diagnostic mammography (list separately in addition to code for primary procedure)

Comment: Individuals have requested that we establish additional G-codes that would specify the use of computer-aided detection with direct digital image mammograms. Currently, the descriptors associated with HCPCS code G0236 (diagnostic) and CPT code 76085 (screening) refer not only to the application of computer-aided detection but also to the conversion of film images to digital images.

Response: When the computer-aided detection codes were originally assigned, we intended that they would be used for the application of computer-aided detection to both direct digital images and to standard film images that were converted to digital images. The current descriptors of both HCPCS code G0236 and CPT code 76085 do not explicitly state that the code can be billed in conjunction with either direct digital images or standard film images converted to digital images. We have revised the descriptor associated with the application of computer-aided detection to diagnostic images (HCPCS code G0236) to incorporate both direct digital images and standard film images converted to digital images. Additionally, we will request that the CPT editorial panel review the current definition associated with the screening computer-aided detection code (CPT code 76085) for future revision. Until such time as a revision is made to CPT code 76085, physicians should use CPT code 76085 for both direct digital screening images as well as for standard film screening images that are converted to digital images.

G0236 is revised to read as follows: Digitization of film radiographic images with computer analysis for lesion detection, or computer analysis of digital mammogram for lesion detection, and further physician review for interpretation, diagnostic mammography (List separately in addition to code for primary procedure).

G0239 Therapeutic procedures to improve respiratory function, other than services described by G0237, two or more (includes monitoring).

For clarity, and to address concerns expressed by individuals about how to code group treatment of patients with procedures described in G0237, we are revising the descriptor for G0239 to read as follows:

G0239 Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more (includes monitoring).

Deletion of G Codes

We will be deleting the following G codes for CY 2003: G0002 Office procedure, insertion of temporary indwelling catheter, foley type (separate procedure)

Services formerly billed under G0002 will be billed under CPT codes 51702 Insertion of temporary indwelling bladder catheter; simple (e.g., Foley) or 51703 Insertion of temporary indwelling bladder catheter; complicated (e.g., altered anatomy, fractured catheter/balloon).

G0004 Patient demand single or multiple event recording with pre-symptom memory loop and 24 hour attended monitoring, per 30 day period; includes transmission, physician review and interpretation; G0005 Patient demand single or multiple event recording with pre-symptom memory loop and 24 hour attended monitoring, per 30 day period; recording (includes hook-up, recording and disconnection); G0006 Patient demand single or multiple event recording with pre-symptom memory loop and 24 hour attended monitoring, per 30 day period; 24 hour attended monitoring, receipt of transmissions, and analysis; and G0007 Patient demand single or multiple event recording with pre-symptom memory loop and 24 hour attended monitoring, per 30 day period; physician review and interpretation only.

Services formerly billed under G0004 will be billed using CPT code 93268, Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30 day period of time; includes transmission, physician review and interpretation; services billed using G0005 will be billed using CPT code 93270, Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30 day period of time; recording (includes hook-up, recording and disconnection); services billed using G0006 will be billed using CPT code 93271, Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30 day period of time; monitoring, receipt of transmissions and analysis; services billed using G0007 will be billed using CPT code 93272 Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30 day period of time; physician review and interpretation only, and services billed using G0015 will be billed using CPT code 93012 Telephonic transmission of post-symptom electrocardiogram rhythm strip(s), per 30 day period of time, tracing only. Unattended monitoring of patient demand single or multiple event recording with presymptom memory loop, per 30 day period of time and unattended telephonic transmission of post symptom electrocardiogram rhythm strip(s), per 30 day period of time should be billed using CPT code 93799, Unlisted cardiovascular service or procedure.

G0050 Measurement of post-voiding residual urine and/or bladder capacity by ultrasound

Services formerly billed under G0050 will be billed using CPT code 51798.

G0131 Computerized tomography bone mineral density study, one or more sites; axial skeleton (e.g., hips, pelvis, spine) and G0132 Computerized tomography bone mineral density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel).

Services formerly billed under G0131 will be billed using CPT code 76070, and those billed under G0132 will be billed using CPT code 76071.

G0185 Destruction of localized lesion of choroids for example, choroidal neovascularization; transpupillary thermotherapy (one or more sessions) and G0186 Destruction of localized lesion of choroids for example, choroidal neovascularization; photocoagulation, feeder vessel technique (one or more sessions).

Services formerly billed under G0185 will be billed using CPT code 0016T, Destruction of localized lesion of choroids (e.g., choroidal revascularization), transpupillary thermotherapy, and G0186 will be billed using CPT code 0017T, Destruction of macular drusen, photocoagulation.

G0193 Endoscopic study of swallowing function (also fiberoptic endoscopic evaluation of swallowing (FEEST)), G0194 Sensory testing during endoscopic study of (add-on code) referred to as fiberoptic endoscopic evaluation of swallowing with sensory (FEEST), G0195 Clinical evaluation of swallowing function (not involving interpretation of dynamic radiological studies or endoscopic study of swallowing), and G0196 Evaluation of swallowing involving swallowing of radio-opaque materials.

Services formerly billed under G0193 will be billed using new CPT code 92612; services billed using G0194 will be billed using new CPT code 92614; services billed using G0195 will be billed using new CPT code 92610; and G0196 should be billed using new CPT code 92611.

G0197 Evaluation of patient for prescription of speech generating devices, G0198 Patient adaptation and training for use of speech generating devices, G0199 Re-evaluation of patient using speech generating devices, G0200 Evaluation of patient for prescription of voice prosthetic, and G0201 Modification or training in use of voice prosthetic.

Services formerly billed under G0197 will be billed using CPT code 92607 Evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with the patient; first hour, and, if appropriate, CPT code 92608, Evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with the patient; each additional 30 minutes; services billed using G0198 will be billed using CPT code 92609 Therapeutic services for the use of speech-generating device, including programming and modification; services billed using G0199 will be billed using CPT code 92607, using the -52 modifier if the service is less than 1 hour; services billed using G0200 will be billed using revised CPT code 92597 Evaluation for use and/or fitting of voice prosthetic device to supplement oral speech; and services billed using G0201 will be billed using CPT code 92507.

G0240 Critical Care Service delivered by a physician; face-to-face, during inter-facility transport of a critically ill or critically injured patient: first 30-74 minutes of active transport, and G0241—each additional 30 minutes (list separately in addition to G0240)

Services formerly billed under G0240 and G0241 will be billed using CPT codes 99289 and 99290.

V. Update to the Codes for Physician Self-Referral Prohibition

A. Background

On January 4, 2001 we published in the Federal Register a final rule with comment period, “Medicare and Medicaid Programs; Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships” (66 FR 856). That final rule incorporated into regulations the provisions in paragraphs (a), (b) and (h) of section 1877 of the Act. Section 1877 of the Act prohibits a physician from referring a Medicare beneficiary for certain “designated health services” to a health care entity with which the physician (or a member of the physician's immediate family) has a financial relationship, unless an exception applies. In the final rule, we published an attachment listing all of the CPT and HCPCS codes that defined the entire scope of the following designated health services for purposes of section 1877 of the Act: clinical laboratory services; physical therapy services (including speech-language pathology services); occupational therapy services; radiology and certain other imaging services; and radiation therapy services and supplies.

In the January 2001 final rule, we stated that we would update the list of codes used to define these designated health services in an addendum to the annual physician fee schedule final rule. The purpose of the update is to conform the code list to the most recent publications of CPT and HCPCS codes. An updated all-inclusive list of codes was included in the November 1, 2001 physician fee schedule final rule in Addendum E and was subsequently corrected in a notice that was published in the Federal Register (66 FR 20681) on April 26, 2002.

The updated all-inclusive list of codes effective for January 1, 2003 is presented in Addendum E in this final rule. It is our intent to always use Addendum E of the annual physician fee schedule final rule for the physician self-referral update. The updated all-inclusive list of codes will also be available on our Web site at http://cms.hhs.gov/​medlearn/​refphys.asp.

B. Response to Comments

We received three comments regarding the code list. The comments and our responses are stated below.

Comment: One commenter agreed with the additions and deletions to the list of designated health services as published in the November 1, 2001 physician fee schedule final rule (66 FR 55312). The commenter expressed the understanding that we would address the comments regarding the original list of designated health services (published in the January 4, 2001 final rule) in a second final rule on the physician self-referral prohibition. A second commenter raised concerns about our decision (announced in the January 4, 2001 final rule) to exclude nuclear medicine from the definition of “radiology and certain other imaging services.”

Response: The first commenter is correct in understanding that we intend to address substantive comments on the designated health services that are defined by reference to HCPCS and CPT codes in a second final rule concerning the physician self-referral prohibition. We will also address the second commenter's concerns regarding nuclear medicine in that final rule. As noted above, this update to the code list merely reflects changes to the most recent publications of HCPCS and CPT codes.

Comment: One commenter noted that we post on our Web site (http://www.hcfa.gov/​stats/​cpt/​rvudown.htm) an Excel spreadsheet file containing all of the CPT/HCPCS codes with accompanying RVUs. The commenter suggested that we add a column indicating whether a code is considered a designated health service for purposes of the physician self-referral law, as well as in which category of designated health services it would be included. The commenter stated that, as changes are made, they would be scattered throughout several physician fee schedules.

Response: We believe that the commenter was concerned that updates to the list of designated health services under the physician self-referral law would be published in various fee schedules throughout the course of a year. This is not the case. We publish the annual update and the entire list of CPT/HCPCS codes in the physician fee schedule final rule. (Addendum E contains the updated all-inclusive list of codes.) We have no plans to publish an updated list of codes for physician self-referral purposes in any other fee schedule. We chose the physician fee schedule, as opposed to one of the other fee schedules, because we believe that physicians would be more likely to see it. We maintain a current list of codes used to define certain designated health services for purposes of the physician self-referral law on our Web site at http://cms.hhs.gov/​medlearn/​refphys.asp. We have decided not to make any changes to the RVU website at this time because we believe the updated all-inclusive list of codes used for purposes of physician self-referral is readily available to all physicians.

C. Revisions Effective for 2003

Table 9, below, identifies the additions and deletions to the comprehensive list of physician self-referral codes published in Addendum E of the November 2001 physician fee schedule final rule and subsequently corrected in the April 26, 2002 correction notice (66 FR 20681). Table 9 also identifies the additions, deletions and revisions to the lists of codes used to identify the items and services that may qualify for the exceptions in § 411.355(g) (regarding EPO and other dialysis-related outpatient prescription drugs furnished in or by an end-stage renal dialysis (ESRD) facility) and in § 411.355(h) (regarding preventive screening tests, immunizations and vaccines).

We will consider comments with respect to the codes listed in Table 9 below, if we receive them by the date specified in the DATES section of this final rule.

Table 9.—Additions and Deletions to the Physician Self-Referral Codes

HCPCS	CPT 1/Descriptor
Additions:
51798	Us urine capacity measure
76070	Ct bone density, axial
76071	Ct bone density, peripheral
76801	Ob us < 14 wks, single fetus
76802	Ob us < 14 wks, addl fetus
76811	Ob us, detailed, sngl fetus
76812	Ob us, detailed, addl fetus
92601	Cochlear implt f/up exam < 7
92602	Reprogram cochlear implt < 7
92603	Cochlear implt f/up exam 7 >
92604	Reprogram cochlear implt 7 >
92607	Ex for speech device rx, 1hr
92608	Ex for speech device rx addl
92609	Use of speech device service
92610	Evaluate swallowing function
92611	Motion fluoroscopy/swallow
92612	Endoscopy swallow tst (fees)
92614	Laryngoscopic sensory test
92616	Fees w/laryngeal sense test
0010T	TB test, gamma interferon
0019T	Extracorp shock wave tx, ms
0020T	Extracorp shock wave tx, ft
0023T	Phenotype drug test, HIV 1
0026T	Measure remnant lipoproteins
0028T	Dexa body composition study
0029T	Magnetic tx for incontinence
0030T	Anitprothrombotin antibody
0041T	Detect UR infect agnt w/cpas
0042T	Ct perfusion w/contrast, cbf
0043T	Co expired gas analysis
G0256	Prostate brachy w palladium
G0261	Prostate brachytherapy w/rad
G0262	Sm intestinal image capsule
G0274	Radiopharm tx, non-Hodgkins
G0279	Excorp shock tx, elbow epi
G0280	Excorp shock tx other than
G0281	Elec stim unattend for press
G0283	Elec stim other than wound
G0288	Recon, CTA for surg plan
J0636	Inj calcitriol per 0.1 mcg
J1756	Iron sucrose injection
J2501	Paricalcitol
J2916	Na ferric gluconate complex
Q3021	Ped hepatitis b vaccine inj
Q3022	Hepatitis b vaccine adult ds
Q3023	Injection hepatitis Bvaccine
Deletions:
76830	Us, exam transvaginal
76872	Echo exam, transrectal
76873	Echograp trans r, pros study
86915	Bone marrow/stem cell prep
90744	Hepb vacc ped/adol 3 dose im
90746	Hep b vaccine, adult, im
90747	Hepb vacc, ill pat 4 dose im
92510	Rehab for ear implant
97014	Electric stimulation therapy
G0026	Fecal leukocyte examination
G0027	Semen analysis
G0050	Residual urine by ultrasound
G0131	CT scan, bone density study
G0132	CT scan, bone density study
G0193	Endoscopicstudyswallowfunctn
G0194	Sensorytestingendoscopicstud
G0195	Clinicalevalswallowingfunct
G0196	Evalofswallowingwithradioopa
G0197	Evalofptforprescipspeechdevi
G0198	Patientadapation&trainforspe
G0199	Reevaluationofpatientusespec
G0200	Evalofpatientprescipofvoicep
G0201	Modifortraininginusevoicepro
J0635	Calcitriol injection
J1755	Iron sucrose injection
J2915	NA Ferric Gluconate Complex
Revisions:
76085	Computer mammogram add-on [when used in conjunction with 76092]
1 CPT codes and descriptions only are copyrighted in the 2002 American Medical Association. All rights are reserved and applicable FARS/DFARS clauses apply.

The “Additions” section of Table 9 generally reflects new CPT and HCPCS codes that become effective January 1, 2003. The one exception is the addition of the following emerging technology codes, referred to as Category III codes, which the AMA first included in the CPT effective January 1, 2002: 0010T, 0019T, 0020T, 0023T, and 0026T. CPT codes 0010T, 0023T, and 0026T represent clinical laboratory services while CPT codes 0019T and 0020T are therapy codes. These codes were addressed in the November 2001 physician fee schedule final rule with the clarification that coverage and payment of these services is generally at the discretion of the carrier. However, the portion of the November 2001 final rule that concerned the list of codes for physician self-referral purposes failed to address these new codes. Thus, we are adding the Category III codes that should have been included in last year's update. We also are adding the following new Category III codes issued for 2003 to which the physician self-referral prohibition applies: 0028T, 0029T, 0030T, 0041T, 0042T, and 0043T. CPT codes 0028T and 0042T are radiology services; CPT code 0029T is a physical therapy service; and, CPT codes 0030T, 0041T and 0043T are clinical laboratory services.

Table 9 also reflects the addition of 4 new codes (J0636, J1756, J2501 and J2916) to the list of dialysis-related outpatient prescription drugs that may qualify for the exception described in § 411.355(g) regarding those items. The physician self-referral prohibition will not apply to these drugs if they meet the conditions set forth in § 411.355(g). Table 9 also reflects the addition of 3 vaccine codes (Q3021, Q3022 and Q3023) to the list that identifies preventive screening tests, immunizations and vaccines that may qualify for the exception described in § 411.355(h) for such items and services. The physician self-referral prohibition will not apply to these vaccines if they meet the conditions set forth in § 411.355(h) concerning the exception for preventive screening tests, immunizations, and vaccines.

With the exception of CPT codes 76830, 76872 and 76873 for ultrasounds, the “Deletions” section of Table 9 reflects changes necessary to conform the code list to the most recent publications of CPT and HCPCS codes. We are deleting CPT code 76830 for transvaginal ultrasound and CPT codes 76872 and 76873 for transrectal ultrasounds because these codes should never have appeared on the list of designated health services. Our definition of “radiology and certain other imaging services” published in the January 2001 final rule (66 FR 956) specifically excludes any ultrasonic procedure that requires “the insertion of a needle, catheter, tube, or probe”. Thus, although the deletion of these codes is not a change to conform to an annual change in CPT or HCPCS codes, we are making the change at this time so that the list of codes will accurately reflect the regulatory definition for “radiology and certain other imaging services.”

Table 9 includes one revised CPT code. That is CPT code 76085, “Computer mammogram add-on.” In the CPT publication effective January 1, 2003, the CPT long descriptor was changed to delete the word “screening” so that the digitization no longer refers only to screening mammography. Because our exception under § 411.355(h) applies to preventive screening tests, we have revised the list of codes that may qualify for that exception to indicate that CPT code 76085 may qualify for the exception only when it is used in conjunction with CPT code 76092, “Mammogram screening.”

VI. Physician Fee Schedule Update for Calendar Year 2003

A. Physician Fee Schedule Update

The physician fee schedule update is determined under a calculation methodology that is specified by statute. Under section 1848(d)(4) of the Act, the update is equal to the product of 1 plus the percentage increase in the Medicare Economic Index (MEI) (divided by 100) and 1 plus the update adjustment factor. For CY 2002, the MEI is equal to 3.0 percent (1.030). The update adjustment factor is equal to -7.0 percent (0.930). Section 1848(d)(4)(F) of the Act requires an additional -0.2 percent (0.998) reduction to the update for 2003. Thus, the product of the MEI (1.030), the update adjustment factor (0.930), and the statutory adjustment factor (0.998) equals the CY 2003 update of -4.4 percent (0.956).

The Department believes that the negative update is inappropriate because the current update system does not reflect actual, after the fact, data from earlier years. Instead, the Act requires the Department to rely upon estimates made in past years, even though the Department now has actual data for these particular years. Even though after-the-fact data show that for certain years actual increases differed to some degree from earlier estimates, the Department is unable to revise estimates without congressional action. We have exhaustively searched for a different interpretation of law that would allow us to revise estimates for earlier years administratively, but unfortunately, we had to conclude that current law does not permit such an interpretation.

Without congressional action to address the current legal framework, the Department is compelled to announce a physician fee schedule update for CY 2003 of -4.4 percent. The Department's calculations are explained below.

We have, however, also identified reasonable adjustments that could result in a positive update in physician fee schedule rates if the Department were permitted by law to make those adjustments. Revisions of estimates used to establish the sustainable growth rates (SGR) for fiscal years (FY) 1998 and 1999 and Medicare volume performance standards (MVPS) for 1990 through 1996 could, under present estimations, result in an increase in the update.

The Department intends to work closely with the Congress to develop legislation that could permit a positive update, and hopes that such legislation can be passed before the negative update takes effect. Because the Department wishes to take action immediately in the event that Congress provides the Department legal authority to make the corrections, we are requesting comments regarding how physician fee schedule rates could and should be recalculated prospectively in the event that Congress provides the Department with legal authority to revise estimates used to establish the sustainable growth rates (SGR) for FYs 1998 and 1999 and the MVPS for 1990-1996.

B. The Percentage Change in the Medicare Economic Index

1. Medicare Economic Index (MEI) Productivity Adjustment

In the June 28, 2002 proposed rule, we reviewed the history of the MEI productivity adjustment, described the current MEI productivity adjustment, identified and evaluated possible alternative MEI productivity adjustments based on the individual contributions we solicited from experts on this topic, and proposed changing the MEI productivity adjustment to reflect an economy-wide multifactor productivity adjustment. In this final rule, we repeat this research information, respond to public comments on the MEI, and determine the CY 2003 MEI using the proposed methodological change.

a. History of MEI Productivity Adjustment

The MEI is required by section 1842(b)(3)(L) of the Act which states that prevailing charge levels beginning after June 30, 1973 may not exceed the level from the previous year except to the extent that the Secretary finds, on the basis of appropriate economic index data, that such higher level is justified by year-to-year economic changes. S. Rep. No. 92-1230, at 191 (1972) provides slightly more detail on that index, stating that:

Initially, the Secretary would be expected to base the proposed economic indexes on presently available information on changes in expenses of practice and general earnings levels combined in a manner consistent with available data on the ratio of the expenses of practice to income from practice occurring among self-employed physicians as a group.

Consistent with section 1842(b)(3)(L) and legislative intent, in 1975, we determined that the MEI would be based on a broad wage measure reflecting overall earnings growth, rather than direct inclusion of physicians' net income. We used average weekly earnings of nonagricultural production (non-supervisory) workers, net of worker's productivity, as the wage proxy in the initial MEI. We included the productivity adjustment because it avoided double counting of gains in earnings resulting from growth in productivity and produced an MEI that approximated an economy-wide output price index similar to the Consumer Price Index (CPI). The productivity adjustment we used was the annual change in economy-wide private non-farm business labor productivity, applied only to the physicians' earnings portion of the MEI (then 60 percent).

As noted, the productivity adjustment in the MEI serves to avoid the double counting of productivity gains. Absent the adjustment, productivity gains from producing additional outputs (procedures) with a given amount of inputs would be included in both the earnings component of the MEI (reflecting growth in overall economy-wide wages) and in the additional procedures that are billed (reflecting physicians' own productivity gains). Therefore, general economic labor productivity growth is removed from the labor portion of the MEI.

Although the basic structure of the MEI remained relatively unchanged from its effective date (July 1, 1975) until 1992, its weights were updated periodically and a component was added for professional liability insurance. Section 9331 of the Omnibus Budget Reconciliation Act of 1986 (Pub. L. 99-509) (OBRA 86) mandated that we conduct a study of the structure of the MEI and prepare a notice and offer the public an opportunity to comment before we revise the methodology for calculating the MEI. Based on this requirement, we held a workshop with experts on the MEI in March 1987 to discuss topics ranging from the specific type of index to use (Laspeyres versus Paasche) to revising the method of reflecting productivity changes. Participants included the Federal government, the Physician Payment Review Commission (PPRC), the Congressional Budget Office, the AMA, and several private consulting firms. The meeting participants concluded that a productivity adjustment in the MEI was appropriate and that an acceptable measure of physician-specific productivity did not currently exist. Many alternative approaches were discussed, including the use of a policy-based “target” measure and several existing economic productivity measures.

Using recommendations from the meeting participants, we revised the MEI and the productivity adjustment with the implementation of the physician fee schedule as discussed in the November 1992 final rule (57 FR 55896). While we retained an adjustment for economy-wide labor productivity, this adjustment was applied to all of the direct labor categories of the MEI (70.448 percent), not just physicians' earnings, and was based on the 10-year moving average percent change (instead of annual percent changes). This form of the index has been used since that time, and was most recently discussed in the November 1998 final rule (63 FR 58845) when the MEI weights were rebased to a 1996 base year.

The BBA replaced the Medicare Volume Performance Standard (MVPS) with a Sustainable Growth Rate (SGR). The SGR is an annual growth rate that applies to physicians' services paid for by Medicare. The use of the SGR is intended to control growth in aggregate Medicare expenditures for physicians' services. Payments for services are not withheld if the percentage increase in actual expenditures exceeds the SGR. Rather, the physician fee schedule update, as specified in section 1848(d)(4) of the Act, is adjusted based on a comparison of allowed expenditures (determined using the SGR) and actual expenditures. If actual expenditures exceed allowed expenditures, the update is reduced. If actual expenditures are less than allowed expenditures, the update is increased. Specifically, the SGR is calculated on the basis of the weighted average percentage increase in fees for physicians' services, growth in fee-for-service Medicare enrollment, growth in real per capita Gross Domestic Product (GDP), and the change in expenditures on physicians' services resulting from changes in law or regulations.

When the SGR was enacted, the Congress specified continued use of the MEI. By 1997, the MEI, including its productivity adjustment, had been used in updating Medicare payments to physicians for over twenty years. We did not propose any changes to the productivity adjustment used in the MEI when the SGR system was enacted because its continued use was consistent with the newly mandated formula. If we did not make a productivity adjustment in the MEI, general economic productivity gains would be reflected in two of the SGR factors, the MEI and real per-capita GDP (which reflects real GDP per hour worked, or labor productivity, and hours worked per person). We believe it is reasonable to remove the effect of general economic productivity from one of these factors (the MEI) to avoid double counting.

As noted previously, since its original development, the MEI productivity adjustment has been based on economy-wide productivity changes. This practice arose from the fact that the physicians' compensation portion of the MEI is proxied to grow at the same rate as general earnings in the overall economy, which reflect growth in overall economy-wide productivity. Removing labor productivity growth reflected in general earnings from the labor portion of the MEI produces an index that is consistent with other economy-wide output price indexes, like the CPI.

b. Research on Alternative MEI Productivity Adjustments

In the June 2002 proposed rule we presented the research we completed on evaluating the most appropriate productivity adjustment for the MEI. This research included evaluating the currently available productivity estimates produced by the BLS to develop a better understanding of the strengths and weaknesses of these measures and reviewing the theoretical foundation of the MEI to understand how labor and multifactor productivity relate to the current physician payment system. We also studied the limited publicly available data to begin to develop preliminary estimates of trends in physician-specific productivity to better understand the current market conditions facing physicians. Finally, we solicited the individual contributions of academic and other professional economic experts on prices and productivity. These experts included individuals from the MedPAC, the AMA, the Office of Management and Budget (OMB), Dr. Uwe Reinhardt from Princeton University, Dr. Joe Newhouse from Harvard University, Dr. Ernst Berndt from MIT, and Dr. Joel Popkin from Joel Popkin and Company. Below we repeat the findings on each of the six options we investigated and detailed in the proposed rule:

• Option 1—Using a physician-specific productivity adjustment.

This option would entail using an estimate of physician-specific productivity to adjust the MEI. This option may have some theoretical attractiveness, but there are major problems in obtaining accurate measures of physician-specific productivity. First, no published measure of physician-specific productivity is available. The Federal agency that produces the official government statistics on productivity, BLS, does not calculate or publish productivity measures for any health sector. Nor are there alternative measures of physician-specific productivity that would conform to the BLS methodology for measuring productivity. Second, it is not clear that using physician-specific productivity within the current structure of the MEI would be appropriate. Because we believe the MEI appropriately uses an economy-wide wage measure as the proxy for physician wages, using physician specific productivity could overstate or understate the appropriate wage increases in the MEI.

We do believe, however, that it is important to understand the rate of change in physician-specific productivity. Toward this end, we have performed our own preliminary analysis of physician-specific productivity, using the limited available data on physician outputs and inputs. Our analysis attempted to simulate the methodology the BLS would use to measure productivity. To help achieve this we have been in contact with experts at the BLS to obtain their feedback on our methodology. While this information cannot be interpreted as an official measure of physician productivity, we do believe it provides a rough indication of the current market conditions facing physicians. We used this information to aid in forming our determination of the most appropriate productivity adjustment to incorporate in the MEI, fully recognizing its preliminary nature and other limitations of our analysis. The results of our preliminary analysis suggest that long-run physician-specific productivity growth is currently near the level of economy-wide multifactor productivity growth. Prior to the recent period, however, our preliminary estimates suggested that physician productivity gains were generally significantly greater than general economy-wide multifactor productivity gains and more in line with economy-wide labor productivity.

As we have emphasized, our rough estimates are inadequate for establishing a formal basis for the productivity adjustment to the MEI. In addition, the underlying economic theory is not sufficiently compelling, at this time, to adopt a physician-specific productivity measure, even if a suitable one were available. We conclude, however, that economy-wide multifactor productivity growth appears to be roughly comparable to our estimates of current physician-specific productivity growth.

Comment: A few commenters urged us to develop a measure of productivity that more accurately reflects the conditions facing physicians. The commenters suggested that we consider issues like increased regulatory burden on physicians and the service-oriented nature of physician services.

Response: As we stated in the June 2002 proposed rule and repeated above, no publicly available measure of physician productivity exists. In addition, no publicly available measure of service-sector productivity exists. Because of this it is not possible at this time to incorporate a productivity adjustment in the MEI that explicitly reflects physician marketplace characteristics.

However, we do believe that it is important that the productivity adjustment included in the MEI be consistent with the market conditions facing physicians. As we have discussed in this final rule, we attempted to understand the trends in physician productivity by researching and making the most optimal use of the sparse data available. We will continue to refine this research, including soliciting contributions both from experts at BLS and outside experts on measuring productivity. In addition, we encourage the commenters to work with BLS to pursue the development of official measures of physician and health sector productivity.

• Option 2—Using economy-wide labor productivity applied to the labor portion of the MEI.

We have applied economy-wide labor productivity growth to a portion of the MEI in some form since the inception of the index in 1975. For the 2002 update, we applied the 10-year moving average percent change in economy-wide labor productivity to the labor portion of the MEI. This adjustment was developed based on the contributions of a 1987 expert panel. That panel concluded that applying labor productivity data to the labor portion of the index was a technically sound way to account for productivity in the physician update. This method made optimal use of the available data because labor productivity data were, and are, available on a more-timely basis than economy-wide multifactor productivity. By applying this measure to the labor portion of the index, the mix of physician-specific labor and non-labor inputs is reflected. Also, the use of a 10-year moving average percentage change reduces the volatility of annual labor productivity changes.

Our research, however, has indicated that using multifactor productivity applied to the entire index is a superior method to using an economy-wide labor productivity measure applied only to the labor portion of the index. The experts with whom we consulted believed it was more appropriate to reflect the explicit contribution to output from all inputs. The current measure explicitly reflects the changes in economy-wide labor inputs but does not reflect the actual change in non-labor inputs. Instead, it implicitly assumes that non-labor inputs would grow at a rate necessary to produce an economy-wide multifactor measure that is equivalent to the current MEI productivity adjustment. That implicit assumption is less precise than a direct, explicit calculation.

In addition, while the implicit approach produced an MEI productivity adjustment in most years that was reasonably consistent with overall multifactor productivity growth, it now appears less consistent with the actual change in non-labor inputs in the economy. In recent years, economy-wide labor productivity has grown very rapidly. This acceleration is partly the result of major investments in non-labor inputs that have helped to create a more productive work force. Also, the Bureau of Economic Analysis (BEA) adopted methodological changes in accounting for computer software purchases in measuring GDP. These changes have significantly increased the measured historical growth rates in real GDP and labor productivity. As a result of these developments, the current MEI productivity adjustment, applying labor productivity only to the labor portion of the MEI, has increased very rapidly. Because the multifactor definition is an explicit calculation of the change in economic output relative to the change in both labor and non-labor inputs, it better reflects the overall productivity trend changes.

Finally, as noted previously, our preliminary estimates of physician-specific productivity suggest a current growth pattern that is similar to growth in multifactor productivity in the economy overall. In consideration of the economic theory underlying productivity measurement, especially in view of the recent developments in labor versus non-labor economic input growth trends, we concluded that using a multifactor productivity adjustment is superior to the current methodology for adjusting for productivity in the MEI.

• Option 3—Change to using economy-wide multifactor productivity.

The option we proposed in the June 2002 proposed rule was to adjust for productivity gains in the MEI using economy-wide multifactor productivity applied to the entire index, instead of labor productivity applied to the labor portion of the MEI. This option would better satisfy the theoretical requirements of an output price, in this case the MEI, by explicitly reflecting the productivity gains from all inputs. In addition, the use of economy-wide multifactor productivity would still be consistent with the MEI's use of economy-wide wages as a proxy for physician earnings. While annual multifactor productivity can fluctuate considerably, though usually less than labor productivity, using a moving-average would produce a relatively stable and predictable adjustment.

Each expert with whom we consulted believed that using a multifactor productivity measure was theoretically superior to the previous methods used to adjust the MEI because it reflects the actual changes in non-labor inputs instead of reflecting an implicit assumption about those changes. These experts also believed that the lack of timely data on multifactor productivity was not as important as would have appeared initially. Instead, they believed it was more appropriate that the adjustment be based on a long-run average that was stable and predictable rather than on annual changes in productivity. Thus, if a long-run average were used, the increased lag time associated with the availability of published data on multifactor productivity becomes less significant. Finally, one expert believed that changing to economy-wide multifactor productivity applied to the entire MEI would make it easier to understand the magnitude of the productivity adjustment.

However, use of multifactor productivity to adjust the MEI poses two concerns. First, multifactor productivity is much harder to measure than labor productivity. Economic inputs other than labor hours can be very difficult to identify and calculate properly. The experts at BLS, however, have adequately overcome these difficulties, and we are satisfied that their official published measurements are sound for the purpose at hand. Moreover, use of a 10-year moving average increase helps to mitigate any remaining measurement variation from year to year.

The second concern relates to the timeliness of the data. BLS publishes multifactor productivity levels and changes annually (as opposed to the quarterly release of labor productivity data) and with an extended time lag (about 11/2 years). These timeframes arise unavoidably from the difficulties of measuring non-labor input as mentioned above, but would result in a misalignment of the data periods for the data used to adjust the MEI and of the historical data on wages and prices underlying the MEI. For the CY 2003 physician payment update, for example, we would use data on wages and prices through the second quarter of CY 2002, but would have to use multifactor productivity data through CY 2000. Although the misalignment of data periods is a concern, we believe it is a reasonable trade-off in view of the improvement offered by an explicit measurement of non-labor inputs. Also, because use of a 10-year moving average is intended to reduce fluctuations and provide a more stable level of the productivity adjustment, availability of the most recent data is of less importance.

The 10-year moving average percent change in economy-wide multifactor productivity that would be used for the CY 2003 update (historical data through CY 2000) is estimated at 0.8 percent. Our preliminary internal analysis of physician-specific productivity gains suggests that these economy-wide multifactor measures are consistent with those trends. Thus, using economy-wide multifactor productivity for MEI productivity adjustment theoretically would be superior to using labor productivity growth applied to the labor portion of the MEI.

• Option 4—Change to using economy-wide multifactor productivity with physician-specific input weights

Another option we explored was using economy-wide labor and capital productivity measures (which, when weighted together, produce multifactor productivity), but with physician-specific input weights. This method would better reflect the proportion of labor and capital inputs used by physicians, and reflect the explicit contribution to productivity of labor and non-labor inputs. The experts with whom we discussed this option thought it was theoretically consistent with a measure of multifactor productivity, even though different productivity measures would be applied to different components of the MEI.

A weakness of this method is that the BLS capital productivity series is not widely used or cited; therefore, we are unsure of the accuracy and reliability of this measure. This method also adds another layer of complexity to the formula, making it more difficult to understand the adjustment. We would prefer that any method we choose be straightforward so that it can be readily understood. Moreover, the labor and capital shares for the overall economy do not appear to vary enough from the physician-specific shares in the MEI to result in a significantly different measure. Overall, we believe that this method does not provide enough of a technical improvement to justify the added complexity that would be required to implement it.

• Option 5—Adjusting productivity using a “Policy Standard”.

In its March 2002 Report to the Congress, MedPAC suggested establishing a policy target for the productivity adjustment. Under this methodology, the level of the policy target would be based on the productivity gains that physicians could reasonably be expected to attain. This level would be set through policy and would likely be based on a long-run average of either economy-wide labor or multifactor productivity (but could reflect other, possibly judgmental, factors). Generally, the level of the policy standard would remain constant for several years, and periodically would be reviewed and adjusted as needed.

Some of the experts we consulted believed that a policy target would lessen the volatility of the adjustment because the target would not be changed often. Conversely, others noted the large, abrupt changes that could result if actual economic performance deviated from the policy standard requiring subsequent adjustments to the standard. Some believed that this method adjusts for the problem of precisely measuring productivity. If we used a policy standard we could avoid having to develop an exact measure. Using a policy target, however, may appear arbitrary without a theoretical basis to support its use.

The policy target recommended by the MedPAC was 0.5 percentage points per year. The MedPAC's justification for this number was that the long-run average of economy-wide multifactor productivity was close to 0.5 percent (the most recent 10-year average is now 0.8 percent). We do not believe this is a preferred option for adjusting the MEI for productivity improvements. Our preference is to use a data based approach that automatically reflects changes in actual economic performance over time, and not through abrupt periodic, possibly large adjustments. Thus, we conclude that a policy target does not provide an improvement over any of the data based methodologies.

Comment: One commenter recommended the productivity adjustment be removed from the MEI to make the index more consistent with our other market baskets.

Response: Since its inception in 1975 the MEI has included a productivity adjustment. By including the productivity adjustment in the MEI and using a general earnings proxy for physician wages, the index approximated an economy-wide output price index like the CPI. This original intent was different from that for the other market baskets, which are defined to reflect pure price changes in inputs associated with providing care. Thus, the MEI appropriately includes an adjustment for productivity changes.

As we described earlier, practically it makes no difference whether productivity is adjusted for within or outside the MEI, as long as an adjustment is present. However, given the historical precedent regarding the definition of the MEI, the apparent legislative intent behind recent legislation that did not prescribe a change to the MEI definition, and the specific update formula that must be used under the SGR, we do not believe it would be appropriate for the productivity adjustment to be made outside the MEI.

• Option 6—Eliminate Productivity Adjustment from the MEI.

Questions are raised occasionally as to the possibility of eliminating the productivity adjustment from the MEI. We did not consider this to be a viable option. Our research concluded that adjusting for productivity in the MEI is necessary in order to have a technically correct measure of an output price increase, free from double-counting of the impact of productivity. Every expert with whom we consulted agreed that a productivity adjustment is appropriate. They believed that the important question is which measure is the most appropriate for the adjustment.

c. Use of a Forecasted MEI and Productivity Adjustment

In a March 2002 Report to the Congress, the MedPAC recommended the use of a forecasted MEI value, rather than the current historical increase. However, implementation of this option raises several legal as well as practical issues. The 1972 Senate Finance Committee report language reflects the intent of the Congress that the MEI should “follow rather than lead” overall inflation. As a result, updates to the physician fee schedule have always been based on historical, rather than forecasted, MEI data. In this way, increases in the MEI do not lead the current measures of inflation but follow them based on historical trends. Furthermore, at the time of implementation of the SGR system, the Congress specified that the SGR system should use the MEI that existed at the time, which was based on historical data measures. The law did not recommend or specify a change in the MEI methodology. Thus, the assumption is that the Congress was satisfied that the MEI was functioning as designed. If we were to use a forecasted MEI and productivity adjustment, there are several practical issues that would need to be addressed. One issue is that a change from a historical-based MEI to a projected MEI would cause transitional problems because there would be a period of data that would not be accounted for in the year of implementation. For example, the CY 2002 MEI update was based on historical data through the second quarter of 2001. If we were to use a forecasted MEI in the update for CY 2003, any changes between the second quarter of 2001 and the first quarter of 2003 would not be accounted for in the update. Additionally, changing to a forecasted MEI and productivity adjustment raises additional questions about correcting for forecast errors. Based on these problems, we will continue to use historical data to make updates under the physician fee schedule.

Comment: One commenter urged us to use a forecast of the MEI change for the update in the upcoming year. The commenter believed that we had the legal authority to make such a change and that the transition issues cited in the proposed rule were not relevant.

Response: We do not believe that it would be appropriate to use a forecast of the MEI for the 2003 update. Since the inception of the MEI, and more recently the implementation of the physician fee schedule, the MEI increase for the upcoming year's update has been based on as much historical data as is available when the update is determined. For the 2003 update this means using data that is available through June 2002.

Our interpretation of the legislative intent is for the MEI update to be based on historical data, and does not contemplate a MEI based on projections. As we stated above, the MEI update has always been based on historical data and we believe that the legislative intent when the SGR system was implemented was to continue using this methodology. In addition, we believe that the transition and forecast error issues described above are legitimate concerns that, at this time, would outweigh the benefits of making such a change. Therefore, we will continue to use historical data in developing the MEI used for the 2003 fee schedule update.

d. Productivity Adjustment to the MEI

Based on the research we conducted on this issue, we are changing the methodology for adjusting for productivity in the MEI. The MEI used for the CY 2003 physician payment update will reflect changes in the 10-year moving average of private non-farm business (economy-wide) multifactor productivity applied to the entire index. Several commenters agreed with this methodological change.

We made this change because—(1) It is theoretically more appropriate to explicitly reflect the productivity gains associated with all inputs (both labor and nonlabor); (2) the recent growth rate in economy-wide multifactor productivity appears more consistent with the current market conditions facing physicians, and (3) the MEI still uses economy-wide wage changes as a proxy for physician wage changes. We believe that using a 10-year moving average change in economy-wide multifactor productivity produces a stable and predictable adjustment and is consistent with the moving-average methodology used in the existing MEI. Thus, the productivity adjustment will be based on the latest available actual historical economy-wide multifactor productivity data, as measured by the BLS.

We currently estimate the MEI to increase 3.0 percent for CY 2003. This is the result of a 3.8 percent increase in the price portion of the MEI, adjusted downward by a 0.8 percent increase in the 10-year moving average change in economy-wide multifactor productivity. Table 10 shows the detailed cost categories of the MEI update for CY 2003.

Table 10.—Increase in the Medicare Economic Index Update for Calendar Year 2003 ¹

Cost categories and price measures	1996 Weights 2	CY 2003 percent changes
Medicare Economic Index Total, productivity adjusted	n/a	3.0
Productivity: 10-year moving average of multifactor productivity, private nonfarm business sector	n/a	0.8
Medicare Economic Index Total, without productivity adjustment	100.0	3.8
1. Physician's own time 3	54.5	3.9
a. Wages and Salaries: Average hourly earnings private nonfarm	44.2	3.7
b. Fringe Benefits: Employment Cost Index, benefits, private nonfarm	10.3	5.0
2. Physician's practice expense 3	45.5	3.6
a. Nonphysician employee compensation	16.8	4.2
1. Wages and Salaries: Employment Cost—Index, wages and salaries, weighted by occupation	12.4	3.7
2. Fringe Benefits: Employment Cost—Index, fringe benefits, white collar	4.4	5.5
b. Office Expense: Consumer Price Index for urban consumers (CPI-U), housing	11.6	2.8
c. Medical Materials and Supplies: Producer Price Index (PPI), ethical drugs/PPI, surgical appliances and supplies/CPI-U, medical equipment and supplies (equally weighted)	4.5	2.0
d. Professional Liability Insurance: CMS professional liability insurance survey 4	3.2	11.3
e. Medical Equipment: PPI, medical instruments and equipment	1.9	1.5
f. Other professional expense	7.6	1.8
1. Professional Car: CPI-U, private transportation	1.3	2.3
2. Other: CPI-U, all items less food and energy	6.3	2.6
1 The rates of historical change are estimated for the 12-month period ending June 30, 2002, which is the period used for computing the calendar year 2003 update. The price proxy values are based upon the latest available Bureau of Labor Statistics data as of September 19, 2002.
2 The weights shown for the MEI components are the 1996 base-year weights, which may not sum to subtotals or totals because of rounding. The MEI is a fixed-weight, Laspeyres-type input price index whose category weights indicate the distribution of expenditures among the inputs to physicians' services for calendar year 1996. To determine the MEI level for a given year, the price proxy level for each component is multiplied by its 1996 weight. The sum of these products (weights multiplied by the price index levels) over all cost categories yields the composite MEI level for a given year. The annual percent change in the MEI levels is an estimate of price change over time for a fixed market basket of inputs to physicians' services.
3 The measures of productivity, average hourly earnings, Employment Cost Indexes, as well as the various Producer and Consumer Price Indexes can be found on the Bureau of Labor Statistics Web site http://stats.bls.gov.
4 Derived from a CMS survey of several major insurers (the latest available historical percent change data are for the period ending second quarter of 2002).
n/a Productivity is factored into the MEI compensation categories as an adjustment to the price variables; therefore, no explicit weight exists for productivity in the MEI.

Comment: Several commenters requested that we ensure that the costs of medical liability insurance are adequately reflected in the MEI by making available all information that is the basis for measuring medical liability costs in the MEI.

Response: We agree with the commenters that it is vital that the MEI accurately reflect the price changes associated with professional liability costs. Accordingly, we continue to incorporate into the MEI a price proxy that accomplishes this goal by making the maximum use of available data on professional liability premiums. Below we describe in more detail the annual CMS data collection from commercial insurance carriers, which are designed to maximize the use of publicly available data.

Each year, we solicit professional liability premium data for physicians from a small sample of commercial carriers. This information is not collected through a survey form, but instead is requested from a few national commercial carriers via letter. The carriers provide information on a voluntary basis, and generally between 5 and 8 carriers volunteer this information.

As we require for our other price proxies, the professional liability price proxy must reflect the pure price change associated with this particular cost category. Thus, it should not capture changes in the mix or level of liability coverage. To accomplish this result, we obtain premium information from commercial carriers for a fixed level of coverage, currently $1 million per occurrence and a $3 million annual limit. This information is collected for every state by physician specialty and risk class. Finally, the state-level, physician-specialty data is aggregated by effective premium date to compute a national total using counts of physicians by state and specialty as provided in the AMA publication “Physician Characteristics and Distribution in the U.S.”

The resulting data provides a quarterly time series, indexed to a base year consistent with the MEI, which reflects the national trend in the average professional liability premium for a given level of coverage. From this series, quarterly and annual percent changes in professional liability insurance are estimated for inclusion in the MEI. This data produced an 11.3 percent increase for professional liability insurance in the MEI for the 2003 update. We believe that, given the limited timely data available on professional liability premiums, this methodology adequately reflects the price trends facing physicians.

Comment: One commenter urged CMS to use the most current professional liability insurance data available when developing the MEI update.

Response: The professional liability data used to develop the 2003 MEI update was based on premium rates effective as of June 2002. We believe our methodology ensures that the MEI update includes the most recent data available. In the spring of 2002 we collected professional liability insurance premiums from commercial insurers as described in the previous comment. These data included both the premium amount and effective date, which we use to create a quarterly time series. Thus, the professional liability insurance component of the 2003 MEI update includes effective premium rates through the 2nd quarter of 2002, which is consistent with the timeliness of other data used in determining this update.

The most comprehensive data on professional liability costs exist with the state insurance commissioners. However, these data are available only with a substantial lag. For instance, when we developed this final rule the most recent professional liability data available from the state insurance commissioners were for 2000. Hence, the data currently incorporated into the MEI are much more timely.

Comment: Several commenters requested that we make an ad hoc adjustment to the MEI to account for recent increases in medical liability insurance.

Response: We disagree with the commenters that an ad hoc adjustment should be made to the MEI to account for recent increases in professional liability insurance. As detailed above, the current methodology reflects recent data collected directly from commercial insurance carriers and specifically reflects the conditions facing physicians. Thus, the MEI adequately accounts for the recent increases in professional liability insurance prices, much the same way it reflects the price changes associated with other inputs, such as office expenses, wages or benefits. Thus, we believe the MEI appropriately reflects the price changes as measured by reliable and relevant data sources, and should not be adjusted through an ad hoc mechanism.

Comment: Several commenters suggested that physicians' earnings more closely follow the wage changes faced by professional and technical occupations. The commenters suggested that we use the employment cost index (ECI) for professional and technical workers as the physicians' wage proxy in the MEI.

Response: As we stated in the November 2, 1998 final rule (63 FR 58848), we believe that the current price proxy for physicians' earnings, average hourly earnings (AHE) in the non-farm business economy, is the most appropriate proxy to use in the MEI. The AHE for the non-farm business economy reflects the impacts of supply, demand and economy-wide productivity for the average worker in the economy. Using the AHE as the proxy for physician earnings captures the parity in the rate of change in wages for the average worker and for physicians. In addition, use of this proxy is consistent with the original legislative intent that the change in the physicians' earnings portion of the MEI parallel the change in general earnings for the economy.

The suggestion to use the ECI for professional and technical workers has a major shortcoming in that, in many instances, occupations, such as engineers, computer scientists, nurses, etc., have unique characteristics that are not reflective of the overall economy or the physician market. Specifically, wage changes for these types of occupations can be influenced by excess supply or demand for these types of workers. We do not believe it would be appropriate to proxy the physician earnings portion of the MEI with a wage proxy that reflects these unique characteristics.

C. The Update Adjustment Factor

Section 1848(d) of the Act provides that the physician fee schedule update is equal to the product of the MEI and an “update adjustment factor.” The update adjustment factor is applied to make actual and target expenditures (referred to in the law as “allowed expenditures”) equal. Allowed expenditures are equal to actual expenditures in a base period updated each year by the SGR. The SGR sets the annual rate of growth in allowed expenditures and is determined by a formula specified in section 1848(f) of the Act.

Since the inception of the physician fee schedule in 1992, physician payment rates have been updated using two different systems. From 1992 to 1998, physician fee schedule rates were updated using the Medicare Volume Performance Standard (MVPS). From 1999 to the present, physician fee schedule rates have been updated using the sustainable growth rate (SGR). While there are significant and important differences between the MVPS and SGR, both use the same general concept that expenditures for physicians' services should grow by a limited percentage amount of allowed expenditures each year. If expenditures exceed the amount in a year, the physician fee schedule update is reduced. If expenditures are less than the amount of allowed expenditures in a year, the physician fee schedule update is increased.

We determined the annual percentage increase in expenditures using the formulas specified in the statute. One important feature of both the MVPS and the SGRs for fiscal years (FYs) 1998 and 1999 was that the percentage increase was based on estimates of the four factors specified in the law, made before the beginning of the year. Under the MVPS and the SGRs for FYs 1998 and 1999, the statute did not permit us to revise the estimates used to set the annual percentage increase. Beginning with the FY 2000 SGR, the statute specifically requires us to use actual, after the fact, data to revise the estimates used to set the SGR.

For some of the component factors of both the MVPS and the SGR, there have been differences between the estimates used to set the annual MVPS and SGR and the actual increase based on actual, after the fact, data. For instance, under both the MVPS and the SGR, we are required to account for increases in Medicare beneficiary fee-for-service enrollment. There have been differences between our estimates of the increase in fee-for-service enrollment and the actual, after the fact increase because it is difficult to predict, before the beginning of the year, beneficiary enrollment in Medicare + Choice plans (or Medicare managed care plans as they were known under the MVPS). Under the MVPS, we generally estimated higher growth in beneficiary fee-for-service enrollment than actually occurred. For the FY 1998 and FY 1999 SGRs, we estimated lower growth in beneficiary fee-for-service enrollment than actually occurred. (For subsequent years, the statute has required us to revise our estimates.)

Under the SGR, the statute also requires us to account for the increase in real per capita gross domestic product (GDP) to determine the annual percentage increase in expenditures for physicians' services. In both FY 1998 and FY 1999, we estimated lower real per capita GDP growth than actually occurred. Because the statute did not permit us to revise estimates for these years, the SGRs for FYs 1998 and 1999 are lower than if we were authorized to revise estimates as required under current law for the FY 2000 SGR and all subsequent SGRs.

Because the physician fee schedule CF has been affected by a comparison of the actual increase in expenditures to the level of allowed expenditures calculated using the MVPS and the SGRs for FYs 1998-1999, revision of our estimates would have resulted in different CFs than those we actually determined. Revision of the estimates used to set the MVPS would have made the physician fee schedule CFs established under the MVPS lower than those we have actually determined. As a result, higher expenditures in 1997 were higher than if we had revised estimates with actual after the fact data. The actual amount of expenditures in 1997 forms the basis for the calculation of allowed expenditures under the SGR.

In contrast, revision of the estimates used to set the SGRs for FYs 1998 and 1999 would have resulted in higher physician fee schedule CFs for CY 2000 and all subsequent years than those we have actually determined. If the statute authorized revisions of the estimates used to establish both the MVPS and the SGRs for FYs 1998 and 1999, the physician fee schedule CF would be higher than it is currently.

We have analyzed the effect that revision of the estimates used to set the MVPS from FY 1990 through 1996 and the SGRs for FYs 1998 and 1999 would have on the physician fee schedule update for CY 2003 and subsequent years. The Department believes that a positive update could result if the statute authorized revisions of the estimates used to establish both the SGR for FYs 1998 and 1999 and MVPS for 1990 to 1996.

As noted above, however, current law does not permit the Department to adopt the positive update for 2003. In the event that Congress enacts legislation permitting the Department to make such an adjustment, the Department wishes to make the adjustment as promptly as possible. We therefore are soliciting public comments regarding the proper adjustments in the event that Congress authorizes the Department to make such an adjustment.

1. Calculation Under Current Law

Under section 1848(d)(4)(A) of the Act, the physician fee schedule update for a year is equal to the product of— (1) 1 plus the Secretary's estimate of the percentage increase in the MEI for the year, divided by 100 and (2) 1 plus the Secretary's estimate of the update adjustment factor for the year. Under section 1848(d)(4)(B) of the Act, the update adjustment factor for a year beginning with 2001 is equal to the sum of the following—

• Prior Year Adjustment Component. An amount determined by—

—Computing the difference (which may be positive or negative) between the amount of the allowed expenditures for physicians' services for the prior year (the year prior to the year for which the update is being determined) and the amount of the actual expenditures for such services for that year;

—Dividing that difference by the amount of the actual expenditures for such services for that year; and

—Multiplying that quotient by 0.75.

• Cumulative Adjustment Component. An amount determined by—

—Computing the difference (which may be positive or negative) between the amount of the allowed expenditures for physicians' services from April 1, 1996, through the end of the prior year and the amount of the actual expenditures for such services during that period;

—Dividing that difference by actual expenditures for such services for the prior year as increased by the sustainable growth rate for the year for which the update adjustment factor is to be determined; and

—Multiplying that quotient by 0.33.

Section 1848(d)(4)(E) of the Act requires the Secretary to recalculate allowed expenditures consistent with section 1848(f)(3) of the Act. Section 1848(f)(3) specifies that the SGR (and, in turn, allowed expenditures) for the upcoming calendar year (2003 in this case), the current calendar year (2002) and the preceding calendar year (2001) are to be determined on the basis of the best data available as of September 1 of the current year. Allowed expenditures are initially estimated and subsequently revised twice. The second revision occurs after the calendar year has ended (that is, we are making the final revision to 2001 allowed expenditures in this final rule). Once the SGR and allowed expenditures for a year have been revised twice, they are final.

Table 11 shows annual and cumulative allowed expenditures for physicians' services from April 1, 1996 through the end of the current calendar year, including the transition period to a calendar year system that occurred in 1999.

Table 11

Period	Annual allowed expenditures (Dollars)	Cumulative allowed expenditures (Dollars)	FY or CY SGR
4/1/96-3/31/97	48.9 billion	48.9 billion	N/A
4/1/97-3/31/98	49.6 billion	98.5 billion	FY 1998=1.5%
4/1/98-3/31/99	49.4 billion	147.9 billion	FY 1999=−0.3%
1/1/99-3/31/99	12.5 billion	Included in 147.9 above	FY 1999=−0.3%
4/1/99-12/31/99	39.6 billion	Included in 187.6 below	FY 2000=6.9%
1/1/99-12/31/99	52.1 billion	187.6 billion	FY 1999/FY 2000 (see note)
1/1/00-12/31/00	55.9 billion	243.5 billion	CY 2000=7.3%
1/1/01-12/31/01	58.4 billion	301.9 billion	CY 2001=4.5%
1/1/02-12/31/02	63.5 billion	365.4 billion	CY 2002=8.8%
1/1/03-12/31/03	68.3 billion	433.8 billion	CY 2003=7.6%

*Note:

Allowed expenditures for the first quarter of 1999 are based on the FY 1999 SGR and allowed expenditures for the last three quarters of 1999 are based on the FY 2000 SGR. Allowed expenditures in the first year (April 1, 1996-March 31, 1997) are equal to actual expenditures. All subsequent figures are equal to quarterly allowed expenditure figures increased by the applicable SGR. Cumulative allowed expenditures are equal to the sum of annual allowed expenditures. We provide more detailed quarterly allowed and actual expenditure data on our Web site under the Medicare Actuary's publications at the following address: http://www.cms.hhs.gov/​statistics/​actuary/​. We expect to update the web site with the most current information later this month.

Consistent with section 1848(d)(4)(E) of the Act, table 12 includes our final revision of allowed expenditures for 2001, a recalculation of allowed expenditures for 2002, and our initial estimate of allowed expenditures for 2003. To determine the update adjustment factor for 2003, the statute requires that we use cumulative allowed expenditures from April 1, 1996 through December 31, 2002, actual expenditures through December 31, 2002, and the SGR for 2003, as well as annual allowed and actual expenditures for 2002. We are using estimates of allowed expenditures for 2002 and 2003 that will subsequently be revised consistent with section 1848(d)(4)(E) of the Act. Because we have incomplete expenditure data for 2002, we are using an estimate for this period. Any difference between current estimates and final figures will be taken into account in determining the update adjustment factor for future years.

We are using figures from table 12 in the statutory formula illustrated below:

UAF = Update Adjustment Factor.

Target₀₂ = Allowed Expenditures for 2002 or $63.5 billion.

Actual₀₂ = Estimated Actual Expenditures for 2002 = $69.1 billion.

Target_4/96-12/02 = Allowed Expenditures from 4/1/1996-12/31/2002 = $365.4 billion.

Actual_4/96-12/02 = Estimated Actual Expenditures from 4/1/1996-12/31/2002 = $381.9 billion.

SGR₀₃ = 7.6 percent (1.076).

Section 1848(d)(4)(D) of the Act indicates that the update adjustment factor determined under section 1848(d)(4)(B) of the Act for a year may not be less than −0.07 or greater than 0.03. Because the calculated update adjustment factor of −0.134 is less than the statutory limit of −0.07, the update adjustment factor for 2003 will be −0.07.

Section 1848(d)(4)(A)(ii) of the Act indicates that 1 should be added to the update adjustment factor determined under section 1848(d)(4)(B) of the Act. Thus, adding 1 to −0.070 makes the update adjustment factor equal to 0.930.

VII. Allowed Expenditures for Physicians' Services and the Sustainable Growth Rate

A. Medicare Sustainable Growth Rate

The SGR is an annual growth rate that applies to physicians' services paid for by Medicare. The use of the SGR is intended to control growth in aggregate Medicare expenditures for physicians' services. Payments for services are not withheld if the percentage increase in actual expenditures exceeds the SGR. Rather, the physician fee schedule update, as specified in section 1848(d)(4) of the Act, is adjusted based on a comparison of allowed expenditures (determined using the SGR) and actual expenditures. If actual expenditures exceed allowed expenditures, the update is reduced. If actual expenditures are less than allowed expenditures, the update is increased.

Section 1848(f)(2) of the Act specifies that the SGR for a year (beginning with 2001) is equal to the product of the following four factors:

(1) The estimated change in fees for physicians' services.

(2) The estimated change in the average number of Medicare fee-for-service beneficiaries.

(3) The estimated projected growth in real GDP per capita.

(4) The estimated change in expenditures due to changes in law or regulations.

In general, section 1848(f)(3) of the Act requires us to publish SGRs for 3 different time periods, no later than November 1 of each year, using the best data available as of September 1 of each year. Under section 1848(f)(3)(C)(i) of the Act, the SGR is estimated and subsequently revised twice (beginning with the FY and CY 2000 SGRs) based on later data. Under section 1848(f)(3)(C)(ii) of the Act, there are no further revisions to the SGR once it has been estimated and subsequently revised in each of the 2 years following the preliminary estimate. In this final rule, we are making our preliminary estimate of the 2003 SGR, a revision to the 2002 SGR, and our final revision to the 2001 SGR.

B. Physicians' Services

Section 1848(f)(4)(A) of the Act defines the scope of physicians' services covered by the SGR. The statute indicates that the term “physicians' services” includes other items and services (such as clinical diagnostic laboratory tests and radiology services), specified by the Secretary, that are commonly performed or furnished by a physician or in a physician's office, but does not include services furnished to a Medicare+Choice plan enrollee. We published a definition of physicians' services for use in the SGR in the Federal Register (66 FR 55316) on November 1, 2001. We defined “physicians' services” to include many of the medical and other health services listed in section 1861(s) of the Act. For purposes of determining allowed expenditures, actual expenditures, and SGRs through December 31, 2002, we have specified that “physicians' services” include the following medical and other health services if bills for the items and services are processed and paid by Medicare carriers:

• Physicians' services.
• Services and supplies furnished incident to physicians' services.
• Outpatient physical therapy services and outpatient occupational therapy services.
• Antigens prepared by or under the direct supervision of a physician.
• Services of physician assistants, certified registered nurse anesthetists, certified nurse midwives, clinical psychologists, clinical social workers, nurse practitioners, and clinical nurse specialists.
• Screening tests for prostate cancer, colorectal cancer, and glaucoma.
• Screening mammography, screening pap smears, and screening pelvic exams.
• Diabetes outpatient self-management training services.
• Medical nutrition therapy services.
• Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests.
• X-ray, radium, and radioactive isotope therapy.
• Surgical dressings, splints, casts, and other devices used for the reduction of fractures and dislocations.
• Bone mass measurements.

In the June 2002 proposed rule (67 FR 43861), we announced a change to our methodology for determining the “weighted average percentage increase in fees for all physicians' services” for the 2001 and subsequent year SGRs. We use a weighted average of the price indices that are used to increase payment for services included in the SGR to determine the percentage increase in fees for physicians' services. Physicians' services are updated using the MEI. Clinical diagnostic laboratory services are updated using the CPI. Drugs furnished “incident to” a physician's service under section 1861(s)(2)(A) of the Act, are also included in the calculation of the SGR. Under section 1842(o) of the Act, payments for drugs are based on 95 percent of average wholesale prices. We are currently using the MEI as a proxy for growth in drug prices. In the proposed rule, we indicated that, rather than using the MEI as proxy for growth in drug prices, we would use growth in actual drug prices to determine the weighted average percentage increase in fees for all physicians' services. In response, we received many comments suggesting that “incident to” drugs should not be included in the definition of physicians' services.

Comment: Comments indicated that the administration of a drug is a physician's service that, by statute, must be included in the definition of physicians' services. The drug itself, however, argued the comments, is not a physician service and should not be included in the SGR. A number of comments indicated that rising Medicare expenditures for drugs are due in large part to the introduction of costly new cancer drugs and not to the failure of physicians to control their use. Many of these comments stated that the increase in drug spending is due to government policies that encourage the rapid development of new drugs, as well as government efforts to urge Americans to be tested and seek early treatment for cancer and other diseases. Some comments indicated that physicians should not be forced to pay for the rising cost of drugs covered by Medicare through reduced fees. Other comments stated that including drugs in the SGR has not led to controls on drug spending and, as a result, removing them would not lead to increased spending. Other comments indicated that the SGR has not been increased to reflect the growing cost of drugs. These comments indicated that the SGR should either account for the growing cost of drugs or exclude them completely. One comment indicated that the SGR should account for the cost of new drugs approved by the FDA and covered by Medicare during the prior year and the cost of covered drugs that have the same biologic effect as non-covered drugs. Several comments indicated that the Secretary does not have the legal authority to include “incident to” drugs in the SGR because the section 1848(f) of the Act refers to physicians' services and not “medical and other health services.” Others provided copies of a detailed legal opinion arguing that drugs may be included in the SGR under section 1848(f) of the Act but cannot be included in the definition of physicians' services for purposes of determining the update adjustment factor under section 1848(d) of the Act.

Response: The statute provides the Secretary with clear authority to specify the services that are included in the SGR. Section 1848(f)(4)(A) of the Act indicates “the term ‘physicians’ services' includes other items and services (such as clinical diagnostic laboratory tests and radiology services) specified by the Secretary, that are commonly performed or furnished by a physician or in a physician's office”. We disagree with the comments suggesting that the Secretary does not have the authority to include drugs in the definition of physicians' services for purposes of determining allowed expenditures, actual expenditures and the SGR. In reviewing section 1861(s) of the Act, we decided to include items and services in the SGR that are commonly furnished by physicians or in physicians' offices. Since “incident to” drugs covered under section 1861(s) of the Act are commonly furnished in physicians' offices, we are including these items in the SGR.

C. Provisions Related to the Sustainable Growth Rate

Section 211(b)(1) of the BBRA amended section 1848(f)(1) of the Act to require that three SGR estimates be published in the Federal Register not later than November 1 of every year. In this final rule, we are publishing our preliminary estimate of the SGR for 2003, a revised estimate of the SGR for 2002, and our final determination of the SGR for 2001. Consistent with section 1848(f)(3)(C) of the Act, we are using the best data available to us as of September 1, 2002 for all of the figures.

D. Preliminary Estimate of the Sustainable Growth Rate for 2003

Our preliminary estimate of the 2003 SGR is 7.6 percent. We first estimated the 2003 SGR in March and made the estimate available to the Medicare Payment Advisory Commission and on our website. Table 12 shows our March estimates and our current estimates of the factors included in the SGR:

Table 12

Statutory factors	March estimate	Current estimate
Fees	1.7% (1.017)	2.9% (1.029)
Enrollment	1.3% (1.013)	1.2% (1.012)
Real per capita GDP	2.9% (1.029)	3.3% (1.033)
Law and regulation	0.0% (1.000)	0.0% (1.000)
Total	6.0% (1.060)	7.6% (1.076)

Note:

Consistent with section 1848(f)(2) of the Act, the statutory factors are multiplied, not added, to produce the total (that is, 1.029 × 1.012 × 1.033 × 1.000 = 1.076.) A more detailed explanation of each figure is provided below in section H.1.

E. Revised Sustainable Growth Rate for 2002

Our current estimate of the 2002 SGR is 8.8 percent. Table 13 shows our preliminary estimate of the 2002 SGR that was published in the Federal Register on November 1, 2001 (66 FR 55317) and our current estimate:

Table 13

Statutory factors	11/1/01 estimate	Current estimate
Fees	2.3 (1.023)	2.5% (1.025)
Enrollment	0.7 (1.007)	2.8% (1.028)
Real per capita GDP	1.7 (1.017)	2.3% (1.023)
Law and regulation	0.8 (1.008)	0.9% (1.009)
Total	5.6 (1.056)	8.8% (1.088)

A more detailed explanation of each figure is provided below in section H.2.

F. Final Sustainable Growth Rate for 2001

The SGR for 2001 is 4.5 percent. Table 14 shows our preliminary estimate of the SGR published in the Federal Register on November 1, 2000 (65 FR 65433), our revised estimate published in the Federal Register on November 1, 2001 (66 FR 55317) and the final figures determined using the latest available data:

Table 14

Statutory factors	11/1/00 estimate	11/1/01 estimate	Current estimate
Fees	1.9 (1.019)	1.9 (1.019)	2.1% (1.021)
Enrollment	0.9 (1.009)	3.0 (1.030)	3.0% (1.030)
Real per capita GDP	2.7 (1.027)	0.7 (1.007)	−0.7% (0.993)
Law and regulation	0.0 (1.000)	0.4 (1.004)	0.1% (1.001)
Total	5.6 (1.056)	6.1 (1.061)	4.5% (1.045)

A more detailed explanation of each figure is provided below in section H.2.

G. Calculation of 2003, 2002, and 2001 Sustainable Growth Rates

1. Detail on the 2003 SGR

A more detailed discussion of our preliminary estimates of the four elements of the 2003 SGR follows. We note that all of the figures used to determine the 2003 SGR are estimates that will be revised based on subsequent data. Any differences between these estimates and the actual measurement of these figures will be included in future revisions of the SGR and incorporated into subsequent physician fee schedule updates.

Factor 1—Changes in Fees for Physicians' Services (Before Applying Legislative Adjustments) for CY 2003

This factor was calculated as a weighted average of the 2002 fee increases for the different types of services included in the definition of physicians' services for the SGR. Medical and other health services paid using the physician fee schedule account for approximately 83.5 percent of total allowed charges included in the SGR and are updated using the MEI. The MEI for 2003 is 3.0 percent. Diagnostic laboratory tests represent approximately 8.0 percent of Medicare allowed charges included in the SGR and the costs of these tests are typically updated by the CPI-U. The CPI-U for 2003 that will be used to update clinical diagnostic laboratory tests is 1.1 percent. Drugs represent 8.5 percent of Medicare allowed charges included in the SGR. Medicare pays for drugs based on 95 percent of AWP under section 1842(o) of the Act. We calculated the weighted average fee increase for drugs to be included in the SGR, we estimate a weighted average fee increase for drugs of 3.3 percent in 2002. Table 15 shows the weighted average of the MEI, laboratory and drug price increases for 2003:

Table 15

	Weight	Update
Physician	0.835	3.0
Laboratory	0.080	1.1
Drugs	0.085	3.3
Weighted Average	1.000	2.9

After taking into account the elements described in table 16, we estimate that the weighted-average increase in fees for physicians' services in 2002 under the SGR (before applying any legislative adjustments) will be 2.9 percent.

Factor 2—The Percentage Change in the Average Number of Part B Enrollees From 2002 to 2003

This factor is our estimate of the percent change in the average number of fee-for-service enrollees from 2002 to 2003. Services provided to Medicare+Choice (M+C) plan enrollees are outside the scope of the SGR and are excluded from this estimate. Our actuaries estimate that the average number of Medicare Part B fee-for-service enrollees will increase by 1.2 percent from 2002 to 2003. Table 16 illustrates how this figure was determined:

Table 16

	2002	2003
Overall	37.986 million	38.321 million
Medicare+Choice	5.070 million	5.012 million
Net	32.916 million	33.309 million
Percent Increase		1.2 percent

An important factor affecting fee-for-service enrollment is beneficiary enrollment in Medicare+Choice plans. Because it is difficult to estimate the size of the Medicare+Choice enrollee population before the start of a calendar year, at this time, we do not know how actual enrollment in Medicare+Choice plans will compare to current estimates. For this reason, there may be substantial changes to this estimate as actual Medicare fee-for-service enrollment for 2003 becomes known.

Factor 3—Estimated Real Gross Domestic Product Per Capita Growth in 2003

We estimate that the growth in real per capita GDP from 2002 to 2003 will be 3.3 percent. Our past experience indicates that there have also been large changes in estimates of real per capita GDP growth made before the year begins and the actual change in GDP computed after the year is complete. Thus, it is likely that this figure will change as actual information on economic performance becomes available to us in 2003.

Factor 4—Percentage Change in Expenditures for Physicians' Services Resulting From Changes in Law or Regulations in CY 2003 Compared With CY 2002

As indicated below, section 101-104 of the BIPA added Medicare coverage for a variety of new services. We estimate no additional costs for these services in 2003 relative to 2002. We will continue to monitor utilization of all of the new benefits provided in BIPA and modify our estimates (up or down) and the SGRs accordingly.

Comment: We received many comments indicating that we should adjust the SGR to account for the addition of the psychiatric diagnostic interview to the list of covered telehealth services.

Response: We agree that the addition of the psychiatric diagnostic interview is a change in regulation that should be accounted for in the SGR. However, since there is such low utilization of the telehealth benefit, we believe the addition of the psychiatric diagnostic interview to the list of covered telehealth services will have no impact on the SGR.

Comment: Several comments noted that section 112 of BIPA changed Medicare's drug payment policy. Prior to the enactment of the BIPA, section 1861(s)(2) of the Act allowed Medicare to pay for “drugs and biologicals, which cannot, as determined in accordance with regulations, be self-administered.” The BIPA amended the Act to allow Medicare to pay for drugs which “are not usually administered by the patient.” The commenters believe that this new drug payment policy will result in an increase in expenditures that should be accounted for in the SGR.

Response: The amendments to Medicare's drug payment policy contained in section 112 of the BIPA constitute a change in law or regulation that is taken into account in determining the SGR. We estimate a 2002 cost for this policy change that will be accounted for in the 2002 SGR described below. At this time, we are not estimating additional Medicare costs in 2003 relative to 2002 for drugs not usually self-administered by patients.

Comment: We received many public comments that argued for adjusting the SGR for changes in expenditures resulting from NCDs. According to these comments, any changes in national Medicare coverage policy that are adopted by us pursuant to a formal or informal rulemaking, such as a Program Memorandum or a national Medicare coverage determination, constitute a regulatory change for purposes of computing factor 4 of the SGR. The comments indicate that our authority to make any regulatory change is derived from law—whether it is a law specifically authorizing Medicare coverage of a new service or a law that provides general rulemaking authority. According to these comments, any new coverage initiative is a direct implementation, by regulation, of a law that should be taken into account in determining the SGR. One commenter indicated that we effectively compare actual expenditure data that include additional utilization resulting from NCDs with a spending target that does not include this additional utilization, making it more likely that the target will be exceeded.

Response: We carefully considered this comment. If the Congress adds a new statutory benefit (for example, medical nutrition therapy), we are required by law to increase the target. Medicare does not have authority to pay for a service lacking a defined statutory benefit listed in section 1861(s) of the Act (for example, prior to January 1, 2002, there was no authority for Medicare to pay for medical nutrition therapy). However, we do have the authority to establish national coverage policies for items and services that are included in a benefit category listed in section 1861(s) of the Act. Further, we contract with Medicare carriers who may establish local coverage policies for items and services that have a statutory benefit category.

The statute requires that real GDP per capita be used in setting the SGR target. We believe that use of real GDP per capita was intended as a proxy for a number of factors that may increase the volume and intensity of physicians' services (other than beneficiary enrollment and statutory changes that increase expenditures, which are separately accounted for by the statute), such as those associated with coverage of new items or services and other miscellaneous factors that cannot be specifically identified, such as any spending associated with NCDs.

The large majority of Medicare spending is for services that are covered at local carrier discretion. While we may establish national coverage (or non-coverage) for a new item or service with a defined statutory benefit category, this NCD does not necessarily increase Medicare spending to the extent that the service has or would have been covered at local carrier discretion in the absence of a NCD. For instance, there was widespread publicity in 2000 about ocular photodynamic therapy (OPT), a new treatment for macular degeneration, a common cause of blindness in the elderly. Prior to our NCD, Medicare carriers had the authority to cover OPT at local carrier discretion as a physician's service under section 1861(s)(1) of the Act. Given the widespread publicity about the effectiveness of this new treatment, it is likely that, in the absence of a NCD, OPT would have been covered at local carrier discretion. That is, application of existing Medicare law and regulations would have allowed Medicare coverage for OPT at local carrier discretion. Because it seems likely that Medicare would covered this procedure in any event, it is unclear whether there are any additional costs associated with the NCD. Indeed the NCD limited the coverage of OPT to a defined subpopulation of Medicare beneficiaries. The local contractor determinations may not have done so, and therefore, the NCD may actually have resulted in a net savings to Medicare. Moreover, we did not change the law or regulations by making a national coverage decision for OPT. Rather, we applied existing law and regulations to a new service to make a national statement about coverage where one did not previously exist.

We may also issue a NCD to clarify Medicare coverage for existing items or services. Such a decision may establish national policy that replaces differing local practices. In such a case, there may not have been consistency among Medicare carriers as to whether an item or service qualified for coverage based on existing law or regulation. Thus, our NCD would not change law or regulation, but replaces differing local practices with a national determination that, based on existing law and regulations, clarifies Medicare coverage for an item or service. Spending may increase or decrease depending upon the degree to which the particular item or service is currently being covered by Medicare carriers and whether the decision is to establish coverage or non-coverage of the item or service.

For the reasons previously discussed, it would be very difficult to estimate any costs or savings associated with specific coverage decisions. Further, we believe any adjustment to the target would likely be of such a small magnitude that it would have little effect on future projected updates.

1. Detail on the 2002 SGR

A more detailed discussion of our revised estimates of the four elements of the 2002 SGR follows.

Factor 1—Changes in Fees for Physicians' Services (Before Applying Legislative Adjustments) for 2002

This factor was calculated as a weighted average of the 2002 fee increases that apply for the different types of services included in the definition of physicians' services for the SGR.

Services paid using the physician fee schedule account for approximately 84.5 percent of total allowed charges included in the SGR, and are updated using the MEI. The MEI for 2002 is 2.6 percent. Diagnostic laboratory tests represent approximately 7.5, and the costs of these tests are typically updated by the CPI-U. However, the BBA required a 0.0 percent update in 2002 for laboratory services. Drugs represent 8.0 percent of Medicare allowed charges included in the SGR. Pursuant to section 1842(o) of the Act, Medicare pays for drugs based on 95 percent of AWP. Using wholesale pricing information and Medicare utilization for drugs included in the SGR, we estimate a weighted average fee increase for drugs of 3.3 percent in 2002. Table 17 shows the weighted average of the MEI, laboratory and drug price increases for 2002:

Table 17

	Weight	Update
Physician	0.845	2.6
Laboratory	0.075	0.0
Drugs	0.080	3.3
Weighted Average	1.000	2.5

After taking into account the elements described in table 18, we estimate that the weighted-average increase in fees for physicians' services in 2002 under the SGR (before applying any legislative adjustments) will be 2.5 percent.

Factor 2—The Percentage Change in the Average Number of Part B Enrollees from 2001 to 2002

Our actuaries estimate that the average number of Medicare Part B fee-for-service enrollees (excluding beneficiaries enrolled in M+C plans) increased by 2.8 percent in 2002. Table 18 illustrates how we determined this figure:

Table 18

	2001	2002
Overall	37.633 million	37.986 million
Medicare+Choice	5.608 million	5.070 million
Net	32.025 million	32.916 million
Percent Increase		2.8 percent

Our actuaries' estimate of the 2.8 percent change in the average number of fee-for-service enrollees, net of Medicare+Choice enrollment for 2002, compared to 2001 is different from our preliminary estimate (0.7 percent for 2002 from the November 1, 2001 final rule (66 FR 55318)) because the historical base from which our actuarial estimate is made has changed. We now have complete information on Medicare fee-for-service enrollment for 2001 that is different than the figure we used one year ago. Further, we now have information on actual fee-for-service enrollment for the first 8 months of 2002. We would caution that our estimate of fee-for-service enrollment for 2002 may change again once we have complete information for the entire year.

Factor 3—Estimated Real Gross Domestic Product Per Capita Growth in 2002

We estimate that the growth in real per capita GDP will be 2.3 percent in 2002. Our past experience indicates that there have also been large differences between our preliminary estimates of real per capita GDP growth and the actual change in this factor. Thus, it is likely that this figure will change further as actual information on economic performance becomes available to us in 2003.

Factor 4—Percentage Change in Expenditures for Physicians' Services Resulting From Changes in Law or Regulations in 2002 Compared With 2001

As indicated earlier, sections 101 through 104 of the BIPA added Medicare coverage for a variety of new services that will affect the 2002 SGR. We included an adjustment in the 2002 SGR based on previous estimates of the costs of these new benefits, but are reducing our estimate of the costs of the new telehealth and medical nutrition therapy benefits based on lower utilization of these services than we had originally anticipated. This change will have little effect on this factor and we are not changing our estimate of the costs of any of the other provisions described earlier. In addition, as explained above, section 112 of BIPA made changes that will result in additional Medicare coverage for certain drugs. Prior to the enactment of the BIPA, Medicare only paid for drugs that cannot be self-administered by the patient. BIPA allows Medicare to pay for drugs that can be but are not usually self-administered. Accordingly, we are accounting for the increased Medicare drug expenditures that will result from implementation of section 112 of the BIPA. After taking these provisions into account, the percentage change in expenditures for physicians' services resulting from changes in law or regulations is estimated to be 0.9 percent for 2002.

3. Detail on the 2001 SGR

A more detailed discussion of our current estimates of the four elements of the 2001 SGR follows. Pursuant to section 1848(f)(3)(C) of the Act, we will be making no further revisions to these figures.

Factor 1—Changes in Fees for Physicians' Services (Before Applying Legislative Adjustments) for 2001

We are using a weighted average of the fee increases that apply to the different services included in the SGR for 2001. Services that are updated by the MEI represent 85.7 percent of allowed charges included in the SGR. The 2001 MEI was 2.1 percent. Pursuant to the BBA, laboratory services were updated by 0.0 percent in 2001 and represent 7.0 percent of allowed charges included in the SGR. The weighted average percentage increase in average wholesale prices for drugs included in the SGR in 2001 was 3.4 percent. Drugs represent 7.3 percent of allowed charges included in the SGR. Using these figures, the weighted average percentage increase in fees for physicians' services is illustrated in table 19:

Table 19

	Weight	Update
Physician	0.857	2.1
Laboratory	0.070	0.0
Drugs	0.073	3.4
Weighted Average	1.000	2.1

Factor 2—The Percentage Change in the Average Number of Fee-for-Service Part B Enrollees From 2000 to 2001

We estimate the increase in the average number of fee-for-service enrollees (excluding Medicare+Choice enrollees) from 2000 to 2001 was 3.0 percent. Table 20 illustrates the calculation of this factor:

Table 20

	2000	2001
Overall	37.330 million	37.633 million
Medicare+Choice	6.233 million	5.608 million
Net	31.098 million	32.205 million
Percent Increase		3.0 percent

Our calculation of this factor is based on complete data from 2001.

Factor 3—Estimated Real Gross Domestic Product Per Capita Growth in 2001

We estimate that the growth in real per capita GDP was −0.7 percent in 2001. This is a final figure based on complete data for 2001.

Factor 4—Percentage Change in Expenditures for Physicians' Services Resulting From Changes in Law or Regulations in CY 2001 Compared With CY 2000

As described above, the BIPA makes changes to the Act that affect Medicare expenditures for services included in the SGR. Some of these provisions had no effect on Medicare expenditures in 2001 because they did not go into effect until 2002. Other provisions became effective at some time during 2001. These provisions relate to coverage of new technology mammography, coverage changes for screening pap smears, screening pelvic exams, screening colonoscopy, expanded access to telehealth services, and Medicare payment for services provided in Indian Health Service hospitals and clinics. After taking these provisions into account, the percentage change in expenditures for physicians' services resulting from changes in law or regulations is estimated to be 0.1 percent for 2001.

VIII. Anesthesia and Physician Fee Schedule Conversion Factors

The 2003 physician fee schedule CF will be $34.5920. The 2003 national average anesthesia conversion factor is $16.0353.

The specific calculations to determine the physician fee schedule and anesthesia CFs for 2003 are explained below.

Detail on Calculation of the 2003 Physician Fee Schedule Conversion Factor

• Physician Fee Schedule Conversion Factor

Under section 1848(d)(1)(A) of the Act, the physician fee schedule CF is equal to the CF for the previous year multiplied by the update determined under section 1848(d)(4) of the Act. In addition, section 1848(c)(2)(B)(ii)(II) of the Act requires that changes to RVUs cannot cause the amount of expenditures to increase or decrease by more than $20 million from the amount of expenditures that would have been made if such adjustments had not been made. We implement this requirement through a uniform budget neutrality adjustment to the CF. There is one change that will require us to make an adjustment to the conversion factor to comply with the budget neutrality requirement in section 1848(c)(2)(B)(ii)(II) of the Act. We are making a 0.04 percent reduction (0.9996) in the CF to account for the increase in anesthesia work resulting from the 5-year review.

We are illustrating the calculation for the 2003 physician fee schedule CF in table 21:

Table 21

2002 Conversion Factor	$36.1992
2003 Update	0.9560
Budget-Neutrality Adjustment: Increase in Anesthesia Work	0.9996
2003 Conversion Factor	34.5920

• Anesthesia Fee Schedule Conversion Factor

Because anesthesia services do not have RVUs like other physician fee schedule services, we are accounting for the increase in anesthesia work through an adjustment to the anesthesia fee schedule conversion factor. As indicated earlier, we are increasing the physician work component of the anesthesia conversion factor by 2.10 percent to reflect a 9.13 percent increase in payment applied to 23 percent of anesthesia allowed charges. The 2002 anesthesia CF is $16.60. The physician work portion of the anesthesia conversion factor is 78 percent. We applied a 1.6 percent (1.016) increase to this part of the anesthesia conversion factor. Similarly, we also simulated the effect of practice expense refinements on the practice expense portion of the anesthesia conversion factor. The refinements reduced this portion of the anesthesia conversion factor by 4.04 percent (0.9596). In addition, we are also applying the physician fee schedule update and the budget neutrality adjustment for the increase in anesthesia work that that also apply to the physician fee schedule CF. To determine the anesthesia fee schedule CF for 2003, we used the following figures:

Table 22

2002 Anesthesia Conversion Factor	$16.6055
Adjustments for work and practice expense	1.0106
2003 Update	0.9560
Budget-Neutrality Adjustment: Increase in Anesthesia Work	0.9996
2003 Conversion Factor	16.0353

IX. Provisions of the Final Rule

This final rule adopts the provisions of the June 2002 proposed rule, except as noted elsewhere in the preamble. The following is a highlight of the changes made from the proposed rule.

For immunization administration, we are developing practice expense RVUs for influenza, pneumonia, and hepatitis B vaccine G codes. This will increase the payment for these codes and make Medicare's payment for vaccine administration more consistent with the rates paid for the CPT codes.

For anesthesia, we are revising the regulations text at § 414.46(g) to incorporate that the policy on multiple procedure codes as well as add-on codes.

For enrollment of PTs and OTs as therapists in private practice, we are revising our regulations text at § 410.59 and § 410.60 to reflect that carriers and fiscal intermediaries can enroll therapists as PTs or OTs in private practice when the therapist is employed by physician groups or groups that are not professional corporations.

We are adopting the process to add or delete telehealth services and adding the psychiatric diagnostic interview examination to the list of telehealth services. In addition, we are referencing the process to add or delete services at new § 410.78(f).

For the definition of a ZZZ global period, we are revising the definition to show that physician work is associated with intraservice time and, in some instances, the pre- and postservice time.

For the definition of a screening fecal-occult blood test, we are revising the definition at § 410.37(a)(2) to permit coverage of non-guaiac based tests.

For the critical access hospital emergency services requirement we are modifying § 485.618(d) to include RNs.

X. Waiver of Proposed Rulemaking for Definition of a Screening Fecal-Occult Blood Test and Critical Access Hospital Emergency Services Requirement

We ordinarily publish a notice of proposed rulemaking in the Federal Register and invite public comment on proposed rules. The notice of proposed rulemaking includes a reference to the legal authority under which the rule is proposed and the terms and substances of the proposed rule or a description of the subjects and issues involved. This procedure can be waived, however, if an agency finds good cause that notice-and-comment procedure is impracticable, unnecessary, or contrary to the public interest and incorporates a statement of the finding and its reasons in the rule issued.

In our proposed rule, we did not propose to modify § 410.37. Still, we received a comment seeking to modify coverage for one particular type of colorectal cancer test, a fecal-occult blood test. As explained earlier in this preamble, we have agreed to modify this regulation in a manner that would permit broader Medicare coverage if that is determined to be appropriate. Consistent with this change, we are modifying § 410.37(a)(1)(v) to announce that we will consider approving new tests or procedures for use in the early detection of colorectal cancer through our process for making national coverage determinations.

The Congress has authorized the Secretary to cover additional tests or procedures that can be used for the early detection of colorectal cancer under the Colorectal Cancer Screening Test benefit in under part B in section 1861(pp)(1)(D) of the Act. The Secretary may determine that coverage of other tests or procedures are appropriate, in consultation with appropriate organizations. We are aware that new colorectal cancer screening tests are being developed. To determine whether it is appropriate to expand coverage to provide Medicare payment for additional tests or procedures, it will be necessary to compare the new tests to tests that are already covered. We are modifying § 410.37(a)(1)(v) to permit determinations on whether to cover (or not cover) additional tests or procedures to be made through NCDs.

Expanding Medicare coverage of additional, effective, and appropriate screening tests would be in the public interest because the tests may discover patients with cancer at an earlier stage, increasing the chances that the patient will obtain proper medical treatment. An NCD, authorized by section 1869(a)(2) of the Act, can be used to develop a national policy regarding the scope of benefits. Moreover, the process for making an NCD will permit public participation, as well as the participation of appropriate groups, as the agency determines whether or not expanded coverage for additional tests or procedures is appropriate. This process offers advantages to the public because it could permit an expansion in the scope of the colorectal cancer screening benefit more rapidly than the notice and comment procedures of the Administrative Procedure Act would normally permit.

In addition, we did not propose to modify § 485.618(d). A delay in implementation of this provision would hinder the ability of small CAHs (with no greater than 10 beds) in some frontier areas or remote locations to provide the necessary critical access hospital emergency services. It was brought to our attention that, in recent months, a number of small CAHs in very remote frontier areas have been struggling to comply with the CAH standard in § 485.618(d) that requires CAHs to have either a doctor of medicine or osteopathy, a physician's assistant, or a nurse practitioner, with training or experience in emergency care to ensure emergency coverage 24-hours-a-day, seven-days-a-week. These CAHs have 10 or less beds. In order to provide additional flexibility for other CAHs of virtually the same size, we believe 10 beds is an appropriate size limit for facilities that may be in the same situation and require potential relief from the existing staffing requirements. These facilities, located in isolated frontier communities, have only one medical practitioner and see a low volume of patients. For these providers the requirement referenced above results in a significant personal hardship to the sole practitioner who must be on call 24-hours-a-day, 52-weeks-a-year. In addition, it is a financial hardship for the facility to find a replacement for the currently required emergency services personnel because frequently the replacement costs far exceed what is recovered through the services provided. We believe that by allowing States to include RNs in the current critical access hospital emergency services personnel requirement, so that RNs may be on call for small CAHs in frontier areas or remote locations, we will help ensure that frontier communities will have continued access to CAH services. In addition, if small CAHs in frontier areas or remote locations close their doors there would be no access to care in these communities.

Accordingly, we find good cause for waiving the prior notice-and-comment procedures as unnecessary and contrary to the public interest. In addition, we note that rules of agency procedure are exempt from the notice and comment requirements of 5 U.S.C. 553.

XI. Collection of Information Requirements

Under the Paperwork Reduction Act of 1995, we are required to provide 60-days notice in the Federal Register and solicit public comment before a collection of information requirement is submitted to the Office of Management and Budget (OMB) for review and approval. In order to fairly evaluate whether an information collection should be approved by OMB, section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires that we solicit comment on the following issues:

• The need for the information collection and its usefulness in carrying out the proper functions of our agency.
• The accuracy of our estimate of the information collection burden.
• The quality, utility, and clarity of the information to be collected.
• Recommendations to minimize the information collection burden on the affected public, including automated collection techniques.

We are soliciting public comment on each of these issues for the following sections of this document that contain information collection requirements:

Section 485.618 permits a CAH located in an area designated as a frontier area or remote location described in paragraph (d)(1)(i) to include in the personnel requirement in paragraph (d) a RN, if the State in which the small CAH is located submits a letter to us, signed by the Governor, following consultation with the State Boards of Medicine and Nursing, and in accordance with State law, requesting that a RN be included temporarily in the list of personnel that must be on call and available on site within 60 minutes.

Since we anticipate that we will receive approximately five requests for an inclusion of RNs on an annual basis, this collection requirement is not subject to the PRA as stipulated under 5 CFR 1320.3(c).

If you comment on these information collection and recordkeeping requirements, please mail copies directly to the following:

Centers for Medicare & Medicaid Services, Office of Strategic Operations & Regulatory Affairs, RDIG, Attn.: John Burke, Room N2-14-26, 7500 Security Boulevard, Baltimore, MD 21244-1850.

Office of Information and Regulatory Affairs, Office of Management and Budget, Room 10235, New Executive Office Building, Washington, DC 20503, Attn: Brenda Aguilar, CMS Desk Officer.

XII. Response to Comments

Because of the large number of items of correspondence we normally receive on Federal Register documents published for comment, we are not able to acknowledge or respond to them individually. We will consider all comments we receive by the date and time specified in the DATES section of this preamble, and, if we proceed with a subsequent document, we will respond to the major comments in the preamble to that document.

XIII. Regulatory Impact Analysis

We have examined the impact of this rule as required by Executive Order 12866 (September 1993, Regulatory Planning and Review), the Regulatory Flexibility Act (RFA) (September 16, 1980 Pub. L. 96-354), section 1102(b) of the Social Security Act, the Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4), and Executive order 13132.

Executive Order 12866 (as amended by Executive Order 13258, which reassigns responsibility of duties) directs agencies to assess all costs and benefits of available regulatory alternatives and, when regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety effects, distributive impacts, and equity). A regulatory impact analysis must be prepared for final rules with economically significant effects (that is, a final rule that would have an annual effect on the economy of $100 million or more in any 1 year, or would adversely affect in a material way the economy, a sector of the economy, productivity, competition, jobs, the environment, public health or safety, or State, local, or tribal governments or communities). We have simulated the effect of increases in payment for anesthesia work and the changes to practice expense RVUs described earlier. The net effect of the changes will not materially increase or decrease Medicare expenditures for physicians' services because the statute requires that these changes cannot increase or decrease expenditures more than $20 million. Since increases in payments resulting from the 5-year review anesthesia work and practice expense RVU changes cannot increase or decreases expenditures by more than $20 million, any increases or decreases in payment will result in a redistribution of payments among physician specialties. The proposed changes to the MEI would result in increases in Medicare expenditures for physicians' services of $150 million in fiscal year (FY) 2003, $340 million in FY 2004, and $550 million in FY 2005. Therefore, this rule is considered to be a major rule because it is economically significant, and, thus, we have prepared a regulatory impact analysis.

The RFA requires that we analyze regulatory options for small businesses and other entities. We prepare a Regulatory Flexibility Analysis unless we certify that a rule would not have a significant economic impact on a substantial number of small entities. The analysis must include a justification concerning the reason action is being taken, the kinds and number of small entities the rule affects, and an explanation of any meaningful options that achieve the objectives with less significant adverse economic impact on the small entities.

Section 1102(b) of the Act requires us to prepare a regulatory impact analysis for any proposed rule that may have a significant impact on the operations of a substantial number of small rural hospitals. This analysis must conform to the provisions of section 604 of the RFA. For purposes of section 1102(b) of the Act, we define a small rural hospital as a hospital that is located outside a Metropolitan Statistical Area and has fewer than 100 beds.

For purposes of the RFA, physicians, non-physician practitioners, and suppliers, are considered small businesses if they generate revenues of $8.5 million or less. Approximately 96 percent of physicians are considered to be small entities. There are about 700,000 physicians, other practitioners and medical suppliers that receive Medicare payment under the physician fee schedule. In addition, CAHs are considered small entities, either by nonprofit status or by having revenues of $6 to $29 million in any one year.

Section 202 of the Unfunded Mandates Reform Act of 1995 also requires that agencies assess anticipated costs and benefits before issuing any rule that may result in expenditure in any 1 year by State, local, or tribal governments, in the aggregate, or by the private sector, of $110 million. We have determined that this proposed rule will have no consequential effect on State, local, or tribal governments.

We have examined this final rule in accordance with Executive Order 13132 and have determined that this regulation would not have any negative impact on the rights, roles, or responsibilities of State, local, or tribal governments.

We have prepared the following analysis, which together with the rest of this preamble, meets all assessment requirements. It explains the rationale for, and purposes of, the rule, details the costs and benefits of the rule, analyzes alternatives, and presents the measures we are using to minimize the burden on small entities. As indicated elsewhere, we are making changes to the Medicare Economic Index, refining resource-based practice based practice expense RVUs, and making a variety of other changes to our regulations, payments, or payment policies to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. We provide information for each of the policy changes in the relevant sections in this rule. In large part, the provisions of this rule are changing only Medicare payment rates for physician fee schedule services. While this rule allows physical and occupational therapists that are employed by physicians to separately enroll in the Medicare program, it does not impose reporting, recordkeeping, and other compliance requirements. We are unaware of any relevant Federal rules that duplicate, overlap, or conflict with this rule. The relevant sections of this contain a description of significant alternatives.

A. Resource-Based Practice Expense Relative Value Units

Under section 1848(c)(2) of the Act, adjustments to RVUs may not cause the amount of expenditures to differ by more than $20 million from the amount of expenditures that would have resulted without such adjustments. We are proposing several changes that would result in a change of expenditures that would exceed $20 million if we made no offsetting adjustments to either the CF or RVUs.

With respect to practice expense, our policy has been to meet the budget-neutrality requirements in the statute by incorporating a rescaling adjustment in the practice expense methodology. That is, we estimate the aggregate number of practice expense RVUs that would be paid under current policies and under the policies we will be using in 2003. We apply a uniform adjustment factor to make the aggregate number of proposed practice expense relative values equal the number estimated that would have been paid under current policy. Consistent with section 1848(c)(2)(B)(ii)(II) of the Act, we ensure that changes to practice expense RVUs do not increase or decrease payments more than $20 million. We are also applying a 0.49 percent (0.9951) reduction to the practice expense RVUs to account for an anticipated increase in the volume and intensity of services in response to payment reductions from refinement of practice expense RVUs.

Table 23 shows the specialty level impact of RVU changes on payment in 2003. As indicated in the June 2002 proposed rule (67 FR 43869), we are showing more specialty categories in our impact tables in this final rule than we have in the past. This change was well-received by the public, and we will continue to show impacts for the more detailed list of physician specialties, non-physician practitioners and medical suppliers. As indicated in the proposed rule, it is important to note that the payment impacts reflect averages for each specialty based on Medicare utilization. The payment impact for an individual physician would be different from the average, based on the mix of services the physician provides. The average change in total revenues would be less than the impact displayed here since physicians furnish services to both Medicare and non-Medicare patients and certain specialties may receive substantial Medicare revenues for services that are not paid under the physician fee schedule. For instance, independent laboratories receive more than 80 percent of their Medicare revenues from clinical laboratory services that are not paid under the physician fee schedule. Table 23 shows only the payment impact on physician fee schedule services.

We modeled the impact of several changes that will affect payment for physician fee schedule services in CY 2003. The column labeled “NPRM” shows the impacts of our proposed rule policies and reflects the figures shown in the June 28, 2002 proposed rule (67 FR 43867). The remaining columns show additional impacts that will result from changes made in this final rule in response to comments. The column labeled practice expense refinements shows the impact on payment resulting from changes to practice expense inputs that are described in section II.A. As indicated earlier, we are making refinements to over 1,100 procedure codes. These changes result in little or no impact for most specialties. Dermatology, nephrology, and audiology will experience an approximate reduction in payment of 3 percent as a result of these changes. Payment will decline by an estimated 2 percent for others (clinical social workers, independent diagnostic testing facilities) while reductions in payments will be more modest for a few other specialties (cardiac surgery, neurosurgery, clinical psychology, orthopedic surgery and physician assistants). Payment will increase by an estimated 4 percent for independent laboratories as a result of these changes and by 2 percent for plastic surgery. Other specialties will experience smaller increases in payments from the practice expense refinements (endocrinology, family practice, general practice, obstetrics, gynecology, pediatrics, physical medicine, rhematology, urology, chiropractor, and optometry).

The column labeled “5-Year Review” shows the impact revisions to payments for anesthesia services resulting from the 5-year review of physician work. As expected, the increase in anesthesia work results in a 1-percent increase in payment to anesthesiologists and a 2-percent increase to certified registered nurse anesthetists (CRNAs) that bill Medicare for anesthesia services. CRNAs bill Medicare almost exclusively for anesthesia services. Anesthesiologists bill Medicare for anesthesia services and other physician fee schedule services. The net increase in payment is slightly less for anesthesia services because it reflects the average increase in payment for anesthesia services and other physician fee schedule services that are not increasing as a result of the 5-year review

The column labeled “All Other Changes” reflects all changes that affect practice expense RVUs described in section II. A. These changes include: (1) As requested by the American Urology Association (AUA), removing several codes From the non-physician work pool; (2) incorporating supplemental data from the American Physical Therapy Association (APTA) and; (3) continuing to determine the global practice expense RVUs as the sum of the PC and TC practice expense RVUs for pathology services. While removing the codes requested by the AUA will increase payments to urologists, it will result in a somewhat smaller increase in payment than proposed for the services remaining in the non-physician work pool. As expected, incorporating supplemental survey data will increase payment to physical and occupational therapists. Payment reductions to pathology and independent laboratories resulting from determining the TC value as the difference between the global and PC will not occur in CY 2003 since we are not making this change for 1 year for pathology services paid using the physician fee schedule.

The column labeled “Total” shows the combined effect of all RVU changes on average Medicare payments for the specialties shown. The net effect of our final rule will continue to benefit several types of suppliers that provide services that are affected by the non-physician work pool methodology. Payments to Independent Diagnostic Testing Facilities will increase by approximately 4 percent. Portable x-ray suppliers will also receive an approximate increase of 4 percent in payments for services paid under the physician fee schedule. However, we note that only about 47 percent of Medicare revenues received by portable x-ray suppliers are attributable to physician fee schedule services. The other Medicare revenues received by portable x-ray suppliers are attributed to the transportation of x-ray equipment paid at rates determined by the Medicare carrier. Any change to the rates for carrier-priced services would be made at local carrier discretion. We recently asked our Medicare carriers to analyze payment for portable x-ray transportation since it has been a number of years since payment for this service has been reviewed.

Table 23.—Impact of Work and Practice Expense Changes on Total Medicare Allowed Charges by Physician, Practitioner and Supplier Subcategory

Category	Medicare allowed charges ($ in billions)	NPRM (percent)	Practice expense refinements (percent)	5-year review (percent)	All other changes (percent)	Total (percent)
Physicians:
ALLERGY/IMMUNOLOGY	0.14	2	0	0	0	1
ANESTHESIOLOGY	1.24	−1	0	1	0	1
CARDIAC SURGERY	0.28	0	−1	0	0	−1
CARDIOLOGY	4.75	1	0	0	−1	1
CLINICS	2.57	0	0	0	0	0
DERMATOLOGY	1.55	−2	−3	0	1	−4
EMERGENCY MEDICINE	1.17	0	0	0	0	0
ENDOCRINOLOGY	0.21	0	1	0	−1	0
FAMILY PRACTICE	3.43	0	1	0	0	0
GASTROENTEROLOGY	1.34	−1	0	0	0	−1
GENERAL PRACTICE	0.84	0	1	0	0	0
GENERAL SURGERY	1.98	−1	0	0	0	−1
GERIATRICS	0.08	0	0	0	0	0
HEMATOLOGY/ONCOLOGY	0.95	1	0	0	0	1
INFECTIOUS DISEASE	0.28	−1	0	0	0	−1
INTERNAL MEDICINE	6.77	0	0	0	0	0
INTERVENTIONAL RADIOLOGY	0.14	1	0	0	−2	−1
NEPHROLOGY	1.09	−1	−3	0	0	−4
NEUROLOGY	0.91	2	0	0	0	2
NEUROSURGERY	0.38	−1	−1	0	0	−1
OBSTETRICS/GYNECOLOGY	0.48	0	1	0	0	1
OPHTHALMOLOGY	3.86	−1	0	0	0	−1
ORTHOPEDIC SURGERY	2.40	0	−1	0	0	−2
OTOLARNGOLOGY	0.66	0	0	0	−1	−1
PATHOLOGY	0.69	−2	0	0	2	0
PEDIATRICS	0.05	0	1	0	0	1
PHYSICAL MEDICINE	0.49	1	1	0	0	2
PLASTIC SURGERY	0.25	−1	2	0	0	0
PSYCHIATRY	1.00	0	0	0	0	−1
PULMONARY DISEASE	1.12	0	0	0	0	0
RADIATION ONCOLOGY	0.81	3	0	0	−2	1
RADIOLOGY	3.47	2	0	0	−1	1
RHEUMATOLOGY	0.30	0	1	0	−1	0
THORACIC SURGERY	0.43	0	0	0	0	−1
UROLOGY	1.36	−1	1	0	2	2
VASCULAR SURGERY	0.37	2	0	0	0	1
Other Practitioners:
AUDIOLOGIST	0.02	8	−3	0	−2	2
CHIROPRACTOR	0.50	−1	1	0	0	−1
CLINICAL PSYCHOLOGIST	0.40	1	−1	0	0	0
CLINICAL SOCIAL WORKER	0.23	0	−2	0	0	−1
NURSE ANESTHETIST	0.38	−1	0	2	0	1
NURSE PRACTITIONER	0.30	0	0	0	0	0
OPTOMETRY	0.54	−2	1	0	−1	−1
PHYSICAL/OCCUPATIONAL THERAPY	0.61	0	0	0	3	2
PHYSICIANS ASSISTANT	0.23	0	−1	0	0	−1
PODIATRY	1.17	−1	0	0	0	0
Suppliers:
DIAGNOSTIC TESTING FACILITY	0.51	9	−2	0	−4	3
INDEPENDENT LABORATORY	0.43	−8	4	0	8	3
PORTABLE X-RAY SUPPLIER	0.07	8	0	0	−3	4
ALL OTHER	0.29	0	−1	0	0	−1
ALL PHYSICIAN FEE SCHEDULE	53.53	0	0	0	0	0

Table 24 shows the combined impact of changes in payment due to RVUs and the physician fee schedule update. As described in section V, section 1848(d)(4) of the Act requires the physician fee schedule update to be −4.4 percent. We do not have the authority to change the physician fee schedule update formula specified in the statute. Table 24 shows the estimated change in average payments by specialty based on the provisions of this final rule and the physician fee schedule update.

Table 24.—Estimated Impact of All Changes on Total Medicare Allowed Charges by Specialty

Category	Medicare allowed charges ($ in billions)	5 Year review/RVU changes percent	Physician fee schedule update percent	Total percent
Physicians:
ALLERGY/IMMUNOLOGY	0.14	1	−4.4	−3
ANESTHESIOLOGY	1.24	1	−4.4	−3
CARDIAC SURGERY	0.28	−1	−4.4	−6
CARDIOLOGY	4.75	1	−4.4	−4
CLINICS	2.57	0	−4.4	−5
DERMATOLOGY	1.55	−4	−4.4	−8
EMERGENCY MEDICINE	1.17	0	−4.4	−5
ENDOCRINOLOGY	0.21	0	−4.4	−5
FAMILY PRACTICE	3.43	0	−4.4	−5
GASTROENTEROLOGY	1.34	−1	−4.4	−5
GENERAL PRACTICE	0.84	0	−4.4	−4
GENERAL SURGERY	1.98	−1	−4.4	−5
GERIATRICS	0.08	0	−4.4	−5
HEMATOLOGY/ONCOLOGY	0.95	1	−4.4	−3
INFECTIOUS DISEASE	0.28	−1	−4.4	−5
INTERNAL MEDICINE	6.77	0	−4.4	−5
INTERVENTIONAL RADIOLOGY	0.14	−1	−4.4	−5
NEPHROLOGY	1.09	−4	−4.4	−8
NEUROLOGY	0.91	2	−4.4	−2
NEUROSURGERY	0.38	−1	−4.4	−6
OBSTETRICS/GYNECOLOGY	0.48	1	−4.4	−3
OPHTHALMOLOGY	3.86	−1	−4.4	−5
ORTHOPEDIC SURGERY	2.40	−2	−4.4	−7
OTOLARNGOLOGY	0.66	−1	−4.4	−5
PATHOLOGY	0.69	0	−4.4	−5
PEDIATRICS	0.05	1	−4.4	−4
PHYSICAL MEDICINE	0.49	2	−4.4	−3
PLASTIC SURGERY	0.25	0	−4.4	−4
PSYCHIATRY	1.00	−1	−4.4	−5
PULMONARY DISEASE	1.12	0	−4.4	−4
RADIATION ONCOLOGY	0.81	1	−4.4	−3
RADIOLOGY	3.47	1	−4.4	−4
RHEUMATOLOGY	0.30	0	−4.4	−4
THORACIC SURGERY	0.43	−1	−4.4	−5
UROLOGY	1.36	2	−4.4	−3
VASCULAR SURGERY	0.37	1	−4.4	−3
Other Practitioners:
AUDIOLOGIST	0.02	2	−4.4	−2
CHIROPRACTOR	0.50	−1	−4.4	−5
CLINICAL PSYCHOLOGIST	0.40	0	−4.4	−4
CLINICAL SOCIAL WORKER	0.23	−1	−4.4	−5
NURSE ANESTHETIST	0.38	1	−4.4	−4
NURSE PRACTITIONER	0.30	0	−4.4	−5
OPTOMETRY	0.54	−1	−4.4	−5
PHYSICAL/OCCUPATIONAL THERAPY	0.61	2	−4.4	−3
PHYSICIANS ASSISTANT	0.23	−1	−4.4	−6
PODIATRY	1.17	0	−4.4	−5
Suppliers:
DIAGNOSTIC TESTING FACILITY	0.51	3	−4.4	−1
INDEPENDENT LABORATORY	0.43	3	−4.4	−1
PORTABLE X−RAY SUPPLIER	0.07	4	−4.4	0
ALL OTHER	0.29	−1	−4.4	−6
ALL PHYSICIAN FEE SCHEDULE	53.53	0	−4.4	−5

Table 25 shows the impact of all of the changes previously discussed on payments for selected high volume procedures. This table shows the combined impact of changes in RVUs and the physician fee schedule update on total payment for the procedure. There are separate columns that show the change in the facility rates and the nonfacility rates. For an explanation of facility and non−facility practice expense refer to § 414.22(b)(5)(i).

 Table 25.—Impact of Proposed Rule and Physician Fee Schedule Update on Medicare Payment for Selected Procedures

HCPCS	MOD	DESC	Non-Facility			Facility
			Old	New	% Change	Old	New	% Change
11721		Debride nail, 6 or more	$36.92	$35.28	^4	$28.96	$27.33	^6
17000		Destroy benign/premlg lesion	62.62	57.77	^8	32.94	31.13	^5
27130		Total hip arthroplasty	N/A	N/A	N/A	1,452.31	1,263.30	^13
27236		Treat thigh fracture	N/A	N/A	N/A	1,113.85	1,005.24	^10
27244		Treat thigh fracture	N/A	N/A	N/A	1,137.38	1,086.53	^4
27447		Total knee arthroplasty	N/A	N/A	N/A	1,514.21	1,359.47	^10
33533		CABG, arterial, single	N/A	N/A	N/A	1,827.34	1,691.89	^7
35301		Rechanneling of artery	N/A	N/A	N/A	1,061.36	1,009.74	^5
43239		Upper GI endoscopy, biopsy	354.75	317.55	^10	154.93	146.67	^5
45385		Lesion removal colonoscopy	571.22	513.00	^10	287.78	273.28	^5
66821		After cataract laser surgery	229.50	215.51	^6	213.94	200.29	^6
66984		Cataract surg w/iol, 1 stage	N/A	N/A	N/A	669.32	630.61	^6
67210		Treatment of retinal lesion	603.08	568.35	^6	546.61	515.77	^6
71010	26	Chest x-ray	9.05	8.65	^4	9.05	8.65	^4
71020	26	Chest x-ray	11.22	10.38	^7	11.22	10.38	^7
76091		Mammogram, both breasts	90.50	88.21	^3	N/A	N/A	N/A
76091	26	Mammogram, both breasts	43.44	41.51	^4	43.44	41.51	^4
76092		Mammogram, screening	81.81	77.83	^5	N/A	N/A	N/A
76092	26	Mammogram, screening	35.48	33.90	^4	35.48	33.90	^4
77427		Radiation tx management, 5	167.96	158.09	^6	167.96	158.09	^6
78465	26	Heart image (3d), multiple	74.93	70.91	^5	74.93	70.91	^5
88305	26	Tissue exam by pathologist	40.54	38.40	^5	40.54	38.40	^5
90801		Psy dx interview	144.80	140.10	^3	137.19	132.14	^4
90806		Psytx, off, 45-50 min	95.93	90.63	^6	91.22	87.17	^4
90807		Psytx, off, 45-50 min w/e&m	103.53	96.51	^7	98.82	94.09	^5
90862		Medication management	51.04	47.74	^6	46.33	44.97	^3
90921		ESRD related services, month	273.30	246.64	^10	273.30	246.64	^10
90935		Hemodialysis, one evaluation	N/A	N/A	N/A	76.38	67.11	^12
92004		Eye exam, new patient	123.44	116.23	^6	87.96	83.02	^6
92012		Eye exam established pat	61.18	57.77	^6	35.84	33.90	^5
92014		Eye exam & treatment	91.22	85.44	^6	58.64	55.35	^6
92980		Insert intracoronary stent	N/A	N/A	N/A	788.06	752.72	^4
92982		Coronary artery dilation	N/A	N/A	N/A	582.45	559.01	^4
93000		Electrocardiogram, complete	25.34	24.91	^2	N/A	N/A	N/A
93010		Electrocardiogram report	9.05	8.30	^8	9.05	8.30	^8
93015		Cardiovascular stress test	99.91	97.55	^2	N/A	N/A	N/A
93307	26	Echo exam of heart	48.14	45.32	^6	48.14	45.32	^6
93510	26	Left heart catheterization	230.59	217.58	^6	230.59	217.58	^6
98941		Chiropractic manipulation	35.48	33.55	^5	31.13	29.40	^6
99202		Office/outpatient visit, new	61.54	58.81	^4	45.61	43.24	^5
99203		Office/outpatient visit, new	91.95	87.17	^5	69.50	66.07	^5
99204		Office/outpatient visit, new	130.68	124.19	^5	102.81	97.55	^5
99205		Office/outpatient visit, new	166.15	158.43	^5	136.47	129.37	^5
99211		Office/outpatient visit, est	20.27	19.37	^4	8.69	8.30	^4
99212		Office/outpatient visit, est	36.20	34.25	^5	23.17	21.79	^6
99213		Office/outpatient visit, est	50.32	48.08	^4	34.03	32.52	^4
99214		Office/outpatient visit, est	78.91	75.06	^5	56.11	53.27	^5
99215		Office/outpatient visit, est	115.84	110.00	^5	90.50	85.79	^5
99221		Initial hospital care	N/A	N/A	N/A	65.16	61.92	^5
99222		Initial hospital care	N/A	N/A	N/A	108.24	102.74	^5
99223		Initial hospital care	N/A	N/A	N/A	150.95	142.86	^5
99231		Subsequent hospital care	N/A	N/A	N/A	32.58	30.79	^5
99232		Subsequent hospital care	N/A	N/A	N/A	53.57	50.85	^5
99233		Subsequent hospital care	N/A	N/A	N/A	76.38	72.30	^5
99236		Observ/hosp same date	N/A	N/A	N/A	214.66	203.75	^5
99238		Hospital discharge day	N/A	N/A	N/A	66.24	65.03	^2
99239		Hospital discharge day	N/A	N/A	N/A	90.86	88.21	^3
99241		Office consultation	47.06	44.62	^5	33.30	31.13	^7
99242		Office consultation	87.24	83.02	^5	68.05	64.00	^6
99243		Office consultation	115.84	109.66	^5	90.14	85.10	^6
99244		Office consultation	164.34	156.01	^5	133.58	126.26	^5
99245		Office consultation	212.85	202.36	^5	177.01	167.08	^6
99251		Initial inpatient consult	N/A	N/A	N/A	34.75	32.86	^5
99252		Initial inpatient consult	N/A	N/A	N/A	69.86	66.07	^5
99253		Initial inpatient consult	N/A	N/A	N/A	95.20	90.29	^5
99254		Initial inpatient consult	N/A	N/A	N/A	136.83	129.72	^5
99255		Initial inpatient consult	N/A	N/A	N/A	188.60	178.49	^5
99261		Follow^up inpatient consult	N/A	N/A	N/A	21.72	20.76	^4
99262		Follow^up inpatient consult	N/A	N/A	N/A	43.44	41.16	^5
99263		Follow^up inpatient consult	N/A	N/A	N/A	64.80	61.23	^6
99282		Emergency dept visit	N/A	N/A	N/A	26.43	25.25	^4
99283		Emergency dept visit	N/A	N/A	N/A	59.37	56.73	^4
99284		Emergency dept visit	N/A	N/A	N/A	92.67	88.56	^4
99285		Emergency dept visit	N/A	N/A	N/A	144.80	138.02	^5
99291		Critical care, first hour	208.87	197.52	^5	198.37	188.18	^5
99292		Critical care, addl 30 min	108.24	101.35	^6	98.82	94.09	^5
99301		Nursing facility care	70.23	66.76	^5	60.09	57.42	^4
99302		Nursing facility care	95.57	90.98	^5	80.72	76.45	^5
99303		Nursing facility care	118.73	112.77	^5	100.27	95.13	^5
99311		Nursing fac care, subseq	40.18	38.40	^4	30.05	28.71	^4
99312		Nursing fac care, subseq	61.90	58.81	^5	49.95	47.39	^5
99313		Nursing fac care, subseq	84.34	80.60	^4	70.95	67.45	^5
99348		Home visit, est patient	73.85	69.88	^5	N/A	N/A	N/A
99350		Home visit, est patient	166.52	157.74	^5	N/A	N/A	N/A
G0008		Admin influenza virus vac	3.98	7.26	82	N/A	N/A	N/A
G0009		Admin pneumococcal vaccine	3.98	7.26	82	N/A	N/A	N/A
G0010		Admin hepatitis b vaccine	3.98	7.26	82	N/A	N/A	N/A

B. Proposed Productivity Adjustment to the MEI

As indicated in section VI.B. of this final rule, we are adopting the proposed change to the methodology for adjusting for productivity in the MEI. We will use the 10-year moving average of private nonfarm business (economy-wide) multifactor productivity applied to the entire index to calculate the MEI beginning in CY 2003. The prior method accounted for productivity by adjusting the labor portion of the MEI by the 10-year moving average change in private nonfarm business (economy-wide) labor productivity. Our reasons for proposing this change and the alternatives we considered are discussed in detail in section VI.

We believe that we have developed a revised MEI methodology that is technically superior to the current MEI and more adequately reflects annual changes in the cost of furnishing services in efficient physicians' practices. The change to the MEI will raise the index by 0.7 percentage points from 2.3 percent to 3.0 percent for 2003. We estimate that this change will increase Federal expenditures by $150 million in FY 2003. The outyear impact is a function of numerous economic variables that fluctuate unpredictably. Our estimate of the impact beyond FY 2003 is based on projections of both the current and revised index. We estimate the change would increase Federal expenditures by $340 million in FY 2004 and $550 million in FY 2005.

C. Site of Service

Relative values for practice expense are determined for both “facility” and “non-facility” settings. (See Addendum B.) We are clarifying whether a given place of service is either a facility or non-facility site for purposes of determining Medicare payment. This clarification should benefit physicians, providers, and Medicare contractors by making the payment rules clearer. We are updating the facility and non-facility designations for several new place-of-service codes and changing the designations for several already in existence. The update for the new place-of-service codes will have no effect on Medicare spending. The place-of-service codes in which we are changing the designation are infrequently used for physician fee schedule services. This rule could result in a minor redistribution in payment among physician fee schedule services through the practice expense budget-neutrality adjustments.

D. Pricing of Technical Components (TC) for Positron Emission Tomography (PET) Scans

As stated earlier, to keep pricing consistent with the manner in which other PET scan services are paid, we are changing from national pricing to carrier pricing for the TC and global value for HCPCS code G0125 Lung Image PET scans. The budgetary impact on the Medicare program and providers would be uncertain since we do not know the payment amounts that carriers would use for this service.

E. Medicare Qualifications for Clinical Nurse Specialists (CNSs)

As previously stated, we are revising regulations regarding qualifications for CNSs by allowing flexibility as to certifying bodies. We believe this change will make the Medicare requirements more consistent with criteria for nurse practitioners. We also believe there will be additional enrollment of CNSs that will qualify for Medicare enrollment. We expect that this policy will have little effect on Medicare expenditures.

F. Process To Add or Delete Services to the Definition of Telehealth

We are finalizing a process for adding or deleting services from the list of telehealth services. In addition, we are adding psychiatric diagnostic interview examinations, CPT code 90801, to the list of Medicare telehealth services. We believe this will have little effect on Medicare expenditures.

G. Change in Global Period for CPT code 77789 (Surface Application of Radiation Source

We are changing the global period for CPT code 77789 (surface application of radiation source) from a 90-day global period to a 000-day global period. We believe physicians that furnish these services will benefit from this change because it will simplify their billing processes. We do not expect it will have a significant impact on the Medicare program because the change will reflect current practices.

H. New HCPCS G-Codes

In section K we discuss new G-codes for—treatment of peripheral neuropathy; current perception sensory nerve conduction threshold tests; PET codes for breast imaging; and home prothrombin time INR monitoring for anticoagulation management. We have withdrawn our proposal for a new G code for bone marrow aspiration and biopsy on the same date of service. All G codes except for the G code for bone marrow aspiration and biopsy on the same date of service have been implemented during CY 2002 through Program Memoranda as a result of national coverage decisions or the need to clarify payment policy. As stated, we are not proceeding with a G code for bone marrow aspiration and biopsy on the same date of service.

I. Endoscopic Base For Urology Codes

We are correcting the pricing of certain endoscopic services. As we previously indicated, we will use CPT procedure code 52000 as the endoscopic base code for CPT procedure codes 52234, 52235, and 52240. This will result in a reduction in payment in instances when these codes are billed in conjunction with either CPT procedure code 52000 or other codes that have CPT procedure code 52000 as the endscopic base code. We expect the savings will be negligible.

J. Physical Therapy and Occupational Therapy Caps

There were no proposals made in this area. The imposition of the physical and occupational therapy caps will occur as a result of application of section 4541(c) of the BBA. While section 221 of the BBRA and section 421 of BIPA placed a moratorium on application of these caps, the moratorium expires for physical and occupational therapy services furnished after December 31, 2002. We estimate that application of the caps will reduce Medicare expenditures for physical and occupational therapy services by $240 million in CY 2003.

K. Enrollment of Physical and Occupational Therapists as Therapists in Private Practice

This change will provide flexibility for therapists by allowing therapists that meet the enrollment criteria to enroll in Medicare without regard to how they are organized to provide services. We do not expect this will have a significant effect on Medicare expenditures because Medicare pays the same amount for these therapy services whether they are billed directly by a therapist or by a physician as an incident to service.

L. Screening Fecal Occult Blood Tests

As discussed in section II.N (1) of the preamble, we are modifying our regulations to allow us to expand coverage when appropriate for (1) screening fecal-occult blood tests for the early detection of colorectal cancer, and (2) additional colorectal cancer screening tests through our national coverage determination process. These changes will allow us to conduct more timely assessments of new types of colon cancer screening tests than is normally possible under the standard rulemaking process. There are no costs or savings to the Medicare program associated with this regulation change.

M. Add-on Anesthesia Codes

The add-on codes, two for obstetrical anesthesia (CPT codes 01968 and 01969) and one for burn excisions (CPT code 01953), represent low volume codes for the Medicare population. We believe the new policy for add-on codes will have a negligible impact on total anesthesia payments.

N. Physician Self-Referral Prohibitions

As discussed in section IV of this preamble, we are updating the list of codes used to define certain designated health services for the purposes of section 1877 of the Act. We are not making any substantive change to the description of any designated health service as set forth in the January 4, 2001 physician self-referral final rule (66 FR 856). Instead, we are merely updating our list of codes to conform to coding changes in the most recent publication of CPT and HCPCS codes.

For this reason, we certify that the changes we are making will not have a significant economic effect on a substantial number of small entities or on the operations of a substantial number of small rural hospitals.

O. Critical Access Hospital Emergency Services Requirement

We anticipate that this rule will reduce cost for small CAHs. Frontier area and remote location CAHs will no longer be limited to hiring only a physician, nurse practitioner or physician assistant to provide emergency coverage in the absence of the sole practitioner. This rule will provide relief to small CAHs in meeting the current emergency staffing requirement by allowing them to utilize a registered nurse to provide emergency care services once the State submits a letter to us, signed by the Governor, following consultation with the State Boards of Medicine and Nursing, and in accordance with State law, requesting that RNs be included as emergency personnel in § 485.618(d).

P. Alternatives Considered

This final rule contains a range of policies. The preamble identifies those policies when discretion has been exercised and presents rationale for our decisions, including a presentation of nonselected options (except for the critical access hospital emergency services requirement which is provided separately).

Critical Access Hospitals Emergency Services Personnel Requirement

We considered allowing each CAH in a frontier area or remote location to individually request a waiver of the requirements at § 485.618(a) and (d). The statute does not provide authority to waive the requirement for continuous emergency room coverage. Section 1820(c)(B)(ii) requires a qualifying CAH to make available the 24-hour emergency care services that a State determines are necessary for ensuring access to emergency care services in each area served by a CAH. However, we believe States may interpret emergency care services to allow CAHs to use a RN in order to comply with the emergency services personnel requirement stated in the regulations at § 485.618. This change is consistent with our policy of respecting State oversight of health care professions by deferring to State law to regulate professional practice.

Q. Impact on Beneficiaries

Although changes in physicians' payments were large when the physician fee schedule was implemented in 1992, we detected no problems with beneficiary access to care. We do not believe that there would be any problem with access to care as a result of the changes in this rule. While it has been suggested that the negative update for CY 2003 may affect beneficiary access to care, we note that the formula to determine this update is set by statute and this regulation cannot, and does not, change it.

As indicated above, the imposition of the physical and occupational therapy caps will occur as a result of application of section 4541(c) of the BBA. It is possible that application of physical and occupational therapy caps will have an impact on Medicare beneficiaries either through increased liability for services exceeding the cap or fewer services being provided. We contracted with the Urban Institute to perform analyses related to the implementation of the therapy caps, based on an analysis of a sample of therapy services provided from CYs 1998 through 2000. The draft reports are available on the CMS website. The contractor report indicated that in CY 2000, about 12 percent of patients who received therapy services would have exceeded the caps. The caps are more likely to be exceeded in skilled nursing facilities, comprehensive outpatient rehabilitation facilities, and other rehabilitation facility settings. The caps do not apply to outpatient therapy services provided in an outpatient hospital. The report does not make assumptions about changes in behavior in response to the caps. Without more experience with the caps, it is difficult to predict the precise impact on beneficiaries.

In addition, CAHs in frontier areas and remote locations will be able to satisfy the CAH emergency services personnel requirement, through the addition of RNs to our personnel requirements and beneficiaries will have greater access to care through the utilization of RNs providing emergency care services to patients.

In accordance with the provisions of Executive Order 12866, the Office of Management and Budget reviewed this regulation.

List of Subjects

42 CFR Part 410

• Health facilities
• Health professions
• Kidney diseases
• Laboratories
• Medicare
• Rural areas
• X-rays

42 CFR Part 414

• Administrative practice and procedure
• Health facilities
• Health professions
• Kidney diseases
• Medicare
• Reporting and recordkeeping requirements
• Rural areas
• X-rays

42 CFR Part 485

• Grant programs-health
• Health facilities
• Medicaid
• Medicare
• Reporting and recordkeeping requirements

For the reasons set forth in the preamble, the Centers for Medicare & Medicaid Services amends 42 CFR chapter IV as follows:

PART 410—SUPPLEMENTARY MEDICAL INSURANCE (SMI) BENEFITS

1. The authority citation for part 410 continues to read as follows:

Authority: Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh).

2. In § 410.37, paragraphs (a)(1)(v) and (a)(2) are revised to read as follows:

§ 410.37

Colorectal cancer screening tests: Conditions for and limitations on coverage.

(a) * * *

(1) * * *

(v) Other tests or procedures established by a national coverage determination, and modifications to tests under this paragraph, with such frequency and payment limits as CMS determines appropriate, in consultation with appropriate organizations

(2) Screening fecal-occult blood test means—

(i) A guaiac-based test for peroxidase activity, testing two samples from each of three consecutive stools, or,

(ii) Other tests as determined by the Secretary through a national coverage determination.

* * * * *

3. Section 410.59 is amended as follows:

A. Paragraph (c)(1)(ii)(C) is revised.

B. A new paragraph (c)(1)(ii)(D) is added.

C. A new paragraph (c)(1)(ii)(E) is added.

The revision and additions read as follows:

§ 410.59

Outpatient occupational therapy services: Conditions.

* * * * *

(c) * * *

(1) * * *

(ii) * * *

(C) An unincorporated solo practice, partnership, or group practice, or a professional corporation or other incorporated occupational therapy practice.

(D) An employee of a physician group.

(E) An employee of a group that is not a professional corporation.

* * * * *

4. Section 410.60 is amended as follows:

A. Paragraph (c)(1)(ii)(C) is revised.

B. A new paragraph (c)(1)(ii)(D) is added.

C. A new paragraph (c)(1)(ii)(E) is added

The revision and additions read as follows:

§ 410.60

Outpatient physical therapy services: Conditions

* * * * *

(c) * * *

(1) * * *

(ii) * * *

(C) An unincorporated solo practice, partnership, or group practice, or a professional corporation or other incorporated physical therapy practice.

(D) An employee of a physician group.

(E) An employee of a group that is not a professional corporation.

* * * * *

5. Section 410.61 is amended by revising paragraph (d)(1)(iii) to read as follows:

§ 410.61

Plan of treatment requirements for outpatient rehabilitation services.

(d) * * *

(1) * * *

(iii) The occupational therapist that furnishes the occupational therapy services.

* * * * *

6. Section 410.76 is amended by revising paragraph (b)(3) to read as follows:

§ 410.76

Clinical nurse specialists' services.

* * * * *

(b) * * *

(3) Be certified as a clinical nurse specialist by a national certifying body that has established standards for clinical nurse specialists and that is approved by the Secretary.

* * * * *

7. Section 410.78 is amended as follows:

a. Revise the heading of the section.

b. Revise the introductory text of paragraph (b).

c. Revise paragraph (b)(1).

d. Add a new paragraph (f).

The revisions and additions read as follows:

§ 410.78

Telehealth services.

* * * * *

(b) General rule. Medicare Part B pays for office and other outpatient visits, professional consultation, psychiatric diagnostic interview examination, individual psychotherapy, and pharmacologic management furnished by an interactive telecommunications system if the following conditions are met:

(1) The physician or practitioner at the distant site must be licensed to furnish the service under State law. The physician or practitioner at the distant site who is licensed under State law to furnish a covered telehealth service described in this section may bill, and receive payment for, the service when it is delivered via a telecommunications system.

* * * * *

(f) Process for adding or deleting services. Changes to the list of Medicare telehealth services are made through the annual physician fee schedule rulemaking process.

PART 414—PAYMENT FOR PART B MEDICAL AND OTHER HEALTH SERVICES

1. The authority citation for part 414 continues to read as follows:

Authority: Secs. 1102, 1871, and 1881(b)(1) of the Social Security Act (42 U.S.C. 1302, 1395hh, and 1395rr(b)(1)).

2. Section 414.46 is amended by revising paragraph (g) to read as follows:

§ 414.46

Additional rules for payment of anesthesia services.

* * * * *

(g) Physician involved in multiple anesthesia services. If the physician is involved in multiple anesthesia services for the same patient during the same operative session, the carrier makes payment according to the base unit associated with the anesthesia service having the highest base unit value and anesthesia time that encompasses the multiple services. The carrier makes payment for add-on anesthesia codes according to program operating instructions.

3. Section 414.65, is amended as follows:

a. Revise the heading of the section.

b. Revise paragraph (a)(1).

c. Revise paragraph (b) introductory text.

The revisions read as follows:

§ 414.65

Payment for telehealth services.

(a) * * *

(1) The Medicare payment amount for office or other outpatient visits, consultation, individual psychotherapy, psychiatric diagnostic interview examination, and pharmacologic management furnished via an interactive telecommunications system is equal to the current fee schedule amount applicable for the service of the physician or practitioner.

* * * * *

(b) Originating site facility fee. For telehealth services furnished on or after October 1, 2001:

* * * * *

PART 485—CONDITIONS OF PARTICIPATION: SPECIALIZED PROVIDERS

Part 485 is amended as set forth below:

1. The authority citation for 485 continues to read as follows:

Authority: Secs. 1102 and 1871 of the Act (42 U.S.C. 1302 and 1396hh).

2. Section 485.618 is amended by revising paragraph (d) to read as follows:

§ 485.618

Condition of participation: Emergency services.

* * * * *

(d) Standard: Personnel. (1) Except as specified in paragraph (d)(2) of this section, there must be a doctor of medicine or osteopathy, a physician assistant, or a nurse practitioner, with training or experience in emergency care on call and immediately available by telephone or radio contact, and available on site within the following timeframes:

(i) Within 30 minutes, on a 24-hour a day basis, if the CAH is located in an area other than an area described in paragraph (d)(1)(ii) of this section; or

(ii) Within 60 minutes, on a 24-hour a day basis, if all of the following requirements are met:

(A) The CAH is located in an area designated as a frontier area (that is, an area with fewer than six residents per square mile based on the latest population data published by the Bureau of the Census) or in an area that meets the criteria for a remote location adopted by the State in its rural health care plan, and approved by CMS, under section 1820(b) of the Act.

(B) The State has determined, under criteria in its rural health care plan, that allowing an emergency response time longer than 30 minutes is the only feasible method of providing emergency care to residents of the area served by the CAH.

(C) The State maintains documentation showing that the response time of up to 60 minutes at a particular CAH it designates is justified because other available alternatives would increase the time needed to stabilize a patient in an emergency.

(2) A registered nurse satisfies the personnel requirement specified in paragraph (d)(1) of this section for a temporary period if—

(i) The CAH has no greater than 10 beds;

(ii) The CAH is located in an area designated as a frontier area or remote location as described in paragraph (d)(1)(ii)(A) of this section;

(iii) The State in which the CAH is located submits a letter to CMS signed by the Governor, following consultation on the issue of using RNs on a temporary basis as part of their State rural healthcare plan with the State Boards of Medicine and Nursing, and in accordance with State law, requesting that a registered nurse with training and experience in emergency care be included in the list of personnel specified in paragraph (d)(1) of this section. The letter from the Governor must attest that he or she has consulted with State Boards of Medicine and Nursing about issues related to access to and the quality of emergency services in the States. The letter from the Governor must also describe the circumstances and duration of the temporary request to include the registered nurses on the list of personnel specified in paragraph (d)(1) of this section;

(iv) Once a Governor submits a letter, as specified in paragraph (d)(2)(ii) of this section, a CAH must submit documentation to the State survey agency demonstrating that it has been unable, due to the shortage of such personnel in the area, to provide adequate coverage as specified in this paragraph (d).

(3) The request, as specified in paragraph(d)(2)(ii) of this section, and the withdrawal of the request, may be submitted to us at any time, and are effective upon submission.

* * * * *

(Catalog of Federal Domestic Assistance Program No. 93.774, Medicare—Supplementary Medical Insurance Program)

Dated: November 26, 2002.

Thomas A. Scully,

Administrator, Centers for Medicare & Medicaid Services.

Approved: December 12, 2002.

Tommy G. Thompson,

Secretary.

Note:

These addenda will not appear in the Code of Federal Regulations.

Addendum A—Explanation and Use of Addenda B

The addenda on the following pages provide various data pertaining to the Medicare fee schedule for physicians' services furnished in 2003. Addendum B contains the RVUs for work, non-facility practice expense, facility practice expense, and malpractice expense, and other information for all services included in the physician fee schedule.

In previous years, we have listed many services in Addendum B that are not paid under the physician fee schedule. To avoid publishing as many pages of codes for these services, we are not including clinical laboratory codes and most alpha-numeric codes (Healthcare Common Procedure Coding System (HCPCS) codes not included in CPT) in Addendum B.

Addendum B—2003 Relative Value Units and Related Information Used in Determining Medicare Payments for 2003

This addendum contains the following information for each CPT code and alphanumeric HCPCS code for services that may be paid under the physician fee schedule as well as all G codes

1. CPT/HCPCS code. This is the CPT or alphanumeric HCPCS number for the service. Alphanumeric HCPCS codes are included at the end of this addendum.

2. Modifier. A modifier is shown if there is a technical component (modifier TC) and a professional component (PC) (modifier -26) for the service. If there is a PC and a TC for the service, Addendum B contains three entries for the code: One for the global values (both professional and technical); one for modifier -26 (PC); and one for modifier TC. The global service is not designated by a modifier, and physicians must bill using the code without a modifier if the physician furnishes both the PC and the TC of the service.

Modifier -53 is shown for a discontinued procedure. There will be RVUs for the code (CPT code 45378) with this modifier.

3. Status indicator. This indicator shows whether the CPT/HCPCS code is in the physician fee schedule and whether it is separately payable if the service is covered.

A = Active code. These codes are separately payable under the fee schedule if covered. There will be RVUs for codes with this status. The presence of an “A” indicator does not mean that Medicare has made a national decision regarding the coverage of the service. Carriers remain responsible for coverage decisions in the absence of a national Medicare policy.

B = Bundled code. Payment for covered services is always bundled into payment for other services not specified. If RVUs are shown, they are not used for Medicare payment. If these services are covered, payment for them is subsumed by the payment for the services to which they are incident. (An example is a telephone call from a hospital nurse regarding care of a patient.)

C = Carrier-priced code. Carriers will establish RVUs and payment amounts for these services, generally on a case-by-case basis following review of documentation, such as an operative report.

D = Deleted code. These codes are deleted effective with the beginning of the calendar year.

E = Excluded from physician fee schedule by regulation. These codes are for items or services that we chose to exclude from the physician fee schedule payment by regulation. No RVUs are shown, and no payment may be made under the physician fee schedule for these codes. Payment for them, if they are covered, continues under reasonable charge or other payment procedures.

F = Deleted/discontinued codes. Code not subject to a 90-day grace period.

G = Code not valid for Medicare purposes. Medicare does not recognize codes assigned this status. Medicare uses another code for reporting of, and payment for, these services.

H = Deleted modifier. Either the TC or PC component shown for the code has been deleted, and the deleted component is shown in the data base with the H status indicator. (Code subject to a 90-day grace period.)

I = Not valid for Medicare purposes. Medicare uses another code for the reporting of, and the payment for these services. (Code NOT subject to a 90-day grace period.)

N = Noncovered service. These codes are noncovered services. Medicare payment may not be made for these codes. If RVUs are shown, they are not used for Medicare payment.

P = Bundled or excluded code. There are no RVUs for these services. No separate payment should be made for them under the physician fee schedule.

—If the item or service is covered as incident to a physician's service and is furnished on the same day as a physician's service, payment for it is bundled into the payment for the physician's service to which it is incident (an example is an elastic bandage furnished by a physician incident to a physician's service).

—If the item or service is covered as other than incident to a physician's service, it is excluded from the physician fee schedule (for example, colostomy supplies) and is paid under the other payment provisions of the Act.

R = Restricted coverage. Special coverage instructions apply. If the service is covered and no RVUs are shown, it is carrier-priced.

T = Injections. There are RVUs for these services, but they are only paid if there are no other services payable under the physician fee schedule billed on the same date by the same provider. If any other services payable under the physician fee schedule are billed on the same date by the same provider, these services are bundled into the service(s) for which payment is made.

X = Exclusion by law. These codes represent an item or service that is not within the definition of “physicians' services” for physician fee schedule payment purposes. No RVUs are shown for these codes, and no payment may be made under the physician fee schedule. (Examples are ambulance services and clinical diagnostic laboratory services.)

4. Description of code. This is an abbreviated version of the narrative description of the code.

5. Physician work RVUs. These are the RVUs for the physician work for this

service in 2003. Codes that are not used for Medicare payment are identified with a “+.”

6. Facility practice expense RVUs. These are the fully implemented resource-based practice expense RVUs for facility settings. An “NA” in the facility column means that we do not pay for the service in a facility setting. For instance, we do not pay using the physician fee schedule for the global or technical component of a radiology service or other diagnostic test in a facility setting. Also, there is no payment in a facility setting for “incident to” services (services that do not have physician work RVUs). Payment is included in our payment for institutional services.

7. Non-facility practice expense RVUs. These are the fully implemented resource-based practice expense RVUs for non-facility settings. An “NA” in the nonfacility column means that the service is generally not provided outside of hospitals and we do not have information upon which to determine a price. In most cases, these are major surgical services.

8. Malpractice expense RVUs. These are the RVUs for the malpractice expense for the service for 2003.

9. Facility total. This is the sum of the work, fully implemented facility practice expense, and malpractice expense RVUs.

10. Non-facility total. This is the sum of the work, fully implemented non-facility practice expense, and malpractice expense RVUs.

11. Global period. This indicator shows the number of days in the global period for the code (0, 10, or 90 days). An explanation of the alpha codes follows:

MMM = The code describes a service furnished in uncomplicated maternity cases including antepartum care, delivery, and postpartum care. The usual global surgical concept does not apply. See the 1999 Physicians' Current Procedural Terminology for specific definitions.

XXX = The global concept does not apply.

YYY = The global period is to be set by the carrier (for example, unlisted surgery codes).

ZZZ = Code related to another service and is always included in the global period of the other service. (Note: Physician work is associated with intra service time and in some instances the pre- and post-service time.)

 

 

 

—————————— ¹ CPT codes and descriptions only are copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply. ² Copyright 2002 American Dental Association. All rights reserved. ³ + Indicates RVUs are not used for Medicare payment.

Addendum B.—Relative Value Units (RVUS) and Related Information

CPT 1/ HCPCS 2	MOD	Status	Description	Physician Work RVUs3	Non- Facility PE RVUs	Facility PE RVUs	Mal- Practice RVUs	Non- Facility Total	Facility Total	Global
0001T		C	Endovas repr abdo ao aneurys	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0002T		C	Endovas repr abdo ao aneurys	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0003T		C	Cervicography	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0005T		C	Perc cath stent/brain cv art	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0006T		C	Perc cath stent/brain cv art	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0007T		C	Perc cath stent/brain cv art	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0008T		C	Upper gi endoscopy w/suture	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0009T		C	Endometrial cryoablation	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0010T		C	Tb test, gamma interferon	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0012T		C	Osteochondral knee autograft	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0013T		C	Osteochondral knee allograft	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0014T		C	Meniscal transplant, knee	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0016T		C	Thermotx choroid vasc lesion	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0017T		C	Photocoagulat macular drusen	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0018T		C	Transcranial magnetic stimul	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0019T		C	Extracorp shock wave tx, ms	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0020T		A	Extracorp shock wave tx, ft	0.06	1.46	0.02	0.01	1.53	0.09	XXX
0021T		C	Fetal oximetry, trnsvag/cerv	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0023T		C	Phenotype drug test, hiv 1	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0024T		C	Transcath cardiac reduction	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0025T		C	Ultrasonic pachymetry	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0026T		C	Measure remnant lipoproteins	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0027T		C	Endoscopic epidural lysis	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0028T		C	Dexa body composition study	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0029T		C	Magnetic tx for incontinence	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0030T		C	Antiprothrombin antibody	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0031T		C	Speculoscopy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0032T		C	Speculoscopy w/direct sample	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0033T		C	Endovasc taa repr incl subcl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0034T		C	Endovasc taa repr w/o subcl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0035T		C	Insert endovasc prosth, taa	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0036T		C	Endovasc prosth, taa, add-on	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0037T		C	Artery transpose/endovas taa	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0038T		C	Rad endovasc taa rpr w/cover	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0039T		C	Rad s/i, endovasc taa repair	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0040T		C	Rad s/i, endovasc taa prosth	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0041T		C	Detect ur infect agnt w/cpas	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0042T		C	Ct perfusion w/contrast, cbf	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0043T		C	Co expired gas analysis	0.00	0.00	0.00	0.00	0.00	0.00	XXX
0044T		C	Whole body photography	0.00	0.00	0.00	0.00	0.00	0.00	XXX
10021		A	Fna w/o image	1.27	2.37	NA	0.07	3.71	NA	XXX
10022		A	Fna w/image	1.27	2.66	NA	0.05	3.98	NA	XXX
10040		A	Acne surgery	1.18	1.10	0.71	0.05	2.33	1.94	010
10060		A	Drainage of skin abscess	1.17	1.49	0.67	0.08	2.74	1.92	010
10061		A	Drainage of skin abscess	2.40	1.88	1.41	0.17	4.45	3.98	010
10080		A	Drainage of pilonidal cyst	1.17	2.13	0.73	0.09	3.39	1.99	010
10081		A	Drainage of pilonidal cyst	2.45	2.90	1.55	0.19	5.54	4.19	010
10120		A	Remove foreign body	1.22	1.54	0.36	0.10	2.86	1.68	010
10121		A	Remove foreign body	2.69	2.96	1.79	0.25	5.90	4.73	010
10140		A	Drainage of hematoma/fluid	1.53	1.49	0.87	0.15	3.17	2.55	010
10160		A	Puncture drainage of lesion	1.20	0.77	0.42	0.11	2.08	1.73	010
10180		A	Complex drainage, wound	2.25	1.48	1.27	0.25	3.98	3.77	010
11000		A	Debride infected skin	0.60	0.64	0.24	0.05	1.29	0.89	000
11001		A	Debride infected skin add-on	0.30	0.38	0.11	0.02	0.70	0.43	ZZZ
11010		A	Debride skin, fx	4.20	2.40	1.96	0.45	7.05	6.61	010
11011		A	Debride skin/muscle, fx	4.95	3.83	2.60	0.53	9.31	8.08	000
11012		A	Debride skin/muscle/bone, fx	6.88	5.51	4.23	0.89	13.28	12.00	000
11040		A	Debride skin, partial	0.50	0.52	0.21	0.05	1.07	0.76	000
11041		A	Debride skin, full	0.82	0.66	0.33	0.06	1.54	1.21	000
11042		A	Debride skin/tissue	1.12	0.97	0.47	0.09	2.18	1.68	000
11043		A	Debride tissue/muscle	2.38	3.57	2.64	0.24	6.19	5.26	010
11044		A	Debride tissue/muscle/bone	3.06	4.73	3.91	0.34	8.13	7.31	010
11055		R	Trim skin lesion	0.43	0.51	0.18	0.02	0.96	0.63	000
11056		R	Trim skin lesions, 2 to 4	0.61	0.58	0.26	0.03	1.22	0.90	000
11057		R	Trim skin lesions, over 4	0.79	0.65	0.33	0.04	1.48	1.16	000
11100		A	Biopsy of skin lesion	0.81	1.24	0.38	0.04	2.09	1.23	000
11101		A	Biopsy, skin add-on	0.41	0.38	0.20	0.02	0.81	0.63	ZZZ
11200		A	Removal of skin tags	0.77	1.23	0.31	0.04	2.04	1.12	010
11201		A	Remove skin tags add-on	0.29	0.56	0.12	0.02	0.87	0.43	ZZZ
11300		A	Shave skin lesion	0.51	0.99	0.22	0.03	1.53	0.76	000
11301		A	Shave skin lesion	0.85	1.10	0.39	0.04	1.99	1.28	000
11302		A	Shave skin lesion	1.05	1.30	0.48	0.05	2.40	1.58	000
11303		A	Shave skin lesion	1.24	1.59	0.54	0.06	2.89	1.84	000
11305		A	Shave skin lesion	0.67	0.84	0.27	0.04	1.55	0.98	000
11306		A	Shave skin lesion	0.99	1.10	0.43	0.05	2.14	1.47	000
11307		A	Shave skin lesion	1.14	1.29	0.50	0.05	2.48	1.69	000
11308		A	Shave skin lesion	1.41	1.45	0.61	0.07	2.93	2.09	000
11310		A	Shave skin lesion	0.73	1.11	0.33	0.04	1.88	1.10	000
11311		A	Shave skin lesion	1.05	1.23	0.50	0.05	2.33	1.60	000
11312		A	Shave skin lesion	1.20	1.43	0.57	0.06	2.69	1.83	000
11313		A	Shave skin lesion	1.62	1.81	0.74	0.09	3.52	2.45	000
11400		A	Exc tr-ext b9+marg 0.5 < cm	0.85	2.08	0.96	0.06	2.99	1.87	010
11401		A	Exc tr-ext b9+marg 0.6-1 cm	1.23	2.12	1.08	0.09	3.44	2.40	010
11402		A	Exc tr-ext b9+marg 1.1-2 cm	1.51	2.28	1.14	0.12	3.91	2.77	010
11403		A	Exc tr-ext b9+marg 2.1-3 cm	1.79	2.50	1.35	0.16	4.45	3.30	010
11404		A	Exc tr-ext b9+marg 3.1-4 cm	2.06	2.84	1.42	0.18	5.08	3.66	010
11406		A	Exc tr-ext b9+marg > 4.0 cm	2.76	3.24	1.68	0.25	6.25	4.69	010
11420		A	Exc h-f-nk-sp b9+marg 0.5 <	0.98	1.81	1.00	0.08	2.87	2.06	010
11421		A	Exc h-f-nk-sp b9+marg 0.6-1	1.42	2.12	1.18	0.11	3.65	2.71	010
11422		A	Exc h-f-nk-sp b9+marg 1.1-2	1.63	2.30	1.38	0.14	4.07	3.15	010
11423		A	Exc h-f-nk-sp b9+marg 2.1-3	2.01	2.66	1.49	0.17	4.84	3.67	010
11424		A	Exc h-f-nk-sp b9+marg 3.1-4	2.43	2.93	1.64	0.21	5.57	4.28	010
11426		A	Exc h-f-nk-sp b9+marg > 4 cm	3.78	3.75	2.15	0.34	7.87	6.27	010
11440		A	Exc face-mm b9+marg 0.5 < cm	1.06	2.27	1.41	0.08	3.41	2.55	010
11441		A	Exc face-mm b9+marg 0.6-1 cm	1.48	2.40	1.59	0.11	3.99	3.18	010
11442		A	Exc face-mm b9+marg 1.1-2 cm	1.72	2.66	1.66	0.14	4.52	3.52	010
11443		A	Exc face-mm b9+marg 2.1-3 cm	2.29	3.04	1.90	0.18	5.51	4.37	010
11444		A	Exc face-mm b9+marg 3.1-4 cm	3.14	3.64	2.28	0.25	7.03	5.67	010
11446		A	Exc face-mm b9+marg > 4 cm	4.49	4.26	2.88	0.30	9.05	7.67	010
11450		A	Removal, sweat gland lesion	2.73	4.12	0.98	0.26	7.11	3.97	090
11451		A	Removal, sweat gland lesion	3.95	4.98	1.43	0.39	9.32	5.77	090
11462		A	Removal, sweat gland lesion	2.51	4.10	0.95	0.23	6.84	3.69	090
11463		A	Removal, sweat gland lesion	3.95	5.60	1.57	0.40	9.95	5.92	090
11470		A	Removal, sweat gland lesion	3.25	4.54	1.23	0.30	8.09	4.78	090
11471		A	Removal, sweat gland lesion	4.41	5.69	1.72	0.40	10.50	6.53	090
11600		A	Exc tr-ext mlg+marg 0.5 < cm	1.31	2.53	0.99	0.09	3.93	2.39	010
11601		A	Exc tr-ext mlg+marg 0.6-1 cm	1.80	2.60	1.24	0.12	4.52	3.16	010
11602		A	Exc tr-ext mlg+marg 1.1-2 cm	1.95	2.73	1.29	0.13	4.81	3.37	010
11603		A	Exc tr-ext mlg+marg 2.1-3 cm	2.19	2.96	1.35	0.16	5.31	3.70	010
11604		A	Exc tr-ext mlg+marg 3.1-4 cm	2.40	3.27	1.41	0.18	5.85	3.99	010
11606		A	Exc tr-ext mlg+marg > 4 cm	3.43	3.96	1.76	0.28	7.67	5.47	010
11620		A	Exc h-f-nk-sp mlg+marg 0.5 <	1.19	2.49	0.97	0.09	3.77	2.25	010
11621		A	Exc h-f-nk-sp mlg+marg 0.6-1	1.76	2.60	1.27	0.12	4.48	3.15	010
11622		A	Exc h-f-nk-sp mlg+marg 1.1-2	2.09	2.87	1.42	0.15	5.11	3.66	010
11623		A	Exc h-f-nk-sp mlg+marg 2.1-3	2.61	3.22	1.62	0.20	6.03	4.43	010
11624		A	Exc h-f-nk-sp mlg+marg 3.1-4	3.06	3.61	1.81	0.25	6.92	5.12	010
11626		A	Exc h-f-nk-sp mlg+mar > 4 cm	4.30	4.56	2.44	0.35	9.21	7.09	010
11640		A	Exc face-mm malig+marg 0.5 <	1.35	2.54	1.14	0.10	3.99	2.59	010
11641		A	Exc face-mm malig+marg 0.6-1	2.16	2.92	1.57	0.15	5.23	3.88	010
11642		A	Exc face-mm malig+marg 1.1-2	2.59	3.30	1.77	0.18	6.07	4.54	010
11643		A	Exc face-mm malig+marg 2.1-3	3.10	3.70	2.01	0.24	7.04	5.35	010
11644		A	Exc face-mm malig+marg 3.1-4	4.03	4.63	2.56	0.33	8.99	6.92	010
11646		A	Exc face-mm mlg+marg > 4 cm	5.95	5.73	3.60	0.46	12.14	10.01	010
11719		R	Trim nail(s)	0.17	0.25	0.07	0.01	0.43	0.25	000
11720		A	Debride nail, 1-5	0.32	0.34	0.13	0.02	0.68	0.47	000
11721		A	Debride nail, 6 or more	0.54	0.44	0.21	0.04	1.02	0.79	000
11730		A	Removal of nail plate	1.13	0.81	0.44	0.09	2.03	1.66	000
11732		A	Remove nail plate, add-on	0.57	0.30	0.23	0.05	0.92	0.85	ZZZ
11740		A	Drain blood from under nail	0.37	0.82	0.14	0.03	1.22	0.54	000
11750		A	Removal of nail bed	1.86	1.72	0.77	0.16	3.74	2.79	010
11752		A	Remove nail bed/finger tip	2.67	2.11	1.76	0.33	5.11	4.76	010
11755		A	Biopsy, nail unit	1.31	1.11	0.56	0.06	2.48	1.93	000
11760		A	Repair of nail bed	1.58	1.80	1.25	0.17	3.55	3.00	010
11762		A	Reconstruction of nail bed	2.89	2.24	1.88	0.32	5.45	5.09	010
11765		A	Excision of nail fold, toe	0.69	1.13	0.49	0.05	1.87	1.23	010
11770		A	Removal of pilonidal lesion	2.61	2.98	1.23	0.24	5.83	4.08	010
11771		A	Removal of pilonidal lesion	5.74	5.50	3.91	0.56	11.80	10.21	090
11772		A	Removal of pilonidal lesion	6.98	6.41	4.36	0.68	14.07	12.02	090
11900		A	Injection into skin lesions	0.52	0.75	0.22	0.02	1.29	0.76	000
11901		A	Added skin lesions injection	0.80	0.72	0.36	0.03	1.55	1.19	000
11920		R	Correct skin color defects	1.61	2.16	0.80	0.17	3.94	2.58	000
11921		R	Correct skin color defects	1.93	2.52	1.00	0.21	4.66	3.14	000
11922		R	Correct skin color defects	0.49	0.38	0.26	0.05	0.92	0.80	ZZZ
11950		R	Therapy for contour defects	0.84	1.22	0.42	0.06	2.12	1.32	000
11951		R	Therapy for contour defects	1.19	1.61	0.52	0.10	2.90	1.81	000
11952		R	Therapy for contour defects	1.69	1.97	0.70	0.17	3.83	2.56	000
11954		R	Therapy for contour defects	1.85	2.59	0.93	0.19	4.63	2.97	000
11960		A	Insert tissue expander(s)	9.08	NA	10.94	0.88	NA	20.90	090
11970		A	Replace tissue expander	7.06	NA	4.98	0.77	NA	12.81	090
11971		A	Remove tissue expander(s)	2.13	6.33	3.86	0.21	8.67	6.20	090
11975		N	Insert contraceptive cap	+1.48	1.44	0.58	0.14	3.06	2.20	XXX
11976		R	Removal of contraceptive cap	1.78	1.62	0.70	0.17	3.57	2.65	000
11977		N	Removal/reinsert contra cap	+3.30	2.30	1.28	0.31	5.91	4.89	XXX
11980		A	Implant hormone pellet(s)	1.48	1.07	0.56	0.10	2.65	2.14	000
11981		A	Insert drug implant device	1.48	1.59	0.58	0.14	3.21	2.20	XXX
11982		A	Remove drug implant device	1.78	1.71	0.70	0.17	3.66	2.65	XXX
11983		A	Remove/insert drug implant	3.30	2.30	1.28	0.31	5.91	4.89	XXX
12001		A	Repair superficial wound(s)	1.70	2.16	0.44	0.13	3.99	2.27	010
12002		A	Repair superficial wound(s)	1.86	2.23	0.92	0.15	4.24	2.93	010
12004		A	Repair superficial wound(s)	2.24	2.51	1.03	0.17	4.92	3.44	010
12005		A	Repair superficial wound(s)	2.86	3.07	1.22	0.23	6.16	4.31	010
12006		A	Repair superficial wound(s)	3.67	3.69	1.53	0.31	7.67	5.51	010
12007		A	Repair superficial wound(s)	4.12	4.16	1.83	0.37	8.65	6.32	010
12011		A	Repair superficial wound(s)	1.76	2.34	0.44	0.14	4.24	2.34	010
12013		A	Repair superficial wound(s)	1.99	2.49	0.96	0.16	4.64	3.11	010
12014		A	Repair superficial wound(s)	2.46	2.77	1.08	0.18	5.41	3.72	010
12015		A	Repair superficial wound(s)	3.19	3.38	1.27	0.24	6.81	4.70	010
12016		A	Repair superficial wound(s)	3.93	3.81	1.55	0.32	8.06	5.80	010
12017		A	Repair superficial wound(s)	4.71	NA	1.90	0.39	NA	7.00	010
12018		A	Repair superficial wound(s)	5.53	NA	2.27	0.46	NA	8.26	010
12020		A	Closure of split wound	2.62	2.55	1.42	0.24	5.41	4.28	010
12021		A	Closure of split wound	1.84	1.70	1.02	0.19	3.73	3.05	010
12031		A	Layer closure of wound(s)	2.15	2.29	0.77	0.15	4.59	3.07	010
12032		A	Layer closure of wound(s)	2.47	2.98	1.28	0.15	5.60	3.90	010
12034		A	Layer closure of wound(s)	2.92	3.21	1.44	0.21	6.34	4.57	010
12035		A	Layer closure of wound(s)	3.43	3.15	1.67	0.30	6.88	5.40	010
12036		A	Layer closure of wound(s)	4.05	5.26	2.46	0.41	9.72	6.92	010
12037		A	Layer closure of wound(s)	4.67	5.62	2.80	0.49	10.78	7.96	010
12041		A	Layer closure of wound(s)	2.37	2.48	0.83	0.17	5.02	3.37	010
12042		A	Layer closure of wound(s)	2.74	3.17	1.41	0.17	6.08	4.32	010
12044		A	Layer closure of wound(s)	3.14	3.26	1.60	0.24	6.64	4.98	010
12045		A	Layer closure of wound(s)	3.64	3.58	1.87	0.34	7.56	5.85	010
12046		A	Layer closure of wound(s)	4.25	5.53	2.55	0.40	10.18	7.20	010
12047		A	Layer closure of wound(s)	4.65	6.15	2.89	0.41	11.21	7.95	010
12051		A	Layer closure of wound(s)	2.47	3.16	1.41	0.16	5.79	4.04	010
12052		A	Layer closure of wound(s)	2.77	3.12	1.38	0.17	6.06	4.32	010
12053		A	Layer closure of wound(s)	3.12	3.26	1.54	0.20	6.58	4.86	010
12054		A	Layer closure of wound(s)	3.46	3.60	1.64	0.25	7.31	5.35	010
12055		A	Layer closure of wound(s)	4.43	4.60	2.19	0.35	9.38	6.97	010
12056		A	Layer closure of wound(s)	5.24	6.62	3.05	0.43	12.29	8.72	010
12057		A	Layer closure of wound(s)	5.96	6.14	3.73	0.50	12.60	10.19	010
13100		A	Repair of wound or lesion	3.12	3.50	1.84	0.21	6.83	5.17	010
13101		A	Repair of wound or lesion	3.92	3.76	2.29	0.22	7.90	6.43	010
13102		A	Repair wound/lesion add-on	1.24	0.76	0.58	0.10	2.10	1.92	ZZZ
13120		A	Repair of wound or lesion	3.30	3.60	1.88	0.23	7.13	5.41	010
13121		A	Repair of wound or lesion	4.33	3.99	2.39	0.25	8.57	6.97	010
13122		A	Repair wound/lesion add-on	1.44	0.89	0.65	0.12	2.45	2.21	ZZZ
13131		A	Repair of wound or lesion	3.79	3.88	2.21	0.25	7.92	6.25	010
13132		A	Repair of wound or lesion	5.95	4.72	3.25	0.32	10.99	9.52	010
13133		A	Repair wound/lesion add-on	2.19	1.22	1.05	0.17	3.58	3.41	ZZZ
13150		A	Repair of wound or lesion	3.81	5.29	2.64	0.29	9.39	6.74	010
13151		A	Repair of wound or lesion	4.45	5.27	3.08	0.28	10.00	7.81	010
13152		A	Repair of wound or lesion	6.33	6.01	3.98	0.38	12.72	10.69	010
13153		A	Repair wound/lesion add-on	2.38	1.37	1.16	0.18	3.93	3.72	ZZZ
13160		A	Late closure of wound	10.48	NA	6.33	1.19	NA	18.00	090
14000		A	Skin tissue rearrangement	5.89	7.60	4.65	0.46	13.95	11.00	090
14001		A	Skin tissue rearrangement	8.47	8.94	5.96	0.65	18.06	15.08	090
14020		A	Skin tissue rearrangement	6.59	8.10	5.35	0.50	15.19	12.44	090
14021		A	Skin tissue rearrangement	10.06	9.53	7.12	0.69	20.28	17.87	090
14040		A	Skin tissue rearrangement	7.87	8.77	7.05	0.55	17.19	15.47	090
14041		A	Skin tissue rearrangement	11.49	11.01	8.91	0.71	23.21	21.11	090
14060		A	Skin tissue rearrangement	8.50	9.48	7.84	0.59	18.57	16.93	090
14061		A	Skin tissue rearrangement	12.29	12.05	9.77	0.75	25.09	22.81	090
14300		A	Skin tissue rearrangement	11.76	11.44	9.36	0.88	24.08	22.00	090
14350		A	Skin tissue rearrangement	9.61	NA	6.36	1.09	NA	17.06	090
15000		A	Skin graft	4.00	3.66	2.22	0.37	8.03	6.59	000
15001		A	Skin graft add-on	1.00	1.26	0.42	0.11	2.37	1.53	ZZZ
15050		A	Skin pinch graft	4.30	5.12	3.99	0.46	9.88	8.75	090
15100		A	Skin split graft	9.05	11.70	8.09	0.94	21.69	18.08	090
15101		A	Skin split graft add-on	1.72	3.27	1.48	0.18	5.17	3.38	ZZZ
15120		A	Skin split graft	9.83	10.23	8.03	0.90	20.96	18.76	090
15121		A	Skin split graft add-on	2.67	4.19	1.85	0.27	7.13	4.79	ZZZ
15200		A	Skin full graft	8.03	9.60	5.54	0.73	18.36	14.30	090
15201		A	Skin full graft add-on	1.32	1.05	0.64	0.14	2.51	2.10	ZZZ
15220		A	Skin full graft	7.87	9.74	6.18	0.68	18.29	14.73	090
15221		A	Skin full graft add-on	1.19	0.93	0.58	0.12	2.24	1.89	ZZZ
15240		A	Skin full graft	9.04	9.25	7.01	0.80	19.09	16.85	090
15241		A	Skin full graft add-on	1.86	1.47	0.94	0.17	3.50	2.97	ZZZ
15260		A	Skin full graft	10.06	9.91	8.90	0.63	20.60	19.59	090
15261		A	Skin full graft add-on	2.23	2.91	1.60	0.17	5.31	4.00	ZZZ
15342		A	Cultured skin graft, 25 cm	1.00	2.06	0.75	0.09	3.15	1.84	010
15343		A	Culture skn graft addl 25 cm	0.25	0.26	0.10	0.02	0.53	0.37	ZZZ
15350		A	Skin homograft	4.00	8.44	4.34	0.42	12.86	8.76	090
15351		A	Skin homograft add-on	1.00	0.95	0.41	0.11	2.06	1.52	ZZZ
15400		A	Skin heterograft	4.00	4.84	4.84	0.40	9.24	9.24	090
15401		A	Skin heterograft add-on	1.00	1.25	0.46	0.11	2.36	1.57	ZZZ
15570		A	Form skin pedicle flap	9.21	8.16	6.07	0.96	18.33	16.24	090
15572		A	Form skin pedicle flap	9.27	7.75	5.80	0.93	17.95	16.00	090
15574		A	Form skin pedicle flap	9.88	8.32	6.84	0.92	19.12	17.64	090
15576		A	Form skin pedicle flap	8.69	8.91	6.29	0.72	18.32	15.70	090
15600		A	Skin graft	1.91	6.13	2.34	0.19	8.23	4.44	090
15610		A	Skin graft	2.42	3.39	2.62	0.25	6.06	5.29	090
15620		A	Skin graft	2.94	6.74	3.39	0.28	9.96	6.61	090
15630		A	Skin graft	3.27	6.19	3.66	0.28	9.74	7.21	090
15650		A	Transfer skin pedicle flap	3.97	6.17	3.73	0.36	10.50	8.06	090
15732		A	Muscle-skin graft, head/neck	17.84	NA	12.70	1.50	NA	32.04	090
15734		A	Muscle-skin graft, trunk	17.79	NA	12.73	1.91	NA	32.43	090
15736		A	Muscle-skin graft, arm	16.27	NA	11.81	1.78	NA	29.86	090
15738		A	Muscle-skin graft, leg	17.92	NA	12.25	1.95	NA	32.12	090
15740		A	Island pedicle flap graft	10.25	9.00	7.05	0.62	19.87	17.92	090
15750		A	Neurovascular pedicle graft	11.41	NA	8.20	1.16	NA	20.77	090
15756		A	Free myo/skin flap microvasc	35.23	NA	20.85	3.11	NA	59.19	090
15757		A	Free skin flap, microvasc	35.23	NA	21.96	3.37	NA	60.56	090
15758		A	Free fascial flap, microvasc	35.10	NA	22.00	3.52	NA	60.62	090
15760		A	Composite skin graft	8.74	9.10	6.62	0.72	18.56	16.08	090
15770		A	Derma-fat-fascia graft	7.52	NA	6.08	0.78	NA	14.38	090
15775		R	Hair transplant punch grafts	3.96	2.87	1.35	0.43	7.26	5.74	000
15776		R	Hair transplant punch grafts	5.54	5.75	2.89	0.60	11.89	9.03	000
15780		A	Abrasion treatment of skin	7.29	6.61	6.58	0.41	14.31	14.28	090
15781		A	Abrasion treatment of skin	4.85	5.07	4.80	0.27	10.19	9.92	090
15782		A	Abrasion treatment of skin	4.32	4.30	4.15	0.21	8.83	8.68	090
15783		A	Abrasion treatment of skin	4.29	4.72	3.57	0.26	9.27	8.12	090
15786		A	Abrasion, lesion, single	2.03	1.77	1.29	0.11	3.91	3.43	010
15787		A	Abrasion, lesions, add-on	0.33	0.32	0.16	0.02	0.67	0.51	ZZZ
15788		R	Chemical peel, face, epiderm	2.09	3.14	1.03	0.11	5.34	3.23	090
15789		R	Chemical peel, face, dermal	4.92	6.17	3.51	0.27	11.36	8.70	090
15792		R	Chemical peel, nonfacial	1.86	2.96	2.17	0.10	4.92	4.13	090
15793		A	Chemical peel, nonfacial	3.74	NA	3.50	0.17	NA	7.41	090
15810		A	Salabrasion	4.74	3.73	3.73	0.42	8.89	8.89	090
15811		A	Salabrasion	5.39	6.09	4.73	0.52	12.00	10.64	090
15819		A	Plastic surgery, neck	9.38	NA	6.67	0.77	NA	16.82	090
15820		A	Revision of lower eyelid	5.15	7.12	5.25	0.30	12.57	10.70	090
15821		A	Revision of lower eyelid	5.72	7.47	5.41	0.31	13.50	11.44	090
15822		A	Revision of upper eyelid	4.45	6.06	4.23	0.22	10.73	8.90	090
15823		A	Revision of upper eyelid	7.05	8.06	6.13	0.32	15.43	13.50	090
15824		R	Removal of forehead wrinkles	0.00	0.00	0.00	0.00	0.00	0.00	000
15825		R	Removal of neck wrinkles	0.00	0.00	0.00	0.00	0.00	0.00	000
15826		R	Removal of brow wrinkles	0.00	0.00	0.00	0.00	0.00	0.00	000
15828		R	Removal of face wrinkles	0.00	0.00	0.00	0.00	0.00	0.00	000
15829		R	Removal of skin wrinkles	0.00	0.00	0.00	0.00	0.00	0.00	000
15831		A	Excise excessive skin tissue	12.40	NA	7.69	1.30	NA	21.39	090
15832		A	Excise excessive skin tissue	11.59	NA	7.68	1.21	NA	20.48	090
15833		A	Excise excessive skin tissue	10.64	NA	7.06	1.17	NA	18.87	090
15834		A	Excise excessive skin tissue	10.85	NA	6.95	1.18	NA	18.98	090
15835		A	Excise excessive skin tissue	11.67	NA	6.93	1.13	NA	19.73	090
15836		A	Excise excessive skin tissue	9.34	NA	6.18	0.95	NA	16.47	090
15837		A	Excise excessive skin tissue	8.43	7.40	6.42	0.78	16.61	15.63	090
15838		A	Excise excessive skin tissue	7.13	NA	5.68	0.58	NA	13.39	090
15839		A	Excise excessive skin tissue	9.38	7.21	5.75	0.88	17.47	16.01	090
15840		A	Graft for face nerve palsy	13.26	NA	9.75	1.15	NA	24.16	090
15841		A	Graft for face nerve palsy	23.26	NA	14.51	2.65	NA	40.42	090
15842		A	Flap for face nerve palsy	37.96	NA	22.78	3.99	NA	64.73	090
15845		A	Skin and muscle repair, face	12.57	NA	8.47	0.80	NA	21.84	090
15850		B	Removal of sutures	+0.78	1.44	0.30	0.04	2.26	1.12	XXX
15851		A	Removal of sutures	0.86	1.64	0.34	0.05	2.55	1.25	000
15852		A	Dressing change,not for burn	0.86	1.75	0.36	0.07	2.68	1.29	000
15860		A	Test for blood flow in graft	1.95	1.30	0.81	0.13	3.38	2.89	000
15876		R	Suction assisted lipectomy	0.00	0.00	0.00	0.00	0.00	0.00	000
15877		R	Suction assisted lipectomy	0.00	0.00	0.00	0.00	0.00	0.00	000
15878		R	Suction assisted lipectomy	0.00	0.00	0.00	0.00	0.00	0.00	000
15879		R	Suction assisted lipectomy	0.00	0.00	0.00	0.00	0.00	0.00	000
15920		A	Removal of tail bone ulcer	7.95	NA	5.49	0.83	NA	14.27	090
15922		A	Removal of tail bone ulcer	9.90	NA	7.31	1.06	NA	18.27	090
15931		A	Remove sacrum pressure sore	9.24	NA	5.56	0.95	NA	15.75	090
15933		A	Remove sacrum pressure sore	10.85	NA	7.98	1.14	NA	19.97	090
15934		A	Remove sacrum pressure sore	12.69	NA	8.29	1.35	NA	22.33	090
15935		A	Remove sacrum pressure sore	14.57	NA	9.96	1.56	NA	26.09	090
15936		A	Remove sacrum pressure sore	12.38	NA	8.79	1.32	NA	22.49	090
15937		A	Remove sacrum pressure sore	14.21	NA	10.25	1.51	NA	25.97	090
15940		A	Remove hip pressure sore	9.34	NA	5.92	0.98	NA	16.24	090
15941		A	Remove hip pressure sore	11.43	NA	9.80	1.23	NA	22.46	090
15944		A	Remove hip pressure sore	11.46	NA	8.59	1.21	NA	21.26	090
15945		A	Remove hip pressure sore	12.69	NA	9.51	1.38	NA	23.58	090
15946		A	Remove hip pressure sore	21.57	NA	13.95	2.32	NA	37.84	090
15950		A	Remove thigh pressure sore	7.54	NA	5.15	0.80	NA	13.49	090
15951		A	Remove thigh pressure sore	10.72	NA	7.99	1.14	NA	19.85	090
15952		A	Remove thigh pressure sore	11.39	NA	7.39	1.19	NA	19.97	090
15953		A	Remove thigh pressure sore	12.63	NA	8.79	1.38	NA	22.80	090
15956		A	Remove thigh pressure sore	15.52	NA	10.40	1.64	NA	27.56	090
15958		A	Remove thigh pressure sore	15.48	NA	10.72	1.66	NA	27.86	090
15999		C	Removal of pressure sore	0.00	0.00	0.00	0.00	0.00	0.00	YYY
16000		A	Initial treatment of burn(s)	0.89	1.07	0.27	0.06	2.02	1.22	000
16010		A	Treatment of burn(s)	0.87	1.19	0.36	0.07	2.13	1.30	000
16015		A	Treatment of burn(s)	2.35	1.89	0.94	0.22	4.46	3.51	000
16020		A	Treatment of burn(s)	0.80	1.13	0.26	0.06	1.99	1.12	000
16025		A	Treatment of burn(s)	1.85	1.88	0.67	0.16	3.89	2.68	000
16030		A	Treatment of burn(s)	2.08	3.05	0.91	0.18	5.31	3.17	000
16035		A	Incision of burn scab, initi	3.75	NA	1.50	0.36	NA	5.61	090
16036		A	Incise burn scab, addl incis	1.50	NA	0.62	0.11	NA	2.23	ZZZ
17000		A	Destroy benign/premlg lesion	0.60	1.04	0.27	0.03	1.67	0.90	010
17003		A	Destroy lesions, 2-14	0.15	0.12	0.07	0.01	0.28	0.23	ZZZ
17004		A	Destroy lesions, 15 or more	2.79	2.45	1.27	0.12	5.36	4.18	010
17106		A	Destruction of skin lesions	4.59	4.77	3.21	0.28	9.64	8.08	090
17107		A	Destruction of skin lesions	9.16	7.30	5.37	0.53	16.99	15.06	090
17108		A	Destruction of skin lesions	13.20	9.35	7.66	0.89	23.44	21.75	090
17110		A	Destruct lesion, 1-14	0.65	1.71	0.45	0.04	2.40	1.14	010
17111		A	Destruct lesion, 15 or more	0.92	1.75	0.56	0.04	2.71	1.52	010
17250		A	Chemical cautery, tissue	0.50	1.23	0.34	0.04	1.77	0.88	000
17260		A	Destruction of skin lesions	0.91	1.37	0.41	0.04	2.32	1.36	010
17261		A	Destruction of skin lesions	1.17	1.62	0.55	0.05	2.84	1.77	010
17262		A	Destruction of skin lesions	1.58	1.89	0.75	0.07	3.54	2.40	010
17263		A	Destruction of skin lesions	1.79	2.07	0.82	0.08	3.94	2.69	010
17264		A	Destruction of skin lesions	1.94	2.25	0.86	0.08	4.27	2.88	010
17266		A	Destruction of skin lesions	2.34	2.57	0.96	0.11	5.02	3.41	010
17270		A	Destruction of skin lesions	1.32	1.70	0.60	0.06	3.08	1.98	010
17271		A	Destruction of skin lesions	1.49	1.79	0.71	0.06	3.34	2.26	010
17272		A	Destruction of skin lesions	1.77	2.00	0.85	0.07	3.84	2.69	010
17273		A	Destruction of skin lesions	2.05	2.23	0.96	0.09	4.37	3.10	010
17274		A	Destruction of skin lesions	2.59	2.61	1.18	0.11	5.31	3.88	010
17276		A	Destruction of skin lesions	3.20	3.03	1.42	0.15	6.38	4.77	010
17280		A	Destruction of skin lesions	1.17	1.61	0.53	0.05	2.83	1.75	010
17281		A	Destruction of skin lesions	1.72	1.92	0.82	0.07	3.71	2.61	010
17282		A	Destruction of skin lesions	2.04	2.17	0.98	0.09	4.30	3.11	010
17283		A	Destruction of skin lesions	2.64	2.58	1.23	0.11	5.33	3.98	010
17284		A	Destruction of skin lesions	3.21	2.99	1.49	0.14	6.34	4.84	010
17286		A	Destruction of skin lesions	4.44	3.78	2.18	0.22	8.44	6.84	010
17304		A	1 stage mohs, up to 5 spec	7.60	8.09	3.66	0.31	16.00	11.57	000
17305		A	2 stage mohs, up to 5 spec	2.85	3.81	1.37	0.12	6.78	4.34	000
17306		A	3 stage mohs, up to 5 spec	2.85	3.81	1.38	0.12	6.78	4.35	000
17307		A	Mohs addl stage up to 5 spec	2.85	3.82	1.40	0.12	6.79	4.37	000
17310		A	Mohs any stage > 5 spec each	0.62	1.48	0.31	0.05	2.15	0.98	ZZZ
17340		A	Cryotherapy of skin	0.76	0.38	0.26	0.04	1.18	1.06	010
17360		A	Skin peel therapy	1.43	1.59	0.72	0.06	3.08	2.21	010
17380		R	Hair removal by electrolysis	0.00	0.00	0.00	0.00	0.00	0.00	000
17999		C	Skin tissue procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
19000		A	Drainage of breast lesion	0.84	1.20	0.29	0.07	2.11	1.20	000
19001		A	Drain breast lesion add-on	0.42	0.82	0.14	0.03	1.27	0.59	ZZZ
19020		A	Incision of breast lesion	3.57	6.81	3.39	0.35	10.73	7.31	090
19030		A	Injection for breast x-ray	1.53	3.56	0.52	0.07	5.16	2.12	000
19100		A	Bx breast percut w/o image	1.27	1.43	0.44	0.10	2.80	1.81	000
19101		A	Biopsy of breast, open	3.18	5.02	1.89	0.20	8.40	5.27	010
19102		A	Bx breast percut w/image	2.00	4.86	0.68	0.13	6.99	2.81	000
19103		A	Bx breast percut w/device	3.70	12.31	1.27	0.16	16.17	5.13	000
19110		A	Nipple exploration	4.30	8.62	4.43	0.44	13.36	9.17	090
19112		A	Excise breast duct fistula	3.67	9.15	3.08	0.38	13.20	7.13	090
19120		A	Removal of breast lesion	5.56	4.92	3.09	0.56	11.04	9.21	090
19125		A	Excision, breast lesion	6.06	5.05	3.26	0.61	11.72	9.93	090
19126		A	Excision, addl breast lesion	2.93	NA	1.02	0.30	NA	4.25	ZZZ
19140		A	Removal of breast tissue	5.14	9.35	3.65	0.52	15.01	9.31	090
19160		A	Removal of breast tissue	5.99	NA	4.52	0.61	NA	11.12	090
19162		A	Remove breast tissue, nodes	13.53	NA	7.88	1.38	NA	22.79	090
19180		A	Removal of breast	8.80	NA	5.93	0.88	NA	15.61	090
19182		A	Removal of breast	7.73	NA	4.98	0.79	NA	13.50	090
19200		A	Removal of breast	15.49	NA	9.07	1.51	NA	26.07	090
19220		A	Removal of breast	15.72	NA	9.12	1.56	NA	26.40	090
19240		A	Removal of breast	16.00	NA	8.74	1.62	NA	26.36	090
19260		A	Removal of chest wall lesion	15.44	NA	9.13	1.64	NA	26.21	090
19271		A	Revision of chest wall	18.90	NA	11.31	2.27	NA	32.48	090
19272		A	Extensive chest wall surgery	21.55	NA	12.24	2.54	NA	36.33	090
19290		A	Place needle wire, breast	1.27	2.89	0.43	0.06	4.22	1.76	000
19291		A	Place needle wire, breast	0.63	1.69	0.21	0.03	2.35	0.87	ZZZ
19295		A	Place breast clip, percut	0.00	2.65	NA	0.01	2.66	NA	ZZZ
19316		A	Suspension of breast	10.69	NA	7.57	1.15	NA	19.41	090
19318		A	Reduction of large breast	15.62	NA	11.72	1.69	NA	29.03	090
19324		A	Enlarge breast	5.85	NA	4.25	0.63	NA	10.73	090
19325		A	Enlarge breast with implant	8.45	NA	6.25	0.90	NA	15.60	090
19328		A	Removal of breast implant	5.68	NA	4.54	0.61	NA	10.83	090
19330		A	Removal of implant material	7.59	NA	5.20	0.81	NA	13.60	090
19340		A	Immediate breast prosthesis	6.33	NA	3.19	0.68	NA	10.20	ZZZ
19342		A	Delayed breast prosthesis	11.20	NA	7.83	1.21	NA	20.24	090
19350		A	Breast reconstruction	8.92	13.45	6.80	0.95	23.32	16.67	090
19355		A	Correct inverted nipple(s)	7.57	13.63	5.41	0.80	22.00	13.78	090
19357		A	Breast reconstruction	18.16	NA	9.82	1.96	NA	29.94	090
19361		A	Breast reconstruction	19.26	NA	10.27	2.08	NA	31.61	090
19364		A	Breast reconstruction	41.00	NA	25.22	3.91	NA	70.13	090
19366		A	Breast reconstruction	21.28	NA	10.27	2.27	NA	33.82	090
19367		A	Breast reconstruction	25.73	NA	17.47	2.78	NA	45.98	090
19368		A	Breast reconstruction	32.42	NA	21.08	3.51	NA	57.01	090
19369		A	Breast reconstruction	29.82	NA	20.65	3.24	NA	53.71	090
19370		A	Surgery of breast capsule	8.05	NA	6.08	0.86	NA	14.99	090
19371		A	Removal of breast capsule	9.35	NA	7.15	1.01	NA	17.51	090
19380		A	Revise breast reconstruction	9.14	NA	7.05	0.98	NA	17.17	090
19396		A	Design custom breast implant	2.17	6.25	1.02	0.23	8.65	3.42	000
19499		C	Breast surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
20000		A	Incision of abscess	2.12	2.16	1.18	0.17	4.45	3.47	010
20005		A	Incision of deep abscess	3.42	3.03	2.21	0.34	6.79	5.97	010
20100		A	Explore wound, neck	10.08	5.82	4.37	0.99	16.89	15.44	010
20101		A	Explore wound, chest	3.22	2.90	1.50	0.24	6.36	4.96	010
20102		A	Explore wound, abdomen	3.94	3.39	1.75	0.35	7.68	6.04	010
20103		A	Explore wound, extremity	5.30	4.26	3.02	0.57	10.13	8.89	010
20150		A	Excise epiphyseal bar	13.69	NA	8.96	0.96	NA	23.61	090
20200		A	Muscle biopsy	1.46	1.70	0.61	0.17	3.33	2.24	000
20205		A	Deep muscle biopsy	2.35	3.87	0.96	0.23	6.45	3.54	000
20206		A	Needle biopsy, muscle	0.99	3.15	0.35	0.06	4.20	1.40	000
20220		A	Bone biopsy, trocar/needle	1.27	4.87	2.93	0.06	6.20	4.26	000
20225		A	Bone biopsy, trocar/needle	1.87	4.37	3.02	0.11	6.35	5.00	000
20240		A	Bone biopsy, excisional	3.23	NA	4.22	0.33	NA	7.78	010
20245		A	Bone biopsy, excisional	7.78	NA	6.91	0.44	NA	15.13	010
20250		A	Open bone biopsy	5.03	NA	4.37	0.50	NA	9.90	010
20251		A	Open bone biopsy	5.56	NA	4.92	0.79	NA	11.27	010
20500		A	Injection of sinus tract	1.23	5.89	3.82	0.10	7.22	5.15	010
20501		A	Inject sinus tract for x-ray	0.76	3.14	0.26	0.03	3.93	1.05	000
20520		A	Removal of foreign body	1.85	5.60	3.59	0.17	7.62	5.61	010
20525		A	Removal of foreign body	3.50	6.84	4.38	0.40	10.74	8.28	010
20526		A	Ther injection, carp tunnel	0.94	0.77	0.41	0.06	1.77	1.41	000
20550		A	Inj tendon sheath/ligament	0.75	0.76	0.24	0.06	1.57	1.05	000
20551		A	Inject tendon origin/insert	0.75	0.70	0.34	0.06	1.51	1.15	000
20552		A	Inject trigger point, 1 or 2	0.66	0.66	0.30	0.06	1.38	1.02	000
20553		A	Inject trigger points, =/> 3	0.75	0.75	0.34	0.06	1.56	1.15	000
20600		A	Drain/inject, joint/bursa	0.66	0.66	0.36	0.06	1.38	1.08	000
20605		A	Drain/inject, joint/bursa	0.68	0.78	0.37	0.06	1.52	1.11	000
20610		A	Drain/inject, joint/bursa	0.79	0.97	0.42	0.08	1.84	1.29	000
20612		A	Aspirate/inj ganglion cyst	0.70	0.77	0.28	0.06	1.53	1.04	000
20615		A	Treatment of bone cyst	2.28	4.87	2.69	0.19	7.34	5.16	010
20650		A	Insert and remove bone pin	2.23	5.08	3.29	0.28	7.59	5.80	010
20660		A	Apply, rem fixation device	2.51	NA	2.28	0.48	NA	5.27	000
20661		A	Application of head brace	4.89	NA	6.91	0.92	NA	12.72	090
20662		A	Application of pelvis brace	6.07	NA	6.27	0.81	NA	13.15	090
20663		A	Application of thigh brace	5.43	NA	5.58	0.77	NA	11.78	090
20664		A	Halo brace application	8.06	NA	8.62	1.49	NA	18.17	090
20665		A	Removal of fixation device	1.31	2.14	1.30	0.17	3.62	2.78	010
20670		A	Removal of support implant	1.74	6.09	3.55	0.23	8.06	5.52	010
20680		A	Removal of support implant	3.35	5.37	5.37	0.46	9.18	9.18	090
20690		A	Apply bone fixation device	3.52	NA	1.82	0.47	NA	5.81	090
20692		A	Apply bone fixation device	6.41	NA	3.05	0.60	NA	10.06	090
20693		A	Adjust bone fixation device	5.86	NA	13.20	0.85	NA	19.91	090
20694		A	Remove bone fixation device	4.16	9.45	6.56	0.57	14.18	11.29	090
20802		A	Replantation, arm, complete	41.15	NA	27.57	5.81	NA	74.53	090
20805		A	Replant forearm, complete	50.00	NA	43.16	3.95	NA	97.11	090
20808		A	Replantation hand, complete	61.65	NA	49.60	6.49	NA	117.74	090
20816		A	Replantation digit, complete	30.94	NA	46.54	3.01	NA	80.49	090
20822		A	Replantation digit, complete	25.59	NA	42.54	3.07	NA	71.20	090
20824		A	Replantation thumb, complete	30.94	NA	45.41	3.48	NA	79.83	090
20827		A	Replantation thumb, complete	26.41	NA	45.08	3.21	NA	74.70	090
20838		A	Replantation foot, complete	41.41	NA	28.58	5.85	NA	75.84	090
20900		A	Removal of bone for graft	5.58	6.60	6.39	0.77	12.95	12.74	090
20902		A	Removal of bone for graft	7.55	NA	9.17	1.06	NA	17.78	090
20910		A	Remove cartilage for graft	5.34	8.85	6.69	0.50	14.69	12.53	090
20912		A	Remove cartilage for graft	6.35	NA	7.49	0.55	NA	14.39	090
20920		A	Removal of fascia for graft	5.31	NA	5.57	0.54	NA	11.42	090
20922		A	Removal of fascia for graft	6.61	8.97	6.40	0.88	16.46	13.89	090
20924		A	Removal of tendon for graft	6.48	NA	7.16	0.82	NA	14.46	090
20926		A	Removal of tissue for graft	5.53	NA	6.42	0.73	NA	12.68	090
20930		B	Spinal bone allograft	0.00	0.00	0.00	0.00	0.00	0.00	XXX
20931		A	Spinal bone allograft	1.81	NA	0.96	0.34	NA	3.11	ZZZ
20936		B	Spinal bone autograft	0.00	0.00	0.00	0.00	0.00	0.00	XXX
20937		A	Spinal bone autograft	2.79	NA	1.49	0.43	NA	4.71	ZZZ
20938		A	Spinal bone autograft	3.02	NA	1.59	0.52	NA	5.13	ZZZ
20950		A	Fluid pressure, muscle	1.26	NA	2.24	0.16	NA	3.66	000
20955		A	Fibula bone graft, microvasc	39.21	NA	29.76	4.35	NA	73.32	090
20956		A	Iliac bone graft, microvasc	39.27	NA	28.79	5.77	NA	73.83	090
20957		A	Mt bone graft, microvasc	40.65	NA	21.19	5.74	NA	67.58	090
20962		A	Other bone graft, microvasc	39.27	NA	28.28	5.19	NA	72.74	090
20969		A	Bone/skin graft, microvasc	43.92	NA	32.14	4.34	NA	80.40	090
20970		A	Bone/skin graft, iliac crest	43.06	NA	30.05	4.64	NA	77.75	090
20972		A	Bone/skin graft, metatarsal	42.99	NA	18.39	6.07	NA	67.45	090
20973		A	Bone/skin graft, great toe	45.76	NA	28.24	4.65	NA	78.65	090
20974		A	Electrical bone stimulation	0.62	0.42	0.33	0.09	1.13	1.04	000
20975		A	Electrical bone stimulation	2.60	NA	1.38	0.42	NA	4.40	000
20979		A	Us bone stimulation	0.62	0.73	0.35	0.04	1.39	1.01	000
20999		C	Musculoskeletal surgery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
21010		A	Incision of jaw joint	10.14	NA	7.16	0.54	NA	17.84	090
21015		A	Resection of facial tumor	5.29	NA	7.09	0.52	NA	12.90	090
21025		A	Excision of bone, lower jaw	10.06	7.35	6.87	0.79	18.20	17.72	090
21026		A	Excision of facial bone(s)	4.85	5.39	5.08	0.40	10.64	10.33	090
21029		A	Contour of face bone lesion	7.71	6.96	6.15	0.74	15.41	14.60	090
21030		A	Excise max/zygoma b9 tumor	3.89	4.36	3.64	0.60	8.85	8.13	090
21031		A	Remove exostosis, mandible	3.24	3.35	2.17	0.28	6.87	5.69	090
21032		A	Remove exostosis, maxilla	3.24	3.32	2.29	0.27	6.83	5.80	090
21034		A	Excise max/zygoma mlg tumor	16.17	10.67	10.64	1.37	28.21	28.18	090
21040		A	Excise mandible lesion	3.89	3.76	2.58	0.19	7.84	6.66	090
21041		D	Removal of jaw bone lesion	0.00	0.00	0.00	0.00	0.00	0.00	090
21044		A	Removal of jaw bone lesion	11.86	NA	7.96	0.87	NA	20.69	090
21045		A	Extensive jaw surgery	16.17	NA	10.29	1.20	NA	27.66	090
21046		A	Remove mandible cyst complex	13.00	NA	10.42	1.01	NA	24.43	090
21047		A	Excise lwr jaw cyst w/repair	18.75	NA	9.87	1.53	NA	30.15	090
21048		A	Remove maxilla cyst complex	13.50	NA	10.63	1.01	NA	25.14	090
21049		A	Excis uppr jaw cyst w/repair	18.00	NA	9.55	1.01	NA	28.56	090
21050		A	Removal of jaw joint	10.77	NA	11.63	0.84	NA	23.24	090
21060		A	Remove jaw joint cartilage	10.23	NA	10.09	1.16	NA	21.48	090
21070		A	Remove coronoid process	8.20	NA	5.98	0.67	NA	14.85	090
21076		A	Prepare face/oral prosthesis	13.42	9.49	7.13	1.36	24.27	21.91	010
21077		A	Prepare face/oral prosthesis	33.75	23.88	17.94	3.43	61.06	55.12	090
21079		A	Prepare face/oral prosthesis	22.34	16.88	12.41	1.59	40.81	36.34	090
21080		A	Prepare face/oral prosthesis	25.10	18.97	13.94	2.55	46.62	41.59	090
21081		A	Prepare face/oral prosthesis	22.88	17.28	12.71	1.87	42.03	37.46	090
21082		A	Prepare face/oral prosthesis	20.87	14.77	11.10	1.46	37.10	33.43	090
21083		A	Prepare face/oral prosthesis	19.30	14.58	10.72	1.96	35.84	31.98	090
21084		A	Prepare face/oral prosthesis	22.51	17.01	12.51	1.57	41.09	36.59	090
21085		A	Prepare face/oral prosthesis	9.00	6.37	4.79	0.65	16.02	14.44	010
21086		A	Prepare face/oral prosthesis	24.92	18.83	13.84	1.86	45.61	40.62	090
21087		A	Prepare face/oral prosthesis	24.92	17.63	13.24	2.22	44.77	40.38	090
21088		C	Prepare face/oral prosthesis	0.00	0.00	0.00	0.00	0.00	0.00	090
21089		C	Prepare face/oral prosthesis	0.00	0.00	0.00	0.00	0.00	0.00	090
21100		A	Maxillofacial fixation	4.22	5.93	4.05	0.18	10.33	8.45	090
21110		A	Interdental fixation	5.21	5.31	4.32	0.28	10.80	9.81	090
21116		A	Injection, jaw joint x-ray	0.81	7.71	0.29	0.05	8.57	1.15	000
21120		A	Reconstruction of chin	4.93	9.80	6.08	0.29	15.02	11.30	090
21121		A	Reconstruction of chin	7.64	7.94	6.21	0.56	16.14	14.41	090
21122		A	Reconstruction of chin	8.52	NA	7.63	0.59	NA	16.74	090
21123		A	Reconstruction of chin	11.16	NA	8.08	1.16	NA	20.40	090
21125		A	Augmentation, lower jaw bone	10.62	9.53	8.07	0.72	20.87	19.41	090
21127		A	Augmentation, lower jaw bone	11.12	9.80	7.50	0.76	21.68	19.38	090
21137		A	Reduction of forehead	9.82	NA	8.03	0.53	NA	18.38	090
21138		A	Reduction of forehead	12.19	NA	9.40	1.47	NA	23.06	090
21139		A	Reduction of forehead	14.61	NA	9.78	1.02	NA	25.41	090
21141		A	Reconstruct midface, lefort	18.10	NA	10.79	1.63	NA	30.52	090
21142		A	Reconstruct midface, lefort	18.81	NA	12.16	1.16	NA	32.13	090
21143		A	Reconstruct midface, lefort	19.58	NA	11.10	0.90	NA	31.58	090
21145		A	Reconstruct midface, lefort	19.94	NA	11.25	2.09	NA	33.28	090
21146		A	Reconstruct midface, lefort	20.71	NA	11.92	2.13	NA	34.76	090
21147		A	Reconstruct midface, lefort	21.77	NA	12.15	1.52	NA	35.44	090
21150		A	Reconstruct midface, lefort	25.24	NA	16.33	1.09	NA	42.66	090
21151		A	Reconstruct midface, lefort	28.30	NA	19.93	1.98	NA	50.21	090
21154		A	Reconstruct midface, lefort	30.52	NA	19.84	4.86	NA	55.22	090
21155		A	Reconstruct midface, lefort	34.45	NA	20.75	5.48	NA	60.68	090
21159		A	Reconstruct midface, lefort	42.38	NA	25.58	6.74	NA	74.70	090
21160		A	Reconstruct midface, lefort	46.44	NA	26.69	4.39	NA	77.52	090
21172		A	Reconstruct orbit/forehead	27.80	NA	15.82	1.91	NA	45.53	090
21175		A	Reconstruct orbit/forehead	33.17	NA	20.06	5.16	NA	58.39	090
21179		A	Reconstruct entire forehead	22.25	NA	17.84	2.48	NA	42.57	090
21180		A	Reconstruct entire forehead	25.19	NA	18.59	2.15	NA	45.93	090
21181		A	Contour cranial bone lesion	9.90	NA	8.34	0.97	NA	19.21	090
21182		A	Reconstruct cranial bone	32.19	NA	21.89	2.53	NA	56.61	090
21183		A	Reconstruct cranial bone	35.31	NA	23.87	2.75	NA	61.93	090
21184		A	Reconstruct cranial bone	38.24	NA	24.30	4.12	NA	66.66	090
21188		A	Reconstruction of midface	22.46	NA	15.62	1.85	NA	39.93	090
21193		A	Reconst lwr jaw w/o graft	17.15	NA	10.78	1.53	NA	29.46	090
21194		A	Reconst lwr jaw w/graft	19.84	NA	12.72	1.39	NA	33.95	090
21195		A	Reconst lwr jaw w/o fixation	17.24	NA	12.35	1.20	NA	30.79	090
21196		A	Reconst lwr jaw w/fixation	18.91	NA	12.91	1.62	NA	33.44	090
21198		A	Reconstr lwr jaw segment	14.16	NA	11.66	1.05	NA	26.87	090
21199		A	Reconstr lwr jaw w/advance	16.00	NA	9.29	1.26	NA	26.55	090
21206		A	Reconstruct upper jaw bone	14.10	NA	9.72	1.01	NA	24.83	090
21208		A	Augmentation of facial bones	10.23	9.69	8.36	0.92	20.84	19.51	090
21209		A	Reduction of facial bones	6.72	7.97	5.79	0.60	15.29	13.11	090
21210		A	Face bone graft	10.23	8.99	8.14	0.88	20.10	19.25	090
21215		A	Lower jaw bone graft	10.77	8.90	7.08	1.04	20.71	18.89	090
21230		A	Rib cartilage graft	10.77	NA	10.06	0.96	NA	21.79	090
21235		A	Ear cartilage graft	6.72	12.21	8.03	0.52	19.45	15.27	090
21240		A	Reconstruction of jaw joint	14.05	NA	11.30	1.15	NA	26.50	090
21242		A	Reconstruction of jaw joint	12.95	NA	11.07	1.40	NA	25.42	090
21243		A	Reconstruction of jaw joint	20.79	NA	13.76	1.85	NA	36.40	090
21244		A	Reconstruction of lower jaw	11.86	NA	9.17	0.95	NA	21.98	090
21245		A	Reconstruction of jaw	11.86	12.18	10.18	0.88	24.92	22.92	090
21246		A	Reconstruction of jaw	12.47	10.33	10.33	1.21	24.01	24.01	090
21247		A	Reconstruct lower jaw bone	22.63	NA	16.39	2.21	NA	41.23	090
21248		A	Reconstruction of jaw	11.48	8.99	7.76	1.01	21.48	20.25	090
21249		A	Reconstruction of jaw	17.52	11.51	10.20	1.39	30.42	29.11	090
21255		A	Reconstruct lower jaw bone	16.72	NA	11.44	1.13	NA	29.29	090
21256		A	Reconstruction of orbit	16.19	NA	13.27	1.04	NA	30.50	090
21260		A	Revise eye sockets	16.52	NA	10.71	1.25	NA	28.48	090
21261		A	Revise eye sockets	31.49	NA	20.59	2.20	NA	54.28	090
21263		A	Revise eye sockets	28.42	NA	12.98	2.16	NA	43.56	090
21267		A	Revise eye sockets	18.90	NA	14.48	1.35	NA	34.73	090
21268		A	Revise eye sockets	24.48	NA	16.12	0.79	NA	41.39	090
21270		A	Augmentation, cheek bone	10.23	9.54	9.54	0.73	20.50	20.50	090
21275		A	Revision, orbitofacial bones	11.24	NA	10.78	1.03	NA	23.05	090
21280		A	Revision of eyelid	6.03	NA	6.07	0.27	NA	12.37	090
21282		A	Revision of eyelid	3.49	NA	5.15	0.21	NA	8.85	090
21295		A	Revision of jaw muscle/bone	1.53	NA	4.35	0.13	NA	6.01	090
21296		A	Revision of jaw muscle/bone	4.25	NA	4.55	0.30	NA	9.10	090
21299		C	Cranio/maxillofacial surgery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
21300		A	Treatment of skull fracture	0.72	2.73	0.26	0.09	3.54	1.07	000
21310		A	Treatment of nose fracture	0.58	2.68	0.15	0.05	3.31	0.78	000
21315		A	Treatment of nose fracture	1.51	3.43	1.27	0.12	5.06	2.90	010
21320		A	Treatment of nose fracture	1.85	4.83	2.03	0.15	6.83	4.03	010
21325		A	Treatment of nose fracture	3.77	NA	3.67	0.31	NA	7.75	090
21330		A	Treatment of nose fracture	5.38	NA	5.51	0.48	NA	11.37	090
21335		A	Treatment of nose fracture	8.61	NA	7.16	0.64	NA	16.41	090
21336		A	Treat nasal septal fracture	5.72	NA	5.55	0.45	NA	11.72	090
21337		A	Treat nasal septal fracture	2.70	5.23	3.25	0.22	8.15	6.17	090
21338		A	Treat nasoethmoid fracture	6.46	NA	5.96	0.53	NA	12.95	090
21339		A	Treat nasoethmoid fracture	8.09	NA	6.70	0.76	NA	15.55	090
21340		A	Treatment of nose fracture	10.77	NA	9.09	0.85	NA	20.71	090
21343		A	Treatment of sinus fracture	12.95	NA	9.77	1.06	NA	23.78	090
21344		A	Treatment of sinus fracture	19.72	NA	13.44	1.72	NA	34.88	090
21345		A	Treat nose/jaw fracture	8.16	9.73	7.91	0.60	18.49	16.67	090
21346		A	Treat nose/jaw fracture	10.61	NA	10.05	0.85	NA	21.51	090
21347		A	Treat nose/jaw fracture	12.69	NA	9.50	1.14	NA	23.33	090
21348		A	Treat nose/jaw fracture	16.69	NA	10.93	1.50	NA	29.12	090
21355		A	Treat cheek bone fracture	3.77	4.40	2.28	0.29	8.46	6.34	010
21356		A	Treat cheek bone fracture	4.15	NA	3.23	0.36	NA	7.74	010
21360		A	Treat cheek bone fracture	6.46	NA	5.63	0.52	NA	12.61	090
21365		A	Treat cheek bone fracture	14.95	NA	11.31	1.30	NA	27.56	090
21366		A	Treat cheek bone fracture	17.77	NA	11.90	1.41	NA	31.08	090
21385		A	Treat eye socket fracture	9.16	NA	7.53	0.64	NA	17.33	090
21386		A	Treat eye socket fracture	9.16	NA	7.97	0.76	NA	17.89	090
21387		A	Treat eye socket fracture	9.70	NA	8.22	0.78	NA	18.70	090
21390		A	Treat eye socket fracture	10.13	NA	8.47	0.70	NA	19.30	090
21395		A	Treat eye socket fracture	12.68	NA	9.79	1.09	NA	23.56	090
21400		A	Treat eye socket fracture	1.40	3.12	1.05	0.12	4.64	2.57	090
21401		A	Treat eye socket fracture	3.26	4.83	3.11	0.34	8.43	6.71	090
21406		A	Treat eye socket fracture	7.01	NA	6.75	0.59	NA	14.35	090
21407		A	Treat eye socket fracture	8.61	NA	7.75	0.67	NA	17.03	090
21408		A	Treat eye socket fracture	12.38	NA	10.01	1.24	NA	23.63	090
21421		A	Treat mouth roof fracture	5.14	7.44	6.09	0.42	13.00	11.65	090
21422		A	Treat mouth roof fracture	8.32	NA	7.49	0.69	NA	16.50	090
21423		A	Treat mouth roof fracture	10.40	NA	8.02	0.95	NA	19.37	090
21431		A	Treat craniofacial fracture	7.05	NA	6.68	0.58	NA	14.31	090
21432		A	Treat craniofacial fracture	8.61	NA	7.74	0.55	NA	16.90	090
21433		A	Treat craniofacial fracture	25.35	NA	17.10	2.46	NA	44.91	090
21435		A	Treat craniofacial fracture	17.25	NA	12.56	1.66	NA	31.47	090
21436		A	Treat craniofacial fracture	28.04	NA	17.16	2.32	NA	47.52	090
21440		A	Treat dental ridge fracture	2.70	5.68	3.64	0.22	8.60	6.56	090
21445		A	Treat dental ridge fracture	5.38	7.04	5.17	0.55	12.97	11.10	090
21450		A	Treat lower jaw fracture	2.97	6.87	2.74	0.23	10.07	5.94	090
21451		A	Treat lower jaw fracture	4.87	6.63	5.65	0.39	11.89	10.91	090
21452		A	Treat lower jaw fracture	1.98	9.39	4.20	0.14	11.51	6.32	090
21453		A	Treat lower jaw fracture	5.54	7.52	6.40	0.49	13.55	12.43	090
21454		A	Treat lower jaw fracture	6.46	NA	5.78	0.55	NA	12.79	090
21461		A	Treat lower jaw fracture	8.09	9.26	7.94	0.73	18.08	16.76	090
21462		A	Treat lower jaw fracture	9.79	10.56	8.08	0.80	21.15	18.67	090
21465		A	Treat lower jaw fracture	11.91	NA	7.87	0.84	NA	20.62	090
21470		A	Treat lower jaw fracture	15.34	NA	9.93	1.36	NA	26.63	090
21480		A	Reset dislocated jaw	0.61	1.58	0.18	0.05	2.24	0.84	000
21485		A	Reset dislocated jaw	3.99	3.85	3.39	0.31	8.15	7.69	090
21490		A	Repair dislocated jaw	11.86	NA	7.57	1.31	NA	20.74	090
21493		A	Treat hyoid bone fracture	1.27	NA	3.38	0.10	NA	4.75	090
21494		A	Treat hyoid bone fracture	6.28	NA	5.06	0.44	NA	11.78	090
21495		A	Treat hyoid bone fracture	5.69	NA	5.00	0.41	NA	11.10	090
21497		A	Interdental wiring	3.86	4.75	3.97	0.31	8.92	8.14	090
21499		C	Head surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
21501		A	Drain neck/chest lesion	3.81	4.39	3.59	0.36	8.56	7.76	090
21502		A	Drain chest lesion	7.12	NA	7.44	0.79	NA	15.35	090
21510		A	Drainage of bone lesion	5.74	NA	7.16	0.67	NA	13.57	090
21550		A	Biopsy of neck/chest	2.06	2.33	1.22	0.13	4.52	3.41	010
21555		A	Remove lesion, neck/chest	4.35	4.26	2.44	0.41	9.02	7.20	090
21556		A	Remove lesion, neck/chest	5.57	NA	3.21	0.51	NA	9.29	090
21557		A	Remove tumor, neck/chest	8.88	NA	7.68	0.85	NA	17.41	090
21600		A	Partial removal of rib	6.89	NA	7.57	0.81	NA	15.27	090
21610		A	Partial removal of rib	14.61	NA	11.24	1.85	NA	27.70	090
21615		A	Removal of rib	9.87	NA	8.07	1.20	NA	19.14	090
21616		A	Removal of rib and nerves	12.04	NA	9.27	1.31	NA	22.62	090
21620		A	Partial removal of sternum	6.79	NA	8.04	0.77	NA	15.60	090
21627		A	Sternal debridement	6.81	NA	12.58	0.82	NA	20.21	090
21630		A	Extensive sternum surgery	17.38	NA	13.52	1.95	NA	32.85	090
21632		A	Extensive sternum surgery	18.14	NA	12.17	2.16	NA	32.47	090
21700		A	Revision of neck muscle	6.19	9.22	7.25	0.31	15.72	13.75	090
21705		A	Revision of neck muscle/rib	9.60	NA	7.62	0.92	NA	18.14	090
21720		A	Revision of neck muscle	5.68	7.95	7.01	0.80	14.43	13.49	090
21725		A	Revision of neck muscle	6.99	NA	7.45	0.90	NA	15.34	090
21740		A	Reconstruction of sternum	16.50	NA	12.48	2.03	NA	31.01	090
21742		C	Repair stern/nuss w/o scope	0.00	0.00	0.00	0.00	0.00	0.00	090
21743		C	Repair sternum/nuss w/scope	0.00	0.00	0.00	0.00	0.00	0.00	090
21750		A	Repair of sternum separation	10.77	NA	9.85	1.35	NA	21.97	090
21800		A	Treatment of rib fracture	0.96	2.38	1.08	0.09	3.43	2.13	090
21805		A	Treatment of rib fracture	2.75	NA	4.71	0.29	NA	7.75	090
21810		A	Treatment of rib fracture(s)	6.86	NA	7.06	0.60	NA	14.52	090
21820		A	Treat sternum fracture	1.28	2.92	1.56	0.15	4.35	2.99	090
21825		A	Treat sternum fracture	7.41	NA	10.26	0.84	NA	18.51	090
21899		C	Neck/chest surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
21920		A	Biopsy soft tissue of back	2.06	2.45	0.75	0.12	4.63	2.93	010
21925		A	Biopsy soft tissue of back	4.49	11.93	4.68	0.44	16.86	9.61	090
21930		A	Remove lesion, back or flank	5.00	4.60	2.62	0.49	10.09	8.11	090
21935		A	Remove tumor, back	17.96	NA	13.01	1.87	NA	32.84	090
22100		A	Remove part of neck vertebra	9.73	NA	8.38	1.55	NA	19.66	090
22101		A	Remove part, thorax vertebra	9.81	NA	8.57	1.51	NA	19.89	090
22102		A	Remove part, lumbar vertebra	9.81	NA	8.77	1.46	NA	20.04	090
22103		A	Remove extra spine segment	2.34	NA	1.24	0.37	NA	3.95	ZZZ
22110		A	Remove part of neck vertebra	12.74	NA	10.66	2.20	NA	25.60	090
22112		A	Remove part, thorax vertebra	12.81	NA	10.54	1.96	NA	25.31	090
22114		A	Remove part, lumbar vertebra	12.81	NA	10.45	1.98	NA	25.24	090
22116		A	Remove extra spine segment	2.32	NA	1.19	0.40	NA	3.91	ZZZ
22210		A	Revision of neck spine	23.82	NA	17.10	4.23	NA	45.15	090
22212		A	Revision of thorax spine	19.42	NA	14.61	2.78	NA	36.81	090
22214		A	Revision of lumbar spine	19.45	NA	15.09	2.78	NA	37.32	090
22216		A	Revise, extra spine segment	6.04	NA	3.21	0.98	NA	10.23	ZZZ
22220		A	Revision of neck spine	21.37	NA	15.50	3.65	NA	40.52	090
22222		A	Revision of thorax spine	21.52	NA	13.08	3.08	NA	37.68	090
22224		A	Revision of lumbar spine	21.52	NA	15.72	3.20	NA	40.44	090
22226		A	Revise, extra spine segment	6.04	NA	3.17	1.01	NA	10.22	ZZZ
22305		A	Treat spine process fracture	2.05	3.40	2.82	0.29	5.74	5.16	090
22310		A	Treat spine fracture	2.61	5.04	4.44	0.37	8.02	7.42	090
22315		A	Treat spine fracture	8.84	NA	8.64	1.37	NA	18.85	090
22318		A	Treat odontoid fx w/o graft	21.50	NA	14.63	4.26	NA	40.39	090
22319		A	Treat odontoid fx w/graft	24.00	NA	17.14	4.76	NA	45.90	090
22325		A	Treat spine fracture	18.30	NA	13.88	2.61	NA	34.79	090
22326		A	Treat neck spine fracture	19.59	NA	15.00	3.54	NA	38.13	090
22327		A	Treat thorax spine fracture	19.20	NA	14.24	2.75	NA	36.19	090
22328		A	Treat each add spine fx	4.61	NA	2.33	0.66	NA	7.60	ZZZ
22505		A	Manipulation of spine	1.87	4.80	3.19	0.27	6.94	5.33	010
22520		A	Percut vertebroplasty thor	8.91	NA	3.98	0.99	NA	13.88	010
22521		A	Percut vertebroplasty lumb	8.34	NA	3.81	0.93	NA	13.08	010
22522		A	Percut vertebroplasty addl	4.31	NA	1.73	0.33	NA	6.37	ZZZ
22548		A	Neck spine fusion	25.82	NA	16.22	4.98	NA	47.02	090
22554		A	Neck spine fusion	18.62	NA	12.63	3.51	NA	34.76	090
22556		A	Thorax spine fusion	23.46	NA	14.89	3.78	NA	42.13	090
22558		A	Lumbar spine fusion	22.28	NA	13.40	3.18	NA	38.86	090
22585		A	Additional spinal fusion	5.53	NA	2.87	0.98	NA	9.38	ZZZ
22590		A	Spine & skull spinal fusion	20.51	NA	13.62	3.81	NA	37.94	090
22595		A	Neck spinal fusion	19.39	NA	13.12	3.62	NA	36.13	090
22600		A	Neck spine fusion	16.14	NA	11.40	2.89	NA	30.43	090
22610		A	Thorax spine fusion	16.02	NA	11.56	2.66	NA	30.24	090
22612		A	Lumbar spine fusion	21.00	NA	14.36	3.28	NA	38.64	090
22614		A	Spine fusion, extra segment	6.44	NA	3.44	1.04	NA	10.92	ZZZ
22630		A	Lumbar spine fusion	20.84	NA	14.01	3.79	NA	38.64	090
22632		A	Spine fusion, extra segment	5.23	NA	2.74	0.90	NA	8.87	ZZZ
22800		A	Fusion of spine	18.25	NA	13.02	2.71	NA	33.98	090
22802		A	Fusion of spine	30.88	NA	19.99	4.42	NA	55.29	090
22804		A	Fusion of spine	36.27	NA	23.15	5.23	NA	64.65	090
22808		A	Fusion of spine	26.27	NA	16.72	4.36	NA	47.35	090
22810		A	Fusion of spine	30.27	NA	18.75	4.49	NA	53.51	090
22812		A	Fusion of spine	32.70	NA	20.27	4.67	NA	57.64	090
22818		A	Kyphectomy, 1-2 segments	31.83	NA	19.49	5.01	NA	56.33	090
22819		A	Kyphectomy, 3 or more	36.44	NA	20.58	5.20	NA	62.22	090
22830		A	Exploration of spinal fusion	10.85	NA	8.32	1.73	NA	20.90	090
22840		A	Insert spine fixation device	12.54	NA	6.67	2.03	NA	21.24	ZZZ
22841		B	Insert spine fixation device	0.00	0.00	0.00	0.00	0.00	0.00	XXX
22842		A	Insert spine fixation device	12.58	NA	6.69	2.04	NA	21.31	ZZZ
22843		A	Insert spine fixation device	13.46	NA	6.78	2.10	NA	22.34	ZZZ
22844		A	Insert spine fixation device	16.44	NA	8.99	2.42	NA	27.85	ZZZ
22845		A	Insert spine fixation device	11.96	NA	6.24	2.22	NA	20.42	ZZZ
22846		A	Insert spine fixation device	12.42	NA	6.51	2.26	NA	21.19	ZZZ
22847		A	Insert spine fixation device	13.80	NA	7.21	2.36	NA	23.37	ZZZ
22848		A	Insert pelv fixation device	6.00	NA	3.27	0.88	NA	10.15	ZZZ
22849		A	Reinsert spinal fixation	18.51	NA	13.75	2.87	NA	35.13	090
22850		A	Remove spine fixation device	9.52	NA	8.50	1.51	NA	19.53	090
22851		A	Apply spine prosth device	6.71	NA	3.45	1.11	NA	11.27	ZZZ
22852		A	Remove spine fixation device	9.01	NA	8.26	1.40	NA	18.67	090
22855		A	Remove spine fixation device	15.13	NA	11.24	2.74	NA	29.11	090
22899		C	Spine surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
22900		A	Remove abdominal wall lesion	5.80	NA	4.29	0.58	NA	10.67	090
22999		C	Abdomen surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
23000		A	Removal of calcium deposits	4.36	8.97	7.38	0.50	13.83	12.24	090
23020		A	Release shoulder joint	8.93	NA	10.95	1.23	NA	21.11	090
23030		A	Drain shoulder lesion	3.43	6.24	4.54	0.42	10.09	8.39	010
23031		A	Drain shoulder bursa	2.74	6.00	4.34	0.33	9.07	7.41	010
23035		A	Drain shoulder bone lesion	8.61	NA	15.81	1.19	NA	25.61	090
23040		A	Exploratory shoulder surgery	9.20	NA	12.15	1.28	NA	22.63	090
23044		A	Exploratory shoulder surgery	7.12	NA	11.01	0.97	NA	19.10	090
23065		A	Biopsy shoulder tissues	2.27	2.71	1.33	0.14	5.12	3.74	010
23066		A	Biopsy shoulder tissues	4.16	7.96	6.49	0.50	12.62	11.15	090
23075		A	Removal of shoulder lesion	2.39	5.36	3.21	0.25	8.00	5.85	010
23076		A	Removal of shoulder lesion	7.63	NA	8.42	0.87	NA	16.92	090
23077		A	Remove tumor of shoulder	16.09	NA	14.26	1.81	NA	32.16	090
23100		A	Biopsy of shoulder joint	6.03	NA	9.13	0.81	NA	15.97	090
23101		A	Shoulder joint surgery	5.58	NA	9.14	0.77	NA	15.49	090
23105		A	Remove shoulder joint lining	8.23	NA	10.55	1.13	NA	19.91	090
23106		A	Incision of collarbone joint	5.96	NA	9.25	0.82	NA	16.03	090
23107		A	Explore treat shoulder joint	8.62	NA	10.74	1.19	NA	20.55	090
23120		A	Partial removal, collar bone	7.11	NA	9.97	0.99	NA	18.07	090
23125		A	Removal of collar bone	9.39	NA	11.08	1.27	NA	21.74	090
23130		A	Remove shoulder bone, part	7.55	NA	10.20	1.06	NA	18.81	090
23140		A	Removal of bone lesion	6.89	NA	8.64	0.82	NA	16.35	090
23145		A	Removal of bone lesion	9.09	NA	12.05	1.24	NA	22.38	090
23146		A	Removal of bone lesion	7.83	NA	11.37	1.11	NA	20.31	090
23150		A	Removal of humerus lesion	8.48	NA	10.37	1.14	NA	19.99	090
23155		A	Removal of humerus lesion	10.35	NA	12.62	1.20	NA	24.17	090
23156		A	Removal of humerus lesion	8.68	NA	10.74	1.18	NA	20.60	090
23170		A	Remove collar bone lesion	6.86	NA	11.17	0.84	NA	18.87	090
23172		A	Remove shoulder blade lesion	6.90	NA	10.70	0.95	NA	18.55	090
23174		A	Remove humerus lesion	9.51	NA	12.19	1.30	NA	23.00	090
23180		A	Remove collar bone lesion	8.53	NA	16.82	1.18	NA	26.53	090
23182		A	Remove shoulder blade lesion	8.15	NA	16.90	1.08	NA	26.13	090
23184		A	Remove humerus lesion	9.38	NA	17.08	1.24	NA	27.70	090
23190		A	Partial removal of scapula	7.24	NA	8.72	0.97	NA	16.93	090
23195		A	Removal of head of humerus	9.81	NA	11.11	1.38	NA	22.30	090
23200		A	Removal of collar bone	12.08	NA	14.52	1.48	NA	28.08	090
23210		A	Removal of shoulder blade	12.49	NA	14.47	1.61	NA	28.57	090
23220		A	Partial removal of humerus	14.56	NA	15.73	2.03	NA	32.32	090
23221		A	Partial removal of humerus	17.74	NA	17.13	2.51	NA	37.38	090
23222		A	Partial removal of humerus	23.92	NA	21.02	3.37	NA	48.31	090
23330		A	Remove shoulder foreign body	1.85	5.75	3.77	0.18	7.78	5.80	010
23331		A	Remove shoulder foreign body	7.38	NA	10.06	1.02	NA	18.46	090
23332		A	Remove shoulder foreign body	11.62	NA	12.40	1.62	NA	25.64	090
23350		A	Injection for shoulder x-ray	1.00	7.30	0.34	0.05	8.35	1.39	000
23395		A	Muscle transfer,shoulder/arm	16.85	NA	14.27	2.29	NA	33.41	090
23397		A	Muscle transfers	16.13	NA	14.61	2.24	NA	32.98	090
23400		A	Fixation of shoulder blade	13.54	NA	14.58	1.91	NA	30.03	090
23405		A	Incision of tendon & muscle	8.37	NA	9.69	1.12	NA	19.18	090
23406		A	Incise tendon(s) & muscle(s)	10.79	NA	11.89	1.48	NA	24.16	090
23410		A	Repair rotator cuff, acute	12.45	NA	12.81	1.72	NA	26.98	090
23412		A	Repair rotator cuff, chronic	13.31	NA	13.32	1.86	NA	28.49	090
23415		A	Release of shoulder ligament	9.97	NA	10.45	1.39	NA	21.81	090
23420		A	Repair of shoulder	13.30	NA	14.31	1.86	NA	29.47	090
23430		A	Repair biceps tendon	9.98	NA	11.50	1.40	NA	22.88	090
23440		A	Remove/transplant tendon	10.48	NA	11.82	1.47	NA	23.77	090
23450		A	Repair shoulder capsule	13.40	NA	13.30	1.86	NA	28.56	090
23455		A	Repair shoulder capsule	14.37	NA	13.88	2.01	NA	30.26	090
23460		A	Repair shoulder capsule	15.37	NA	14.46	2.17	NA	32.00	090
23462		A	Repair shoulder capsule	15.30	NA	14.13	2.16	NA	31.59	090
23465		A	Repair shoulder capsule	15.85	NA	14.31	1.61	NA	31.77	090
23466		A	Repair shoulder capsule	14.22	NA	13.84	2.00	NA	30.06	090
23470		A	Reconstruct shoulder joint	17.15	NA	12.42	2.40	NA	31.97	090
23472		A	Reconstruct shoulder joint	21.10	NA	14.64	2.37	NA	38.11	090
23480		A	Revision of collar bone	11.18	NA	12.16	1.56	NA	24.90	090
23485		A	Revision of collar bone	13.43	NA	13.35	1.84	NA	28.62	090
23490		A	Reinforce clavicle	11.86	NA	12.24	1.11	NA	25.21	090
23491		A	Reinforce shoulder bones	14.21	NA	13.76	2.00	NA	29.97	090
23500		A	Treat clavicle fracture	2.08	4.08	2.60	0.26	6.42	4.94	090
23505		A	Treat clavicle fracture	3.69	6.20	4.12	0.50	10.39	8.31	090
23515		A	Treat clavicle fracture	7.41	NA	8.43	1.03	NA	16.87	090
23520		A	Treat clavicle dislocation	2.16	4.12	2.68	0.26	6.54	5.10	090
23525		A	Treat clavicle dislocation	3.60	6.00	3.98	0.44	10.04	8.02	090
23530		A	Treat clavicle dislocation	7.31	NA	8.20	0.85	NA	16.36	090
23532		A	Treat clavicle dislocation	8.01	NA	8.60	1.13	NA	17.74	090
23540		A	Treat clavicle dislocation	2.23	4.68	2.57	0.24	7.15	5.04	090
23545		A	Treat clavicle dislocation	3.25	5.26	3.69	0.39	8.90	7.33	090
23550		A	Treat clavicle dislocation	7.24	NA	8.37	0.94	NA	16.55	090
23552		A	Treat clavicle dislocation	8.45	NA	9.03	1.18	NA	18.66	090
23570		A	Treat shoulder blade fx	2.23	4.06	2.77	0.29	6.58	5.29	090
23575		A	Treat shoulder blade fx	4.06	6.41	4.37	0.53	11.00	8.96	090
23585		A	Treat scapula fracture	8.96	NA	9.58	1.25	NA	19.79	090
23600		A	Treat humerus fracture	2.93	5.91	3.74	0.39	9.23	7.06	090
23605		A	Treat humerus fracture	4.87	8.79	6.83	0.67	14.33	12.37	090
23615		A	Treat humerus fracture	9.35	NA	10.47	1.31	NA	21.13	090
23616		A	Treat humerus fracture	21.27	NA	16.24	2.98	NA	40.49	090
23620		A	Treat humerus fracture	2.40	5.62	3.47	0.32	8.34	6.19	090
23625		A	Treat humerus fracture	3.93	7.75	5.75	0.53	12.21	10.21	090
23630		A	Treat humerus fracture	7.35	NA	8.44	1.03	NA	16.82	090
23650		A	Treat shoulder dislocation	3.39	5.74	3.58	0.31	9.44	7.28	090
23655		A	Treat shoulder dislocation	4.57	NA	4.38	0.52	NA	9.47	090
23660		A	Treat shoulder dislocation	7.49	NA	8.24	1.01	NA	16.74	090
23665		A	Treat dislocation/fracture	4.47	7.93	5.99	0.60	13.00	11.06	090
23670		A	Treat dislocation/fracture	7.90	NA	8.93	1.10	NA	17.93	090
23675		A	Treat dislocation/fracture	6.05	8.66	6.87	0.83	15.54	13.75	090
23680		A	Treat dislocation/fracture	10.06	NA	10.06	1.39	NA	21.51	090
23700		A	Fixation of shoulder	2.52	NA	3.65	0.35	NA	6.52	010
23800		A	Fusion of shoulder joint	14.16	NA	14.66	1.97	NA	30.79	090
23802		A	Fusion of shoulder joint	16.60	NA	13.91	2.34	NA	32.85	090
23900		A	Amputation of arm & girdle	19.72	NA	15.69	2.47	NA	37.88	090
23920		A	Amputation at shoulder joint	14.61	NA	14.02	1.92	NA	30.55	090
23921		A	Amputation follow-up surgery	5.49	NA	6.90	0.78	NA	13.17	090
23929		C	Shoulder surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
23930		A	Drainage of arm lesion	2.94	6.19	4.05	0.32	9.45	7.31	010
23931		A	Drainage of arm bursa	1.79	5.97	3.88	0.21	7.97	5.88	010
23935		A	Drain arm/elbow bone lesion	6.09	NA	13.61	0.84	NA	20.54	090
24000		A	Exploratory elbow surgery	5.82	NA	6.17	0.77	NA	12.76	090
24006		A	Release elbow joint	9.31	NA	8.70	1.27	NA	19.28	090
24065		A	Biopsy arm/elbow soft tissue	2.08	5.87	3.35	0.14	8.09	5.57	010
24066		A	Biopsy arm/elbow soft tissue	5.21	8.94	6.82	0.61	14.76	12.64	090
24075		A	Remove arm/elbow lesion	3.92	8.20	6.14	0.43	12.55	10.49	090
24076		A	Remove arm/elbow lesion	6.30	NA	7.34	0.70	NA	14.34	090
24077		A	Remove tumor of arm/elbow	11.76	NA	13.78	1.32	NA	26.86	090
24100		A	Biopsy elbow joint lining	4.93	NA	5.79	0.62	NA	11.34	090
24101		A	Explore/treat elbow joint	6.13	NA	6.96	0.84	NA	13.93	090
24102		A	Remove elbow joint lining	8.03	NA	7.95	1.09	NA	17.07	090
24105		A	Removal of elbow bursa	3.61	NA	5.38	0.49	NA	9.48	090
24110		A	Remove humerus lesion	7.39	NA	10.13	0.99	NA	18.51	090
24115		A	Remove/graft bone lesion	9.63	NA	10.52	1.15	NA	21.30	090
24116		A	Remove/graft bone lesion	11.81	NA	12.57	1.66	NA	26.04	090
24120		A	Remove elbow lesion	6.65	NA	6.95	0.87	NA	14.47	090
24125		A	Remove/graft bone lesion	7.89	NA	7.28	0.88	NA	16.05	090
24126		A	Remove/graft bone lesion	8.31	NA	8.03	0.90	NA	17.24	090
24130		A	Removal of head of radius	6.25	NA	7.05	0.87	NA	14.17	090
24134		A	Removal of arm bone lesion	9.73	NA	16.46	1.31	NA	27.50	090
24136		A	Remove radius bone lesion	7.99	NA	6.55	0.85	NA	15.39	090
24138		A	Remove elbow bone lesion	8.05	NA	8.03	1.12	NA	17.20	090
24140		A	Partial removal of arm bone	9.18	NA	17.56	1.23	NA	27.97	090
24145		A	Partial removal of radius	7.58	NA	11.64	1.01	NA	20.23	090
24147		A	Partial removal of elbow	7.54	NA	11.64	1.04	NA	20.22	090
24149		A	Radical resection of elbow	14.20	NA	11.19	1.90	NA	27.29	090
24150		A	Extensive humerus surgery	13.27	NA	15.23	1.81	NA	30.31	090
24151		A	Extensive humerus surgery	15.58	NA	16.96	2.19	NA	34.73	090
24152		A	Extensive radius surgery	10.06	NA	9.83	1.19	NA	21.08	090
24153		A	Extensive radius surgery	11.54	NA	7.06	0.64	NA	19.24	090
24155		A	Removal of elbow joint	11.73	NA	9.42	1.42	NA	22.57	090
24160		A	Remove elbow joint implant	7.83	NA	6.95	1.07	NA	15.85	090
24164		A	Remove radius head implant	6.23	NA	5.95	0.84	NA	13.02	090
24200		A	Removal of arm foreign body	1.76	5.73	3.35	0.15	7.64	5.26	010
24201		A	Removal of arm foreign body	4.56	8.91	7.06	0.56	14.03	12.18	090
24220		A	Injection for elbow x-ray	1.31	11.02	0.46	0.07	12.40	1.84	000
24300		A	Manipulate elbow w/anesth	3.75	NA	5.53	0.49	NA	9.77	090
24301		A	Muscle/tendon transfer	10.20	NA	9.22	1.30	NA	20.72	090
24305		A	Arm tendon lengthening	7.45	NA	7.79	0.98	NA	16.22	090
24310		A	Revision of arm tendon	5.98	NA	8.53	0.74	NA	15.25	090
24320		A	Repair of arm tendon	10.56	NA	11.05	1.00	NA	22.61	090
24330		A	Revision of arm muscles	9.60	NA	8.87	1.21	NA	19.68	090
24331		A	Revision of arm muscles	10.65	NA	9.48	1.41	NA	21.54	090
24332		A	Tenolysis, triceps	7.45	NA	5.21	0.77	NA	13.43	090
24340		A	Repair of biceps tendon	7.89	NA	7.86	1.08	NA	16.83	090
24341		A	Repair arm tendon/muscle	7.90	NA	7.86	1.08	NA	16.84	090
24342		A	Repair of ruptured tendon	10.62	NA	9.44	1.48	NA	21.54	090
24343		A	Repr elbow lat ligmnt w/tiss	8.65	NA	7.89	1.13	NA	17.67	090
24344		A	Reconstruct elbow lat ligmnt	14.00	NA	11.18	1.83	NA	27.01	090
24345		A	Repr elbw med ligmnt w/tissu	8.65	NA	7.89	1.13	NA	17.67	090
24346		A	Reconstruct elbow med ligmnt	14.00	NA	11.18	1.83	NA	27.01	090
24350		A	Repair of tennis elbow	5.25	NA	6.44	0.72	NA	12.41	090
24351		A	Repair of tennis elbow	5.91	NA	6.93	0.82	NA	13.66	090
24352		A	Repair of tennis elbow	6.43	NA	7.19	0.90	NA	14.52	090
24354		A	Repair of tennis elbow	6.48	NA	7.15	0.88	NA	14.51	090
24356		A	Revision of tennis elbow	6.68	NA	7.33	0.90	NA	14.91	090
24360		A	Reconstruct elbow joint	12.34	NA	9.65	1.69	NA	23.68	090
24361		A	Reconstruct elbow joint	14.08	NA	10.64	1.95	NA	26.67	090
24362		A	Reconstruct elbow joint	14.99	NA	12.41	1.92	NA	29.32	090
24363		A	Replace elbow joint	18.49	NA	11.53	2.52	NA	32.54	090
24365		A	Reconstruct head of radius	8.39	NA	7.31	1.11	NA	16.81	090
24366		A	Reconstruct head of radius	9.13	NA	7.69	1.28	NA	18.10	090
24400		A	Revision of humerus	11.06	NA	12.99	1.53	NA	25.58	090
24410		A	Revision of humerus	14.82	NA	14.11	1.89	NA	30.82	090
24420		A	Revision of humerus	13.44	NA	17.27	1.82	NA	32.53	090
24430		A	Repair of humerus	12.81	NA	13.18	1.80	NA	27.79	090
24435		A	Repair humerus with graft	13.17	NA	14.37	1.84	NA	29.38	090
24470		A	Revision of elbow joint	8.74	NA	8.50	1.23	NA	18.47	090
24495		A	Decompression of forearm	8.12	NA	10.28	0.92	NA	19.32	090
24498		A	Reinforce humerus	11.92	NA	12.68	1.67	NA	26.27	090
24500		A	Treat humerus fracture	3.21	5.31	3.38	0.41	8.93	7.00	090
24505		A	Treat humerus fracture	5.17	9.31	7.10	0.72	15.20	12.99	090
24515		A	Treat humerus fracture	11.65	NA	11.58	1.63	NA	24.86	090
24516		A	Treat humerus fracture	11.65	NA	12.14	1.63	NA	25.42	090
24530		A	Treat humerus fracture	3.50	6.52	4.97	0.47	10.49	8.94	090
24535		A	Treat humerus fracture	6.87	9.14	6.89	0.96	16.97	14.72	090
24538		A	Treat humerus fracture	9.43	NA	10.85	1.25	NA	21.53	090
24545		A	Treat humerus fracture	10.46	NA	10.37	1.47	NA	22.30	090
24546		A	Treat humerus fracture	15.69	NA	13.83	2.18	NA	31.70	090
24560		A	Treat humerus fracture	2.80	5.10	3.16	0.35	8.25	6.31	090
24565		A	Treat humerus fracture	5.56	8.24	6.05	0.74	14.54	12.35	090
24566		A	Treat humerus fracture	7.79	NA	10.34	1.10	NA	19.23	090
24575		A	Treat humerus fracture	10.66	NA	8.43	1.44	NA	20.53	090
24576		A	Treat humerus fracture	2.86	4.85	3.31	0.38	8.09	6.55	090
24577		A	Treat humerus fracture	5.79	8.47	6.32	0.81	15.07	12.92	090
24579		A	Treat humerus fracture	11.60	NA	11.31	1.62	NA	24.53	090
24582		A	Treat humerus fracture	8.55	NA	10.77	1.20	NA	20.52	090
24586		A	Treat elbow fracture	15.21	NA	11.05	2.12	NA	28.38	090
24587		A	Treat elbow fracture	15.16	NA	10.88	2.14	NA	28.18	090
24600		A	Treat elbow dislocation	4.23	7.12	5.11	0.49	11.84	9.83	090
24605		A	Treat elbow dislocation	5.42	NA	5.09	0.72	NA	11.23	090
24615		A	Treat elbow dislocation	9.42	NA	7.97	1.31	NA	18.70	090
24620		A	Treat elbow fracture	6.98	NA	6.71	0.90	NA	14.59	090
24635		A	Treat elbow fracture	13.19	NA	16.64	1.84	NA	31.67	090
24640		A	Treat elbow dislocation	1.20	3.54	1.84	0.11	4.85	3.15	010
24650		A	Treat radius fracture	2.16	4.81	2.92	0.28	7.25	5.36	090
24655		A	Treat radius fracture	4.40	7.66	5.41	0.58	12.64	10.39	090
24665		A	Treat radius fracture	8.14	NA	9.72	1.13	NA	18.99	090
24666		A	Treat radius fracture	9.49	NA	10.48	1.32	NA	21.29	090
24670		A	Treat ulnar fracture	2.54	4.71	3.13	0.33	7.58	6.00	090
24675		A	Treat ulnar fracture	4.72	7.86	5.68	0.65	13.23	11.05	090
24685		A	Treat ulnar fracture	8.80	NA	10.08	1.23	NA	20.11	090
24800		A	Fusion of elbow joint	11.20	NA	9.94	1.41	NA	22.55	090
24802		A	Fusion/graft of elbow joint	13.69	NA	11.56	1.89	NA	27.14	090
24900		A	Amputation of upper arm	9.60	NA	11.21	1.18	NA	21.99	090
24920		A	Amputation of upper arm	9.54	NA	12.82	1.22	NA	23.58	090
24925		A	Amputation follow-up surgery	7.07	NA	9.68	0.95	NA	17.70	090
24930		A	Amputation follow-up surgery	10.25	NA	11.78	1.23	NA	23.26	090
24931		A	Amputate upper arm & implant	12.72	NA	9.23	1.56	NA	23.51	090
24935		A	Revision of amputation	15.56	NA	12.63	1.58	NA	29.77	090
24940		C	Revision of upper arm	0.00	0.00	0.00	0.00	0.00	0.00	090
24999		C	Upper arm/elbow surgery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
25000		A	Incision of tendon sheath	3.38	NA	7.59	0.45	NA	11.42	090
25001		A	Incise flexor carpi radialis	3.38	NA	4.37	0.45	NA	8.20	090
25020		A	Decompress forearm 1 space	5.92	NA	11.38	0.76	NA	18.06	090
25023		A	Decompress forearm 1 space	12.96	NA	17.36	1.52	NA	31.84	090
25024		A	Decompress forearm 2 spaces	9.50	NA	8.08	1.24	NA	18.82	090
25025		A	Decompress forarm 2 spaces	16.54	NA	11.75	2.18	NA	30.47	090
25028		A	Drainage of forearm lesion	5.25	NA	10.17	0.61	NA	16.03	090
25031		A	Drainage of forearm bursa	4.14	NA	10.14	0.50	NA	14.78	090
25035		A	Treat forearm bone lesion	7.36	NA	16.87	0.98	NA	25.21	090
25040		A	Explore/treat wrist joint	7.18	NA	9.48	0.96	NA	17.62	090
25065		A	Biopsy forearm soft tissues	1.99	2.58	2.58	0.12	4.69	4.69	010
25066		A	Biopsy forearm soft tissues	4.13	NA	8.42	0.49	NA	13.04	090
25075		A	Removel forearm lesion subcu	3.74	NA	7.39	0.40	NA	11.53	090
25076		A	Removel forearm lesion deep	4.92	NA	12.88	0.59	NA	18.39	090
25077		A	Remove tumor, forearm/wrist	9.76	NA	15.51	1.10	NA	26.37	090
25085		A	Incision of wrist capsule	5.50	NA	11.29	0.71	NA	17.50	090
25100		A	Biopsy of wrist joint	3.90	NA	7.66	0.50	NA	12.06	090
25101		A	Explore/treat wrist joint	4.69	NA	8.02	0.60	NA	13.31	090
25105		A	Remove wrist joint lining	5.85	NA	11.25	0.77	NA	17.87	090
25107		A	Remove wrist joint cartilage	6.43	NA	11.62	0.82	NA	18.87	090
25110		A	Remove wrist tendon lesion	3.92	NA	8.62	0.48	NA	13.02	090
25111		A	Remove wrist tendon lesion	3.39	NA	6.67	0.42	NA	10.48	090
25112		A	Reremove wrist tendon lesion	4.53	NA	7.49	0.54	NA	12.56	090
25115		A	Remove wrist/forearm lesion	8.82	NA	17.36	1.11	NA	27.29	090
25116		A	Remove wrist/forearm lesion	7.11	NA	16.36	0.90	NA	24.37	090
25118		A	Excise wrist tendon sheath	4.37	NA	8.09	0.55	NA	13.01	090
25119		A	Partial removal of ulna	6.04	NA	11.54	0.80	NA	18.38	090
25120		A	Removal of forearm lesion	6.10	NA	15.31	0.81	NA	22.22	090
25125		A	Remove/graft forearm lesion	7.48	NA	16.39	1.02	NA	24.89	090
25126		A	Remove/graft forearm lesion	7.55	NA	15.93	1.00	NA	24.48	090
25130		A	Removal of wrist lesion	5.26	NA	8.44	0.66	NA	14.36	090
25135		A	Remove & graft wrist lesion	6.89	NA	9.27	0.89	NA	17.05	090
25136		A	Remove & graft wrist lesion	5.97	NA	8.50	0.58	NA	15.05	090
25145		A	Remove forearm bone lesion	6.37	NA	15.73	0.82	NA	22.92	090
25150		A	Partial removal of ulna	7.09	NA	12.28	0.96	NA	20.33	090
25151		A	Partial removal of radius	7.39	NA	16.28	0.93	NA	24.60	090
25170		A	Extensive forearm surgery	11.09	NA	17.76	1.52	NA	30.37	090
25210		A	Removal of wrist bone	5.95	NA	8.84	0.73	NA	15.52	090
25215		A	Removal of wrist bones	7.89	NA	12.52	1.02	NA	21.43	090
25230		A	Partial removal of radius	5.23	NA	8.35	0.66	NA	14.24	090
25240		A	Partial removal of ulna	5.17	NA	11.07	0.69	NA	16.93	090
25246		A	Injection for wrist x-ray	1.45	10.27	0.50	0.07	11.79	2.02	000
25248		A	Remove forearm foreign body	5.14	NA	10.23	0.54	NA	15.91	090
25250		A	Removal of wrist prosthesis	6.60	NA	6.19	0.84	NA	13.63	090
25251		A	Removal of wrist prosthesis	9.57	NA	8.08	1.15	NA	18.80	090
25259		A	Manipulate wrist w/anesthes	3.75	NA	5.46	0.50	NA	9.71	090
25260		A	Repair forearm tendon/muscle	7.80	NA	17.12	0.97	NA	25.89	090
25263		A	Repair forearm tendon/muscle	7.82	NA	16.99	0.94	NA	25.75	090
25265		A	Repair forearm tendon/muscle	9.88	NA	17.71	1.19	NA	28.78	090
25270		A	Repair forearm tendon/muscle	6.00	NA	16.17	0.76	NA	22.93	090
25272		A	Repair forearm tendon/muscle	7.04	NA	16.74	0.89	NA	24.67	090
25274		A	Repair forearm tendon/muscle	8.75	NA	17.17	1.14	NA	27.06	090
25275		A	Repair forearm tendon sheath	8.50	NA	7.44	1.13	NA	17.07	090
25280		A	Revise wrist/forearm tendon	7.22	NA	16.29	0.91	NA	24.42	090
25290		A	Incise wrist/forearm tendon	5.29	NA	18.62	0.66	NA	24.57	090
25295		A	Release wrist/forearm tendon	6.55	NA	15.93	0.86	NA	23.34	090
25300		A	Fusion of tendons at wrist	8.80	NA	10.06	1.07	NA	19.93	090
25301		A	Fusion of tendons at wrist	8.40	NA	9.98	1.08	NA	19.46	090
25310		A	Transplant forearm tendon	8.14	NA	16.74	1.01	NA	25.89	090
25312		A	Transplant forearm tendon	9.57	NA	17.49	1.22	NA	28.28	090
25315		A	Revise palsy hand tendon(s)	10.20	NA	18.31	1.26	NA	29.77	090
25316		A	Revise palsy hand tendon(s)	12.33	NA	19.71	1.74	NA	33.78	090
25320		A	Repair/revise wrist joint	10.77	NA	11.50	1.32	NA	23.59	090
25332		A	Revise wrist joint	11.41	NA	9.34	1.46	NA	22.21	090
25335		A	Realignment of hand	12.88	NA	14.95	1.66	NA	29.49	090
25337		A	Reconstruct ulna/radioulnar	10.17	NA	13.85	1.31	NA	25.33	090
25350		A	Revision of radius	8.78	NA	16.98	1.17	NA	26.93	090
25355		A	Revision of radius	10.17	NA	17.60	1.44	NA	29.21	090
25360		A	Revision of ulna	8.43	NA	16.89	1.17	NA	26.49	090
25365		A	Revise radius & ulna	12.40	NA	18.51	1.67	NA	32.58	090
25370		A	Revise radius or ulna	13.36	NA	18.42	1.88	NA	33.66	090
25375		A	Revise radius & ulna	13.04	NA	19.42	1.84	NA	34.30	090
25390		A	Shorten radius or ulna	10.40	NA	17.69	1.38	NA	29.47	090
25391		A	Lengthen radius or ulna	13.65	NA	19.37	1.73	NA	34.75	090
25392		A	Shorten radius & ulna	13.95	NA	18.37	1.73	NA	34.05	090
25393		A	Lengthen radius & ulna	15.87	NA	20.63	1.87	NA	38.37	090
25394		A	Repair carpal bone, shorten	10.40	NA	8.29	1.40	NA	20.09	090
25400		A	Repair radius or ulna	10.92	NA	18.22	1.50	NA	30.64	090
25405		A	Repair/graft radius or ulna	14.38	NA	20.48	1.95	NA	36.81	090
25415		A	Repair radius & ulna	13.35	NA	19.39	1.87	NA	34.61	090
25420		A	Repair/graft radius & ulna	16.33	NA	21.34	2.20	NA	39.87	090
25425		A	Repair/graft radius or ulna	13.21	NA	26.80	1.61	NA	41.62	090
25426		A	Repair/graft radius & ulna	15.82	NA	20.12	2.23	NA	38.17	090
25430		A	Vasc graft into carpal bone	9.25	NA	7.62	1.07	NA	17.94	090
25431		A	Repair nonunion carpal bone	10.44	NA	6.38	0.56	NA	17.38	090
25440		A	Repair/graft wrist bone	10.44	NA	11.25	1.41	NA	23.10	090
25441		A	Reconstruct wrist joint	12.90	NA	10.14	1.83	NA	24.87	090
25442		A	Reconstruct wrist joint	10.85	NA	9.00	1.24	NA	21.09	090
25443		A	Reconstruct wrist joint	10.39	NA	8.89	1.30	NA	20.58	090
25444		A	Reconstruct wrist joint	11.15	NA	9.17	1.43	NA	21.75	090
25445		A	Reconstruct wrist joint	9.69	NA	8.18	1.26	NA	19.13	090
25446		A	Wrist replacement	16.55	NA	12.17	2.20	NA	30.92	090
25447		A	Repair wrist joint(s)	10.37	NA	8.76	1.34	NA	20.47	090
25449		A	Remove wrist joint implant	14.49	NA	10.89	1.77	NA	27.15	090
25450		A	Revision of wrist joint	7.87	NA	13.09	0.88	NA	21.84	090
25455		A	Revision of wrist joint	9.49	NA	14.28	1.07	NA	24.84	090
25490		A	Reinforce radius	9.54	NA	16.71	1.19	NA	27.44	090
25491		A	Reinforce ulna	9.96	NA	17.58	1.41	NA	28.95	090
25492		A	Reinforce radius and ulna	12.33	NA	18.06	1.62	NA	32.01	090
25500		A	Treat fracture of radius	2.45	4.37	2.93	0.28	7.10	5.66	090
25505		A	Treat fracture of radius	5.21	8.04	5.81	0.69	13.94	11.71	090
25515		A	Treat fracture of radius	9.18	NA	10.00	1.22	NA	20.40	090
25520		A	Treat fracture of radius	6.26	8.23	6.43	0.85	15.34	13.54	090
25525		A	Treat fracture of radius	12.24	NA	11.92	1.68	NA	25.84	090
25526		A	Treat fracture of radius	12.98	NA	15.40	1.80	NA	30.18	090
25530		A	Treat fracture of ulna	2.09	4.42	2.92	0.27	6.78	5.28	090
25535		A	Treat fracture of ulna	5.14	7.81	5.86	0.68	13.63	11.68	090
25545		A	Treat fracture of ulna	8.90	NA	10.14	1.23	NA	20.27	090
25560		A	Treat fracture radius & ulna	2.44	4.41	2.90	0.27	7.12	5.61	090
25565		A	Treat fracture radius & ulna	5.63	8.28	6.02	0.76	14.67	12.41	090
25574		A	Treat fracture radius & ulna	7.01	NA	9.05	0.96	NA	17.02	090
25575		A	Treat fracture radius/ulna	10.45	NA	10.98	1.46	NA	22.89	090
25600		A	Treat fracture radius/ulna	2.63	4.75	3.11	0.34	7.72	6.08	090
25605		A	Treat fracture radius/ulna	5.81	8.51	6.27	0.81	15.13	12.89	090
25611		A	Treat fracture radius/ulna	7.77	NA	10.37	1.08	NA	19.22	090
25620		A	Treat fracture radius/ulna	8.55	NA	9.91	1.17	NA	19.63	090
25622		A	Treat wrist bone fracture	2.61	4.70	3.08	0.33	7.64	6.02	090
25624		A	Treat wrist bone fracture	4.53	7.73	5.49	0.61	12.87	10.63	090
25628		A	Treat wrist bone fracture	8.43	NA	9.95	1.14	NA	19.52	090
25630		A	Treat wrist bone fracture	2.88	4.86	3.14	0.37	8.11	6.39	090
25635		A	Treat wrist bone fracture	4.39	7.68	4.75	0.39	12.46	9.53	090
25645		A	Treat wrist bone fracture	7.25	NA	9.47	0.93	NA	17.65	090
25650		A	Treat wrist bone fracture	3.05	4.91	3.21	0.37	8.33	6.63	090
25651		A	Pin ulnar styloid fracture	5.36	NA	5.69	0.72	NA	11.77	090
25652		A	Treat fracture ulnar styloid	7.60	NA	6.85	1.02	NA	15.47	090
25660		A	Treat wrist dislocation	4.76	NA	5.49	0.59	NA	10.84	090
25670		A	Treat wrist dislocation	7.92	NA	9.73	1.07	NA	18.72	090
25671		A	Pin radioulnar dislocation	6.00	NA	6.02	0.81	NA	12.83	090
25675		A	Treat wrist dislocation	4.67	7.52	5.43	0.57	12.76	10.67	090
25676		A	Treat wrist dislocation	8.04	NA	9.78	1.10	NA	18.92	090
25680		A	Treat wrist fracture	5.99	NA	6.48	0.61	NA	13.08	090
25685		A	Treat wrist fracture	9.78	NA	10.44	1.25	NA	21.47	090
25690		A	Treat wrist dislocation	5.50	NA	7.21	0.78	NA	13.49	090
25695		A	Treat wrist dislocation	8.34	NA	9.86	1.07	NA	19.27	090
25800		A	Fusion of wrist joint	9.76	NA	10.92	1.30	NA	21.98	090
25805		A	Fusion/graft of wrist joint	11.28	NA	11.81	1.51	NA	24.60	090
25810		A	Fusion/graft of wrist joint	10.57	NA	11.34	1.37	NA	23.28	090
25820		A	Fusion of hand bones	7.45	NA	9.68	0.96	NA	18.09	090
25825		A	Fuse hand bones with graft	9.27	NA	10.66	1.20	NA	21.13	090
25830		A	Fusion, radioulnar jnt/ulna	10.06	NA	17.12	1.27	NA	28.45	090
25900		A	Amputation of forearm	9.01	NA	14.48	1.08	NA	24.57	090
25905		A	Amputation of forearm	9.12	NA	15.75	1.06	NA	25.93	090
25907		A	Amputation follow-up surgery	7.80	NA	15.19	1.01	NA	24.00	090
25909		A	Amputation follow-up surgery	8.96	NA	15.62	1.07	NA	25.65	090
25915		A	Amputation of forearm	17.08	NA	23.14	2.41	NA	42.63	090
25920		A	Amputate hand at wrist	8.68	NA	9.91	1.06	NA	19.65	090
25922		A	Amputate hand at wrist	7.42	NA	9.06	0.93	NA	17.41	090
25924		A	Amputation follow-up surgery	8.46	NA	10.25	1.07	NA	19.78	090
25927		A	Amputation of hand	8.80	NA	14.18	1.02	NA	24.00	090
25929		A	Amputation follow-up surgery	7.59	NA	7.83	0.89	NA	16.31	090
25931		A	Amputation follow-up surgery	7.81	NA	15.09	0.88	NA	23.78	090
25999		C	Forearm or wrist surgery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
26010		A	Drainage of finger abscess	1.54	5.97	1.78	0.14	7.65	3.46	010
26011		A	Drainage of finger abscess	2.19	12.48	2.48	0.25	14.92	4.92	010
26020		A	Drain hand tendon sheath	4.67	NA	5.31	0.59	NA	10.57	090
26025		A	Drainage of palm bursa	4.82	NA	5.18	0.60	NA	10.60	090
26030		A	Drainage of palm bursa(s)	5.93	NA	5.85	0.72	NA	12.50	090
26034		A	Treat hand bone lesion	6.23	NA	6.04	0.79	NA	13.06	090
26035		A	Decompress fingers/hand	9.51	NA	7.99	1.12	NA	18.62	090
26037		A	Decompress fingers/hand	7.25	NA	6.48	0.87	NA	14.60	090
26040		A	Release palm contracture	3.33	NA	3.75	0.45	NA	7.53	090
26045		A	Release palm contracture	5.56	NA	5.30	0.74	NA	11.60	090
26055		A	Incise finger tendon sheath	2.69	15.46	3.59	0.36	18.51	6.64	090
26060		A	Incision of finger tendon	2.81	NA	3.28	0.35	NA	6.44	090
26070		A	Explore/treat hand joint	3.69	NA	3.32	0.35	NA	7.36	090
26075		A	Explore/treat finger joint	3.79	NA	3.67	0.40	NA	7.86	090
26080		A	Explore/treat finger joint	4.24	NA	4.58	0.52	NA	9.34	090
26100		A	Biopsy hand joint lining	3.67	NA	3.90	0.45	NA	8.02	090
26105		A	Biopsy finger joint lining	3.71	NA	3.93	0.45	NA	8.09	090
26110		A	Biopsy finger joint lining	3.53	NA	3.80	0.44	NA	7.77	090
26115		A	Removel hand lesion subcut	3.86	14.42	4.43	0.48	18.76	8.77	090
26116		A	Removel hand lesion, deep	5.53	NA	5.66	0.69	NA	11.88	090
26117		A	Remove tumor, hand/finger	8.55	NA	6.94	1.01	NA	16.50	090
26121		A	Release palm contracture	7.54	NA	6.72	0.94	NA	15.20	090
26123		A	Release palm contracture	9.29	NA	8.65	1.17	NA	19.11	090
26125		A	Release palm contracture	4.61	NA	2.51	0.57	NA	7.69	ZZZ
26130		A	Remove wrist joint lining	5.42	NA	5.12	0.65	NA	11.19	090
26135		A	Revise finger joint, each	6.96	NA	6.20	0.87	NA	14.03	090
26140		A	Revise finger joint, each	6.17	NA	5.75	0.76	NA	12.68	090
26145		A	Tendon excision, palm/finger	6.32	NA	5.78	0.77	NA	12.87	090
26160		A	Remove tendon sheath lesion	3.15	18.94	3.86	0.39	22.48	7.40	090
26170		A	Removal of palm tendon, each	4.77	NA	4.72	0.60	NA	10.09	090
26180		A	Removal of finger tendon	5.18	NA	5.10	0.64	NA	10.92	090
26185		A	Remove finger bone	5.25	NA	5.62	0.67	NA	11.54	090
26200		A	Remove hand bone lesion	5.51	NA	5.14	0.71	NA	11.36	090
26205		A	Remove/graft bone lesion	7.70	NA	6.69	0.95	NA	15.34	090
26210		A	Removal of finger lesion	5.15	NA	5.12	0.64	NA	10.91	090
26215		A	Remove/graft finger lesion	7.10	NA	6.07	0.77	NA	13.94	090
26230		A	Partial removal of hand bone	6.33	NA	5.68	0.84	NA	12.85	090
26235		A	Partial removal, finger bone	6.19	NA	5.62	0.78	NA	12.59	090
26236		A	Partial removal, finger bone	5.32	NA	5.17	0.66	NA	11.15	090
26250		A	Extensive hand surgery	7.55	NA	6.23	0.92	NA	14.70	090
26255		A	Extensive hand surgery	12.43	NA	9.26	1.05	NA	22.74	090
26260		A	Extensive finger surgery	7.03	NA	5.98	0.83	NA	13.84	090
26261		A	Extensive finger surgery	9.09	NA	6.22	0.84	NA	16.15	090
26262		A	Partial removal of finger	5.67	NA	5.18	0.70	NA	11.55	090
26320		A	Removal of implant from hand	3.98	NA	4.50	0.49	NA	8.97	090
26340		A	Manipulate finger w/anesth	2.50	NA	4.64	0.30	NA	7.44	090
26350		A	Repair finger/hand tendon	5.99	NA	20.03	0.73	NA	26.75	090
26352		A	Repair/graft hand tendon	7.68	NA	20.50	0.93	NA	29.11	090
26356		A	Repair finger/hand tendon	8.07	NA	21.49	0.99	NA	30.55	090
26357		A	Repair finger/hand tendon	8.58	NA	21.19	1.02	NA	30.79	090
26358		A	Repair/graft hand tendon	9.14	NA	21.74	1.07	NA	31.95	090
26370		A	Repair finger/hand tendon	7.11	NA	20.67	0.90	NA	28.68	090
26372		A	Repair/graft hand tendon	8.76	NA	22.00	1.06	NA	31.82	090
26373		A	Repair finger/hand tendon	8.16	NA	21.56	0.98	NA	30.70	090
26390		A	Revise hand/finger tendon	9.19	NA	16.75	1.09	NA	27.03	090
26392		A	Repair/graft hand tendon	10.26	NA	22.55	1.26	NA	34.07	090
26410		A	Repair hand tendon	4.63	NA	16.30	0.57	NA	21.50	090
26412		A	Repair/graft hand tendon	6.31	NA	17.39	0.80	NA	24.50	090
26415		A	Excision, hand/finger tendon	8.34	NA	15.90	0.77	NA	25.01	090
26416		A	Graft hand or finger tendon	9.37	NA	18.56	1.20	NA	29.13	090
26418		A	Repair finger tendon	4.25	NA	16.13	0.50	NA	20.88	090
26420		A	Repair/graft finger tendon	6.77	NA	17.69	0.83	NA	25.29	090
26426		A	Repair finger/hand tendon	6.15	NA	17.16	0.77	NA	24.08	090
26428		A	Repair/graft finger tendon	7.21	NA	18.24	0.84	NA	26.29	090
26432		A	Repair finger tendon	4.02	NA	13.36	0.48	NA	17.86	090
26433		A	Repair finger tendon	4.56	NA	14.27	0.56	NA	19.39	090
26434		A	Repair/graft finger tendon	6.09	NA	14.67	0.71	NA	21.47	090
26437		A	Realignment of tendons	5.82	NA	14.40	0.74	NA	20.96	090
26440		A	Release palm/finger tendon	5.02	NA	18.87	0.62	NA	24.51	090
26442		A	Release palm & finger tendon	8.16	NA	20.31	0.94	NA	29.41	090
26445		A	Release hand/finger tendon	4.31	NA	18.71	0.54	NA	23.56	090
26449		A	Release forearm/hand tendon	7.00	NA	20.02	0.84	NA	27.86	090
26450		A	Incision of palm tendon	3.67	NA	8.57	0.46	NA	12.70	090
26455		A	Incision of finger tendon	3.64	NA	8.45	0.47	NA	12.56	090
26460		A	Incise hand/finger tendon	3.46	NA	8.20	0.44	NA	12.10	090
26471		A	Fusion of finger tendons	5.73	NA	14.06	0.73	NA	20.52	090
26474		A	Fusion of finger tendons	5.32	NA	14.31	0.69	NA	20.32	090
26476		A	Tendon lengthening	5.18	NA	13.80	0.62	NA	19.60	090
26477		A	Tendon shortening	5.15	NA	14.01	0.60	NA	19.76	090
26478		A	Lengthening of hand tendon	5.80	NA	14.65	0.77	NA	21.22	090
26479		A	Shortening of hand tendon	5.74	NA	14.65	0.76	NA	21.15	090
26480		A	Transplant hand tendon	6.69	NA	19.94	0.84	NA	27.47	090
26483		A	Transplant/graft hand tendon	8.29	NA	20.43	1.03	NA	29.75	090
26485		A	Transplant palm tendon	7.70	NA	20.34	0.94	NA	28.98	090
26489		A	Transplant/graft palm tendon	9.55	NA	17.04	0.98	NA	27.57	090
26490		A	Revise thumb tendon	8.41	NA	15.54	1.05	NA	25.00	090
26492		A	Tendon transfer with graft	9.62	NA	16.15	1.19	NA	26.96	090
26494		A	Hand tendon/muscle transfer	8.47	NA	16.14	1.13	NA	25.74	090
26496		A	Revise thumb tendon	9.59	NA	15.87	1.17	NA	26.63	090
26497		A	Finger tendon transfer	9.57	NA	16.32	1.17	NA	27.06	090
26498		A	Finger tendon transfer	14.00	NA	18.71	1.74	NA	34.45	090
26499		A	Revision of finger	8.98	NA	17.02	0.94	NA	26.94	090
26500		A	Hand tendon reconstruction	5.96	NA	14.98	0.66	NA	21.60	090
26502		A	Hand tendon reconstruction	7.14	NA	15.27	0.87	NA	23.28	090
26504		A	Hand tendon reconstruction	7.47	NA	15.08	0.84	NA	23.39	090
26508		A	Release thumb contracture	6.01	NA	14.59	0.76	NA	21.36	090
26510		A	Thumb tendon transfer	5.43	NA	14.30	0.71	NA	20.44	090
26516		A	Fusion of knuckle joint	7.15	NA	15.07	0.90	NA	23.12	090
26517		A	Fusion of knuckle joints	8.83	NA	16.41	0.96	NA	26.20	090
26518		A	Fusion of knuckle joints	9.02	NA	16.12	1.13	NA	26.27	090
26520		A	Release knuckle contracture	5.30	NA	18.85	0.65	NA	24.80	090
26525		A	Release finger contracture	5.33	NA	19.02	0.66	NA	25.01	090
26530		A	Revise knuckle joint	6.69	NA	6.04	0.86	NA	13.59	090
26531		A	Revise knuckle with implant	7.91	NA	6.95	1.01	NA	15.87	090
26535		A	Revise finger joint	5.24	NA	3.69	0.66	NA	9.59	090
26536		A	Revise/implant finger joint	6.37	NA	10.32	0.80	NA	17.49	090
26540		A	Repair hand joint	6.43	NA	14.89	0.81	NA	22.13	090
26541		A	Repair hand joint with graft	8.62	NA	16.25	1.12	NA	25.99	090
26542		A	Repair hand joint with graft	6.78	NA	14.78	0.87	NA	22.43	090
26545		A	Reconstruct finger joint	6.92	NA	15.52	0.79	NA	23.23	090
26546		A	Repair nonunion hand	8.92	NA	16.15	1.14	NA	26.21	090
26548		A	Reconstruct finger joint	8.03	NA	16.02	0.98	NA	25.03	090
26550		A	Construct thumb replacement	21.24	NA	23.47	1.80	NA	46.51	090
26551		A	Great toe-hand transfer	46.58	NA	36.90	6.57	NA	90.05	090
26553		A	Single transfer, toe-hand	46.27	NA	28.16	1.99	NA	76.42	090
26554		A	Double transfer, toe-hand	54.95	NA	38.79	7.76	NA	101.50	090
26555		A	Positional change of finger	16.63	NA	22.51	2.13	NA	41.27	090
26556		A	Toe joint transfer	47.26	NA	34.27	6.67	NA	88.20	090
26560		A	Repair of web finger	5.38	NA	12.99	0.60	NA	18.97	090
26561		A	Repair of web finger	10.92	NA	16.12	0.69	NA	27.73	090
26562		A	Repair of web finger	15.00	NA	19.37	0.98	NA	35.35	090
26565		A	Correct metacarpal flaw	6.74	NA	14.95	0.84	NA	22.53	090
26567		A	Correct finger deformity	6.82	NA	14.88	0.84	NA	22.54	090
26568		A	Lengthen metacarpal/finger	9.08	NA	20.41	1.10	NA	30.59	090
26580		A	Repair hand deformity	18.18	NA	15.87	1.46	NA	35.51	090
26587		A	Reconstruct extra finger	14.05	6.36	NA	1.12	21.53	NA	090
26590		A	Repair finger deformity	17.96	NA	17.46	1.32	NA	36.74	090
26591		A	Repair muscles of hand	3.25	NA	13.80	0.37	NA	17.42	090
26593		A	Release muscles of hand	5.31	NA	13.78	0.64	NA	19.73	090
26596		A	Excision constricting tissue	8.95	NA	9.86	0.87	NA	19.68	090
26600		A	Treat metacarpal fracture	1.96	4.36	2.83	0.25	6.57	5.04	090
26605		A	Treat metacarpal fracture	2.85	6.33	4.45	0.38	9.56	7.68	090
26607		A	Treat metacarpal fracture	5.36	NA	8.46	0.70	NA	14.52	090
26608		A	Treat metacarpal fracture	5.36	NA	9.07	0.73	NA	15.16	090
26615		A	Treat metacarpal fracture	5.33	NA	8.49	0.70	NA	14.52	090
26641		A	Treat thumb dislocation	3.94	6.70	4.86	0.42	11.06	9.22	090
26645		A	Treat thumb fracture	4.41	7.51	5.35	0.54	12.46	10.30	090
26650		A	Treat thumb fracture	5.72	NA	9.24	0.77	NA	15.73	090
26665		A	Treat thumb fracture	7.60	NA	9.52	0.97	NA	18.09	090
26670		A	Treat hand dislocation	3.69	6.53	4.75	0.36	10.58	8.80	090
26675		A	Treat hand dislocation	4.64	6.66	4.57	0.56	11.86	9.77	090
26676		A	Pin hand dislocation	5.52	NA	9.30	0.76	NA	15.58	090
26685		A	Treat hand dislocation	6.98	NA	9.14	0.95	NA	17.07	090
26686		A	Treat hand dislocation	7.94	NA	9.73	1.05	NA	18.72	090
26700		A	Treat knuckle dislocation	3.69	5.13	2.96	0.35	9.17	7.00	090
26705		A	Treat knuckle dislocation	4.19	6.47	4.41	0.50	11.16	9.10	090
26706		A	Pin knuckle dislocation	5.12	NA	5.98	0.64	NA	11.74	090
26715		A	Treat knuckle dislocation	5.74	NA	8.65	0.75	NA	15.14	090
26720		A	Treat finger fracture, each	1.66	3.22	1.69	0.20	5.08	3.55	090
26725		A	Treat finger fracture, each	3.33	5.47	3.28	0.43	9.23	7.04	090
26727		A	Treat finger fracture, each	5.23	NA	9.18	0.69	NA	15.10	090
26735		A	Treat finger fracture, each	5.98	NA	8.91	0.77	NA	15.66	090
26740		A	Treat finger fracture, each	1.94	4.01	2.67	0.24	6.19	4.85	090
26742		A	Treat finger fracture, each	3.85	7.41	5.28	0.49	11.75	9.62	090
26746		A	Treat finger fracture, each	5.81	NA	8.98	0.74	NA	15.53	090
26750		A	Treat finger fracture, each	1.70	3.82	2.41	0.19	5.71	4.30	090
26755		A	Treat finger fracture, each	3.10	5.25	3.10	0.37	8.72	6.57	090
26756		A	Pin finger fracture, each	4.39	NA	8.89	0.56	NA	13.84	090
26765		A	Treat finger fracture, each	4.17	NA	7.97	0.51	NA	12.65	090
26770		A	Treat finger dislocation	3.02	4.98	2.71	0.27	8.27	6.00	090
26775		A	Treat finger dislocation	3.71	6.25	4.06	0.43	10.39	8.20	090
26776		A	Pin finger dislocation	4.80	NA	9.01	0.63	NA	14.44	090
26785		A	Treat finger dislocation	4.21	NA	7.94	0.54	NA	12.69	090
26820		A	Thumb fusion with graft	8.26	NA	16.22	1.11	NA	25.59	090
26841		A	Fusion of thumb	7.13	NA	15.46	0.97	NA	23.56	090
26842		A	Thumb fusion with graft	8.24	NA	16.24	1.10	NA	25.58	090
26843		A	Fusion of hand joint	7.61	NA	14.93	0.99	NA	23.53	090
26844		A	Fusion/graft of hand joint	8.73	NA	16.20	1.12	NA	26.05	090
26850		A	Fusion of knuckle	6.97	NA	14.89	0.89	NA	22.75	090
26852		A	Fusion of knuckle with graft	8.46	NA	15.84	1.05	NA	25.35	090
26860		A	Fusion of finger joint	4.69	NA	13.75	0.60	NA	19.04	090
26861		A	Fusion of finger jnt, add-on	1.74	NA	0.96	0.22	NA	2.92	ZZZ
26862		A	Fusion/graft of finger joint	7.37	NA	15.38	0.92	NA	23.67	090
26863		A	Fuse/graft added joint	3.90	NA	2.17	0.51	NA	6.58	ZZZ
26910		A	Amputate metacarpal bone	7.60	NA	14.07	0.90	NA	22.57	090
26951		A	Amputation of finger/thumb	4.59	NA	13.06	0.56	NA	18.21	090
26952		A	Amputation of finger/thumb	6.31	NA	14.25	0.74	NA	21.30	090
26989		C	Hand/finger surgery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
26990		A	Drainage of pelvis lesion	7.48	NA	16.35	0.92	NA	24.75	090
26991		A	Drainage of pelvis bursa	6.68	11.94	9.87	0.85	19.47	17.40	090
26992		A	Drainage of bone lesion	13.02	NA	20.25	1.75	NA	35.02	090
27000		A	Incision of hip tendon	5.62	NA	7.78	0.76	NA	14.16	090
27001		A	Incision of hip tendon	6.94	NA	8.52	0.95	NA	16.41	090
27003		A	Incision of hip tendon	7.34	NA	9.52	0.93	NA	17.79	090
27005		A	Incision of hip tendon	9.66	NA	10.84	1.36	NA	21.86	090
27006		A	Incision of hip tendons	9.68	NA	10.84	1.33	NA	21.85	090
27025		A	Incision of hip/thigh fascia	11.16	NA	10.70	1.38	NA	23.24	090
27030		A	Drainage of hip joint	13.01	NA	12.69	1.81	NA	27.51	090
27033		A	Exploration of hip joint	13.39	NA	12.81	1.87	NA	28.07	090
27035		A	Denervation of hip joint	16.69	NA	17.51	1.70	NA	35.90	090
27036		A	Excision of hip joint/muscle	12.88	NA	14.25	1.80	NA	28.93	090
27040		A	Biopsy of soft tissues	2.87	6.16	3.97	0.21	9.24	7.05	010
27041		A	Biopsy of soft tissues	9.89	NA	8.60	1.01	NA	19.50	090
27047		A	Remove hip/pelvis lesion	7.45	9.54	7.15	0.79	17.78	15.39	090
27048		A	Remove hip/pelvis lesion	6.25	NA	8.06	0.73	NA	15.04	090
27049		A	Remove tumor, hip/pelvis	13.66	NA	13.54	1.60	NA	28.80	090
27050		A	Biopsy of sacroiliac joint	4.36	NA	7.42	0.53	NA	12.31	090
27052		A	Biopsy of hip joint	6.23	NA	8.71	0.85	NA	15.79	090
27054		A	Removal of hip joint lining	8.54	NA	11.05	1.17	NA	20.76	090
27060		A	Removal of ischial bursa	5.43	NA	7.63	0.60	NA	13.66	090
27062		A	Remove femur lesion/bursa	5.37	NA	7.59	0.74	NA	13.70	090
27065		A	Removal of hip bone lesion	5.90	NA	9.09	0.76	NA	15.75	090
27066		A	Removal of hip bone lesion	10.33	NA	12.88	1.42	NA	24.63	090
27067		A	Remove/graft hip bone lesion	13.83	NA	14.91	1.95	NA	30.69	090
27070		A	Partial removal of hip bone	10.72	NA	18.36	1.36	NA	30.44	090
27071		A	Partial removal of hip bone	11.46	NA	19.32	1.51	NA	32.29	090
27075		A	Extensive hip surgery	35.00	NA	25.82	2.22	NA	63.04	090
27076		A	Extensive hip surgery	22.12	NA	20.29	2.86	NA	45.27	090
27077		A	Extensive hip surgery	40.00	NA	29.14	3.18	NA	72.32	090
27078		A	Extensive hip surgery	13.44	NA	15.81	1.67	NA	30.92	090
27079		A	Extensive hip surgery	13.75	NA	15.34	1.86	NA	30.95	090
27080		A	Removal of tail bone	6.39	NA	7.66	0.80	NA	14.85	090
27086		A	Remove hip foreign body	1.87	5.13	3.97	0.17	7.17	6.01	010
27087		A	Remove hip foreign body	8.54	NA	9.19	1.09	NA	18.82	090
27090		A	Removal of hip prosthesis	11.15	NA	8.95	1.55	NA	21.65	090
27091		A	Removal of hip prosthesis	22.14	NA	14.22	3.11	NA	39.47	090
27093		A	Injection for hip x-ray	1.30	12.50	0.50	0.09	13.89	1.89	000
27095		A	Injection for hip x-ray	1.50	11.47	0.54	0.10	13.07	2.14	000
27096		A	Inject sacroiliac joint	1.40	10.28	0.34	0.08	11.76	1.82	000
27097		A	Revision of hip tendon	8.80	NA	9.44	1.22	NA	19.46	090
27098		A	Transfer tendon to pelvis	8.83	NA	9.88	1.24	NA	19.95	090
27100		A	Transfer of abdominal muscle	11.08	NA	13.03	1.57	NA	25.68	090
27105		A	Transfer of spinal muscle	11.77	NA	12.72	1.66	NA	26.15	090
27110		A	Transfer of iliopsoas muscle	13.26	NA	13.59	1.38	NA	28.23	090
27111		A	Transfer of iliopsoas muscle	12.15	NA	12.43	1.48	NA	26.06	090
27120		A	Reconstruction of hip socket	18.01	NA	12.05	2.45	NA	32.51	090
27122		A	Reconstruction of hip socket	14.98	NA	11.19	2.08	NA	28.25	090
27125		A	Partial hip replacement	14.69	NA	10.75	2.05	NA	27.49	090
27130		A	Total hip arthroplasty	20.12	NA	13.58	2.82	NA	36.52	090
27132		A	Total hip arthroplasty	23.30	NA	15.87	3.26	NA	42.43	090
27134		A	Revise hip joint replacement	28.52	NA	18.20	3.97	NA	50.69	090
27137		A	Revise hip joint replacement	21.17	NA	14.24	2.97	NA	38.38	090
27138		A	Revise hip joint replacement	22.17	NA	14.72	3.11	NA	40.00	090
27140		A	Transplant femur ridge	12.24	NA	12.27	1.67	NA	26.18	090
27146		A	Incision of hip bone	17.43	NA	16.51	2.27	NA	36.21	090
27147		A	Revision of hip bone	20.58	NA	17.71	2.61	NA	40.90	090
27151		A	Incision of hip bones	22.51	NA	12.83	3.12	NA	38.46	090
27156		A	Revision of hip bones	24.63	NA	20.37	3.48	NA	48.48	090
27158		A	Revision of pelvis	19.74	NA	16.00	2.60	NA	38.34	090
27161		A	Incision of neck of femur	16.71	NA	14.57	2.32	NA	33.60	090
27165		A	Incision/fixation of femur	17.91	NA	15.11	2.51	NA	35.53	090
27170		A	Repair/graft femur head/neck	16.07	NA	14.30	2.20	NA	32.57	090
27175		A	Treat slipped epiphysis	8.46	NA	7.39	1.19	NA	17.04	090
27176		A	Treat slipped epiphysis	12.05	NA	10.20	1.68	NA	23.93	090
27177		A	Treat slipped epiphysis	15.08	NA	11.88	2.11	NA	29.07	090
27178		A	Treat slipped epiphysis	11.99	NA	9.63	1.68	NA	23.30	090
27179		A	Revise head/neck of femur	12.98	NA	11.01	1.84	NA	25.83	090
27181		A	Treat slipped epiphysis	14.68	NA	11.17	1.74	NA	27.59	090
27185		A	Revision of femur epiphysis	9.18	NA	10.51	1.29	NA	20.98	090
27187		A	Reinforce hip bones	13.54	NA	13.81	1.89	NA	29.24	090
27193		A	Treat pelvic ring fracture	5.56	7.39	5.47	0.77	13.72	11.80	090
27194		A	Treat pelvic ring fracture	9.65	9.40	7.71	1.32	20.37	18.68	090
27200		A	Treat tail bone fracture	1.84	3.25	1.83	0.22	5.31	3.89	090
27202		A	Treat tail bone fracture	7.04	NA	22.21	0.69	NA	29.94	090
27215		A	Treat pelvic fracture(s)	10.05	NA	10.59	1.37	NA	22.01	090
27216		A	Treat pelvic ring fracture	15.19	NA	14.82	2.15	NA	32.16	090
27217		A	Treat pelvic ring fracture	14.11	NA	13.07	1.95	NA	29.13	090
27218		A	Treat pelvic ring fracture	20.15	NA	14.41	2.85	NA	37.41	090
27220		A	Treat hip socket fracture	6.18	7.73	5.82	0.85	14.76	12.85	090
27222		A	Treat hip socket fracture	12.70	NA	10.44	1.77	NA	24.91	090
27226		A	Treat hip wall fracture	14.91	NA	10.98	2.07	NA	27.96	090
27227		A	Treat hip fracture(s)	23.45	NA	17.40	3.24	NA	44.09	090
27228		A	Treat hip fracture(s)	27.16	NA	19.68	3.77	NA	50.61	090
27230		A	Treat thigh fracture	5.50	8.01	6.44	0.73	14.24	12.67	090
27232		A	Treat thigh fracture	10.68	NA	9.48	1.45	NA	21.61	090
27235		A	Treat thigh fracture	12.16	NA	11.34	1.71	NA	25.21	090
27236		A	Treat thigh fracture	15.60	NA	11.28	2.18	NA	29.06	090
27238		A	Treat thigh fracture	5.52	NA	6.55	0.76	NA	12.83	090
27240		A	Treat thigh fracture	12.50	NA	10.52	1.69	NA	24.71	090
27244		A	Treat thigh fracture	15.94	NA	13.24	2.23	NA	31.41	090
27245		A	Treat thigh fracture	20.31	NA	15.64	2.85	NA	38.80	090
27246		A	Treat thigh fracture	4.71	7.73	6.19	0.66	13.10	11.56	090
27248		A	Treat thigh fracture	10.45	NA	10.25	1.45	NA	22.15	090
27250		A	Treat hip dislocation	6.95	NA	6.49	0.68	NA	14.12	090
27252		A	Treat hip dislocation	10.39	NA	8.43	1.37	NA	20.19	090
27253		A	Treat hip dislocation	12.92	NA	11.14	1.81	NA	25.87	090
27254		A	Treat hip dislocation	18.26	NA	14.04	2.52	NA	34.82	090
27256		A	Treat hip dislocation	4.12	NA	4.45	0.49	NA	9.06	010
27257		A	Treat hip dislocation	5.22	NA	4.77	0.56	NA	10.55	010
27258		A	Treat hip dislocation	15.43	NA	14.26	2.06	NA	31.75	090
27259		A	Treat hip dislocation	21.55	NA	17.51	2.99	NA	42.05	090
27265		A	Treat hip dislocation	5.05	NA	6.25	0.65	NA	11.95	090
27266		A	Treat hip dislocation	7.49	NA	7.69	1.04	NA	16.22	090
27275		A	Manipulation of hip joint	2.27	NA	3.75	0.31	NA	6.33	010
27280		A	Fusion of sacroiliac joint	13.39	NA	14.60	1.98	NA	29.97	090
27282		A	Fusion of pubic bones	11.34	NA	12.54	1.14	NA	25.02	090
27284		A	Fusion of hip joint	23.45	NA	18.80	2.36	NA	44.61	090
27286		A	Fusion of hip joint	23.45	NA	19.33	2.37	NA	45.15	090
27290		A	Amputation of leg at hip	23.28	NA	17.03	2.94	NA	43.25	090
27295		A	Amputation of leg at hip	18.65	NA	14.46	2.35	NA	35.46	090
27299		C	Pelvis/hip joint surgery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
27301		A	Drain thigh/knee lesion	6.49	16.43	14.49	0.80	23.72	21.78	090
27303		A	Drainage of bone lesion	8.28	NA	15.57	1.14	NA	24.99	090
27305		A	Incise thigh tendon & fascia	5.92	NA	9.50	0.77	NA	16.19	090
27306		A	Incision of thigh tendon	4.62	NA	7.93	0.62	NA	13.17	090
27307		A	Incision of thigh tendons	5.80	NA	8.53	0.78	NA	15.11	090
27310		A	Exploration of knee joint	9.27	NA	10.40	1.29	NA	20.96	090
27315		A	Partial removal, thigh nerve	6.97	NA	4.45	0.79	NA	12.21	090
27320		A	Partial removal, thigh nerve	6.30	NA	4.68	0.78	NA	11.76	090
27323		A	Biopsy, thigh soft tissues	2.28	6.01	3.57	0.17	8.46	6.02	010
27324		A	Biopsy, thigh soft tissues	4.90	NA	7.14	0.59	NA	12.63	090
27327		A	Removal of thigh lesion	4.47	8.59	6.51	0.50	13.56	11.48	090
27328		A	Removal of thigh lesion	5.57	NA	7.28	0.66	NA	13.51	090
27329		A	Remove tumor, thigh/knee	14.14	NA	14.74	1.68	NA	30.56	090
27330		A	Biopsy, knee joint lining	4.97	NA	6.61	0.66	NA	12.24	090
27331		A	Explore/treat knee joint	5.88	NA	7.83	0.81	NA	14.52	090
27332		A	Removal of knee cartilage	8.27	NA	9.06	1.15	NA	18.48	090
27333		A	Removal of knee cartilage	7.30	NA	8.59	1.03	NA	16.92	090
27334		A	Remove knee joint lining	8.70	NA	9.97	1.21	NA	19.88	090
27335		A	Remove knee joint lining	10.00	NA	10.83	1.41	NA	22.24	090
27340		A	Removal of kneecap bursa	4.18	NA	6.26	0.58	NA	11.02	090
27345		A	Removal of knee cyst	5.92	NA	7.70	0.81	NA	14.43	090
27347		A	Remove knee cyst	5.78	NA	7.45	0.76	NA	13.99	090
27350		A	Removal of kneecap	8.17	NA	9.17	1.15	NA	18.49	090
27355		A	Remove femur lesion	7.65	NA	10.74	1.07	NA	19.46	090
27356		A	Remove femur lesion/graft	9.48	NA	11.74	1.29	NA	22.51	090
27357		A	Remove femur lesion/graft	10.53	NA	12.24	1.48	NA	24.25	090
27358		A	Remove femur lesion/fixation	4.74	NA	2.59	0.67	NA	8.00	ZZZ
27360		A	Partial removal, leg bone(s)	10.50	NA	18.97	1.42	NA	30.89	090
27365		A	Extensive leg surgery	16.27	NA	14.68	2.26	NA	33.21	090
27370		A	Injection for knee x-ray	0.96	11.98	0.33	0.06	13.00	1.35	000
27372		A	Removal of foreign body	5.07	8.64	6.69	0.62	14.33	12.38	090
27380		A	Repair of kneecap tendon	7.16	NA	8.67	1.00	NA	16.83	090
27381		A	Repair/graft kneecap tendon	10.34	NA	10.37	1.44	NA	22.15	090
27385		A	Repair of thigh muscle	7.76	NA	9.02	1.09	NA	17.87	090
27386		A	Repair/graft of thigh muscle	10.56	NA	11.17	1.49	NA	23.22	090
27390		A	Incision of thigh tendon	5.33	NA	8.20	0.69	NA	14.22	090
27391		A	Incision of thigh tendons	7.20	NA	9.33	0.99	NA	17.52	090
27392		A	Incision of thigh tendons	9.20	NA	11.43	1.23	NA	21.86	090
27393		A	Lengthening of thigh tendon	6.39	NA	8.74	0.90	NA	16.03	090
27394		A	Lengthening of thigh tendons	8.50	NA	11.13	1.17	NA	20.80	090
27395		A	Lengthening of thigh tendons	11.73	NA	14.02	1.63	NA	27.38	090
27396		A	Transplant of thigh tendon	7.86	NA	11.02	1.11	NA	19.99	090
27397		A	Transplants of thigh tendons	11.28	NA	12.48	1.58	NA	25.34	090
27400		A	Revise thigh muscles/tendons	9.02	NA	11.20	1.18	NA	21.40	090
27403		A	Repair of knee cartilage	8.33	NA	9.19	1.16	NA	18.68	090
27405		A	Repair of knee ligament	8.65	NA	10.04	1.21	NA	19.90	090
27407		A	Repair of knee ligament	10.28	NA	10.74	1.38	NA	22.40	090
27409		A	Repair of knee ligaments	12.90	NA	12.29	1.75	NA	26.94	090
27418		A	Repair degenerated kneecap	10.85	NA	11.28	1.51	NA	23.64	090
27420		A	Revision of unstable kneecap	9.83	NA	10.02	1.38	NA	21.23	090
27422		A	Revision of unstable kneecap	9.78	NA	10.04	1.37	NA	21.19	090
27424		A	Revision/removal of kneecap	9.81	NA	10.00	1.38	NA	21.19	090
27425		A	Lat retinacular release open	5.22	NA	7.58	0.73	NA	13.53	090
27427		A	Reconstruction, knee	9.36	NA	9.64	1.29	NA	20.29	090
27428		A	Reconstruction, knee	14.00	NA	12.86	1.95	NA	28.81	090
27429		A	Reconstruction, knee	15.52	NA	13.68	2.18	NA	31.38	090
27430		A	Revision of thigh muscles	9.67	NA	10.08	1.35	NA	21.10	090
27435		A	Incision of knee joint	9.49	NA	9.91	1.33	NA	20.73	090
27437		A	Revise kneecap	8.46	NA	7.31	1.18	NA	16.95	090
27438		A	Revise kneecap with implant	11.23	NA	8.71	1.56	NA	21.50	090
27440		A	Revision of knee joint	10.43	NA	6.23	1.42	NA	18.08	090
27441		A	Revision of knee joint	10.82	NA	6.90	1.49	NA	19.21	090
27442		A	Revision of knee joint	11.89	NA	9.09	1.68	NA	22.66	090
27443		A	Revision of knee joint	10.93	NA	8.85	1.52	NA	21.30	090
27445		A	Revision of knee joint	17.68	NA	12.52	2.49	NA	32.69	090
27446		A	Revision of knee joint	15.84	NA	11.50	2.22	NA	29.56	090
27447		A	Total knee arthroplasty	21.48	NA	14.82	3.00	NA	39.30	090
27448		A	Incision of thigh	11.06	NA	12.41	1.51	NA	24.98	090
27450		A	Incision of thigh	13.98	NA	14.20	1.96	NA	30.14	090
27454		A	Realignment of thigh bone	17.56	NA	16.02	2.46	NA	36.04	090
27455		A	Realignment of knee	12.82	NA	12.70	1.78	NA	27.30	090
27457		A	Realignment of knee	13.45	NA	11.87	1.88	NA	27.20	090
27465		A	Shortening of thigh bone	13.87	NA	14.06	1.86	NA	29.79	090
27466		A	Lengthening of thigh bone	16.33	NA	16.39	1.92	NA	34.64	090
27468		A	Shorten/lengthen thighs	18.97	NA	16.56	2.68	NA	38.21	090
27470		A	Repair of thigh	16.07	NA	16.45	2.24	NA	34.76	090
27472		A	Repair/graft of thigh	17.72	NA	17.33	2.49	NA	37.54	090
27475		A	Surgery to stop leg growth	8.64	NA	9.62	1.13	NA	19.39	090
27477		A	Surgery to stop leg growth	9.85	NA	10.08	1.31	NA	21.24	090
27479		A	Surgery to stop leg growth	12.80	NA	12.35	1.81	NA	26.96	090
27485		A	Surgery to stop leg growth	8.84	NA	9.79	1.24	NA	19.87	090
27486		A	Revise/replace knee joint	19.27	NA	13.67	2.70	NA	35.64	090
27487		A	Revise/replace knee joint	25.27	NA	16.83	3.54	NA	45.64	090
27488		A	Removal of knee prosthesis	15.74	NA	11.83	2.21	NA	29.78	090
27495		A	Reinforce thigh	15.55	NA	16.19	2.18	NA	33.92	090
27496		A	Decompression of thigh/knee	6.11	NA	8.25	0.77	NA	15.13	090
27497		A	Decompression of thigh/knee	7.17	NA	8.28	0.84	NA	16.29	090
27498		A	Decompression of thigh/knee	7.99	NA	8.67	0.97	NA	17.63	090
27499		A	Decompression of thigh/knee	9.00	NA	9.28	1.18	NA	19.46	090
27500		A	Treatment of thigh fracture	5.92	10.40	7.84	0.80	17.12	14.56	090
27501		A	Treatment of thigh fracture	5.92	11.65	9.09	0.83	18.40	15.84	090
27502		A	Treatment of thigh fracture	10.58	NA	11.60	1.49	NA	23.67	090
27503		A	Treatment of thigh fracture	10.58	NA	11.64	1.49	NA	23.71	090
27506		A	Treatment of thigh fracture	17.45	NA	14.57	2.33	NA	34.35	090
27507		A	Treatment of thigh fracture	13.99	NA	12.74	1.95	NA	28.68	090
27508		A	Treatment of thigh fracture	5.83	7.42	5.52	0.80	14.05	12.15	090
27509		A	Treatment of thigh fracture	7.71	NA	9.50	1.08	NA	18.29	090
27510		A	Treatment of thigh fracture	9.13	NA	7.39	1.26	NA	17.78	090
27511		A	Treatment of thigh fracture	13.64	NA	13.34	1.91	NA	28.89	090
27513		A	Treatment of thigh fracture	17.92	NA	15.66	2.51	NA	36.09	090
27514		A	Treatment of thigh fracture	17.30	NA	14.78	2.41	NA	34.49	090
27516		A	Treat thigh fx growth plate	5.37	8.20	6.00	0.74	14.31	12.11	090
27517		A	Treat thigh fx growth plate	8.78	9.86	7.97	1.22	19.86	17.97	090
27519		A	Treat thigh fx growth plate	15.02	NA	13.83	2.09	NA	30.94	090
27520		A	Treat kneecap fracture	2.86	5.79	3.90	0.38	9.03	7.14	090
27524		A	Treat kneecap fracture	10.00	NA	9.05	1.40	NA	20.45	090
27530		A	Treat knee fracture	3.78	6.31	4.45	0.51	10.60	8.74	090
27532		A	Treat knee fracture	7.30	7.79	5.87	1.02	16.11	14.19	090
27535		A	Treat knee fracture	11.50	NA	12.23	1.61	NA	25.34	090
27536		A	Treat knee fracture	15.65	NA	12.09	2.19	NA	29.93	090
27538		A	Treat knee fracture(s)	4.87	7.97	5.73	0.67	13.51	11.27	090
27540		A	Treat knee fracture	13.10	NA	10.55	1.80	NA	25.45	090
27550		A	Treat knee dislocation	5.76	7.57	5.83	0.68	14.01	12.27	090
27552		A	Treat knee dislocation	7.90	NA	8.23	1.10	NA	17.23	090
27556		A	Treat knee dislocation	14.41	NA	14.69	2.01	NA	31.11	090
27557		A	Treat knee dislocation	16.77	NA	15.93	2.37	NA	35.07	090
27558		A	Treat knee dislocation	17.72	NA	16.13	2.51	NA	36.36	090
27560		A	Treat kneecap dislocation	3.82	6.20	3.99	0.40	10.42	8.21	090
27562		A	Treat kneecap dislocation	5.79	NA	5.85	0.69	NA	12.33	090
27566		A	Treat kneecap dislocation	12.23	NA	10.20	1.73	NA	24.16	090
27570		A	Fixation of knee joint	1.74	NA	3.45	0.24	NA	5.43	010
27580		A	Fusion of knee	19.37	NA	16.57	2.70	NA	38.64	090
27590		A	Amputate leg at thigh	12.03	NA	12.59	1.35	NA	25.97	090
27591		A	Amputate leg at thigh	12.68	NA	14.63	1.63	NA	28.94	090
27592		A	Amputate leg at thigh	10.02	NA	12.18	1.17	NA	23.37	090
27594		A	Amputation follow-up surgery	6.92	NA	9.10	0.82	NA	16.84	090
27596		A	Amputation follow-up surgery	10.60	NA	12.65	1.24	NA	24.49	090
27598		A	Amputate lower leg at knee	10.53	NA	11.61	1.24	NA	23.38	090
27599		C	Leg surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
27600		A	Decompression of lower leg	5.65	NA	7.85	0.68	NA	14.18	090
27601		A	Decompression of lower leg	5.64	NA	7.79	0.69	NA	14.12	090
27602		A	Decompression of lower leg	7.35	NA	8.13	0.85	NA	16.33	090
27603		A	Drain lower leg lesion	4.94	16.03	10.71	0.56	21.53	16.21	090
27604		A	Drain lower leg bursa	4.47	11.74	8.69	0.54	16.75	13.70	090
27605		A	Incision of achilles tendon	2.87	10.88	4.01	0.38	14.13	7.26	010
27606		A	Incision of achilles tendon	4.14	13.17	5.24	0.57	17.88	9.95	010
27607		A	Treat lower leg bone lesion	7.97	NA	14.85	1.08	NA	23.90	090
27610		A	Explore/treat ankle joint	8.34	NA	10.90	1.15	NA	20.39	090
27612		A	Exploration of ankle joint	7.33	NA	8.61	1.01	NA	16.95	090
27613		A	Biopsy lower leg soft tissue	2.17	5.93	3.16	0.16	8.26	5.49	010
27614		A	Biopsy lower leg soft tissue	5.66	11.55	7.39	0.62	17.83	13.67	090
27615		A	Remove tumor, lower leg	12.56	NA	16.85	1.39	NA	30.80	090
27618		A	Remove lower leg lesion	5.09	11.86	6.86	0.54	17.49	12.49	090
27619		A	Remove lower leg lesion	8.40	13.36	9.46	1.01	22.77	18.87	090
27620		A	Explore/treat ankle joint	5.98	NA	8.48	0.83	NA	15.29	090
27625		A	Remove ankle joint lining	8.30	NA	10.10	1.16	NA	19.56	090
27626		A	Remove ankle joint lining	8.91	NA	10.79	1.23	NA	20.93	090
27630		A	Removal of tendon lesion	4.80	11.52	7.24	0.60	16.92	12.64	090
27635		A	Remove lower leg bone lesion	7.78	NA	11.58	1.06	NA	20.42	090
27637		A	Remove/graft leg bone lesion	9.85	NA	12.91	1.38	NA	24.14	090
27638		A	Remove/graft leg bone lesion	10.57	NA	13.24	1.47	NA	25.28	090
27640		A	Partial removal of tibia	11.37	NA	18.94	1.54	NA	31.85	090
27641		A	Partial removal of fibula	9.24	NA	16.89	1.22	NA	27.35	090
27645		A	Extensive lower leg surgery	14.17	NA	18.70	1.98	NA	34.85	090
27646		A	Extensive lower leg surgery	12.66	NA	17.64	1.55	NA	31.85	090
27647		A	Extensive ankle/heel surgery	12.24	NA	11.52	1.64	NA	25.40	090
27648		A	Injection for ankle x-ray	0.96	9.75	0.34	0.05	10.76	1.35	000
27650		A	Repair achilles tendon	9.69	NA	9.79	1.35	NA	20.83	090
27652		A	Repair/graft achilles tendon	10.33	NA	10.02	1.45	NA	21.80	090
27654		A	Repair of achilles tendon	10.02	NA	10.51	1.41	NA	21.94	090
27656		A	Repair leg fascia defect	4.57	12.84	6.76	0.48	17.89	11.81	090
27658		A	Repair of leg tendon, each	4.98	13.20	9.52	0.68	18.86	15.18	090
27659		A	Repair of leg tendon, each	6.81	14.89	10.27	0.96	22.66	18.04	090
27664		A	Repair of leg tendon, each	4.59	15.00	9.66	0.63	20.22	14.88	090
27665		A	Repair of leg tendon, each	5.40	14.63	9.79	0.75	20.78	15.94	090
27675		A	Repair lower leg tendons	7.18	NA	8.63	1.01	NA	16.82	090
27676		A	Repair lower leg tendons	8.42	NA	9.68	1.15	NA	19.25	090
27680		A	Release of lower leg tendon	5.74	NA	8.48	0.80	NA	15.02	090
27681		A	Release of lower leg tendons	6.82	NA	8.98	0.92	NA	16.72	090
27685		A	Revision of lower leg tendon	6.50	10.50	8.74	0.91	17.91	16.15	090
27686		A	Revise lower leg tendons	7.46	15.11	10.39	1.05	23.62	18.90	090
27687		A	Revision of calf tendon	6.24	NA	8.90	0.88	NA	16.02	090
27690		A	Revise lower leg tendon	8.71	NA	9.75	1.22	NA	19.68	090
27691		A	Revise lower leg tendon	9.96	NA	11.37	1.40	NA	22.73	090
27692		A	Revise additional leg tendon	1.87	NA	0.95	0.26	NA	3.08	ZZZ
27695		A	Repair of ankle ligament	6.51	NA	9.63	0.90	NA	17.04	090
27696		A	Repair of ankle ligaments	8.27	NA	9.97	1.16	NA	19.40	090
27698		A	Repair of ankle ligament	9.36	NA	9.72	1.31	NA	20.39	090
27700		A	Revision of ankle joint	9.29	NA	5.81	1.24	NA	16.34	090
27702		A	Reconstruct ankle joint	13.67	NA	10.57	1.92	NA	26.16	090
27703		A	Reconstruction, ankle joint	15.87	NA	11.36	2.24	NA	29.47	090
27704		A	Removal of ankle implant	7.62	NA	5.75	0.61	NA	13.98	090
27705		A	Incision of tibia	10.38	NA	11.94	1.44	NA	23.76	090
27707		A	Incision of fibula	4.37	NA	8.83	0.60	NA	13.80	090
27709		A	Incision of tibia & fibula	9.95	NA	11.93	1.39	NA	23.27	090
27712		A	Realignment of lower leg	14.25	NA	14.10	2.00	NA	30.35	090
27715		A	Revision of lower leg	14.39	NA	15.50	2.00	NA	31.89	090
27720		A	Repair of tibia	11.79	NA	14.12	1.66	NA	27.57	090
27722		A	Repair/graft of tibia	11.82	NA	13.88	1.65	NA	27.35	090
27724		A	Repair/graft of tibia	18.20	NA	17.61	2.10	NA	37.91	090
27725		A	Repair of lower leg	15.59	NA	16.06	2.20	NA	33.85	090
27727		A	Repair of lower leg	14.01	NA	14.96	1.84	NA	30.81	090
27730		A	Repair of tibia epiphysis	7.41	21.22	10.17	0.75	29.38	18.33	090
27732		A	Repair of fibula epiphysis	5.32	14.21	8.71	0.63	20.16	14.66	090
27734		A	Repair lower leg epiphyses	8.48	NA	9.91	0.85	NA	19.24	090
27740		A	Repair of leg epiphyses	9.30	23.90	11.76	1.31	34.51	22.37	090
27742		A	Repair of leg epiphyses	10.30	16.69	10.97	1.55	28.54	22.82	090
27745		A	Reinforce tibia	10.07	NA	12.05	1.38	NA	23.50	090
27750		A	Treatment of tibia fracture	3.19	5.93	4.10	0.43	9.55	7.72	090
27752		A	Treatment of tibia fracture	5.84	8.53	6.34	0.82	15.19	13.00	090
27756		A	Treatment of tibia fracture	6.78	NA	11.38	0.94	NA	19.10	090
27758		A	Treatment of tibia fracture	11.67	NA	12.42	1.52	NA	25.61	090
27759		A	Treatment of tibia fracture	13.76	NA	13.74	1.93	NA	29.43	090
27760		A	Treatment of ankle fracture	3.01	5.69	3.91	0.39	9.09	7.31	090
27762		A	Treatment of ankle fracture	5.25	7.99	5.87	0.71	13.95	11.83	090
27766		A	Treatment of ankle fracture	8.36	NA	8.68	1.17	NA	18.21	090
27780		A	Treatment of fibula fracture	2.65	5.61	3.71	0.33	8.59	6.69	090
27781		A	Treatment of fibula fracture	4.40	6.84	4.69	0.57	11.81	9.66	090
27784		A	Treatment of fibula fracture	7.11	NA	8.92	0.98	NA	17.01	090
27786		A	Treatment of ankle fracture	2.84	5.66	3.83	0.37	8.87	7.04	090
27788		A	Treatment of ankle fracture	4.45	6.92	4.75	0.61	11.98	9.81	090
27792		A	Treatment of ankle fracture	7.66	NA	8.40	1.07	NA	17.13	090
27808		A	Treatment of ankle fracture	2.83	6.81	4.62	0.38	10.02	7.83	090
27810		A	Treatment of ankle fracture	5.13	8.08	5.88	0.71	13.92	11.72	090
27814		A	Treatment of ankle fracture	10.68	NA	11.19	1.50	NA	23.37	090
27816		A	Treatment of ankle fracture	2.89	6.27	4.63	0.37	9.53	7.89	090
27818		A	Treatment of ankle fracture	5.50	8.22	6.02	0.74	14.46	12.26	090
27822		A	Treatment of ankle fracture	11.00	NA	13.50	1.29	NA	25.79	090
27823		A	Treatment of ankle fracture	13.00	NA	14.56	1.65	NA	29.21	090
27824		A	Treat lower leg fracture	2.89	6.73	4.63	0.39	10.01	7.91	090
27825		A	Treat lower leg fracture	6.19	8.70	6.50	0.85	15.74	13.54	090
27826		A	Treat lower leg fracture	8.54	NA	12.17	1.19	NA	21.90	090
27827		A	Treat lower leg fracture	14.06	NA	15.23	1.96	NA	31.25	090
27828		A	Treat lower leg fracture	16.23	NA	15.93	2.27	NA	34.43	090
27829		A	Treat lower leg joint	5.49	NA	8.94	0.77	NA	15.20	090
27830		A	Treat lower leg dislocation	3.79	5.77	4.31	0.44	10.00	8.54	090
27831		A	Treat lower leg dislocation	4.56	NA	5.53	0.61	NA	10.70	090
27832		A	Treat lower leg dislocation	6.49	NA	8.61	0.91	NA	16.01	090
27840		A	Treat ankle dislocation	4.58	NA	6.11	0.47	NA	11.16	090
27842		A	Treat ankle dislocation	6.21	NA	5.25	0.76	NA	12.22	090
27846		A	Treat ankle dislocation	9.79	NA	10.58	1.36	NA	21.73	090
27848		A	Treat ankle dislocation	11.20	NA	11.92	1.55	NA	24.67	090
27860		A	Fixation of ankle joint	2.34	NA	3.76	0.31	NA	6.41	010
27870		A	Fusion of ankle joint, open	13.91	NA	14.08	1.95	NA	29.94	090
27871		A	Fusion of tibiofibular joint	9.17	NA	11.36	1.29	NA	21.82	090
27880		A	Amputation of lower leg	11.85	NA	11.88	1.38	NA	25.11	090
27881		A	Amputation of lower leg	12.34	NA	13.55	1.59	NA	27.48	090
27882		A	Amputation of lower leg	8.94	NA	12.97	1.03	NA	22.94	090
27884		A	Amputation follow-up surgery	8.21	NA	10.83	0.95	NA	19.99	090
27886		A	Amputation follow-up surgery	9.32	NA	11.37	1.13	NA	21.82	090
27888		A	Amputation of foot at ankle	9.67	NA	11.23	1.26	NA	22.16	090
27889		A	Amputation of foot at ankle	9.98	NA	10.58	1.19	NA	21.75	090
27892		A	Decompression of leg	7.39	NA	8.26	0.86	NA	16.51	090
27893		A	Decompression of leg	7.35	NA	8.11	0.90	NA	16.36	090
27894		A	Decompression of leg	10.49	NA	9.56	1.25	NA	21.30	090
27899		C	Leg/ankle surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
28001		A	Drainage of bursa of foot	2.73	5.63	3.23	0.31	8.67	6.27	010
28002		A	Treatment of foot infection	4.62	6.93	4.33	0.56	12.11	9.51	010
28003		A	Treatment of foot infection	8.41	11.29	10.81	1.03	20.73	20.25	090
28005		A	Treat foot bone lesion	8.68	NA	10.68	1.14	NA	20.50	090
28008		A	Incision of foot fascia	4.45	8.11	6.33	0.56	13.12	11.34	090
28010		A	Incision of toe tendon	2.84	7.56	5.29	0.39	10.79	8.52	090
28011		A	Incision of toe tendons	4.14	9.37	7.07	0.58	14.09	11.79	090
28020		A	Exploration of foot joint	5.01	9.32	6.74	0.64	14.97	12.39	090
28022		A	Exploration of foot joint	4.67	8.13	6.33	0.62	13.42	11.62	090
28024		A	Exploration of toe joint	4.38	8.30	6.56	0.50	13.18	11.44	090
28030		A	Removal of foot nerve	6.15	NA	3.46	0.85	NA	10.46	090
28035		A	Decompression of tibia nerve	5.09	9.32	5.50	0.71	15.12	11.30	090
28043		A	Excision of foot lesion	3.54	7.53	5.21	0.45	11.52	9.20	090
28045		A	Excision of foot lesion	4.72	8.14	5.91	0.62	13.48	11.25	090
28046		A	Resection of tumor, foot	10.18	12.35	10.95	1.13	23.66	22.26	090
28050		A	Biopsy of foot joint lining	4.25	7.78	6.03	0.55	12.58	10.83	090
28052		A	Biopsy of foot joint lining	3.94	8.10	6.14	0.51	12.55	10.59	090
28054		A	Biopsy of toe joint lining	3.45	8.01	5.96	0.45	11.91	9.86	090
28060		A	Partial removal, foot fascia	5.23	8.76	6.63	0.69	14.68	12.55	090
28062		A	Removal of foot fascia	6.52	9.62	6.52	0.85	16.99	13.89	090
28070		A	Removal of foot joint lining	5.10	7.95	6.12	0.68	13.73	11.90	090
28072		A	Removal of foot joint lining	4.58	8.50	7.07	0.64	13.72	12.29	090
28080		A	Removal of foot lesion	3.58	7.89	5.68	0.50	11.97	9.76	090
28086		A	Excise foot tendon sheath	4.78	11.42	7.64	0.66	16.86	13.08	090
28088		A	Excise foot tendon sheath	3.86	9.48	6.95	0.52	13.86	11.33	090
28090		A	Removal of foot lesion	4.41	8.05	5.73	0.57	13.03	10.71	090
28092		A	Removal of toe lesions	3.64	8.48	6.17	0.46	12.58	10.27	090
28100		A	Removal of ankle/heel lesion	5.66	11.90	7.91	0.76	18.32	14.33	090
28102		A	Remove/graft foot lesion	7.73	NA	9.27	0.97	NA	17.97	090
28103		A	Remove/graft foot lesion	6.50	10.07	7.46	0.89	17.46	14.85	090
28104		A	Removal of foot lesion	5.12	8.79	6.99	0.69	14.60	12.80	090
28106		A	Remove/graft foot lesion	7.16	NA	6.84	1.01	NA	15.01	090
28107		A	Remove/graft foot lesion	5.56	10.01	7.09	0.74	16.31	13.39	090
28108		A	Removal of toe lesions	4.16	7.42	5.44	0.52	12.10	10.12	090
28110		A	Part removal of metatarsal	4.08	8.95	7.08	0.49	13.52	11.65	090
28111		A	Part removal of metatarsal	5.01	10.65	7.86	0.63	16.29	13.50	090
28112		A	Part removal of metatarsal	4.49	9.66	7.66	0.60	14.75	12.75	090
28113		A	Part removal of metatarsal	4.79	9.24	7.32	0.63	14.66	12.74	090
28114		A	Removal of metatarsal heads	9.79	14.07	11.12	1.36	25.22	22.27	090
28116		A	Revision of foot	7.75	8.88	6.83	1.03	17.66	15.61	090
28118		A	Removal of heel bone	5.96	9.52	7.26	0.79	16.27	14.01	090
28119		A	Removal of heel spur	5.39	8.54	6.23	0.74	14.67	12.36	090
28120		A	Part removal of ankle/heel	5.40	12.72	10.02	0.69	18.81	16.11	090
28122		A	Partial removal of foot bone	7.29	11.28	9.68	0.96	19.53	17.93	090
28124		A	Partial removal of toe	4.81	9.52	7.87	0.65	14.98	13.33	090
28126		A	Partial removal of toe	3.52	8.27	7.11	0.49	12.28	11.12	090
28130		A	Removal of ankle bone	8.11	NA	9.03	1.11	NA	18.25	090
28140		A	Removal of metatarsal	6.91	10.80	7.99	0.84	18.55	15.74	090
28150		A	Removal of toe	4.09	8.94	7.33	0.52	13.55	11.94	090
28153		A	Partial removal of toe	3.66	8.27	5.96	0.49	12.42	10.11	090
28160		A	Partial removal of toe	3.74	8.58	7.50	0.51	12.83	11.75	090
28171		A	Extensive foot surgery	9.60	NA	8.48	1.13	NA	19.21	090
28173		A	Extensive foot surgery	8.80	11.13	8.87	1.04	20.97	18.71	090
28175		A	Extensive foot surgery	6.05	9.58	6.90	0.75	16.38	13.70	090
28190		A	Removal of foot foreign body	1.96	6.41	3.42	0.16	8.53	5.54	010
28192		A	Removal of foot foreign body	4.64	8.20	5.59	0.52	13.36	10.75	090
28193		A	Removal of foot foreign body	5.73	8.77	6.70	0.63	15.13	13.06	090
28200		A	Repair of foot tendon	4.60	8.41	6.53	0.59	13.60	11.72	090
28202		A	Repair/graft of foot tendon	6.84	11.55	7.11	0.86	19.25	14.81	090
28208		A	Repair of foot tendon	4.37	8.15	6.10	0.59	13.11	11.06	090
28210		A	Repair/graft of foot tendon	6.35	9.60	6.56	0.77	16.72	13.68	090
28220		A	Release of foot tendon	4.53	7.94	6.29	0.63	13.10	11.45	090
28222		A	Release of foot tendons	5.62	8.34	7.12	0.77	14.73	13.51	090
28225		A	Release of foot tendon	3.66	7.72	5.83	0.50	11.88	9.99	090
28226		A	Release of foot tendons	4.53	7.99	6.80	0.62	13.14	11.95	090
28230		A	Incision of foot tendon(s)	4.24	8.10	7.09	0.59	12.93	11.92	090
28232		A	Incision of toe tendon	3.39	8.14	6.78	0.48	12.01	10.65	090
28234		A	Incision of foot tendon	3.37	8.22	6.25	0.46	12.05	10.08	090
28238		A	Revision of foot tendon	7.73	10.31	7.61	1.08	19.12	16.42	090
28240		A	Release of big toe	4.36	8.05	6.67	0.61	13.02	11.64	090
28250		A	Revision of foot fascia	5.92	9.00	7.08	0.81	15.73	13.81	090
28260		A	Release of midfoot joint	7.96	9.47	7.73	1.08	18.51	16.77	090
28261		A	Revision of foot tendon	11.73	11.02	9.66	1.66	24.41	23.05	090
28262		A	Revision of foot and ankle	15.83	17.31	15.44	2.22	35.36	33.49	090
28264		A	Release of midfoot joint	10.35	11.28	11.28	1.46	23.09	23.09	090
28270		A	Release of foot contracture	4.76	8.70	7.46	0.67	14.13	12.89	090
28272		A	Release of toe joint, each	3.80	7.59	5.63	0.52	11.91	9.95	090
28280		A	Fusion of toes	5.19	9.25	7.16	0.72	15.16	13.07	090
28285		A	Repair of hammertoe	4.59	8.76	6.85	0.64	13.99	12.08	090
28286		A	Repair of hammertoe	4.56	8.62	6.80	0.64	13.82	12.00	090
28288		A	Partial removal of foot bone	4.74	9.14	8.50	0.65	14.53	13.89	090
28289		A	Repair hallux rigidus	7.04	11.61	9.63	0.96	19.61	17.63	090
28290		A	Correction of bunion	5.66	9.89	9.25	0.79	16.34	15.70	090
28292		A	Correction of bunion	7.04	9.86	7.77	0.98	17.88	15.79	090
28293		A	Correction of bunion	9.15	8.28	5.99	1.28	18.71	16.42	090
28294		A	Correction of bunion	8.56	10.47	7.96	1.16	20.19	17.68	090
28296		A	Correction of bunion	9.18	10.94	8.74	1.28	21.40	19.20	090
28297		A	Correction of bunion	9.18	11.96	10.51	1.31	22.45	21.00	090
28298		A	Correction of bunion	7.94	10.07	8.40	1.12	19.13	17.46	090
28299		A	Correction of bunion	10.58	11.36	9.11	1.24	23.18	20.93	090
28300		A	Incision of heel bone	9.54	15.04	9.59	1.31	25.89	20.44	090
28302		A	Incision of ankle bone	9.55	14.76	9.53	1.15	25.46	20.23	090
28304		A	Incision of midfoot bones	9.16	10.31	7.89	1.00	20.47	18.05	090
28305		A	Incise/graft midfoot bones	10.50	14.76	9.73	0.55	25.81	20.78	090
28306		A	Incision of metatarsal	5.86	9.21	6.48	0.81	15.88	13.15	090
28307		A	Incision of metatarsal	6.33	13.36	8.20	0.71	20.40	15.24	090
28308		A	Incision of metatarsal	5.29	7.88	5.45	0.74	13.91	11.48	090
28309		A	Incision of metatarsals	12.78	NA	10.66	1.64	NA	25.08	090
28310		A	Revision of big toe	5.43	9.14	6.99	0.76	15.33	13.18	090
28312		A	Revision of toe	4.55	8.87	7.70	0.62	14.04	12.87	090
28313		A	Repair deformity of toe	5.01	9.36	9.36	0.68	15.05	15.05	090
28315		A	Removal of sesamoid bone	4.86	7.91	5.75	0.66	13.43	11.27	090
28320		A	Repair of foot bones	9.18	NA	9.14	1.27	NA	19.59	090
28322		A	Repair of metatarsals	8.34	11.91	8.67	1.17	21.42	18.18	090
28340		A	Resect enlarged toe tissue	6.98	9.40	6.86	0.98	17.36	14.82	090
28341		A	Resect enlarged toe	8.41	9.50	7.14	1.18	19.09	16.73	090
28344		A	Repair extra toe(s)	4.26	8.82	5.99	0.60	13.68	10.85	090
28345		A	Repair webbed toe(s)	5.92	9.33	7.70	0.84	16.09	14.46	090
28360		A	Reconstruct cleft foot	13.34	NA	13.96	1.88	NA	29.18	090
28400		A	Treatment of heel fracture	2.16	6.16	4.90	0.29	8.61	7.35	090
28405		A	Treatment of heel fracture	4.57	7.06	6.09	0.63	12.26	11.29	090
28406		A	Treatment of heel fracture	6.31	NA	9.13	0.87	NA	16.31	090
28415		A	Treat heel fracture	15.97	NA	15.68	2.24	NA	33.89	090
28420		A	Treat/graft heel fracture	16.64	NA	16.03	2.29	NA	34.96	090
28430		A	Treatment of ankle fracture	2.09	5.58	4.27	0.27	7.94	6.63	090
28435		A	Treatment of ankle fracture	3.40	5.82	4.89	0.47	9.69	8.76	090
28436		A	Treatment of ankle fracture	4.71	NA	8.17	0.66	NA	13.54	090
28445		A	Treat ankle fracture	15.62	NA	14.08	1.29	NA	30.99	090
28450		A	Treat midfoot fracture, each	1.90	5.53	4.16	0.25	7.68	6.31	090
28455		A	Treat midfoot fracture, each	3.09	5.46	5.08	0.43	8.98	8.60	090
28456		A	Treat midfoot fracture	2.68	NA	6.50	0.36	NA	9.54	090
28465		A	Treat midfoot fracture, each	7.01	NA	8.48	0.87	NA	16.36	090
28470		A	Treat metatarsal fracture	1.99	4.77	3.44	0.26	7.02	5.69	090
28475		A	Treat metatarsal fracture	2.97	5.37	4.59	0.41	8.75	7.97	090
28476		A	Treat metatarsal fracture	3.38	NA	7.01	0.46	NA	10.85	090
28485		A	Treat metatarsal fracture	5.71	NA	8.18	0.80	NA	14.69	090
28490		A	Treat big toe fracture	1.09	2.86	2.18	0.13	4.08	3.40	090
28495		A	Treat big toe fracture	1.58	2.96	2.31	0.19	4.73	4.08	090
28496		A	Treat big toe fracture	2.33	10.94	5.26	0.32	13.59	7.91	090
28505		A	Treat big toe fracture	3.81	11.49	6.99	0.50	15.80	11.30	090
28510		A	Treatment of toe fracture	1.09	2.55	2.17	0.13	3.77	3.39	090
28515		A	Treatment of toe fracture	1.46	2.80	2.26	0.17	4.43	3.89	090
28525		A	Treat toe fracture	3.32	11.14	6.62	0.44	14.90	10.38	090
28530		A	Treat sesamoid bone fracture	1.06	3.07	2.81	0.13	4.26	4.00	090
28531		A	Treat sesamoid bone fracture	2.35	11.17	4.20	0.33	13.85	6.88	090
28540		A	Treat foot dislocation	2.04	3.82	3.82	0.24	6.10	6.10	090
28545		A	Treat foot dislocation	2.45	4.11	4.11	0.33	6.89	6.89	090
28546		A	Treat foot dislocation	3.20	9.17	6.25	0.46	12.83	9.91	090
28555		A	Repair foot dislocation	6.30	13.38	8.67	0.88	20.56	15.85	090
28570		A	Treat foot dislocation	1.66	4.23	4.00	0.22	6.11	5.88	090
28575		A	Treat foot dislocation	3.31	6.02	5.69	0.45	9.78	9.45	090
28576		A	Treat foot dislocation	4.17	11.89	6.88	0.56	16.62	11.61	090
28585		A	Repair foot dislocation	7.99	9.70	8.46	1.13	18.82	17.58	090
28600		A	Treat foot dislocation	1.89	4.58	4.15	0.24	6.71	6.28	090
28605		A	Treat foot dislocation	2.71	5.24	5.20	0.35	8.30	8.26	090
28606		A	Treat foot dislocation	4.90	16.53	7.41	0.68	22.11	12.99	090
28615		A	Repair foot dislocation	7.77	NA	9.71	1.09	NA	18.57	090
28630		A	Treat toe dislocation	1.70	2.39	2.39	0.17	4.26	4.26	010
28635		A	Treat toe dislocation	1.91	2.60	2.60	0.24	4.75	4.75	010
28636		A	Treat toe dislocation	2.77	7.15	3.21	0.39	10.31	6.37	010
28645		A	Repair toe dislocation	4.22	6.72	4.42	0.58	11.52	9.22	090
28660		A	Treat toe dislocation	1.23	3.15	2.47	0.11	4.49	3.81	010
28665		A	Treat toe dislocation	1.92	2.63	2.63	0.24	4.79	4.79	010
28666		A	Treat toe dislocation	2.66	7.78	2.94	0.38	10.82	5.98	010
28675		A	Repair of toe dislocation	2.92	9.64	5.13	0.41	12.97	8.46	090
28705		A	Fusion of foot bones	18.80	NA	15.42	2.13	NA	36.35	090
28715		A	Fusion of foot bones	13.10	NA	12.85	1.84	NA	27.79	090
28725		A	Fusion of foot bones	11.61	NA	11.67	1.63	NA	24.91	090
28730		A	Fusion of foot bones	10.76	NA	11.03	1.51	NA	23.30	090
28735		A	Fusion of foot bones	10.85	NA	10.81	1.51	NA	23.17	090
28737		A	Revision of foot bones	9.64	NA	9.45	1.36	NA	20.45	090
28740		A	Fusion of foot bones	8.02	13.73	9.19	1.13	22.88	18.34	090
28750		A	Fusion of big toe joint	7.30	14.99	9.59	1.03	23.32	17.92	090
28755		A	Fusion of big toe joint	4.74	9.24	6.76	0.66	14.64	12.16	090
28760		A	Fusion of big toe joint	7.75	10.17	7.89	1.07	18.99	16.71	090
28800		A	Amputation of midfoot	8.21	NA	9.11	0.98	NA	18.30	090
28805		A	Amputation thru metatarsal	8.39	NA	9.05	0.97	NA	18.41	090
28810		A	Amputation toe & metatarsal	6.21	NA	7.96	0.70	NA	14.87	090
28820		A	Amputation of toe	4.41	11.19	7.26	0.51	16.11	12.18	090
28825		A	Partial amputation of toe	3.59	10.58	7.11	0.43	14.60	11.13	090
28899		C	Foot/toes surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
29000		A	Application of body cast	2.25	3.08	1.74	0.30	5.63	4.29	000
29010		A	Application of body cast	2.06	3.07	1.72	0.27	5.40	4.05	000
29015		A	Application of body cast	2.41	2.97	1.60	0.21	5.59	4.22	000
29020		A	Application of body cast	2.11	3.27	1.44	0.16	5.54	3.71	000
29025		A	Application of body cast	2.40	3.16	1.86	0.26	5.82	4.52	000
29035		A	Application of body cast	1.77	3.10	1.53	0.24	5.11	3.54	000
29040		A	Application of body cast	2.22	2.48	1.54	0.35	5.05	4.11	000
29044		A	Application of body cast	2.12	3.42	1.83	0.29	5.83	4.24	000
29046		A	Application of body cast	2.41	3.12	2.01	0.34	5.87	4.76	000
29049		A	Application of figure eight	0.89	1.10	0.57	0.12	2.11	1.58	000
29055		A	Application of shoulder cast	1.78	2.54	1.44	0.24	4.56	3.46	000
29058		A	Application of shoulder cast	1.31	1.36	0.76	0.14	2.81	2.21	000
29065		A	Application of long arm cast	0.87	1.15	0.70	0.12	2.14	1.69	000
29075		A	Application of forearm cast	0.77	1.09	0.64	0.11	1.97	1.52	000
29085		A	Apply hand/wrist cast	0.87	1.13	0.62	0.11	2.11	1.60	000
29086		A	Apply finger cast	0.62	0.72	0.55	0.06	1.40	1.23	000
29105		A	Apply long arm splint	0.87	1.08	0.51	0.11	2.06	1.49	000
29125		A	Apply forearm splint	0.59	0.91	0.40	0.06	1.56	1.05	000
29126		A	Apply forearm splint	0.77	1.13	0.47	0.06	1.96	1.30	000
29130		A	Application of finger splint	0.50	0.44	0.17	0.05	0.99	0.72	000
29131		A	Application of finger splint	0.55	0.71	0.24	0.03	1.29	0.82	000
29200		A	Strapping of chest	0.65	0.80	0.36	0.04	1.49	1.05	000
29220		A	Strapping of low back	0.64	0.75	0.40	0.07	1.46	1.11	000
29240		A	Strapping of shoulder	0.71	0.88	0.39	0.05	1.64	1.15	000
29260		A	Strapping of elbow or wrist	0.55	0.77	0.34	0.04	1.36	0.93	000
29280		A	Strapping of hand or finger	0.51	0.81	0.34	0.04	1.36	0.89	000
29305		A	Application of hip cast	2.03	2.91	1.65	0.29	5.23	3.97	000
29325		A	Application of hip casts	2.32	3.09	1.83	0.31	5.72	4.46	000
29345		A	Application of long leg cast	1.40	1.55	1.02	0.19	3.14	2.61	000
29355		A	Application of long leg cast	1.53	1.53	1.07	0.20	3.26	2.80	000
29358		A	Apply long leg cast brace	1.43	1.80	1.04	0.19	3.42	2.66	000
29365		A	Application of long leg cast	1.18	1.44	0.90	0.17	2.79	2.25	000
29405		A	Apply short leg cast	0.86	1.07	0.67	0.12	2.05	1.65	000
29425		A	Apply short leg cast	1.01	1.08	0.70	0.14	2.23	1.85	000
29435		A	Apply short leg cast	1.18	1.37	0.89	0.17	2.72	2.24	000
29440		A	Addition of walker to cast	0.57	0.63	0.27	0.07	1.27	0.91	000
29445		A	Apply rigid leg cast	1.78	1.64	0.95	0.24	3.66	2.97	000
29450		A	Application of leg cast	2.08	1.39	1.08	0.13	3.60	3.29	000
29505		A	Application, long leg splint	0.69	1.06	0.47	0.06	1.81	1.22	000
29515		A	Application lower leg splint	0.73	0.80	0.47	0.07	1.60	1.27	000
29520		A	Strapping of hip	0.54	0.88	0.44	0.02	1.44	1.00	000
29530		A	Strapping of knee	0.57	0.82	0.35	0.04	1.43	0.96	000
29540		A	Strapping of ankle and/or ft	0.51	0.39	0.32	0.04	0.94	0.87	000
29550		A	Strapping of toes	0.47	0.40	0.27	0.05	0.92	0.79	000
29580		A	Application of paste boot	0.57	0.60	0.35	0.05	1.22	0.97	000
29590		A	Application of foot splint	0.76	0.49	0.30	0.06	1.31	1.12	000
29700		A	Removal/revision of cast	0.57	0.81	0.29	0.07	1.45	0.93	000
29705		A	Removal/revision of cast	0.76	0.74	0.39	0.10	1.60	1.25	000
29710		A	Removal/revision of cast	1.34	1.41	0.71	0.17	2.92	2.22	000
29715		A	Removal/revision of cast	0.94	1.08	0.41	0.08	2.10	1.43	000
29720		A	Repair of body cast	0.68	1.00	0.39	0.10	1.78	1.17	000
29730		A	Windowing of cast	0.75	0.73	0.35	0.10	1.58	1.20	000
29740		A	Wedging of cast	1.12	1.04	0.50	0.15	2.31	1.77	000
29750		A	Wedging of clubfoot cast	1.26	1.00	0.59	0.16	2.42	2.01	000
29799		C	Casting/strapping procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
29800		A	Jaw arthroscopy/surgery	6.43	NA	9.06	0.84	NA	16.33	090
29804		A	Jaw arthroscopy/surgery	8.14	NA	8.53	0.66	NA	17.33	090
29805		A	Shoulder arthroscopy, dx	5.89	NA	7.85	0.84	NA	14.58	090
29806		A	Shoulder arthroscopy/surgery	14.37	NA	11.17	2.00	NA	27.54	090
29807		A	Shoulder arthroscopy/surgery	13.90	NA	10.93	1.94	NA	26.77	090
29819		A	Shoulder arthroscopy/surgery	7.62	NA	6.87	1.07	NA	15.56	090
29820		A	Shoulder arthroscopy/surgery	7.07	NA	6.39	0.99	NA	14.45	090
29821		A	Shoulder arthroscopy/surgery	7.72	NA	6.89	1.08	NA	15.69	090
29822		A	Shoulder arthroscopy/surgery	7.43	NA	6.77	1.04	NA	15.24	090
29823		A	Shoulder arthroscopy/surgery	8.17	NA	7.32	1.15	NA	16.64	090
29824		A	Shoulder arthroscopy/surgery	8.25	NA	7.46	1.15	NA	16.86	090
29825		A	Shoulder arthroscopy/surgery	7.62	NA	6.86	1.06	NA	15.54	090
29826		A	Shoulder arthroscopy/surgery	8.99	NA	7.63	1.26	NA	17.88	090
29827		A	Arthroscop rotator cuff repr	15.36	NA	11.55	1.86	NA	28.77	090
29830		A	Elbow arthroscopy	5.76	NA	5.47	0.79	NA	12.02	090
29834		A	Elbow arthroscopy/surgery	6.28	NA	5.96	0.86	NA	13.10	090
29835		A	Elbow arthroscopy/surgery	6.48	NA	6.02	0.88	NA	13.38	090
29836		A	Elbow arthroscopy/surgery	7.55	NA	6.83	1.06	NA	15.44	090
29837		A	Elbow arthroscopy/surgery	6.87	NA	6.27	0.96	NA	14.10	090
29838		A	Elbow arthroscopy/surgery	7.71	NA	6.98	1.07	NA	15.76	090
29840		A	Wrist arthroscopy	5.54	NA	5.49	0.69	NA	11.72	090
29843		A	Wrist arthroscopy/surgery	6.01	NA	5.74	0.82	NA	12.57	090
29844		A	Wrist arthroscopy/surgery	6.37	NA	5.96	0.86	NA	13.19	090
29845		A	Wrist arthroscopy/surgery	7.52	NA	6.61	0.84	NA	14.97	090
29846		A	Wrist arthroscopy/surgery	6.75	NA	6.19	0.89	NA	13.83	090
29847		A	Wrist arthroscopy/surgery	7.08	NA	6.33	0.91	NA	14.32	090
29848		A	Wrist endoscopy/surgery	5.44	NA	5.69	0.72	NA	11.85	090
29850		A	Knee arthroscopy/surgery	8.19	NA	5.27	0.74	NA	14.20	090
29851		A	Knee arthroscopy/surgery	13.10	NA	9.94	1.81	NA	24.85	090
29855		A	Tibial arthroscopy/surgery	10.62	NA	8.79	1.50	NA	20.91	090
29856		A	Tibial arthroscopy/surgery	14.14	NA	10.74	2.00	NA	26.88	090
29860		A	Hip arthroscopy, dx	8.05	NA	7.06	1.14	NA	16.25	090
29861		A	Hip arthroscopy/surgery	9.15	NA	7.48	1.29	NA	17.92	090
29862		A	Hip arthroscopy/surgery	9.90	NA	8.58	1.39	NA	19.87	090
29863		A	Hip arthroscopy/surgery	9.90	NA	8.53	1.40	NA	19.83	090
29870		A	Knee arthroscopy, dx	5.07	NA	5.00	0.67	NA	10.74	090
29871		A	Knee arthroscopy/drainage	6.55	NA	5.98	0.88	NA	13.41	090
29873		A	Knee arthroscopy/surgery	6.00	NA	6.56	0.73	NA	13.29	090
29874		A	Knee arthroscopy/surgery	7.05	NA	6.27	0.87	NA	14.19	090
29875		A	Knee arthroscopy/surgery	6.31	NA	5.98	0.88	NA	13.17	090
29876		A	Knee arthroscopy/surgery	7.92	NA	7.12	1.11	NA	16.15	090
29877		A	Knee arthroscopy/surgery	7.35	NA	6.81	1.03	NA	15.19	090
29879		A	Knee arthroscopy/surgery	8.04	NA	7.21	1.13	NA	16.38	090
29880		A	Knee arthroscopy/surgery	8.50	NA	7.46	1.19	NA	17.15	090
29881		A	Knee arthroscopy/surgery	7.76	NA	7.04	1.09	NA	15.89	090
29882		A	Knee arthroscopy/surgery	8.65	NA	7.34	1.09	NA	17.08	090
29883		A	Knee arthroscopy/surgery	11.05	NA	9.16	1.33	NA	21.54	090
29884		A	Knee arthroscopy/surgery	7.33	NA	6.76	1.03	NA	15.12	090
29885		A	Knee arthroscopy/surgery	9.09	NA	7.98	1.27	NA	18.34	090
29886		A	Knee arthroscopy/surgery	7.54	NA	6.94	1.06	NA	15.54	090
29887		A	Knee arthroscopy/surgery	9.04	NA	7.95	1.27	NA	18.26	090
29888		A	Knee arthroscopy/surgery	13.90	NA	10.42	1.95	NA	26.27	090
29889		A	Knee arthroscopy/surgery	16.00	NA	12.48	2.11	NA	30.59	090
29891		A	Ankle arthroscopy/surgery	8.40	NA	7.50	1.17	NA	17.07	090
29892		A	Ankle arthroscopy/surgery	9.00	NA	7.77	1.26	NA	18.03	090
29893		A	Scope, plantar fasciotomy	5.22	NA	3.88	0.74	NA	9.84	090
29894		A	Ankle arthroscopy/surgery	7.21	NA	5.61	1.01	NA	13.83	090
29895		A	Ankle arthroscopy/surgery	6.99	NA	5.60	0.97	NA	13.56	090
29897		A	Ankle arthroscopy/surgery	7.18	NA	6.04	1.01	NA	14.23	090
29898		A	Ankle arthroscopy/surgery	8.32	NA	6.28	1.14	NA	15.74	090
29899		A	Ankle arthroscopy/surgery	13.91	NA	10.58	1.95	NA	26.44	090
29900		A	Mcp joint arthroscopy, dx	5.42	NA	5.92	0.75	NA	12.09	090
29901		A	Mcp joint arthroscopy, surg	6.13	NA	6.30	0.85	NA	13.28	090
29902		A	Mcp joint arthroscopy, surg	6.70	NA	6.61	0.93	NA	14.24	090
29999		C	Arthroscopy of joint	0.00	0.00	0.00	0.00	0.00	0.00	YYY
30000		A	Drainage of nose lesion	1.43	2.52	1.47	0.10	4.05	3.00	010
30020		A	Drainage of nose lesion	1.43	2.71	1.56	0.08	4.22	3.07	010
30100		A	Intranasal biopsy	0.94	1.33	0.52	0.06	2.33	1.52	000
30110		A	Removal of nose polyp(s)	1.63	2.80	0.87	0.12	4.55	2.62	010
30115		A	Removal of nose polyp(s)	4.35	NA	4.49	0.31	NA	9.15	090
30117		A	Removal of intranasal lesion	3.16	4.97	3.15	0.22	8.35	6.53	090
30118		A	Removal of intranasal lesion	9.69	NA	8.17	0.66	NA	18.52	090
30120		A	Revision of nose	5.27	5.97	5.97	0.41	11.65	11.65	090
30124		A	Removal of nose lesion	3.10	NA	3.31	0.20	NA	6.61	090
30125		A	Removal of nose lesion	7.16	NA	6.42	0.54	NA	14.12	090
30130		A	Removal of turbinate bones	3.38	NA	3.94	0.22	NA	7.54	090
30140		A	Removal of turbinate bones	3.43	NA	4.58	0.24	NA	8.25	090
30150		A	Partial removal of nose	9.14	NA	8.56	0.76	NA	18.46	090
30160		A	Removal of nose	9.58	NA	8.47	0.78	NA	18.83	090
30200		A	Injection treatment of nose	0.78	1.21	0.44	0.06	2.05	1.28	000
30210		A	Nasal sinus therapy	1.08	2.15	0.59	0.08	3.31	1.75	010
30220		A	Insert nasal septal button	1.54	2.51	0.84	0.11	4.16	2.49	010
30300		A	Remove nasal foreign body	1.04	2.60	0.38	0.07	3.71	1.49	010
30310		A	Remove nasal foreign body	1.96	NA	1.88	0.14	NA	3.98	010
30320		A	Remove nasal foreign body	4.52	NA	5.24	0.36	NA	10.12	090
30400		R	Reconstruction of nose	9.83	NA	8.81	0.80	NA	19.44	090
30410		R	Reconstruction of nose	12.98	NA	10.50	1.08	NA	24.56	090
30420		R	Reconstruction of nose	15.88	NA	12.20	1.24	NA	29.32	090
30430		R	Revision of nose	7.21	NA	7.14	0.62	NA	14.97	090
30435		R	Revision of nose	11.71	NA	10.22	1.10	NA	23.03	090
30450		R	Revision of nose	18.65	NA	13.82	1.53	NA	34.00	090
30460		A	Revision of nose	9.96	NA	9.12	0.85	NA	19.93	090
30462		A	Revision of nose	19.57	NA	14.40	1.92	NA	35.89	090
30465		A	Repair nasal stenosis	11.64	NA	8.64	0.97	NA	21.25	090
30520		A	Repair of nasal septum	5.70	NA	5.85	0.41	NA	11.96	090
30540		A	Repair nasal defect	7.75	NA	6.43	0.53	NA	14.71	090
30545		A	Repair nasal defect	11.38	NA	9.58	0.80	NA	21.76	090
30560		A	Release of nasal adhesions	1.26	2.33	1.50	0.09	3.68	2.85	010
30580		A	Repair upper jaw fistula	6.69	4.97	4.97	0.50	12.16	12.16	090
30600		A	Repair mouth/nose fistula	6.02	4.93	4.93	0.70	11.65	11.65	090
30620		A	Intranasal reconstruction	5.97	NA	6.54	0.45	NA	12.96	090
30630		A	Repair nasal septum defect	7.12	NA	7.08	0.51	NA	14.71	090
30801		A	Cauterization, inner nose	1.09	2.55	2.30	0.08	3.72	3.47	010
30802		A	Cauterization, inner nose	2.03	3.10	2.84	0.15	5.28	5.02	010
30901		A	Control of nosebleed	1.21	1.40	0.33	0.09	2.70	1.63	000
30903		A	Control of nosebleed	1.54	3.14	0.51	0.12	4.80	2.17	000
30905		A	Control of nosebleed	1.97	3.79	0.78	0.15	5.91	2.90	000
30906		A	Repeat control of nosebleed	2.45	4.19	1.23	0.17	6.81	3.85	000
30915		A	Ligation, nasal sinus artery	7.20	NA	7.03	0.50	NA	14.73	090
30920		A	Ligation, upper jaw artery	9.83	NA	8.48	0.69	NA	19.00	090
30930		A	Therapy, fracture of nose	1.26	NA	2.16	0.09	NA	3.51	010
30999		C	Nasal surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
31000		A	Irrigation, maxillary sinus	1.15	2.43	0.64	0.08	3.66	1.87	010
31002		A	Irrigation, sphenoid sinus	1.91	NA	2.03	0.14	NA	4.08	010
31020		A	Exploration, maxillary sinus	2.94	4.30	3.64	0.20	7.44	6.78	090
31030		A	Exploration, maxillary sinus	5.92	4.77	4.60	0.42	11.11	10.94	090
31032		A	Explore sinus, remove polyps	6.57	NA	6.06	0.47	NA	13.10	090
31040		A	Exploration behind upper jaw	9.42	NA	6.97	0.71	NA	17.10	090
31050		A	Exploration, sphenoid sinus	5.28	NA	5.04	0.39	NA	10.71	090
31051		A	Sphenoid sinus surgery	7.11	NA	6.51	0.55	NA	14.17	090
31070		A	Exploration of frontal sinus	4.28	NA	5.00	0.30	NA	9.58	090
31075		A	Exploration of frontal sinus	9.16	NA	8.16	0.64	NA	17.96	090
31080		A	Removal of frontal sinus	11.42	NA	8.78	0.78	NA	20.98	090
31081		A	Removal of frontal sinus	12.75	NA	9.73	1.84	NA	24.32	090
31084		A	Removal of frontal sinus	13.51	NA	10.49	0.96	NA	24.96	090
31085		A	Removal of frontal sinus	14.20	NA	10.73	1.18	NA	26.11	090
31086		A	Removal of frontal sinus	12.86	NA	10.42	0.90	NA	24.18	090
31087		A	Removal of frontal sinus	13.10	NA	10.43	1.15	NA	24.68	090
31090		A	Exploration of sinuses	9.53	NA	8.89	0.66	NA	19.08	090
31200		A	Removal of ethmoid sinus	4.97	NA	5.70	0.25	NA	10.92	090
31201		A	Removal of ethmoid sinus	8.37	NA	7.76	0.58	NA	16.71	090
31205		A	Removal of ethmoid sinus	10.24	NA	8.39	0.58	NA	19.21	090
31225		A	Removal of upper jaw	19.23	NA	15.01	1.38	NA	35.62	090
31230		A	Removal of upper jaw	21.94	NA	16.66	1.57	NA	40.17	090
31231		A	Nasal endoscopy, dx	1.10	1.99	0.59	0.08	3.17	1.77	000
31233		A	Nasal/sinus endoscopy, dx	2.18	2.63	1.19	0.16	4.97	3.53	000
31235		A	Nasal/sinus endoscopy, dx	2.64	2.90	1.45	0.18	5.72	4.27	000
31237		A	Nasal/sinus endoscopy, surg	2.98	3.17	1.61	0.21	6.36	4.80	000
31238		A	Nasal/sinus endoscopy, surg	3.26	3.71	1.82	0.23	7.20	5.31	000
31239		A	Nasal/sinus endoscopy, surg	8.70	NA	6.51	0.46	NA	15.67	010
31240		A	Nasal/sinus endoscopy, surg	2.61	NA	1.55	0.18	NA	4.34	000
31254		A	Revision of ethmoid sinus	4.65	NA	2.71	0.32	NA	7.68	000
31255		A	Removal of ethmoid sinus	6.96	NA	4.01	0.49	NA	11.46	000
31256		A	Exploration maxillary sinus	3.29	NA	1.95	0.23	NA	5.47	000
31267		A	Endoscopy, maxillary sinus	5.46	NA	3.16	0.38	NA	9.00	000
31276		A	Sinus endoscopy, surgical	8.85	NA	5.05	0.62	NA	14.52	000
31287		A	Nasal/sinus endoscopy, surg	3.92	NA	2.30	0.27	NA	6.49	000
31288		A	Nasal/sinus endoscopy, surg	4.58	NA	2.67	0.32	NA	7.57	000
31290		A	Nasal/sinus endoscopy, surg	17.24	NA	11.56	1.20	NA	30.00	010
31291		A	Nasal/sinus endoscopy, surg	18.19	NA	11.87	1.73	NA	31.79	010
31292		A	Nasal/sinus endoscopy, surg	14.76	NA	10.05	0.99	NA	25.80	010
31293		A	Nasal/sinus endoscopy, surg	16.21	NA	10.76	0.97	NA	27.94	010
31294		A	Nasal/sinus endoscopy, surg	19.06	NA	12.32	1.04	NA	32.42	010
31299		C	Sinus surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
31300		A	Removal of larynx lesion	14.29	NA	17.26	0.99	NA	32.54	090
31320		A	Diagnostic incision, larynx	5.26	NA	12.98	0.40	NA	18.64	090
31360		A	Removal of larynx	17.08	NA	19.03	1.20	NA	37.31	090
31365		A	Removal of larynx	24.16	NA	22.76	1.72	NA	48.64	090
31367		A	Partial removal of larynx	21.86	NA	23.63	1.57	NA	47.06	090
31368		A	Partial removal of larynx	27.09	NA	28.25	1.90	NA	57.24	090
31370		A	Partial removal of larynx	21.38	NA	23.28	1.51	NA	46.17	090
31375		A	Partial removal of larynx	20.21	NA	20.86	1.43	NA	42.50	090
31380		A	Partial removal of larynx	20.21	NA	20.88	1.40	NA	42.49	090
31382		A	Partial removal of larynx	20.52	NA	22.86	1.44	NA	44.82	090
31390		A	Removal of larynx & pharynx	27.53	NA	28.42	1.95	NA	57.90	090
31395		A	Reconstruct larynx & pharynx	31.09	NA	34.27	2.27	NA	67.63	090
31400		A	Revision of larynx	10.31	NA	15.66	0.72	NA	26.69	090
31420		A	Removal of epiglottis	10.22	NA	15.35	0.71	NA	26.28	090
31500		A	Insert emergency airway	2.33	NA	0.67	0.15	NA	3.15	000
31502		A	Change of windpipe airway	0.65	1.98	0.26	0.04	2.67	0.95	000
31505		A	Diagnostic laryngoscopy	0.61	0.67	0.23	0.04	1.32	0.88	000
31510		A	Laryngoscopy with biopsy	1.92	2.83	0.98	0.15	4.90	3.05	000
31511		A	Remove foreign body, larynx	2.16	3.12	0.75	0.16	5.44	3.07	000
31512		A	Removal of larynx lesion	2.07	3.07	1.07	0.16	5.30	3.30	000
31513		A	Injection into vocal cord	2.10	NA	1.28	0.15	NA	3.53	000
31515		A	Laryngoscopy for aspiration	1.80	2.39	0.85	0.12	4.31	2.77	000
31520		A	Diagnostic laryngoscopy	2.56	NA	1.38	0.17	NA	4.11	000
31525		A	Diagnostic laryngoscopy	2.63	2.91	1.48	0.18	5.72	4.29	000
31526		A	Diagnostic laryngoscopy	2.57	NA	1.54	0.18	NA	4.29	000
31527		A	Laryngoscopy for treatment	3.27	NA	1.71	0.21	NA	5.19	000
31528		A	Laryngoscopy and dilation	2.37	NA	1.26	0.16	NA	3.79	000
31529		A	Laryngoscopy and dilation	2.68	NA	1.55	0.18	NA	4.41	000
31530		A	Operative laryngoscopy	3.39	NA	1.75	0.24	NA	5.38	000
31531		A	Operative laryngoscopy	3.59	NA	2.12	0.25	NA	5.96	000
31535		A	Operative laryngoscopy	3.16	NA	1.82	0.22	NA	5.20	000
31536		A	Operative laryngoscopy	3.56	NA	2.09	0.25	NA	5.90	000
31540		A	Operative laryngoscopy	4.13	NA	2.40	0.29	NA	6.82	000
31541		A	Operative laryngoscopy	4.53	NA	2.64	0.32	NA	7.49	000
31560		A	Operative laryngoscopy	5.46	NA	3.05	0.38	NA	8.89	000
31561		A	Operative laryngoscopy	6.00	NA	3.26	0.42	NA	9.68	000
31570		A	Laryngoscopy with injection	3.87	4.16	2.23	0.24	8.27	6.34	000
31571		A	Laryngoscopy with injection	4.27	NA	2.45	0.30	NA	7.02	000
31575		A	Diagnostic laryngoscopy	1.10	2.07	0.57	0.08	3.25	1.75	000
31576		A	Laryngoscopy with biopsy	1.97	2.45	1.02	0.13	4.55	3.12	000
31577		A	Remove foreign body, larynx	2.47	2.93	1.25	0.17	5.57	3.89	000
31578		A	Removal of larynx lesion	2.84	3.19	1.24	0.20	6.23	4.28	000
31579		A	Diagnostic laryngoscopy	2.26	2.94	1.20	0.16	5.36	3.62	000
31580		A	Revision of larynx	12.38	NA	16.18	0.87	NA	29.43	090
31582		A	Revision of larynx	21.62	NA	21.69	1.52	NA	44.83	090
31584		A	Treat larynx fracture	19.64	NA	18.64	1.42	NA	39.70	090
31585		A	Treat larynx fracture	4.64	NA	8.94	0.30	NA	13.88	090
31586		A	Treat larynx fracture	8.03	NA	12.77	0.56	NA	21.36	090
31587		A	Revision of larynx	11.99	NA	14.23	0.88	NA	27.10	090
31588		A	Revision of larynx	13.11	NA	17.11	0.92	NA	31.14	090
31590		A	Reinnervate larynx	6.97	NA	12.52	0.50	NA	19.99	090
31595		A	Larynx nerve surgery	8.34	NA	11.32	0.62	NA	20.28	090
31599		C	Larynx surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
31600		A	Incision of windpipe	7.18	NA	3.05	0.34	NA	10.57	000
31601		A	Incision of windpipe	4.45	NA	2.15	0.39	NA	6.99	000
31603		A	Incision of windpipe	4.15	NA	1.75	0.35	NA	6.25	000
31605		A	Incision of windpipe	3.58	NA	1.21	0.33	NA	5.12	000
31610		A	Incision of windpipe	8.76	NA	10.79	0.69	NA	20.24	090
31611		A	Surgery/speech prosthesis	5.64	NA	10.19	0.40	NA	16.23	090
31612		A	Puncture/clear windpipe	0.91	1.49	0.42	0.06	2.46	1.39	000
31613		A	Repair windpipe opening	4.59	NA	8.88	0.37	NA	13.84	090
31614		A	Repair windpipe opening	7.12	NA	12.24	0.51	NA	19.87	090
31615		A	Visualization of windpipe	2.09	3.74	1.17	0.14	5.97	3.40	000
31622		A	Dx bronchoscope/wash	2.78	3.44	1.15	0.14	6.36	4.07	000
31623		A	Dx bronchoscope/brush	2.88	3.18	1.14	0.14	6.20	4.16	000
31624		A	Dx bronchoscope/lavage	2.88	2.89	1.14	0.13	5.90	4.15	000
31625		A	Bronchoscopy w/biopsy(s)	3.37	NA	1.30	0.16	NA	4.83	000
31628		A	Bronchoscopy/lung bx, each	3.81	3.36	1.40	0.14	7.31	5.35	000
31629		A	Bronchoscopy/needle bx, each	3.37	NA	1.27	0.13	NA	4.77	000
31630		A	Bronchoscopy dilate/fx repr	3.82	NA	1.97	0.30	NA	6.09	000
31631		A	Bronchoscopy, dilate w/stent	4.37	NA	2.01	0.31	NA	6.69	000
31635		A	Bronchoscopy w/fb removal	3.68	NA	1.67	0.21	NA	5.56	000
31640		A	Bronchoscopy w/tumor excise	4.94	NA	2.34	0.37	NA	7.65	000
31641		A	Bronchoscopy, treat blockage	5.03	NA	2.13	0.30	NA	7.46	000
31643		A	Diag bronchoscope/catheter	3.50	NA	1.32	0.15	NA	4.97	000
31645		A	Bronchoscopy, clear airways	3.16	NA	1.22	0.13	NA	4.51	000
31646		A	Bronchoscopy, reclear airway	2.72	NA	1.09	0.12	NA	3.93	000
31656		A	Bronchoscopy, inj for x-ray	2.17	NA	0.93	0.10	NA	3.20	000
31700		A	Insertion of airway catheter	1.34	2.34	0.69	0.07	3.75	2.10	000
31708		A	Instill airway contrast dye	1.41	NA	0.60	0.06	NA	2.07	000
31710		A	Insertion of airway catheter	1.30	NA	0.71	0.06	NA	2.07	000
31715		A	Injection for bronchus x-ray	1.11	NA	0.61	0.06	NA	1.78	000
31717		A	Bronchial brush biopsy	2.12	3.40	0.88	0.09	5.61	3.09	000
31720		A	Clearance of airways	1.06	1.86	0.33	0.06	2.98	1.45	000
31725		A	Clearance of airways	1.96	NA	0.60	0.10	NA	2.66	000
31730		A	Intro, windpipe wire/tube	2.85	2.42	1.10	0.15	5.42	4.10	000
31750		A	Repair of windpipe	13.02	NA	16.00	1.02	NA	30.04	090
31755		A	Repair of windpipe	15.93	NA	19.11	1.15	NA	36.19	090
31760		A	Repair of windpipe	22.35	NA	12.34	1.48	NA	36.17	090
31766		A	Reconstruction of windpipe	30.43	NA	16.11	3.16	NA	49.70	090
31770		A	Repair/graft of bronchus	22.51	NA	14.25	2.27	NA	39.03	090
31775		A	Reconstruct bronchus	23.54	NA	15.35	2.91	NA	41.80	090
31780		A	Reconstruct windpipe	17.72	NA	12.85	1.55	NA	32.12	090
31781		A	Reconstruct windpipe	23.53	NA	14.74	2.04	NA	40.31	090
31785		A	Remove windpipe lesion	17.23	NA	12.68	1.36	NA	31.27	090
31786		A	Remove windpipe lesion	23.98	NA	15.62	2.20	NA	41.80	090
31800		A	Repair of windpipe injury	7.43	NA	6.79	0.67	NA	14.89	090
31805		A	Repair of windpipe injury	13.13	NA	10.71	1.45	NA	25.29	090
31820		A	Closure of windpipe lesion	4.49	8.08	7.96	0.35	12.92	12.80	090
31825		A	Repair of windpipe defect	6.81	11.16	11.16	0.50	18.47	18.47	090
31830		A	Revise windpipe scar	4.50	7.97	7.97	0.36	12.83	12.83	090
31899		C	Airways surgical procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
32000		A	Drainage of chest	1.54	3.11	0.50	0.07	4.72	2.11	000
32002		A	Treatment of collapsed lung	2.19	NA	0.85	0.11	NA	3.15	000
32005		A	Treat lung lining chemically	2.19	NA	0.87	0.17	NA	3.23	000
32020		A	Insertion of chest tube	3.98	NA	1.44	0.36	NA	5.78	000
32035		A	Exploration of chest	8.67	NA	7.97	1.02	NA	17.66	090
32036		A	Exploration of chest	9.68	NA	8.69	1.20	NA	19.57	090
32095		A	Biopsy through chest wall	8.36	NA	8.13	0.99	NA	17.48	090
32100		A	Exploration/biopsy of chest	15.24	NA	10.39	1.45	NA	27.08	090
32110		A	Explore/repair chest	23.00	NA	12.89	1.63	NA	37.52	090
32120		A	Re-exploration of chest	11.54	NA	9.49	1.42	NA	22.45	090
32124		A	Explore chest free adhesions	12.72	NA	9.42	1.51	NA	23.65	090
32140		A	Removal of lung lesion(s)	13.93	NA	9.97	1.68	NA	25.58	090
32141		A	Remove/treat lung lesions	14.00	NA	9.87	1.72	NA	25.59	090
32150		A	Removal of lung lesion(s)	14.15	NA	9.84	1.60	NA	25.59	090
32151		A	Remove lung foreign body	14.21	NA	10.50	1.49	NA	26.20	090
32160		A	Open chest heart massage	9.30	NA	6.31	1.01	NA	16.62	090
32200		A	Drain, open, lung lesion	15.29	NA	10.04	1.46	NA	26.79	090
32201		A	Drain, percut, lung lesion	4.00	NA	5.54	0.18	NA	9.72	000
32215		A	Treat chest lining	11.33	NA	9.44	1.34	NA	22.11	090
32220		A	Release of lung	24.00	NA	13.45	2.39	NA	39.84	090
32225		A	Partial release of lung	13.96	NA	10.11	1.70	NA	25.77	090
32310		A	Removal of chest lining	13.44	NA	9.75	1.65	NA	24.84	090
32320		A	Free/remove chest lining	24.00	NA	13.18	2.50	NA	39.68	090
32400		A	Needle biopsy chest lining	1.76	1.86	0.57	0.07	3.69	2.40	000
32402		A	Open biopsy chest lining	7.56	NA	8.06	0.91	NA	16.53	090
32405		A	Biopsy, lung or mediastinum	1.93	2.38	0.65	0.09	4.40	2.67	000
32420		A	Puncture/clear lung	2.18	NA	0.85	0.11	NA	3.14	000
32440		A	Removal of lung	25.00	NA	12.43	2.56	NA	39.99	090
32442		A	Sleeve pneumonectomy	26.24	NA	14.04	3.12	NA	43.40	090
32445		A	Removal of lung	25.09	NA	13.48	3.11	NA	41.68	090
32480		A	Partial removal of lung	23.75	NA	12.47	2.24	NA	38.46	090
32482		A	Bilobectomy	25.00	NA	12.50	2.35	NA	39.85	090
32484		A	Segmentectomy	20.69	NA	10.93	2.54	NA	34.16	090
32486		A	Sleeve lobectomy	23.92	NA	12.63	3.00	NA	39.55	090
32488		A	Completion pneumonectomy	25.71	NA	13.20	3.18	NA	42.09	090
32491		R	Lung volume reduction	21.25	NA	11.97	2.66	NA	35.88	090
32500		A	Partial removal of lung	22.00	NA	11.79	1.77	NA	35.56	090
32501		A	Repair bronchus add-on	4.69	NA	1.54	0.56	NA	6.79	ZZZ
32520		A	Remove lung & revise chest	21.68	NA	10.87	2.71	NA	35.26	090
32522		A	Remove lung & revise chest	24.20	NA	11.71	2.84	NA	38.75	090
32525		A	Remove lung & revise chest	26.50	NA	12.42	3.25	NA	42.17	090
32540		A	Removal of lung lesion	14.64	NA	9.12	1.84	NA	25.60	090
32601		A	Thoracoscopy, diagnostic	5.46	NA	3.61	0.63	NA	9.70	000
32602		A	Thoracoscopy, diagnostic	5.96	NA	3.76	0.70	NA	10.42	000
32603		A	Thoracoscopy, diagnostic	7.81	NA	4.19	0.76	NA	12.76	000
32604		A	Thoracoscopy, diagnostic	8.78	NA	4.74	0.97	NA	14.49	000
32605		A	Thoracoscopy, diagnostic	6.93	NA	4.26	0.86	NA	12.05	000
32606		A	Thoracoscopy, diagnostic	8.40	NA	4.57	0.99	NA	13.96	000
32650		A	Thoracoscopy, surgical	10.75	NA	6.50	1.25	NA	18.50	090
32651		A	Thoracoscopy, surgical	12.91	NA	7.05	1.50	NA	21.46	090
32652		A	Thoracoscopy, surgical	18.66	NA	9.74	2.30	NA	30.70	090
32653		A	Thoracoscopy, surgical	12.87	NA	6.78	1.55	NA	21.20	090
32654		A	Thoracoscopy, surgical	12.44	NA	7.20	1.51	NA	21.15	090
32655		A	Thoracoscopy, surgical	13.10	NA	7.07	1.53	NA	21.70	090
32656		A	Thoracoscopy, surgical	12.91	NA	7.53	1.61	NA	22.05	090
32657		A	Thoracoscopy, surgical	13.65	NA	7.42	1.64	NA	22.71	090
32658		A	Thoracoscopy, surgical	11.63	NA	7.01	1.47	NA	20.11	090
32659		A	Thoracoscopy, surgical	11.59	NA	7.12	1.39	NA	20.10	090
32660		A	Thoracoscopy, surgical	17.43	NA	9.05	2.09	NA	28.57	090
32661		A	Thoracoscopy, surgical	13.25	NA	7.47	1.66	NA	22.38	090
32662		A	Thoracoscopy, surgical	16.44	NA	8.51	2.01	NA	26.96	090
32663		A	Thoracoscopy, surgical	18.47	NA	10.22	2.28	NA	30.97	090
32664		A	Thoracoscopy, surgical	14.20	NA	7.48	1.70	NA	23.38	090
32665		A	Thoracoscopy, surgical	15.54	NA	8.02	1.79	NA	25.35	090
32800		A	Repair lung hernia	13.69	NA	9.82	1.51	NA	25.02	090
32810		A	Close chest after drainage	13.05	NA	10.08	1.55	NA	24.68	090
32815		A	Close bronchial fistula	23.15	NA	13.56	2.84	NA	39.55	090
32820		A	Reconstruct injured chest	21.48	NA	13.98	2.31	NA	37.77	090
32850		X	Donor pneumonectomy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
32851		A	Lung transplant, single	38.63	NA	20.19	4.90	NA	63.72	090
32852		A	Lung transplant with bypass	41.80	NA	21.70	5.17	NA	68.67	090
32853		A	Lung transplant, double	47.81	NA	23.60	6.13	NA	77.54	090
32854		A	Lung transplant with bypass	50.98	NA	24.25	6.41	NA	81.64	090
32900		A	Removal of rib(s)	20.27	NA	12.20	2.42	NA	34.89	090
32905		A	Revise & repair chest wall	20.75	NA	12.57	2.54	NA	35.86	090
32906		A	Revise & repair chest wall	26.77	NA	14.61	3.30	NA	44.68	090
32940		A	Revision of lung	19.43	NA	11.85	2.47	NA	33.75	090
32960		A	Therapeutic pneumothorax	1.84	2.15	0.57	0.12	4.11	2.53	000
32997		A	Total lung lavage	6.00	NA	1.93	0.55	NA	8.48	000
32999		C	Chest surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
33010		A	Drainage of heart sac	2.24	NA	0.98	0.13	NA	3.35	000
33011		A	Repeat drainage of heart sac	2.24	NA	1.02	0.13	NA	3.39	000
33015		A	Incision of heart sac	6.80	NA	4.52	0.64	NA	11.96	090
33020		A	Incision of heart sac	12.61	NA	8.01	1.50	NA	22.12	090
33025		A	Incision of heart sac	12.09	NA	7.88	1.50	NA	21.47	090
33030		A	Partial removal of heart sac	18.71	NA	12.30	2.40	NA	33.41	090
33031		A	Partial removal of heart sac	21.79	NA	13.57	2.78	NA	38.14	090
33050		A	Removal of heart sac lesion	14.36	NA	10.31	1.73	NA	26.40	090
33120		A	Removal of heart lesion	24.56	NA	16.05	3.06	NA	43.67	090
33130		A	Removal of heart lesion	21.39	NA	12.74	2.51	NA	36.64	090
33140		A	Heart revascularize (tmr)	20.00	NA	10.67	2.27	NA	32.94	090
33141		A	Heart tmr w/other procedure	4.84	NA	1.57	0.55	NA	6.96	ZZZ
33200		A	Insertion of heart pacemaker	12.48	NA	9.72	1.17	NA	23.37	090
33201		A	Insertion of heart pacemaker	10.18	NA	9.71	1.21	NA	21.10	090
33206		A	Insertion of heart pacemaker	6.67	NA	5.69	0.50	NA	12.86	090
33207		A	Insertion of heart pacemaker	8.04	NA	6.23	0.57	NA	14.84	090
33208		A	Insertion of heart pacemaker	8.13	NA	6.43	0.54	NA	15.10	090
33210		A	Insertion of heart electrode	3.30	NA	1.28	0.17	NA	4.75	000
33211		A	Insertion of heart electrode	3.40	NA	1.34	0.17	NA	4.91	000
33212		A	Insertion of pulse generator	5.52	NA	4.62	0.44	NA	10.58	090
33213		A	Insertion of pulse generator	6.37	NA	5.06	0.46	NA	11.89	090
33214		A	Upgrade of pacemaker system	7.75	NA	6.19	0.52	NA	14.46	090
33215		A	Reposition pacing-defib lead	4.76	NA	3.15	0.36	NA	8.27	090
33216		A	Insert lead pace-defib, one	5.78	NA	5.32	0.36	NA	11.46	090
33217		A	Insert lead pace-defib, dual	5.75	NA	5.58	0.36	NA	11.69	090
33218		A	Repair lead pace-defib, one	5.44	NA	4.68	0.40	NA	10.52	090
33220		A	Repair lead pace-defib, dual	5.52	NA	4.69	0.39	NA	10.60	090
33222		A	Revise pocket, pacemaker	4.96	NA	4.08	0.39	NA	9.43	090
33223		A	Revise pocket, pacing-defib	6.46	NA	5.41	0.44	NA	12.31	090
33224		A	Insert pacing lead & connect	9.05	NA	3.92	0.36	NA	13.33	090
33225		A	L ventric pacing lead add-on	8.34	NA	3.11	0.36	NA	11.81	ZZZ
33226		A	Reposition l ventric lead	8.69	NA	3.79	0.36	NA	12.84	000
33233		A	Removal of pacemaker system	3.29	NA	4.12	0.22	NA	7.63	090
33234		A	Removal of pacemaker system	7.82	NA	5.66	0.56	NA	14.04	090
33235		A	Removal pacemaker electrode	9.40	NA	6.50	0.68	NA	16.58	090
33236		A	Remove electrode/thoracotomy	12.60	NA	9.38	1.49	NA	23.47	090
33237		A	Remove electrode/thoracotomy	13.71	NA	9.78	1.57	NA	25.06	090
33238		A	Remove electrode/thoracotomy	15.22	NA	9.27	1.56	NA	26.05	090
33240		A	Insert pulse generator	7.60	NA	5.77	0.53	NA	13.90	090
33241		A	Remove pulse generator	3.24	NA	3.71	0.21	NA	7.16	090
33243		A	Remove eltrd/thoracotomy	22.64	NA	10.90	2.53	NA	36.07	090
33244		A	Remove eltrd, transven	13.76	NA	8.43	1.05	NA	23.24	090
33245		A	Insert epic eltrd pace-defib	14.30	NA	11.02	1.28	NA	26.60	090
33246		A	Insert epic eltrd/generator	20.71	NA	14.36	2.22	NA	37.29	090
33249		A	Eltrd/insert pace-defib	14.23	NA	9.27	0.80	NA	24.30	090
33250		A	Ablate heart dysrhythm focus	21.85	NA	14.42	1.01	NA	37.28	090
33251		A	Ablate heart dysrhythm focus	24.88	NA	14.53	2.41	NA	41.82	090
33253		A	Reconstruct atria	31.06	NA	16.79	3.68	NA	51.53	090
33261		A	Ablate heart dysrhythm focus	24.88	NA	14.79	2.82	NA	42.49	090
33282		A	Implant pat-active ht record	4.17	NA	4.91	0.39	NA	9.47	090
33284		A	Remove pat-active ht record	2.50	NA	4.39	0.23	NA	7.12	090
33300		A	Repair of heart wound	17.92	NA	12.08	1.91	NA	31.91	090
33305		A	Repair of heart wound	21.44	NA	13.53	2.68	NA	37.65	090
33310		A	Exploratory heart surgery	18.51	NA	12.43	2.26	NA	33.20	090
33315		A	Exploratory heart surgery	22.37	NA	13.74	2.90	NA	39.01	090
33320		A	Repair major blood vessel(s)	16.79	NA	11.44	1.66	NA	29.89	090
33321		A	Repair major vessel	20.20	NA	12.72	2.70	NA	35.62	090
33322		A	Repair major blood vessel(s)	20.62	NA	13.32	2.51	NA	36.45	090
33330		A	Insert major vessel graft	21.43	NA	12.93	2.49	NA	36.85	090
33332		A	Insert major vessel graft	23.96	NA	13.18	2.45	NA	39.59	090
33335		A	Insert major vessel graft	30.01	NA	16.23	3.79	NA	50.03	090
33400		A	Repair of aortic valve	28.50	NA	15.00	3.09	NA	46.59	090
33401		A	Valvuloplasty, open	23.91	NA	13.33	2.71	NA	39.95	090
33403		A	Valvuloplasty, w/cp bypass	24.89	NA	13.71	2.48	NA	41.08	090
33404		A	Prepare heart-aorta conduit	28.54	NA	13.94	3.31	NA	45.79	090
33405		A	Replacement of aortic valve	35.00	NA	17.52	3.86	NA	56.38	090
33406		A	Replacement of aortic valve	37.50	NA	18.31	4.07	NA	59.88	090
33410		A	Replacement of aortic valve	32.46	NA	16.00	4.11	NA	52.57	090
33411		A	Replacement of aortic valve	36.25	NA	17.97	4.16	NA	58.38	090
33412		A	Replacement of aortic valve	42.00	NA	19.77	4.66	NA	66.43	090
33413		A	Replacement of aortic valve	43.50	NA	20.10	4.26	NA	67.86	090
33414		A	Repair of aortic valve	30.35	NA	17.98	3.79	NA	52.12	090
33415		A	Revision, subvalvular tissue	27.15	NA	16.05	3.25	NA	46.45	090
33416		A	Revise ventricle muscle	30.35	NA	16.41	3.85	NA	50.61	090
33417		A	Repair of aortic valve	28.53	NA	17.51	3.58	NA	49.62	090
33420		A	Revision of mitral valve	22.70	NA	10.12	1.48	NA	34.30	090
33422		A	Revision of mitral valve	25.94	NA	13.03	3.30	NA	42.27	090
33425		A	Repair of mitral valve	27.00	NA	12.58	3.00	NA	42.58	090
33426		A	Repair of mitral valve	33.00	NA	16.42	3.87	NA	53.29	090
33427		A	Repair of mitral valve	40.00	NA	18.59	4.30	NA	62.89	090
33430		A	Replacement of mitral valve	33.50	NA	16.54	3.95	NA	53.99	090
33460		A	Revision of tricuspid valve	23.60	NA	14.13	3.02	NA	40.75	090
33463		A	Valvuloplasty, tricuspid	25.62	NA	14.87	3.17	NA	43.66	090
33464		A	Valvuloplasty, tricuspid	27.33	NA	15.47	3.47	NA	46.27	090
33465		A	Replace tricuspid valve	28.79	NA	15.80	3.61	NA	48.20	090
33468		A	Revision of tricuspid valve	30.12	NA	20.10	4.00	NA	54.22	090
33470		A	Revision of pulmonary valve	20.81	NA	13.67	2.81	NA	37.29	090
33471		A	Valvotomy, pulmonary valve	22.25	NA	12.72	3.00	NA	37.97	090
33472		A	Revision of pulmonary valve	22.25	NA	15.25	2.92	NA	40.42	090
33474		A	Revision of pulmonary valve	23.04	NA	13.42	2.84	NA	39.30	090
33475		A	Replacement, pulmonary valve	33.00	NA	18.87	2.64	NA	54.51	090
33476		A	Revision of heart chamber	25.77	NA	14.07	2.40	NA	42.24	090
33478		A	Revision of heart chamber	26.74	NA	15.15	3.56	NA	45.45	090
33496		A	Repair, prosth valve clot	27.25	NA	17.18	3.44	NA	47.87	090
33500		A	Repair heart vessel fistula	25.55	NA	13.86	2.80	NA	42.21	090
33501		A	Repair heart vessel fistula	17.78	NA	10.55	2.05	NA	30.38	090
33502		A	Coronary artery correction	21.04	NA	17.04	2.51	NA	40.59	090
33503		A	Coronary artery graft	21.78	NA	14.05	1.42	NA	37.25	090
33504		A	Coronary artery graft	24.66	NA	16.92	3.04	NA	44.62	090
33505		A	Repair artery w/tunnel	26.84	NA	18.36	1.52	NA	46.72	090
33506		A	Repair artery, translocation	35.50	NA	19.69	3.19	NA	58.38	090
33508		A	Endoscopic vein harvest	0.31	NA	0.11	0.03	NA	0.45	ZZZ
33510		A	CABG, vein, single	29.00	NA	15.52	3.13	NA	47.65	090
33511		A	CABG, vein, two	30.00	NA	16.21	3.34	NA	49.55	090
33512		A	CABG, vein, three	31.80	NA	16.75	3.70	NA	52.25	090
33513		A	CABG, vein, four	32.00	NA	16.91	3.99	NA	52.90	090
33514		A	CABG, vein, five	32.75	NA	17.16	4.37	NA	54.28	090
33516		A	Cabg, vein, six or more	35.00	NA	17.91	4.62	NA	57.53	090
33517		A	CABG, artery-vein, single	2.57	NA	0.84	0.32	NA	3.73	ZZZ
33518		A	CABG, artery-vein, two	4.85	NA	1.58	0.61	NA	7.04	ZZZ
33519		A	CABG, artery-vein, three	7.12	NA	2.31	0.89	NA	10.32	ZZZ
33521		A	CABG, artery-vein, four	9.40	NA	3.05	1.18	NA	13.63	ZZZ
33522		A	CABG, artery-vein, five	11.67	NA	3.79	1.48	NA	16.94	ZZZ
33523		A	Cabg, art-vein, six or more	13.95	NA	4.50	1.78	NA	20.23	ZZZ
33530		A	Coronary artery, bypass/reop	5.86	NA	1.90	0.73	NA	8.49	ZZZ
33533		A	CABG, arterial, single	30.00	NA	15.67	3.24	NA	48.91	090
33534		A	CABG, arterial, two	32.20	NA	16.81	3.63	NA	52.64	090
33535		A	CABG, arterial, three	34.50	NA	17.30	3.97	NA	55.77	090
33536		A	Cabg, arterial, four or more	37.50	NA	17.63	3.29	NA	58.42	090
33542		A	Removal of heart lesion	28.85	NA	17.43	3.61	NA	49.89	090
33545		A	Repair of heart damage	36.78	NA	20.01	4.40	NA	61.19	090
33572		A	Open coronary endarterectomy	4.45	NA	1.44	0.55	NA	6.44	ZZZ
33600		A	Closure of valve	29.51	NA	16.89	2.30	NA	48.70	090
33602		A	Closure of valve	28.54	NA	16.43	2.90	NA	47.87	090
33606		A	Anastomosis/artery-aorta	30.74	NA	18.23	3.59	NA	52.56	090
33608		A	Repair anomaly w/conduit	31.09	NA	17.62	4.17	NA	52.88	090
33610		A	Repair by enlargement	30.61	NA	18.66	4.02	NA	53.29	090
33611		A	Repair double ventricle	34.00	NA	19.21	3.28	NA	56.49	090
33612		A	Repair double ventricle	35.00	NA	19.97	4.44	NA	59.41	090
33615		A	Repair, modified fontan	34.00	NA	18.80	3.15	NA	55.95	090
33617		A	Repair single ventricle	37.00	NA	21.91	4.09	NA	63.00	090
33619		A	Repair single ventricle	45.00	NA	27.24	4.71	NA	76.95	090
33641		A	Repair heart septum defect	21.39	NA	11.95	2.67	NA	36.01	090
33645		A	Revision of heart veins	24.82	NA	14.27	3.27	NA	42.36	090
33647		A	Repair heart septum defects	28.73	NA	17.65	3.37	NA	49.75	090
33660		A	Repair of heart defects	30.00	NA	17.37	2.82	NA	50.19	090
33665		A	Repair of heart defects	28.60	NA	17.67	3.81	NA	50.08	090
33670		A	Repair of heart chambers	35.00	NA	16.19	2.18	NA	53.37	090
33681		A	Repair heart septum defect	30.61	NA	18.07	3.53	NA	52.21	090
33684		A	Repair heart septum defect	29.65	NA	16.93	3.77	NA	50.35	090
33688		A	Repair heart septum defect	30.62	NA	14.40	3.89	NA	48.91	090
33690		A	Reinforce pulmonary artery	19.55	NA	13.65	2.56	NA	35.76	090
33692		A	Repair of heart defects	30.75	NA	17.47	3.77	NA	51.99	090
33694		A	Repair of heart defects	34.00	NA	18.41	4.27	NA	56.68	090
33697		A	Repair of heart defects	36.00	NA	19.61	4.54	NA	60.15	090
33702		A	Repair of heart defects	26.54	NA	16.85	3.45	NA	46.84	090
33710		A	Repair of heart defects	29.71	NA	18.23	3.85	NA	51.79	090
33720		A	Repair of heart defect	26.56	NA	16.34	3.21	NA	46.11	090
33722		A	Repair of heart defect	28.41	NA	17.91	3.80	NA	50.12	090
33730		A	Repair heart-vein defect(s)	34.25	NA	18.02	2.85	NA	55.12	090
33732		A	Repair heart-vein defect	28.16	NA	17.20	2.78	NA	48.14	090
33735		A	Revision of heart chamber	21.39	NA	12.25	1.12	NA	34.76	090
33736		A	Revision of heart chamber	23.52	NA	15.56	2.70	NA	41.78	090
33737		A	Revision of heart chamber	21.76	NA	14.86	2.93	NA	39.55	090
33750		A	Major vessel shunt	21.41	NA	13.38	1.74	NA	36.53	090
33755		A	Major vessel shunt	21.79	NA	12.25	2.93	NA	36.97	090
33762		A	Major vessel shunt	21.79	NA	13.40	1.59	NA	36.78	090
33764		A	Major vessel shunt & graft	21.79	NA	13.15	1.93	NA	36.87	090
33766		A	Major vessel shunt	22.76	NA	15.33	3.04	NA	41.13	090
33767		A	Major vessel shunt	24.50	NA	15.19	3.14	NA	42.83	090
33770		A	Repair great vessels defect	37.00	NA	17.97	4.49	NA	59.46	090
33771		A	Repair great vessels defect	34.65	NA	14.95	4.67	NA	54.27	090
33774		A	Repair great vessels defect	30.98	NA	16.58	4.18	NA	51.74	090
33775		A	Repair great vessels defect	32.20	NA	16.92	4.34	NA	53.46	090
33776		A	Repair great vessels defect	34.04	NA	18.41	4.58	NA	57.03	090
33777		A	Repair great vessels defect	33.46	NA	17.41	4.51	NA	55.38	090
33778		A	Repair great vessels defect	40.00	NA	20.72	4.83	NA	65.55	090
33779		A	Repair great vessels defect	36.21	NA	18.16	2.40	NA	56.77	090
33780		A	Repair great vessels defect	41.75	NA	22.40	5.21	NA	69.36	090
33781		A	Repair great vessels defect	36.45	NA	15.41	4.91	NA	56.77	090
33786		A	Repair arterial trunk	39.00	NA	20.17	4.69	NA	63.86	090
33788		A	Revision of pulmonary artery	26.62	NA	15.38	3.32	NA	45.32	090
33800		A	Aortic suspension	16.24	NA	12.45	1.11	NA	29.80	090
33802		A	Repair vessel defect	17.66	NA	13.02	1.56	NA	32.24	090
33803		A	Repair vessel defect	19.60	NA	13.51	2.63	NA	35.74	090
33813		A	Repair septal defect	20.65	NA	14.94	2.78	NA	38.37	090
33814		A	Repair septal defect	25.77	NA	16.47	2.52	NA	44.76	090
33820		A	Revise major vessel	16.29	NA	11.45	2.10	NA	29.84	090
33822		A	Revise major vessel	17.32	NA	13.84	2.33	NA	33.49	090
33824		A	Revise major vessel	19.52	NA	12.63	2.61	NA	34.76	090
33840		A	Remove aorta constriction	20.63	NA	13.95	2.36	NA	36.94	090
33845		A	Remove aorta constriction	22.12	NA	15.13	2.90	NA	40.15	090
33851		A	Remove aorta constriction	21.27	NA	14.80	2.86	NA	38.93	090
33852		A	Repair septal defect	23.71	NA	15.34	3.19	NA	42.24	090
33853		A	Repair septal defect	31.72	NA	18.90	4.23	NA	54.85	090
33860		A	Ascending aortic graft	38.00	NA	18.90	4.30	NA	61.20	090
33861		A	Ascending aortic graft	42.00	NA	20.18	4.24	NA	66.42	090
33863		A	Ascending aortic graft	45.00	NA	21.14	4.60	NA	70.74	090
33870		A	Transverse aortic arch graft	44.00	NA	20.83	5.09	NA	69.92	090
33875		A	Thoracic aortic graft	33.06	NA	17.10	4.08	NA	54.24	090
33877		A	Thoracoabdominal graft	42.60	NA	21.75	5.07	NA	69.42	090
33910		A	Remove lung artery emboli	24.59	NA	14.28	3.06	NA	41.93	090
33915		A	Remove lung artery emboli	21.02	NA	12.37	1.20	NA	34.59	090
33916		A	Surgery of great vessel	25.83	NA	14.94	3.04	NA	43.81	090
33917		A	Repair pulmonary artery	24.50	NA	15.94	3.17	NA	43.61	090
33918		A	Repair pulmonary atresia	26.45	NA	15.59	3.42	NA	45.46	090
33919		A	Repair pulmonary atresia	40.00	NA	21.68	3.48	NA	65.16	090
33920		A	Repair pulmonary atresia	31.95	NA	16.90	3.61	NA	52.46	090
33922		A	Transect pulmonary artery	23.52	NA	14.38	2.30	NA	40.20	090
33924		A	Remove pulmonary shunt	5.50	NA	1.82	0.74	NA	8.06	ZZZ
33930		X	Removal of donor heart/lung	0.00	0.00	0.00	0.00	0.00	0.00	XXX
33935		R	Transplantation, heart/lung	60.96	NA	27.89	8.15	NA	97.00	090
33940		X	Removal of donor heart	0.00	0.00	0.00	0.00	0.00	0.00	XXX
33945		R	Transplantation of heart	42.10	NA	21.79	5.42	NA	69.31	090
33960		A	External circulation assist	19.36	NA	4.96	2.14	NA	26.46	000
33961		A	External circulation assist	10.93	NA	3.65	1.47	NA	16.05	ZZZ
33967		A	Insert ia percut device	4.85	1.90	1.87	0.28	7.03	7.00	000
33968		A	Remove aortic assist device	0.64	NA	0.23	0.07	NA	0.94	000
33970		A	Aortic circulation assist	6.75	NA	2.29	0.70	NA	9.74	000
33971		A	Aortic circulation assist	9.69	NA	8.18	0.97	NA	18.84	090
33973		A	Insert balloon device	9.76	NA	3.31	1.01	NA	14.08	000
33974		A	Remove intra-aortic balloon	14.41	NA	10.98	1.48	NA	26.87	090
33975		A	Implant ventricular device	21.00	NA	6.28	1.72	NA	29.00	XXX
33976		A	Implant ventricular device	23.00	NA	7.52	2.82	NA	33.34	XXX
33977		A	Remove ventricular device	19.29	NA	10.50	2.44	NA	32.23	090
33978		A	Remove ventricular device	21.73	NA	11.37	2.66	NA	35.76	090
33979		A	Insert intracorporeal device	46.00	17.88	17.88	3.98	67.86	67.86	XXX
33980		A	Remove intracorporeal device	56.25	NA	26.47	4.60	NA	87.32	090
33999		C	Cardiac surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
34001		A	Removal of artery clot	12.91	NA	5.85	1.46	NA	20.22	090
34051		A	Removal of artery clot	15.21	NA	6.91	1.90	NA	24.02	090
34101		A	Removal of artery clot	10.00	NA	4.71	1.11	NA	15.82	090
34111		A	Removal of arm artery clot	10.00	NA	4.77	0.85	NA	15.62	090
34151		A	Removal of artery clot	25.00	NA	10.24	1.84	NA	37.08	090
34201		A	Removal of artery clot	10.03	NA	5.03	1.02	NA	16.08	090
34203		A	Removal of leg artery clot	16.50	NA	7.46	1.37	NA	25.33	090
34401		A	Removal of vein clot	25.00	NA	10.05	1.20	NA	36.25	090
34421		A	Removal of vein clot	12.00	NA	5.88	0.95	NA	18.83	090
34451		A	Removal of vein clot	27.00	NA	10.76	1.59	NA	39.35	090
34471		A	Removal of vein clot	10.18	NA	4.93	0.90	NA	16.01	090
34490		A	Removal of vein clot	9.86	NA	6.12	0.73	NA	16.71	090
34501		A	Repair valve, femoral vein	16.00	NA	9.25	1.37	NA	26.62	090
34502		A	Reconstruct vena cava	26.95	NA	10.98	2.99	NA	40.92	090
34510		A	Transposition of vein valve	18.95	NA	10.27	1.60	NA	30.82	090
34520		A	Cross-over vein graft	17.95	NA	9.30	1.41	NA	28.66	090
34530		A	Leg vein fusion	16.64	NA	8.74	2.06	NA	27.44	090
34800		A	Endovasc abdo repair w/tube	20.75	NA	8.94	1.49	NA	31.18	090
34802		A	Endovasc abdo repr w/device	23.00	NA	9.69	1.65	NA	34.34	090
34804		A	Endovasc abdo repr w/device	23.00	NA	9.69	1.65	NA	34.34	090
34808		A	Endovasc abdo occlud device	4.13	NA	1.40	0.29	NA	5.82	ZZZ
34812		A	Xpose for endoprosth, femorl	6.75	NA	2.29	0.49	NA	9.53	000
34813		A	Femoral endovas graft add-on	4.80	NA	1.60	0.34	NA	6.74	ZZZ
34820		A	Xpose for endoprosth, iliac	9.75	NA	3.30	0.70	NA	13.75	000
34825		A	Endovasc extend prosth, init	12.00	NA	5.95	0.86	NA	18.81	090
34826		A	Endovasc exten prosth, addl	4.13	NA	1.41	0.29	NA	5.83	ZZZ
34830		A	Open aortic tube prosth repr	32.59	NA	13.31	2.34	NA	48.24	090
34831		A	Open aortoiliac prosth repr	35.34	NA	11.68	2.53	NA	49.55	090
34832		A	Open aortofemor prosth repr	35.34	NA	14.38	2.53	NA	52.25	090
34833		A	Xpose for endoprosth, iliac	12.00	NA	4.98	0.70	NA	17.68	000
34834		A	Xpose, endoprosth, brachial	5.35	NA	2.48	0.49	NA	8.32	000
34900		A	Endovasc iliac repr w/graft	16.38	NA	8.24	1.49	NA	26.11	090
35001		A	Repair defect of artery	19.64	NA	8.39	2.44	NA	30.47	090
35002		A	Repair artery rupture, neck	21.00	NA	9.07	1.82	NA	31.89	090
35005		A	Repair defect of artery	18.12	NA	7.79	1.35	NA	27.26	090
35011		A	Repair defect of artery	18.00	NA	7.40	1.30	NA	26.70	090
35013		A	Repair artery rupture, arm	22.00	NA	8.74	1.91	NA	32.65	090
35021		A	Repair defect of artery	19.65	NA	8.61	1.93	NA	30.19	090
35022		A	Repair artery rupture, chest	23.18	NA	9.43	1.99	NA	34.60	090
35045		A	Repair defect of arm artery	17.57	NA	8.61	1.25	NA	27.43	090
35081		A	Repair defect of artery	28.01	NA	11.65	3.20	NA	42.86	090
35082		A	Repair artery rupture, aorta	38.50	NA	14.60	4.07	NA	57.17	090
35091		A	Repair defect of artery	35.40	NA	13.91	4.09	NA	53.40	090
35092		A	Repair artery rupture, aorta	45.00	NA	16.93	4.31	NA	66.24	090
35102		A	Repair defect of artery	30.76	NA	12.33	3.44	NA	46.53	090
35103		A	Repair artery rupture, groin	40.50	NA	15.39	3.79	NA	59.68	090
35111		A	Repair defect of artery	25.00	NA	10.18	1.81	NA	36.99	090
35112		A	Repair artery rupture,spleen	30.00	NA	11.65	1.95	NA	43.60	090
35121		A	Repair defect of artery	30.00	NA	12.07	2.93	NA	45.00	090
35122		A	Repair artery rupture, belly	35.00	NA	13.46	3.54	NA	52.00	090
35131		A	Repair defect of artery	25.00	NA	10.38	2.11	NA	37.49	090
35132		A	Repair artery rupture, groin	30.00	NA	11.82	2.48	NA	44.30	090
35141		A	Repair defect of artery	20.00	NA	8.50	1.65	NA	30.15	090
35142		A	Repair artery rupture, thigh	23.30	NA	9.56	1.75	NA	34.61	090
35151		A	Repair defect of artery	22.64	NA	9.54	1.93	NA	34.11	090
35152		A	Repair artery rupture, knee	25.62	NA	10.42	1.93	NA	37.97	090
35161		A	Repair defect of artery	18.76	NA	8.70	2.21	NA	29.67	090
35162		A	Repair artery rupture	19.78	NA	8.86	2.21	NA	30.85	090
35180		A	Repair blood vessel lesion	13.62	NA	6.35	1.44	NA	21.41	090
35182		A	Repair blood vessel lesion	30.00	NA	12.30	1.88	NA	44.18	090
35184		A	Repair blood vessel lesion	18.00	NA	7.79	1.34	NA	27.13	090
35188		A	Repair blood vessel lesion	14.28	NA	6.58	1.53	NA	22.39	090
35189		A	Repair blood vessel lesion	28.00	NA	11.46	2.12	NA	41.58	090
35190		A	Repair blood vessel lesion	12.75	NA	5.88	1.33	NA	19.96	090
35201		A	Repair blood vessel lesion	16.14	NA	7.02	1.17	NA	24.33	090
35206		A	Repair blood vessel lesion	13.25	NA	7.51	1.04	NA	21.80	090
35207		A	Repair blood vessel lesion	10.15	NA	9.76	1.15	NA	21.06	090
35211		A	Repair blood vessel lesion	22.12	NA	13.77	2.83	NA	38.72	090
35216		A	Repair blood vessel lesion	18.75	NA	11.67	2.17	NA	32.59	090
35221		A	Repair blood vessel lesion	24.39	NA	10.09	1.79	NA	36.27	090
35226		A	Repair blood vessel lesion	14.50	NA	8.95	0.84	NA	24.29	090
35231		A	Repair blood vessel lesion	20.00	NA	9.24	1.32	NA	30.56	090
35236		A	Repair blood vessel lesion	17.11	NA	8.89	1.19	NA	27.19	090
35241		A	Repair blood vessel lesion	23.12	NA	14.42	2.90	NA	40.44	090
35246		A	Repair blood vessel lesion	26.45	NA	14.23	2.22	NA	42.90	090
35251		A	Repair blood vessel lesion	30.20	NA	12.03	1.87	NA	44.10	090
35256		A	Repair blood vessel lesion	18.36	NA	9.43	1.32	NA	29.11	090
35261		A	Repair blood vessel lesion	17.80	NA	7.43	1.34	NA	26.57	090
35266		A	Repair blood vessel lesion	14.91	NA	7.98	1.16	NA	24.05	090
35271		A	Repair blood vessel lesion	22.12	NA	13.57	2.77	NA	38.46	090
35276		A	Repair blood vessel lesion	24.25	NA	13.84	2.37	NA	40.46	090
35281		A	Repair blood vessel lesion	28.00	NA	11.41	1.82	NA	41.23	090
35286		A	Repair blood vessel lesion	16.16	NA	8.73	1.36	NA	26.25	090
35301		A	Rechanneling of artery	18.70	NA	8.26	2.23	NA	29.19	090
35311		A	Rechanneling of artery	27.00	NA	10.92	2.75	NA	40.67	090
35321		A	Rechanneling of artery	16.00	NA	6.72	1.36	NA	24.08	090
35331		A	Rechanneling of artery	26.20	NA	10.82	2.71	NA	39.73	090
35341		A	Rechanneling of artery	25.11	NA	10.41	2.87	NA	38.39	090
35351		A	Rechanneling of artery	23.00	NA	9.63	2.29	NA	34.92	090
35355		A	Rechanneling of artery	18.50	NA	8.12	1.80	NA	28.42	090
35361		A	Rechanneling of artery	28.20	NA	11.37	2.66	NA	42.23	090
35363		A	Rechanneling of artery	30.20	NA	12.12	2.77	NA	45.09	090
35371		A	Rechanneling of artery	14.72	NA	6.58	1.32	NA	22.62	090
35372		A	Rechanneling of artery	18.00	NA	7.73	1.53	NA	27.26	090
35381		A	Rechanneling of artery	15.81	NA	7.21	1.80	NA	24.82	090
35390		A	Reoperation, carotid add-on	3.19	NA	1.07	0.38	NA	4.64	ZZZ
35400		A	Angioscopy	3.00	NA	1.05	0.34	NA	4.39	ZZZ
35450		A	Repair arterial blockage	10.07	NA	4.02	0.84	NA	14.93	000
35452		A	Repair arterial blockage	6.91	NA	3.09	0.76	NA	10.76	000
35454		A	Repair arterial blockage	6.04	NA	2.77	0.67	NA	9.48	000
35456		A	Repair arterial blockage	7.35	NA	3.21	0.82	NA	11.38	000
35458		A	Repair arterial blockage	9.49	NA	3.92	1.09	NA	14.50	000
35459		A	Repair arterial blockage	8.63	NA	3.59	0.96	NA	13.18	000
35460		A	Repair venous blockage	6.04	NA	2.63	0.66	NA	9.33	000
35470		A	Repair arterial blockage	8.63	NA	3.89	0.50	NA	13.02	000
35471		A	Repair arterial blockage	10.07	NA	4.53	0.50	NA	15.10	000
35472		A	Repair arterial blockage	6.91	NA	3.26	0.39	NA	10.56	000
35473		A	Repair arterial blockage	6.04	NA	2.95	0.34	NA	9.33	000
35474		A	Repair arterial blockage	7.36	NA	2.94	0.40	NA	10.70	000
35475		R	Repair arterial blockage	9.49	NA	4.12	0.47	NA	14.08	000
35476		A	Repair venous blockage	6.04	NA	2.88	0.27	NA	9.19	000
35480		A	Atherectomy, open	11.08	NA	4.50	1.13	NA	16.71	000
35481		A	Atherectomy, open	7.61	NA	3.38	0.84	NA	11.83	000
35482		A	Atherectomy, open	6.65	NA	3.04	0.75	NA	10.44	000
35483		A	Atherectomy, open	8.10	NA	3.47	0.81	NA	12.38	000
35484		A	Atherectomy, open	10.44	NA	4.19	1.13	NA	15.76	000
35485		A	Atherectomy, open	9.49	NA	4.02	1.06	NA	14.57	000
35490		A	Atherectomy, percutaneous	11.08	NA	4.80	0.55	NA	16.43	000
35491		A	Atherectomy, percutaneous	7.61	NA	3.32	0.49	NA	11.42	000
35492		A	Atherectomy, percutaneous	6.65	NA	3.20	0.43	NA	10.28	000
35493		A	Atherectomy, percutaneous	8.10	NA	3.86	0.47	NA	12.43	000
35494		A	Atherectomy, percutaneous	10.44	NA	4.46	0.48	NA	15.38	000
35495		A	Atherectomy, percutaneous	9.49	NA	4.46	0.51	NA	14.46	000
35500		A	Harvest vein for bypass	6.45	NA	2.07	0.63	NA	9.15	ZZZ
35501		A	Artery bypass graft	19.19	NA	7.43	2.33	NA	28.95	090
35506		A	Artery bypass graft	19.67	NA	8.13	2.33	NA	30.13	090
35507		A	Artery bypass graft	19.67	NA	8.09	2.27	NA	30.03	090
35508		A	Artery bypass graft	18.65	NA	7.85	2.34	NA	28.84	090
35509		A	Artery bypass graft	18.07	NA	7.54	2.12	NA	27.73	090
35511		A	Artery bypass graft	21.20	NA	8.69	1.74	NA	31.63	090
35515		A	Artery bypass graft	18.65	NA	7.93	2.26	NA	28.84	090
35516		A	Artery bypass graft	16.32	NA	5.80	1.88	NA	24.00	090
35518		A	Artery bypass graft	21.20	NA	8.49	1.78	NA	31.47	090
35521		A	Artery bypass graft	22.20	NA	9.33	1.82	NA	33.35	090
35526		A	Artery bypass graft	29.95	NA	12.00	2.18	NA	44.13	090
35531		A	Artery bypass graft	36.20	NA	14.13	2.91	NA	53.24	090
35533		A	Artery bypass graft	28.00	NA	11.36	2.35	NA	41.71	090
35536		A	Artery bypass graft	31.70	NA	12.58	2.62	NA	46.90	090
35541		A	Artery bypass graft	25.80	NA	10.72	2.74	NA	39.26	090
35546		A	Artery bypass graft	25.54	NA	10.48	2.84	NA	38.86	090
35548		A	Artery bypass graft	21.57	NA	9.06	2.45	NA	33.08	090
35549		A	Artery bypass graft	23.35	NA	9.81	2.77	NA	35.93	090
35551		A	Artery bypass graft	26.67	NA	10.89	3.19	NA	40.75	090
35556		A	Artery bypass graft	21.76	NA	9.24	2.48	NA	33.48	090
35558		A	Artery bypass graft	21.20	NA	8.99	1.58	NA	31.77	090
35560		A	Artery bypass graft	32.00	NA	12.78	2.73	NA	47.51	090
35563		A	Artery bypass graft	24.20	NA	10.09	1.68	NA	35.97	090
35565		A	Artery bypass graft	23.20	NA	9.71	1.71	NA	34.62	090
35566		A	Artery bypass graft	26.92	NA	11.67	3.02	NA	41.61	090
35571		A	Artery bypass graft	24.06	NA	11.90	2.14	NA	38.10	090
35572		A	Harvest femoropopliteal vein	6.82	NA	2.57	0.63	NA	10.02	ZZZ
35582		A	Vein bypass graft	27.13	NA	11.09	3.11	NA	41.33	090
35583		A	Vein bypass graft	22.37	NA	10.39	2.53	NA	35.29	090
35585		A	Vein bypass graft	28.39	NA	14.29	3.21	NA	45.89	090
35587		A	Vein bypass graft	24.75	NA	12.58	2.17	NA	39.50	090
35600		A	Harvest artery for cabg	4.95	NA	1.62	0.60	NA	7.17	ZZZ
35601		A	Artery bypass graft	17.50	NA	7.33	2.08	NA	26.91	090
35606		A	Artery bypass graft	18.71	NA	7.75	2.17	NA	28.63	090
35612		A	Artery bypass graft	15.76	NA	6.72	1.72	NA	24.20	090
35616		A	Artery bypass graft	15.70	NA	6.78	1.84	NA	24.32	090
35621		A	Artery bypass graft	20.00	NA	8.67	1.68	NA	30.35	090
35623		A	Bypass graft, not vein	24.00	NA	9.98	1.91	NA	35.89	090
35626		A	Artery bypass graft	27.75	NA	10.93	2.89	NA	41.57	090
35631		A	Artery bypass graft	34.00	NA	13.41	2.83	NA	50.24	090
35636		A	Artery bypass graft	29.50	NA	12.11	2.37	NA	43.98	090
35641		A	Artery bypass graft	24.57	NA	10.27	2.83	NA	37.67	090
35642		A	Artery bypass graft	17.98	NA	7.86	1.84	NA	27.68	090
35645		A	Artery bypass graft	17.47	NA	7.69	1.91	NA	27.07	090
35646		A	Artery bypass graft	31.00	NA	13.00	3.63	NA	47.63	090
35647		A	Artery bypass graft	28.00	NA	11.76	3.28	NA	43.04	090
35650		A	Artery bypass graft	19.00	NA	7.77	1.64	NA	28.41	090
35651		A	Artery bypass graft	25.04	NA	10.50	2.53	NA	38.07	090
35654		A	Artery bypass graft	25.00	NA	10.34	2.10	NA	37.44	090
35656		A	Artery bypass graft	19.53	NA	8.22	2.21	NA	29.96	090
35661		A	Artery bypass graft	19.00	NA	8.09	1.50	NA	28.59	090
35663		A	Artery bypass graft	22.00	NA	9.44	1.55	NA	32.99	090
35665		A	Artery bypass graft	21.00	NA	8.98	1.76	NA	31.74	090
35666		A	Artery bypass graft	22.19	NA	11.72	2.19	NA	36.10	090
35671		A	Artery bypass graft	19.33	NA	10.39	1.68	NA	31.40	090
35681		A	Composite bypass graft	1.60	NA	0.55	0.18	NA	2.33	ZZZ
35682		A	Composite bypass graft	7.20	NA	2.44	0.83	NA	10.47	ZZZ
35683		A	Composite bypass graft	8.50	NA	2.88	0.98	NA	12.36	ZZZ
35685		A	Bypass graft patency/patch	4.05	NA	1.52	0.25	NA	5.82	ZZZ
35686		A	Bypass graft/av fist patency	3.35	NA	1.26	0.21	NA	4.82	ZZZ
35691		A	Arterial transposition	18.05	NA	7.54	2.06	NA	27.65	090
35693		A	Arterial transposition	15.36	NA	6.59	1.80	NA	23.75	090
35694		A	Arterial transposition	19.16	NA	7.83	2.13	NA	29.12	090
35695		A	Arterial transposition	19.16	NA	7.78	2.19	NA	29.13	090
35700		A	Reoperation, bypass graft	3.08	NA	1.03	0.36	NA	4.47	ZZZ
35701		A	Exploration, carotid artery	8.50	NA	4.59	0.64	NA	13.73	090
35721		A	Exploration, femoral artery	7.18	NA	5.13	0.59	NA	12.90	090
35741		A	Exploration popliteal artery	8.00	NA	5.34	0.60	NA	13.94	090
35761		A	Exploration of artery/vein	5.37	NA	4.42	0.60	NA	10.39	090
35800		A	Explore neck vessels	7.02	NA	3.90	0.79	NA	11.71	090
35820		A	Explore chest vessels	12.88	NA	4.19	1.61	NA	18.68	090
35840		A	Explore abdominal vessels	9.77	NA	5.10	1.06	NA	15.93	090
35860		A	Explore limb vessels	5.55	NA	3.54	0.63	NA	9.72	090
35870		A	Repair vessel graft defect	22.17	NA	9.95	2.47	NA	34.59	090
35875		A	Removal of clot in graft	10.13	NA	6.30	0.97	NA	17.40	090
35876		A	Removal of clot in graft	17.00	NA	8.80	1.88	NA	27.68	090
35879		A	Revise graft w/vein	16.00	NA	7.61	1.35	NA	24.96	090
35881		A	Revise graft w/vein	18.00	NA	8.46	1.44	NA	27.90	090
35901		A	Excision, graft, neck	8.19	NA	5.82	0.90	NA	14.91	090
35903		A	Excision, graft, extremity	9.39	NA	8.08	1.03	NA	18.50	090
35905		A	Excision, graft, thorax	31.25	NA	15.12	2.15	NA	48.52	090
35907		A	Excision, graft, abdomen	35.00	NA	14.57	2.17	NA	51.74	090
36000		A	Place needle in vein	0.18	0.66	0.05	0.01	0.85	0.24	XXX
36002		A	Pseudoaneurysm injection trt	1.96	2.45	1.00	0.10	4.51	3.06	000
36005		A	Injection ext venography	0.95	8.51	0.32	0.04	9.50	1.31	000
36010		A	Place catheter in vein	2.43	NA	0.81	0.16	NA	3.40	XXX
36011		A	Place catheter in vein	3.14	NA	1.05	0.17	NA	4.36	XXX
36012		A	Place catheter in vein	3.52	NA	1.18	0.17	NA	4.87	XXX
36013		A	Place catheter in artery	2.52	NA	0.67	0.17	NA	3.36	XXX
36014		A	Place catheter in artery	3.02	NA	1.02	0.14	NA	4.18	XXX
36015		A	Place catheter in artery	3.52	NA	1.18	0.16	NA	4.86	XXX
36100		A	Establish access to artery	3.02	NA	1.12	0.18	NA	4.32	XXX
36120		A	Establish access to artery	2.01	NA	0.67	0.11	NA	2.79	XXX
36140		A	Establish access to artery	2.01	NA	0.66	0.12	NA	2.79	XXX
36145		A	Artery to vein shunt	2.01	NA	0.68	0.10	NA	2.79	XXX
36160		A	Establish access to aorta	2.52	NA	0.86	0.20	NA	3.58	XXX
36200		A	Place catheter in aorta	3.02	NA	1.04	0.15	NA	4.21	XXX
36215		A	Place catheter in artery	4.68	NA	1.62	0.22	NA	6.52	XXX
36216		A	Place catheter in artery	5.28	NA	1.81	0.24	NA	7.33	XXX
36217		A	Place catheter in artery	6.30	NA	2.21	0.32	NA	8.83	XXX
36218		A	Place catheter in artery	1.01	NA	0.35	0.05	NA	1.41	ZZZ
36245		A	Place catheter in artery	4.68	NA	1.69	0.23	NA	6.60	XXX
36246		A	Place catheter in artery	5.28	NA	1.83	0.26	NA	7.37	XXX
36247		A	Place catheter in artery	6.30	NA	2.17	0.32	NA	8.79	XXX
36248		A	Place catheter in artery	1.01	NA	0.36	0.06	NA	1.43	ZZZ
36260		A	Insertion of infusion pump	9.71	NA	5.50	1.00	NA	16.21	090
36261		A	Revision of infusion pump	5.45	NA	3.33	0.50	NA	9.28	090
36262		A	Removal of infusion pump	4.02	NA	2.48	0.43	NA	6.93	090
36299		C	Vessel injection procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
36400		A	Bl draw < 3 yrs fem/jugular	0.38	0.89	0.10	0.01	1.28	0.49	XXX
36405		A	Bl draw < 3 yrs scalp vein	0.31	0.33	0.08	0.01	0.65	0.40	XXX
36406		A	Bl draw < 3 yrs other vein	0.18	0.37	0.05	0.01	0.56	0.24	XXX
36410		A	Non-routine bl draw > 3 yrs	0.18	0.39	0.05	0.01	0.58	0.24	XXX
36415		I	Routine venipuncture	0.00	0.00	0.00	0.00	0.00	0.00	XXX
36416		I	Capillary blood draw	0.00	0.00	0.00	0.00	0.00	0.00	XXX
36420		A	Vein access cutdown < 1 yr	1.01	NA	0.31	0.09	NA	1.41	XXX
36425		A	Vein access cutdown > 1 yr	0.76	NA	0.22	0.05	NA	1.03	XXX
36430		A	Blood transfusion service	0.00	1.01	NA	0.05	1.06	NA	XXX
36440		A	Bl push transfuse, 2 yr or <	1.03	NA	0.29	0.08	NA	1.40	XXX
36450		A	Bl exchange/transfuse, nb	2.23	NA	0.72	0.16	NA	3.11	XXX
36455		A	Bl exchange/transfuse non-nb	2.43	NA	0.85	0.10	NA	3.38	XXX
36460		A	Transfusion service, fetal	6.59	NA	2.27	0.56	NA	9.42	XXX
36468		R	Injection(s), spider veins	0.00	0.00	0.00	0.00	0.00	0.00	000
36469		R	Injection(s), spider veins	0.00	0.00	0.00	0.00	0.00	0.00	000
36470		A	Injection therapy of vein	1.09	2.33	0.39	0.10	3.52	1.58	010
36471		A	Injection therapy of veins	1.57	2.68	0.55	0.15	4.40	2.27	010
36481		A	Insertion of catheter, vein	6.99	NA	2.80	0.40	NA	10.19	000
36488		A	Insertion of catheter, vein	1.35	NA	0.74	0.09	NA	2.18	000
36489		A	Insertion of catheter, vein	2.50	4.11	1.04	0.08	6.69	3.62	000
36490		A	Insertion of catheter, vein	1.67	NA	0.83	0.17	NA	2.67	000
36491		A	Insertion of catheter, vein	1.43	NA	0.76	0.13	NA	2.32	000
36493		A	Repositioning of cvc	1.21	NA	0.86	0.06	NA	2.13	000
36500		A	Insertion of catheter, vein	3.52	NA	1.26	0.14	NA	4.92	000
36510		A	Insertion of catheter, vein	1.09	NA	0.72	0.06	NA	1.87	000
36511		A	Apheresis wbc	1.74	NA	0.70	0.06	NA	2.50	000
36512		A	Apheresis rbc	1.74	NA	0.70	0.06	NA	2.50	000
36513		A	Apheresis platelets	1.74	NA	0.70	0.06	NA	2.50	000
36514		A	Apheresis plasma	1.74	NA	0.70	0.06	NA	2.50	000
36515		A	Apheresis, adsorp/reinfuse	1.74	NA	0.70	0.06	NA	2.50	000
36516		A	Apheresis, selective	1.74	NA	0.70	0.06	NA	2.50	000
36520		D	Plasma and/or cell exchange	0.00	0.00	0.00	0.00	0.00	0.00	000
36521		D	Apheresis w/ adsorp/reinfuse	0.00	0.00	0.00	0.00	0.00	0.00	000
36522		A	Photopheresis	1.67	6.77	1.15	0.07	8.51	2.89	000
36530		R	Insertion of infusion pump	6.20	NA	3.70	0.56	NA	10.46	010
36531		R	Revision of infusion pump	4.87	NA	3.25	0.44	NA	8.56	010
36532		R	Removal of infusion pump	3.30	NA	1.52	0.34	NA	5.16	010
36533		A	Insertion of access device	5.32	13.55	3.38	0.49	19.36	9.19	010
36534		A	Revision of access device	2.80	NA	1.46	0.19	NA	4.45	010
36535		A	Removal of access device	2.27	2.81	1.82	0.21	5.29	4.30	010
36536		A	Remove cva device obstruct	3.60	33.54	1.47	0.23	37.37	5.30	000
36537		A	Remove cva lumen obstruct	0.75	7.69	0.49	0.04	8.48	1.28	000
36540		B	Collect blood venous device	0.00	0.00	0.00	0.00	0.00	0.00	XXX
36550		A	Declot vascular device	0.00	0.38	NA	0.31	0.69	NA	XXX
36600		A	Withdrawal of arterial blood	0.32	0.41	0.09	0.02	0.75	0.43	XXX
36620		A	Insertion catheter, artery	1.15	NA	0.24	0.06	NA	1.45	000
36625		A	Insertion catheter, artery	2.11	NA	0.53	0.16	NA	2.80	000
36640		A	Insertion catheter, artery	2.10	NA	0.72	0.18	NA	3.00	000
36660		A	Insertion catheter, artery	1.40	NA	0.45	0.08	NA	1.93	000
36680		A	Insert needle, bone cavity	1.20	NA	0.62	0.08	NA	1.90	000
36800		A	Insertion of cannula	2.43	NA	1.76	0.17	NA	4.36	000
36810		A	Insertion of cannula	3.97	NA	2.24	0.40	NA	6.61	000
36815		A	Insertion of cannula	2.62	NA	1.26	0.26	NA	4.14	000
36819		A	Av fusion/uppr arm vein	14.00	NA	6.41	1.56	NA	21.97	090
36820		A	Av fusion/forearm vein	14.00	NA	6.43	1.56	NA	21.99	090
36821		A	Av fusion direct any site	8.93	NA	4.94	0.97	NA	14.84	090
36822		A	Insertion of cannula(s)	5.42	NA	7.14	0.63	NA	13.19	090
36823		A	Insertion of cannula(s)	21.00	NA	10.38	2.18	NA	33.56	090
36825		A	Artery-vein autograft	9.84	NA	5.48	1.09	NA	16.41	090
36830		A	Artery-vein nonautograft	12.00	NA	6.04	1.32	NA	19.36	090
36831		A	Open thrombect av fistula	8.00	NA	3.93	0.79	NA	12.72	090
36832		A	Av fistula revision, open	10.50	NA	5.53	1.13	NA	17.16	090
36833		A	Av fistula revision	11.95	NA	6.00	1.29	NA	19.24	090
36834		A	Repair A-V aneurysm	9.93	NA	3.79	1.06	NA	14.78	090
36835		A	Artery to vein shunt	7.15	NA	4.52	0.80	NA	12.47	090
36860		A	External cannula declotting	2.01	2.62	1.34	0.10	4.73	3.45	000
36861		A	Cannula declotting	2.52	NA	1.46	0.14	NA	4.12	000
36870		A	Percut thrombect av fistula	5.16	42.32	2.39	0.23	47.71	7.78	090
37140		A	Revision of circulation	23.60	NA	10.31	1.21	NA	35.12	090
37145		A	Revision of circulation	24.61	NA	10.93	2.48	NA	38.02	090
37160		A	Revision of circulation	21.60	NA	9.14	2.16	NA	32.90	090
37180		A	Revision of circulation	24.61	NA	10.27	2.63	NA	37.51	090
37181		A	Splice spleen/kidney veins	26.68	NA	10.86	2.67	NA	40.21	090
37182		A	Insert hepatic shunt (tips)	17.00	NA	6.37	1.49	NA	24.86	000
37183		A	Remove hepatic shunt (tips)	8.00	NA	3.12	0.43	NA	11.55	000
37195		A	Thrombolytic therapy, stroke	0.00	8.02	NA	0.38	8.40	NA	XXX
37200		A	Transcatheter biopsy	4.56	NA	1.55	0.19	NA	6.30	000
37201		A	Transcatheter therapy infuse	5.00	NA	2.53	0.24	NA	7.77	000
37202		A	Transcatheter therapy infuse	5.68	NA	3.10	0.38	NA	9.16	000
37203		A	Transcatheter retrieval	5.03	NA	2.55	0.23	NA	7.81	000
37204		A	Transcatheter occlusion	18.14	NA	6.11	0.91	NA	25.16	000
37205		A	Transcatheter stent	8.28	NA	3.79	0.43	NA	12.50	000
37206		A	Transcatheter stent add-on	4.13	NA	1.48	0.22	NA	5.83	ZZZ
37207		A	Transcatheter stent	8.28	NA	3.53	0.89	NA	12.70	000
37208		A	Transcatheter stent add-on	4.13	NA	1.41	0.44	NA	5.98	ZZZ
37209		A	Exchange arterial catheter	2.27	NA	0.77	0.11	NA	3.15	000
37250		A	Iv us first vessel add-on	2.10	NA	0.77	0.17	NA	3.04	ZZZ
37251		A	Iv us each add vessel add-on	1.60	NA	0.57	0.14	NA	2.31	ZZZ
37500		A	Endoscopy ligate perf veins	11.00	NA	8.70	0.40	NA	20.10	090
37501		C	Vascular endoscopy procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
37565		A	Ligation of neck vein	10.88	NA	5.08	0.45	NA	16.41	090
37600		A	Ligation of neck artery	11.25	NA	6.30	0.40	NA	17.95	090
37605		A	Ligation of neck artery	13.11	NA	6.48	0.77	NA	20.36	090
37606		A	Ligation of neck artery	6.28	NA	3.98	0.79	NA	11.05	090
37607		A	Ligation of a-v fistula	6.16	NA	3.65	0.67	NA	10.48	090
37609		A	Temporal artery procedure	3.00	7.02	2.52	0.21	10.23	5.73	010
37615		A	Ligation of neck artery	5.73	NA	3.64	0.57	NA	9.94	090
37616		A	Ligation of chest artery	16.49	NA	10.58	1.93	NA	29.00	090
37617		A	Ligation of abdomen artery	22.06	NA	9.42	1.69	NA	33.17	090
37618		A	Ligation of extremity artery	4.84	NA	3.49	0.54	NA	8.87	090
37620		A	Revision of major vein	10.56	NA	5.40	0.75	NA	16.71	090
37650		A	Revision of major vein	7.80	NA	4.65	0.56	NA	13.01	090
37660		A	Revision of major vein	21.00	NA	9.32	1.17	NA	31.49	090
37700		A	Revise leg vein	3.73	NA	3.14	0.40	NA	7.27	090
37720		A	Removal of leg vein	5.66	NA	3.63	0.61	NA	9.90	090
37730		A	Removal of leg veins	7.33	NA	4.51	0.77	NA	12.61	090
37735		A	Removal of leg veins/lesion	10.53	NA	5.77	1.17	NA	17.47	090
37760		A	Ligation, leg veins, open	10.47	NA	5.63	1.11	NA	17.21	090
37780		A	Revision of leg vein	3.84	NA	2.96	0.41	NA	7.21	090
37785		A	Revise secondary varicosity	3.84	6.98	2.85	0.41	11.23	7.10	090
37788		A	Revascularization, penis	22.01	NA	11.50	1.35	NA	34.86	090
37790		A	Penile venous occlusion	8.34	NA	6.11	0.63	NA	15.08	090
37799		C	Vascular surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
38100		A	Removal of spleen, total	14.50	NA	6.56	1.30	NA	22.36	090
38101		A	Removal of spleen, partial	15.31	NA	6.94	1.38	NA	23.63	090
38102		A	Removal of spleen, total	4.80	NA	1.68	0.49	NA	6.97	ZZZ
38115		A	Repair of ruptured spleen	15.82	NA	7.04	1.40	NA	24.26	090
38120		A	Laparoscopy, splenectomy	17.00	NA	7.37	1.73	NA	26.10	090
38129		C	Laparoscope proc, spleen	0.00	0.00	0.00	0.00	0.00	0.00	YYY
38200		A	Injection for spleen x-ray	2.64	NA	0.92	0.12	NA	3.68	000
38204		B	Bl donor search management	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38205		R	Harvest allogenic stem cells	1.50	NA	0.61	0.05	NA	2.16	000
38206		R	Harvest auto stem cells	1.50	NA	0.61	0.05	NA	2.16	000
38207		I	Cryopreserve stem cells	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38208		I	Thaw preserved stem cells	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38209		I	Wash harvest stem cells	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38210		I	T-cell depletion of harvest	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38211		I	Tumor cell deplete of harvst	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38212		I	Rbc depletion of harvest	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38213		I	Platelet deplete of harvest	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38214		I	Volume deplete of harvest	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38215		I	Harvest stem cell concentrte	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38220		A	Bone marrow aspiration	1.08	4.64	0.43	0.03	5.75	1.54	XXX
38221		A	Bone marrow biopsy	1.37	4.79	0.54	0.04	6.20	1.95	XXX
38230		R	Bone marrow collection	4.54	NA	2.42	0.25	NA	7.21	010
38231		D	Stem cell collection	0.00	0.00	0.00	0.00	0.00	0.00	000
38240		R	Bone marrow/stem transplant	2.24	NA	0.84	0.08	NA	3.16	XXX
38241		R	Bone marrow/stem transplant	2.24	NA	0.84	0.08	NA	3.16	XXX
38242		A	Lymphocyte infuse transplant	1.71	NA	0.70	0.05	NA	2.46	000
38300		A	Drainage, lymph node lesion	1.99	4.51	2.59	0.15	6.65	4.73	010
38305		A	Drainage, lymph node lesion	6.00	8.72	6.29	0.36	15.08	12.65	090
38308		A	Incision of lymph channels	6.45	NA	5.70	0.51	NA	12.66	090
38380		A	Thoracic duct procedure	7.46	NA	7.55	0.68	NA	15.69	090
38381		A	Thoracic duct procedure	12.88	NA	9.83	1.58	NA	24.29	090
38382		A	Thoracic duct procedure	10.08	NA	9.18	1.08	NA	20.34	090
38500		A	Biopsy/removal, lymph nodes	3.75	3.04	2.56	0.28	7.07	6.59	010
38505		A	Needle biopsy, lymph nodes	1.14	3.13	1.09	0.09	4.36	2.32	000
38510		A	Biopsy/removal, lymph nodes	6.43	NA	5.41	0.38	NA	12.22	010
38520		A	Biopsy/removal, lymph nodes	6.67	NA	5.55	0.52	NA	12.74	090
38525		A	Biopsy/removal, lymph nodes	6.07	NA	4.40	0.48	NA	10.95	090
38530		A	Biopsy/removal, lymph nodes	7.98	NA	5.84	0.63	NA	14.45	090
38542		A	Explore deep node(s), neck	5.91	NA	6.00	0.50	NA	12.41	090
38550		A	Removal, neck/armpit lesion	6.92	NA	4.90	0.69	NA	12.51	090
38555		A	Removal, neck/armpit lesion	14.14	NA	10.28	1.46	NA	25.88	090
38562		A	Removal, pelvic lymph nodes	10.49	NA	6.53	0.97	NA	17.99	090
38564		A	Removal, abdomen lymph nodes	10.83	NA	6.27	1.06	NA	18.16	090
38570		A	Laparoscopy, lymph node biop	9.25	NA	4.47	0.89	NA	14.61	010
38571		A	Laparoscopy, lymphadenectomy	14.68	NA	6.10	0.80	NA	21.58	010
38572		A	Laparoscopy, lymphadenectomy	16.59	NA	7.40	1.32	NA	25.31	010
38589		C	Laparoscope proc, lymphatic	0.00	0.00	0.00	0.00	0.00	0.00	YYY
38700		A	Removal of lymph nodes, neck	8.24	NA	13.43	0.60	NA	22.27	090
38720		A	Removal of lymph nodes, neck	13.61	NA	15.95	1.03	NA	30.59	090
38724		A	Removal of lymph nodes, neck	14.54	NA	16.51	1.10	NA	32.15	090
38740		A	Remove armpit lymph nodes	10.03	NA	5.79	0.69	NA	16.51	090
38745		A	Remove armpit lymph nodes	13.10	NA	8.25	0.90	NA	22.25	090
38746		A	Remove thoracic lymph nodes	4.89	NA	1.60	0.55	NA	7.04	ZZZ
38747		A	Remove abdominal lymph nodes	4.89	NA	1.70	0.50	NA	7.09	ZZZ
38760		A	Remove groin lymph nodes	12.95	NA	7.14	0.88	NA	20.97	090
38765		A	Remove groin lymph nodes	19.98	NA	11.22	1.50	NA	32.70	090
38770		A	Remove pelvis lymph nodes	13.23	NA	6.79	0.99	NA	21.01	090
38780		A	Remove abdomen lymph nodes	16.59	NA	9.28	1.60	NA	27.47	090
38790		A	Inject for lymphatic x-ray	1.29	31.59	0.45	0.09	32.97	1.83	000
38792		A	Identify sentinel node	0.52	NA	0.18	0.04	NA	0.74	000
38794		A	Access thoracic lymph duct	4.45	NA	1.54	0.17	NA	6.16	090
38999		C	Blood/lymph system procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
39000		A	Exploration of chest	6.10	NA	7.58	0.73	NA	14.41	090
39010		A	Exploration of chest	11.79	NA	7.19	1.46	NA	20.44	090
39200		A	Removal chest lesion	13.62	NA	7.30	1.65	NA	22.57	090
39220		A	Removal chest lesion	17.42	NA	9.05	2.10	NA	28.57	090
39400		A	Visualization of chest	5.61	NA	4.59	0.69	NA	10.89	010
39499		C	Chest procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
39501		A	Repair diaphragm laceration	13.19	NA	7.73	1.38	NA	22.30	090
39502		A	Repair paraesophageal hernia	16.33	NA	8.22	1.68	NA	26.23	090
39503		A	Repair of diaphragm hernia	95.00	NA	34.45	3.52	NA	132.97	090
39520		A	Repair of diaphragm hernia	16.10	NA	9.68	1.83	NA	27.61	090
39530		A	Repair of diaphragm hernia	15.41	NA	8.56	1.66	NA	25.63	090
39531		A	Repair of diaphragm hernia	16.42	NA	8.75	1.83	NA	27.00	090
39540		A	Repair of diaphragm hernia	13.32	NA	7.77	1.38	NA	22.47	090
39541		A	Repair of diaphragm hernia	14.41	NA	7.86	1.52	NA	23.79	090
39545		A	Revision of diaphragm	13.37	NA	9.29	1.55	NA	24.21	090
39560		A	Resect diaphragm, simple	12.00	NA	7.53	1.35	NA	20.88	090
39561		A	Resect diaphragm, complex	17.50	NA	9.76	1.97	NA	29.23	090
39599		C	Diaphragm surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
40490		A	Biopsy of lip	1.22	1.73	0.62	0.06	3.01	1.90	000
40500		A	Partial excision of lip	4.28	5.89	5.69	0.31	10.48	10.28	090
40510		A	Partial excision of lip	4.70	6.76	6.51	0.38	11.84	11.59	090
40520		A	Partial excision of lip	4.67	7.77	6.87	0.42	12.86	11.96	090
40525		A	Reconstruct lip with flap	7.55	NA	8.36	0.68	NA	16.59	090
40527		A	Reconstruct lip with flap	9.13	NA	9.24	0.82	NA	19.19	090
40530		A	Partial removal of lip	5.40	6.60	6.24	0.47	12.47	12.11	090
40650		A	Repair lip	3.64	5.44	4.81	0.31	9.39	8.76	090
40652		A	Repair lip	4.26	6.83	6.80	0.39	11.48	11.45	090
40654		A	Repair lip	5.31	7.71	7.50	0.48	13.50	13.29	090
40700		A	Repair cleft lip/nasal	12.79	NA	10.32	0.93	NA	24.04	090
40701		A	Repair cleft lip/nasal	15.85	NA	12.70	1.36	NA	29.91	090
40702		A	Repair cleft lip/nasal	13.04	NA	9.54	1.01	NA	23.59	090
40720		A	Repair cleft lip/nasal	13.55	NA	11.93	1.31	NA	26.79	090
40761		A	Repair cleft lip/nasal	14.72	NA	12.39	1.41	NA	28.52	090
40799		C	Lip surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
40800		A	Drainage of mouth lesion	1.17	1.82	0.87	0.09	3.08	2.13	010
40801		A	Drainage of mouth lesion	2.53	2.42	1.55	0.18	5.13	4.26	010
40804		A	Removal, foreign body, mouth	1.24	2.31	1.03	0.09	3.64	2.36	010
40805		A	Removal, foreign body, mouth	2.69	2.75	1.75	0.17	5.61	4.61	010
40806		A	Incision of lip fold	0.31	0.96	0.86	0.02	1.29	1.19	000
40808		A	Biopsy of mouth lesion	0.96	1.94	1.02	0.07	2.97	2.05	010
40810		A	Excision of mouth lesion	1.31	2.07	1.16	0.09	3.47	2.56	010
40812		A	Excise/repair mouth lesion	2.31	2.43	1.72	0.17	4.91	4.20	010
40814		A	Excise/repair mouth lesion	3.42	3.34	2.98	0.26	7.02	6.66	090
40816		A	Excision of mouth lesion	3.67	3.46	3.17	0.27	7.40	7.11	090
40818		A	Excise oral mucosa for graft	2.41	4.11	4.11	0.14	6.66	6.66	090
40819		A	Excise lip or cheek fold	2.41	3.57	3.55	0.17	6.15	6.13	090
40820		A	Treatment of mouth lesion	1.28	2.47	2.30	0.08	3.83	3.66	010
40830		A	Repair mouth laceration	1.76	2.53	2.50	0.14	4.43	4.40	010
40831		A	Repair mouth laceration	2.46	2.78	2.78	0.21	5.45	5.45	010
40840		R	Reconstruction of mouth	8.73	6.14	6.14	0.79	15.66	15.66	090
40842		R	Reconstruction of mouth	8.73	6.00	6.00	0.65	15.38	15.38	090
40843		R	Reconstruction of mouth	12.10	7.31	7.31	0.84	20.25	20.25	090
40844		R	Reconstruction of mouth	16.01	8.98	8.95	1.63	26.62	26.59	090
40845		R	Reconstruction of mouth	18.58	10.94	10.94	1.47	30.99	30.99	090
40899		C	Mouth surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
41000		A	Drainage of mouth lesion	1.30	2.38	1.50	0.09	3.77	2.89	010
41005		A	Drainage of mouth lesion	1.26	2.26	1.47	0.09	3.61	2.82	010
41006		A	Drainage of mouth lesion	3.24	3.75	3.40	0.25	7.24	6.89	090
41007		A	Drainage of mouth lesion	3.10	3.87	3.19	0.22	7.19	6.51	090
41008		A	Drainage of mouth lesion	3.37	3.60	3.28	0.24	7.21	6.89	090
41009		A	Drainage of mouth lesion	3.59	3.67	3.27	0.25	7.51	7.11	090
41010		A	Incision of tongue fold	1.06	3.26	3.26	0.06	4.38	4.38	010
41015		A	Drainage of mouth lesion	3.96	4.22	3.23	0.29	8.47	7.48	090
41016		A	Drainage of mouth lesion	4.07	4.15	3.38	0.28	8.50	7.73	090
41017		A	Drainage of mouth lesion	4.07	4.16	3.32	0.32	8.55	7.71	090
41018		A	Drainage of mouth lesion	5.10	4.55	3.79	0.35	10.00	9.24	090
41100		A	Biopsy of tongue	1.63	2.36	1.40	0.12	4.11	3.15	010
41105		A	Biopsy of tongue	1.42	2.18	1.32	0.10	3.70	2.84	010
41108		A	Biopsy of floor of mouth	1.05	2.04	1.10	0.08	3.17	2.23	010
41110		A	Excision of tongue lesion	1.51	2.44	1.31	0.11	4.06	2.93	010
41112		A	Excision of tongue lesion	2.73	3.38	2.71	0.20	6.31	5.64	090
41113		A	Excision of tongue lesion	3.19	3.40	2.94	0.23	6.82	6.36	090
41114		A	Excision of tongue lesion	8.47	NA	5.44	0.64	NA	14.55	090
41115		A	Excision of tongue fold	1.74	2.61	2.54	0.13	4.48	4.41	010
41116		A	Excision of mouth lesion	2.44	3.40	3.40	0.17	6.01	6.01	090
41120		A	Partial removal of tongue	9.77	NA	8.88	0.70	NA	19.35	090
41130		A	Partial removal of tongue	11.15	NA	9.66	0.81	NA	21.62	090
41135		A	Tongue and neck surgery	23.09	NA	15.99	1.66	NA	40.74	090
41140		A	Removal of tongue	25.50	NA	17.32	1.85	NA	44.67	090
41145		A	Tongue removal, neck surgery	30.06	NA	21.30	2.11	NA	53.47	090
41150		A	Tongue, mouth, jaw surgery	23.04	NA	17.16	1.67	NA	41.87	090
41153		A	Tongue, mouth, neck surgery	23.77	NA	17.77	1.71	NA	43.25	090
41155		A	Tongue, jaw, & neck surgery	27.72	NA	19.97	2.02	NA	49.71	090
41250		A	Repair tongue laceration	1.91	2.88	1.71	0.15	4.94	3.77	010
41251		A	Repair tongue laceration	2.27	2.72	2.00	0.18	5.17	4.45	010
41252		A	Repair tongue laceration	2.97	3.50	2.34	0.23	6.70	5.54	010
41500		A	Fixation of tongue	3.71	NA	4.33	0.26	NA	8.30	090
41510		A	Tongue to lip surgery	3.42	NA	4.80	0.24	NA	8.46	090
41520		A	Reconstruction, tongue fold	2.73	3.03	3.03	0.19	5.95	5.95	090
41599		C	Tongue and mouth surgery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
41800		A	Drainage of gum lesion	1.17	1.97	1.37	0.09	3.23	2.63	010
41805		A	Removal foreign body, gum	1.24	1.95	1.95	0.09	3.28	3.28	010
41806		A	Removal foreign body,jawbone	2.69	2.57	2.45	0.22	5.48	5.36	010
41820		R	Excision, gum, each quadrant	0.00	0.00	0.00	0.00	0.00	0.00	000
41821		R	Excision of gum flap	0.00	0.00	0.00	0.00	0.00	0.00	000
41822		R	Excision of gum lesion	2.31	2.83	0.96	0.24	5.38	3.51	010
41823		R	Excision of gum lesion	3.30	3.58	3.00	0.29	7.17	6.59	090
41825		A	Excision of gum lesion	1.31	2.40	2.36	0.10	3.81	3.77	010
41826		A	Excision of gum lesion	2.31	2.64	2.64	0.17	5.12	5.12	010
41827		A	Excision of gum lesion	3.42	3.58	3.58	0.25	7.25	7.25	090
41828		R	Excision of gum lesion	3.09	3.01	2.40	0.22	6.32	5.71	010
41830		R	Removal of gum tissue	3.35	3.30	2.94	0.23	6.88	6.52	010
41850		R	Treatment of gum lesion	0.00	0.00	0.00	0.00	0.00	0.00	000
41870		R	Gum graft	0.00	0.00	0.00	0.00	0.00	0.00	000
41872		R	Repair gum	2.59	2.88	2.88	0.18	5.65	5.65	090
41874		R	Repair tooth socket	3.09	2.88	2.40	0.23	6.20	5.72	090
41899		C	Dental surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
42000		A	Drainage mouth roof lesion	1.23	2.53	1.53	0.10	3.86	2.86	010
42100		A	Biopsy roof of mouth	1.31	2.51	2.50	0.10	3.92	3.91	010
42104		A	Excision lesion, mouth roof	1.64	2.57	2.57	0.12	4.33	4.33	010
42106		A	Excision lesion, mouth roof	2.10	2.64	2.64	0.16	4.90	4.90	010
42107		A	Excision lesion, mouth roof	4.44	4.11	4.11	0.32	8.87	8.87	090
42120		A	Remove palate/lesion	6.17	NA	6.11	0.44	NA	12.72	090
42140		A	Excision of uvula	1.62	3.91	3.37	0.12	5.65	5.11	090
42145		A	Repair palate, pharynx/uvula	8.05	NA	7.50	0.56	NA	16.11	090
42160		A	Treatment mouth roof lesion	1.80	3.28	2.70	0.13	5.21	4.63	010
42180		A	Repair palate	2.50	2.99	2.11	0.19	5.68	4.80	010
42182		A	Repair palate	3.83	3.47	3.06	0.27	7.57	7.16	010
42200		A	Reconstruct cleft palate	12.00	NA	10.14	0.97	NA	23.11	090
42205		A	Reconstruct cleft palate	13.29	NA	9.23	0.82	NA	23.34	090
42210		A	Reconstruct cleft palate	14.50	NA	9.51	1.24	NA	25.25	090
42215		A	Reconstruct cleft palate	8.82	NA	8.69	0.96	NA	18.47	090
42220		A	Reconstruct cleft palate	7.02	NA	6.73	0.41	NA	14.16	090
42225		A	Reconstruct cleft palate	9.54	NA	9.15	0.75	NA	19.44	090
42226		A	Lengthening of palate	10.01	NA	9.52	0.73	NA	20.26	090
42227		A	Lengthening of palate	9.52	NA	8.09	0.70	NA	18.31	090
42235		A	Repair palate	7.87	NA	6.18	0.49	NA	14.54	090
42260		A	Repair nose to lip fistula	9.80	6.99	6.99	0.85	17.64	17.64	090
42280		A	Preparation, palate mold	1.54	1.43	0.75	0.12	3.09	2.41	010
42281		A	Insertion, palate prosthesis	1.93	1.81	0.97	0.14	3.88	3.04	010
42299		C	Palate/uvula surgery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
42300		A	Drainage of salivary gland	1.93	2.65	1.89	0.15	4.73	3.97	010
42305		A	Drainage of salivary gland	6.07	NA	5.29	0.46	NA	11.82	090
42310		A	Drainage of salivary gland	1.56	2.32	1.65	0.11	3.99	3.32	010
42320		A	Drainage of salivary gland	2.35	2.77	2.13	0.17	5.29	4.65	010
42325		A	Create salivary cyst drain	2.75	3.36	1.15	0.17	6.28	4.07	090
42326		A	Create salivary cyst drain	3.78	3.34	1.76	0.34	7.46	5.88	090
42330		A	Removal of salivary stone	2.21	2.78	1.05	0.16	5.15	3.42	010
42335		A	Removal of salivary stone	3.31	3.66	3.66	0.23	7.20	7.20	090
42340		A	Removal of salivary stone	4.60	4.80	4.80	0.34	9.74	9.74	090
42400		A	Biopsy of salivary gland	0.78	2.49	0.39	0.06	3.33	1.23	000
42405		A	Biopsy of salivary gland	3.29	3.40	3.34	0.24	6.93	6.87	010
42408		A	Excision of salivary cyst	4.54	4.54	4.54	0.34	9.42	9.42	090
42409		A	Drainage of salivary cyst	2.81	3.39	3.39	0.20	6.40	6.40	090
42410		A	Excise parotid gland/lesion	9.34	NA	7.87	0.77	NA	17.98	090
42415		A	Excise parotid gland/lesion	16.89	NA	12.47	1.26	NA	30.62	090
42420		A	Excise parotid gland/lesion	19.59	NA	14.03	1.45	NA	35.07	090
42425		A	Excise parotid gland/lesion	13.02	NA	10.46	0.98	NA	24.46	090
42426		A	Excise parotid gland/lesion	21.26	NA	14.83	1.57	NA	37.66	090
42440		A	Excise submaxillary gland	6.97	NA	5.98	0.51	NA	13.46	090
42450		A	Excise sublingual gland	4.62	4.78	4.78	0.34	9.74	9.74	090
42500		A	Repair salivary duct	4.30	4.84	4.84	0.30	9.44	9.44	090
42505		A	Repair salivary duct	6.18	5.46	5.46	0.44	12.08	12.08	090
42507		A	Parotid duct diversion	6.11	NA	5.98	0.66	NA	12.75	090
42508		A	Parotid duct diversion	9.10	NA	8.12	0.64	NA	17.86	090
42509		A	Parotid duct diversion	11.54	NA	9.65	1.24	NA	22.43	090
42510		A	Parotid duct diversion	8.15	NA	7.09	0.57	NA	15.81	090
42550		A	Injection for salivary x-ray	1.25	12.74	0.43	0.06	14.05	1.74	000
42600		A	Closure of salivary fistula	4.82	6.30	5.67	0.34	11.46	10.83	090
42650		A	Dilation of salivary duct	0.77	1.09	0.40	0.06	1.92	1.23	000
42660		A	Dilation of salivary duct	1.13	1.18	1.18	0.07	2.38	2.38	000
42665		A	Ligation of salivary duct	2.53	3.51	3.51	0.17	6.21	6.21	090
42699		C	Salivary surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
42700		A	Drainage of tonsil abscess	1.62	3.27	1.88	0.12	5.01	3.62	010
42720		A	Drainage of throat abscess	5.42	4.88	4.76	0.39	10.69	10.57	010
42725		A	Drainage of throat abscess	10.72	NA	8.52	0.80	NA	20.04	090
42800		A	Biopsy of throat	1.39	3.09	2.62	0.10	4.58	4.11	010
42802		A	Biopsy of throat	1.54	3.18	2.70	0.11	4.83	4.35	010
42804		A	Biopsy of upper nose/throat	1.24	3.05	2.57	0.09	4.38	3.90	010
42806		A	Biopsy of upper nose/throat	1.58	3.52	2.76	0.12	5.22	4.46	010
42808		A	Excise pharynx lesion	2.30	5.06	3.15	0.17	7.53	5.62	010
42809		A	Remove pharynx foreign body	1.81	3.50	1.74	0.13	5.44	3.68	010
42810		A	Excision of neck cyst	3.25	5.52	4.50	0.25	9.02	8.00	090
42815		A	Excision of neck cyst	7.07	NA	6.58	0.53	NA	14.18	090
42820		A	Remove tonsils and adenoids	3.91	NA	3.35	0.28	NA	7.54	090
42821		A	Remove tonsils and adenoids	4.29	NA	4.23	0.30	NA	8.82	090
42825		A	Removal of tonsils	3.42	NA	3.69	0.24	NA	7.35	090
42826		A	Removal of tonsils	3.38	NA	3.75	0.23	NA	7.36	090
42830		A	Removal of adenoids	2.57	NA	2.42	0.18	NA	5.17	090
42831		A	Removal of adenoids	2.71	NA	2.55	0.19	NA	5.45	090
42835		A	Removal of adenoids	2.30	NA	3.15	0.17	NA	5.62	090
42836		A	Removal of adenoids	3.18	NA	3.68	0.22	NA	7.08	090
42842		A	Extensive surgery of throat	8.76	NA	7.82	0.61	NA	17.19	090
42844		A	Extensive surgery of throat	14.31	NA	11.36	1.04	NA	26.71	090
42845		A	Extensive surgery of throat	24.29	NA	17.44	1.76	NA	43.49	090
42860		A	Excision of tonsil tags	2.22	NA	3.08	0.16	NA	5.46	090
42870		A	Excision of lingual tonsil	5.40	NA	6.10	0.38	NA	11.88	090
42890		A	Partial removal of pharynx	12.94	NA	10.82	0.91	NA	24.67	090
42892		A	Revision of pharyngeal walls	15.83	NA	12.34	1.14	NA	29.31	090
42894		A	Revision of pharyngeal walls	22.88	NA	16.97	1.64	NA	41.49	090
42900		A	Repair throat wound	5.25	NA	3.76	0.39	NA	9.40	010
42950		A	Reconstruction of throat	8.10	NA	7.52	0.58	NA	16.20	090
42953		A	Repair throat, esophagus	8.96	NA	8.99	0.73	NA	18.68	090
42955		A	Surgical opening of throat	7.39	NA	6.53	0.63	NA	14.55	090
42960		A	Control throat bleeding	2.33	NA	2.11	0.17	NA	4.61	010
42961		A	Control throat bleeding	5.59	NA	5.27	0.40	NA	11.26	090
42962		A	Control throat bleeding	7.14	NA	6.18	0.51	NA	13.83	090
42970		A	Control nose/throat bleeding	5.43	NA	3.77	0.37	NA	9.57	090
42971		A	Control nose/throat bleeding	6.21	NA	5.81	0.45	NA	12.47	090
42972		A	Control nose/throat bleeding	7.20	NA	5.54	0.54	NA	13.28	090
42999		C	Throat surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
43020		A	Incision of esophagus	8.09	NA	6.46	0.70	NA	15.25	090
43030		A	Throat muscle surgery	7.69	NA	6.93	0.60	NA	15.22	090
43045		A	Incision of esophagus	20.12	NA	11.08	2.15	NA	33.35	090
43100		A	Excision of esophagus lesion	9.19	NA	7.20	0.79	NA	17.18	090
43101		A	Excision of esophagus lesion	16.24	NA	8.62	1.81	NA	26.67	090
43107		A	Removal of esophagus	40.00	NA	18.02	3.29	NA	61.31	090
43108		A	Removal of esophagus	34.19	NA	15.85	3.78	NA	53.82	090
43112		A	Removal of esophagus	43.50	NA	19.49	3.67	NA	66.66	090
43113		A	Removal of esophagus	35.27	NA	16.48	4.33	NA	56.08	090
43116		A	Partial removal of esophagus	31.22	NA	18.82	2.62	NA	52.66	090
43117		A	Partial removal of esophagus	40.00	NA	17.09	3.51	NA	60.60	090
43118		A	Partial removal of esophagus	33.20	NA	15.40	3.56	NA	52.16	090
43121		A	Partial removal of esophagus	29.19	NA	13.36	3.44	NA	45.99	090
43122		A	Partial removal of esophagus	40.00	NA	17.29	3.27	NA	60.56	090
43123		A	Partial removal of esophagus	33.20	NA	15.82	3.96	NA	52.98	090
43124		A	Removal of esophagus	27.32	NA	14.94	2.95	NA	45.21	090
43130		A	Removal of esophagus pouch	11.75	NA	8.86	1.06	NA	21.67	090
43135		A	Removal of esophagus pouch	16.10	NA	9.91	1.85	NA	27.86	090
43200		A	Esophagus endoscopy	1.59	7.97	1.18	0.11	9.67	2.88	000
43201		A	Esoph scope w/submucous inj	2.09	4.44	1.27	0.12	6.65	3.48	000
43202		A	Esophagus endoscopy, biopsy	1.89	6.25	1.13	0.12	8.26	3.14	000
43204		A	Esoph scope w/sclerosis inj	3.77	NA	1.67	0.18	NA	5.62	000
43205		A	Esophagus endoscopy/ligation	3.79	NA	1.68	0.17	NA	5.64	000
43215		A	Esophagus endoscopy	2.60	NA	1.23	0.17	NA	4.00	000
43216		A	Esophagus endoscopy/lesion	2.40	NA	1.18	0.15	NA	3.73	000
43217		A	Esophagus endoscopy	2.90	NA	1.33	0.17	NA	4.40	000
43219		A	Esophagus endoscopy	2.80	NA	1.40	0.16	NA	4.36	000
43220		A	Esoph endoscopy, dilation	2.10	NA	1.10	0.12	NA	3.32	000
43226		A	Esoph endoscopy, dilation	2.34	NA	1.17	0.12	NA	3.63	000
43227		A	Esoph endoscopy, repair	3.60	NA	1.60	0.18	NA	5.38	000
43228		A	Esoph endoscopy, ablation	3.77	NA	1.72	0.25	NA	5.74	000
43231		A	Esoph endoscopy w/us exam	3.19	NA	1.57	0.20	NA	4.96	000
43232		A	Esoph endoscopy w/us fn bx	4.48	NA	2.10	0.26	NA	6.84	000
43234		A	Upper GI endoscopy, exam	2.01	4.28	1.04	0.13	6.42	3.18	000
43235		A	Uppr gi endoscopy, diagnosis	2.39	5.85	1.06	0.13	8.37	3.58	000
43236		A	Uppr gi scope w/submuc inj	2.92	4.70	1.26	0.14	7.76	4.32	000
43239		A	Upper GI endoscopy, biopsy	2.87	6.17	1.23	0.14	9.18	4.24	000
43240		A	Esoph endoscope w/drain cyst	6.86	NA	2.70	0.36	NA	9.92	000
43241		A	Upper GI endoscopy with tube	2.59	NA	1.14	0.14	NA	3.87	000
43242		A	Uppr gi endoscopy w/us fn bx	7.31	NA	2.83	0.29	NA	10.43	000
43243		A	Upper gi endoscopy & inject	4.57	NA	1.86	0.21	NA	6.64	000
43244		A	Upper GI endoscopy/ligation	5.05	NA	2.03	0.21	NA	7.29	000
43245		A	Uppr gi scope dilate strictr	3.18	13.87	1.34	0.18	17.23	4.70	000
43246		A	Place gastrostomy tube	4.33	NA	1.75	0.24	NA	6.32	000
43247		A	Operative upper GI endoscopy	3.39	NA	1.42	0.17	NA	4.98	000
43248		A	Uppr gi endoscopy/guide wire	3.15	NA	1.35	0.15	NA	4.65	000
43249		A	Esoph endoscopy, dilation	2.90	NA	1.26	0.15	NA	4.31	000
43250		A	Upper GI endoscopy/tumor	3.20	NA	1.35	0.17	NA	4.72	000
43251		A	Operative upper GI endoscopy	3.70	NA	1.53	0.19	NA	5.42	000
43255		A	Operative upper GI endoscopy	4.82	NA	1.95	0.20	NA	6.97	000
43256		A	Uppr gi endoscopy w stent	4.35	NA	1.77	0.23	NA	6.35	000
43258		A	Operative upper GI endoscopy	4.55	NA	1.85	0.22	NA	6.62	000
43259		A	Endoscopic ultrasound exam	4.89	NA	1.95	0.22	NA	7.06	000
43260		A	Endo cholangiopancreatograph	5.96	NA	2.44	0.27	NA	8.67	000
43261		A	Endo cholangiopancreatograph	6.27	NA	2.55	0.29	NA	9.11	000
43262		A	Endo cholangiopancreatograph	7.39	NA	2.96	0.34	NA	10.69	000
43263		A	Endo cholangiopancreatograph	7.29	NA	2.93	0.28	NA	10.50	000
43264		A	Endo cholangiopancreatograph	8.90	NA	3.49	0.41	NA	12.80	000
43265		A	Endo cholangiopancreatograph	10.02	NA	3.89	0.42	NA	14.33	000
43267		A	Endo cholangiopancreatograph	7.39	NA	2.96	0.34	NA	10.69	000
43268		A	Endo cholangiopancreatograph	7.39	NA	2.96	0.34	NA	10.69	000
43269		A	Endo cholangiopancreatograph	8.21	NA	3.24	0.28	NA	11.73	000
43271		A	Endo cholangiopancreatograph	7.39	NA	2.95	0.34	NA	10.68	000
43272		A	Endo cholangiopancreatograph	7.39	NA	2.96	0.34	NA	10.69	000
43280		A	Laparoscopy, fundoplasty	17.25	NA	8.20	1.76	NA	27.21	090
43289		C	Laparoscope proc, esoph	0.00	0.00	0.00	0.00	0.00	0.00	YYY
43300		A	Repair of esophagus	9.14	NA	7.25	0.85	NA	17.24	090
43305		A	Repair esophagus and fistula	17.39	NA	12.70	1.36	NA	31.45	090
43310		A	Repair of esophagus	25.39	NA	14.66	3.18	NA	43.23	090
43312		A	Repair esophagus and fistula	28.42	NA	18.20	3.38	NA	50.00	090
43313		A	Esophagoplasty congenital	45.28	NA	21.66	5.43	NA	72.37	090
43314		A	Tracheo-esophagoplasty cong	50.27	NA	23.68	5.53	NA	79.48	090
43320		A	Fuse esophagus & stomach	19.93	NA	10.45	1.59	NA	31.97	090
43324		A	Revise esophagus & stomach	20.57	NA	9.48	1.72	NA	31.77	090
43325		A	Revise esophagus & stomach	20.06	NA	9.85	1.65	NA	31.56	090
43326		A	Revise esophagus & stomach	19.74	NA	10.49	1.84	NA	32.07	090
43330		A	Repair of esophagus	19.77	NA	9.56	1.52	NA	30.85	090
43331		A	Repair of esophagus	20.13	NA	11.13	1.93	NA	33.19	090
43340		A	Fuse esophagus & intestine	19.61	NA	10.61	1.53	NA	31.75	090
43341		A	Fuse esophagus & intestine	20.85	NA	12.08	2.14	NA	35.07	090
43350		A	Surgical opening, esophagus	15.78	NA	10.17	1.15	NA	27.10	090
43351		A	Surgical opening, esophagus	18.35	NA	10.61	1.51	NA	30.47	090
43352		A	Surgical opening, esophagus	15.26	NA	9.72	1.28	NA	26.26	090
43360		A	Gastrointestinal repair	35.70	NA	16.54	3.00	NA	55.24	090
43361		A	Gastrointestinal repair	40.50	NA	18.38	3.52	NA	62.40	090
43400		A	Ligate esophagus veins	21.20	NA	10.34	0.99	NA	32.53	090
43401		A	Esophagus surgery for veins	22.09	NA	10.35	1.73	NA	34.17	090
43405		A	Ligate/staple esophagus	20.01	NA	9.51	1.63	NA	31.15	090
43410		A	Repair esophagus wound	13.47	NA	8.93	1.15	NA	23.55	090
43415		A	Repair esophagus wound	25.00	NA	12.26	1.92	NA	39.18	090
43420		A	Repair esophagus opening	14.35	NA	8.92	0.86	NA	24.13	090
43425		A	Repair esophagus opening	21.03	NA	11.22	2.03	NA	34.28	090
43450		A	Dilate esophagus	1.38	1.38	0.62	0.07	2.83	2.07	000
43453		A	Dilate esophagus	1.51	NA	0.67	0.08	NA	2.26	000
43456		A	Dilate esophagus	2.57	NA	1.04	0.14	NA	3.75	000
43458		A	Dilate esophagus	3.06	NA	1.23	0.17	NA	4.46	000
43460		A	Pressure treatment esophagus	3.80	NA	1.50	0.21	NA	5.51	000
43496		C	Free jejunum flap, microvasc	0.00	0.00	0.00	0.00	0.00	0.00	090
43499		C	Esophagus surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
43500		A	Surgical opening of stomach	11.05	NA	5.08	0.84	NA	16.97	090
43501		A	Surgical repair of stomach	20.04	NA	8.60	1.55	NA	30.19	090
43502		A	Surgical repair of stomach	23.13	NA	9.77	1.83	NA	34.73	090
43510		A	Surgical opening of stomach	13.08	NA	7.53	0.90	NA	21.51	090
43520		A	Incision of pyloric muscle	9.99	NA	5.81	0.84	NA	16.64	090
43600		A	Biopsy of stomach	1.91	NA	1.02	0.11	NA	3.04	000
43605		A	Biopsy of stomach	11.98	NA	5.39	0.93	NA	18.30	090
43610		A	Excision of stomach lesion	14.60	NA	6.69	1.14	NA	22.43	090
43611		A	Excision of stomach lesion	17.84	NA	7.93	1.38	NA	27.15	090
43620		A	Removal of stomach	30.04	NA	12.69	2.29	NA	45.02	090
43621		A	Removal of stomach	30.73	NA	12.88	2.36	NA	45.97	090
43622		A	Removal of stomach	32.53	NA	13.48	2.48	NA	48.49	090
43631		A	Removal of stomach, partial	22.59	NA	9.45	1.99	NA	34.03	090
43632		A	Removal of stomach, partial	22.59	NA	9.46	2.00	NA	34.05	090
43633		A	Removal of stomach, partial	23.10	NA	9.64	2.05	NA	34.79	090
43634		A	Removal of stomach, partial	25.12	NA	10.41	2.18	NA	37.71	090
43635		A	Removal of stomach, partial	2.06	NA	0.72	0.21	NA	2.99	ZZZ
43638		A	Removal of stomach, partial	29.00	NA	11.77	2.24	NA	43.01	090
43639		A	Removal of stomach, partial	29.65	NA	12.01	2.31	NA	43.97	090
43640		A	Vagotomy & pylorus repair	17.02	NA	7.52	1.51	NA	26.05	090
43641		A	Vagotomy & pylorus repair	17.27	NA	7.63	1.53	NA	26.43	090
43651		A	Laparoscopy, vagus nerve	10.15	NA	4.59	1.03	NA	15.77	090
43652		A	Laparoscopy, vagus nerve	12.15	NA	5.37	1.25	NA	18.77	090
43653		A	Laparoscopy, gastrostomy	7.73	NA	4.23	0.78	NA	12.74	090
43659		C	Laparoscope proc, stom	0.00	0.00	0.00	0.00	0.00	0.00	YYY
43750		A	Place gastrostomy tube	4.49	NA	2.62	0.33	NA	7.44	010
43752		B	Nasal/orogastric w/stent	0.00	0.00	0.00	0.00	0.00	0.00	XXX
43760		A	Change gastrostomy tube	1.10	1.42	0.46	0.07	2.59	1.63	000
43761		A	Reposition gastrostomy tube	2.01	NA	0.80	0.10	NA	2.91	000
43800		A	Reconstruction of pylorus	13.69	NA	6.44	1.07	NA	21.20	090
43810		A	Fusion of stomach and bowel	14.65	NA	6.74	1.10	NA	22.49	090
43820		A	Fusion of stomach and bowel	15.37	NA	6.96	1.18	NA	23.51	090
43825		A	Fusion of stomach and bowel	19.22	NA	8.30	1.50	NA	29.02	090
43830		A	Place gastrostomy tube	9.53	NA	4.91	0.69	NA	15.13	090
43831		A	Place gastrostomy tube	7.84	NA	4.28	0.81	NA	12.93	090
43832		A	Place gastrostomy tube	15.60	NA	7.46	1.13	NA	24.19	090
43840		A	Repair of stomach lesion	15.56	NA	7.02	1.20	NA	23.78	090
43842		A	Gastroplasty for obesity	18.47	NA	11.21	1.51	NA	31.19	090
43843		A	Gastroplasty for obesity	18.65	NA	10.81	1.53	NA	30.99	090
43846		A	Gastric bypass for obesity	24.05	NA	13.23	1.96	NA	39.24	090
43847		A	Gastric bypass for obesity	26.92	NA	14.86	2.14	NA	43.92	090
43848		A	Revision gastroplasty	29.39	NA	15.91	2.39	NA	47.69	090
43850		A	Revise stomach-bowel fusion	24.72	NA	10.14	1.97	NA	36.83	090
43855		A	Revise stomach-bowel fusion	26.16	NA	10.73	2.01	NA	38.90	090
43860		A	Revise stomach-bowel fusion	25.00	NA	10.30	2.03	NA	37.33	090
43865		A	Revise stomach-bowel fusion	26.52	NA	10.85	2.15	NA	39.52	090
43870		A	Repair stomach opening	9.69	NA	5.05	0.71	NA	15.45	090
43880		A	Repair stomach-bowel fistula	24.65	NA	10.67	1.94	NA	37.26	090
43999		C	Stomach surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
44005		A	Freeing of bowel adhesion	16.23	NA	7.20	1.39	NA	24.82	090
44010		A	Incision of small bowel	12.52	NA	6.32	1.05	NA	19.89	090
44015		A	Insert needle cath bowel	2.62	NA	0.91	0.25	NA	3.78	ZZZ
44020		A	Explore small intestine	13.99	NA	6.40	1.20	NA	21.59	090
44021		A	Decompress small bowel	14.08	NA	6.84	1.18	NA	22.10	090
44025		A	Incision of large bowel	14.28	NA	6.49	1.21	NA	21.98	090
44050		A	Reduce bowel obstruction	14.03	NA	6.42	1.15	NA	21.60	090
44055		A	Correct malrotation of bowel	22.00	NA	9.20	1.32	NA	32.52	090
44100		A	Biopsy of bowel	2.01	NA	1.06	0.12	NA	3.19	000
44110		A	Excise intestine lesion(s)	11.81	NA	5.69	1.00	NA	18.50	090
44111		A	Excision of bowel lesion(s)	14.29	NA	7.05	1.22	NA	22.56	090
44120		A	Removal of small intestine	17.00	NA	7.45	1.46	NA	25.91	090
44121		A	Removal of small intestine	4.45	NA	1.56	0.46	NA	6.47	ZZZ
44125		A	Removal of small intestine	17.54	NA	7.64	1.49	NA	26.67	090
44126		A	Enterectomy w/o taper, cong	35.50	NA	17.79	0.36	NA	53.65	090
44127		A	Enterectomy w/taper, cong	41.00	NA	20.28	0.41	NA	61.69	090
44128		A	Enterectomy cong, add-on	4.45	NA	1.73	0.45	NA	6.63	ZZZ
44130		A	Bowel to bowel fusion	14.49	NA	6.57	1.23	NA	22.29	090
44132		R	Enterectomy, cadaver donor	0.00	0.00	0.00	0.00	0.00	0.00	XXX
44133		R	Enterectomy, live donor	0.00	0.00	0.00	0.00	0.00	0.00	XXX
44135		R	Intestine transplnt, cadaver	0.00	0.00	0.00	0.00	0.00	0.00	XXX
44136		R	Intestine transplant, live	0.00	0.00	0.00	0.00	0.00	0.00	XXX
44139		A	Mobilization of colon	2.23	NA	0.78	0.21	NA	3.22	ZZZ
44140		A	Partial removal of colon	21.00	NA	8.86	2.14	NA	32.00	090
44141		A	Partial removal of colon	19.51	NA	10.20	1.95	NA	31.66	090
44143		A	Partial removal of colon	22.99	NA	10.89	2.02	NA	35.90	090
44144		A	Partial removal of colon	21.53	NA	9.70	1.89	NA	33.12	090
44145		A	Partial removal of colon	26.42	NA	11.04	2.22	NA	39.68	090
44146		A	Partial removal of colon	27.54	NA	13.12	2.20	NA	42.86	090
44147		A	Partial removal of colon	20.71	NA	8.85	1.74	NA	31.30	090
44150		A	Removal of colon	23.95	NA	12.20	2.05	NA	38.20	090
44151		A	Removal of colon/ileostomy	26.88	NA	13.55	1.97	NA	42.40	090
44152		A	Removal of colon/ileostomy	27.83	NA	11.94	2.36	NA	42.13	090
44153		A	Removal of colon/ileostomy	30.59	NA	14.74	2.33	NA	47.66	090
44155		A	Removal of colon/ileostomy	27.86	NA	13.56	2.26	NA	43.68	090
44156		A	Removal of colon/ileostomy	30.79	NA	15.19	2.19	NA	48.17	090
44160		A	Removal of colon	18.62	NA	7.93	1.86	NA	28.41	090
44200		A	Laparoscopy, enterolysis	14.44	NA	6.38	1.46	NA	22.28	090
44201		A	Laparoscopy, jejunostomy	9.78	NA	4.63	0.97	NA	15.38	090
44202		A	Lap resect s/intestine singl	22.04	NA	9.14	2.16	NA	33.34	090
44203		A	Lap resect s/intestine, addl	4.45	NA	1.56	0.46	NA	6.47	ZZZ
44204		A	Laparo partial colectomy	25.08	NA	10.21	2.55	NA	37.84	090
44205		A	Lap colectomy part w/ileum	22.23	NA	9.07	2.23	NA	33.53	090
44206		A	Lap part colectomy w/stoma	27.00	NA	11.22	2.02	NA	40.24	090
44207		A	L colectomy/coloproctostomy	30.00	NA	11.82	2.22	NA	44.04	090
44208		A	L colectomy/coloproctostomy	32.00	NA	13.42	2.20	NA	47.62	090
44209		D	Laparoscope proc, intestine	0.00	0.00	0.00	0.00	0.00	0.00	YYY
44210		A	Laparo total proctocolectomy	28.00	NA	12.11	2.05	NA	42.16	090
44211		A	Laparo total proctocolectomy	35.00	NA	15.02	2.33	NA	52.35	090
44212		A	Laparo total proctocolectomy	32.50	NA	14.16	2.26	NA	48.92	090
44238		C	Laparoscope proc, intestine	0.00	0.00	0.00	0.00	0.00	0.00	YYY
44239		C	Laparoscope proc, rectum	0.00	0.00	0.00	0.00	0.00	0.00	YYY
44300		A	Open bowel to skin	12.11	NA	5.63	0.88	NA	18.62	090
44310		A	Ileostomy/jejunostomy	15.95	NA	6.88	1.13	NA	23.96	090
44312		A	Revision of ileostomy	8.02	NA	4.09	0.54	NA	12.65	090
44314		A	Revision of ileostomy	15.05	NA	6.71	0.99	NA	22.75	090
44316		A	Devise bowel pouch	21.09	NA	8.71	1.41	NA	31.21	090
44320		A	Colostomy	17.64	NA	7.83	1.28	NA	26.75	090
44322		A	Colostomy with biopsies	11.98	NA	8.75	1.18	NA	21.91	090
44340		A	Revision of colostomy	7.72	NA	4.35	0.56	NA	12.63	090
44345		A	Revision of colostomy	15.43	NA	7.03	1.11	NA	23.57	090
44346		A	Revision of colostomy	16.99	NA	7.54	1.20	NA	25.73	090
44360		A	Small bowel endoscopy	2.59	NA	1.36	0.14	NA	4.09	000
44361		A	Small bowel endoscopy/biopsy	2.87	NA	1.45	0.15	NA	4.47	000
44363		A	Small bowel endoscopy	3.50	NA	1.64	0.19	NA	5.33	000
44364		A	Small bowel endoscopy	3.74	NA	1.76	0.21	NA	5.71	000
44365		A	Small bowel endoscopy	3.31	NA	1.63	0.18	NA	5.12	000
44366		A	Small bowel endoscopy	4.41	NA	2.01	0.22	NA	6.64	000
44369		A	Small bowel endoscopy	4.52	NA	2.01	0.23	NA	6.76	000
44370		A	Small bowel endoscopy/stent	4.80	NA	2.15	0.21	NA	7.16	000
44372		A	Small bowel endoscopy	4.41	NA	2.00	0.27	NA	6.68	000
44373		A	Small bowel endoscopy	3.50	NA	1.72	0.19	NA	5.41	000
44376		A	Small bowel endoscopy	5.26	NA	2.30	0.29	NA	7.85	000
44377		A	Small bowel endoscopy/biopsy	5.53	NA	2.43	0.28	NA	8.24	000
44378		A	Small bowel endoscopy	7.13	NA	2.99	0.37	NA	10.49	000
44379		A	S bowel endoscope w/stent	7.47	NA	3.11	0.38	NA	10.96	000
44380		A	Small bowel endoscopy	1.05	NA	0.78	0.08	NA	1.91	000
44382		A	Small bowel endoscopy	1.27	NA	0.87	0.09	NA	2.23	000
44383		A	Ileoscopy w/stent	2.94	NA	1.42	0.13	NA	4.49	000
44385		A	Endoscopy of bowel pouch	1.82	4.53	0.96	0.12	6.47	2.90	000
44386		A	Endoscopy, bowel pouch/biop	2.12	5.99	1.09	0.15	8.26	3.36	000
44388		A	Colon endoscopy	2.82	6.49	1.38	0.18	9.49	4.38	000
44389		A	Colonoscopy with biopsy	3.13	7.24	1.51	0.18	10.55	4.82	000
44390		A	Colonoscopy for foreign body	3.83	6.96	1.73	0.22	11.01	5.78	000
44391		A	Colonoscopy for bleeding	4.32	6.01	1.73	0.23	10.56	6.28	000
44392		A	Colonoscopy & polypectomy	3.82	7.44	1.74	0.23	11.49	5.79	000
44393		A	Colonoscopy, lesion removal	4.84	7.76	2.12	0.27	12.87	7.23	000
44394		A	Colonoscopy w/snare	4.43	7.96	1.98	0.26	12.65	6.67	000
44397		A	Colonoscopy w/stent	4.71	NA	2.06	0.28	NA	7.05	000
44500		A	Intro, gastrointestinal tube	0.49	NA	0.36	0.02	NA	0.87	000
44602		A	Suture, small intestine	16.03	NA	6.63	1.07	NA	23.73	090
44603		A	Suture, small intestine	18.66	NA	7.52	1.39	NA	27.57	090
44604		A	Suture, large intestine	16.03	NA	6.69	1.42	NA	24.14	090
44605		A	Repair of bowel lesion	19.53	NA	8.66	1.54	NA	29.73	090
44615		A	Intestinal stricturoplasty	15.93	NA	6.89	1.39	NA	24.21	090
44620		A	Repair bowel opening	12.20	NA	5.48	1.05	NA	18.73	090
44625		A	Repair bowel opening	15.05	NA	6.49	1.30	NA	22.84	090
44626		A	Repair bowel opening	25.36	NA	10.09	2.53	NA	37.98	090
44640		A	Repair bowel-skin fistula	21.65	NA	8.82	1.46	NA	31.93	090
44650		A	Repair bowel fistula	22.57	NA	9.13	1.49	NA	33.19	090
44660		A	Repair bowel-bladder fistula	21.36	NA	8.56	1.14	NA	31.06	090
44661		A	Repair bowel-bladder fistula	24.81	NA	9.80	1.53	NA	36.14	090
44680		A	Surgical revision, intestine	15.40	NA	6.64	1.37	NA	23.41	090
44700		A	Suspend bowel w/prosthesis	16.11	NA	6.88	1.21	NA	24.20	090
44701		A	Intraop colon lavage add-on	3.10	NA	1.07	0.21	NA	4.38	ZZZ
44799		C	Intestine surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
44800		A	Excision of bowel pouch	11.23	NA	5.50	1.11	NA	17.84	090
44820		A	Excision of mesentery lesion	12.09	NA	5.63	1.03	NA	18.75	090
44850		A	Repair of mesentery	10.74	NA	5.13	0.99	NA	16.86	090
44899		C	Bowel surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
44900		A	Drain app abscess, open	10.14	NA	4.87	0.84	NA	15.85	090
44901		A	Drain app abscess, percut	3.38	NA	4.51	0.17	NA	8.06	000
44950		A	Appendectomy	10.00	NA	4.50	0.88	NA	15.38	090
44955		A	Appendectomy add-on	1.53	NA	0.55	0.16	NA	2.24	ZZZ
44960		A	Appendectomy	12.34	NA	5.52	1.09	NA	18.95	090
44970		A	Laparoscopy, appendectomy	8.70	NA	4.22	0.88	NA	13.80	090
44979		C	Laparoscope proc, app	0.00	0.00	0.00	0.00	0.00	0.00	YYY
45000		A	Drainage of pelvic abscess	4.52	NA	3.08	0.37	NA	7.97	090
45005		A	Drainage of rectal abscess	1.99	4.51	1.57	0.18	6.68	3.74	010
45020		A	Drainage of rectal abscess	4.72	NA	3.38	0.41	NA	8.51	090
45100		A	Biopsy of rectum	3.68	NA	2.49	0.33	NA	6.50	090
45108		A	Removal of anorectal lesion	4.76	NA	3.02	0.46	NA	8.24	090
45110		A	Removal of rectum	28.00	NA	12.51	2.26	NA	42.77	090
45111		A	Partial removal of rectum	16.48	NA	7.35	1.60	NA	25.43	090
45112		A	Removal of rectum	30.54	NA	12.07	2.35	NA	44.96	090
45113		A	Partial proctectomy	30.58	NA	12.98	2.13	NA	45.69	090
45114		A	Partial removal of rectum	27.32	NA	11.19	2.28	NA	40.79	090
45116		A	Partial removal of rectum	24.58	NA	10.22	2.00	NA	36.80	090
45119		A	Remove rectum w/reservoir	30.84	NA	12.85	2.13	NA	45.82	090
45120		A	Removal of rectum	24.60	NA	10.31	2.28	NA	37.19	090
45121		A	Removal of rectum and colon	27.04	NA	11.34	2.66	NA	41.04	090
45123		A	Partial proctectomy	16.71	NA	7.02	1.04	NA	24.77	090
45126		A	Pelvic exenteration	45.16	NA	19.41	3.23	NA	67.80	090
45130		A	Excision of rectal prolapse	16.44	NA	6.93	1.12	NA	24.49	090
45135		A	Excision of rectal prolapse	19.28	NA	8.54	1.52	NA	29.34	090
45136		A	Excise ileoanal reservior	27.30	NA	12.31	2.72	NA	42.33	090
45150		A	Excision of rectal stricture	5.67	NA	3.08	0.46	NA	9.21	090
45160		A	Excision of rectal lesion	15.32	NA	6.78	1.07	NA	23.17	090
45170		A	Excision of rectal lesion	11.49	NA	5.39	0.89	NA	17.77	090
45190		A	Destruction, rectal tumor	9.74	NA	5.12	0.76	NA	15.62	090
45300		A	Proctosigmoidoscopy dx	0.38	1.33	0.23	0.05	1.76	0.66	000
45303		A	Proctosigmoidoscopy dilate	0.44	1.58	0.26	0.06	2.08	0.76	000
45305		A	Proctosigmoidoscopy w/bx	1.01	1.58	0.45	0.09	2.68	1.55	000
45307		A	Proctosigmoidoscopy fb	0.94	2.52	0.42	0.15	3.61	1.51	000
45308		A	Proctosigmoidoscopy removal	0.83	1.52	0.39	0.13	2.48	1.35	000
45309		A	Proctosigmoidoscopy removal	2.01	2.39	0.79	0.17	4.57	2.97	000
45315		A	Proctosigmoidoscopy removal	1.40	2.55	0.59	0.20	4.15	2.19	000
45317		A	Proctosigmoidoscopy bleed	1.50	1.84	0.62	0.20	3.54	2.32	000
45320		A	Proctosigmoidoscopy ablate	1.58	1.80	0.66	0.20	3.58	2.44	000
45321		A	Proctosigmoidoscopy volvul	1.17	NA	0.51	0.17	NA	1.85	000
45327		A	Proctosigmoidoscopy w/stent	1.65	NA	0.86	0.10	NA	2.61	000
45330		A	Diagnostic sigmoidoscopy	0.96	1.82	0.52	0.05	2.83	1.53	000
45331		A	Sigmoidoscopy and biopsy	1.15	2.24	0.53	0.07	3.46	1.75	000
45332		A	Sigmoidoscopy w/fb removal	1.79	3.96	0.75	0.11	5.86	2.65	000
45333		A	Sigmoidoscopy & polypectomy	1.79	3.57	0.75	0.12	5.48	2.66	000
45334		A	Sigmoidoscopy for bleeding	2.73	NA	1.08	0.16	NA	3.97	000
45335		A	Sigmoidoscope w/submuc inj	1.36	2.48	0.65	0.07	3.91	2.08	000
45337		A	Sigmoidoscopy & decompress	2.36	NA	0.95	0.15	NA	3.46	000
45338		A	Sigmoidoscpy w/tumr remove	2.34	4.29	0.95	0.15	6.78	3.44	000
45339		A	Sigmoidoscopy w/ablate tumr	3.14	3.26	1.23	0.17	6.57	4.54	000
45340		A	Sig w/balloon dilation	1.66	7.19	0.76	0.07	8.92	2.49	000
45341		A	Sigmoidoscopy w/ultrasound	2.60	NA	1.37	0.20	NA	4.17	000
45342		A	Sigmoidoscopy w/us guide bx	4.06	NA	1.81	0.23	NA	6.10	000
45345		A	Sigmoidoscopy w/stent	2.92	NA	1.40	0.15	NA	4.47	000
45355		A	Surgical colonoscopy	3.52	NA	1.24	0.26	NA	5.02	000
45378		A	Diagnostic colonoscopy	3.70	8.03	1.72	0.20	11.93	5.62	000
45378	53	A	Diagnostic colonoscopy	0.96	1.82	0.52	0.05	2.83	1.53	000
45379		A	Colonoscopy w/fb removal	4.69	8.34	2.08	0.25	13.28	7.02	000
45380		A	Colonoscopy and biopsy	4.44	8.46	2.00	0.21	13.11	6.65	000
45381		A	Colonoscope, submucous inj	4.20	6.15	1.70	0.21	10.56	6.11	000
45382		A	Colonoscopy/control bleeding	5.69	9.73	2.23	0.27	15.69	8.19	000
45383		A	Lesion removal colonoscopy	5.87	9.34	2.50	0.32	15.53	8.69	000
45384		A	Lesion remove colonoscopy	4.70	9.07	2.09	0.24	14.01	7.03	000
45385		A	Lesion removal colonoscopy	5.31	9.24	2.31	0.28	14.83	7.90	000
45386		A	Colonoscope dilate stricture	4.58	15.29	1.84	0.21	20.08	6.63	000
45387		A	Colonoscopy w/stent	5.91	NA	2.52	0.33	NA	8.76	000
45500		A	Repair of rectum	7.29	NA	4.14	0.56	NA	11.99	090
45505		A	Repair of rectum	7.58	NA	3.70	0.50	NA	11.78	090
45520		A	Treatment of rectal prolapse	0.55	0.77	0.19	0.04	1.36	0.78	000
45540		A	Correct rectal prolapse	16.27	NA	7.90	1.17	NA	25.34	090
45541		A	Correct rectal prolapse	13.40	NA	6.78	0.88	NA	21.06	090
45550		A	Repair rectum/remove sigmoid	23.00	NA	10.15	1.58	NA	34.73	090
45560		A	Repair of rectocele	10.58	NA	5.89	0.73	NA	17.20	090
45562		A	Exploration/repair of rectum	15.38	NA	7.30	1.15	NA	23.83	090
45563		A	Exploration/repair of rectum	23.47	NA	10.90	1.84	NA	36.21	090
45800		A	Repair rect/bladder fistula	17.77	NA	7.91	1.14	NA	26.82	090
45805		A	Repair fistula w/colostomy	20.78	NA	9.91	1.47	NA	32.16	090
45820		A	Repair rectourethral fistula	18.48	NA	8.15	1.17	NA	27.80	090
45825		A	Repair fistula w/colostomy	21.25	NA	10.13	0.97	NA	32.35	090
45900		A	Reduction of rectal prolapse	2.61	NA	1.02	0.17	NA	3.80	010
45905		A	Dilation of anal sphincter	2.30	11.46	0.94	0.14	13.90	3.38	010
45910		A	Dilation of rectal narrowing	2.80	15.87	1.12	0.14	18.81	4.06	010
45915		A	Remove rectal obstruction	3.14	4.65	1.10	0.17	7.96	4.41	010
45999		C	Rectum surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
46020		A	Placement of seton	2.90	3.12	2.38	0.22	6.24	5.50	010
46030		A	Removal of rectal marker	1.23	3.00	1.19	0.11	4.34	2.53	010
46040		A	Incision of rectal abscess	4.96	5.34	3.05	0.48	10.78	8.49	090
46045		A	Incision of rectal abscess	4.32	NA	2.77	0.40	NA	7.49	090
46050		A	Incision of anal abscess	1.19	3.52	1.32	0.11	4.82	2.62	010
46060		A	Incision of rectal abscess	5.69	NA	3.71	0.52	NA	9.92	090
46070		A	Incision of anal septum	2.71	NA	2.40	0.27	NA	5.38	090
46080		A	Incision of anal sphincter	2.49	3.61	1.60	0.23	6.33	4.32	010
46083		A	Incise external hemorrhoid	1.40	4.66	1.53	0.12	6.18	3.05	010
46200		A	Removal of anal fissure	3.42	3.84	2.35	0.30	7.56	6.07	090
46210		A	Removal of anal crypt	2.67	5.08	2.17	0.26	8.01	5.10	090
46211		A	Removal of anal crypts	4.25	5.20	2.88	0.37	9.82	7.50	090
46220		A	Removal of anal tag	1.56	1.26	0.55	0.14	2.96	2.25	010
46221		A	Ligation of hemorrhoid(s)	2.04	1.71	1.07	0.12	3.87	3.23	010
46230		A	Removal of anal tags	2.57	4.26	1.65	0.22	7.05	4.44	010
46250		A	Hemorrhoidectomy	3.89	5.32	2.65	0.43	9.64	6.97	090
46255		A	Hemorrhoidectomy	4.60	6.00	2.87	0.51	11.11	7.98	090
46257		A	Remove hemorrhoids & fissure	5.40	NA	3.05	0.59	NA	9.04	090
46258		A	Remove hemorrhoids & fistula	5.73	NA	3.19	0.64	NA	9.56	090
46260		A	Hemorrhoidectomy	6.37	NA	3.92	0.68	NA	10.97	090
46261		A	Remove hemorrhoids & fissure	7.08	NA	4.04	0.70	NA	11.82	090
46262		A	Remove hemorrhoids & fistula	7.50	NA	4.26	0.76	NA	12.52	090
46270		A	Removal of anal fistula	3.72	5.01	2.56	0.36	9.09	6.64	090
46275		A	Removal of anal fistula	4.56	4.66	2.76	0.40	9.62	7.72	090
46280		A	Removal of anal fistula	5.98	NA	3.69	0.50	NA	10.17	090
46285		A	Removal of anal fistula	4.09	4.07	2.60	0.34	8.50	7.03	090
46288		A	Repair anal fistula	7.13	NA	4.19	0.60	NA	11.92	090
46320		A	Removal of hemorrhoid clot	1.61	3.86	1.54	0.14	5.61	3.29	010
46500		A	Injection into hemorrhoid(s)	1.61	2.71	0.57	0.12	4.44	2.30	010
46600		A	Diagnostic anoscopy	0.50	0.80	0.15	0.04	1.34	0.69	000
46604		A	Anoscopy and dilation	1.31	0.96	0.46	0.09	2.36	1.86	000
46606		A	Anoscopy and biopsy	0.81	0.87	0.28	0.07	1.75	1.16	000
46608		A	Anoscopy, remove for body	1.51	1.83	0.47	0.13	3.47	2.11	000
46610		A	Anoscopy, remove lesion	1.32	1.42	0.47	0.12	2.86	1.91	000
46611		A	Anoscopy	1.81	2.00	0.64	0.15	3.96	2.60	000
46612		A	Anoscopy, remove lesions	2.34	2.45	0.84	0.18	4.97	3.36	000
46614		A	Anoscopy, control bleeding	2.01	1.79	0.69	0.14	3.94	2.84	000
46615		A	Anoscopy	2.68	1.73	0.94	0.23	4.64	3.85	000
46700		A	Repair of anal stricture	9.13	NA	4.64	0.56	NA	14.33	090
46705		A	Repair of anal stricture	6.90	NA	4.06	0.73	NA	11.69	090
46706		A	Repr of anal fistula w/glue	2.39	NA	1.24	0.17	NA	3.80	010
46715		A	Repair of anovaginal fistula	7.20	NA	4.23	0.76	NA	12.19	090
46716		A	Repair of anovaginal fistula	15.07	NA	7.38	1.30	NA	23.75	090
46730		A	Construction of absent anus	26.75	NA	12.23	2.03	NA	41.01	090
46735		A	Construction of absent anus	32.17	NA	14.08	2.64	NA	48.89	090
46740		A	Construction of absent anus	30.00	NA	12.54	1.99	NA	44.53	090
46742		A	Repair of imperforated anus	35.80	NA	18.00	2.63	NA	56.43	090
46744		A	Repair of cloacal anomaly	52.63	NA	21.43	2.27	NA	76.33	090
46746		A	Repair of cloacal anomaly	58.22	NA	25.90	2.51	NA	86.63	090
46748		A	Repair of cloacal anomaly	64.21	NA	25.75	2.77	NA	92.73	090
46750		A	Repair of anal sphincter	10.25	NA	5.63	0.69	NA	16.57	090
46751		A	Repair of anal sphincter	8.77	NA	6.38	0.78	NA	15.93	090
46753		A	Reconstruction of anus	8.29	NA	4.01	0.58	NA	12.88	090
46754		A	Removal of suture from anus	2.20	5.44	1.36	0.12	7.76	3.68	010
46760		A	Repair of anal sphincter	14.43	NA	7.07	0.86	NA	22.36	090
46761		A	Repair of anal sphincter	13.84	NA	6.57	0.84	NA	21.25	090
46762		A	Implant artificial sphincter	12.71	NA	5.72	0.71	NA	19.14	090
46900		A	Destruction, anal lesion(s)	1.91	3.44	0.75	0.13	5.48	2.79	010
46910		A	Destruction, anal lesion(s)	1.86	3.74	1.46	0.14	5.74	3.46	010
46916		A	Cryosurgery, anal lesion(s)	1.86	3.36	1.67	0.09	5.31	3.62	010
46917		A	Laser surgery, anal lesions	1.86	4.72	1.52	0.16	6.74	3.54	010
46922		A	Excision of anal lesion(s)	1.86	3.86	1.43	0.17	5.89	3.46	010
46924		A	Destruction, anal lesion(s)	2.76	5.09	1.69	0.20	8.05	4.65	010
46934		A	Destruction of hemorrhoids	3.51	6.23	3.58	0.26	10.00	7.35	090
46935		A	Destruction of hemorrhoids	2.43	4.23	0.86	0.17	6.83	3.46	010
46936		A	Destruction of hemorrhoids	3.69	5.91	3.43	0.30	9.90	7.42	090
46937		A	Cryotherapy of rectal lesion	2.69	4.41	1.77	0.12	7.22	4.58	010
46938		A	Cryotherapy of rectal lesion	4.66	5.03	3.25	0.40	10.09	8.31	090
46940		A	Treatment of anal fissure	2.32	3.14	0.81	0.17	5.63	3.30	010
46942		A	Treatment of anal fissure	2.04	2.86	0.69	0.14	5.04	2.87	010
46945		A	Ligation of hemorrhoids	1.84	3.93	2.15	0.17	5.94	4.16	090
46946		A	Ligation of hemorrhoids	2.58	4.99	2.45	0.22	7.79	5.25	090
46999		C	Anus surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
47000		A	Needle biopsy of liver	1.90	8.24	0.65	0.09	10.23	2.64	000
47001		A	Needle biopsy, liver add-on	1.90	NA	0.67	0.18	NA	2.75	ZZZ
47010		A	Open drainage, liver lesion	16.01	NA	9.66	0.65	NA	26.32	090
47011		A	Percut drain, liver lesion	3.70	NA	4.38	0.17	NA	8.25	000
47015		A	Inject/aspirate liver cyst	15.11	NA	7.84	0.86	NA	23.81	090
47100		A	Wedge biopsy of liver	11.67	NA	6.30	0.75	NA	18.72	090
47120		A	Partial removal of liver	35.50	NA	16.55	2.29	NA	54.34	090
47122		A	Extensive removal of liver	55.13	NA	23.43	3.60	NA	82.16	090
47125		A	Partial removal of liver	49.19	NA	21.42	3.18	NA	73.79	090
47130		A	Partial removal of liver	53.35	NA	22.88	3.47	NA	79.70	090
47133		X	Removal of donor liver	0.00	0.00	0.00	0.00	0.00	0.00	XXX
47134		R	Partial removal, donor liver	39.15	NA	13.56	3.98	NA	56.69	XXX
47135		R	Transplantation of liver	81.52	NA	42.52	8.13	NA	132.17	090
47136		R	Transplantation of liver	68.60	NA	41.83	6.93	NA	117.36	090
47300		A	Surgery for liver lesion	15.08	NA	7.53	0.97	NA	23.58	090
47350		A	Repair liver wound	19.56	NA	9.21	1.25	NA	30.02	090
47360		A	Repair liver wound	26.92	NA	12.51	1.71	NA	41.14	090
47361		A	Repair liver wound	47.12	NA	19.57	3.11	NA	69.80	090
47362		A	Repair liver wound	18.51	NA	9.54	1.22	NA	29.27	090
47370		A	Laparo ablate liver tumor rf	19.69	NA	9.72	0.85	NA	30.26	090
47371		A	Laparo ablate liver cryosurg	19.69	NA	9.72	0.85	NA	30.26	090
47379		C	Laparoscope procedure, liver	0.00	0.00	0.00	0.00	0.00	0.00	YYY
47380		A	Open ablate liver tumor rf	23.00	NA	11.01	0.85	NA	34.86	090
47381		A	Open ablate liver tumor cryo	23.27	NA	11.12	0.85	NA	35.24	090
47382		A	Percut ablate liver rf	15.19	NA	6.25	1.14	NA	22.58	010
47399		C	Liver surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
47400		A	Incision of liver duct	32.49	NA	14.44	1.82	NA	48.75	090
47420		A	Incision of bile duct	19.88	NA	9.15	1.70	NA	30.73	090
47425		A	Incision of bile duct	19.83	NA	9.22	1.60	NA	30.65	090
47460		A	Incise bile duct sphincter	18.04	NA	8.96	1.24	NA	28.24	090
47480		A	Incision of gallbladder	10.82	NA	6.58	0.85	NA	18.25	090
47490		A	Incision of gallbladder	7.23	NA	7.49	0.33	NA	15.05	090
47500		A	Injection for liver x-rays	1.96	NA	0.66	0.09	NA	2.71	000
47505		A	Injection for liver x-rays	0.76	2.65	0.26	0.03	3.44	1.05	000
47510		A	Insert catheter, bile duct	7.83	NA	4.69	0.36	NA	12.88	090
47511		A	Insert bile duct drain	10.50	NA	10.37	0.47	NA	21.34	090
47525		A	Change bile duct catheter	5.55	NA	3.25	0.24	NA	9.04	010
47530		A	Revise/reinsert bile tube	5.85	NA	4.93	0.29	NA	11.07	090
47550		A	Bile duct endoscopy add-on	3.02	NA	1.04	0.30	NA	4.36	ZZZ
47552		A	Biliary endoscopy thru skin	6.04	NA	2.44	0.42	NA	8.90	000
47553		A	Biliary endoscopy thru skin	6.35	NA	2.64	0.30	NA	9.29	000
47554		A	Biliary endoscopy thru skin	9.06	NA	3.44	0.74	NA	13.24	000
47555		A	Biliary endoscopy thru skin	7.56	NA	3.05	0.35	NA	10.96	000
47556		A	Biliary endoscopy thru skin	8.56	NA	3.39	0.38	NA	12.33	000
47560		A	Laparoscopy w/cholangio	4.89	NA	1.84	0.49	NA	7.22	000
47561		A	Laparo w/cholangio/biopsy	5.18	NA	2.13	0.49	NA	7.80	000
47562		A	Laparoscopic cholecystectomy	11.09	NA	5.01	1.13	NA	17.23	090
47563		A	Laparo cholecystectomy/graph	11.94	NA	5.27	1.21	NA	18.42	090
47564		A	Laparo cholecystectomy/explr	14.23	NA	6.08	1.44	NA	21.75	090
47570		A	Laparo cholecystoenterostomy	12.58	NA	5.50	1.28	NA	19.36	090
47579		C	Laparoscope proc, biliary	0.00	0.00	0.00	0.00	0.00	0.00	YYY
47600		A	Removal of gallbladder	13.58	NA	6.67	1.16	NA	21.41	090
47605		A	Removal of gallbladder	14.69	NA	7.03	1.25	NA	22.97	090
47610		A	Removal of gallbladder	18.82	NA	8.59	1.61	NA	29.02	090
47612		A	Removal of gallbladder	18.78	NA	8.45	1.60	NA	28.83	090
47620		A	Removal of gallbladder	20.64	NA	9.12	1.77	NA	31.53	090
47630		A	Remove bile duct stone	9.11	NA	3.08	0.46	NA	12.65	090
47700		A	Exploration of bile ducts	15.62	NA	8.51	1.40	NA	25.53	090
47701		A	Bile duct revision	27.81	NA	13.06	3.00	NA	43.87	090
47711		A	Excision of bile duct tumor	23.03	NA	11.02	1.98	NA	36.03	090
47712		A	Excision of bile duct tumor	30.24	NA	13.63	2.67	NA	46.54	090
47715		A	Excision of bile duct cyst	18.80	NA	8.75	1.59	NA	29.14	090
47716		A	Fusion of bile duct cyst	16.44	NA	8.20	1.41	NA	26.05	090
47720		A	Fuse gallbladder & bowel	15.91	NA	8.48	1.37	NA	25.76	090
47721		A	Fuse upper gi structures	19.12	NA	9.60	1.63	NA	30.35	090
47740		A	Fuse gallbladder & bowel	18.48	NA	9.40	1.59	NA	29.47	090
47741		A	Fuse gallbladder & bowel	21.34	NA	10.33	1.82	NA	33.49	090
47760		A	Fuse bile ducts and bowel	25.85	NA	11.93	2.21	NA	39.99	090
47765		A	Fuse liver ducts & bowel	24.88	NA	12.37	2.18	NA	39.43	090
47780		A	Fuse bile ducts and bowel	26.50	NA	12.17	2.27	NA	40.94	090
47785		A	Fuse bile ducts and bowel	31.18	NA	14.49	2.69	NA	48.36	090
47800		A	Reconstruction of bile ducts	23.30	NA	11.15	1.95	NA	36.40	090
47801		A	Placement, bile duct support	15.17	NA	10.03	0.69	NA	25.89	090
47802		A	Fuse liver duct & intestine	21.55	NA	11.13	1.84	NA	34.52	090
47900		A	Suture bile duct injury	19.90	NA	9.91	1.65	NA	31.46	090
47999		C	Bile tract surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
48000		A	Drainage of abdomen	28.07	NA	12.40	1.32	NA	41.79	090
48001		A	Placement of drain, pancreas	35.45	NA	14.70	1.90	NA	52.05	090
48005		A	Resect/debride pancreas	42.17	NA	16.99	2.26	NA	61.42	090
48020		A	Removal of pancreatic stone	15.70	NA	7.38	1.36	NA	24.44	090
48100		A	Biopsy of pancreas, open	12.23	NA	6.83	1.08	NA	20.14	090
48102		A	Needle biopsy, pancreas	4.68	8.84	2.38	0.20	13.72	7.26	010
48120		A	Removal of pancreas lesion	15.85	NA	7.36	1.35	NA	24.56	090
48140		A	Partial removal of pancreas	22.94	NA	10.51	2.12	NA	35.57	090
48145		A	Partial removal of pancreas	24.02	NA	11.18	2.25	NA	37.45	090
48146		A	Pancreatectomy	26.40	NA	13.29	2.43	NA	42.12	090
48148		A	Removal of pancreatic duct	17.34	NA	8.98	1.61	NA	27.93	090
48150		A	Partial removal of pancreas	48.00	NA	21.38	4.43	NA	73.81	090
48152		A	Pancreatectomy	43.75	NA	20.25	4.07	NA	68.07	090
48153		A	Pancreatectomy	47.89	NA	21.58	4.40	NA	73.87	090
48154		A	Pancreatectomy	44.10	NA	20.13	4.10	NA	68.33	090
48155		A	Removal of pancreas	24.64	NA	13.48	2.30	NA	40.42	090
48160		N	Pancreas removal/transplant	0.00	0.00	0.00	0.00	0.00	0.00	XXX
48180		A	Fuse pancreas and bowel	24.72	NA	10.85	2.24	NA	37.81	090
48400		A	Injection, intraop add-on	1.95	NA	0.67	0.10	NA	2.72	ZZZ
48500		A	Surgery of pancreatic cyst	15.28	NA	7.24	1.35	NA	23.87	090
48510		A	Drain pancreatic pseudocyst	14.31	NA	7.49	1.07	NA	22.87	090
48511		A	Drain pancreatic pseudocyst	4.00	NA	3.72	0.17	NA	7.89	000
48520		A	Fuse pancreas cyst and bowel	15.59	NA	7.21	1.41	NA	24.21	090
48540		A	Fuse pancreas cyst and bowel	19.72	NA	8.62	1.82	NA	30.16	090
48545		A	Pancreatorrhaphy	18.18	NA	8.68	1.61	NA	28.47	090
48547		A	Duodenal exclusion	25.83	NA	10.79	2.30	NA	38.92	090
48550		X	Donor pancreatectomy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
48554		R	Transpl allograft pancreas	34.17	NA	11.94	3.30	NA	49.41	090
48556		A	Removal, allograft pancreas	15.71	NA	8.46	1.52	NA	25.69	090
48999		C	Pancreas surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
49000		A	Exploration of abdomen	11.68	NA	6.06	1.17	NA	18.91	090
49002		A	Reopening of abdomen	10.49	NA	5.96	1.06	NA	17.51	090
49010		A	Exploration behind abdomen	12.28	NA	6.93	1.22	NA	20.43	090
49020		A	Drain abdominal abscess	22.84	NA	11.41	1.31	NA	35.56	090
49021		A	Drain abdominal abscess	3.38	NA	5.28	0.16	NA	8.82	000
49040		A	Drain, open, abdom abscess	13.52	NA	8.19	0.84	NA	22.55	090
49041		A	Drain, percut, abdom abscess	4.00	NA	5.61	0.18	NA	9.79	000
49060		A	Drain, open, retrop abscess	15.86	NA	9.58	0.77	NA	26.21	090
49061		A	Drain, percut, retroper absc	3.70	NA	5.62	0.17	NA	9.49	000
49062		A	Drain to peritoneal cavity	11.36	NA	7.07	1.08	NA	19.51	090
49080		A	Puncture, peritoneal cavity	1.35	4.39	0.47	0.07	5.81	1.89	000
49081		A	Removal of abdominal fluid	1.26	3.07	0.58	0.06	4.39	1.90	000
49085		A	Remove abdomen foreign body	12.14	NA	6.56	0.88	NA	19.58	090
49180		A	Biopsy, abdominal mass	1.73	8.22	0.59	0.08	10.03	2.40	000
49200		A	Removal of abdominal lesion	10.25	NA	6.27	0.92	NA	17.44	090
49201		A	Remove abdom lesion, complex	14.84	NA	8.56	1.47	NA	24.87	090
49215		A	Excise sacral spine tumor	33.50	NA	14.74	2.48	NA	50.72	090
49220		A	Multiple surgery, abdomen	14.88	NA	7.63	1.51	NA	24.02	090
49250		A	Excision of umbilicus	8.35	NA	5.08	0.84	NA	14.27	090
49255		A	Removal of omentum	11.14	NA	6.49	1.12	NA	18.75	090
49320		A	Diag laparo separate proc	5.10	NA	3.01	0.50	NA	8.61	010
49321		A	Laparoscopy, biopsy	5.40	NA	2.99	0.53	NA	8.92	010
49322		A	Laparoscopy, aspiration	5.70	NA	3.42	0.57	NA	9.69	010
49323		A	Laparo drain lymphocele	9.48	NA	4.03	0.88	NA	14.39	090
49329		C	Laparo proc, abdm/per/oment	0.00	0.00	0.00	0.00	0.00	0.00	YYY
49400		A	Air injection into abdomen	1.88	NA	0.80	0.11	NA	2.79	000
49419		A	Insrt abdom cath for chemotx	6.65	NA	3.81	0.55	NA	11.01	090
49420		A	Insert abdom drain, temp	2.22	NA	0.97	0.13	NA	3.32	000
49421		A	Insert abdom drain, perm	5.54	NA	4.06	0.55	NA	10.15	090
49422		A	Remove perm cannula/catheter	6.25	NA	2.93	0.63	NA	9.81	010
49423		A	Exchange drainage catheter	1.46	NA	0.68	0.07	NA	2.21	000
49424		A	Assess cyst, contrast inject	0.76	NA	0.44	0.03	NA	1.23	000
49425		A	Insert abdomen-venous drain	11.37	NA	6.69	1.21	NA	19.27	090
49426		A	Revise abdomen-venous shunt	9.63	NA	6.07	0.93	NA	16.63	090
49427		A	Injection, abdominal shunt	0.89	NA	0.48	0.05	NA	1.42	000
49428		A	Ligation of shunt	6.06	NA	3.16	0.31	NA	9.53	010
49429		A	Removal of shunt	7.40	NA	3.44	0.81	NA	11.65	010
49491		A	Rpr hern preemie reduc	11.13	NA	5.51	1.10	NA	17.74	090
49492		A	Rpr ing hern premie, blocked	14.03	NA	6.28	1.47	NA	21.78	090
49495		A	Rpr ing hernia baby, reduc	5.89	NA	3.48	0.58	NA	9.95	090
49496		A	Rpr ing hernia baby, blocked	8.79	NA	6.11	0.92	NA	15.82	090
49500		A	Rpr ing hernia, init, reduce	5.48	NA	3.34	0.46	NA	9.28	090
49501		A	Rpr ing hernia, init blocked	8.88	NA	4.43	0.76	NA	14.07	090
49505		A	Prp i/hern init reduc>5 yr	7.60	4.48	4.01	0.65	12.73	12.26	090
49507		A	Prp i/hern init block>5 yr	9.57	NA	6.01	0.83	NA	16.41	090
49520		A	Rerepair ing hernia, reduce	9.63	NA	5.34	0.84	NA	15.81	090
49521		A	Rerepair ing hernia, blocked	11.97	NA	5.68	1.04	NA	18.69	090
49525		A	Repair ing hernia, sliding	8.57	NA	4.83	0.74	NA	14.14	090
49540		A	Repair lumbar hernia	10.39	NA	5.51	0.90	NA	16.80	090
49550		A	Rpr rem hernia, init, reduce	8.63	NA	4.42	0.75	NA	13.80	090
49553		A	Rpr fem hernia, init blocked	9.44	NA	4.84	0.83	NA	15.11	090
49555		A	Rerepair fem hernia, reduce	9.03	NA	5.17	0.79	NA	14.99	090
49557		A	Rerepair fem hernia, blocked	11.15	NA	5.42	0.97	NA	17.54	090
49560		A	Rpr ventral hern init, reduc	11.57	NA	5.95	1.00	NA	18.52	090
49561		A	Rpr ventral hern init, block	14.25	NA	6.53	1.23	NA	22.01	090
49565		A	Rerepair ventrl hern, reduce	11.57	NA	6.11	1.00	NA	18.68	090
49566		A	Rerepair ventrl hern, block	14.40	NA	6.60	1.24	NA	22.24	090
49568		A	Hernia repair w/mesh	4.89	NA	1.71	0.50	NA	7.10	ZZZ
49570		A	Rpr epigastric hern, reduce	5.69	NA	3.43	0.50	NA	9.62	090
49572		A	Rpr epigastric hern, blocked	6.73	NA	3.91	0.58	NA	11.22	090
49580		A	Rpr umbil hern, reduc < 5 yr	4.11	NA	2.92	0.34	NA	7.37	090
49582		A	Rpr umbil hern, block < 5 yr	6.65	NA	4.86	0.57	NA	12.08	090
49585		A	Rpr umbil hern, reduc > 5 yr	6.23	NA	4.04	0.53	NA	10.80	090
49587		A	Rpr umbil hern, block > 5 yr	7.56	NA	4.15	0.65	NA	12.36	090
49590		A	Repair spigilian hernia	8.54	NA	4.85	0.74	NA	14.13	090
49600		A	Repair umbilical lesion	10.96	NA	6.07	1.13	NA	18.16	090
49605		A	Repair umbilical lesion	76.00	NA	29.89	2.57	NA	108.46	090
49606		A	Repair umbilical lesion	18.60	NA	9.06	2.22	NA	29.88	090
49610		A	Repair umbilical lesion	10.50	NA	6.77	0.77	NA	18.04	090
49611		A	Repair umbilical lesion	8.92	NA	9.64	0.65	NA	19.21	090
49650		A	Laparo hernia repair initial	6.27	NA	3.23	0.64	NA	10.14	090
49651		A	Laparo hernia repair recur	8.24	NA	4.28	0.84	NA	13.36	090
49659		C	Laparo proc, hernia repair	0.00	0.00	0.00	0.00	0.00	0.00	YYY
49900		A	Repair of abdominal wall	12.28	NA	6.65	1.23	NA	20.16	090
49904		A	Omental flap, extra-abdom	20.00	NA	15.98	1.91	NA	37.89	090
49905		A	Omental flap, intra-abdom	6.55	NA	2.34	0.61	NA	9.50	ZZZ
49906		C	Free omental flap, microvasc	0.00	0.00	0.00	0.00	0.00	0.00	090
49999		C	Abdomen surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
50010		A	Exploration of kidney	10.98	NA	6.48	0.79	NA	18.25	090
50020		A	Renal abscess, open drain	14.66	NA	13.74	0.80	NA	29.20	090
50021		A	Renal abscess, percut drain	3.38	NA	9.98	0.15	NA	13.51	000
50040		A	Drainage of kidney	14.94	NA	10.83	0.82	NA	26.59	090
50045		A	Exploration of kidney	15.46	NA	7.88	1.06	NA	24.40	090
50060		A	Removal of kidney stone	19.30	NA	9.13	1.14	NA	29.57	090
50065		A	Incision of kidney	20.79	NA	8.01	1.13	NA	29.93	090
50070		A	Incision of kidney	20.32	NA	9.53	1.20	NA	31.05	090
50075		A	Removal of kidney stone	25.34	NA	11.61	1.51	NA	38.46	090
50080		A	Removal of kidney stone	14.71	NA	9.63	0.86	NA	25.20	090
50081		A	Removal of kidney stone	21.80	NA	11.66	1.30	NA	34.76	090
50100		A	Revise kidney blood vessels	16.09	NA	9.66	1.64	NA	27.39	090
50120		A	Exploration of kidney	15.91	NA	8.08	1.04	NA	25.03	090
50125		A	Explore and drain kidney	16.52	NA	8.36	1.07	NA	25.95	090
50130		A	Removal of kidney stone	17.29	NA	8.41	1.04	NA	26.74	090
50135		A	Exploration of kidney	19.18	NA	9.05	1.18	NA	29.41	090
50200		A	Biopsy of kidney	2.63	NA	0.93	0.12	NA	3.68	000
50205		A	Biopsy of kidney	11.31	NA	6.20	0.94	NA	18.45	090
50220		A	Remove kidney, open	17.15	NA	8.57	1.16	NA	26.88	090
50225		A	Removal kidney open, complex	20.23	NA	9.46	1.26	NA	30.95	090
50230		A	Removal kidney open, radical	22.07	NA	10.04	1.35	NA	33.46	090
50234		A	Removal of kidney & ureter	22.40	NA	10.14	1.37	NA	33.91	090
50236		A	Removal of kidney & ureter	24.86	NA	12.69	1.50	NA	39.05	090
50240		A	Partial removal of kidney	22.00	NA	11.82	1.36	NA	35.18	090
50280		A	Removal of kidney lesion	15.67	NA	7.95	0.99	NA	24.61	090
50290		A	Removal of kidney lesion	14.73	NA	7.80	1.11	NA	23.64	090
50300		X	Removal of donor kidney	0.00	0.00	0.00	0.00	0.00	0.00	XXX
50320		A	Removal of donor kidney	22.21	NA	10.24	1.78	NA	34.23	090
50340		A	Removal of kidney	12.15	NA	9.07	1.15	NA	22.37	090
50360		A	Transplantation of kidney	31.53	NA	17.43	2.97	NA	51.93	090
50365		A	Transplantation of kidney	36.81	NA	21.07	3.51	NA	61.39	090
50370		A	Remove transplanted kidney	13.72	NA	9.47	1.26	NA	24.45	090
50380		A	Reimplantation of kidney	20.76	NA	13.49	1.80	NA	36.05	090
50390		A	Drainage of kidney lesion	1.96	NA	0.66	0.09	NA	2.71	000
50392		A	Insert kidney drain	3.38	NA	1.13	0.15	NA	4.66	000
50393		A	Insert ureteral tube	4.16	NA	1.39	0.18	NA	5.73	000
50394		A	Injection for kidney x-ray	0.76	2.44	0.26	0.04	3.24	1.06	000
50395		A	Create passage to kidney	3.38	NA	1.13	0.16	NA	4.67	000
50396		A	Measure kidney pressure	2.09	NA	0.87	0.10	NA	3.06	000
50398		A	Change kidney tube	1.46	1.19	0.49	0.07	2.72	2.02	000
50400		A	Revision of kidney/ureter	19.50	NA	9.19	1.21	NA	29.90	090
50405		A	Revision of kidney/ureter	23.93	NA	11.44	1.45	NA	36.82	090
50500		A	Repair of kidney wound	19.57	NA	10.59	1.45	NA	31.61	090
50520		A	Close kidney-skin fistula	17.23	NA	10.04	1.26	NA	28.53	090
50525		A	Repair renal-abdomen fistula	22.27	NA	11.99	1.51	NA	35.77	090
50526		A	Repair renal-abdomen fistula	24.02	NA	13.43	1.62	NA	39.07	090
50540		A	Revision of horseshoe kidney	19.93	NA	9.97	1.28	NA	31.18	090
50541		A	Laparo ablate renal cyst	16.00	NA	6.37	0.99	NA	23.36	090
50542		A	Laparo ablate renal mass	20.00	NA	8.34	1.36	NA	29.70	090
50543		A	Laparo partial nephrectomy	25.50	NA	10.48	1.36	NA	37.34	090
50544		A	Laparoscopy, pyeloplasty	22.40	NA	8.56	1.41	NA	32.37	090
50545		A	Laparo radical nephrectomy	24.00	NA	9.14	1.53	NA	34.67	090
50546		A	Laparoscopic nephrectomy	20.48	NA	7.95	1.37	NA	29.80	090
50547		A	Laparo removal donor kidney	25.50	NA	10.79	2.04	NA	38.33	090
50548		A	Laparo remove k/ureter	24.40	NA	9.18	1.49	NA	35.07	090
50549		C	Laparoscope proc, renal	0.00	0.00	0.00	0.00	0.00	0.00	YYY
50551		A	Kidney endoscopy	5.60	4.06	1.84	0.33	9.99	7.77	000
50553		A	Kidney endoscopy	5.99	11.31	2.00	0.35	17.65	8.34	000
50555		A	Kidney endoscopy & biopsy	6.53	13.90	2.17	0.38	20.81	9.08	000
50557		A	Kidney endoscopy & treatment	6.62	11.67	2.18	0.39	18.68	9.19	000
50559		A	Renal endoscopy/radiotracer	6.78	NA	2.31	0.27	NA	9.36	000
50561		A	Kidney endoscopy & treatment	7.59	11.94	2.51	0.44	19.97	10.54	000
50562		A	Renal scope w/tumor resect	10.92	NA	4.02	0.84	NA	15.78	090
50570		A	Kidney endoscopy	9.54	NA	3.13	0.56	NA	13.23	000
50572		A	Kidney endoscopy	10.35	NA	3.41	0.64	NA	14.40	000
50574		A	Kidney endoscopy & biopsy	11.02	NA	3.64	0.65	NA	15.31	000
50575		A	Kidney endoscopy	13.98	NA	4.60	0.84	NA	19.42	000
50576		A	Kidney endoscopy & treatment	10.99	NA	3.60	0.66	NA	15.25	000
50578		A	Renal endoscopy/radiotracer	11.35	NA	3.73	0.67	NA	15.75	000
50580		A	Kidney endoscopy & treatment	11.86	NA	3.90	0.70	NA	16.46	000
50590		A	Fragmenting of kidney stone	9.09	10.73	4.94	0.54	20.36	14.57	090
50600		A	Exploration of ureter	15.84	NA	8.11	0.99	NA	24.94	090
50605		A	Insert ureteral support	15.46	NA	8.26	1.13	NA	24.85	090
50610		A	Removal of ureter stone	15.92	NA	8.44	1.08	NA	25.44	090
50620		A	Removal of ureter stone	15.16	NA	7.64	0.91	NA	23.71	090
50630		A	Removal of ureter stone	14.94	NA	7.60	0.90	NA	23.44	090
50650		A	Removal of ureter	17.41	NA	8.83	1.07	NA	27.31	090
50660		A	Removal of ureter	19.55	NA	9.57	1.19	NA	30.31	090
50684		A	Injection for ureter x-ray	0.76	11.21	0.25	0.04	12.01	1.05	000
50686		A	Measure ureter pressure	1.51	2.45	0.67	0.09	4.05	2.27	000
50688		A	Change of ureter tube	1.17	NA	1.69	0.06	NA	2.92	010
50690		A	Injection for ureter x-ray	1.16	11.17	0.39	0.06	12.39	1.61	000
50700		A	Revision of ureter	15.21	NA	8.75	0.86	NA	24.82	090
50715		A	Release of ureter	18.90	NA	11.71	1.68	NA	32.29	090
50722		A	Release of ureter	16.35	NA	9.56	1.41	NA	27.32	090
50725		A	Release/revise ureter	18.49	NA	9.86	1.44	NA	29.79	090
50727		A	Revise ureter	8.18	NA	5.79	0.51	NA	14.48	090
50728		A	Revise ureter	12.02	NA	7.55	0.88	NA	20.45	090
50740		A	Fusion of ureter & kidney	18.42	NA	9.09	1.49	NA	29.00	090
50750		A	Fusion of ureter & kidney	19.51	NA	9.63	1.24	NA	30.38	090
50760		A	Fusion of ureters	18.42	NA	9.37	1.25	NA	29.04	090
50770		A	Splicing of ureters	19.51	NA	9.55	1.25	NA	30.31	090
50780		A	Reimplant ureter in bladder	18.36	NA	9.22	1.20	NA	28.78	090
50782		A	Reimplant ureter in bladder	19.54	NA	11.06	1.13	NA	31.73	090
50783		A	Reimplant ureter in bladder	20.55	NA	10.18	1.35	NA	32.08	090
50785		A	Reimplant ureter in bladder	20.52	NA	9.96	1.30	NA	31.78	090
50800		A	Implant ureter in bowel	14.52	NA	8.99	0.92	NA	24.43	090
50810		A	Fusion of ureter & bowel	20.05	NA	12.28	1.78	NA	34.11	090
50815		A	Urine shunt to intestine	19.93	NA	10.98	1.31	NA	32.22	090
50820		A	Construct bowel bladder	21.89	NA	11.33	1.38	NA	34.60	090
50825		A	Construct bowel bladder	28.18	NA	14.12	1.81	NA	44.11	090
50830		A	Revise urine flow	31.28	NA	14.80	2.20	NA	48.28	090
50840		A	Replace ureter by bowel	20.00	NA	10.92	1.26	NA	32.18	090
50845		A	Appendico-vesicostomy	20.89	NA	9.62	1.26	NA	31.77	090
50860		A	Transplant ureter to skin	15.36	NA	8.23	1.01	NA	24.60	090
50900		A	Repair of ureter	13.62	NA	7.40	0.98	NA	22.00	090
50920		A	Closure ureter/skin fistula	14.33	NA	7.95	0.84	NA	23.12	090
50930		A	Closure ureter/bowel fistula	18.72	NA	9.48	1.57	NA	29.77	090
50940		A	Release of ureter	14.51	NA	7.65	1.04	NA	23.20	090
50945		A	Laparoscopy ureterolithotomy	17.00	NA	6.99	1.15	NA	25.14	090
50947		A	Laparo new ureter/bladder	24.50	NA	9.90	1.99	NA	36.39	090
50948		A	Laparo new ureter/bladder	22.50	NA	8.85	1.83	NA	33.18	090
50949		C	Laparoscope proc, ureter	0.00	0.00	0.00	0.00	0.00	0.00	YYY
50951		A	Endoscopy of ureter	5.84	4.50	1.92	0.35	10.69	8.11	000
50953		A	Endoscopy of ureter	6.24	11.22	2.06	0.37	17.83	8.67	000
50955		A	Ureter endoscopy & biopsy	6.75	16.74	2.26	0.38	23.87	9.39	000
50957		A	Ureter endoscopy & treatment	6.79	11.23	2.24	0.40	18.42	9.43	000
50959		A	Ureter endoscopy & tracer	4.40	NA	1.45	0.18	NA	6.03	000
50961		A	Ureter endoscopy & treatment	6.05	13.85	1.99	0.35	20.25	8.39	000
50970		A	Ureter endoscopy	7.14	NA	2.36	0.43	NA	9.93	000
50972		A	Ureter endoscopy & catheter	6.89	NA	2.32	0.39	NA	9.60	000
50974		A	Ureter endoscopy & biopsy	9.17	NA	3.01	0.53	NA	12.71	000
50976		A	Ureter endoscopy & treatment	9.04	NA	2.99	0.53	NA	12.56	000
50978		A	Ureter endoscopy & tracer	5.10	NA	1.74	0.30	NA	7.14	000
50980		A	Ureter endoscopy & treatment	6.85	NA	2.26	0.41	NA	9.52	000
51000		A	Drainage of bladder	0.78	1.87	0.25	0.05	2.70	1.08	000
51005		A	Drainage of bladder	1.02	3.05	0.35	0.08	4.15	1.45	000
51010		A	Drainage of bladder	3.53	4.87	1.93	0.23	8.63	5.69	010
51020		A	Incise & treat bladder	6.71	NA	5.08	0.42	NA	12.21	090
51030		A	Incise & treat bladder	6.77	NA	5.36	0.42	NA	12.55	090
51040		A	Incise & drain bladder	4.40	NA	3.80	0.27	NA	8.47	090
51045		A	Incise bladder/drain ureter	6.77	NA	5.46	0.47	NA	12.70	090
51050		A	Removal of bladder stone	6.92	NA	4.53	0.42	NA	11.87	090
51060		A	Removal of ureter stone	8.85	NA	5.65	0.54	NA	15.04	090
51065		A	Remove ureter calculus	8.85	NA	5.50	0.53	NA	14.88	090
51080		A	Drainage of bladder abscess	5.96	NA	5.14	0.35	NA	11.45	090
51500		A	Removal of bladder cyst	10.14	NA	5.85	0.88	NA	16.87	090
51520		A	Removal of bladder lesion	9.29	NA	5.87	0.58	NA	15.74	090
51525		A	Removal of bladder lesion	13.97	NA	7.28	0.85	NA	22.10	090
51530		A	Removal of bladder lesion	12.38	NA	7.08	0.82	NA	20.28	090
51535		A	Repair of ureter lesion	12.57	NA	7.63	0.90	NA	21.10	090
51550		A	Partial removal of bladder	15.66	NA	7.97	1.05	NA	24.68	090
51555		A	Partial removal of bladder	21.23	NA	10.19	1.37	NA	32.79	090
51565		A	Revise bladder & ureter(s)	21.62	NA	10.66	1.40	NA	33.68	090
51570		A	Removal of bladder	24.24	NA	11.71	1.59	NA	37.54	090
51575		A	Removal of bladder & nodes	30.45	NA	14.33	1.88	NA	46.66	090
51580		A	Remove bladder/revise tract	31.08	NA	14.97	1.94	NA	47.99	090
51585		A	Removal of bladder & nodes	35.23	NA	16.07	2.18	NA	53.48	090
51590		A	Remove bladder/revise tract	32.66	NA	14.90	2.01	NA	49.57	090
51595		A	Remove bladder/revise tract	37.14	NA	16.33	2.23	NA	55.70	090
51596		A	Remove bladder/create pouch	39.52	NA	17.60	2.39	NA	59.51	090
51597		A	Removal of pelvic structures	38.35	NA	17.28	2.49	NA	58.12	090
51600		A	Injection for bladder x-ray	0.88	4.76	0.30	0.04	5.68	1.22	000
51605		A	Preparation for bladder xray	0.64	12.01	0.22	0.04	12.69	0.90	000
51610		A	Injection for bladder x-ray	1.05	12.17	0.35	0.05	13.27	1.45	000
51700		A	Irrigation of bladder	0.88	1.16	0.29	0.05	2.09	1.22	000
51701		A	Insert bladder catheter	0.50	1.06	0.20	0.03	1.59	0.73	000
51702		A	Insert temp bladder cath	0.50	1.97	0.27	0.03	2.50	0.80	000
51703		A	Insert bladder cath, complex	1.47	1.91	0.59	0.09	3.47	2.15	000
51705		A	Change of bladder tube	1.02	1.40	0.54	0.06	2.48	1.62	010
51710		A	Change of bladder tube	1.49	3.24	1.21	0.09	4.82	2.79	010
51715		A	Endoscopic injection/implant	3.74	3.64	1.24	0.24	7.62	5.22	000
51720		A	Treatment of bladder lesion	1.96	1.41	0.73	0.12	3.49	2.81	000
51725		A	Simple cystometrogram	1.51	7.29	NA	0.13	8.93	NA	000
51725	26	A	Simple cystometrogram	1.51	0.51	0.51	0.10	2.12	2.12	000
51725	TC	A	Simple cystometrogram	0.00	6.78	NA	0.03	6.81	NA	000
51726		A	Complex cystometrogram	1.71	9.35	NA	0.15	11.21	NA	000
51726	26	A	Complex cystometrogram	1.71	0.58	0.58	0.11	2.40	2.40	000
51726	TC	A	Complex cystometrogram	0.00	8.77	NA	0.04	8.81	NA	000
51736		A	Urine flow measurement	0.61	0.55	NA	0.05	1.21	NA	000
51736	26	A	Urine flow measurement	0.61	0.21	0.21	0.04	0.86	0.86	000
51736	TC	A	Urine flow measurement	0.00	0.34	NA	0.01	0.35	NA	000
51741		A	Electro-uroflowmetry, first	1.14	0.79	NA	0.09	2.02	NA	000
51741	26	A	Electro-uroflowmetry, first	1.14	0.38	0.38	0.07	1.59	1.59	000
51741	TC	A	Electro-uroflowmetry, first	0.00	0.41	NA	0.02	0.43	NA	000
51772		A	Urethra pressure profile	1.61	8.81	NA	0.16	10.58	NA	000
51772	26	A	Urethra pressure profile	1.61	0.57	0.57	0.12	2.30	2.30	000
51772	TC	A	Urethra pressure profile	0.00	8.24	NA	0.04	8.28	NA	000
51784		A	Anal/urinary muscle study	1.53	4.56	NA	0.13	6.22	NA	000
51784	26	A	Anal/urinary muscle study	1.53	0.52	0.52	0.10	2.15	2.15	000
51784	TC	A	Anal/urinary muscle study	0.00	4.04	NA	0.03	4.07	NA	000
51785		A	Anal/urinary muscle study	1.53	4.68	NA	0.12	6.33	NA	000
51785	26	A	Anal/urinary muscle study	1.53	0.52	0.52	0.09	2.14	2.14	000
51785	TC	A	Anal/urinary muscle study	0.00	4.16	NA	0.03	4.19	NA	000
51792		A	Urinary reflex study	1.10	23.28	NA	0.20	24.58	NA	000
51792	26	A	Urinary reflex study	1.10	0.43	0.43	0.09	1.62	1.62	000
51792	TC	A	Urinary reflex study	0.00	22.85	NA	0.11	22.96	NA	000
51795		A	Urine voiding pressure study	1.53	8.93	NA	0.18	10.64	NA	000
51795	26	A	Urine voiding pressure study	1.53	0.52	0.52	0.10	2.15	2.15	000
51795	TC	A	Urine voiding pressure study	0.00	8.41	NA	0.08	8.49	NA	000
51797		A	Intraabdominal pressure test	1.60	4.31	NA	0.14	6.05	NA	000
51797	26	A	Intraabdominal pressure test	1.60	0.54	0.54	0.10	2.24	2.24	000
51797	TC	A	Intraabdominal pressure test	0.00	3.77	NA	0.04	3.81	NA	000
51798		A	Us urine capacity measure	0.00	0.48	NA	0.07	0.55	NA	XXX
51800		A	Revision of bladder/urethra	17.42	NA	8.79	1.17	NA	27.38	090
51820		A	Revision of urinary tract	17.89	NA	10.56	1.45	NA	29.90	090
51840		A	Attach bladder/urethra	10.71	NA	6.31	0.87	NA	17.89	090
51841		A	Attach bladder/urethra	13.03	NA	7.98	1.04	NA	22.05	090
51845		A	Repair bladder neck	9.73	NA	6.13	0.62	NA	16.48	090
51860		A	Repair of bladder wound	12.02	NA	7.34	0.89	NA	20.25	090
51865		A	Repair of bladder wound	15.04	NA	8.18	1.01	NA	24.23	090
51880		A	Repair of bladder opening	7.66	NA	5.30	0.54	NA	13.50	090
51900		A	Repair bladder/vagina lesion	12.97	NA	7.62	0.87	NA	21.46	090
51920		A	Close bladder-uterus fistula	11.81	NA	6.82	0.86	NA	19.49	090
51925		A	Hysterectomy/bladder repair	15.58	NA	9.31	1.48	NA	26.37	090
51940		A	Correction of bladder defect	28.43	NA	15.43	1.97	NA	45.83	090
51960		A	Revision of bladder & bowel	23.01	NA	12.19	1.41	NA	36.61	090
51980		A	Construct bladder opening	11.36	NA	6.56	0.74	NA	18.66	090
51990		A	Laparo urethral suspension	12.50	NA	6.53	1.02	NA	20.05	090
51992		A	Laparo sling operation	14.01	NA	6.44	0.93	NA	21.38	090
52000		A	Cystoscopy	2.01	5.22	0.78	0.12	7.35	2.91	000
52001		A	Cystoscopy, removal of clots	5.45	7.89	2.33	0.32	13.66	8.10	000
52005		A	Cystoscopy & ureter catheter	2.37	9.91	0.92	0.15	12.43	3.44	000
52007		A	Cystoscopy and biopsy	3.02	NA	1.17	0.18	NA	4.37	000
52010		A	Cystoscopy & duct catheter	3.02	11.79	1.14	0.18	14.99	4.34	000
52204		A	Cystoscopy	2.37	15.85	0.93	0.15	18.37	3.45	000
52214		A	Cystoscopy and treatment	3.71	46.64	1.36	0.22	50.57	5.29	000
52224		A	Cystoscopy and treatment	3.14	46.25	1.18	0.18	49.57	4.50	000
52234		A	Cystoscopy and treatment	4.63	NA	1.67	0.27	NA	6.57	000
52235		A	Cystoscopy and treatment	5.45	NA	1.95	0.32	NA	7.72	000
52240		A	Cystoscopy and treatment	9.72	NA	3.37	0.58	NA	13.67	000
52250		A	Cystoscopy and radiotracer	4.50	NA	1.70	0.27	NA	6.47	000
52260		A	Cystoscopy and treatment	3.92	NA	1.46	0.23	NA	5.61	000
52265		A	Cystoscopy and treatment	2.94	16.04	1.14	0.18	19.16	4.26	000
52270		A	Cystoscopy & revise urethra	3.37	23.02	1.32	0.20	26.59	4.89	000
52275		A	Cystoscopy & revise urethra	4.70	17.12	1.76	0.28	22.10	6.74	000
52276		A	Cystoscopy and treatment	5.00	23.83	1.88	0.30	29.13	7.18	000
52277		A	Cystoscopy and treatment	6.17	NA	2.31	0.38	NA	8.86	000
52281		A	Cystoscopy and treatment	2.80	8.59	1.10	0.17	11.56	4.07	000
52282		A	Cystoscopy, implant stent	6.40	81.32	2.29	0.38	88.10	9.07	000
52283		A	Cystoscopy and treatment	3.74	13.84	1.41	0.22	17.80	5.37	000
52285		A	Cystoscopy and treatment	3.61	9.79	1.37	0.22	13.62	5.20	000
52290		A	Cystoscopy and treatment	4.59	NA	1.69	0.27	NA	6.55	000
52300		A	Cystoscopy and treatment	5.31	NA	1.95	0.32	NA	7.58	000
52301		A	Cystoscopy and treatment	5.51	NA	2.04	0.39	NA	7.94	000
52305		A	Cystoscopy and treatment	5.31	NA	1.90	0.31	NA	7.52	000
52310		A	Cystoscopy and treatment	2.81	5.38	1.05	0.17	8.36	4.03	000
52315		A	Cystoscopy and treatment	5.21	7.67	1.88	0.31	13.19	7.40	000
52317		A	Remove bladder stone	6.72	37.82	2.34	0.40	44.94	9.46	000
52318		A	Remove bladder stone	9.19	NA	3.17	0.54	NA	12.90	000
52320		A	Cystoscopy and treatment	4.70	NA	1.68	0.28	NA	6.66	000
52325		A	Cystoscopy, stone removal	6.16	NA	2.17	0.37	NA	8.70	000
52327		A	Cystoscopy, inject material	5.19	NA	1.87	0.32	NA	7.38	000
52330		A	Cystoscopy and treatment	5.04	18.51	1.79	0.30	23.85	7.13	000
52332		A	Cystoscopy and treatment	2.83	14.97	1.07	0.17	17.97	4.07	000
52334		A	Create passage to kidney	4.83	NA	1.80	0.28	NA	6.91	000
52341		A	Cysto w/ureter stricture tx	6.00	NA	2.26	0.37	NA	8.63	000
52342		A	Cysto w/up stricture tx	6.50	NA	2.41	0.40	NA	9.31	000
52343		A	Cysto w/renal stricture tx	7.20	NA	2.69	0.44	NA	10.33	000
52344		A	Cysto/uretero, stone remove	7.70	NA	2.87	0.47	NA	11.04	000
52345		A	Cysto/uretero w/up stricture	8.20	NA	3.03	0.50	NA	11.73	000
52346		A	Cystouretero w/renal strict	9.23	NA	3.38	0.57	NA	13.18	000
52347		A	Cystoscopy, resect ducts	5.28	NA	2.09	0.33	NA	7.70	000
52351		A	Cystouretero & or pyeloscope	5.86	NA	2.19	0.36	NA	8.41	000
52352		A	Cystouretero w/stone remove	6.88	NA	2.57	0.42	NA	9.87	000
52353		A	Cystouretero w/lithotripsy	7.97	NA	2.93	0.49	NA	11.39	000
52354		A	Cystouretero w/biopsy	7.34	NA	2.74	0.45	NA	10.53	000
52355		A	Cystouretero w/excise tumor	8.82	NA	3.22	0.55	NA	12.59	000
52400		A	Cystouretero w/congen repr	9.68	NA	4.31	0.60	NA	14.59	090
52450		A	Incision of prostate	7.64	NA	3.65	0.46	NA	11.75	090
52500		A	Revision of bladder neck	8.47	NA	3.91	0.50	NA	12.88	090
52510		A	Dilation prostatic urethra	6.72	NA	3.24	0.40	NA	10.36	090
52601		A	Prostatectomy (TURP)	12.37	NA	5.23	0.74	NA	18.34	090
52606		A	Control postop bleeding	8.13	NA	3.56	0.49	NA	12.18	090
52612		A	Prostatectomy, first stage	7.98	NA	3.83	0.48	NA	12.29	090
52614		A	Prostatectomy, second stage	6.84	NA	3.42	0.41	NA	10.67	090
52620		A	Remove residual prostate	6.61	NA	3.08	0.39	NA	10.08	090
52630		A	Remove prostate regrowth	7.26	NA	3.20	0.43	NA	10.89	090
52640		A	Relieve bladder contracture	6.62	NA	3.10	0.39	NA	10.11	090
52647		A	Laser surgery of prostate	10.36	33.41	4.66	0.61	44.38	15.63	090
52648		A	Laser surgery of prostate	11.21	NA	4.78	0.66	NA	16.65	090
52700		A	Drainage of prostate abscess	6.80	NA	3.24	0.41	NA	10.45	090
53000		A	Incision of urethra	2.28	7.31	2.23	0.13	9.72	4.64	010
53010		A	Incision of urethra	3.64	NA	4.08	0.20	NA	7.92	090
53020		A	Incision of urethra	1.77	3.05	0.66	0.11	4.93	2.54	000
53025		A	Incision of urethra	1.13	3.04	0.45	0.07	4.24	1.65	000
53040		A	Drainage of urethra abscess	6.40	10.66	6.47	0.41	17.47	13.28	090
53060		A	Drainage of urethra abscess	2.63	5.91	2.67	0.23	8.77	5.53	010
53080		A	Drainage of urinary leakage	6.29	NA	6.48	0.42	NA	13.19	090
53085		A	Drainage of urinary leakage	10.27	NA	7.86	0.67	NA	18.80	090
53200		A	Biopsy of urethra	2.59	4.18	0.95	0.17	6.94	3.71	000
53210		A	Removal of urethra	12.57	NA	7.49	0.81	NA	20.87	090
53215		A	Removal of urethra	15.58	NA	8.08	0.93	NA	24.59	090
53220		A	Treatment of urethra lesion	7.00	NA	5.08	0.44	NA	12.52	090
53230		A	Removal of urethra lesion	9.58	NA	5.80	0.60	NA	15.98	090
53235		A	Removal of urethra lesion	10.14	NA	6.00	0.60	NA	16.74	090
53240		A	Surgery for urethra pouch	6.45	NA	4.85	0.42	NA	11.72	090
53250		A	Removal of urethra gland	5.89	NA	4.24	0.35	NA	10.48	090
53260		A	Treatment of urethra lesion	2.98	5.30	2.24	0.23	8.51	5.45	010
53265		A	Treatment of urethra lesion	3.12	5.13	2.19	0.20	8.45	5.51	010
53270		A	Removal of urethra gland	3.09	5.05	2.45	0.21	8.35	5.75	010
53275		A	Repair of urethra defect	4.53	NA	3.04	0.28	NA	7.85	010
53400		A	Revise urethra, stage 1	12.77	NA	7.42	0.85	NA	21.04	090
53405		A	Revise urethra, stage 2	14.48	NA	7.70	0.91	NA	23.09	090
53410		A	Reconstruction of urethra	16.44	NA	8.43	0.99	NA	25.86	090
53415		A	Reconstruction of urethra	19.41	NA	8.99	1.16	NA	29.56	090
53420		A	Reconstruct urethra, stage 1	14.08	NA	8.53	0.90	NA	23.51	090
53425		A	Reconstruct urethra, stage 2	15.98	NA	8.49	0.97	NA	25.44	090
53430		A	Reconstruction of urethra	16.34	NA	8.62	1.01	NA	25.97	090
53431		A	Reconstruct urethra/bladder	19.89	NA	9.04	1.30	NA	30.23	090
53440		A	Male sling procedure	13.62	NA	6.33	0.73	NA	20.68	090
53442		A	Remove/revise male sling	11.57	NA	5.93	0.55	NA	18.05	090
53444		A	Insert tandem cuff	13.40	NA	6.14	0.88	NA	20.42	090
53445		A	Insert uro/ves nck sphincter	14.06	NA	7.76	0.84	NA	22.66	090
53446		A	Remove uro sphincter	10.23	NA	5.82	0.67	NA	16.72	090
53447		A	Remove/replace ur sphincter	13.49	NA	6.55	0.79	NA	20.83	090
53448		A	Remov/replc ur sphinctr comp	21.15	NA	9.85	1.39	NA	32.39	090
53449		A	Repair uro sphincter	9.70	NA	5.90	0.57	NA	16.17	090
53450		A	Revision of urethra	6.14	NA	4.53	0.37	NA	11.04	090
53460		A	Revision of urethra	7.12	NA	4.90	0.43	NA	12.45	090
53502		A	Repair of urethra injury	7.63	NA	5.32	0.50	NA	13.45	090
53505		A	Repair of urethra injury	7.63	NA	5.04	0.46	NA	13.13	090
53510		A	Repair of urethra injury	10.11	NA	6.43	0.60	NA	17.14	090
53515		A	Repair of urethra injury	13.31	NA	7.05	0.83	NA	21.19	090
53520		A	Repair of urethra defect	8.68	NA	5.50	0.53	NA	14.71	090
53600		A	Dilate urethra stricture	1.21	0.87	0.45	0.07	2.15	1.73	000
53601		A	Dilate urethra stricture	0.98	0.95	0.39	0.06	1.99	1.43	000
53605		A	Dilate urethra stricture	1.28	NA	0.42	0.08	NA	1.78	000
53620		A	Dilate urethra stricture	1.62	1.30	0.62	0.10	3.02	2.34	000
53621		A	Dilate urethra stricture	1.35	1.33	0.51	0.08	2.76	1.94	000
53660		A	Dilation of urethra	0.71	1.01	0.33	0.04	1.76	1.08	000
53661		A	Dilation of urethra	0.72	0.97	0.31	0.04	1.73	1.07	000
53665		A	Dilation of urethra	0.76	NA	0.26	0.05	NA	1.07	000
53670		D	Insert urinary catheter	0.00	0.00	0.00	0.00	0.00	0.00	000
53675		D	Insert urinary catheter	0.00	0.00	0.00	0.00	0.00	0.00	000
53850		A	Prostatic microwave thermotx	9.45	52.02	4.16	0.56	62.03	14.17	090
53852		A	Prostatic rf thermotx	9.88	40.46	4.32	0.58	50.92	14.78	090
53853		A	Prostatic water thermother	4.14	29.01	3.22	0.27	33.42	7.63	090
53899		C	Urology surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
54000		A	Slitting of prepuce	1.54	4.11	1.34	0.10	5.75	2.98	010
54001		A	Slitting of prepuce	2.19	4.67	1.92	0.14	7.00	4.25	010
54015		A	Drain penis lesion	5.32	5.91	2.97	0.33	11.56	8.62	010
54050		A	Destruction, penis lesion(s)	1.24	2.78	0.50	0.07	4.09	1.81	010
54055		A	Destruction, penis lesion(s)	1.22	4.91	1.34	0.07	6.20	2.63	010
54056		A	Cryosurgery, penis lesion(s)	1.24	3.12	0.54	0.06	4.42	1.84	010
54057		A	Laser surg, penis lesion(s)	1.24	3.09	1.24	0.08	4.41	2.56	010
54060		A	Excision of penis lesion(s)	1.93	4.38	1.49	0.12	6.43	3.54	010
54065		A	Destruction, penis lesion(s)	2.42	5.24	2.02	0.13	7.79	4.57	010
54100		A	Biopsy of penis	1.90	3.32	0.76	0.10	5.32	2.76	000
54105		A	Biopsy of penis	3.50	4.86	2.00	0.21	8.57	5.71	010
54110		A	Treatment of penis lesion	10.13	NA	6.86	0.60	NA	17.59	090
54111		A	Treat penis lesion, graft	13.57	NA	7.86	0.79	NA	22.22	090
54112		A	Treat penis lesion, graft	15.86	NA	8.86	0.94	NA	25.66	090
54115		A	Treatment of penis lesion	6.15	8.40	5.58	0.39	14.94	12.12	090
54120		A	Partial removal of penis	9.97	NA	6.73	0.60	NA	17.30	090
54125		A	Removal of penis	13.53	NA	7.92	0.81	NA	22.26	090
54130		A	Remove penis & nodes	20.14	NA	10.42	1.19	NA	31.75	090
54135		A	Remove penis & nodes	26.36	NA	12.50	1.58	NA	40.44	090
54150		A	Circumcision	1.81	5.45	1.88	0.17	7.43	3.86	010
54152		A	Circumcision	2.31	NA	1.65	0.16	NA	4.12	010
54160		A	Circumcision	2.48	4.40	1.70	0.16	7.04	4.34	010
54161		A	Circumcision	3.27	NA	1.92	0.20	NA	5.39	010
54162		A	Lysis penil circumic lesion	3.00	NA	2.30	0.20	NA	5.50	010
54163		A	Repair of circumcision	3.00	NA	2.07	0.20	NA	5.27	010
54164		A	Frenulotomy of penis	2.50	NA	1.90	0.16	NA	4.56	010
54200		A	Treatment of penis lesion	1.06	2.40	0.37	0.06	3.52	1.49	010
54205		A	Treatment of penis lesion	7.93	NA	5.95	0.47	NA	14.35	090
54220		A	Treatment of penis lesion	2.42	1.89	1.02	0.15	4.46	3.59	000
54230		A	Prepare penis study	1.34	NA	0.44	0.08	NA	1.86	000
54231		A	Dynamic cavernosometry	2.04	2.14	0.81	0.14	4.32	2.99	000
54235		A	Penile injection	1.19	1.12	0.40	0.07	2.38	1.66	000
54240		A	Penis study	1.31	1.85	NA	0.13	3.29	NA	000
54240	26	A	Penis study	1.31	0.44	0.44	0.08	1.83	1.83	000
54240	TC	A	Penis study	0.00	1.41	NA	0.05	1.46	NA	000
54250		A	Penis study	2.22	2.85	NA	0.16	5.23	NA	000
54250	26	A	Penis study	2.22	0.73	0.73	0.14	3.09	3.09	000
54250	TC	A	Penis study	0.00	2.12	NA	0.02	2.14	NA	000
54300		A	Revision of penis	10.41	NA	7.53	0.64	NA	18.58	090
54304		A	Revision of penis	12.49	NA	8.72	0.74	NA	21.95	090
54308		A	Reconstruction of urethra	11.83	NA	8.29	0.70	NA	20.82	090
54312		A	Reconstruction of urethra	13.57	NA	9.35	0.81	NA	23.73	090
54316		A	Reconstruction of urethra	16.82	NA	10.83	1.00	NA	28.65	090
54318		A	Reconstruction of urethra	11.25	NA	8.64	1.15	NA	21.04	090
54322		A	Reconstruction of urethra	13.01	NA	8.06	0.77	NA	21.84	090
54324		A	Reconstruction of urethra	16.31	NA	10.56	1.03	NA	27.90	090
54326		A	Reconstruction of urethra	15.72	NA	10.15	0.93	NA	26.80	090
54328		A	Revise penis/urethra	15.65	NA	9.53	0.92	NA	26.10	090
54332		A	Revise penis/urethra	17.08	NA	10.06	1.01	NA	28.15	090
54336		A	Revise penis/urethra	20.04	NA	14.12	1.90	NA	36.06	090
54340		A	Secondary urethral surgery	8.91	NA	7.34	0.72	NA	16.97	090
54344		A	Secondary urethral surgery	15.94	NA	9.83	1.10	NA	26.87	090
54348		A	Secondary urethral surgery	17.15	NA	11.25	1.02	NA	29.42	090
54352		A	Reconstruct urethra/penis	24.74	NA	14.53	1.62	NA	40.89	090
54360		A	Penis plastic surgery	11.93	NA	7.33	0.72	NA	19.98	090
54380		A	Repair penis	13.18	NA	9.50	1.16	NA	23.84	090
54385		A	Repair penis	15.39	NA	12.19	0.71	NA	28.29	090
54390		A	Repair penis and bladder	21.61	NA	13.02	1.28	NA	35.91	090
54400		A	Insert semi-rigid prosthesis	8.99	NA	5.68	0.53	NA	15.20	090
54401		A	Insert self-contd prosthesis	10.28	NA	6.46	0.61	NA	17.35	090
54405		A	Insert multi-comp penis pros	13.43	NA	7.53	0.80	NA	21.76	090
54406		A	Remove muti-comp penis pros	12.10	NA	5.50	0.75	NA	18.35	090
54408		A	Repair multi-comp penis pros	12.75	NA	5.86	0.79	NA	19.40	090
54410		A	Remove/replace penis prosth	15.50	NA	6.77	0.96	NA	23.23	090
54411		A	Remov/replc penis pros, comp	16.00	NA	8.90	0.80	NA	25.70	090
54415		A	Remove self-contd penis pros	8.20	NA	4.61	0.54	NA	13.35	090
54416		A	Remv/repl penis contain pros	10.87	NA	6.91	0.55	NA	18.33	090
54417		A	Remv/replc penis pros, compl	14.19	NA	7.81	0.55	NA	22.55	090
54420		A	Revision of penis	11.42	NA	7.47	0.72	NA	19.61	090
54430		A	Revision of penis	10.15	NA	6.77	0.60	NA	17.52	090
54435		A	Revision of penis	6.12	NA	5.01	0.36	NA	11.49	090
54440		C	Repair of penis	0.00	0.00	0.00	0.00	0.00	0.00	090
54450		A	Preputial stretching	1.12	1.00	0.48	0.07	2.19	1.67	000
54500		A	Biopsy of testis	1.31	4.86	0.44	0.08	6.25	1.83	000
54505		A	Biopsy of testis	3.46	NA	2.28	0.21	NA	5.95	010
54512		A	Excise lesion testis	8.58	NA	4.50	0.56	NA	13.64	090
54520		A	Removal of testis	5.23	NA	3.24	0.33	NA	8.80	090
54522		A	Orchiectomy, partial	9.50	NA	5.12	0.62	NA	15.24	090
54530		A	Removal of testis	8.58	NA	4.86	0.53	NA	13.97	090
54535		A	Extensive testis surgery	12.16	NA	6.72	0.83	NA	19.71	090
54550		A	Exploration for testis	7.78	NA	4.38	0.49	NA	12.65	090
54560		A	Exploration for testis	11.13	NA	6.34	0.79	NA	18.26	090
54600		A	Reduce testis torsion	7.01	NA	3.88	0.45	NA	11.34	090
54620		A	Suspension of testis	4.90	NA	2.77	0.31	NA	7.98	010
54640		A	Suspension of testis	6.90	NA	3.94	0.49	NA	11.33	090
54650		A	Orchiopexy (Fowler-Stephens)	11.45	NA	6.59	0.81	NA	18.85	090
54660		A	Revision of testis	5.11	NA	3.11	0.35	NA	8.57	090
54670		A	Repair testis injury	6.41	NA	3.83	0.41	NA	10.65	090
54680		A	Relocation of testis(es)	12.65	NA	7.06	0.94	NA	20.65	090
54690		A	Laparoscopy, orchiectomy	10.96	NA	6.32	0.99	NA	18.27	090
54692		A	Laparoscopy, orchiopexy	12.88	NA	5.47	0.87	NA	19.22	090
54699		C	Laparoscope proc, testis	0.00	0.00	0.00	0.00	0.00	0.00	YYY
54700		A	Drainage of scrotum	3.43	6.06	2.82	0.23	9.72	6.48	010
54800		A	Biopsy of epididymis	2.33	4.98	0.79	0.14	7.45	3.26	000
54820		A	Exploration of epididymis	5.14	NA	3.26	0.33	NA	8.73	090
54830		A	Remove epididymis lesion	5.38	NA	3.33	0.34	NA	9.05	090
54840		A	Remove epididymis lesion	5.20	NA	3.24	0.31	NA	8.75	090
54860		A	Removal of epididymis	6.32	NA	3.80	0.38	NA	10.50	090
54861		A	Removal of epididymis	8.90	NA	4.64	0.52	NA	14.06	090
54900		A	Fusion of spermatic ducts	13.20	NA	6.22	1.34	NA	20.76	090
54901		A	Fusion of spermatic ducts	17.94	NA	8.49	1.83	NA	28.26	090
55000		A	Drainage of hydrocele	1.43	2.17	0.48	0.10	3.70	2.01	000
55040		A	Removal of hydrocele	5.36	NA	3.10	0.35	NA	8.81	090
55041		A	Removal of hydroceles	7.74	NA	4.11	0.50	NA	12.35	090
55060		A	Repair of hydrocele	5.52	NA	3.19	0.37	NA	9.08	090
55100		A	Drainage of scrotum abscess	2.13	6.59	2.91	0.15	8.87	5.19	010
55110		A	Explore scrotum	5.70	NA	3.22	0.36	NA	9.28	090
55120		A	Removal of scrotum lesion	5.09	NA	3.05	0.33	NA	8.47	090
55150		A	Removal of scrotum	7.22	NA	4.22	0.47	NA	11.91	090
55175		A	Revision of scrotum	5.24	NA	3.31	0.33	NA	8.88	090
55180		A	Revision of scrotum	10.72	NA	5.99	0.72	NA	17.43	090
55200		A	Incision of sperm duct	4.24	NA	2.79	0.25	NA	7.28	090
55250		A	Removal of sperm duct(s)	3.29	6.56	2.74	0.21	10.06	6.24	090
55300		A	Prepare, sperm duct x-ray	3.51	NA	1.54	0.20	NA	5.25	000
55400		A	Repair of sperm duct	8.49	NA	4.80	0.50	NA	13.79	090
55450		A	Ligation of sperm duct	4.12	5.09	2.36	0.24	9.45	6.72	010
55500		A	Removal of hydrocele	5.59	NA	3.44	0.43	NA	9.46	090
55520		A	Removal of sperm cord lesion	6.03	NA	3.64	0.56	NA	10.23	090
55530		A	Revise spermatic cord veins	5.66	NA	3.43	0.36	NA	9.45	090
55535		A	Revise spermatic cord veins	6.56	NA	3.71	0.42	NA	10.69	090
55540		A	Revise hernia & sperm veins	7.67	NA	4.20	0.74	NA	12.61	090
55550		A	Laparo ligate spermatic vein	6.57	NA	3.50	0.47	NA	10.54	090
55559		C	Laparo proc, spermatic cord	0.00	0.00	0.00	0.00	0.00	0.00	YYY
55600		A	Incise sperm duct pouch	6.38	NA	3.82	0.38	NA	10.58	090
55605		A	Incise sperm duct pouch	7.96	NA	4.90	0.54	NA	13.40	090
55650		A	Remove sperm duct pouch	11.80	NA	5.81	0.72	NA	18.33	090
55680		A	Remove sperm pouch lesion	5.19	NA	3.48	0.31	NA	8.98	090
55700		A	Biopsy of prostate	1.57	2.83	0.73	0.10	4.50	2.40	000
55705		A	Biopsy of prostate	4.57	NA	3.30	0.26	NA	8.13	010
55720		A	Drainage of prostate abscess	7.64	NA	5.30	0.44	NA	13.38	090
55725		A	Drainage of prostate abscess	8.68	NA	5.85	0.51	NA	15.04	090
55801		A	Removal of prostate	17.80	NA	8.82	1.08	NA	27.70	090
55810		A	Extensive prostate surgery	22.58	NA	10.79	1.35	NA	34.72	090
55812		A	Extensive prostate surgery	27.51	NA	12.97	1.69	NA	42.17	090
55815		A	Extensive prostate surgery	30.46	NA	13.85	1.84	NA	46.15	090
55821		A	Removal of prostate	14.25	NA	7.33	0.85	NA	22.43	090
55831		A	Removal of prostate	15.62	NA	7.81	0.94	NA	24.37	090
55840		A	Extensive prostate surgery	22.69	NA	11.27	1.37	NA	35.33	090
55842		A	Extensive prostate surgery	24.38	NA	11.85	1.48	NA	37.71	090
55845		A	Extensive prostate surgery	28.55	NA	13.14	1.71	NA	43.40	090
55859		A	Percut/needle insert, pros	12.52	NA	6.86	0.74	NA	20.12	090
55860		A	Surgical exposure, prostate	14.45	NA	7.58	0.82	NA	22.85	090
55862		A	Extensive prostate surgery	18.39	NA	9.19	1.14	NA	28.72	090
55865		A	Extensive prostate surgery	22.87	NA	10.50	1.37	NA	34.74	090
55866		A	Laparo radical prostatectomy	30.74	NA	11.79	1.37	NA	43.90	090
55870		A	Vag hyst w/enterocele repair	2.58	1.94	1.04	0.14	4.66	3.76	000
55873		A	Cryoablate prostate	19.47	NA	8.91	1.02	NA	29.40	090
55899		C	Genital surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
55970		N	Sex transformation, M to F	0.00	0.00	0.00	0.00	0.00	0.00	XXX
55980		N	Sex transformation, F to M	0.00	0.00	0.00	0.00	0.00	0.00	XXX
56405		A	I & D of vulva/perineum	1.44	2.29	1.23	0.14	3.87	2.81	010
56420		A	Drainage of gland abscess	1.39	2.29	1.24	0.13	3.81	2.76	010
56440		A	Surgery for vulva lesion	2.84	3.45	2.22	0.28	6.57	5.34	010
56441		A	Lysis of labial lesion(s)	1.97	2.33	1.81	0.17	4.47	3.95	010
56501		A	Destroy, vulva lesions, sim	1.53	2.24	1.29	0.15	3.92	2.97	010
56515		A	Destroy vulva lesion/s compl	2.76	3.01	2.24	0.18	5.95	5.18	010
56605		A	Biopsy of vulva/perineum	1.10	1.09	0.47	0.11	2.30	1.68	000
56606		A	Biopsy of vulva/perineum	0.55	0.51	0.22	0.06	1.12	0.83	ZZZ
56620		A	Partial removal of vulva	7.47	NA	4.85	0.76	NA	13.08	090
56625		A	Complete removal of vulva	8.40	NA	5.78	0.84	NA	15.02	090
56630		A	Extensive vulva surgery	12.36	NA	7.60	1.23	NA	21.19	090
56631		A	Extensive vulva surgery	16.20	NA	10.27	1.63	NA	28.10	090
56632		A	Extensive vulva surgery	20.29	NA	10.23	2.03	NA	32.55	090
56633		A	Extensive vulva surgery	16.47	NA	9.27	1.66	NA	27.40	090
56634		A	Extensive vulva surgery	17.88	NA	10.95	1.78	NA	30.61	090
56637		A	Extensive vulva surgery	21.97	NA	12.64	2.18	NA	36.79	090
56640		A	Extensive vulva surgery	22.17	NA	12.24	2.26	NA	36.67	090
56700		A	Partial removal of hymen	2.52	NA	1.70	0.24	NA	4.46	010
56720		A	Incision of hymen	0.68	NA	0.41	0.07	NA	1.16	000
56740		A	Remove vagina gland lesion	4.57	NA	2.58	0.37	NA	7.52	010
56800		A	Repair of vagina	3.89	NA	2.61	0.37	NA	6.87	010
56805		A	Repair clitoris	18.86	NA	9.12	1.82	NA	29.80	090
56810		A	Repair of perineum	4.13	NA	2.72	0.41	NA	7.26	010
56820		A	Exam of vulva w/scope	1.50	1.64	0.65	0.10	3.24	2.25	000
56821		A	Exam/biopsy of vulva w/scope	2.05	2.02	0.92	0.13	4.20	3.10	000
57000		A	Exploration of vagina	2.97	NA	2.19	0.28	NA	5.44	010
57010		A	Drainage of pelvic abscess	6.03	NA	3.79	0.57	NA	10.39	090
57020		A	Drainage of pelvic fluid	1.50	1.56	0.63	0.15	3.21	2.28	000
57022		A	I & d vaginal hematoma, pp	2.56	NA	2.03	0.24	NA	4.83	010
57023		A	I & d vag hematoma, non-ob	4.75	NA	2.89	0.24	NA	7.88	010
57061		A	Destroy vag lesions, simple	1.25	2.16	1.16	0.13	3.54	2.54	010
57065		A	Destroy vag lesions, complex	2.61	2.88	2.23	0.26	5.75	5.10	010
57100		A	Biopsy of vagina	1.20	1.11	0.50	0.10	2.41	1.80	000
57105		A	Biopsy of vagina	1.69	2.00	1.31	0.17	3.86	3.17	010
57106		A	Remove vagina wall, partial	6.36	NA	3.87	0.58	NA	10.81	090
57107		A	Remove vagina tissue, part	23.00	NA	10.28	2.17	NA	35.45	090
57109		A	Vaginectomy partial w/nodes	27.00	NA	11.53	1.97	NA	40.50	090
57110		A	Remove vagina wall, complete	14.29	NA	7.21	1.43	NA	22.93	090
57111		A	Remove vagina tissue, compl	27.00	NA	12.30	2.71	NA	42.01	090
57112		A	Vaginectomy w/nodes, compl	29.00	NA	12.39	2.19	NA	43.58	090
57120		A	Closure of vagina	7.41	NA	4.59	0.75	NA	12.75	090
57130		A	Remove vagina lesion	2.43	NA	2.03	0.23	NA	4.69	010
57135		A	Remove vagina lesion	2.67	2.87	2.13	0.26	5.80	5.06	010
57150		A	Treat vagina infection	0.55	0.99	0.22	0.06	1.60	0.83	000
57155		A	Insert uteri tandems/ovoids	6.27	NA	3.68	0.59	NA	10.54	090
57160		A	Insert pessary/other device	0.89	1.10	0.40	0.09	2.08	1.38	000
57170		A	Fitting of diaphragm/cap	0.91	1.38	0.34	0.09	2.38	1.34	000
57180		A	Treat vaginal bleeding	1.58	2.22	1.41	0.16	3.96	3.15	010
57200		A	Repair of vagina	3.94	NA	3.11	0.38	NA	7.43	090
57210		A	Repair vagina/perineum	5.17	NA	3.67	0.50	NA	9.34	090
57220		A	Revision of urethra	4.31	NA	3.34	0.42	NA	8.07	090
57230		A	Repair of urethral lesion	5.64	NA	3.54	0.50	NA	9.68	090
57240		A	Repair bladder & vagina	6.07	NA	3.90	0.53	NA	10.50	090
57250		A	Repair rectum & vagina	5.53	NA	3.81	0.54	NA	9.88	090
57260		A	Repair of vagina	8.27	NA	5.14	0.83	NA	14.24	090
57265		A	Extensive repair of vagina	11.34	NA	6.38	1.14	NA	18.86	090
57268		A	Repair of bowel bulge	6.76	NA	4.48	0.66	NA	11.90	090
57270		A	Repair of bowel pouch	12.11	NA	6.60	1.17	NA	19.88	090
57280		A	Suspension of vagina	15.04	NA	7.73	1.44	NA	24.21	090
57282		A	Repair of vaginal prolapse	8.86	NA	5.58	0.86	NA	15.30	090
57284		A	Repair paravaginal defect	12.70	NA	7.12	1.17	NA	20.99	090
57287		A	Revise/remove sling repair	10.71	NA	5.60	0.74	NA	17.05	090
57288		A	Repair bladder defect	13.02	NA	6.05	0.86	NA	19.93	090
57289		A	Repair bladder & vagina	11.58	NA	6.26	0.95	NA	18.79	090
57291		A	Construction of vagina	7.95	NA	5.29	0.78	NA	14.02	090
57292		A	Construct vagina with graft	13.09	NA	7.38	1.29	NA	21.76	090
57300		A	Repair rectum-vagina fistula	7.61	NA	4.85	0.70	NA	13.16	090
57305		A	Repair rectum-vagina fistula	13.77	NA	6.49	1.33	NA	21.59	090
57307		A	Fistula repair & colostomy	15.93	NA	7.55	1.59	NA	25.07	090
57308		A	Fistula repair, transperine	9.94	NA	5.89	0.91	NA	16.74	090
57310		A	Repair urethrovaginal lesion	6.78	NA	4.29	0.45	NA	11.52	090
57311		A	Repair urethrovaginal lesion	7.98	NA	4.85	0.51	NA	13.34	090
57320		A	Repair bladder-vagina lesion	8.01	NA	4.95	0.60	NA	13.56	090
57330		A	Repair bladder-vagina lesion	12.35	NA	6.29	0.86	NA	19.50	090
57335		A	Repair vagina	18.73	NA	8.97	1.66	NA	29.36	090
57400		A	Dilation of vagina	2.27	NA	1.14	0.22	NA	3.63	000
57410		A	Pelvic examination	1.75	2.55	1.03	0.14	4.44	2.92	000
57415		A	Remove vaginal foreign body	2.17	3.21	1.87	0.19	5.57	4.23	010
57420		A	Exam of vagina w/scope	1.60	1.68	0.69	0.10	3.38	2.39	000
57421		A	Exam/biopsy of vag w/scope	2.20	2.08	0.98	0.13	4.41	3.31	000
57452		A	Exam of cervix w/scope	1.50	1.70	0.65	0.10	3.30	2.25	000
57454		A	Bx/curett of cervix w/scope	2.33	2.05	1.02	0.13	4.51	3.48	000
57455		A	Biopsy of cervix w/scope	1.99	1.94	0.89	0.13	4.06	3.01	000
57456		A	Endocerv curettage w/scope	1.85	1.86	0.84	0.13	3.84	2.82	000
57460		A	Bx of cervix w/scope, leep	2.83	5.01	1.25	0.28	8.12	4.36	000
57461		A	Conz of cervix w/scope, leep	3.44	5.32	1.50	0.28	9.04	5.22	000
57500		A	Biopsy of cervix	0.97	2.02	0.49	0.10	3.09	1.56	000
57505		A	Endocervical curettage	1.14	1.90	1.21	0.12	3.16	2.47	010
57510		A	Cauterization of cervix	1.90	3.01	1.51	0.18	5.09	3.59	010
57511		A	Cryocautery of cervix	1.90	2.36	0.75	0.18	4.44	2.83	010
57513		A	Laser surgery of cervix	1.90	2.57	1.50	0.19	4.66	3.59	010
57520		A	Conization of cervix	4.04	4.13	2.76	0.41	8.58	7.21	090
57522		A	Conization of cervix	3.36	3.66	2.49	0.34	7.36	6.19	090
57530		A	Removal of cervix	4.79	NA	3.53	0.48	NA	8.80	090
57531		A	Removal of cervix, radical	28.00	NA	13.53	2.46	NA	43.99	090
57540		A	Removal of residual cervix	12.22	NA	6.14	1.21	NA	19.57	090
57545		A	Remove cervix/repair pelvis	13.03	NA	6.59	1.30	NA	20.92	090
57550		A	Removal of residual cervix	5.53	NA	3.78	0.55	NA	9.86	090
57555		A	Remove cervix/repair vagina	8.95	NA	5.60	0.89	NA	15.44	090
57556		A	Remove cervix, repair bowel	8.37	NA	4.83	0.80	NA	14.00	090
57700		A	Revision of cervix	3.55	NA	2.44	0.33	NA	6.32	090
57720		A	Revision of cervix	4.13	NA	3.20	0.41	NA	7.74	090
57800		A	Dilation of cervical canal	0.77	0.77	0.48	0.08	1.62	1.33	000
57820		A	D & c of residual cervix	1.67	1.51	1.11	0.17	3.35	2.95	010
58100		A	Biopsy of uterus lining	1.53	1.45	0.75	0.07	3.05	2.35	000
58120		A	Dilation and curettage	3.27	2.35	1.97	0.33	5.95	5.57	010
58140		A	Myomectomy abdom method	14.60	NA	7.01	1.46	NA	23.07	090
58145		A	Myomectomy vag method	8.04	NA	4.84	0.80	NA	13.68	090
58146		A	Myomectomy abdom complex	19.00	NA	9.15	1.46	NA	29.61	090
58150		A	Total hysterectomy	15.24	NA	7.89	1.57	NA	24.70	090
58152		A	Total hysterectomy	20.60	NA	10.28	1.52	NA	32.40	090
58180		A	Partial hysterectomy	15.29	NA	7.85	1.54	NA	24.68	090
58200		A	Extensive hysterectomy	21.59	NA	10.60	2.15	NA	34.34	090
58210		A	Extensive hysterectomy	28.85	NA	13.96	2.91	NA	45.72	090
58240		A	Removal of pelvis contents	38.39	NA	18.48	3.76	NA	60.63	090
58260		A	Vaginal hysterectomy	12.98	NA	6.68	1.23	NA	20.89	090
58262		A	Vag hyst including t/o	14.77	NA	7.43	1.42	NA	23.62	090
58263		A	Vag hyst w/t/o & vag repair	16.06	NA	7.95	1.55	NA	25.56	090
58267		A	Vag hyst w/urinary repair	17.04	NA	8.52	1.51	NA	27.07	090
58270		A	Vag hyst w/enterocele repair	14.26	NA	7.19	1.37	NA	22.82	090
58275		A	Hysterectomy/revise vagina	15.76	NA	7.72	1.51	NA	24.99	090
58280		A	Hysterectomy/revise vagina	17.01	NA	8.21	1.54	NA	26.76	090
58285		A	Extensive hysterectomy	22.26	NA	10.85	1.88	NA	34.99	090
58290		A	Vag hyst complex	19.00	NA	9.37	1.23	NA	29.60	090
58291		A	Vag hyst incl t/o, complex	20.79	NA	10.34	1.42	NA	32.55	090
58292		A	Vag hyst t/o & repair, compl	22.08	NA	10.85	1.55	NA	34.48	090
58293		A	Vag hyst w/uro repair, compl	23.06	NA	11.25	1.51	NA	35.82	090
58294		A	Vag hyst w/enterocele, compl	20.28	NA	10.10	1.37	NA	31.75	090
58300		N	Insert intrauterine device	+1.01	1.44	0.39	0.10	2.55	1.50	XXX
58301		A	Remove intrauterine device	1.27	1.54	0.50	0.13	2.94	1.90	000
58321		A	Artificial insemination	0.92	0.94	0.38	0.10	1.96	1.40	000
58322		A	Artificial insemination	1.10	1.00	0.43	0.11	2.21	1.64	000
58323		A	Sperm washing	0.23	0.54	0.10	0.02	0.79	0.35	000
58340		A	Catheter for hysterography	0.88	12.10	0.33	0.08	13.06	1.29	000
58345		A	Reopen fallopian tube	4.66	NA	1.73	0.36	NA	6.75	010
58346		A	Insert heyman uteri capsule	6.75	NA	3.87	0.64	NA	11.26	090
58350		A	Reopen fallopian tube	1.01	1.93	1.05	0.10	3.04	2.16	010
58353		A	Endometr ablate, thermal	3.56	NA	2.23	0.37	NA	6.16	010
58400		A	Suspension of uterus	6.36	NA	3.93	0.62	NA	10.91	090
58410		A	Suspension of uterus	12.73	NA	6.55	1.09	NA	20.37	090
58520		A	Repair of ruptured uterus	11.92	NA	5.93	1.17	NA	19.02	090
58540		A	Revision of uterus	14.64	NA	6.90	1.28	NA	22.82	090
58545		A	Laparoscopic myomectomy	14.60	NA	7.76	1.45	NA	23.81	090
58546		A	Laparo-myomectomy, complex	19.00	NA	9.55	1.45	NA	30.00	090
58550		A	Laparo-asst vag hysterectomy	14.19	NA	7.21	1.44	NA	22.84	010
58551		D	Laparoscopy, remove myoma	0.00	0.00	0.00	0.00	0.00	0.00	010
58552		A	Laparo-vag hyst incl t/o	14.19	NA	7.56	1.44	NA	23.19	090
58553		A	Laparo-vag hyst, complex	19.00	NA	9.57	1.23	NA	29.80	090
58554		A	Laparo-vag hyst w/t/o, compl	19.00	NA	9.26	1.23	NA	29.49	090
58555		A	Hysteroscopy, dx, sep proc	3.33	2.10	1.49	0.34	5.77	5.16	000
58558		A	Hysteroscopy, biopsy	4.75	NA	2.12	0.49	NA	7.36	000
58559		A	Hysteroscopy, lysis	6.17	NA	2.69	0.62	NA	9.48	000
58560		A	Hysteroscopy, resect septum	7.00	NA	3.05	0.71	NA	10.76	000
58561		A	Hysteroscopy, remove myoma	10.00	NA	4.28	1.02	NA	15.30	000
58562		A	Hysteroscopy, remove fb	5.21	NA	2.27	0.52	NA	8.00	000
58563		A	Hysteroscopy, ablation	6.17	NA	2.71	0.62	NA	9.50	000
58578		C	Laparo proc, uterus	0.00	0.00	0.00	0.00	0.00	0.00	YYY
58579		C	Hysteroscope procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
58600		A	Division of fallopian tube	5.60	NA	3.28	0.39	NA	9.27	090
58605		A	Division of fallopian tube	5.00	NA	3.12	0.33	NA	8.45	090
58611		A	Ligate oviduct(s) add-on	1.45	NA	0.59	0.07	NA	2.11	ZZZ
58615		A	Occlude fallopian tube(s)	3.90	NA	3.11	0.40	NA	7.41	010
58660		A	Laparoscopy, lysis	11.29	NA	5.60	1.14	NA	18.03	090
58661		A	Laparoscopy, remove adnexa	11.05	NA	5.27	1.12	NA	17.44	010
58662		A	Laparoscopy, excise lesions	11.79	NA	5.54	1.18	NA	18.51	090
58670		A	Laparoscopy, tubal cautery	5.60	NA	3.62	0.55	NA	9.77	090
58671		A	Laparoscopy, tubal block	5.60	NA	3.63	0.56	NA	9.79	090
58672		A	Laparoscopy, fimbrioplasty	12.88	NA	6.52	1.22	NA	20.62	090
58673		A	Laparoscopy, salpingostomy	13.74	NA	6.86	1.40	NA	22.00	090
58679		C	Laparo proc, oviduct-ovary	0.00	0.00	0.00	0.00	0.00	0.00	YYY
58700		A	Removal of fallopian tube	12.05	NA	5.80	0.64	NA	18.49	090
58720		A	Removal of ovary/tube(s)	11.36	NA	5.75	1.14	NA	18.25	090
58740		A	Revise fallopian tube(s)	14.00	NA	6.99	0.59	NA	21.58	090
58750		A	Repair oviduct	14.84	NA	7.37	1.52	NA	23.73	090
58752		A	Revise ovarian tube(s)	14.84	NA	7.06	1.51	NA	23.41	090
58760		A	Remove tubal obstruction	13.13	NA	6.67	1.34	NA	21.14	090
58770		A	Create new tubal opening	13.97	NA	6.97	1.42	NA	22.36	090
58800		A	Drainage of ovarian cyst(s)	4.14	4.39	4.36	0.36	8.89	8.86	090
58805		A	Drainage of ovarian cyst(s)	5.88	NA	3.47	0.56	NA	9.91	090
58820		A	Drain ovary abscess, open	4.22	NA	3.34	0.29	NA	7.85	090
58822		A	Drain ovary abscess, percut	10.13	NA	5.04	0.92	NA	16.09	090
58823		A	Drain pelvic abscess, percut	3.38	NA	2.32	0.18	NA	5.88	000
58825		A	Transposition, ovary(s)	10.98	NA	5.74	0.62	NA	17.34	090
58900		A	Biopsy of ovary(s)	5.99	NA	3.53	0.56	NA	10.08	090
58920		A	Partial removal of ovary(s)	11.36	NA	5.58	0.68	NA	17.62	090
58925		A	Removal of ovarian cyst(s)	11.36	NA	5.54	1.14	NA	18.04	090
58940		A	Removal of ovary(s)	7.29	NA	3.94	0.73	NA	11.96	090
58943		A	Removal of ovary(s)	18.43	NA	9.44	1.86	NA	29.73	090
58950		A	Resect ovarian malignancy	16.93	NA	9.00	1.55	NA	27.48	090
58951		A	Resect ovarian malignancy	22.38	NA	11.32	2.20	NA	35.90	090
58952		A	Resect ovarian malignancy	25.01	NA	12.41	2.57	NA	39.99	090
58953		A	Tah, rad dissect for debulk	32.00	NA	15.08	3.30	NA	50.38	090
58954		A	Tah rad debulk/lymph remove	35.00	NA	16.15	3.56	NA	54.71	090
58960		A	Exploration of abdomen	14.65	NA	8.12	1.47	NA	24.24	090
58970		A	Retrieval of oocyte	3.53	8.36	1.67	0.36	12.25	5.56	000
58974		C	Transfer of embryo	0.00	0.00	0.00	0.00	0.00	0.00	000
58976		A	Transfer of embryo	3.83	2.29	1.59	0.39	6.51	5.81	000
58999		C	Genital surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
59000		A	Amniocentesis, diagnostic	1.30	1.88	0.71	0.23	3.41	2.24	000
59001		A	Amniocentesis, therapeutic	3.00	NA	1.35	0.23	NA	4.58	000
59012		A	Fetal cord puncture,prenatal	3.45	NA	1.60	0.62	NA	5.67	000
59015		A	Chorion biopsy	2.20	1.59	1.08	0.40	4.19	3.68	000
59020		A	Fetal contract stress test	0.66	0.79	NA	0.20	1.65	NA	000
59020	26	A	Fetal contract stress test	0.66	0.27	0.27	0.12	1.05	1.05	000
59020	TC	A	Fetal contract stress test	0.00	0.52	NA	0.08	0.60	NA	000
59025		A	Fetal non-stress test	0.53	0.45	NA	0.12	1.10	NA	000
59025	26	A	Fetal non-stress test	0.53	0.22	0.22	0.10	0.85	0.85	000
59025	TC	A	Fetal non-stress test	0.00	0.23	NA	0.02	0.25	NA	000
59030		A	Fetal scalp blood sample	1.99	NA	1.06	0.36	NA	3.41	000
59050		A	Fetal monitor w/report	0.89	NA	0.36	0.16	NA	1.41	XXX
59051		A	Fetal monitor/interpret only	0.74	NA	0.30	0.14	NA	1.18	XXX
59100		A	Remove uterus lesion	12.35	NA	6.29	2.21	NA	20.85	090
59120		A	Treat ectopic pregnancy	11.49	NA	6.06	2.06	NA	19.61	090
59121		A	Treat ectopic pregnancy	11.67	NA	6.19	2.09	NA	19.95	090
59130		A	Treat ectopic pregnancy	14.22	NA	5.81	2.54	NA	22.57	090
59135		A	Treat ectopic pregnancy	13.88	NA	7.04	2.49	NA	23.41	090
59136		A	Treat ectopic pregnancy	13.18	NA	6.61	2.36	NA	22.15	090
59140		A	Treat ectopic pregnancy	5.46	NA	3.36	0.98	NA	9.80	090
59150		A	Treat ectopic pregnancy	11.67	NA	6.40	1.23	NA	19.30	090
59151		A	Treat ectopic pregnancy	11.49	NA	5.84	1.41	NA	18.74	090
59160		A	D & c after delivery	2.71	3.48	2.15	0.49	6.68	5.35	010
59200		A	Insert cervical dilator	0.79	1.32	0.31	0.15	2.26	1.25	000
59300		A	Episiotomy or vaginal repair	2.41	2.08	0.99	0.43	4.92	3.83	000
59320		A	Revision of cervix	2.48	NA	1.29	0.45	NA	4.22	000
59325		A	Revision of cervix	4.07	NA	1.96	0.73	NA	6.76	000
59350		A	Repair of uterus	4.95	NA	2.00	0.88	NA	7.83	000
59400		A	Obstetrical care	23.06	NA	16.09	4.14	NA	43.29	MMM
59409		A	Obstetrical care	13.50	NA	5.44	2.42	NA	21.36	MMM
59410		A	Obstetrical care	14.78	NA	6.48	2.65	NA	23.91	MMM
59412		A	Antepartum manipulation	1.71	NA	0.84	0.31	NA	2.86	MMM
59414		A	Deliver placenta	1.61	NA	0.65	0.29	NA	2.55	MMM
59425		A	Antepartum care only	4.81	4.46	1.90	0.86	10.13	7.57	MMM
59426		A	Antepartum care only	8.28	8.04	3.30	1.49	17.81	13.07	MMM
59430		A	Care after delivery	2.13	NA	0.98	0.38	NA	3.49	MMM
59510		A	Cesarean delivery	26.22	NA	18.21	4.70	NA	49.13	MMM
59514		A	Cesarean delivery only	15.97	NA	6.38	2.86	NA	25.21	MMM
59515		A	Cesarean delivery	17.37	NA	8.05	3.12	NA	28.54	MMM
59525		A	Remove uterus after cesarean	8.54	NA	3.39	1.53	NA	13.46	ZZZ
59610		A	Vbac delivery	24.62	NA	16.66	4.41	NA	45.69	MMM
59612		A	Vbac delivery only	15.06	NA	6.21	2.70	NA	23.97	MMM
59614		A	Vbac care after delivery	16.34	NA	7.12	2.93	NA	26.39	MMM
59618		A	Attempted vbac delivery	27.78	NA	19.52	4.98	NA	52.28	MMM
59620		A	Attempted vbac delivery only	17.53	NA	6.94	3.15	NA	27.62	MMM
59622		A	Attempted vbac after care	18.93	NA	8.87	3.39	NA	31.19	MMM
59812		A	Treatment of miscarriage	4.01	3.60	2.53	0.58	8.19	7.12	090
59820		A	Care of miscarriage	4.01	3.62	2.66	0.72	8.35	7.39	090
59821		A	Treatment of miscarriage	4.47	3.79	2.85	0.80	9.06	8.12	090
59830		A	Treat uterus infection	6.11	NA	3.94	1.10	NA	11.15	090
59840		R	Abortion	3.01	3.98	2.24	0.54	7.53	5.79	010
59841		R	Abortion	5.24	5.60	3.55	0.94	11.78	9.73	010
59850		R	Abortion	5.91	NA	2.73	1.06	NA	9.70	090
59851		R	Abortion	5.93	NA	3.13	1.06	NA	10.12	090
59852		R	Abortion	8.24	NA	4.57	1.48	NA	14.29	090
59855		R	Abortion	6.12	NA	3.24	1.10	NA	10.46	090
59856		R	Abortion	7.48	NA	3.83	1.34	NA	12.65	090
59857		R	Abortion	9.29	NA	4.39	1.66	NA	15.34	090
59866		R	Abortion (mpr)	4.00	NA	1.55	0.72	NA	6.27	000
59870		A	Evacuate mole of uterus	6.01	NA	3.78	0.77	NA	10.56	090
59871		A	Remove cerclage suture	2.13	2.00	0.90	0.38	4.51	3.41	000
59898		C	Laparo proc, ob care/deliver	0.00	0.00	0.00	0.00	0.00	0.00	YYY
59899		C	Maternity care procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
60000		A	Drain thyroid/tongue cyst	1.76	2.36	2.15	0.14	4.26	4.05	010
60001		A	Aspirate/inject thyriod cyst	0.97	1.64	0.35	0.06	2.67	1.38	000
60100		A	Biopsy of thyroid	1.56	1.86	0.55	0.05	3.47	2.16	000
60200		A	Remove thyroid lesion	9.55	NA	6.57	0.84	NA	16.96	090
60210		A	Partial thyroid excision	10.88	NA	6.45	1.01	NA	18.34	090
60212		A	Partial thyroid excision	16.03	NA	8.23	1.51	NA	25.77	090
60220		A	Partial removal of thyroid	11.90	NA	6.99	0.97	NA	19.86	090
60225		A	Partial removal of thyroid	14.19	NA	7.82	1.31	NA	23.32	090
60240		A	Removal of thyroid	16.06	NA	9.05	1.50	NA	26.61	090
60252		A	Removal of thyroid	20.57	NA	11.39	1.63	NA	33.59	090
60254		A	Extensive thyroid surgery	26.99	NA	15.79	1.96	NA	44.74	090
60260		A	Repeat thyroid surgery	17.47	NA	10.30	1.39	NA	29.16	090
60270		A	Removal of thyroid	20.27	NA	11.50	1.78	NA	33.55	090
60271		A	Removal of thyroid	16.83	NA	9.82	1.35	NA	28.00	090
60280		A	Remove thyroid duct lesion	5.87	NA	5.16	0.45	NA	11.48	090
60281		A	Remove thyroid duct lesion	8.53	NA	6.35	0.67	NA	15.55	090
60500		A	Explore parathyroid glands	16.23	NA	7.75	1.61	NA	25.59	090
60502		A	Re-explore parathyroids	20.35	NA	9.59	2.00	NA	31.94	090
60505		A	Explore parathyroid glands	21.49	NA	11.42	2.14	NA	35.05	090
60512		A	Autotransplant parathyroid	4.45	NA	1.66	0.44	NA	6.55	ZZZ
60520		A	Removal of thymus gland	16.81	NA	9.84	1.84	NA	28.49	090
60521		A	Removal of thymus gland	18.87	NA	11.77	2.34	NA	32.98	090
60522		A	Removal of thymus gland	23.09	NA	13.01	2.83	NA	38.93	090
60540		A	Explore adrenal gland	17.03	NA	7.64	1.42	NA	26.09	090
60545		A	Explore adrenal gland	19.88	NA	9.33	1.75	NA	30.96	090
60600		A	Remove carotid body lesion	17.93	NA	13.24	1.87	NA	33.04	090
60605		A	Remove carotid body lesion	20.24	NA	18.11	2.28	NA	40.63	090
60650		A	Laparoscopy adrenalectomy	20.00	NA	8.06	1.98	NA	30.04	090
60659		C	Laparo proc, endocrine	0.00	0.00	0.00	0.00	0.00	0.00	YYY
60699		C	Endocrine surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
61000		A	Remove cranial cavity fluid	1.58	NA	0.98	0.13	NA	2.69	000
61001		A	Remove cranial cavity fluid	1.49	NA	1.08	0.15	NA	2.72	000
61020		A	Remove brain cavity fluid	1.51	NA	1.38	0.26	NA	3.15	000
61026		A	Injection into brain canal	1.69	NA	1.45	0.21	NA	3.35	000
61050		A	Remove brain canal fluid	1.51	NA	1.27	0.13	NA	2.91	000
61055		A	Injection into brain canal	2.10	NA	1.42	0.13	NA	3.65	000
61070		A	Brain canal shunt procedure	0.89	NA	1.04	0.09	NA	2.02	000
61105		A	Twist drill hole	5.14	NA	4.04	1.05	NA	10.23	090
61107		A	Drill skull for implantation	5.00	NA	3.38	1.02	NA	9.40	000
61108		A	Drill skull for drainage	10.19	NA	7.29	2.04	NA	19.52	090
61120		A	Burr hole for puncture	8.76	NA	6.12	1.81	NA	16.69	090
61140		A	Pierce skull for biopsy	15.90	NA	10.11	3.15	NA	29.16	090
61150		A	Pierce skull for drainage	17.57	NA	10.66	3.52	NA	31.75	090
61151		A	Pierce skull for drainage	12.42	NA	8.01	2.45	NA	22.88	090
61154		A	Pierce skull & remove clot	14.99	NA	9.70	3.05	NA	27.74	090
61156		A	Pierce skull for drainage	16.32	NA	10.07	3.42	NA	29.81	090
61210		A	Pierce skull, implant device	5.84	NA	3.78	1.16	NA	10.78	000
61215		A	Insert brain-fluid device	4.89	NA	4.09	0.99	NA	9.97	090
61250		A	Pierce skull & explore	10.42	NA	7.01	2.02	NA	19.45	090
61253		A	Pierce skull & explore	12.36	NA	7.87	2.26	NA	22.49	090
61304		A	Open skull for exploration	21.96	NA	13.18	4.33	NA	39.47	090
61305		A	Open skull for exploration	26.61	NA	15.70	5.25	NA	47.56	090
61312		A	Open skull for drainage	24.57	NA	15.42	4.99	NA	44.98	090
61313		A	Open skull for drainage	24.93	NA	15.20	5.07	NA	45.20	090
61314		A	Open skull for drainage	24.23	NA	13.34	4.00	NA	41.57	090
61315		A	Open skull for drainage	27.68	NA	16.42	5.62	NA	49.72	090
61316		A	Implt cran bone flap to abdo	1.39	NA	0.57	0.43	NA	2.39	ZZZ
61320		A	Open skull for drainage	25.62	NA	15.16	5.20	NA	45.98	090
61321		A	Open skull for drainage	28.50	NA	16.55	5.35	NA	50.40	090
61322		A	Decompressive craniotomy	29.50	NA	13.88	4.99	NA	48.37	090
61323		A	Decompressive lobectomy	31.00	NA	14.08	4.99	NA	50.07	090
61330		A	Decompress eye socket	23.32	NA	14.10	2.58	NA	40.00	090
61332		A	Explore/biopsy eye socket	27.28	NA	15.97	4.15	NA	47.40	090
61333		A	Explore orbit/remove lesion	27.95	NA	16.02	2.24	NA	46.21	090
61334		A	Explore orbit/remove object	18.27	NA	10.93	3.02	NA	32.22	090
61340		A	Subtemporal decompression	18.66	NA	11.41	3.66	NA	33.73	090
61343		A	Incise skull (press relief)	29.77	NA	17.97	6.04	NA	53.78	090
61345		A	Relieve cranial pressure	27.20	NA	16.51	5.23	NA	48.94	090
61440		A	Incise skull for surgery	26.63	NA	15.30	5.57	NA	47.50	090
61450		A	Incise skull for surgery	25.95	NA	15.53	5.11	NA	46.59	090
61458		A	Incise skull for brain wound	27.29	NA	16.59	5.28	NA	49.16	090
61460		A	Incise skull for surgery	28.39	NA	17.53	5.13	NA	51.05	090
61470		A	Incise skull for surgery	26.06	NA	15.06	4.65	NA	45.77	090
61480		A	Incise skull for surgery	26.49	NA	15.99	5.54	NA	48.02	090
61490		A	Incise skull for surgery	25.66	NA	15.56	5.37	NA	46.59	090
61500		A	Removal of skull lesion	17.92	NA	11.76	3.26	NA	32.94	090
61501		A	Remove infected skull bone	14.84	NA	9.97	2.63	NA	27.44	090
61510		A	Removal of brain lesion	28.45	NA	17.22	5.77	NA	51.44	090
61512		A	Remove brain lining lesion	35.09	NA	20.72	7.14	NA	62.95	090
61514		A	Removal of brain abscess	25.26	NA	15.47	5.12	NA	45.85	090
61516		A	Removal of brain lesion	24.61	NA	14.92	4.94	NA	44.47	090
61517		A	Implt brain chemotx add-on	1.38	NA	0.56	0.08	NA	2.02	ZZZ
61518		A	Removal of brain lesion	37.32	NA	22.22	7.53	NA	67.07	090
61519		A	Remove brain lining lesion	41.39	NA	24.21	8.15	NA	73.75	090
61520		A	Removal of brain lesion	54.84	NA	31.73	10.10	NA	96.67	090
61521		A	Removal of brain lesion	44.48	NA	25.76	8.85	NA	79.09	090
61522		A	Removal of brain abscess	29.45	NA	17.56	5.30	NA	52.31	090
61524		A	Removal of brain lesion	27.86	NA	16.79	5.01	NA	49.66	090
61526		A	Removal of brain lesion	52.17	NA	30.71	6.72	NA	89.60	090
61530		A	Removal of brain lesion	43.86	NA	26.94	6.17	NA	76.97	090
61531		A	Implant brain electrodes	14.63	NA	9.66	2.84	NA	27.13	090
61533		A	Implant brain electrodes	19.71	NA	12.32	3.80	NA	35.83	090
61534		A	Removal of brain lesion	20.97	NA	13.13	4.15	NA	38.25	090
61535		A	Remove brain electrodes	11.63	NA	8.10	2.29	NA	22.02	090
61536		A	Removal of brain lesion	35.52	NA	21.02	6.68	NA	63.22	090
61538		A	Removal of brain tissue	26.81	NA	16.32	5.38	NA	48.51	090
61539		A	Removal of brain tissue	32.08	NA	18.97	6.62	NA	57.67	090
61541		A	Incision of brain tissue	28.85	NA	16.91	5.50	NA	51.26	090
61542		A	Removal of brain tissue	31.02	NA	19.07	6.49	NA	56.58	090
61543		A	Removal of brain tissue	29.22	NA	17.52	6.11	NA	52.85	090
61544		A	Remove & treat brain lesion	25.50	NA	14.52	4.91	NA	44.93	090
61545		A	Excision of brain tumor	43.80	NA	25.02	8.88	NA	77.70	090
61546		A	Removal of pituitary gland	31.30	NA	18.68	6.06	NA	56.04	090
61548		A	Removal of pituitary gland	21.53	NA	13.64	3.63	NA	38.80	090
61550		A	Release of skull seams	14.65	NA	7.34	1.14	NA	23.13	090
61552		A	Release of skull seams	19.56	NA	9.84	0.88	NA	30.28	090
61556		A	Incise skull/sutures	22.26	NA	12.01	3.57	NA	37.84	090
61557		A	Incise skull/sutures	22.38	NA	13.86	4.68	NA	40.92	090
61558		A	Excision of skull/sutures	25.58	NA	15.13	2.61	NA	43.32	090
61559		A	Excision of skull/sutures	32.79	NA	19.67	6.86	NA	59.32	090
61563		A	Excision of skull tumor	26.83	NA	16.07	4.46	NA	47.36	090
61564		A	Excision of skull tumor	33.83	NA	18.72	7.08	NA	59.63	090
61570		A	Remove foreign body, brain	24.60	NA	14.37	4.60	NA	43.57	090
61571		A	Incise skull for brain wound	26.39	NA	15.70	5.23	NA	47.32	090
61575		A	Skull base/brainstem surgery	34.36	NA	21.20	5.02	NA	60.58	090
61576		A	Skull base/brainstem surgery	52.43	NA	30.80	4.68	NA	87.91	090
61580		A	Craniofacial approach, skull	30.35	NA	19.15	2.75	NA	52.25	090
61581		A	Craniofacial approach, skull	34.60	NA	15.39	3.37	NA	53.36	090
61582		A	Craniofacial approach, skull	31.66	NA	19.26	6.30	NA	57.22	090
61583		A	Craniofacial approach, skull	36.21	NA	22.62	6.94	NA	65.77	090
61584		A	Orbitocranial approach/skull	34.65	NA	20.92	6.53	NA	62.10	090
61585		A	Orbitocranial approach/skull	38.61	NA	22.58	6.19	NA	67.38	090
61586		A	Resect nasopharynx, skull	25.10	NA	16.22	3.52	NA	44.84	090
61590		A	Infratemporal approach/skull	41.78	NA	25.53	4.28	NA	71.59	090
61591		A	Infratemporal approach/skull	43.68	NA	26.34	5.26	NA	75.28	090
61592		A	Orbitocranial approach/skull	39.64	NA	23.61	7.55	NA	70.80	090
61595		A	Transtemporal approach/skull	29.57	NA	19.32	3.05	NA	51.94	090
61596		A	Transcochlear approach/skull	35.63	NA	22.01	4.25	NA	61.89	090
61597		A	Transcondylar approach/skull	37.96	NA	21.20	6.65	NA	65.81	090
61598		A	Transpetrosal approach/skull	33.41	NA	20.65	4.60	NA	58.66	090
61600		A	Resect/excise cranial lesion	25.85	NA	15.96	3.12	NA	44.93	090
61601		A	Resect/excise cranial lesion	27.89	NA	17.32	5.29	NA	50.50	090
61605		A	Resect/excise cranial lesion	29.33	NA	18.50	2.51	NA	50.34	090
61606		A	Resect/excise cranial lesion	38.83	NA	23.37	6.81	NA	69.01	090
61607		A	Resect/excise cranial lesion	36.27	NA	22.05	5.69	NA	64.01	090
61608		A	Resect/excise cranial lesion	42.10	NA	24.77	8.31	NA	75.18	090
61609		A	Transect artery, sinus	9.89	NA	4.91	2.07	NA	16.87	ZZZ
61610		A	Transect artery, sinus	29.67	NA	13.48	3.52	NA	46.67	ZZZ
61611		A	Transect artery, sinus	7.42	NA	3.40	1.55	NA	12.37	ZZZ
61612		A	Transect artery, sinus	27.88	NA	13.67	3.55	NA	45.10	ZZZ
61613		A	Remove aneurysm, sinus	40.86	NA	23.95	8.32	NA	73.13	090
61615		A	Resect/excise lesion, skull	32.07	NA	20.58	4.64	NA	57.29	090
61616		A	Resect/excise lesion, skull	43.33	NA	26.87	7.02	NA	77.22	090
61618		A	Repair dura	16.99	NA	11.45	2.92	NA	31.36	090
61619		A	Repair dura	20.71	NA	13.38	3.42	NA	37.51	090
61623		A	Endovasc tempory vessel occl	9.96	NA	4.23	0.50	NA	14.69	000
61624		A	Transcath occlusion, cns	20.15	NA	7.13	1.15	NA	28.43	000
61626		A	Transcath occlusion, non-cns	16.62	NA	5.70	0.84	NA	23.16	000
61680		A	Intracranial vessel surgery	30.71	NA	18.44	6.04	NA	55.19	090
61682		A	Intracranial vessel surgery	61.57	NA	34.01	12.69	NA	108.27	090
61684		A	Intracranial vessel surgery	39.81	NA	23.12	7.87	NA	70.80	090
61686		A	Intracranial vessel surgery	64.49	NA	36.02	13.20	NA	113.71	090
61690		A	Intracranial vessel surgery	29.31	NA	17.76	5.51	NA	52.58	090
61692		A	Intracranial vessel surgery	51.87	NA	28.84	10.17	NA	90.88	090
61697		A	Brain aneurysm repr, complx	50.52	NA	28.73	10.31	NA	89.56	090
61698		A	Brain aneurysm repr, complx	48.41	NA	27.36	9.99	NA	85.76	090
61700		A	Brain aneurysm repr, simple	50.52	NA	28.68	10.18	NA	89.38	090
61702		A	Inner skull vessel surgery	48.41	NA	27.66	9.75	NA	85.82	090
61703		A	Clamp neck artery	17.47	NA	11.24	3.62	NA	32.33	090
61705		A	Revise circulation to head	36.20	NA	20.05	6.67	NA	62.92	090
61708		A	Revise circulation to head	35.30	NA	15.87	2.18	NA	53.35	090
61710		A	Revise circulation to head	29.67	NA	14.53	2.42	NA	46.62	090
61711		A	Fusion of skull arteries	36.33	NA	20.63	7.39	NA	64.35	090
61720		A	Incise skull/brain surgery	16.77	NA	10.74	3.51	NA	31.02	090
61735		A	Incise skull/brain surgery	20.43	NA	12.76	4.16	NA	37.35	090
61750		A	Incise skull/brain biopsy	18.20	NA	10.96	3.71	NA	32.87	090
61751		A	Brain biopsy w/ct/mr guide	17.62	NA	10.77	3.57	NA	31.96	090
61760		A	Implant brain electrodes	22.27	NA	8.83	4.59	NA	35.69	090
61770		A	Incise skull for treatment	21.44	NA	13.05	4.09	NA	38.58	090
61790		A	Treat trigeminal nerve	10.86	NA	6.02	1.82	NA	18.70	090
61791		A	Treat trigeminal tract	14.61	NA	9.26	3.03	NA	26.90	090
61793		A	Focus radiation beam	17.24	NA	10.93	3.51	NA	31.68	090
61795		A	Brain surgery using computer	4.04	NA	2.09	0.81	NA	6.94	ZZZ
61850		A	Implant neuroelectrodes	12.39	NA	8.08	2.23	NA	22.70	090
61860		A	Implant neuroelectrodes	20.87	NA	12.88	4.04	NA	37.79	090
61862		A	Implant neurostimul, subcort	19.34	NA	12.08	3.97	NA	35.39	090
61870		A	Implant neuroelectrodes	14.94	NA	10.85	1.70	NA	27.49	090
61875		A	Implant neuroelectrodes	15.06	NA	9.28	2.42	NA	26.76	090
61880		A	Revise/remove neuroelectrode	6.29	NA	5.34	1.31	NA	12.94	090
61885		A	Implant neurostim one array	5.85	NA	5.09	1.22	NA	12.16	090
61886		A	Implant neurostim arrays	8.00	NA	6.15	1.64	NA	15.79	090
61888		A	Revise/remove neuroreceiver	5.07	NA	3.90	1.04	NA	10.01	010
62000		A	Treat skull fracture	12.53	NA	5.65	0.87	NA	19.05	090
62005		A	Treat skull fracture	16.17	NA	9.46	2.33	NA	27.96	090
62010		A	Treatment of head injury	19.81	NA	12.28	4.05	NA	36.14	090
62100		A	Repair brain fluid leakage	22.03	NA	13.85	4.07	NA	39.95	090
62115		A	Reduction of skull defect	21.66	NA	11.69	4.53	NA	37.88	090
62116		A	Reduction of skull defect	23.59	NA	13.79	4.85	NA	42.23	090
62117		A	Reduction of skull defect	26.60	NA	15.87	5.56	NA	48.03	090
62120		A	Repair skull cavity lesion	23.35	NA	14.38	3.07	NA	40.80	090
62121		A	Incise skull repair	21.58	NA	13.55	2.47	NA	37.60	090
62140		A	Repair of skull defect	13.51	NA	8.61	2.60	NA	24.72	090
62141		A	Repair of skull defect	14.91	NA	9.78	2.85	NA	27.54	090
62142		A	Remove skull plate/flap	10.79	NA	7.24	2.10	NA	20.13	090
62143		A	Replace skull plate/flap	13.05	NA	8.75	2.55	NA	24.35	090
62145		A	Repair of skull & brain	18.82	NA	11.69	3.81	NA	34.32	090
62146		A	Repair of skull with graft	16.12	NA	10.40	2.94	NA	29.46	090
62147		A	Repair of skull with graft	19.34	NA	12.14	3.64	NA	35.12	090
62148		A	Retr bone flap to fix skull	2.00	NA	0.82	0.43	NA	3.25	ZZZ
62160		A	Neuroendoscopy add-on	3.00	NA	1.16	0.52	NA	4.68	ZZZ
62161		A	Dissect brain w/scope	20.00	NA	9.71	3.70	NA	33.41	090
62162		A	Remove colloid cyst w/scope	25.25	NA	11.89	5.77	NA	42.91	090
62163		A	Neuroendoscopy w/fb removal	15.50	NA	7.97	3.70	NA	27.17	090
62164		A	Remove brain tumor w/scope	27.50	NA	13.12	5.77	NA	46.39	090
62165		A	Remove pituit tumor w/scope	22.00	NA	10.68	3.63	NA	36.31	090
62180		A	Establish brain cavity shunt	21.06	NA	12.90	4.32	NA	38.28	090
62190		A	Establish brain cavity shunt	11.07	NA	7.73	2.18	NA	20.98	090
62192		A	Establish brain cavity shunt	12.25	NA	8.27	2.46	NA	22.98	090
62194		A	Replace/irrigate catheter	5.03	NA	2.77	0.50	NA	8.30	010
62200		A	Establish brain cavity shunt	18.32	NA	11.59	3.70	NA	33.61	090
62201		A	Brain cavity shunt w/scope	14.86	NA	9.77	2.52	NA	27.15	090
62220		A	Establish brain cavity shunt	13.00	NA	8.65	2.53	NA	24.18	090
62223		A	Establish brain cavity shunt	12.87	NA	8.51	2.58	NA	23.96	090
62225		A	Replace/irrigate catheter	5.41	NA	4.81	1.09	NA	11.31	090
62230		A	Replace/revise brain shunt	10.54	NA	7.23	2.10	NA	19.87	090
62252		A	Csf shunt reprogram	0.74	1.47	NA	0.18	2.39	NA	XXX
62252	26	A	Csf shunt reprogram	0.74	0.38	0.38	0.16	1.28	1.28	XXX
62252	TC	A	Csf shunt reprogram	0.00	1.09	NA	0.02	1.11	NA	XXX
62256		A	Remove brain cavity shunt	6.60	NA	5.45	1.34	NA	13.39	090
62258		A	Replace brain cavity shunt	14.54	NA	9.34	2.91	NA	26.79	090
62263		A	Epidural lysis mult sessions	6.14	13.45	2.43	0.42	20.01	8.99	010
62264		A	Epidural lysis on single day	4.43	11.38	1.32	0.30	16.11	6.05	010
62268		A	Drain spinal cord cyst	4.74	NA	2.71	0.29	NA	7.74	000
62269		A	Needle biopsy, spinal cord	5.02	NA	2.37	0.29	NA	7.68	000
62270		A	Spinal fluid tap, diagnostic	1.13	3.78	0.50	0.06	4.97	1.69	000
62272		A	Drain cerebro spinal fluid	1.35	4.85	0.65	0.13	6.33	2.13	000
62273		A	Treat epidural spine lesion	2.15	2.79	0.58	0.14	5.08	2.87	000
62280		A	Treat spinal cord lesion	2.63	9.34	0.82	0.17	12.14	3.62	010
62281		A	Treat spinal cord lesion	2.66	7.92	0.72	0.16	10.74	3.54	010
62282		A	Treat spinal canal lesion	2.33	11.43	0.73	0.14	13.90	3.20	010
62284		A	Injection for myelogram	1.54	5.07	0.61	0.10	6.71	2.25	000
62287		A	Percutaneous diskectomy	8.08	NA	5.04	0.66	NA	13.78	090
62290		A	Inject for spine disk x-ray	3.00	8.54	1.29	0.20	11.74	4.49	000
62291		A	Inject for spine disk x-ray	2.91	7.28	1.15	0.17	10.36	4.23	000
62292		A	Injection into disk lesion	7.86	NA	5.04	0.65	NA	13.55	090
62294		A	Injection into spinal artery	11.83	NA	6.68	0.85	NA	19.36	090
62310		A	Inject spine c/t	1.91	4.91	0.51	0.11	6.93	2.53	000
62311		A	Inject spine l/s (cd)	1.54	5.02	0.45	0.09	6.65	2.08	000
62318		A	Inject spine w/cath, c/t	2.04	5.53	0.52	0.12	7.69	2.68	000
62319		A	Inject spine w/cath l/s (cd)	1.87	4.90	0.48	0.11	6.88	2.46	000
62350		A	Implant spinal canal cath	6.87	NA	3.64	0.64	NA	11.15	090
62351		A	Implant spinal canal cath	10.00	NA	6.72	1.79	NA	18.51	090
62355		A	Remove spinal canal catheter	5.45	NA	2.82	0.47	NA	8.74	090
62360		A	Insert spine infusion device	2.62	NA	2.28	0.21	NA	5.11	090
62361		A	Implant spine infusion pump	5.42	NA	3.50	0.50	NA	9.42	090
62362		A	Implant spine infusion pump	7.04	NA	4.06	0.86	NA	11.96	090
62365		A	Remove spine infusion device	5.42	NA	4.09	0.58	NA	10.09	090
62367		C	Analyze spine infusion pump	0.00	0.00	0.00	0.00	0.00	0.00	XXX
62367	26	A	Analyze spine infusion pump	0.48	0.13	0.13	0.03	0.64	0.64	XXX
62367	TC	C	Analyze spine infusion pump	0.00	0.00	0.00	0.00	0.00	0.00	XXX
62368		C	Analyze spine infusion pump	0.00	0.00	0.00	0.00	0.00	0.00	XXX
62368	26	A	Analyze spine infusion pump	0.75	0.19	0.19	0.05	0.99	0.99	XXX
62368	TC	C	Analyze spine infusion pump	0.00	0.00	0.00	0.00	0.00	0.00	XXX
63001		A	Removal of spinal lamina	15.82	NA	9.93	3.03	NA	28.78	090
63003		A	Removal of spinal lamina	15.95	NA	10.28	2.98	NA	29.21	090
63005		A	Removal of spinal lamina	14.92	NA	10.31	2.62	NA	27.85	090
63011		A	Removal of spinal lamina	14.52	NA	8.60	1.43	NA	24.55	090
63012		A	Removal of spinal lamina	15.40	NA	10.45	2.71	NA	28.56	090
63015		A	Removal of spinal lamina	19.35	NA	12.36	3.84	NA	35.55	090
63016		A	Removal of spinal lamina	19.20	NA	12.22	3.62	NA	35.04	090
63017		A	Removal of spinal lamina	15.94	NA	10.77	2.91	NA	29.62	090
63020		A	Neck spine disk surgery	14.81	NA	10.08	2.89	NA	27.78	090
63030		A	Low back disk surgery	12.00	NA	8.75	2.21	NA	22.96	090
63035		A	Spinal disk surgery add-on	3.15	NA	1.63	0.57	NA	5.35	ZZZ
63040		A	Laminotomy, single cervical	18.81	NA	11.91	3.36	NA	34.08	090
63042		A	Laminotomy, single lumbar	17.47	NA	11.71	3.11	NA	32.29	090
63043		C	Laminotomy, addl cervical	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
63044		C	Laminotomy, addl lumbar	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
63045		A	Removal of spinal lamina	16.50	NA	10.76	3.19	NA	30.45	090
63046		A	Removal of spinal lamina	15.80	NA	10.54	2.89	NA	29.23	090
63047		A	Removal of spinal lamina	14.61	NA	10.23	2.61	NA	27.45	090
63048		A	Remove spinal lamina add-on	3.26	NA	1.71	0.58	NA	5.55	ZZZ
63055		A	Decompress spinal cord	21.99	NA	13.60	4.09	NA	39.68	090
63056		A	Decompress spinal cord	20.36	NA	12.98	3.34	NA	36.68	090
63057		A	Decompress spine cord add-on	5.26	NA	2.71	0.81	NA	8.78	ZZZ
63064		A	Decompress spinal cord	24.61	NA	14.93	4.72	NA	44.26	090
63066		A	Decompress spine cord add-on	3.26	NA	1.71	0.63	NA	5.60	ZZZ
63075		A	Neck spine disk surgery	19.41	NA	12.53	3.73	NA	35.67	090
63076		A	Neck spine disk surgery	4.05	NA	2.11	0.78	NA	6.94	ZZZ
63077		A	Spine disk surgery, thorax	21.44	NA	13.08	3.44	NA	37.96	090
63078		A	Spine disk surgery, thorax	3.28	NA	1.67	0.50	NA	5.45	ZZZ
63081		A	Removal of vertebral body	23.73	NA	14.80	4.46	NA	42.99	090
63082		A	Remove vertebral body add-on	4.37	NA	2.29	0.82	NA	7.48	ZZZ
63085		A	Removal of vertebral body	26.92	NA	15.83	4.70	NA	47.45	090
63086		A	Remove vertebral body add-on	3.19	NA	1.63	0.55	NA	5.37	ZZZ
63087		A	Removal of vertebral body	35.57	NA	19.93	5.87	NA	61.37	090
63088		A	Remove vertebral body add-on	4.33	NA	2.23	0.77	NA	7.33	ZZZ
63090		A	Removal of vertebral body	28.16	NA	16.40	4.27	NA	48.83	090
63091		A	Remove vertebral body add-on	3.03	NA	1.49	0.45	NA	4.97	ZZZ
63170		A	Incise spinal cord tract(s)	19.83	NA	13.69	3.89	NA	37.41	090
63172		A	Drainage of spinal cyst	17.66	NA	13.21	3.46	NA	34.33	090
63173		A	Drainage of spinal cyst	21.99	NA	15.22	4.14	NA	41.35	090
63180		A	Revise spinal cord ligaments	18.27	NA	13.27	3.83	NA	35.37	090
63182		A	Revise spinal cord ligaments	20.50	NA	12.93	3.48	NA	36.91	090
63185		A	Incise spinal column/nerves	15.04	NA	9.82	2.08	NA	26.94	090
63190		A	Incise spinal column/nerves	17.45	NA	11.92	2.88	NA	32.25	090
63191		A	Incise spinal column/nerves	17.54	NA	12.31	3.50	NA	33.35	090
63194		A	Incise spinal column & cord	19.19	NA	13.35	4.01	NA	36.55	090
63195		A	Incise spinal column & cord	18.84	NA	12.97	3.44	NA	35.25	090
63196		A	Incise spinal column & cord	22.30	NA	13.65	4.66	NA	40.61	090
63197		A	Incise spinal column & cord	21.11	NA	13.85	4.42	NA	39.38	090
63198		A	Incise spinal column & cord	25.38	NA	10.80	5.31	NA	41.49	090
63199		A	Incise spinal column & cord	26.89	NA	16.29	5.62	NA	48.80	090
63200		A	Release of spinal cord	19.18	NA	13.10	3.61	NA	35.89	090
63250		A	Revise spinal cord vessels	40.76	NA	20.69	7.65	NA	69.10	090
63251		A	Revise spinal cord vessels	41.20	NA	23.26	7.98	NA	72.44	090
63252		A	Revise spinal cord vessels	41.19	NA	22.90	7.75	NA	71.84	090
63265		A	Excise intraspinal lesion	21.56	NA	13.30	4.29	NA	39.15	090
63266		A	Excise intraspinal lesion	22.30	NA	13.73	4.47	NA	40.50	090
63267		A	Excise intraspinal lesion	17.95	NA	11.53	3.50	NA	32.98	090
63268		A	Excise intraspinal lesion	18.52	NA	10.86	3.18	NA	32.56	090
63270		A	Excise intraspinal lesion	26.80	NA	16.10	5.41	NA	48.31	090
63271		A	Excise intraspinal lesion	26.92	NA	16.20	5.56	NA	48.68	090
63272		A	Excise intraspinal lesion	25.32	NA	15.27	5.07	NA	45.66	090
63273		A	Excise intraspinal lesion	24.29	NA	14.89	5.08	NA	44.26	090
63275		A	Biopsy/excise spinal tumor	23.68	NA	14.35	4.68	NA	42.71	090
63276		A	Biopsy/excise spinal tumor	23.45	NA	14.23	4.63	NA	42.31	090
63277		A	Biopsy/excise spinal tumor	20.83	NA	13.01	4.03	NA	37.87	090
63278		A	Biopsy/excise spinal tumor	20.56	NA	12.84	4.02	NA	37.42	090
63280		A	Biopsy/excise spinal tumor	28.35	NA	16.80	5.80	NA	50.95	090
63281		A	Biopsy/excise spinal tumor	28.05	NA	16.64	5.67	NA	50.36	090
63282		A	Biopsy/excise spinal tumor	26.39	NA	15.77	5.33	NA	47.49	090
63283		A	Biopsy/excise spinal tumor	25.00	NA	15.09	5.12	NA	45.21	090
63285		A	Biopsy/excise spinal tumor	36.00	NA	20.53	7.31	NA	63.84	090
63286		A	Biopsy/excise spinal tumor	35.63	NA	20.47	7.07	NA	63.17	090
63287		A	Biopsy/excise spinal tumor	36.70	NA	21.04	7.48	NA	65.22	090
63290		A	Biopsy/excise spinal tumor	37.38	NA	21.18	7.65	NA	66.21	090
63300		A	Removal of vertebral body	24.43	NA	14.84	4.78	NA	44.05	090
63301		A	Removal of vertebral body	27.60	NA	15.84	5.03	NA	48.47	090
63302		A	Removal of vertebral body	27.81	NA	16.16	5.25	NA	49.22	090
63303		A	Removal of vertebral body	30.50	NA	17.39	5.21	NA	53.10	090
63304		A	Removal of vertebral body	30.33	NA	17.77	4.72	NA	52.82	090
63305		A	Removal of vertebral body	32.03	NA	18.30	5.39	NA	55.72	090
63306		A	Removal of vertebral body	32.22	NA	18.04	2.39	NA	52.65	090
63307		A	Removal of vertebral body	31.63	NA	17.33	4.23	NA	53.19	090
63308		A	Remove vertebral body add-on	5.25	NA	2.67	1.01	NA	8.93	ZZZ
63600		A	Remove spinal cord lesion	14.02	NA	6.03	1.22	NA	21.27	090
63610		A	Stimulation of spinal cord	8.73	NA	3.79	0.43	NA	12.95	000
63615		A	Remove lesion of spinal cord	16.28	NA	9.99	2.85	NA	29.12	090
63650		A	Implant neuroelectrodes	6.74	NA	2.96	0.48	NA	10.18	090
63655		A	Implant neuroelectrodes	10.29	NA	7.23	1.85	NA	19.37	090
63660		A	Revise/remove neuroelectrode	6.16	NA	3.74	0.65	NA	10.55	090
63685		A	Implant neuroreceiver	7.04	NA	4.28	0.96	NA	12.28	090
63688		A	Revise/remove neuroreceiver	5.39	NA	3.68	0.70	NA	9.77	090
63700		A	Repair of spinal herniation	16.53	NA	10.45	2.69	NA	29.67	090
63702		A	Repair of spinal herniation	18.48	NA	10.71	1.36	NA	30.55	090
63704		A	Repair of spinal herniation	21.18	NA	12.61	3.84	NA	37.63	090
63706		A	Repair of spinal herniation	24.11	NA	13.52	4.73	NA	42.36	090
63707		A	Repair spinal fluid leakage	11.26	NA	8.01	1.96	NA	21.23	090
63709		A	Repair spinal fluid leakage	14.32	NA	9.70	2.49	NA	26.51	090
63710		A	Graft repair of spine defect	14.07	NA	9.43	2.61	NA	26.11	090
63740		A	Install spinal shunt	11.36	NA	7.76	2.15	NA	21.27	090
63741		A	Install spinal shunt	8.25	NA	4.86	1.05	NA	14.16	090
63744		A	Revision of spinal shunt	8.10	NA	5.58	1.51	NA	15.19	090
63746		A	Removal of spinal shunt	6.43	NA	4.04	1.15	NA	11.62	090
64400		A	N block inj, trigeminal	1.11	1.96	0.36	0.06	3.13	1.53	000
64402		A	N block inj, facial	1.25	1.57	0.54	0.07	2.89	1.86	000
64405		A	N block inj, occipital	1.32	1.70	0.40	0.08	3.10	1.80	000
64408		A	N block inj, vagus	1.41	2.60	0.67	0.09	4.10	2.17	000
64410		A	N block inj, phrenic	1.43	2.48	0.40	0.08	3.99	1.91	000
64412		A	N block inj, spinal accessor	1.18	2.62	0.37	0.08	3.88	1.63	000
64413		A	N block inj, cervical plexus	1.40	1.99	0.44	0.09	3.48	1.93	000
64415		A	N block inj, brachial plexus	1.48	3.05	0.39	0.08	4.61	1.95	000
64416		A	N block cont infuse, b plex	3.50	NA	0.75	0.08	NA	4.33	010
64417		A	N block inj, axillary	1.44	3.25	0.43	0.09	4.78	1.96	000
64418		A	N block inj, suprascapular	1.32	2.67	0.37	0.07	4.06	1.76	000
64420		A	N block inj, intercost, sng	1.18	3.56	0.35	0.07	4.81	1.60	000
64421		A	N block inj, intercost, mlt	1.68	5.30	0.46	0.10	7.08	2.24	000
64425		A	N block inj ilio-ing/hypogi	1.75	1.60	0.48	0.11	3.46	2.34	000
64430		A	N block inj, pudendal	1.46	2.09	0.50	0.11	3.66	2.07	000
64435		A	N block inj, paracervical	1.45	2.24	0.65	0.15	3.84	2.25	000
64445		A	N block inj, sciatic, sng	1.48	2.78	0.38	0.08	4.34	1.94	000
64446		A	N blk inj, sciatic, cont inf	3.25	NA	1.15	0.08	NA	4.48	010
64447		A	N block inj fem, single	1.50	NA	0.52	0.08	NA	2.10	000
64448		A	N block inj fem, cont inf	3.00	NA	1.04	0.08	NA	4.12	010
64450		A	N block, other peripheral	1.27	1.30	0.42	0.08	2.65	1.77	000
64470		A	Inj paravertebral c/t	1.85	4.99	0.57	0.12	6.96	2.54	000
64472		A	Inj paravertebral c/t add-on	1.29	1.99	0.32	0.09	3.37	1.70	ZZZ
64475		A	Inj paravertebral l/s	1.41	4.65	0.48	0.09	6.15	1.98	000
64476		A	Inj paravertebral l/s add-on	0.98	1.86	0.25	0.06	2.90	1.29	ZZZ
64479		A	Inj foramen epidural c/t	2.20	7.32	0.73	0.14	9.66	3.07	000
64480		A	Inj foramen epidural add-on	1.54	2.36	0.48	0.09	3.99	2.11	ZZZ
64483		A	Inj foramen epidural l/s	1.90	7.75	0.67	0.12	9.77	2.69	000
64484		A	Inj foramen epidural add-on	1.33	2.70	0.38	0.08	4.11	1.79	ZZZ
64505		A	N block, spenopalatine gangl	1.36	1.89	0.49	0.08	3.33	1.93	000
64508		A	N block, carotid sinus s/p	1.12	4.79	0.52	0.06	5.97	1.70	000
64510		A	N block, stellate ganglion	1.22	3.19	0.38	0.07	4.48	1.67	000
64520		A	N block, lumbar/thoracic	1.35	4.54	0.42	0.08	5.97	1.85	000
64530		A	N block inj, celiac pelus	1.58	5.83	0.48	0.09	7.50	2.15	000
64550		A	Apply neurostimulator	0.18	0.56	0.05	0.01	0.75	0.24	000
64553		A	Implant neuroelectrodes	2.31	1.89	1.27	0.17	4.37	3.75	010
64555		A	Implant neuroelectrodes	2.27	2.47	0.64	0.11	4.85	3.02	010
64560		A	Implant neuroelectrodes	2.36	2.43	0.71	0.17	4.96	3.24	010
64561		A	Implant neuroelectrodes	6.74	15.24	3.78	0.11	22.09	10.63	010
64565		A	Implant neuroelectrodes	1.76	3.26	0.66	0.08	5.10	2.50	010
64573		A	Implant neuroelectrodes	7.50	NA	5.40	1.48	NA	14.38	090
64575		A	Implant neuroelectrodes	4.35	NA	3.01	0.37	NA	7.73	090
64577		A	Implant neuroelectrodes	4.62	NA	3.63	0.50	NA	8.75	090
64580		A	Implant neuroelectrodes	4.12	NA	4.01	0.21	NA	8.34	090
64581		A	Implant neuroelectrodes	13.50	NA	6.61	0.37	NA	20.48	090
64585		A	Revise/remove neuroelectrode	2.06	3.38	2.09	0.29	5.73	4.44	010
64590		A	Implant neuroreceiver	2.40	NA	2.24	0.40	NA	5.04	010
64595		A	Revise/remove neuroreceiver	1.73	NA	1.91	0.22	NA	3.86	010
64600		A	Injection treatment of nerve	3.45	9.19	1.50	0.28	12.92	5.23	010
64605		A	Injection treatment of nerve	5.61	10.60	2.01	0.53	16.74	8.15	010
64610		A	Injection treatment of nerve	7.16	NA	3.58	1.12	NA	11.86	010
64612		A	Destroy nerve, face muscle	1.96	2.29	1.03	0.09	4.34	3.08	010
64613		A	Destroy nerve, spine muscle	1.96	2.96	0.96	0.10	5.02	3.02	010
64614		A	Destroy nerve, extrem musc	2.20	4.40	1.04	0.09	6.69	3.33	010
64620		A	Injection treatment of nerve	2.84	6.13	1.10	0.17	9.14	4.11	010
64622		A	Destr paravertebrl nerve l/s	3.00	8.53	1.17	0.17	11.70	4.34	010
64623		A	Destr paravertebral n add-on	0.99	2.49	0.23	0.06	3.54	1.28	ZZZ
64626		A	Destr paravertebrl nerve c/t	3.28	8.46	1.84	0.22	11.96	5.34	010
64627		A	Destr paravertebral n add-on	1.16	2.70	0.27	0.08	3.94	1.51	ZZZ
64630		A	Injection treatment of nerve	3.00	4.46	1.22	0.16	7.62	4.38	010
64640		A	Injection treatment of nerve	2.76	6.72	1.70	0.11	9.59	4.57	010
64680		A	Injection treatment of nerve	2.62	7.28	1.21	0.15	10.05	3.98	010
64702		A	Revise finger/toe nerve	4.23	NA	3.99	0.51	NA	8.73	090
64704		A	Revise hand/foot nerve	4.57	NA	3.22	0.59	NA	8.38	090
64708		A	Revise arm/leg nerve	6.12	NA	5.12	0.82	NA	12.06	090
64712		A	Revision of sciatic nerve	7.75	NA	5.27	0.54	NA	13.56	090
64713		A	Revision of arm nerve(s)	11.00	NA	5.80	1.01	NA	17.81	090
64714		A	Revise low back nerve(s)	10.33	NA	4.22	0.64	NA	15.19	090
64716		A	Revision of cranial nerve	6.31	NA	4.97	0.59	NA	11.87	090
64718		A	Revise ulnar nerve at elbow	5.99	NA	5.30	0.87	NA	12.16	090
64719		A	Revise ulnar nerve at wrist	4.85	NA	4.77	0.63	NA	10.25	090
64721		A	Carpal tunnel surgery	4.29	5.97	5.64	0.59	10.85	10.52	090
64722		A	Relieve pressure on nerve(s)	4.70	NA	3.33	0.32	NA	8.35	090
64726		A	Release foot/toe nerve	4.18	NA	3.09	0.57	NA	7.84	090
64727		A	Internal nerve revision	3.10	NA	1.54	0.40	NA	5.04	ZZZ
64732		A	Incision of brow nerve	4.41	NA	3.64	0.77	NA	8.82	090
64734		A	Incision of cheek nerve	4.92	NA	3.65	0.83	NA	9.40	090
64736		A	Incision of chin nerve	4.60	NA	2.95	0.71	NA	8.26	090
64738		A	Incision of jaw nerve	5.73	NA	3.65	0.84	NA	10.22	090
64740		A	Incision of tongue nerve	5.59	NA	3.82	0.43	NA	9.84	090
64742		A	Incision of facial nerve	6.22	NA	4.71	0.69	NA	11.62	090
64744		A	Incise nerve, back of head	5.24	NA	4.00	0.98	NA	10.22	090
64746		A	Incise diaphragm nerve	5.93	NA	4.49	0.75	NA	11.17	090
64752		A	Incision of vagus nerve	7.06	NA	4.70	0.83	NA	12.59	090
64755		A	Incision of stomach nerves	13.52	NA	6.17	1.16	NA	20.85	090
64760		A	Incision of vagus nerve	6.96	NA	4.02	0.51	NA	11.49	090
64761		A	Incision of pelvis nerve	6.41	NA	3.63	0.26	NA	10.30	090
64763		A	Incise hip/thigh nerve	6.93	NA	6.07	0.77	NA	13.77	090
64766		A	Incise hip/thigh nerve	8.67	NA	5.68	0.99	NA	15.34	090
64771		A	Sever cranial nerve	7.35	NA	5.62	1.32	NA	14.29	090
64772		A	Incision of spinal nerve	7.21	NA	4.89	1.20	NA	13.30	090
64774		A	Remove skin nerve lesion	5.17	NA	3.78	0.60	NA	9.55	090
64776		A	Remove digit nerve lesion	5.12	NA	3.84	0.63	NA	9.59	090
64778		A	Digit nerve surgery add-on	3.11	NA	1.54	0.38	NA	5.03	ZZZ
64782		A	Remove limb nerve lesion	6.23	NA	3.72	0.79	NA	10.74	090
64783		A	Limb nerve surgery add-on	3.72	NA	1.89	0.48	NA	6.09	ZZZ
64784		A	Remove nerve lesion	9.82	NA	6.68	1.17	NA	17.67	090
64786		A	Remove sciatic nerve lesion	15.46	NA	10.13	2.22	NA	27.81	090
64787		A	Implant nerve end	4.30	NA	2.18	0.56	NA	7.04	ZZZ
64788		A	Remove skin nerve lesion	4.61	NA	3.48	0.54	NA	8.63	090
64790		A	Removal of nerve lesion	11.31	NA	7.29	1.68	NA	20.28	090
64792		A	Removal of nerve lesion	14.92	NA	8.85	1.88	NA	25.65	090
64795		A	Biopsy of nerve	3.01	NA	1.80	0.40	NA	5.21	000
64802		A	Remove sympathetic nerves	9.15	NA	5.43	0.87	NA	15.45	090
64804		A	Remove sympathetic nerves	14.64	NA	7.42	1.79	NA	23.85	090
64809		A	Remove sympathetic nerves	13.67	NA	6.31	0.96	NA	20.94	090
64818		A	Remove sympathetic nerves	10.30	NA	5.77	1.08	NA	17.15	090
64820		A	Remove sympathetic nerves	10.37	NA	7.44	1.17	NA	18.98	090
64821		A	Remove sympathestic nerves	8.75	NA	9.23	0.99	NA	18.97	090
64822		A	Remove sympathetic nerves	8.75	NA	9.23	0.99	NA	18.97	090
64823		A	Remove sympathetic nerves	10.37	NA	10.03	1.17	NA	21.57	090
64831		A	Repair of digit nerve	9.44	NA	7.24	1.14	NA	17.82	090
64832		A	Repair nerve add-on	5.66	NA	3.02	0.68	NA	9.36	ZZZ
64834		A	Repair of hand or foot nerve	10.19	NA	7.18	1.23	NA	18.60	090
64835		A	Repair of hand or foot nerve	10.94	NA	7.86	1.36	NA	20.16	090
64836		A	Repair of hand or foot nerve	10.94	NA	7.83	1.32	NA	20.09	090
64837		A	Repair nerve add-on	6.26	NA	3.31	0.80	NA	10.37	ZZZ
64840		A	Repair of leg nerve	13.02	NA	8.34	0.86	NA	22.22	090
64856		A	Repair/transpose nerve	13.80	NA	9.40	1.71	NA	24.91	090
64857		A	Repair arm/leg nerve	14.49	NA	9.87	1.76	NA	26.12	090
64858		A	Repair sciatic nerve	16.49	NA	10.82	2.78	NA	30.09	090
64859		A	Nerve surgery	4.26	NA	2.25	0.50	NA	7.01	ZZZ
64861		A	Repair of arm nerves	19.24	NA	12.64	2.45	NA	34.33	090
64862		A	Repair of low back nerves	19.44	NA	12.26	2.47	NA	34.17	090
64864		A	Repair of facial nerve	12.55	NA	8.52	1.13	NA	22.20	090
64865		A	Repair of facial nerve	15.24	NA	10.09	1.37	NA	26.70	090
64866		A	Fusion of facial/other nerve	15.74	NA	9.99	1.06	NA	26.79	090
64868		A	Fusion of facial/other nerve	14.04	NA	9.32	1.40	NA	24.76	090
64870		A	Fusion of facial/other nerve	15.99	NA	9.09	1.08	NA	26.16	090
64872		A	Subsequent repair of nerve	1.99	NA	1.08	0.24	NA	3.31	ZZZ
64874		A	Repair & revise nerve add-on	2.98	NA	1.54	0.34	NA	4.86	ZZZ
64876		A	Repair nerve/shorten bone	3.38	NA	1.31	0.39	NA	5.08	ZZZ
64885		A	Nerve graft, head or neck	17.53	NA	11.16	1.51	NA	30.20	090
64886		A	Nerve graft, head or neck	20.75	NA	13.07	1.73	NA	35.55	090
64890		A	Nerve graft, hand or foot	15.15	NA	10.25	1.74	NA	27.14	090
64891		A	Nerve graft, hand or foot	16.14	NA	7.75	1.38	NA	25.27	090
64892		A	Nerve graft, arm or leg	14.65	NA	9.10	1.65	NA	25.40	090
64893		A	Nerve graft, arm or leg	15.60	NA	10.05	1.77	NA	27.42	090
64895		A	Nerve graft, hand or foot	19.25	NA	9.82	2.04	NA	31.11	090
64896		A	Nerve graft, hand or foot	20.49	NA	11.11	1.85	NA	33.45	090
64897		A	Nerve graft, arm or leg	18.24	NA	10.91	2.64	NA	31.79	090
64898		A	Nerve graft, arm or leg	19.50	NA	11.88	2.71	NA	34.09	090
64901		A	Nerve graft add-on	10.22	NA	5.41	0.99	NA	16.62	ZZZ
64902		A	Nerve graft add-on	11.83	NA	6.13	1.10	NA	19.06	ZZZ
64905		A	Nerve pedicle transfer	14.02	NA	8.94	1.52	NA	24.48	090
64907		A	Nerve pedicle transfer	18.83	NA	12.38	1.79	NA	33.00	090
64999		C	Nervous system surgery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
65091		A	Revise eye	6.46	NA	11.28	0.26	NA	18.00	090
65093		A	Revise eye with implant	6.87	NA	11.50	0.28	NA	18.65	090
65101		A	Removal of eye	7.03	NA	11.59	0.28	NA	18.90	090
65103		A	Remove eye/insert implant	7.57	NA	11.74	0.30	NA	19.61	090
65105		A	Remove eye/attach implant	8.49	NA	12.24	0.34	NA	21.07	090
65110		A	Removal of eye	13.95	NA	15.29	0.68	NA	29.92	090
65112		A	Remove eye/revise socket	16.38	NA	17.54	0.96	NA	34.88	090
65114		A	Remove eye/revise socket	17.53	NA	17.50	0.94	NA	35.97	090
65125		A	Revise ocular implant	3.12	5.96	1.45	0.15	9.23	4.72	090
65130		A	Insert ocular implant	7.15	NA	11.22	0.28	NA	18.65	090
65135		A	Insert ocular implant	7.33	NA	11.43	0.29	NA	19.05	090
65140		A	Attach ocular implant	8.02	NA	11.71	0.31	NA	20.04	090
65150		A	Revise ocular implant	6.26	NA	10.75	0.25	NA	17.26	090
65155		A	Reinsert ocular implant	8.66	NA	12.54	0.40	NA	21.60	090
65175		A	Removal of ocular implant	6.28	NA	10.82	0.26	NA	17.36	090
65205		A	Remove foreign body from eye	0.71	0.62	0.19	0.03	1.36	0.93	000
65210		A	Remove foreign body from eye	0.84	0.77	0.30	0.03	1.64	1.17	000
65220		A	Remove foreign body from eye	0.71	8.06	0.18	0.05	8.82	0.94	000
65222		A	Remove foreign body from eye	0.93	0.78	0.28	0.04	1.75	1.25	000
65235		A	Remove foreign body from eye	7.57	NA	6.84	0.30	NA	14.71	090
65260		A	Remove foreign body from eye	10.96	NA	12.38	0.43	NA	23.77	090
65265		A	Remove foreign body from eye	12.59	NA	13.88	0.50	NA	26.97	090
65270		A	Repair of eye wound	1.90	3.97	2.31	0.08	5.95	4.29	010
65272		A	Repair of eye wound	3.82	5.59	4.64	0.16	9.57	8.62	090
65273		A	Repair of eye wound	4.36	NA	4.98	0.17	NA	9.51	090
65275		A	Repair of eye wound	5.34	5.56	5.08	0.27	11.17	10.69	090
65280		A	Repair of eye wound	7.66	NA	7.64	0.30	NA	15.60	090
65285		A	Repair of eye wound	12.90	NA	13.46	0.51	NA	26.87	090
65286		A	Repair of eye wound	5.51	8.82	7.61	0.21	14.54	13.33	090
65290		A	Repair of eye socket wound	5.41	NA	6.27	0.26	NA	11.94	090
65400		A	Removal of eye lesion	6.06	8.38	6.91	0.24	14.68	13.21	090
65410		A	Biopsy of cornea	1.47	1.71	0.67	0.06	3.24	2.20	000
65420		A	Removal of eye lesion	4.17	8.08	6.97	0.17	12.42	11.31	090
65426		A	Removal of eye lesion	5.25	7.80	6.54	0.20	13.25	11.99	090
65430		A	Corneal smear	1.47	8.34	0.68	0.06	9.87	2.21	000
65435		A	Curette/treat cornea	0.92	1.33	0.40	0.04	2.29	1.36	000
65436		A	Curette/treat cornea	4.19	5.81	4.86	0.17	10.17	9.22	090
65450		A	Treatment of corneal lesion	3.27	7.76	6.57	0.13	11.16	9.97	090
65600		A	Revision of cornea	3.40	5.39	1.43	0.14	8.93	4.97	090
65710		A	Corneal transplant	12.35	NA	12.72	0.49	NA	25.56	090
65730		A	Corneal transplant	14.25	NA	11.77	0.56	NA	26.58	090
65750		A	Corneal transplant	15.00	NA	14.13	0.59	NA	29.72	090
65755		A	Corneal transplant	14.89	NA	14.04	0.58	NA	29.51	090
65760		N	Revision of cornea	0.00	0.00	0.00	0.00	0.00	0.00	XXX
65765		N	Revision of cornea	0.00	0.00	0.00	0.00	0.00	0.00	XXX
65767		N	Corneal tissue transplant	0.00	0.00	0.00	0.00	0.00	0.00	XXX
65770		A	Revise cornea with implant	17.56	NA	15.06	0.69	NA	33.31	090
65771		N	Radial keratotomy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
65772		A	Correction of astigmatism	4.29	7.24	6.24	0.17	11.70	10.70	090
65775		A	Correction of astigmatism	5.79	NA	8.38	0.22	NA	14.39	090
65800		A	Drainage of eye	1.91	2.26	1.40	0.08	4.25	3.39	000
65805		A	Drainage of eye	1.91	2.26	1.41	0.08	4.25	3.40	000
65810		A	Drainage of eye	4.87	NA	8.65	0.19	NA	13.71	090
65815		A	Drainage of eye	5.05	9.08	7.88	0.20	14.33	13.13	090
65820		A	Relieve inner eye pressure	8.13	NA	10.64	0.32	NA	19.09	090
65850		A	Incision of eye	10.52	NA	9.99	0.41	NA	20.92	090
65855		A	Laser surgery of eye	3.85	5.01	3.56	0.17	9.03	7.58	010
65860		A	Incise inner eye adhesions	3.55	4.01	3.07	0.14	7.70	6.76	090
65865		A	Incise inner eye adhesions	5.60	NA	6.69	0.22	NA	12.51	090
65870		A	Incise inner eye adhesions	6.27	NA	7.02	0.24	NA	13.53	090
65875		A	Incise inner eye adhesions	6.54	NA	7.12	0.25	NA	13.91	090
65880		A	Incise inner eye adhesions	7.09	NA	7.38	0.28	NA	14.75	090
65900		A	Remove eye lesion	10.93	NA	12.48	0.46	NA	23.87	090
65920		A	Remove implant of eye	8.40	NA	7.99	0.33	NA	16.72	090
65930		A	Remove blood clot from eye	7.44	NA	8.56	0.29	NA	16.29	090
66020		A	Injection treatment of eye	1.59	2.36	1.52	0.07	4.02	3.18	010
66030		A	Injection treatment of eye	1.25	2.20	1.35	0.05	3.50	2.65	010
66130		A	Remove eye lesion	7.69	7.39	6.48	0.31	15.39	14.48	090
66150		A	Glaucoma surgery	8.30	NA	10.61	0.33	NA	19.24	090
66155		A	Glaucoma surgery	8.29	NA	10.58	0.32	NA	19.19	090
66160		A	Glaucoma surgery	10.17	NA	11.44	0.41	NA	22.02	090
66165		A	Glaucoma surgery	8.01	NA	10.44	0.31	NA	18.76	090
66170		A	Glaucoma surgery	12.16	NA	16.52	0.48	NA	29.16	090
66172		A	Incision of eye	15.04	NA	15.12	0.59	NA	30.75	090
66180		A	Implant eye shunt	14.55	NA	12.04	0.57	NA	27.16	090
66185		A	Revise eye shunt	8.14	NA	8.23	0.32	NA	16.69	090
66220		A	Repair eye lesion	7.77	NA	9.93	0.32	NA	18.02	090
66225		A	Repair/graft eye lesion	11.05	NA	9.31	0.44	NA	20.80	090
66250		A	Follow-up surgery of eye	5.98	7.79	6.33	0.23	14.00	12.54	090
66500		A	Incision of iris	3.71	NA	4.65	0.15	NA	8.51	090
66505		A	Incision of iris	4.08	NA	4.80	0.17	NA	9.05	090
66600		A	Remove iris and lesion	8.68	NA	8.62	0.34	NA	17.64	090
66605		A	Removal of iris	12.79	NA	12.14	0.61	NA	25.54	090
66625		A	Removal of iris	5.13	7.62	6.59	0.20	12.95	11.92	090
66630		A	Removal of iris	6.16	NA	7.50	0.24	NA	13.90	090
66635		A	Removal of iris	6.25	NA	6.46	0.24	NA	12.95	090
66680		A	Repair iris & ciliary body	5.44	NA	6.06	0.21	NA	11.71	090
66682		A	Repair iris & ciliary body	6.21	NA	7.51	0.24	NA	13.96	090
66700		A	Destruction, ciliary body	4.78	5.44	4.27	0.19	10.41	9.24	090
66710		A	Destruction, ciliary body	4.78	5.14	3.81	0.18	10.11	8.76	090
66720		A	Destruction, ciliary body	4.78	5.45	4.49	0.19	10.42	9.34	090
66740		A	Destruction, ciliary body	4.78	NA	4.84	0.18	NA	10.76	090
66761		A	Revision of iris	4.07	5.25	3.98	0.16	10.48	9.18	090
66762		A	Revision of iris	4.58	5.33	3.97	0.18	9.99	9.70	090
66770		A	Removal of inner eye lesion	5.18	5.76	4.48	0.20	12.14	10.84	090
66820		A	Incision, secondary cataract	3.89	NA	8.19	0.16	NA	12.24	090
66821		A	After cataract laser surgery	2.35	3.78	3.34	0.10	6.23	5.79	090
66825		A	Reposition intraocular lens	8.23	NA	10.19	0.32	NA	18.74	090
66830		A	Removal of lens lesion	8.20	NA	6.83	0.32	NA	15.35	090
66840		A	Removal of lens material	7.91	NA	6.74	0.31	NA	14.96	090
66850		A	Removal of lens material	9.11	NA	7.26	0.36	NA	16.73	090
66852		A	Removal of lens material	9.97	NA	7.72	0.39	NA	18.08	090
66920		A	Extraction of lens	8.86	NA	7.19	0.35	NA	16.40	090
66930		A	Extraction of lens	10.18	NA	8.68	0.41	NA	19.27	090
66940		A	Extraction of lens	8.93	NA	8.12	0.35	NA	17.40	090
66982		A	Cataract surgery, complex	13.50	NA	9.09	0.56	NA	23.15	090
66983		A	Cataract surg w/iol, 1 stage	8.99	NA	5.88	0.37	NA	15.24	090
66984		A	Cataract surg w/iol, 1 stage	10.23	NA	7.59	0.41	NA	18.23	090
66985		A	Insert lens prosthesis	8.39	NA	6.82	0.33	NA	15.54	090
66986		A	Exchange lens prosthesis	12.28	NA	8.57	0.49	NA	21.34	090
66990		A	Ophthalmic endoscope add-on	1.51	NA	0.70	0.06	NA	2.27	ZZZ
66999		C	Eye surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
67005		A	Partial removal of eye fluid	5.70	NA	2.65	0.22	NA	8.57	090
67010		A	Partial removal of eye fluid	6.87	NA	3.20	0.27	NA	10.34	090
67015		A	Release of eye fluid	6.92	NA	8.12	0.27	NA	15.31	090
67025		A	Replace eye fluid	6.84	16.76	7.51	0.27	23.87	14.62	090
67027		A	Implant eye drug system	10.85	14.10	8.71	0.46	25.41	20.02	090
67028		A	Injection eye drug	2.52	10.43	1.16	0.11	13.06	3.79	000
67030		A	Incise inner eye strands	4.84	NA	6.72	0.19	NA	11.75	090
67031		A	Laser surgery, eye strands	3.67	4.08	3.13	0.15	7.90	6.95	090
67036		A	Removal of inner eye fluid	11.89	NA	8.99	0.47	NA	21.35	090
67038		A	Strip retinal membrane	21.24	NA	15.45	0.84	NA	37.53	090
67039		A	Laser treatment of retina	14.52	NA	12.33	0.57	NA	27.42	090
67040		A	Laser treatment of retina	17.23	NA	13.59	0.68	NA	31.50	090
67101		A	Repair detached retina	7.53	10.94	8.87	0.29	18.76	16.69	090
67105		A	Repair detached retina	7.41	7.56	5.54	0.29	15.26	13.24	090
67107		A	Repair detached retina	14.84	NA	13.18	0.58	NA	28.60	090
67108		A	Repair detached retina	20.82	NA	17.69	0.82	NA	39.33	090
67110		A	Repair detached retina	8.81	20.18	10.29	0.35	29.34	19.45	090
67112		A	Rerepair detached retina	16.86	NA	15.69	0.66	NA	33.21	090
67115		A	Release encircling material	4.99	NA	6.81	0.19	NA	11.99	090
67120		A	Remove eye implant material	5.98	16.07	7.12	0.23	22.28	13.33	090
67121		A	Remove eye implant material	10.67	NA	12.10	0.42	NA	23.19	090
67141		A	Treatment of retina	5.20	8.03	6.95	0.20	13.43	12.35	090
67145		A	Treatment of retina	5.37	5.27	4.16	0.21	10.85	9.74	090
67208		A	Treatment of retinal lesion	6.70	8.36	7.13	0.26	15.32	14.09	090
67210		A	Treatment of retinal lesion	8.82	7.26	5.74	0.35	16.43	14.91	090
67218		A	Treatment of retinal lesion	18.53	NA	15.79	0.53	NA	34.85	090
67220		A	Treatment of choroid lesion	13.13	10.81	9.62	0.51	24.45	23.26	090
67221		A	Ocular photodynamic ther	4.01	4.63	1.88	0.16	8.80	6.05	000
67225		A	Eye photodynamic ther add-on	0.47	0.28	0.21	0.01	0.76	0.69	ZZZ
67227		A	Treatment of retinal lesion	6.58	9.10	7.15	0.26	15.94	13.99	090
67228		A	Treatment of retinal lesion	12.74	9.84	7.21	0.50	23.08	20.45	090
67250		A	Reinforce eye wall	8.66	NA	11.67	0.36	NA	20.69	090
67255		A	Reinforce/graft eye wall	8.90	NA	11.84	0.35	NA	21.09	090
67299		C	Eye surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
67311		A	Revise eye muscle	6.65	NA	6.15	0.27	NA	13.07	090
67312		A	Revise two eye muscles	8.54	NA	7.20	0.35	NA	16.09	090
67314		A	Revise eye muscle	7.52	NA	6.72	0.30	NA	14.54	090
67316		A	Revise two eye muscles	9.66	NA	7.70	0.40	NA	17.76	090
67318		A	Revise eye muscle(s)	7.85	NA	7.11	0.31	NA	15.27	090
67320		A	Revise eye muscle(s) add-on	4.33	NA	2.01	0.17	NA	6.51	ZZZ
67331		A	Eye surgery follow-up add-on	4.06	NA	1.94	0.17	NA	6.17	ZZZ
67332		A	Rerevise eye muscles add-on	4.49	NA	2.08	0.18	NA	6.75	ZZZ
67334		A	Revise eye muscle w/suture	3.98	NA	1.84	0.16	NA	5.98	ZZZ
67335		A	Eye suture during surgery	2.49	NA	1.15	0.10	NA	3.74	ZZZ
67340		A	Revise eye muscle add-on	4.93	NA	2.28	0.19	NA	7.40	ZZZ
67343		A	Release eye tissue	7.35	NA	7.00	0.30	NA	14.65	090
67345		A	Destroy nerve of eye muscle	2.96	4.33	1.34	0.13	7.42	4.43	010
67350		A	Biopsy eye muscle	2.87	NA	1.93	0.13	NA	4.93	000
67399		C	Eye muscle surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
67400		A	Explore/biopsy eye socket	9.76	NA	13.39	0.43	NA	23.58	090
67405		A	Explore/drain eye socket	7.93	NA	12.30	0.36	NA	20.59	090
67412		A	Explore/treat eye socket	9.50	NA	15.45	0.41	NA	25.36	090
67413		A	Explore/treat eye socket	10.00	NA	13.35	0.43	NA	23.78	090
67414		A	Explr/decompress eye socket	11.13	NA	16.37	0.48	NA	27.98	090
67415		A	Aspiration, orbital contents	1.76	NA	0.79	0.09	NA	2.64	000
67420		A	Explore/treat eye socket	20.06	NA	20.10	0.84	NA	41.00	090
67430		A	Explore/treat eye socket	13.39	NA	17.12	0.97	NA	31.48	090
67440		A	Explore/drain eye socket	13.09	NA	16.53	0.58	NA	30.20	090
67445		A	Explr/decompress eye socket	14.42	NA	17.65	0.63	NA	32.70	090
67450		A	Explore/biopsy eye socket	13.51	NA	16.68	0.56	NA	30.75	090
67500		A	Inject/treat eye socket	0.79	0.84	0.19	0.04	1.67	1.02	000
67505		A	Inject/treat eye socket	0.82	0.93	0.21	0.04	1.79	1.07	000
67515		A	Inject/treat eye socket	0.61	0.84	0.28	0.02	1.47	0.91	000
67550		A	Insert eye socket implant	10.19	NA	13.19	0.50	NA	23.88	090
67560		A	Revise eye socket implant	10.60	NA	13.05	0.47	NA	24.12	090
67570		A	Decompress optic nerve	13.58	NA	17.13	0.69	NA	31.40	090
67599		C	Orbit surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
67700		A	Drainage of eyelid abscess	1.35	7.46	0.58	0.06	8.87	1.99	010
67710		A	Incision of eyelid	1.02	7.61	0.48	0.04	8.67	1.54	010
67715		A	Incision of eyelid fold	1.22	NA	0.57	0.05	NA	1.84	010
67800		A	Remove eyelid lesion	1.38	2.58	0.64	0.06	4.02	2.08	010
67801		A	Remove eyelid lesions	1.88	7.91	0.88	0.08	9.87	2.84	010
67805		A	Remove eyelid lesions	2.22	8.08	1.03	0.09	10.39	3.34	010
67808		A	Remove eyelid lesion(s)	3.80	NA	4.16	0.17	NA	8.13	090
67810		A	Biopsy of eyelid	1.48	5.52	0.70	0.06	7.06	2.24	000
67820		A	Revise eyelashes	0.89	1.96	0.38	0.04	2.89	1.31	000
67825		A	Revise eyelashes	1.38	5.49	1.03	0.06	6.93	2.47	010
67830		A	Revise eyelashes	1.70	11.06	2.11	0.07	12.83	3.88	010
67835		A	Revise eyelashes	5.56	NA	4.65	0.22	NA	10.43	090
67840		A	Remove eyelid lesion	2.04	7.87	0.96	0.08	9.99	3.08	010
67850		A	Treat eyelid lesion	1.69	9.04	2.06	0.07	10.80	3.82	010
67875		A	Closure of eyelid by suture	1.35	11.20	2.08	0.06	12.61	3.49	000
67880		A	Revision of eyelid	3.80	12.26	3.13	0.16	16.22	7.09	090
67882		A	Revision of eyelid	5.07	14.08	4.62	0.21	19.36	9.90	090
67900		A	Repair brow defect	6.14	10.96	6.46	0.30	17.40	12.90	090
67901		A	Repair eyelid defect	6.97	NA	6.80	0.32	NA	14.09	090
67902		A	Repair eyelid defect	7.03	NA	6.88	0.34	NA	14.25	090
67903		A	Repair eyelid defect	6.37	12.11	7.18	0.39	18.87	13.94	090
67904		A	Repair eyelid defect	6.26	14.38	8.10	0.26	20.90	14.62	090
67906		A	Repair eyelid defect	6.79	9.57	6.37	0.42	16.78	13.58	090
67908		A	Repair eyelid defect	5.13	9.32	6.10	0.20	14.65	11.43	090
67909		A	Revise eyelid defect	5.40	9.94	6.58	0.25	15.59	12.23	090
67911		A	Revise eyelid defect	5.27	NA	6.68	0.23	NA	12.18	090
67914		A	Repair eyelid defect	3.68	12.71	3.56	0.16	16.55	7.40	090
67915		A	Repair eyelid defect	3.18	11.26	1.48	0.13	14.57	4.79	090
67916		A	Repair eyelid defect	5.31	15.80	5.33	0.22	21.33	10.86	090
67917		A	Repair eyelid defect	6.02	10.26	6.60	0.25	16.53	12.87	090
67921		A	Repair eyelid defect	3.40	12.44	3.35	0.14	15.98	6.89	090
67922		A	Repair eyelid defect	3.06	11.23	3.16	0.13	14.42	6.35	090
67923		A	Repair eyelid defect	5.88	14.92	5.42	0.24	21.04	11.54	090
67924		A	Repair eyelid defect	5.79	9.60	5.96	0.23	15.62	11.98	090
67930		A	Repair eyelid wound	3.61	12.28	3.05	0.17	16.06	6.83	010
67935		A	Repair eyelid wound	6.22	15.02	5.40	0.29	21.53	11.91	090
67938		A	Remove eyelid foreign body	1.33	9.40	0.51	0.06	10.79	1.90	010
67950		A	Revision of eyelid	5.82	8.75	7.27	0.30	14.87	13.39	090
67961		A	Revision of eyelid	5.69	9.12	5.75	0.26	15.07	11.70	090
67966		A	Revision of eyelid	6.57	8.80	5.89	0.33	15.70	12.79	090
67971		A	Reconstruction of eyelid	9.79	NA	7.53	0.42	NA	17.74	090
67973		A	Reconstruction of eyelid	12.87	NA	9.54	0.59	NA	23.00	090
67974		A	Reconstruction of eyelid	12.84	NA	9.45	0.54	NA	22.83	090
67975		A	Reconstruction of eyelid	9.13	NA	7.20	0.38	NA	16.71	090
67999		C	Revision of eyelid	0.00	0.00	0.00	0.00	0.00	0.00	YYY
68020		A	Incise/drain eyelid lining	1.37	7.52	0.63	0.06	8.95	2.06	010
68040		A	Treatment of eyelid lesions	0.85	7.38	0.39	0.03	8.26	1.27	000
68100		A	Biopsy of eyelid lining	1.35	7.59	0.62	0.06	9.00	2.03	000
68110		A	Remove eyelid lining lesion	1.77	8.64	1.35	0.07	10.48	3.19	010
68115		A	Remove eyelid lining lesion	2.36	8.14	1.09	0.10	10.60	3.55	010
68130		A	Remove eyelid lining lesion	4.93	NA	2.30	0.19	NA	7.42	090
68135		A	Remove eyelid lining lesion	1.84	7.89	0.86	0.07	9.80	2.77	010
68200		A	Treat eyelid by injection	0.49	0.74	0.23	0.02	1.25	0.74	000
68320		A	Revise/graft eyelid lining	5.37	5.56	5.14	0.21	11.14	10.72	090
68325		A	Revise/graft eyelid lining	7.36	NA	6.16	0.30	NA	13.82	090
68326		A	Revise/graft eyelid lining	7.15	NA	6.03	0.30	NA	13.48	090
68328		A	Revise/graft eyelid lining	8.18	NA	6.79	0.40	NA	15.37	090
68330		A	Revise eyelid lining	4.83	7.04	5.53	0.19	12.06	10.55	090
68335		A	Revise/graft eyelid lining	7.19	NA	5.48	0.29	NA	12.96	090
68340		A	Separate eyelid adhesions	4.17	14.49	4.17	0.17	18.83	8.51	090
68360		A	Revise eyelid lining	4.37	6.58	5.23	0.17	11.12	9.77	090
68362		A	Revise eyelid lining	7.34	NA	7.82	0.29	NA	15.45	090
68399		C	Eyelid lining surgery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
68400		A	Incise/drain tear gland	1.69	11.17	2.13	0.07	12.93	3.89	010
68420		A	Incise/drain tear sac	2.30	11.50	2.44	0.10	13.90	4.84	010
68440		A	Incise tear duct opening	0.94	7.52	0.44	0.04	8.50	1.42	010
68500		A	Removal of tear gland	11.02	NA	9.59	0.60	NA	21.21	090
68505		A	Partial removal, tear gland	10.94	NA	10.69	0.57	NA	22.20	090
68510		A	Biopsy of tear gland	4.61	12.31	2.15	0.19	17.11	6.95	000
68520		A	Removal of tear sac	7.51	NA	7.17	0.33	NA	15.01	090
68525		A	Biopsy of tear sac	4.43	NA	2.07	0.18	NA	6.68	000
68530		A	Clearance of tear duct	3.66	13.81	3.00	0.16	17.63	6.82	010
68540		A	Remove tear gland lesion	10.60	NA	9.17	0.46	NA	20.23	090
68550		A	Remove tear gland lesion	13.26	NA	11.19	0.66	NA	25.11	090
68700		A	Repair tear ducts	6.60	NA	6.64	0.27	NA	13.51	090
68705		A	Revise tear duct opening	2.06	8.07	0.97	0.08	10.21	3.11	010
68720		A	Create tear sac drain	8.96	NA	7.78	0.38	NA	17.12	090
68745		A	Create tear duct drain	8.63	NA	7.66	0.38	NA	16.67	090
68750		A	Create tear duct drain	8.66	NA	8.17	0.37	NA	17.20	090
68760		A	Close tear duct opening	1.73	6.49	1.19	0.07	8.29	2.99	010
68761		A	Close tear duct opening	1.36	3.00	0.95	0.06	4.42	2.37	010
68770		A	Close tear system fistula	7.02	16.24	5.98	0.28	23.54	13.28	090
68801		A	Dilate tear duct opening	0.94	0.85	0.56	0.04	1.83	1.54	010
68810		A	Probe nasolacrimal duct	1.90	2.40	0.88	0.08	4.38	2.86	010
68811		A	Probe nasolacrimal duct	2.35	NA	2.39	0.10	NA	4.84	010
68815		A	Probe nasolacrimal duct	3.20	12.25	2.83	0.14	15.59	6.17	010
68840		A	Explore/irrigate tear ducts	1.25	1.56	0.93	0.05	2.86	2.23	010
68850		A	Injection for tear sac x-ray	0.80	14.94	0.31	0.03	15.77	1.14	000
68899		C	Tear duct system surgery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
69000		A	Drain external ear lesion	1.45	2.10	0.55	0.10	3.65	2.10	010
69005		A	Drain external ear lesion	2.11	2.53	2.01	0.16	4.80	4.28	010
69020		A	Drain outer ear canal lesion	1.48	2.22	0.71	0.11	3.81	2.30	010
69090		N	Pierce earlobes	0.00	0.00	0.00	0.00	0.00	0.00	XXX
69100		A	Biopsy of external ear	0.81	1.59	0.41	0.04	2.44	1.26	000
69105		A	Biopsy of external ear canal	0.85	1.51	1.02	0.06	2.42	1.93	000
69110		A	Remove external ear, partial	3.44	3.53	2.78	0.24	7.21	6.46	090
69120		A	Removal of external ear	4.05	NA	4.45	0.31	NA	8.81	090
69140		A	Remove ear canal lesion(s)	7.97	NA	8.07	0.56	NA	16.60	090
69145		A	Remove ear canal lesion(s)	2.62	3.37	2.52	0.18	6.17	5.32	090
69150		A	Extensive ear canal surgery	13.43	NA	11.17	1.07	NA	25.67	090
69155		A	Extensive ear/neck surgery	20.80	NA	15.26	1.51	NA	37.57	090
69200		A	Clear outer ear canal	0.77	1.44	0.76	0.05	2.26	1.58	000
69205		A	Clear outer ear canal	1.20	NA	1.56	0.09	NA	2.85	010
69210		A	Remove impacted ear wax	0.61	0.58	0.24	0.04	1.23	0.89	000
69220		A	Clean out mastoid cavity	0.83	1.52	0.43	0.06	2.41	1.32	000
69222		A	Clean out mastoid cavity	1.40	2.23	1.70	0.10	3.73	3.20	010
69300		R	Revise external ear	6.36	NA	4.37	0.43	NA	11.16	YYY
69310		A	Rebuild outer ear canal	10.79	NA	9.71	0.77	NA	21.27	090
69320		A	Rebuild outer ear canal	16.96	NA	13.79	1.17	NA	31.92	090
69399		C	Outer ear surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
69400		A	Inflate middle ear canal	0.83	1.51	0.40	0.06	2.40	1.29	000
69401		A	Inflate middle ear canal	0.63	1.41	0.35	0.04	2.08	1.02	000
69405		A	Catheterize middle ear canal	2.63	3.09	1.46	0.18	5.90	4.27	010
69410		A	Inset middle ear (baffle)	0.33	1.42	0.16	0.02	1.77	0.51	000
69420		A	Incision of eardrum	1.33	2.36	0.71	0.10	3.79	2.14	010
69421		A	Incision of eardrum	1.73	2.58	1.90	0.13	4.44	3.76	010
69424		A	Remove ventilating tube	0.85	1.69	0.90	0.06	2.60	1.81	000
69433		A	Create eardrum opening	1.52	2.31	0.85	0.11	3.94	2.48	010
69436		A	Create eardrum opening	1.96	NA	2.04	0.14	NA	4.14	010
69440		A	Exploration of middle ear	7.57	NA	7.30	0.53	NA	15.40	090
69450		A	Eardrum revision	5.57	NA	6.11	0.39	NA	12.07	090
69501		A	Mastoidectomy	9.07	NA	8.07	0.65	NA	17.79	090
69502		A	Mastoidectomy	12.38	NA	10.64	0.86	NA	23.88	090
69505		A	Remove mastoid structures	12.99	NA	10.89	0.92	NA	24.80	090
69511		A	Extensive mastoid surgery	13.52	NA	11.23	0.96	NA	25.71	090
69530		A	Extensive mastoid surgery	19.19	NA	14.75	1.32	NA	35.26	090
69535		A	Remove part of temporal bone	36.14	NA	24.17	2.59	NA	62.90	090
69540		A	Remove ear lesion	1.20	2.27	1.59	0.09	3.56	2.88	010
69550		A	Remove ear lesion	10.99	NA	9.75	0.80	NA	21.54	090
69552		A	Remove ear lesion	19.46	NA	14.32	1.36	NA	35.14	090
69554		A	Remove ear lesion	33.16	NA	21.82	2.32	NA	57.30	090
69601		A	Mastoid surgery revision	13.24	NA	11.82	0.92	NA	25.98	090
69602		A	Mastoid surgery revision	13.58	NA	11.36	0.94	NA	25.88	090
69603		A	Mastoid surgery revision	14.02	NA	11.55	1.00	NA	26.57	090
69604		A	Mastoid surgery revision	14.02	NA	11.48	0.98	NA	26.48	090
69605		A	Mastoid surgery revision	18.49	NA	14.48	1.29	NA	34.26	090
69610		A	Repair of eardrum	4.43	4.22	3.40	0.31	8.96	8.14	010
69620		A	Repair of eardrum	5.89	6.87	3.19	0.40	13.16	9.48	090
69631		A	Repair eardrum structures	9.86	NA	9.19	0.69	NA	19.74	090
69632		A	Rebuild eardrum structures	12.75	NA	11.54	0.89	NA	25.18	090
69633		A	Rebuild eardrum structures	12.10	NA	11.19	0.84	NA	24.13	090
69635		A	Repair eardrum structures	13.33	NA	10.74	0.87	NA	24.94	090
69636		A	Rebuild eardrum structures	15.22	NA	13.01	1.07	NA	29.30	090
69637		A	Rebuild eardrum structures	15.11	NA	12.92	1.06	NA	29.09	090
69641		A	Revise middle ear & mastoid	12.71	NA	10.87	0.89	NA	24.47	090
69642		A	Revise middle ear & mastoid	16.84	NA	13.86	1.18	NA	31.88	090
69643		A	Revise middle ear & mastoid	15.32	NA	13.01	1.08	NA	29.41	090
69644		A	Revise middle ear & mastoid	16.97	NA	13.94	1.19	NA	32.10	090
69645		A	Revise middle ear & mastoid	16.38	NA	13.57	1.16	NA	31.11	090
69646		A	Revise middle ear & mastoid	17.99	NA	14.53	1.26	NA	33.78	090
69650		A	Release middle ear bone	9.66	NA	8.43	0.68	NA	18.77	090
69660		A	Revise middle ear bone	11.90	NA	9.65	0.84	NA	22.39	090
69661		A	Revise middle ear bone	15.74	NA	12.44	1.10	NA	29.28	090
69662		A	Revise middle ear bone	15.44	NA	12.31	1.08	NA	28.83	090
69666		A	Repair middle ear structures	9.75	NA	8.51	0.68	NA	18.94	090
69667		A	Repair middle ear structures	9.76	NA	8.49	0.72	NA	18.97	090
69670		A	Remove mastoid air cells	11.51	NA	10.11	0.78	NA	22.40	090
69676		A	Remove middle ear nerve	9.52	NA	9.03	0.69	NA	19.24	090
69700		A	Close mastoid fistula	8.23	NA	5.53	0.55	NA	14.31	090
69710		N	Implant/replace hearing aid	0.00	0.00	0.00	0.00	0.00	0.00	XXX
69711		A	Remove/repair hearing aid	10.44	NA	9.35	0.62	NA	20.41	090
69714		A	Implant temple bone w/stimul	14.00	NA	11.17	1.01	NA	26.18	090
69715		A	Temple bne implnt w/stimulat	18.25	NA	13.73	1.32	NA	33.30	090
69717		A	Temple bone implant revision	14.98	NA	10.55	1.08	NA	26.61	090
69718		A	Revise temple bone implant	18.50	NA	13.61	1.34	NA	33.45	090
69720		A	Release facial nerve	14.38	NA	12.47	1.03	NA	27.88	090
69725		A	Release facial nerve	25.38	NA	18.04	1.78	NA	45.20	090
69740		A	Repair facial nerve	15.96	NA	11.27	1.13	NA	28.36	090
69745		A	Repair facial nerve	16.69	NA	12.77	1.00	NA	30.46	090
69799		C	Middle ear surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
69801		A	Incise inner ear	8.56	NA	7.84	0.60	NA	17.00	090
69802		A	Incise inner ear	13.10	NA	11.13	0.91	NA	25.14	090
69805		A	Explore inner ear	13.82	NA	10.80	0.97	NA	25.59	090
69806		A	Explore inner ear	12.35	NA	10.68	0.86	NA	23.89	090
69820		A	Establish inner ear window	10.34	NA	8.97	0.66	NA	19.97	090
69840		A	Revise inner ear window	10.26	NA	7.64	0.64	NA	18.54	090
69905		A	Remove inner ear	11.10	NA	9.73	0.77	NA	21.60	090
69910		A	Remove inner ear & mastoid	13.63	NA	11.19	0.94	NA	25.76	090
69915		A	Incise inner ear nerve	21.23	NA	15.65	1.54	NA	38.42	090
69930		A	Implant cochlear device	16.81	NA	12.70	1.19	NA	30.70	090
69949		C	Inner ear surgery procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
69950		A	Incise inner ear nerve	25.64	NA	16.46	2.90	NA	45.00	090
69955		A	Release facial nerve	27.04	NA	18.64	1.89	NA	47.57	090
69960		A	Release inner ear canal	27.04	NA	18.13	2.43	NA	47.60	090
69970		A	Remove inner ear lesion	30.04	NA	18.91	2.34	NA	51.29	090
69979		C	Temporal bone surgery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
69990		R	Microsurgery add-on	3.47	NA	1.84	0.56	NA	5.87	ZZZ
70010		A	Contrast x-ray of brain	1.19	4.72	NA	0.24	6.15	NA	XXX
70010	26	A	Contrast x-ray of brain	1.19	0.41	0.41	0.06	1.66	1.66	XXX
70010	TC	A	Contrast x-ray of brain	0.00	4.31	NA	0.18	4.49	NA	XXX
70015		A	Contrast x-ray of brain	1.19	1.75	NA	0.12	3.06	NA	XXX
70015	26	A	Contrast x-ray of brain	1.19	0.41	0.41	0.05	1.65	1.65	XXX
70015	TC	A	Contrast x-ray of brain	0.00	1.34	NA	0.07	1.41	NA	XXX
70030		A	X-ray eye for foreign body	0.17	0.48	NA	0.03	0.68	NA	XXX
70030	26	A	X-ray eye for foreign body	0.17	0.06	0.06	0.01	0.24	0.24	XXX
70030	TC	A	X-ray eye for foreign body	0.00	0.42	NA	0.02	0.44	NA	XXX
70100		A	X-ray exam of jaw	0.18	0.58	NA	0.03	0.79	NA	XXX
70100	26	A	X-ray exam of jaw	0.18	0.06	0.06	0.01	0.25	0.25	XXX
70100	TC	A	X-ray exam of jaw	0.00	0.52	NA	0.02	0.54	NA	XXX
70110		A	X-ray exam of jaw	0.25	0.70	NA	0.04	0.99	NA	XXX
70110	26	A	X-ray exam of jaw	0.25	0.08	0.08	0.01	0.34	0.34	XXX
70110	TC	A	X-ray exam of jaw	0.00	0.62	NA	0.03	0.65	NA	XXX
70120		A	X-ray exam of mastoids	0.18	0.68	NA	0.04	0.90	NA	XXX
70120	26	A	X-ray exam of mastoids	0.18	0.06	0.06	0.01	0.25	0.25	XXX
70120	TC	A	X-ray exam of mastoids	0.00	0.62	NA	0.03	0.65	NA	XXX
70130		A	X-ray exam of mastoids	0.34	0.90	NA	0.05	1.29	NA	XXX
70130	26	A	X-ray exam of mastoids	0.34	0.12	0.12	0.01	0.47	0.47	XXX
70130	TC	A	X-ray exam of mastoids	0.00	0.78	NA	0.04	0.82	NA	XXX
70134		A	X-ray exam of middle ear	0.34	0.86	NA	0.05	1.25	NA	XXX
70134	26	A	X-ray exam of middle ear	0.34	0.12	0.12	0.01	0.47	0.47	XXX
70134	TC	A	X-ray exam of middle ear	0.00	0.74	NA	0.04	0.78	NA	XXX
70140		A	X-ray exam of facial bones	0.19	0.68	NA	0.04	0.91	NA	XXX
70140	26	A	X-ray exam of facial bones	0.19	0.06	0.06	0.01	0.26	0.26	XXX
70140	TC	A	X-ray exam of facial bones	0.00	0.62	NA	0.03	0.65	NA	XXX
70150		A	X-ray exam of facial bones	0.26	0.87	NA	0.05	1.18	NA	XXX
70150	26	A	X-ray exam of facial bones	0.26	0.09	0.09	0.01	0.36	0.36	XXX
70150	TC	A	X-ray exam of facial bones	0.00	0.78	NA	0.04	0.82	NA	XXX
70160		A	X-ray exam of nasal bones	0.17	0.58	NA	0.03	0.78	NA	XXX
70160	26	A	X-ray exam of nasal bones	0.17	0.06	0.06	0.01	0.24	0.24	XXX
70160	TC	A	X-ray exam of nasal bones	0.00	0.52	NA	0.02	0.54	NA	XXX
70170		A	X-ray exam of tear duct	0.30	1.05	NA	0.06	1.41	NA	XXX
70170	26	A	X-ray exam of tear duct	0.30	0.10	0.10	0.01	0.41	0.41	XXX
70170	TC	A	X-ray exam of tear duct	0.00	0.95	NA	0.05	1.00	NA	XXX
70190		A	X-ray exam of eye sockets	0.21	0.69	NA	0.04	0.94	NA	XXX
70190	26	A	X-ray exam of eye sockets	0.21	0.07	0.07	0.01	0.29	0.29	XXX
70190	TC	A	X-ray exam of eye sockets	0.00	0.62	NA	0.03	0.65	NA	XXX
70200		A	X-ray exam of eye sockets	0.28	0.88	NA	0.05	1.21	NA	XXX
70200	26	A	X-ray exam of eye sockets	0.28	0.10	0.10	0.01	0.39	0.39	XXX
70200	TC	A	X-ray exam of eye sockets	0.00	0.78	NA	0.04	0.82	NA	XXX
70210		A	X-ray exam of sinuses	0.17	0.68	NA	0.04	0.89	NA	XXX
70210	26	A	X-ray exam of sinuses	0.17	0.06	0.06	0.01	0.24	0.24	XXX
70210	TC	A	X-ray exam of sinuses	0.00	0.62	NA	0.03	0.65	NA	XXX
70220		A	X-ray exam of sinuses	0.25	0.87	NA	0.05	1.17	NA	XXX
70220	26	A	X-ray exam of sinuses	0.25	0.09	0.09	0.01	0.35	0.35	XXX
70220	TC	A	X-ray exam of sinuses	0.00	0.78	NA	0.04	0.82	NA	XXX
70240		A	X-ray exam, pituitary saddle	0.19	0.48	NA	0.03	0.70	NA	XXX
70240	26	A	X-ray exam, pituitary saddle	0.19	0.06	0.06	0.01	0.26	0.26	XXX
70240	TC	A	X-ray exam, pituitary saddle	0.00	0.42	NA	0.02	0.44	NA	XXX
70250		A	X-ray exam of skull	0.24	0.70	NA	0.04	0.98	NA	XXX
70250	26	A	X-ray exam of skull	0.24	0.08	0.08	0.01	0.33	0.33	XXX
70250	TC	A	X-ray exam of skull	0.00	0.62	NA	0.03	0.65	NA	XXX
70260		A	X-ray exam of skull	0.34	1.01	NA	0.06	1.41	NA	XXX
70260	26	A	X-ray exam of skull	0.34	0.12	0.12	0.01	0.47	0.47	XXX
70260	TC	A	X-ray exam of skull	0.00	0.89	NA	0.05	0.94	NA	XXX
70300		A	X-ray exam of teeth	0.10	0.30	NA	0.03	0.43	NA	XXX
70300	26	A	X-ray exam of teeth	0.10	0.04	0.04	0.01	0.15	0.15	XXX
70300	TC	A	X-ray exam of teeth	0.00	0.26	NA	0.02	0.28	NA	XXX
70310		A	X-ray exam of teeth	0.16	0.48	NA	0.03	0.67	NA	XXX
70310	26	A	X-ray exam of teeth	0.16	0.06	0.06	0.01	0.23	0.23	XXX
70310	TC	A	X-ray exam of teeth	0.00	0.42	NA	0.02	0.44	NA	XXX
70320		A	Full mouth x-ray of teeth	0.22	0.86	NA	0.05	1.13	NA	XXX
70320	26	A	Full mouth x-ray of teeth	0.22	0.08	0.08	0.01	0.31	0.31	XXX
70320	TC	A	Full mouth x-ray of teeth	0.00	0.78	NA	0.04	0.82	NA	XXX
70328		A	X-ray exam of jaw joint	0.18	0.55	NA	0.03	0.76	NA	XXX
70328	26	A	X-ray exam of jaw joint	0.18	0.06	0.06	0.01	0.25	0.25	XXX
70328	TC	A	X-ray exam of jaw joint	0.00	0.49	NA	0.02	0.51	NA	XXX
70330		A	X-ray exam of jaw joints	0.24	0.92	NA	0.05	1.21	NA	XXX
70330	26	A	X-ray exam of jaw joints	0.24	0.08	0.08	0.01	0.33	0.33	XXX
70330	TC	A	X-ray exam of jaw joints	0.00	0.84	NA	0.04	0.88	NA	XXX
70332		A	X-ray exam of jaw joint	0.54	2.28	NA	0.12	2.94	NA	XXX
70332	26	A	X-ray exam of jaw joint	0.54	0.19	0.19	0.02	0.75	0.75	XXX
70332	TC	A	X-ray exam of jaw joint	0.00	2.09	NA	0.10	2.19	NA	XXX
70336		A	Magnetic image, jaw joint	1.48	11.67	NA	0.56	13.71	NA	XXX
70336	26	A	Magnetic image, jaw joint	1.48	0.51	0.51	0.07	2.06	2.06	XXX
70336	TC	A	Magnetic image, jaw joint	0.00	11.16	NA	0.49	11.65	NA	XXX
70350		A	X-ray head for orthodontia	0.17	0.44	NA	0.03	0.64	NA	XXX
70350	26	A	X-ray head for orthodontia	0.17	0.06	0.06	0.01	0.24	0.24	XXX
70350	TC	A	X-ray head for orthodontia	0.00	0.38	NA	0.02	0.40	NA	XXX
70355		A	Panoramic x-ray of jaws	0.20	0.64	NA	0.04	0.88	NA	XXX
70355	26	A	Panoramic x-ray of jaws	0.20	0.07	0.07	0.01	0.28	0.28	XXX
70355	TC	A	Panoramic x-ray of jaws	0.00	0.57	NA	0.03	0.60	NA	XXX
70360		A	X-ray exam of neck	0.17	0.48	NA	0.03	0.68	NA	XXX
70360	26	A	X-ray exam of neck	0.17	0.06	0.06	0.01	0.24	0.24	XXX
70360	TC	A	X-ray exam of neck	0.00	0.42	NA	0.02	0.44	NA	XXX
70370		A	Throat x-ray & fluoroscopy	0.32	1.41	NA	0.07	1.80	NA	XXX
70370	26	A	Throat x-ray & fluoroscopy	0.32	0.11	0.11	0.01	0.44	0.44	XXX
70370	TC	A	Throat x-ray & fluoroscopy	0.00	1.30	NA	0.06	1.36	NA	XXX
70371		A	Speech evaluation, complex	0.84	2.38	NA	0.14	3.36	NA	XXX
70371	26	A	Speech evaluation, complex	0.84	0.29	0.29	0.04	1.17	1.17	XXX
70371	TC	A	Speech evaluation, complex	0.00	2.09	NA	0.10	2.19	NA	XXX
70373		A	Contrast x-ray of larynx	0.44	1.92	NA	0.11	2.47	NA	XXX
70373	26	A	Contrast x-ray of larynx	0.44	0.15	0.15	0.02	0.61	0.61	XXX
70373	TC	A	Contrast x-ray of larynx	0.00	1.77	NA	0.09	1.86	NA	XXX
70380		A	X-ray exam of salivary gland	0.17	0.73	NA	0.04	0.94	NA	XXX
70380	26	A	X-ray exam of salivary gland	0.17	0.06	0.06	0.01	0.24	0.24	XXX
70380	TC	A	X-ray exam of salivary gland	0.00	0.67	NA	0.03	0.70	NA	XXX
70390		A	X-ray exam of salivary duct	0.38	1.90	NA	0.11	2.39	NA	XXX
70390	26	A	X-ray exam of salivary duct	0.38	0.13	0.13	0.02	0.53	0.53	XXX
70390	TC	A	X-ray exam of salivary duct	0.00	1.77	NA	0.09	1.86	NA	XXX
70450		A	Ct head/brain w/o dye	0.85	4.99	NA	0.25	6.09	NA	XXX
70450	26	A	Ct head/brain w/o dye	0.85	0.29	0.29	0.04	1.18	1.18	XXX
70450	TC	A	Ct head/brain w/o dye	0.00	4.70	NA	0.21	4.91	NA	XXX
70460		A	Ct head/brain w/dye	1.13	6.02	NA	0.30	7.45	NA	XXX
70460	26	A	Ct head/brain w/dye	1.13	0.39	0.39	0.05	1.57	1.57	XXX
70460	TC	A	Ct head/brain w/dye	0.00	5.63	NA	0.25	5.88	NA	XXX
70470		A	Ct head/brain w/o&w dye	1.27	7.47	NA	0.37	9.11	NA	XXX
70470	26	A	Ct head/brain w/o&w dye	1.27	0.43	0.43	0.06	1.76	1.76	XXX
70470	TC	A	Ct head/brain w/o&w dye	0.00	7.04	NA	0.31	7.35	NA	XXX
70480		A	Ct orbit/ear/fossa w/o dye	1.28	5.14	NA	0.27	6.69	NA	XXX
70480	26	A	Ct orbit/ear/fossa w/o dye	1.28	0.44	0.44	0.06	1.78	1.78	XXX
70480	TC	A	Ct orbit/ear/fossa w/o dye	0.00	4.70	NA	0.21	4.91	NA	XXX
70481		A	Ct orbit/ear/fossa w/dye	1.38	6.10	NA	0.31	7.79	NA	XXX
70481	26	A	Ct orbit/ear/fossa w/dye	1.38	0.47	0.47	0.06	1.91	1.91	XXX
70481	TC	A	Ct orbit/ear/fossa w/dye	0.00	5.63	NA	0.25	5.88	NA	XXX
70482		A	Ct orbit/ear/fossa w/o&w dye	1.45	7.53	NA	0.37	9.35	NA	XXX
70482	26	A	Ct orbit/ear/fossa w/o&w dye	1.45	0.49	0.49	0.06	2.00	2.00	XXX
70482	TC	A	Ct orbit/ear/fossa w/o&w dye	0.00	7.04	NA	0.31	7.35	NA	XXX
70486		A	Ct maxillofacial w/o dye	1.14	5.09	NA	0.26	6.49	NA	XXX
70486	26	A	Ct maxillofacial w/o dye	1.14	0.39	0.39	0.05	1.58	1.58	XXX
70486	TC	A	Ct maxillofacial w/o dye	0.00	4.70	NA	0.21	4.91	NA	XXX
70487		A	Ct maxillofacial w/dye	1.30	6.07	NA	0.31	7.68	NA	XXX
70487	26	A	Ct maxillofacial w/dye	1.30	0.44	0.44	0.06	1.80	1.80	XXX
70487	TC	A	Ct maxillofacial w/dye	0.00	5.63	NA	0.25	5.88	NA	XXX
70488		A	Ct maxillofacial w/o&w dye	1.42	7.52	NA	0.37	9.31	NA	XXX
70488	26	A	Ct maxillofacial w/o&w dye	1.42	0.48	0.48	0.06	1.96	1.96	XXX
70488	TC	A	Ct maxillofacial w/o&w dye	0.00	7.04	NA	0.31	7.35	NA	XXX
70490		A	Ct soft tissue neck w/o dye	1.28	5.13	NA	0.27	6.68	NA	XXX
70490	26	A	Ct soft tissue neck w/o dye	1.28	0.43	0.43	0.06	1.77	1.77	XXX
70490	TC	A	Ct soft tissue neck w/o dye	0.00	4.70	NA	0.21	4.91	NA	XXX
70491		A	Ct soft tissue neck w/dye	1.38	6.10	NA	0.31	7.79	NA	XXX
70491	26	A	Ct soft tissue neck w/dye	1.38	0.47	0.47	0.06	1.91	1.91	XXX
70491	TC	A	Ct soft tissue neck w/dye	0.00	5.63	NA	0.25	5.88	NA	XXX
70492		A	Ct sft tsue nck w/o & w/dye	1.45	7.53	NA	0.37	9.35	NA	XXX
70492	26	A	Ct sft tsue nck w/o & w/dye	1.45	0.49	0.49	0.06	2.00	2.00	XXX
70492	TC	A	Ct sft tsue nck w/o & w/dye	0.00	7.04	NA	0.31	7.35	NA	XXX
70496		A	Ct angiography, head	1.75	11.15	NA	0.56	13.46	NA	XXX
70496	26	A	Ct angiography, head	1.75	0.59	0.59	0.08	2.42	2.42	XXX
70496	TC	A	Ct angiography, head	0.00	10.56	NA	0.48	11.04	NA	XXX
70498		A	Ct angiography, neck	1.75	11.16	NA	0.56	13.47	NA	XXX
70498	26	A	Ct angiography, neck	1.75	0.60	0.60	0.08	2.43	2.43	XXX
70498	TC	A	Ct angiography, neck	0.00	10.56	NA	0.48	11.04	NA	XXX
70540		A	Mri orbit/face/neck w/o dye	1.35	11.62	NA	0.36	13.33	NA	XXX
70540	26	A	Mri orbit/face/neck w/o dye	1.35	0.46	0.46	0.04	1.85	1.85	XXX
70540	TC	A	Mri orbit/face/neck w/o dye	0.00	11.16	NA	0.32	11.48	NA	XXX
70542		A	Mri orbit/face/neck w/dye	1.62	13.94	NA	0.44	16.00	NA	XXX
70542	26	A	Mri orbit/face/neck w/dye	1.62	0.56	0.56	0.05	2.23	2.23	XXX
70542	TC	A	Mri orbit/face/neck w/dye	0.00	13.38	NA	0.39	13.77	NA	XXX
70543		A	Mri orbt/fac/nck w/o&w dye	2.15	25.51	NA	0.77	28.43	NA	XXX
70543	26	A	Mri orbt/fac/nck w/o&w dye	2.15	0.73	0.73	0.07	2.95	2.95	XXX
70543	TC	A	Mri orbt/fac/nck w/o&w dye	0.00	24.78	NA	0.70	25.48	NA	XXX
70544		A	Mr angiography head w/o dye	1.20	11.57	NA	0.54	13.31	NA	XXX
70544	26	A	Mr angiography head w/o dye	1.20	0.41	0.41	0.05	1.66	1.66	XXX
70544	TC	A	Mr angiography head w/o dye	0.00	11.16	NA	0.49	11.65	NA	XXX
70545		A	Mr angiography head w/dye	1.20	11.57	NA	0.54	13.31	NA	XXX
70545	26	A	Mr angiography head w/dye	1.20	0.41	0.41	0.05	1.66	1.66	XXX
70545	TC	A	Mr angiography head w/dye	0.00	11.16	NA	0.49	11.65	NA	XXX
70546		A	Mr angiograph head w/o&w dye	1.80	22.93	NA	0.57	25.30	NA	XXX
70546	26	A	Mr angiograph head w/o&w dye	1.80	0.62	0.62	0.08	2.50	2.50	XXX
70546	TC	A	Mr angiograph head w/o&w dye	0.00	22.31	NA	0.49	22.80	NA	XXX
70547		A	Mr angiography neck w/o dye	1.20	11.57	NA	0.54	13.31	NA	XXX
70547	26	A	Mr angiography neck w/o dye	1.20	0.41	0.41	0.05	1.66	1.66	XXX
70547	TC	A	Mr angiography neck w/o dye	0.00	11.16	NA	0.49	11.65	NA	XXX
70548		A	Mr angiography neck w/dye	1.20	11.57	NA	0.54	13.31	NA	XXX
70548	26	A	Mr angiography neck w/dye	1.20	0.41	0.41	0.05	1.66	1.66	XXX
70548	TC	A	Mr angiography neck w/dye	0.00	11.16	NA	0.49	11.65	NA	XXX
70549		A	Mr angiograph neck w/o&w dye	1.80	22.93	NA	0.57	25.30	NA	XXX
70549	26	A	Mr angiograph neck w/o&w dye	1.80	0.62	0.62	0.08	2.50	2.50	XXX
70549	TC	A	Mr angiograph neck w/o&w dye	0.00	22.31	NA	0.49	22.80	NA	XXX
70551		A	Mri brain w/o dye	1.48	11.67	NA	0.56	13.71	NA	XXX
70551	26	A	Mri brain w/o dye	1.48	0.51	0.51	0.07	2.06	2.06	XXX
70551	TC	A	Mri brain w/o dye	0.00	11.16	NA	0.49	11.65	NA	XXX
70552		A	Mri brain w/dye	1.78	14.00	NA	0.66	16.44	NA	XXX
70552	26	A	Mri brain w/dye	1.78	0.62	0.62	0.08	2.48	2.48	XXX
70552	TC	A	Mri brain w/dye	0.00	13.38	NA	0.58	13.96	NA	XXX
70553		A	Mri brain w/o&w dye	2.36	25.59	NA	1.19	29.14	NA	XXX
70553	26	A	Mri brain w/o&w dye	2.36	0.81	0.81	0.10	3.27	3.27	XXX
70553	TC	A	Mri brain w/o&w dye	0.00	24.78	NA	1.09	25.87	NA	XXX
71010		A	Chest x-ray	0.18	0.53	NA	0.03	0.74	NA	XXX
71010	26	A	Chest x-ray	0.18	0.06	0.06	0.01	0.25	0.25	XXX
71010	TC	A	Chest x-ray	0.00	0.47	NA	0.02	0.49	NA	XXX
71015		A	Chest x-ray	0.21	0.59	NA	0.03	0.83	NA	XXX
71015	26	A	Chest x-ray	0.21	0.07	0.07	0.01	0.29	0.29	XXX
71015	TC	A	Chest x-ray	0.00	0.52	NA	0.02	0.54	NA	XXX
71020		A	Chest x-ray	0.22	0.69	NA	0.04	0.95	NA	XXX
71020	26	A	Chest x-ray	0.22	0.07	0.07	0.01	0.30	0.30	XXX
71020	TC	A	Chest x-ray	0.00	0.62	NA	0.03	0.65	NA	XXX
71021		A	Chest x-ray	0.27	0.83	NA	0.05	1.15	NA	XXX
71021	26	A	Chest x-ray	0.27	0.09	0.09	0.01	0.37	0.37	XXX
71021	TC	A	Chest x-ray	0.00	0.74	NA	0.04	0.78	NA	XXX
71022		A	Chest x-ray	0.31	0.85	NA	0.06	1.22	NA	XXX
71022	26	A	Chest x-ray	0.31	0.11	0.11	0.02	0.44	0.44	XXX
71022	TC	A	Chest x-ray	0.00	0.74	NA	0.04	0.78	NA	XXX
71023		A	Chest x-ray and fluoroscopy	0.38	0.92	NA	0.06	1.36	NA	XXX
71023	26	A	Chest x-ray and fluoroscopy	0.38	0.14	0.14	0.02	0.54	0.54	XXX
71023	TC	A	Chest x-ray and fluoroscopy	0.00	0.78	NA	0.04	0.82	NA	XXX
71030		A	Chest x-ray	0.31	0.88	NA	0.05	1.24	NA	XXX
71030	26	A	Chest x-ray	0.31	0.10	0.10	0.01	0.42	0.42	XXX
71030	TC	A	Chest x-ray	0.00	0.78	NA	0.04	0.82	NA	XXX
71034		A	Chest x-ray and fluoroscopy	0.46	1.60	NA	0.09	2.15	NA	XXX
71034	26	A	Chest x-ray and fluoroscopy	0.46	0.17	0.17	0.02	0.65	0.65	XXX
71034	TC	A	Chest x-ray and fluoroscopy	0.00	1.43	NA	0.07	1.50	NA	XXX
71035		A	Chest x-ray	0.18	0.58	NA	0.03	0.79	NA	XXX
71035	26	A	Chest x-ray	0.18	0.06	0.06	0.01	0.25	0.25	XXX
71035	TC	A	Chest x-ray	0.00	0.52	NA	0.02	0.54	NA	XXX
71040		A	Contrast x-ray of bronchi	0.58	1.65	NA	0.10	2.33	NA	XXX
71040	26	A	Contrast x-ray of bronchi	0.58	0.20	0.20	0.03	0.81	0.81	XXX
71040	TC	A	Contrast x-ray of bronchi	0.00	1.45	NA	0.07	1.52	NA	XXX
71060		A	Contrast x-ray of bronchi	0.74	2.45	NA	0.14	3.33	NA	XXX
71060	26	A	Contrast x-ray of bronchi	0.74	0.25	0.25	0.03	1.02	1.02	XXX
71060	TC	A	Contrast x-ray of bronchi	0.00	2.20	NA	0.11	2.31	NA	XXX
71090		A	X-ray & pacemaker insertion	0.54	1.88	NA	0.11	2.53	NA	XXX
71090	26	A	X-ray & pacemaker insertion	0.54	0.21	0.21	0.02	0.77	0.77	XXX
71090	TC	A	X-ray & pacemaker insertion	0.00	1.67	NA	0.09	1.76	NA	XXX
71100		A	X-ray exam of ribs	0.22	0.64	NA	0.04	0.90	NA	XXX
71100	26	A	X-ray exam of ribs	0.22	0.07	0.07	0.01	0.30	0.30	XXX
71100	TC	A	X-ray exam of ribs	0.00	0.57	NA	0.03	0.60	NA	XXX
71101		A	X-ray exam of ribs/chest	0.27	0.76	NA	0.04	1.07	NA	XXX
71101	26	A	X-ray exam of ribs/chest	0.27	0.09	0.09	0.01	0.37	0.37	XXX
71101	TC	A	X-ray exam of ribs/chest	0.00	0.67	NA	0.03	0.70	NA	XXX
71110		A	X-ray exam of ribs	0.27	0.87	NA	0.05	1.19	NA	XXX
71110	26	A	X-ray exam of ribs	0.27	0.09	0.09	0.01	0.37	0.37	XXX
71110	TC	A	X-ray exam of ribs	0.00	0.78	NA	0.04	0.82	NA	XXX
71111		A	X-ray exam of ribs/ chest	0.32	1.00	NA	0.06	1.38	NA	XXX
71111	26	A	X-ray exam of ribs/ chest	0.32	0.11	0.11	0.01	0.44	0.44	XXX
71111	TC	A	X-ray exam of ribs/ chest	0.00	0.89	NA	0.05	0.94	NA	XXX
71120		A	X-ray exam of breastbone	0.20	0.72	NA	0.04	0.96	NA	XXX
71120	26	A	X-ray exam of breastbone	0.20	0.07	0.07	0.01	0.28	0.28	XXX
71120	TC	A	X-ray exam of breastbone	0.00	0.65	NA	0.03	0.68	NA	XXX
71130		A	X-ray exam of breastbone	0.22	0.78	NA	0.04	1.04	NA	XXX
71130	26	A	X-ray exam of breastbone	0.22	0.07	0.07	0.01	0.30	0.30	XXX
71130	TC	A	X-ray exam of breastbone	0.00	0.71	NA	0.03	0.74	NA	XXX
71250		A	Ct thorax w/o dye	1.16	6.27	NA	0.31	7.74	NA	XXX
71250	26	A	Ct thorax w/o dye	1.16	0.39	0.39	0.05	1.60	1.60	XXX
71250	TC	A	Ct thorax w/o dye	0.00	5.88	NA	0.26	6.14	NA	XXX
71260		A	Ct thorax w/dye	1.24	7.46	NA	0.36	9.06	NA	XXX
71260	26	A	Ct thorax w/dye	1.24	0.42	0.42	0.05	1.71	1.71	XXX
71260	TC	A	Ct thorax w/dye	0.00	7.04	NA	0.31	7.35	NA	XXX
71270		A	Ct thorax w/o&w dye	1.38	9.28	NA	0.44	11.10	NA	XXX
71270	26	A	Ct thorax w/o&w dye	1.38	0.47	0.47	0.06	1.91	1.91	XXX
71270	TC	A	Ct thorax w/o&w dye	0.00	8.81	NA	0.38	9.19	NA	XXX
71275		A	Ct angiography, chest	1.92	9.46	NA	0.38	11.76	NA	XXX
71275	26	A	Ct angiography, chest	1.92	0.65	0.65	0.06	2.63	2.63	XXX
71275	TC	A	Ct angiography, chest	0.00	8.81	NA	0.32	9.13	NA	XXX
71550		A	Mri chest w/o dye	1.46	11.66	NA	0.41	13.53	NA	XXX
71550	26	A	Mri chest w/o dye	1.46	0.50	0.50	0.04	2.00	2.00	XXX
71550	TC	A	Mri chest w/o dye	0.00	11.16	NA	0.37	11.53	NA	XXX
71551		A	Mri chest w/dye	1.73	13.97	NA	0.49	16.19	NA	XXX
71551	26	A	Mri chest w/dye	1.73	0.59	0.59	0.06	2.38	2.38	XXX
71551	TC	A	Mri chest w/dye	0.00	13.38	NA	0.43	13.81	NA	XXX
71552		A	Mri chest w/o&w/dye	2.26	25.55	NA	0.64	28.45	NA	XXX
71552	26	A	Mri chest w/o&w/dye	2.26	0.77	0.77	0.08	3.11	3.11	XXX
71552	TC	A	Mri chest w/o&w/dye	0.00	24.78	NA	0.56	25.34	NA	XXX
71555		R	Mri angio chest w or w/o dye	1.81	11.78	NA	0.57	14.16	NA	XXX
71555	26	R	Mri angio chest w or w/o dye	1.81	0.62	0.62	0.08	2.51	2.51	XXX
71555	TC	R	Mri angio chest w or w/o dye	0.00	11.16	NA	0.49	11.65	NA	XXX
72010		A	X-ray exam of spine	0.45	1.17	NA	0.08	1.70	NA	XXX
72010	26	A	X-ray exam of spine	0.45	0.15	0.15	0.03	0.63	0.63	XXX
72010	TC	A	X-ray exam of spine	0.00	1.02	NA	0.05	1.07	NA	XXX
72020		A	X-ray exam of spine	0.15	0.47	NA	0.03	0.65	NA	XXX
72020	26	A	X-ray exam of spine	0.15	0.05	0.05	0.01	0.21	0.21	XXX
72020	TC	A	X-ray exam of spine	0.00	0.42	NA	0.02	0.44	NA	XXX
72040		A	X-ray exam of neck spine	0.22	0.67	NA	0.04	0.93	NA	XXX
72040	26	A	X-ray exam of neck spine	0.22	0.07	0.07	0.01	0.30	0.30	XXX
72040	TC	A	X-ray exam of neck spine	0.00	0.60	NA	0.03	0.63	NA	XXX
72050		A	X-ray exam of neck spine	0.31	1.00	NA	0.07	1.38	NA	XXX
72050	26	A	X-ray exam of neck spine	0.31	0.11	0.11	0.02	0.44	0.44	XXX
72050	TC	A	X-ray exam of neck spine	0.00	0.89	NA	0.05	0.94	NA	XXX
72052		A	X-ray exam of neck spine	0.36	1.24	NA	0.07	1.67	NA	XXX
72052	26	A	X-ray exam of neck spine	0.36	0.12	0.12	0.02	0.50	0.50	XXX
72052	TC	A	X-ray exam of neck spine	0.00	1.12	NA	0.05	1.17	NA	XXX
72069		A	X-ray exam of trunk spine	0.22	0.57	NA	0.04	0.83	NA	XXX
72069	26	A	X-ray exam of trunk spine	0.22	0.08	0.08	0.02	0.32	0.32	XXX
72069	TC	A	X-ray exam of trunk spine	0.00	0.49	NA	0.02	0.51	NA	XXX
72070		A	X-ray exam of thoracic spine	0.22	0.72	NA	0.04	0.98	NA	XXX
72070	26	A	X-ray exam of thoracic spine	0.22	0.07	0.07	0.01	0.30	0.30	XXX
72070	TC	A	X-ray exam of thoracic spine	0.00	0.65	NA	0.03	0.68	NA	XXX
72072		A	X-ray exam of thoracic spine	0.22	0.81	NA	0.05	1.08	NA	XXX
72072	26	A	X-ray exam of thoracic spine	0.22	0.07	0.07	0.01	0.30	0.30	XXX
72072	TC	A	X-ray exam of thoracic spine	0.00	0.74	NA	0.04	0.78	NA	XXX
72074		A	X-ray exam of thoracic spine	0.22	0.98	NA	0.06	1.26	NA	XXX
72074	26	A	X-ray exam of thoracic spine	0.22	0.07	0.07	0.01	0.30	0.30	XXX
72074	TC	A	X-ray exam of thoracic spine	0.00	0.91	NA	0.05	0.96	NA	XXX
72080		A	X-ray exam of trunk spine	0.22	0.75	NA	0.05	1.02	NA	XXX
72080	26	A	X-ray exam of trunk spine	0.22	0.08	0.08	0.02	0.32	0.32	XXX
72080	TC	A	X-ray exam of trunk spine	0.00	0.67	NA	0.03	0.70	NA	XXX
72090		A	X-ray exam of trunk spine	0.28	0.77	NA	0.05	1.10	NA	XXX
72090	26	A	X-ray exam of trunk spine	0.28	0.10	0.10	0.02	0.40	0.40	XXX
72090	TC	A	X-ray exam of trunk spine	0.00	0.67	NA	0.03	0.70	NA	XXX
72100		A	X-ray exam of lower spine	0.22	0.75	NA	0.05	1.02	NA	XXX
72100	26	A	X-ray exam of lower spine	0.22	0.08	0.08	0.02	0.32	0.32	XXX
72100	TC	A	X-ray exam of lower spine	0.00	0.67	NA	0.03	0.70	NA	XXX
72110		A	X-ray exam of lower spine	0.31	1.02	NA	0.07	1.40	NA	XXX
72110	26	A	X-ray exam of lower spine	0.31	0.11	0.11	0.02	0.44	0.44	XXX
72110	TC	A	X-ray exam of lower spine	0.00	0.91	NA	0.05	0.96	NA	XXX
72114		A	X-ray exam of lower spine	0.36	1.30	NA	0.08	1.74	NA	XXX
72114	26	A	X-ray exam of lower spine	0.36	0.12	0.12	0.03	0.51	0.51	XXX
72114	TC	A	X-ray exam of lower spine	0.00	1.18	NA	0.05	1.23	NA	XXX
72120		A	X-ray exam of lower spine	0.22	0.97	NA	0.07	1.26	NA	XXX
72120	26	A	X-ray exam of lower spine	0.22	0.08	0.08	0.02	0.32	0.32	XXX
72120	TC	A	X-ray exam of lower spine	0.00	0.89	NA	0.05	0.94	NA	XXX
72125		A	Ct neck spine w/o dye	1.16	6.27	NA	0.31	7.74	NA	XXX
72125	26	A	Ct neck spine w/o dye	1.16	0.39	0.39	0.05	1.60	1.60	XXX
72125	TC	A	Ct neck spine w/o dye	0.00	5.88	NA	0.26	6.14	NA	XXX
72126		A	Ct neck spine w/dye	1.22	7.45	NA	0.36	9.03	NA	XXX
72126	26	A	Ct neck spine w/dye	1.22	0.41	0.41	0.05	1.68	1.68	XXX
72126	TC	A	Ct neck spine w/dye	0.00	7.04	NA	0.31	7.35	NA	XXX
72127		A	Ct neck spine w/o&w/dye	1.27	9.24	NA	0.44	10.95	NA	XXX
72127	26	A	Ct neck spine w/o&w/dye	1.27	0.43	0.43	0.06	1.76	1.76	XXX
72127	TC	A	Ct neck spine w/o&w/dye	0.00	8.81	NA	0.38	9.19	NA	XXX
72128		A	Ct chest spine w/o dye	1.16	6.27	NA	0.31	7.74	NA	XXX
72128	26	A	Ct chest spine w/o dye	1.16	0.39	0.39	0.05	1.60	1.60	XXX
72128	TC	A	Ct chest spine w/o dye	0.00	5.88	NA	0.26	6.14	NA	XXX
72129		A	Ct chest spine w/dye	1.22	7.45	NA	0.36	9.03	NA	XXX
72129	26	A	Ct chest spine w/dye	1.22	0.41	0.41	0.05	1.68	1.68	XXX
72129	TC	A	Ct chest spine w/dye	0.00	7.04	NA	0.31	7.35	NA	XXX
72130		A	Ct chest spine w/o&w/dye	1.27	9.24	NA	0.44	10.95	NA	XXX
72130	26	A	Ct chest spine w/o&w/dye	1.27	0.43	0.43	0.06	1.76	1.76	XXX
72130	TC	A	Ct chest spine w/o&w/dye	0.00	8.81	NA	0.38	9.19	NA	XXX
72131		A	Ct lumbar spine w/o dye	1.16	6.28	NA	0.31	7.75	NA	XXX
72131	26	A	Ct lumbar spine w/o dye	1.16	0.40	0.40	0.05	1.61	1.61	XXX
72131	TC	A	Ct lumbar spine w/o dye	0.00	5.88	NA	0.26	6.14	NA	XXX
72132		A	Ct lumbar spine w/dye	1.22	7.45	NA	0.37	9.04	NA	XXX
72132	26	A	Ct lumbar spine w/dye	1.22	0.41	0.41	0.06	1.69	1.69	XXX
72132	TC	A	Ct lumbar spine w/dye	0.00	7.04	NA	0.31	7.35	NA	XXX
72133		A	Ct lumbar spine w/o&w/dye	1.27	9.25	NA	0.44	10.96	NA	XXX
72133	26	A	Ct lumbar spine w/o&w/dye	1.27	0.44	0.44	0.06	1.77	1.77	XXX
72133	TC	A	Ct lumbar spine w/o&w/dye	0.00	8.81	NA	0.38	9.19	NA	XXX
72141		A	Mri neck spine w/o dye	1.60	11.71	NA	0.56	13.87	NA	XXX
72141	26	A	Mri neck spine w/o dye	1.60	0.55	0.55	0.07	2.22	2.22	XXX
72141	TC	A	Mri neck spine w/o dye	0.00	11.16	NA	0.49	11.65	NA	XXX
72142		A	Mri neck spine w/dye	1.92	14.05	NA	0.67	16.64	NA	XXX
72142	26	A	Mri neck spine w/dye	1.92	0.67	0.67	0.09	2.68	2.68	XXX
72142	TC	A	Mri neck spine w/dye	0.00	13.38	NA	0.58	13.96	NA	XXX
72146		A	Mri chest spine w/o dye	1.60	12.94	NA	0.60	15.14	NA	XXX
72146	26	A	Mri chest spine w/o dye	1.60	0.55	0.55	0.07	2.22	2.22	XXX
72146	TC	A	Mri chest spine w/o dye	0.00	12.39	NA	0.53	12.92	NA	XXX
72147		A	Mri chest spine w/dye	1.92	14.04	NA	0.67	16.63	NA	XXX
72147	26	A	Mri chest spine w/dye	1.92	0.66	0.66	0.09	2.67	2.67	XXX
72147	TC	A	Mri chest spine w/dye	0.00	13.38	NA	0.58	13.96	NA	XXX
72148		A	Mri lumbar spine w/o dye	1.48	12.90	NA	0.60	14.98	NA	XXX
72148	26	A	Mri lumbar spine w/o dye	1.48	0.51	0.51	0.07	2.06	2.06	XXX
72148	TC	A	Mri lumbar spine w/o dye	0.00	12.39	NA	0.53	12.92	NA	XXX
72149		A	Mri lumbar spine w/dye	1.78	14.00	NA	0.67	16.45	NA	XXX
72149	26	A	Mri lumbar spine w/dye	1.78	0.62	0.62	0.09	2.49	2.49	XXX
72149	TC	A	Mri lumbar spine w/dye	0.00	13.38	NA	0.58	13.96	NA	XXX
72156		A	Mri neck spine w/o&w/dye	2.57	25.66	NA	1.20	29.43	NA	XXX
72156	26	A	Mri neck spine w/o&w/dye	2.57	0.88	0.88	0.11	3.56	3.56	XXX
72156	TC	A	Mri neck spine w/o&w/dye	0.00	24.78	NA	1.09	25.87	NA	XXX
72157		A	Mri chest spine w/o&w/dye	2.57	25.66	NA	1.20	29.43	NA	XXX
72157	26	A	Mri chest spine w/o&w/dye	2.57	0.88	0.88	0.11	3.56	3.56	XXX
72157	TC	A	Mri chest spine w/o&w/dye	0.00	24.78	NA	1.09	25.87	NA	XXX
72158		A	Mri lumbar spine w/o&w/dye	2.36	25.59	NA	1.20	29.15	NA	XXX
72158	26	A	Mri lumbar spine w/o&w/dye	2.36	0.81	0.81	0.11	3.28	3.28	XXX
72158	TC	A	Mri lumbar spine w/o&w/dye	0.00	24.78	NA	1.09	25.87	NA	XXX
72159		N	Mr angio spine w/o&w/dye	+1.80	13.09	NA	0.61	15.50	NA	XXX
72159	26	N	Mr angio spine w/o&w/dye	+1.80	0.70	0.70	0.08	2.58	2.58	XXX
72159	TC	N	Mr angio spine w/o&w/dye	+0.00	12.39	NA	0.53	12.92	NA	XXX
72170		A	X-ray exam of pelvis	0.17	0.58	NA	0.03	0.78	NA	XXX
72170	26	A	X-ray exam of pelvis	0.17	0.06	0.06	0.01	0.24	0.24	XXX
72170	TC	A	X-ray exam of pelvis	0.00	0.52	NA	0.02	0.54	NA	XXX
72190		A	X-ray exam of pelvis	0.21	0.74	NA	0.04	0.99	NA	XXX
72190	26	A	X-ray exam of pelvis	0.21	0.07	0.07	0.01	0.29	0.29	XXX
72190	TC	A	X-ray exam of pelvis	0.00	0.67	NA	0.03	0.70	NA	XXX
72191		A	Ct angiograph pelv w/o&w/dye	1.81	9.07	NA	0.38	11.26	NA	XXX
72191	26	A	Ct angiograph pelv w/o&w/dye	1.81	0.62	0.62	0.06	2.49	2.49	XXX
72191	TC	A	Ct angiograph pelv w/o&w/dye	0.00	8.45	NA	0.32	8.77	NA	XXX
72192		A	Ct pelvis w/o dye	1.09	6.25	NA	0.31	7.65	NA	XXX
72192	26	A	Ct pelvis w/o dye	1.09	0.37	0.37	0.05	1.51	1.51	XXX
72192	TC	A	Ct pelvis w/o dye	0.00	5.88	NA	0.26	6.14	NA	XXX
72193		A	Ct pelvis w/dye	1.16	7.21	NA	0.35	8.72	NA	XXX
72193	26	A	Ct pelvis w/dye	1.16	0.39	0.39	0.05	1.60	1.60	XXX
72193	TC	A	Ct pelvis w/dye	0.00	6.82	NA	0.30	7.12	NA	XXX
72194		A	Ct pelvis w/o&w/dye	1.22	8.86	NA	0.41	10.49	NA	XXX
72194	26	A	Ct pelvis w/o&w/dye	1.22	0.41	0.41	0.05	1.68	1.68	XXX
72194	TC	A	Ct pelvis w/o&w/dye	0.00	8.45	NA	0.36	8.81	NA	XXX
72195		A	Mri pelvis w/o dye	1.46	11.66	NA	0.42	13.54	NA	XXX
72195	26	A	Mri pelvis w/o dye	1.46	0.50	0.50	0.05	2.01	2.01	XXX
72195	TC	A	Mri pelvis w/o dye	0.00	11.16	NA	0.37	11.53	NA	XXX
72196		A	Mri pelvis w/dye	1.73	13.97	NA	0.48	16.18	NA	XXX
72196	26	A	Mri pelvis w/dye	1.73	0.59	0.59	0.05	2.37	2.37	XXX
72196	TC	A	Mri pelvis w/dye	0.00	13.38	NA	0.43	13.81	NA	XXX
72197		A	Mri pelvis w/o & w/dye	2.26	25.55	NA	0.84	28.65	NA	XXX
72197	26	A	Mri pelvis w/o & w/dye	2.26	0.77	0.77	0.08	3.11	3.11	XXX
72197	TC	A	Mri pelvis w/o & w/dye	0.00	24.78	NA	0.76	25.54	NA	XXX
72198		N	Mr angio pelvis w/o&w/dye	+1.80	11.86	NA	0.57	14.23	NA	XXX
72198	26	N	Mr angio pelvis w/o&w/dye	+1.80	0.70	0.70	0.08	2.58	2.58	XXX
72198	TC	N	Mr angio pelvis w/o&w/dye	+0.00	11.16	NA	0.49	11.65	NA	XXX
72200		A	X-ray exam sacroiliac joints	0.17	0.58	NA	0.03	0.78	NA	XXX
72200	26	A	X-ray exam sacroiliac joints	0.17	0.06	0.06	0.01	0.24	0.24	XXX
72200	TC	A	X-ray exam sacroiliac joints	0.00	0.52	NA	0.02	0.54	NA	XXX
72202		A	X-ray exam sacroiliac joints	0.19	0.68	NA	0.04	0.91	NA	XXX
72202	26	A	X-ray exam sacroiliac joints	0.19	0.06	0.06	0.01	0.26	0.26	XXX
72202	TC	A	X-ray exam sacroiliac joints	0.00	0.62	NA	0.03	0.65	NA	XXX
72220		A	X-ray exam of tailbone	0.17	0.63	NA	0.04	0.84	NA	XXX
72220	26	A	X-ray exam of tailbone	0.17	0.06	0.06	0.01	0.24	0.24	XXX
72220	TC	A	X-ray exam of tailbone	0.00	0.57	NA	0.03	0.60	NA	XXX
72240		A	Contrast x-ray of neck spine	0.91	5.03	NA	0.25	6.19	NA	XXX
72240	26	A	Contrast x-ray of neck spine	0.91	0.30	0.30	0.04	1.25	1.25	XXX
72240	TC	A	Contrast x-ray of neck spine	0.00	4.73	NA	0.21	4.94	NA	XXX
72255		A	Contrast x-ray, thorax spine	0.91	4.59	NA	0.22	5.72	NA	XXX
72255	26	A	Contrast x-ray, thorax spine	0.91	0.28	0.28	0.04	1.23	1.23	XXX
72255	TC	A	Contrast x-ray, thorax spine	0.00	4.31	NA	0.18	4.49	NA	XXX
72265		A	Contrast x-ray, lower spine	0.83	4.31	NA	0.22	5.36	NA	XXX
72265	26	A	Contrast x-ray, lower spine	0.83	0.26	0.26	0.04	1.13	1.13	XXX
72265	TC	A	Contrast x-ray, lower spine	0.00	4.05	NA	0.18	4.23	NA	XXX
72270		A	Contrast x-ray of spine	1.33	6.50	NA	0.34	8.17	NA	XXX
72270	26	A	Contrast x-ray of spine	1.33	0.43	0.43	0.07	1.83	1.83	XXX
72270	TC	A	Contrast x-ray of spine	0.00	6.07	NA	0.27	6.34	NA	XXX
72275		A	Epidurography	0.76	2.29	NA	0.21	3.26	NA	XXX
72275	26	A	Epidurography	0.76	0.20	0.20	0.03	0.99	0.99	XXX
72275	TC	A	Epidurography	0.00	2.09	NA	0.18	2.27	NA	XXX
72285		A	X-ray c/t spine disk	1.16	8.72	NA	0.42	10.30	NA	XXX
72285	26	A	X-ray c/t spine disk	1.16	0.37	0.37	0.06	1.59	1.59	XXX
72285	TC	A	X-ray c/t spine disk	0.00	8.35	NA	0.36	8.71	NA	XXX
72295		A	X-ray of lower spine disk	0.83	8.10	NA	0.37	9.30	NA	XXX
72295	26	A	X-ray of lower spine disk	0.83	0.28	0.28	0.04	1.15	1.15	XXX
72295	TC	A	X-ray of lower spine disk	0.00	7.82	NA	0.33	8.15	NA	XXX
73000		A	X-ray exam of collar bone	0.16	0.57	NA	0.03	0.76	NA	XXX
73000	26	A	X-ray exam of collar bone	0.16	0.05	0.05	0.01	0.22	0.22	XXX
73000	TC	A	X-ray exam of collar bone	0.00	0.52	NA	0.02	0.54	NA	XXX
73010		A	X-ray exam of shoulder blade	0.17	0.58	NA	0.03	0.78	NA	XXX
73010	26	A	X-ray exam of shoulder blade	0.17	0.06	0.06	0.01	0.24	0.24	XXX
73010	TC	A	X-ray exam of shoulder blade	0.00	0.52	NA	0.02	0.54	NA	XXX
73020		A	X-ray exam of shoulder	0.15	0.52	NA	0.03	0.70	NA	XXX
73020	26	A	X-ray exam of shoulder	0.15	0.05	0.05	0.01	0.21	0.21	XXX
73020	TC	A	X-ray exam of shoulder	0.00	0.47	NA	0.02	0.49	NA	XXX
73030		A	X-ray exam of shoulder	0.18	0.63	NA	0.04	0.85	NA	XXX
73030	26	A	X-ray exam of shoulder	0.18	0.06	0.06	0.01	0.25	0.25	XXX
73030	TC	A	X-ray exam of shoulder	0.00	0.57	NA	0.03	0.60	NA	XXX
73040		A	Contrast x-ray of shoulder	0.54	2.27	NA	0.13	2.94	NA	XXX
73040	26	A	Contrast x-ray of shoulder	0.54	0.18	0.18	0.03	0.75	0.75	XXX
73040	TC	A	Contrast x-ray of shoulder	0.00	2.09	NA	0.10	2.19	NA	XXX
73050		A	X-ray exam of shoulders	0.20	0.74	NA	0.05	0.99	NA	XXX
73050	26	A	X-ray exam of shoulders	0.20	0.07	0.07	0.02	0.29	0.29	XXX
73050	TC	A	X-ray exam of shoulders	0.00	0.67	NA	0.03	0.70	NA	XXX
73060		A	X-ray exam of humerus	0.17	0.63	NA	0.04	0.84	NA	XXX
73060	26	A	X-ray exam of humerus	0.17	0.06	0.06	0.01	0.24	0.24	XXX
73060	TC	A	X-ray exam of humerus	0.00	0.57	NA	0.03	0.60	NA	XXX
73070		A	X-ray exam of elbow	0.15	0.57	NA	0.03	0.75	NA	XXX
73070	26	A	X-ray exam of elbow	0.15	0.05	0.05	0.01	0.21	0.21	XXX
73070	TC	A	X-ray exam of elbow	0.00	0.52	NA	0.02	0.54	NA	XXX
73080		A	X-ray exam of elbow	0.17	0.63	NA	0.04	0.84	NA	XXX
73080	26	A	X-ray exam of elbow	0.17	0.06	0.06	0.01	0.24	0.24	XXX
73080	TC	A	X-ray exam of elbow	0.00	0.57	NA	0.03	0.60	NA	XXX
73085		A	Contrast x-ray of elbow	0.54	2.28	NA	0.13	2.95	NA	XXX
73085	26	A	Contrast x-ray of elbow	0.54	0.19	0.19	0.03	0.76	0.76	XXX
73085	TC	A	Contrast x-ray of elbow	0.00	2.09	NA	0.10	2.19	NA	XXX
73090		A	X-ray exam of forearm	0.16	0.57	NA	0.03	0.76	NA	XXX
73090	26	A	X-ray exam of forearm	0.16	0.05	0.05	0.01	0.22	0.22	XXX
73090	TC	A	X-ray exam of forearm	0.00	0.52	NA	0.02	0.54	NA	XXX
73092		A	X-ray exam of arm, infant	0.16	0.54	NA	0.03	0.73	NA	XXX
73092	26	A	X-ray exam of arm, infant	0.16	0.05	0.05	0.01	0.22	0.22	XXX
73092	TC	A	X-ray exam of arm, infant	0.00	0.49	NA	0.02	0.51	NA	XXX
73100		A	X-ray exam of wrist	0.16	0.55	NA	0.04	0.75	NA	XXX
73100	26	A	X-ray exam of wrist	0.16	0.06	0.06	0.02	0.24	0.24	XXX
73100	TC	A	X-ray exam of wrist	0.00	0.49	NA	0.02	0.51	NA	XXX
73110		A	X-ray exam of wrist	0.17	0.59	NA	0.03	0.79	NA	XXX
73110	26	A	X-ray exam of wrist	0.17	0.06	0.06	0.01	0.24	0.24	XXX
73110	TC	A	X-ray exam of wrist	0.00	0.53	NA	0.02	0.55	NA	XXX
73115		A	Contrast x-ray of wrist	0.54	1.76	NA	0.11	2.41	NA	XXX
73115	26	A	Contrast x-ray of wrist	0.54	0.19	0.19	0.03	0.76	0.76	XXX
73115	TC	A	Contrast x-ray of wrist	0.00	1.57	NA	0.08	1.65	NA	XXX
73120		A	X-ray exam of hand	0.16	0.55	NA	0.03	0.74	NA	XXX
73120	26	A	X-ray exam of hand	0.16	0.06	0.06	0.01	0.23	0.23	XXX
73120	TC	A	X-ray exam of hand	0.00	0.49	NA	0.02	0.51	NA	XXX
73130		A	X-ray exam of hand	0.17	0.59	NA	0.03	0.79	NA	XXX
73130	26	A	X-ray exam of hand	0.17	0.06	0.06	0.01	0.24	0.24	XXX
73130	TC	A	X-ray exam of hand	0.00	0.53	NA	0.02	0.55	NA	XXX
73140		A	X-ray exam of finger(s)	0.13	0.46	NA	0.03	0.62	NA	XXX
73140	26	A	X-ray exam of finger(s)	0.13	0.04	0.04	0.01	0.18	0.18	XXX
73140	TC	A	X-ray exam of finger(s)	0.00	0.42	NA	0.02	0.44	NA	XXX
73200		A	Ct upper extremity w/o dye	1.09	5.31	NA	0.26	6.66	NA	XXX
73200	26	A	Ct upper extremity w/o dye	1.09	0.37	0.37	0.05	1.51	1.51	XXX
73200	TC	A	Ct upper extremity w/o dye	0.00	4.94	NA	0.21	5.15	NA	XXX
73201		A	Ct upper extremity w/dye	1.16	6.28	NA	0.31	7.75	NA	XXX
73201	26	A	Ct upper extremity w/dye	1.16	0.40	0.40	0.05	1.61	1.61	XXX
73201	TC	A	Ct upper extremity w/dye	0.00	5.88	NA	0.26	6.14	NA	XXX
73202		A	Ct uppr extremity w/o&w/dye	1.22	7.81	NA	0.38	9.41	NA	XXX
73202	26	A	Ct uppr extremity w/o&w/dye	1.22	0.42	0.42	0.06	1.70	1.70	XXX
73202	TC	A	Ct uppr extremity w/o&w/dye	0.00	7.39	NA	0.32	7.71	NA	XXX
73206		A	Ct angio upr extrm w/o&w/dye	1.81	8.01	NA	0.38	10.20	NA	XXX
73206	26	A	Ct angio upr extrm w/o&w/dye	1.81	0.62	0.62	0.06	2.49	2.49	XXX
73206	TC	A	Ct angio upr extrm w/o&w/dye	0.00	7.39	NA	0.32	7.71	NA	XXX
73218		A	Mri upper extremity w/o dye	1.35	11.62	NA	0.36	13.33	NA	XXX
73218	26	A	Mri upper extremity w/o dye	1.35	0.46	0.46	0.04	1.85	1.85	XXX
73218	TC	A	Mri upper extremity w/o dye	0.00	11.16	NA	0.32	11.48	NA	XXX
73219		A	Mri upper extremity w/dye	1.62	13.94	NA	0.44	16.00	NA	XXX
73219	26	A	Mri upper extremity w/dye	1.62	0.56	0.56	0.05	2.23	2.23	XXX
73219	TC	A	Mri upper extremity w/dye	0.00	13.38	NA	0.39	13.77	NA	XXX
73220		A	Mri uppr extremity w/o&w/dye	2.15	25.52	NA	0.78	28.45	NA	XXX
73220	26	A	Mri uppr extremity w/o&w/dye	2.15	0.74	0.74	0.08	2.97	2.97	XXX
73220	TC	A	Mri uppr extremity w/o&w/dye	0.00	24.78	NA	0.70	25.48	NA	XXX
73221		A	Mri joint upr extrem w/o dye	1.35	11.62	NA	0.36	13.33	NA	XXX
73221	26	A	Mri joint upr extrem w/o dye	1.35	0.46	0.46	0.04	1.85	1.85	XXX
73221	TC	A	Mri joint upr extrem w/o dye	0.00	11.16	NA	0.32	11.48	NA	XXX
73222		A	Mri joint upr extrem w/dye	1.62	13.93	NA	0.44	15.99	NA	XXX
73222	26	A	Mri joint upr extrem w/dye	1.62	0.55	0.55	0.05	2.22	2.22	XXX
73222	TC	A	Mri joint upr extrem w/dye	0.00	13.38	NA	0.39	13.77	NA	XXX
73223		A	Mri joint upr extr w/o&w/dye	2.15	25.52	NA	0.77	28.44	NA	XXX
73223	26	A	Mri joint upr extr w/o&w/dye	2.15	0.74	0.74	0.07	2.96	2.96	XXX
73223	TC	A	Mri joint upr extr w/o&w/dye	0.00	24.78	NA	0.70	25.48	NA	XXX
73225		N	Mr angio upr extr w/o&w/dye	+1.73	11.84	NA	0.57	14.14	NA	XXX
73225	26	N	Mr angio upr extr w/o&w/dye	+1.73	0.68	0.68	0.08	2.49	2.49	XXX
73225	TC	N	Mr angio upr extr w/o&w/dye	+0.00	11.16	NA	0.49	11.65	NA	XXX
73500		A	X-ray exam of hip	0.17	0.53	NA	0.03	0.73	NA	XXX
73500	26	A	X-ray exam of hip	0.17	0.06	0.06	0.01	0.24	0.24	XXX
73500	TC	A	X-ray exam of hip	0.00	0.47	NA	0.02	0.49	NA	XXX
73510		A	X-ray exam of hip	0.21	0.64	NA	0.05	0.90	NA	XXX
73510	26	A	X-ray exam of hip	0.21	0.07	0.07	0.02	0.30	0.30	XXX
73510	TC	A	X-ray exam of hip	0.00	0.57	NA	0.03	0.60	NA	XXX
73520		A	X-ray exam of hips	0.26	0.76	NA	0.05	1.07	NA	XXX
73520	26	A	X-ray exam of hips	0.26	0.09	0.09	0.02	0.37	0.37	XXX
73520	TC	A	X-ray exam of hips	0.00	0.67	NA	0.03	0.70	NA	XXX
73525		A	Contrast x-ray of hip	0.54	2.27	NA	0.13	2.94	NA	XXX
73525	26	A	Contrast x-ray of hip	0.54	0.18	0.18	0.03	0.75	0.75	XXX
73525	TC	A	Contrast x-ray of hip	0.00	2.09	NA	0.10	2.19	NA	XXX
73530		A	X-ray exam of hip	0.29	0.62	NA	0.03	0.94	NA	XXX
73530	26	A	X-ray exam of hip	0.29	0.10	0.10	0.01	0.40	0.40	XXX
73530	TC	A	X-ray exam of hip	0.00	0.52	NA	0.02	0.54	NA	XXX
73540		A	X-ray exam of pelvis & hips	0.20	0.64	NA	0.05	0.89	NA	XXX
73540	26	A	X-ray exam of pelvis & hips	0.20	0.07	0.07	0.02	0.29	0.29	XXX
73540	TC	A	X-ray exam of pelvis & hips	0.00	0.57	NA	0.03	0.60	NA	XXX
73542		A	X-ray exam, sacroiliac joint	0.59	2.26	NA	0.13	2.98	NA	XXX
73542	26	A	X-ray exam, sacroiliac joint	0.59	0.17	0.17	0.03	0.79	0.79	XXX
73542	TC	A	X-ray exam, sacroiliac joint	0.00	2.09	NA	0.10	2.19	NA	XXX
73550		A	X-ray exam of thigh	0.17	0.63	NA	0.04	0.84	NA	XXX
73550	26	A	X-ray exam of thigh	0.17	0.06	0.06	0.01	0.24	0.24	XXX
73550	TC	A	X-ray exam of thigh	0.00	0.57	NA	0.03	0.60	NA	XXX
73560		A	X-ray exam of knee, 1 or 2	0.17	0.58	NA	0.04	0.79	NA	XXX
73560	26	A	X-ray exam of knee, 1 or 2	0.17	0.06	0.06	0.02	0.25	0.25	XXX
73560	TC	A	X-ray exam of knee, 1 or 2	0.00	0.52	NA	0.02	0.54	NA	XXX
73562		A	X-ray exam of knee, 3	0.18	0.63	NA	0.05	0.86	NA	XXX
73562	26	A	X-ray exam of knee, 3	0.18	0.06	0.06	0.02	0.26	0.26	XXX
73562	TC	A	X-ray exam of knee, 3	0.00	0.57	NA	0.03	0.60	NA	XXX
73564		A	X-ray exam, knee, 4 or more	0.22	0.70	NA	0.05	0.97	NA	XXX
73564	26	A	X-ray exam, knee, 4 or more	0.22	0.08	0.08	0.02	0.32	0.32	XXX
73564	TC	A	X-ray exam, knee, 4 or more	0.00	0.62	NA	0.03	0.65	NA	XXX
73565		A	X-ray exam of knees	0.17	0.55	NA	0.04	0.76	NA	XXX
73565	26	A	X-ray exam of knees	0.17	0.06	0.06	0.02	0.25	0.25	XXX
73565	TC	A	X-ray exam of knees	0.00	0.49	NA	0.02	0.51	NA	XXX
73580		A	Contrast x-ray of knee joint	0.54	2.79	NA	0.15	3.48	NA	XXX
73580	26	A	Contrast x-ray of knee joint	0.54	0.18	0.18	0.03	0.75	0.75	XXX
73580	TC	A	Contrast x-ray of knee joint	0.00	2.61	NA	0.12	2.73	NA	XXX
73590		A	X-ray exam of lower leg	0.17	0.58	NA	0.03	0.78	NA	XXX
73590	26	A	X-ray exam of lower leg	0.17	0.06	0.06	0.01	0.24	0.24	XXX
73590	TC	A	X-ray exam of lower leg	0.00	0.52	NA	0.02	0.54	NA	XXX
73592		A	X-ray exam of leg, infant	0.16	0.55	NA	0.03	0.74	NA	XXX
73592	26	A	X-ray exam of leg, infant	0.16	0.06	0.06	0.01	0.23	0.23	XXX
73592	TC	A	X-ray exam of leg, infant	0.00	0.49	NA	0.02	0.51	NA	XXX
73600		A	X-ray exam of ankle	0.16	0.55	NA	0.03	0.74	NA	XXX
73600	26	A	X-ray exam of ankle	0.16	0.06	0.06	0.01	0.23	0.23	XXX
73600	TC	A	X-ray exam of ankle	0.00	0.49	NA	0.02	0.51	NA	XXX
73610		A	X-ray exam of ankle	0.17	0.59	NA	0.03	0.79	NA	XXX
73610	26	A	X-ray exam of ankle	0.17	0.06	0.06	0.01	0.24	0.24	XXX
73610	TC	A	X-ray exam of ankle	0.00	0.53	NA	0.02	0.55	NA	XXX
73615		A	Contrast x-ray of ankle	0.54	2.28	NA	0.13	2.95	NA	XXX
73615	26	A	Contrast x-ray of ankle	0.54	0.19	0.19	0.03	0.76	0.76	XXX
73615	TC	A	Contrast x-ray of ankle	0.00	2.09	NA	0.10	2.19	NA	XXX
73620		A	X-ray exam of foot	0.16	0.55	NA	0.03	0.74	NA	XXX
73620	26	A	X-ray exam of foot	0.16	0.06	0.06	0.01	0.23	0.23	XXX
73620	TC	A	X-ray exam of foot	0.00	0.49	NA	0.02	0.51	NA	XXX
73630		A	X-ray exam of foot	0.17	0.59	NA	0.03	0.79	NA	XXX
73630	26	A	X-ray exam of foot	0.17	0.06	0.06	0.01	0.24	0.24	XXX
73630	TC	A	X-ray exam of foot	0.00	0.53	NA	0.02	0.55	NA	XXX
73650		A	X-ray exam of heel	0.16	0.53	NA	0.03	0.72	NA	XXX
73650	26	A	X-ray exam of heel	0.16	0.06	0.06	0.01	0.23	0.23	XXX
73650	TC	A	X-ray exam of heel	0.00	0.47	NA	0.02	0.49	NA	XXX
73660		A	X-ray exam of toe(s)	0.13	0.46	NA	0.03	0.62	NA	XXX
73660	26	A	X-ray exam of toe(s)	0.13	0.04	0.04	0.01	0.18	0.18	XXX
73660	TC	A	X-ray exam of toe(s)	0.00	0.42	NA	0.02	0.44	NA	XXX
73700		A	Ct lower extremity w/o dye	1.09	5.31	NA	0.26	6.66	NA	XXX
73700	26	A	Ct lower extremity w/o dye	1.09	0.37	0.37	0.05	1.51	1.51	XXX
73700	TC	A	Ct lower extremity w/o dye	0.00	4.94	NA	0.21	5.15	NA	XXX
73701		A	Ct lower extremity w/dye	1.16	6.27	NA	0.31	7.74	NA	XXX
73701	26	A	Ct lower extremity w/dye	1.16	0.39	0.39	0.05	1.60	1.60	XXX
73701	TC	A	Ct lower extremity w/dye	0.00	5.88	NA	0.26	6.14	NA	XXX
73702		A	Ct lwr extremity w/o&w/dye	1.22	7.80	NA	0.37	9.39	NA	XXX
73702	26	A	Ct lwr extremity w/o&w/dye	1.22	0.41	0.41	0.05	1.68	1.68	XXX
73702	TC	A	Ct lwr extremity w/o&w/dye	0.00	7.39	NA	0.32	7.71	NA	XXX
73706		A	Ct angio lwr extr w/o&w/dye	1.90	8.04	NA	0.38	10.32	NA	XXX
73706	26	A	Ct angio lwr extr w/o&w/dye	1.90	0.65	0.65	0.06	2.61	2.61	XXX
73706	TC	A	Ct angio lwr extr w/o&w/dye	0.00	7.39	NA	0.32	7.71	NA	XXX
73718		A	Mri lower extremity w/o dye	1.35	11.62	NA	0.36	13.33	NA	XXX
73718	26	A	Mri lower extremity w/o dye	1.35	0.46	0.46	0.04	1.85	1.85	XXX
73718	TC	A	Mri lower extremity w/o dye	0.00	11.16	NA	0.32	11.48	NA	XXX
73719		A	Mri lower extremity w/dye	1.62	13.93	NA	0.44	15.99	NA	XXX
73719	26	A	Mri lower extremity w/dye	1.62	0.55	0.55	0.05	2.22	2.22	XXX
73719	TC	A	Mri lower extremity w/dye	0.00	13.38	NA	0.39	13.77	NA	XXX
73720		A	Mri lwr extremity w/o&w/dye	2.15	25.51	NA	0.78	28.44	NA	XXX
73720	26	A	Mri lwr extremity w/o&w/dye	2.15	0.73	0.73	0.08	2.96	2.96	XXX
73720	TC	A	Mri lwr extremity w/o&w/dye	0.00	24.78	NA	0.70	25.48	NA	XXX
73721		A	Mri jnt of lwr extre w/o dye	1.35	11.62	NA	0.36	13.33	NA	XXX
73721	26	A	Mri jnt of lwr extre w/o dye	1.35	0.46	0.46	0.04	1.85	1.85	XXX
73721	TC	A	Mri jnt of lwr extre w/o dye	0.00	11.16	NA	0.32	11.48	NA	XXX
73722		A	Mri joint of lwr extr w/dye	1.62	13.94	NA	0.45	16.01	NA	XXX
73722	26	A	Mri joint of lwr extr w/dye	1.62	0.56	0.56	0.06	2.24	2.24	XXX
73722	TC	A	Mri joint of lwr extr w/dye	0.00	13.38	NA	0.39	13.77	NA	XXX
73723		A	Mri joint lwr extr w/o&w/dye	2.15	25.52	NA	0.77	28.44	NA	XXX
73723	26	A	Mri joint lwr extr w/o&w/dye	2.15	0.74	0.74	0.07	2.96	2.96	XXX
73723	TC	A	Mri joint lwr extr w/o&w/dye	0.00	24.78	NA	0.70	25.48	NA	XXX
73725		R	Mr ang lwr ext w or w/o dye	1.82	11.78	NA	0.57	14.17	NA	XXX
73725	26	R	Mr ang lwr ext w or w/o dye	1.82	0.62	0.62	0.08	2.52	2.52	XXX
73725	TC	R	Mr ang lwr ext w or w/o dye	0.00	11.16	NA	0.49	11.65	NA	XXX
74000		A	X-ray exam of abdomen	0.18	0.58	NA	0.03	0.79	NA	XXX
74000	26	A	X-ray exam of abdomen	0.18	0.06	0.06	0.01	0.25	0.25	XXX
74000	TC	A	X-ray exam of abdomen	0.00	0.52	NA	0.02	0.54	NA	XXX
74010		A	X-ray exam of abdomen	0.23	0.65	NA	0.04	0.92	NA	XXX
74010	26	A	X-ray exam of abdomen	0.23	0.08	0.08	0.01	0.32	0.32	XXX
74010	TC	A	X-ray exam of abdomen	0.00	0.57	NA	0.03	0.60	NA	XXX
74020		A	X-ray exam of abdomen	0.27	0.71	NA	0.04	1.02	NA	XXX
74020	26	A	X-ray exam of abdomen	0.27	0.09	0.09	0.01	0.37	0.37	XXX
74020	TC	A	X-ray exam of abdomen	0.00	0.62	NA	0.03	0.65	NA	XXX
74022		A	X-ray exam series, abdomen	0.32	0.85	NA	0.05	1.22	NA	XXX
74022	26	A	X-ray exam series, abdomen	0.32	0.11	0.11	0.01	0.44	0.44	XXX
74022	TC	A	X-ray exam series, abdomen	0.00	0.74	NA	0.04	0.78	NA	XXX
74150		A	Ct abdomen w/o dye	1.19	6.03	NA	0.30	7.52	NA	XXX
74150	26	A	Ct abdomen w/o dye	1.19	0.40	0.40	0.05	1.64	1.64	XXX
74150	TC	A	Ct abdomen w/o dye	0.00	5.63	NA	0.25	5.88	NA	XXX
74160		A	Ct abdomen w/dye	1.27	7.25	NA	0.36	8.88	NA	XXX
74160	26	A	Ct abdomen w/dye	1.27	0.43	0.43	0.06	1.76	1.76	XXX
74160	TC	A	Ct abdomen w/dye	0.00	6.82	NA	0.30	7.12	NA	XXX
74170		A	Ct abdomen w/o&w/dye	1.40	8.93	NA	0.42	10.75	NA	XXX
74170	26	A	Ct abdomen w/o&w/dye	1.40	0.48	0.48	0.06	1.94	1.94	XXX
74170	TC	A	Ct abdomen w/o&w/dye	0.00	8.45	NA	0.36	8.81	NA	XXX
74175		A	Ct angio abdom w/o&w/dye	1.90	9.10	NA	0.38	11.38	NA	XXX
74175	26	A	Ct angio abdom w/o&w/dye	1.90	0.65	0.65	0.06	2.61	2.61	XXX
74175	TC	A	Ct angio abdom w/o&w/dye	0.00	8.45	NA	0.32	8.77	NA	XXX
74181		A	Mri abdomen w/o dye	1.46	11.66	NA	0.43	13.55	NA	XXX
74181	26	A	Mri abdomen w/o dye	1.46	0.50	0.50	0.06	2.02	2.02	XXX
74181	TC	A	Mri abdomen w/o dye	0.00	11.16	NA	0.37	11.53	NA	XXX
74182		A	Mri abdomen w/dye	1.73	13.97	NA	0.49	16.19	NA	XXX
74182	26	A	Mri abdomen w/dye	1.73	0.59	0.59	0.06	2.38	2.38	XXX
74182	TC	A	Mri abdomen w/dye	0.00	13.38	NA	0.43	13.81	NA	XXX
74183		A	Mri abdomen w/o&w/dye	2.26	25.55	NA	0.84	28.65	NA	XXX
74183	26	A	Mri abdomen w/o&w/dye	2.26	0.77	0.77	0.08	3.11	3.11	XXX
74183	TC	A	Mri abdomen w/o&w/dye	0.00	24.78	NA	0.76	25.54	NA	XXX
74185		R	Mri angio, abdom w or w/o dy	1.80	11.77	NA	0.57	14.14	NA	XXX
74185	26	R	Mri angio, abdom w or w/o dy	1.80	0.61	0.61	0.08	2.49	2.49	XXX
74185	TC	R	Mri angio, abdom w or w/o dy	0.00	11.16	NA	0.49	11.65	NA	XXX
74190		A	X-ray exam of peritoneum	0.48	1.46	NA	0.08	2.02	NA	XXX
74190	26	A	X-ray exam of peritoneum	0.48	0.16	0.16	0.02	0.66	0.66	XXX
74190	TC	A	X-ray exam of peritoneum	0.00	1.30	NA	0.06	1.36	NA	XXX
74210		A	Contrst x-ray exam of throat	0.36	1.30	NA	0.07	1.73	NA	XXX
74210	26	A	Contrst x-ray exam of throat	0.36	0.12	0.12	0.02	0.50	0.50	XXX
74210	TC	A	Contrst x-ray exam of throat	0.00	1.18	NA	0.05	1.23	NA	XXX
74220		A	Contrast x-ray, esophagus	0.46	1.34	NA	0.07	1.87	NA	XXX
74220	26	A	Contrast x-ray, esophagus	0.46	0.16	0.16	0.02	0.64	0.64	XXX
74220	TC	A	Contrast x-ray, esophagus	0.00	1.18	NA	0.05	1.23	NA	XXX
74230		A	Cine/vid x-ray, throat/esoph	0.53	1.48	NA	0.08	2.09	NA	XXX
74230	26	A	Cine/vid x-ray, throat/esoph	0.53	0.18	0.18	0.02	0.73	0.73	XXX
74230	TC	A	Cine/vid x-ray, throat/esoph	0.00	1.30	NA	0.06	1.36	NA	XXX
74235		A	Remove esophagus obstruction	1.19	3.02	NA	0.17	4.38	NA	XXX
74235	26	A	Remove esophagus obstruction	1.19	0.41	0.41	0.05	1.65	1.65	XXX
74235	TC	A	Remove esophagus obstruction	0.00	2.61	NA	0.12	2.73	NA	XXX
74240		A	X-ray exam, upper gi tract	0.69	1.68	NA	0.10	2.47	NA	XXX
74240	26	A	X-ray exam, upper gi tract	0.69	0.23	0.23	0.03	0.95	0.95	XXX
74240	TC	A	X-ray exam, upper gi tract	0.00	1.45	NA	0.07	1.52	NA	XXX
74241		A	X-ray exam, upper gi tract	0.69	1.71	NA	0.10	2.50	NA	XXX
74241	26	A	X-ray exam, upper gi tract	0.69	0.23	0.23	0.03	0.95	0.95	XXX
74241	TC	A	X-ray exam, upper gi tract	0.00	1.48	NA	0.07	1.55	NA	XXX
74245		A	X-ray exam, upper gi tract	0.91	2.68	NA	0.15	3.74	NA	XXX
74245	26	A	X-ray exam, upper gi tract	0.91	0.31	0.31	0.04	1.26	1.26	XXX
74245	TC	A	X-ray exam, upper gi tract	0.00	2.37	NA	0.11	2.48	NA	XXX
74246		A	Contrst x-ray uppr gi tract	0.69	1.86	NA	0.11	2.66	NA	XXX
74246	26	A	Contrst x-ray uppr gi tract	0.69	0.23	0.23	0.03	0.95	0.95	XXX
74246	TC	A	Contrst x-ray uppr gi tract	0.00	1.63	NA	0.08	1.71	NA	XXX
74247		A	Contrst x-ray uppr gi tract	0.69	1.90	NA	0.12	2.71	NA	XXX
74247	26	A	Contrst x-ray uppr gi tract	0.69	0.23	0.23	0.03	0.95	0.95	XXX
74247	TC	A	Contrst x-ray uppr gi tract	0.00	1.67	NA	0.09	1.76	NA	XXX
74249		A	Contrst x-ray uppr gi tract	0.91	2.87	NA	0.16	3.94	NA	XXX
74249	26	A	Contrst x-ray uppr gi tract	0.91	0.31	0.31	0.04	1.26	1.26	XXX
74249	TC	A	Contrst x-ray uppr gi tract	0.00	2.56	NA	0.12	2.68	NA	XXX
74250		A	X-ray exam of small bowel	0.47	1.46	NA	0.08	2.01	NA	XXX
74250	26	A	X-ray exam of small bowel	0.47	0.16	0.16	0.02	0.65	0.65	XXX
74250	TC	A	X-ray exam of small bowel	0.00	1.30	NA	0.06	1.36	NA	XXX
74251		A	X-ray exam of small bowel	0.69	1.53	NA	0.09	2.31	NA	XXX
74251	26	A	X-ray exam of small bowel	0.69	0.23	0.23	0.03	0.95	0.95	XXX
74251	TC	A	X-ray exam of small bowel	0.00	1.30	NA	0.06	1.36	NA	XXX
74260		A	X-ray exam of small bowel	0.50	1.65	NA	0.09	2.24	NA	XXX
74260	26	A	X-ray exam of small bowel	0.50	0.17	0.17	0.02	0.69	0.69	XXX
74260	TC	A	X-ray exam of small bowel	0.00	1.48	NA	0.07	1.55	NA	XXX
74270		A	Contrast x-ray exam of colon	0.69	1.92	NA	0.12	2.73	NA	XXX
74270	26	A	Contrast x-ray exam of colon	0.69	0.23	0.23	0.03	0.95	0.95	XXX
74270	TC	A	Contrast x-ray exam of colon	0.00	1.69	NA	0.09	1.78	NA	XXX
74280		A	Contrast x-ray exam of colon	0.99	2.56	NA	0.15	3.70	NA	XXX
74280	26	A	Contrast x-ray exam of colon	0.99	0.34	0.34	0.04	1.37	1.37	XXX
74280	TC	A	Contrast x-ray exam of colon	0.00	2.22	NA	0.11	2.33	NA	XXX
74283		A	Contrast x-ray exam of colon	2.02	3.24	NA	0.21	5.47	NA	XXX
74283	26	A	Contrast x-ray exam of colon	2.02	0.69	0.69	0.09	2.80	2.80	XXX
74283	TC	A	Contrast x-ray exam of colon	0.00	2.55	NA	0.12	2.67	NA	XXX
74290		A	Contrast x-ray, gallbladder	0.32	0.85	NA	0.05	1.22	NA	XXX
74290	26	A	Contrast x-ray, gallbladder	0.32	0.11	0.11	0.01	0.44	0.44	XXX
74290	TC	A	Contrast x-ray, gallbladder	0.00	0.74	NA	0.04	0.78	NA	XXX
74291		A	Contrast x-rays, gallbladder	0.20	0.49	NA	0.03	0.72	NA	XXX
74291	26	A	Contrast x-rays, gallbladder	0.20	0.07	0.07	0.01	0.28	0.28	XXX
74291	TC	A	Contrast x-rays, gallbladder	0.00	0.42	NA	0.02	0.44	NA	XXX
74300		C	X-ray bile ducts/pancreas	0.00	0.00	0.00	0.00	0.00	0.00	XXX
74300	26	A	X-ray bile ducts/pancreas	0.36	0.12	0.12	0.02	0.50	0.50	XXX
74300	TC	C	X-ray bile ducts/pancreas	0.00	0.00	0.00	0.00	0.00	0.00	XXX
74301		C	X-rays at surgery add-on	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
74301	26	A	X-rays at surgery add-on	0.21	0.07	0.07	0.01	0.29	0.29	ZZZ
74301	TC	C	X-rays at surgery add-on	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
74305		A	X-ray bile ducts/pancreas	0.42	0.92	NA	0.06	1.40	NA	XXX
74305	26	A	X-ray bile ducts/pancreas	0.42	0.14	0.14	0.02	0.58	0.58	XXX
74305	TC	A	X-ray bile ducts/pancreas	0.00	0.78	NA	0.04	0.82	NA	XXX
74320		A	Contrast x-ray of bile ducts	0.54	3.31	NA	0.16	4.01	NA	XXX
74320	26	A	Contrast x-ray of bile ducts	0.54	0.18	0.18	0.02	0.74	0.74	XXX
74320	TC	A	Contrast x-ray of bile ducts	0.00	3.13	NA	0.14	3.27	NA	XXX
74327		A	X-ray bile stone removal	0.70	1.99	NA	0.12	2.81	NA	XXX
74327	26	A	X-ray bile stone removal	0.70	0.24	0.24	0.03	0.97	0.97	XXX
74327	TC	A	X-ray bile stone removal	0.00	1.75	NA	0.09	1.84	NA	XXX
74328		A	X-ray bile duct endoscopy	0.70	3.37	NA	0.17	4.24	NA	XXX
74328	26	A	X-ray bile duct endoscopy	0.70	0.24	0.24	0.03	0.97	0.97	XXX
74328	TC	A	X-ray bile duct endoscopy	0.00	3.13	NA	0.14	3.27	NA	XXX
74329		A	X-ray for pancreas endoscopy	0.70	3.37	NA	0.17	4.24	NA	XXX
74329	26	A	X-ray for pancreas endoscopy	0.70	0.24	0.24	0.03	0.97	0.97	XXX
74329	TC	A	X-ray for pancreas endoscopy	0.00	3.13	NA	0.14	3.27	NA	XXX
74330		A	X-ray bile/panc endoscopy	0.90	3.44	NA	0.18	4.52	NA	XXX
74330	26	A	X-ray bile/panc endoscopy	0.90	0.31	0.31	0.04	1.25	1.25	XXX
74330	TC	A	X-ray bile/panc endoscopy	0.00	3.13	NA	0.14	3.27	NA	XXX
74340		A	X-ray guide for GI tube	0.54	2.79	NA	0.14	3.47	NA	XXX
74340	26	A	X-ray guide for GI tube	0.54	0.18	0.18	0.02	0.74	0.74	XXX
74340	TC	A	X-ray guide for GI tube	0.00	2.61	NA	0.12	2.73	NA	XXX
74350		A	X-ray guide, stomach tube	0.76	3.39	NA	0.17	4.32	NA	XXX
74350	26	A	X-ray guide, stomach tube	0.76	0.26	0.26	0.03	1.05	1.05	XXX
74350	TC	A	X-ray guide, stomach tube	0.00	3.13	NA	0.14	3.27	NA	XXX
74355		A	X-ray guide, intestinal tube	0.76	2.87	NA	0.15	3.78	NA	XXX
74355	26	A	X-ray guide, intestinal tube	0.76	0.26	0.26	0.03	1.05	1.05	XXX
74355	TC	A	X-ray guide, intestinal tube	0.00	2.61	NA	0.12	2.73	NA	XXX
74360		A	X-ray guide, GI dilation	0.54	3.32	NA	0.16	4.02	NA	XXX
74360	26	A	X-ray guide, GI dilation	0.54	0.19	0.19	0.02	0.75	0.75	XXX
74360	TC	A	X-ray guide, GI dilation	0.00	3.13	NA	0.14	3.27	NA	XXX
74363		A	X-ray, bile duct dilation	0.88	6.37	NA	0.31	7.56	NA	XXX
74363	26	A	X-ray, bile duct dilation	0.88	0.30	0.30	0.04	1.22	1.22	XXX
74363	TC	A	X-ray, bile duct dilation	0.00	6.07	NA	0.27	6.34	NA	XXX
74400		A	Contrst x-ray, urinary tract	0.49	1.84	NA	0.11	2.44	NA	XXX
74400	26	A	Contrst x-ray, urinary tract	0.49	0.17	0.17	0.02	0.68	0.68	XXX
74400	TC	A	Contrst x-ray, urinary tract	0.00	1.67	NA	0.09	1.76	NA	XXX
74410		A	Contrst x-ray, urinary tract	0.49	2.11	NA	0.11	2.71	NA	XXX
74410	26	A	Contrst x-ray, urinary tract	0.49	0.17	0.17	0.02	0.68	0.68	XXX
74410	TC	A	Contrst x-ray, urinary tract	0.00	1.94	NA	0.09	2.03	NA	XXX
74415		A	Contrst x-ray, urinary tract	0.49	2.28	NA	0.12	2.89	NA	XXX
74415	26	A	Contrst x-ray, urinary tract	0.49	0.17	0.17	0.02	0.68	0.68	XXX
74415	TC	A	Contrst x-ray, urinary tract	0.00	2.11	NA	0.10	2.21	NA	XXX
74420		A	Contrst x-ray, urinary tract	0.36	2.73	NA	0.14	3.23	NA	XXX
74420	26	A	Contrst x-ray, urinary tract	0.36	0.12	0.12	0.02	0.50	0.50	XXX
74420	TC	A	Contrst x-ray, urinary tract	0.00	2.61	NA	0.12	2.73	NA	XXX
74425		A	Contrst x-ray, urinary tract	0.36	1.42	NA	0.08	1.86	NA	XXX
74425	26	A	Contrst x-ray, urinary tract	0.36	0.12	0.12	0.02	0.50	0.50	XXX
74425	TC	A	Contrst x-ray, urinary tract	0.00	1.30	NA	0.06	1.36	NA	XXX
74430		A	Contrast x-ray, bladder	0.32	1.15	NA	0.07	1.54	NA	XXX
74430	26	A	Contrast x-ray, bladder	0.32	0.11	0.11	0.02	0.45	0.45	XXX
74430	TC	A	Contrast x-ray, bladder	0.00	1.04	NA	0.05	1.09	NA	XXX
74440		A	X-ray, male genital tract	0.38	1.25	NA	0.07	1.70	NA	XXX
74440	26	A	X-ray, male genital tract	0.38	0.13	0.13	0.02	0.53	0.53	XXX
74440	TC	A	X-ray, male genital tract	0.00	1.12	NA	0.05	1.17	NA	XXX
74445		A	X-ray exam of penis	1.14	1.50	NA	0.10	2.74	NA	XXX
74445	26	A	X-ray exam of penis	1.14	0.38	0.38	0.05	1.57	1.57	XXX
74445	TC	A	X-ray exam of penis	0.00	1.12	NA	0.05	1.17	NA	XXX
74450		A	X-ray, urethra/bladder	0.33	1.56	NA	0.09	1.98	NA	XXX
74450	26	A	X-ray, urethra/bladder	0.33	0.11	0.11	0.02	0.46	0.46	XXX
74450	TC	A	X-ray, urethra/bladder	0.00	1.45	NA	0.07	1.52	NA	XXX
74455		A	X-ray, urethra/bladder	0.33	1.68	NA	0.10	2.11	NA	XXX
74455	26	A	X-ray, urethra/bladder	0.33	0.11	0.11	0.02	0.46	0.46	XXX
74455	TC	A	X-ray, urethra/bladder	0.00	1.57	NA	0.08	1.65	NA	XXX
74470		A	X-ray exam of kidney lesion	0.54	1.42	NA	0.08	2.04	NA	XXX
74470	26	A	X-ray exam of kidney lesion	0.54	0.18	0.18	0.02	0.74	0.74	XXX
74470	TC	A	X-ray exam of kidney lesion	0.00	1.24	NA	0.06	1.30	NA	XXX
74475		A	X-ray control, cath insert	0.54	4.23	NA	0.20	4.97	NA	XXX
74475	26	A	X-ray control, cath insert	0.54	0.18	0.18	0.02	0.74	0.74	XXX
74475	TC	A	X-ray control, cath insert	0.00	4.05	NA	0.18	4.23	NA	XXX
74480		A	X-ray control, cath insert	0.54	4.23	NA	0.20	4.97	NA	XXX
74480	26	A	X-ray control, cath insert	0.54	0.18	0.18	0.02	0.74	0.74	XXX
74480	TC	A	X-ray control, cath insert	0.00	4.05	NA	0.18	4.23	NA	XXX
74485		A	X-ray guide, GU dilation	0.54	3.31	NA	0.17	4.02	NA	XXX
74485	26	A	X-ray guide, GU dilation	0.54	0.18	0.18	0.03	0.75	0.75	XXX
74485	TC	A	X-ray guide, GU dilation	0.00	3.13	NA	0.14	3.27	NA	XXX
74710		A	X-ray measurement of pelvis	0.34	1.16	NA	0.07	1.57	NA	XXX
74710	26	A	X-ray measurement of pelvis	0.34	0.12	0.12	0.02	0.48	0.48	XXX
74710	TC	A	X-ray measurement of pelvis	0.00	1.04	NA	0.05	1.09	NA	XXX
74740		A	X-ray, female genital tract	0.38	1.43	NA	0.08	1.89	NA	XXX
74740	26	A	X-ray, female genital tract	0.38	0.13	0.13	0.02	0.53	0.53	XXX
74740	TC	A	X-ray, female genital tract	0.00	1.30	NA	0.06	1.36	NA	XXX
74742		A	X-ray, fallopian tube	0.61	3.34	NA	0.16	4.11	NA	XXX
74742	26	A	X-ray, fallopian tube	0.61	0.21	0.21	0.02	0.84	0.84	XXX
74742	TC	A	X-ray, fallopian tube	0.00	3.13	NA	0.14	3.27	NA	XXX
74775		A	X-ray exam of perineum	0.62	1.67	NA	0.10	2.39	NA	XXX
74775	26	A	X-ray exam of perineum	0.62	0.22	0.22	0.03	0.87	0.87	XXX
74775	TC	A	X-ray exam of perineum	0.00	1.45	NA	0.07	1.52	NA	XXX
75552		A	Heart mri for morph w/o dye	1.60	11.71	NA	0.56	13.87	NA	XXX
75552	26	A	Heart mri for morph w/o dye	1.60	0.55	0.55	0.07	2.22	2.22	XXX
75552	TC	A	Heart mri for morph w/o dye	0.00	11.16	NA	0.49	11.65	NA	XXX
75553		A	Heart mri for morph w/dye	2.00	11.84	NA	0.58	14.42	NA	XXX
75553	26	A	Heart mri for morph w/dye	2.00	0.68	0.68	0.09	2.77	2.77	XXX
75553	TC	A	Heart mri for morph w/dye	0.00	11.16	NA	0.49	11.65	NA	XXX
75554		A	Cardiac MRI/function	1.83	11.83	NA	0.56	14.22	NA	XXX
75554	26	A	Cardiac MRI/function	1.83	0.67	0.67	0.07	2.57	2.57	XXX
75554	TC	A	Cardiac MRI/function	0.00	11.16	NA	0.49	11.65	NA	XXX
75555		A	Cardiac MRI/limited study	1.74	11.82	NA	0.56	14.12	NA	XXX
75555	26	A	Cardiac MRI/limited study	1.74	0.66	0.66	0.07	2.47	2.47	XXX
75555	TC	A	Cardiac MRI/limited study	0.00	11.16	NA	0.49	11.65	NA	XXX
75556		N	Cardiac MRI/flow mapping	0.00	0.00	0.00	0.00	0.00	0.00	XXX
75600		A	Contrast x-ray exam of aorta	0.49	12.74	NA	0.56	13.79	NA	XXX
75600	26	A	Contrast x-ray exam of aorta	0.49	0.19	0.19	0.02	0.70	0.70	XXX
75600	TC	A	Contrast x-ray exam of aorta	0.00	12.55	NA	0.54	13.09	NA	XXX
75605		A	Contrast x-ray exam of aorta	1.14	12.96	NA	0.59	14.69	NA	XXX
75605	26	A	Contrast x-ray exam of aorta	1.14	0.41	0.41	0.05	1.60	1.60	XXX
75605	TC	A	Contrast x-ray exam of aorta	0.00	12.55	NA	0.54	13.09	NA	XXX
75625		A	Contrast x-ray exam of aorta	1.14	12.94	NA	0.59	14.67	NA	XXX
75625	26	A	Contrast x-ray exam of aorta	1.14	0.39	0.39	0.05	1.58	1.58	XXX
75625	TC	A	Contrast x-ray exam of aorta	0.00	12.55	NA	0.54	13.09	NA	XXX
75630		A	X-ray aorta, leg arteries	1.79	13.72	NA	0.65	16.16	NA	XXX
75630	26	A	X-ray aorta, leg arteries	1.79	0.64	0.64	0.08	2.51	2.51	XXX
75630	TC	A	X-ray aorta, leg arteries	0.00	13.08	NA	0.57	13.65	NA	XXX
75635		A	Ct angio abdominal arteries	2.40	16.66	NA	0.41	19.47	NA	XXX
75635	26	A	Ct angio abdominal arteries	2.40	0.82	0.82	0.09	3.31	3.31	XXX
75635	TC	A	Ct angio abdominal arteries	0.00	15.84	NA	0.32	16.16	NA	XXX
75650		A	Artery x-rays, head & neck	1.49	13.06	NA	0.61	15.16	NA	XXX
75650	26	A	Artery x-rays, head & neck	1.49	0.51	0.51	0.07	2.07	2.07	XXX
75650	TC	A	Artery x-rays, head & neck	0.00	12.55	NA	0.54	13.09	NA	XXX
75658		A	Artery x-rays, arm	1.31	13.04	NA	0.60	14.95	NA	XXX
75658	26	A	Artery x-rays, arm	1.31	0.49	0.49	0.06	1.86	1.86	XXX
75658	TC	A	Artery x-rays, arm	0.00	12.55	NA	0.54	13.09	NA	XXX
75660		A	Artery x-rays, head & neck	1.31	13.01	NA	0.60	14.92	NA	XXX
75660	26	A	Artery x-rays, head & neck	1.31	0.46	0.46	0.06	1.83	1.83	XXX
75660	TC	A	Artery x-rays, head & neck	0.00	12.55	NA	0.54	13.09	NA	XXX
75662		A	Artery x-rays, head & neck	1.66	13.16	NA	0.62	15.44	NA	XXX
75662	26	A	Artery x-rays, head & neck	1.66	0.61	0.61	0.08	2.35	2.35	XXX
75662	TC	A	Artery x-rays, head & neck	0.00	12.55	NA	0.54	13.09	NA	XXX
75665		A	Artery x-rays, head & neck	1.31	13.00	NA	0.61	14.92	NA	XXX
75665	26	A	Artery x-rays, head & neck	1.31	0.45	0.45	0.07	1.83	1.83	XXX
75665	TC	A	Artery x-rays, head & neck	0.00	12.55	NA	0.54	13.09	NA	XXX
75671		A	Artery x-rays, head & neck	1.66	13.12	NA	0.62	15.40	NA	XXX
75671	26	A	Artery x-rays, head & neck	1.66	0.57	0.57	0.08	2.31	2.31	XXX
75671	TC	A	Artery x-rays, head & neck	0.00	12.55	NA	0.54	13.09	NA	XXX
75676		A	Artery x-rays, neck	1.31	13.01	NA	0.61	14.93	NA	XXX
75676	26	A	Artery x-rays, neck	1.31	0.46	0.46	0.07	1.84	1.84	XXX
75676	TC	A	Artery x-rays, neck	0.00	12.55	NA	0.54	13.09	NA	XXX
75680		A	Artery x-rays, neck	1.66	13.12	NA	0.62	15.40	NA	XXX
75680	26	A	Artery x-rays, neck	1.66	0.57	0.57	0.08	2.31	2.31	XXX
75680	TC	A	Artery x-rays, neck	0.00	12.55	NA	0.54	13.09	NA	XXX
75685		A	Artery x-rays, spine	1.31	13.00	NA	0.60	14.91	NA	XXX
75685	26	A	Artery x-rays, spine	1.31	0.45	0.45	0.06	1.82	1.82	XXX
75685	TC	A	Artery x-rays, spine	0.00	12.55	NA	0.54	13.09	NA	XXX
75705		A	Artery x-rays, spine	2.18	13.31	NA	0.65	16.14	NA	XXX
75705	26	A	Artery x-rays, spine	2.18	0.76	0.76	0.11	3.05	3.05	XXX
75705	TC	A	Artery x-rays, spine	0.00	12.55	NA	0.54	13.09	NA	XXX
75710		A	Artery x-rays, arm/leg	1.14	12.95	NA	0.60	14.69	NA	XXX
75710	26	A	Artery x-rays, arm/leg	1.14	0.40	0.40	0.06	1.60	1.60	XXX
75710	TC	A	Artery x-rays, arm/leg	0.00	12.55	NA	0.54	13.09	NA	XXX
75716		A	Artery x-rays, arms/legs	1.31	13.00	NA	0.60	14.91	NA	XXX
75716	26	A	Artery x-rays, arms/legs	1.31	0.45	0.45	0.06	1.82	1.82	XXX
75716	TC	A	Artery x-rays, arms/legs	0.00	12.55	NA	0.54	13.09	NA	XXX
75722		A	Artery x-rays, kidney	1.14	12.96	NA	0.59	14.69	NA	XXX
75722	26	A	Artery x-rays, kidney	1.14	0.41	0.41	0.05	1.60	1.60	XXX
75722	TC	A	Artery x-rays, kidney	0.00	12.55	NA	0.54	13.09	NA	XXX
75724		A	Artery x-rays, kidneys	1.49	13.13	NA	0.59	15.21	NA	XXX
75724	26	A	Artery x-rays, kidneys	1.49	0.58	0.58	0.05	2.12	2.12	XXX
75724	TC	A	Artery x-rays, kidneys	0.00	12.55	NA	0.54	13.09	NA	XXX
75726		A	Artery x-rays, abdomen	1.14	12.94	NA	0.59	14.67	NA	XXX
75726	26	A	Artery x-rays, abdomen	1.14	0.39	0.39	0.05	1.58	1.58	XXX
75726	TC	A	Artery x-rays, abdomen	0.00	12.55	NA	0.54	13.09	NA	XXX
75731		A	Artery x-rays, adrenal gland	1.14	12.94	NA	0.59	14.67	NA	XXX
75731	26	A	Artery x-rays, adrenal gland	1.14	0.39	0.39	0.05	1.58	1.58	XXX
75731	TC	A	Artery x-rays, adrenal gland	0.00	12.55	NA	0.54	13.09	NA	XXX
75733		A	Artery x-rays, adrenals	1.31	13.00	NA	0.60	14.91	NA	XXX
75733	26	A	Artery x-rays, adrenals	1.31	0.45	0.45	0.06	1.82	1.82	XXX
75733	TC	A	Artery x-rays, adrenals	0.00	12.55	NA	0.54	13.09	NA	XXX
75736		A	Artery x-rays, pelvis	1.14	12.94	NA	0.59	14.67	NA	XXX
75736	26	A	Artery x-rays, pelvis	1.14	0.39	0.39	0.05	1.58	1.58	XXX
75736	TC	A	Artery x-rays, pelvis	0.00	12.55	NA	0.54	13.09	NA	XXX
75741		A	Artery x-rays, lung	1.31	13.00	NA	0.60	14.91	NA	XXX
75741	26	A	Artery x-rays, lung	1.31	0.45	0.45	0.06	1.82	1.82	XXX
75741	TC	A	Artery x-rays, lung	0.00	12.55	NA	0.54	13.09	NA	XXX
75743		A	Artery x-rays, lungs	1.66	13.11	NA	0.61	15.38	NA	XXX
75743	26	A	Artery x-rays, lungs	1.66	0.56	0.56	0.07	2.29	2.29	XXX
75743	TC	A	Artery x-rays, lungs	0.00	12.55	NA	0.54	13.09	NA	XXX
75746		A	Artery x-rays, lung	1.14	12.94	NA	0.59	14.67	NA	XXX
75746	26	A	Artery x-rays, lung	1.14	0.39	0.39	0.05	1.58	1.58	XXX
75746	TC	A	Artery x-rays, lung	0.00	12.55	NA	0.54	13.09	NA	XXX
75756		A	Artery x-rays, chest	1.14	13.01	NA	0.58	14.73	NA	XXX
75756	26	A	Artery x-rays, chest	1.14	0.46	0.46	0.04	1.64	1.64	XXX
75756	TC	A	Artery x-rays, chest	0.00	12.55	NA	0.54	13.09	NA	XXX
75774		A	Artery x-ray, each vessel	0.36	12.68	NA	0.56	13.60	NA	ZZZ
75774	26	A	Artery x-ray, each vessel	0.36	0.13	0.13	0.02	0.51	0.51	ZZZ
75774	TC	A	Artery x-ray, each vessel	0.00	12.55	NA	0.54	13.09	NA	ZZZ
75790		A	Visualize A-V shunt	1.84	1.96	NA	0.16	3.96	NA	XXX
75790	26	A	Visualize A-V shunt	1.84	0.62	0.62	0.09	2.55	2.55	XXX
75790	TC	A	Visualize A-V shunt	0.00	1.34	NA	0.07	1.41	NA	XXX
75801		A	Lymph vessel x-ray, arm/leg	0.81	5.67	NA	0.29	6.77	NA	XXX
75801	26	A	Lymph vessel x-ray, arm/leg	0.81	0.28	0.28	0.05	1.14	1.14	XXX
75801	TC	A	Lymph vessel x-ray, arm/leg	0.00	5.39	NA	0.24	5.63	NA	XXX
75803		A	Lymph vessel x-ray,arms/legs	1.17	5.79	NA	0.29	7.25	NA	XXX
75803	26	A	Lymph vessel x-ray,arms/legs	1.17	0.40	0.40	0.05	1.62	1.62	XXX
75803	TC	A	Lymph vessel x-ray,arms/legs	0.00	5.39	NA	0.24	5.63	NA	XXX
75805		A	Lymph vessel x-ray, trunk	0.81	6.35	NA	0.31	7.47	NA	XXX
75805	26	A	Lymph vessel x-ray, trunk	0.81	0.28	0.28	0.04	1.13	1.13	XXX
75805	TC	A	Lymph vessel x-ray, trunk	0.00	6.07	NA	0.27	6.34	NA	XXX
75807		A	Lymph vessel x-ray, trunk	1.17	6.47	NA	0.32	7.96	NA	XXX
75807	26	A	Lymph vessel x-ray, trunk	1.17	0.40	0.40	0.05	1.62	1.62	XXX
75807	TC	A	Lymph vessel x-ray, trunk	0.00	6.07	NA	0.27	6.34	NA	XXX
75809		A	Nonvascular shunt, x-ray	0.47	0.94	NA	0.06	1.47	NA	XXX
75809	26	A	Nonvascular shunt, x-ray	0.47	0.16	0.16	0.02	0.65	0.65	XXX
75809	TC	A	Nonvascular shunt, x-ray	0.00	0.78	NA	0.04	0.82	NA	XXX
75810		A	Vein x-ray, spleen/liver	1.14	12.94	NA	0.60	14.68	NA	XXX
75810	26	A	Vein x-ray, spleen/liver	1.14	0.39	0.39	0.06	1.59	1.59	XXX
75810	TC	A	Vein x-ray, spleen/liver	0.00	12.55	NA	0.54	13.09	NA	XXX
75820		A	Vein x-ray, arm/leg	0.70	1.19	NA	0.08	1.97	NA	XXX
75820	26	A	Vein x-ray, arm/leg	0.70	0.24	0.24	0.03	0.97	0.97	XXX
75820	TC	A	Vein x-ray, arm/leg	0.00	0.95	NA	0.05	1.00	NA	XXX
75822		A	Vein x-ray, arms/legs	1.06	1.83	NA	0.12	3.01	NA	XXX
75822	26	A	Vein x-ray, arms/legs	1.06	0.36	0.36	0.05	1.47	1.47	XXX
75822	TC	A	Vein x-ray, arms/legs	0.00	1.47	NA	0.07	1.54	NA	XXX
75825		A	Vein x-ray, trunk	1.14	12.94	NA	0.60	14.68	NA	XXX
75825	26	A	Vein x-ray, trunk	1.14	0.39	0.39	0.06	1.59	1.59	XXX
75825	TC	A	Vein x-ray, trunk	0.00	12.55	NA	0.54	13.09	NA	XXX
75827		A	Vein x-ray, chest	1.14	12.93	NA	0.59	14.66	NA	XXX
75827	26	A	Vein x-ray, chest	1.14	0.38	0.38	0.05	1.57	1.57	XXX
75827	TC	A	Vein x-ray, chest	0.00	12.55	NA	0.54	13.09	NA	XXX
75831		A	Vein x-ray, kidney	1.14	12.93	NA	0.59	14.66	NA	XXX
75831	26	A	Vein x-ray, kidney	1.14	0.38	0.38	0.05	1.57	1.57	XXX
75831	TC	A	Vein x-ray, kidney	0.00	12.55	NA	0.54	13.09	NA	XXX
75833		A	Vein x-ray, kidneys	1.49	13.06	NA	0.61	15.16	NA	XXX
75833	26	A	Vein x-ray, kidneys	1.49	0.51	0.51	0.07	2.07	2.07	XXX
75833	TC	A	Vein x-ray, kidneys	0.00	12.55	NA	0.54	13.09	NA	XXX
75840		A	Vein x-ray, adrenal gland	1.14	12.94	NA	0.61	14.69	NA	XXX
75840	26	A	Vein x-ray, adrenal gland	1.14	0.39	0.39	0.07	1.60	1.60	XXX
75840	TC	A	Vein x-ray, adrenal gland	0.00	12.55	NA	0.54	13.09	NA	XXX
75842		A	Vein x-ray, adrenal glands	1.49	13.05	NA	0.61	15.15	NA	XXX
75842	26	A	Vein x-ray, adrenal glands	1.49	0.50	0.50	0.07	2.06	2.06	XXX
75842	TC	A	Vein x-ray, adrenal glands	0.00	12.55	NA	0.54	13.09	NA	XXX
75860		A	Vein x-ray, neck	1.14	12.95	NA	0.60	14.69	NA	XXX
75860	26	A	Vein x-ray, neck	1.14	0.40	0.40	0.06	1.60	1.60	XXX
75860	TC	A	Vein x-ray, neck	0.00	12.55	NA	0.54	13.09	NA	XXX
75870		A	Vein x-ray, skull	1.14	12.95	NA	0.60	14.69	NA	XXX
75870	26	A	Vein x-ray, skull	1.14	0.40	0.40	0.06	1.60	1.60	XXX
75870	TC	A	Vein x-ray, skull	0.00	12.55	NA	0.54	13.09	NA	XXX
75872		A	Vein x-ray, skull	1.14	12.94	NA	0.59	14.67	NA	XXX
75872	26	A	Vein x-ray, skull	1.14	0.39	0.39	0.05	1.58	1.58	XXX
75872	TC	A	Vein x-ray, skull	0.00	12.55	NA	0.54	13.09	NA	XXX
75880		A	Vein x-ray, eye socket	0.70	1.19	NA	0.08	1.97	NA	XXX
75880	26	A	Vein x-ray, eye socket	0.70	0.24	0.24	0.03	0.97	0.97	XXX
75880	TC	A	Vein x-ray, eye socket	0.00	0.95	NA	0.05	1.00	NA	XXX
75885		A	Vein x-ray, liver	1.44	13.04	NA	0.60	15.08	NA	XXX
75885	26	A	Vein x-ray, liver	1.44	0.49	0.49	0.06	1.99	1.99	XXX
75885	TC	A	Vein x-ray, liver	0.00	12.55	NA	0.54	13.09	NA	XXX
75887		A	Vein x-ray, liver	1.44	13.04	NA	0.60	15.08	NA	XXX
75887	26	A	Vein x-ray, liver	1.44	0.49	0.49	0.06	1.99	1.99	XXX
75887	TC	A	Vein x-ray, liver	0.00	12.55	NA	0.54	13.09	NA	XXX
75889		A	Vein x-ray, liver	1.14	12.93	NA	0.59	14.66	NA	XXX
75889	26	A	Vein x-ray, liver	1.14	0.38	0.38	0.05	1.57	1.57	XXX
75889	TC	A	Vein x-ray, liver	0.00	12.55	NA	0.54	13.09	NA	XXX
75891		A	Vein x-ray, liver	1.14	12.93	NA	0.59	14.66	NA	XXX
75891	26	A	Vein x-ray, liver	1.14	0.38	0.38	0.05	1.57	1.57	XXX
75891	TC	A	Vein x-ray, liver	0.00	12.55	NA	0.54	13.09	NA	XXX
75893		A	Venous sampling by catheter	0.54	12.74	NA	0.56	13.84	NA	XXX
75893	26	A	Venous sampling by catheter	0.54	0.19	0.19	0.02	0.75	0.75	XXX
75893	TC	A	Venous sampling by catheter	0.00	12.55	NA	0.54	13.09	NA	XXX
75894		A	X-rays, transcath therapy	1.31	24.48	NA	1.12	26.91	NA	XXX
75894	26	A	X-rays, transcath therapy	1.31	0.45	0.45	0.07	1.83	1.83	XXX
75894	TC	A	X-rays, transcath therapy	0.00	24.03	NA	1.05	25.08	NA	XXX
75896		A	X-rays, transcath therapy	1.31	21.37	NA	0.97	23.65	NA	XXX
75896	26	A	X-rays, transcath therapy	1.31	0.47	0.47	0.06	1.84	1.84	XXX
75896	TC	A	X-rays, transcath therapy	0.00	20.90	NA	0.91	21.81	NA	XXX
75898		A	Follow-up angiography	1.65	1.61	NA	0.12	3.38	NA	XXX
75898	26	A	Follow-up angiography	1.65	0.57	0.57	0.07	2.29	2.29	XXX
75898	TC	A	Follow-up angiography	0.00	1.04	NA	0.05	1.09	NA	XXX
75900		A	Arterial catheter exchange	0.49	21.05	NA	0.94	22.48	NA	XXX
75900	26	A	Arterial catheter exchange	0.49	0.17	0.17	0.02	0.68	0.68	XXX
75900	TC	A	Arterial catheter exchange	0.00	20.88	NA	0.92	21.80	NA	XXX
75901		A	Remove cva device obstruct	0.49	1.47	NA	0.71	2.67	NA	XXX
75901	26	A	Remove cva device obstruct	0.49	0.17	0.17	0.02	0.68	0.68	XXX
75901	TC	A	Remove cva device obstruct	0.00	1.30	NA	0.69	1.99	NA	XXX
75902		A	Remove cva lumen obstruct	0.39	1.43	NA	0.71	2.53	NA	XXX
75902	26	A	Remove cva lumen obstruct	0.39	0.13	0.13	0.02	0.54	0.54	XXX
75902	TC	A	Remove cva lumen obstruct	0.00	1.30	NA	0.69	1.99	NA	XXX
75940		A	X-ray placement, vein filter	0.54	12.73	NA	0.57	13.84	NA	XXX
75940	26	A	X-ray placement, vein filter	0.54	0.18	0.18	0.03	0.75	0.75	XXX
75940	TC	A	X-ray placement, vein filter	0.00	12.55	NA	0.54	13.09	NA	XXX
75945		A	Intravascular us	0.40	4.70	NA	0.23	5.33	NA	XXX
75945	26	A	Intravascular us	0.40	0.15	0.15	0.03	0.58	0.58	XXX
75945	TC	A	Intravascular us	0.00	4.55	NA	0.20	4.75	NA	XXX
75946		A	Intravascular us add-on	0.40	2.42	NA	0.14	2.96	NA	ZZZ
75946	26	A	Intravascular us add-on	0.40	0.14	0.14	0.03	0.57	0.57	ZZZ
75946	TC	A	Intravascular us add-on	0.00	2.28	NA	0.11	2.39	NA	ZZZ
75952		C	Endovasc repair abdom aorta	0.00	0.00	0.00	0.00	0.00	0.00	XXX
75952	26	A	Endovasc repair abdom aorta	4.50	1.75	1.75	0.68	6.93	6.93	XXX
75952	TC	C	Endovasc repair abdom aorta	0.00	0.00	0.00	0.00	0.00	0.00	XXX
75953		C	Abdom aneurysm endovas rpr	0.00	0.00	0.00	0.00	0.00	0.00	XXX
75953	26	A	Abdom aneurysm endovas rpr	1.36	0.53	0.53	0.68	2.57	2.57	XXX
75953	TC	C	Abdom aneurysm endovas rpr	0.00	0.00	0.00	0.00	0.00	0.00	XXX
75954		C	Iliac aneurysm endovas rpr	0.00	0.00	0.00	0.00	0.00	0.00	XXX
75954	26	A	Iliac aneurysm endovas rpr	1.36	0.48	0.48	0.68	2.52	2.52	XXX
75954	TC	C	Iliac aneurysm endovas rpr	0.00	0.00	0.00	0.00	0.00	0.00	XXX
75960		A	Transcatheter intro, stent	0.82	15.13	NA	0.68	16.63	NA	XXX
75960	26	A	Transcatheter intro, stent	0.82	0.29	0.29	0.04	1.15	1.15	XXX
75960	TC	A	Transcatheter intro, stent	0.00	14.84	NA	0.64	15.48	NA	XXX
75961		A	Retrieval, broken catheter	4.25	11.90	NA	0.64	16.79	NA	XXX
75961	26	A	Retrieval, broken catheter	4.25	1.44	1.44	0.18	5.87	5.87	XXX
75961	TC	A	Retrieval, broken catheter	0.00	10.46	NA	0.46	10.92	NA	XXX
75962		A	Repair arterial blockage	0.54	15.86	NA	0.72	17.12	NA	XXX
75962	26	A	Repair arterial blockage	0.54	0.19	0.19	0.03	0.76	0.76	XXX
75962	TC	A	Repair arterial blockage	0.00	15.67	NA	0.69	16.36	NA	XXX
75964		A	Repair artery blockage, each	0.36	8.49	NA	0.38	9.23	NA	ZZZ
75964	26	A	Repair artery blockage, each	0.36	0.13	0.13	0.02	0.51	0.51	ZZZ
75964	TC	A	Repair artery blockage, each	0.00	8.36	NA	0.36	8.72	NA	ZZZ
75966		A	Repair arterial blockage	1.31	16.15	NA	0.75	18.21	NA	XXX
75966	26	A	Repair arterial blockage	1.31	0.48	0.48	0.06	1.85	1.85	XXX
75966	TC	A	Repair arterial blockage	0.00	15.67	NA	0.69	16.36	NA	XXX
75968		A	Repair artery blockage, each	0.36	8.49	NA	0.37	9.22	NA	ZZZ
75968	26	A	Repair artery blockage, each	0.36	0.13	0.13	0.01	0.50	0.50	ZZZ
75968	TC	A	Repair artery blockage, each	0.00	8.36	NA	0.36	8.72	NA	ZZZ
75970		A	Vascular biopsy	0.83	11.78	NA	0.54	13.15	NA	XXX
75970	26	A	Vascular biopsy	0.83	0.29	0.29	0.04	1.16	1.16	XXX
75970	TC	A	Vascular biopsy	0.00	11.49	NA	0.50	11.99	NA	XXX
75978		A	Repair venous blockage	0.54	15.85	NA	0.71	17.10	NA	XXX
75978	26	A	Repair venous blockage	0.54	0.18	0.18	0.02	0.74	0.74	XXX
75978	TC	A	Repair venous blockage	0.00	15.67	NA	0.69	16.36	NA	XXX
75980		A	Contrast xray exam bile duct	1.44	5.88	NA	0.30	7.62	NA	XXX
75980	26	A	Contrast xray exam bile duct	1.44	0.49	0.49	0.06	1.99	1.99	XXX
75980	TC	A	Contrast xray exam bile duct	0.00	5.39	NA	0.24	5.63	NA	XXX
75982		A	Contrast xray exam bile duct	1.44	6.55	NA	0.33	8.32	NA	XXX
75982	26	A	Contrast xray exam bile duct	1.44	0.48	0.48	0.06	1.98	1.98	XXX
75982	TC	A	Contrast xray exam bile duct	0.00	6.07	NA	0.27	6.34	NA	XXX
75984		A	Xray control catheter change	0.72	2.18	NA	0.12	3.02	NA	XXX
75984	26	A	Xray control catheter change	0.72	0.24	0.24	0.03	0.99	0.99	XXX
75984	TC	A	Xray control catheter change	0.00	1.94	NA	0.09	2.03	NA	XXX
75989		A	Abscess drainage under x-ray	1.19	3.53	NA	0.19	4.91	NA	XXX
75989	26	A	Abscess drainage under x-ray	1.19	0.40	0.40	0.05	1.64	1.64	XXX
75989	TC	A	Abscess drainage under x-ray	0.00	3.13	NA	0.14	3.27	NA	XXX
75992		A	Atherectomy, x-ray exam	0.54	15.87	NA	0.71	17.12	NA	XXX
75992	26	A	Atherectomy, x-ray exam	0.54	0.20	0.20	0.02	0.76	0.76	XXX
75992	TC	A	Atherectomy, x-ray exam	0.00	15.67	NA	0.69	16.36	NA	XXX
75993		A	Atherectomy, x-ray exam	0.36	8.50	NA	0.37	9.23	NA	ZZZ
75993	26	A	Atherectomy, x-ray exam	0.36	0.14	0.14	0.01	0.51	0.51	ZZZ
75993	TC	A	Atherectomy, x-ray exam	0.00	8.36	NA	0.36	8.72	NA	ZZZ
75994		A	Atherectomy, x-ray exam	1.31	16.15	NA	0.75	18.21	NA	XXX
75994	26	A	Atherectomy, x-ray exam	1.31	0.48	0.48	0.06	1.85	1.85	XXX
75994	TC	A	Atherectomy, x-ray exam	0.00	15.67	NA	0.69	16.36	NA	XXX
75995		A	Atherectomy, x-ray exam	1.31	16.16	NA	0.75	18.22	NA	XXX
75995	26	A	Atherectomy, x-ray exam	1.31	0.49	0.49	0.06	1.86	1.86	XXX
75995	TC	A	Atherectomy, x-ray exam	0.00	15.67	NA	0.69	16.36	NA	XXX
75996		A	Atherectomy, x-ray exam	0.36	8.48	NA	0.37	9.21	NA	ZZZ
75996	26	A	Atherectomy, x-ray exam	0.36	0.12	0.12	0.01	0.49	0.49	ZZZ
75996	TC	A	Atherectomy, x-ray exam	0.00	8.36	NA	0.36	8.72	NA	ZZZ
76000		A	Fluoroscope examination	0.17	1.35	NA	0.07	1.59	NA	XXX
76000	26	A	Fluoroscope examination	0.17	0.05	0.05	0.01	0.23	0.23	XXX
76000	TC	A	Fluoroscope examination	0.00	1.30	NA	0.06	1.36	NA	XXX
76001		A	Fluoroscope exam, extensive	0.67	2.84	NA	0.15	3.66	NA	XXX
76001	26	A	Fluoroscope exam, extensive	0.67	0.23	0.23	0.03	0.93	0.93	XXX
76001	TC	A	Fluoroscope exam, extensive	0.00	2.61	NA	0.12	2.73	NA	XXX
76003		A	Needle localization by x-ray	0.54	1.48	NA	0.09	2.11	NA	XXX
76003	26	A	Needle localization by x-ray	0.54	0.18	0.18	0.03	0.75	0.75	XXX
76003	TC	A	Needle localization by x-ray	0.00	1.30	NA	0.06	1.36	NA	XXX
76005		A	Fluoroguide for spine inject	0.60	1.46	NA	0.09	2.15	NA	XXX
76005	26	A	Fluoroguide for spine inject	0.60	0.16	0.16	0.03	0.79	0.79	XXX
76005	TC	A	Fluoroguide for spine inject	0.00	1.30	NA	0.06	1.36	NA	XXX
76006		A	X-ray stress view	0.41	0.19	0.19	0.04	0.64	0.64	XXX
76010		A	X-ray, nose to rectum	0.18	0.58	NA	0.03	0.79	NA	XXX
76010	26	A	X-ray, nose to rectum	0.18	0.06	0.06	0.01	0.25	0.25	XXX
76010	TC	A	X-ray, nose to rectum	0.00	0.52	NA	0.02	0.54	NA	XXX
76012		C	Percut vertebroplasty fluor	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76012	26	A	Percut vertebroplasty fluor	1.31	0.51	0.51	0.23	2.05	2.05	XXX
76012	TC	C	Percut vertebroplasty fluor	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76013		C	Percut vertebroplasty, ct	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76013	26	A	Percut vertebroplasty, ct	1.38	0.54	0.54	0.48	2.40	2.40	XXX
76013	TC	C	Percut vertebroplasty, ct	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76020		A	X-rays for bone age	0.19	0.58	NA	0.03	0.80	NA	XXX
76020	26	A	X-rays for bone age	0.19	0.06	0.06	0.01	0.26	0.26	XXX
76020	TC	A	X-rays for bone age	0.00	0.52	NA	0.02	0.54	NA	XXX
76040		A	X-rays, bone evaluation	0.27	0.87	NA	0.07	1.21	NA	XXX
76040	26	A	X-rays, bone evaluation	0.27	0.09	0.09	0.03	0.39	0.39	XXX
76040	TC	A	X-rays, bone evaluation	0.00	0.78	NA	0.04	0.82	NA	XXX
76061		A	X-rays, bone survey	0.45	1.15	NA	0.07	1.67	NA	XXX
76061	26	A	X-rays, bone survey	0.45	0.15	0.15	0.02	0.62	0.62	XXX
76061	TC	A	X-rays, bone survey	0.00	1.00	NA	0.05	1.05	NA	XXX
76062		A	X-rays, bone survey	0.54	1.61	NA	0.09	2.24	NA	XXX
76062	26	A	X-rays, bone survey	0.54	0.18	0.18	0.02	0.74	0.74	XXX
76062	TC	A	X-rays, bone survey	0.00	1.43	NA	0.07	1.50	NA	XXX
76065		A	X-rays, bone evaluation	0.70	0.98	NA	0.05	1.73	NA	XXX
76065	26	A	X-rays, bone evaluation	0.70	0.24	0.24	0.01	0.95	0.95	XXX
76065	TC	A	X-rays, bone evaluation	0.00	0.74	NA	0.04	0.78	NA	XXX
76066		A	Joint survey, single view	0.31	1.21	NA	0.07	1.59	NA	XXX
76066	26	A	Joint survey, single view	0.31	0.11	0.11	0.02	0.44	0.44	XXX
76066	TC	A	Joint survey, single view	0.00	1.10	NA	0.05	1.15	NA	XXX
76070		A	Ct bone density, axial	0.25	3.02	NA	0.14	3.41	NA	XXX
76070	26	A	Ct bone density, axial	0.25	0.08	0.08	0.01	0.34	0.34	XXX
76070	TC	A	Ct bone density, axial	0.00	2.94	NA	0.13	3.07	NA	XXX
76071		A	Ct bone density, peripheral	0.22	3.01	NA	0.05	3.28	NA	XXX
76071	26	A	Ct bone density, peripheral	0.22	0.07	0.07	0.01	0.30	0.30	XXX
76071	TC	A	Ct bone density, peripheral	0.00	2.94	NA	0.04	2.98	NA	XXX
76075		A	Dexa, axial skeleton study	0.30	3.19	NA	0.15	3.64	NA	XXX
76075	26	A	Dexa, axial skeleton study	0.30	0.11	0.11	0.01	0.42	0.42	XXX
76075	TC	A	Dexa, axial skeleton study	0.00	3.08	NA	0.14	3.22	NA	XXX
76076		A	Dexa, peripheral study	0.22	0.83	NA	0.05	1.10	NA	XXX
76076	26	A	Dexa, peripheral study	0.22	0.08	0.08	0.01	0.31	0.31	XXX
76076	TC	A	Dexa, peripheral study	0.00	0.75	NA	0.04	0.79	NA	XXX
76078		A	Radiographic absorptiometry	0.20	0.82	NA	0.05	1.07	NA	XXX
76078	26	A	Radiographic absorptiometry	0.20	0.07	0.07	0.01	0.28	0.28	XXX
76078	TC	A	Radiographic absorptiometry	0.00	0.75	NA	0.04	0.79	NA	XXX
76080		A	X-ray exam of fistula	0.54	1.22	NA	0.07	1.83	NA	XXX
76080	26	A	X-ray exam of fistula	0.54	0.18	0.18	0.02	0.74	0.74	XXX
76080	TC	A	X-ray exam of fistula	0.00	1.04	NA	0.05	1.09	NA	XXX
76085		A	Computer mammogram add-on	0.06	0.44	NA	0.02	0.52	NA	ZZZ
76085	26	A	Computer mammogram add-on	0.06	0.02	0.02	0.01	0.09	0.09	ZZZ
76085	TC	A	Computer mammogram add-on	0.00	0.42	NA	0.01	0.43	NA	ZZZ
76086		A	X-ray of mammary duct	0.36	2.73	NA	0.14	3.23	NA	XXX
76086	26	A	X-ray of mammary duct	0.36	0.12	0.12	0.02	0.50	0.50	XXX
76086	TC	A	X-ray of mammary duct	0.00	2.61	NA	0.12	2.73	NA	XXX
76088		A	X-ray of mammary ducts	0.45	3.80	NA	0.18	4.43	NA	XXX
76088	26	A	X-ray of mammary ducts	0.45	0.15	0.15	0.02	0.62	0.62	XXX
76088	TC	A	X-ray of mammary ducts	0.00	3.65	NA	0.16	3.81	NA	XXX
76090		A	Mammogram, one breast	0.70	1.28	NA	0.08	2.06	NA	XXX
76090	26	A	Mammogram, one breast	0.70	0.24	0.24	0.03	0.97	0.97	XXX
76090	TC	A	Mammogram, one breast	0.00	1.04	NA	0.05	1.09	NA	XXX
76091		A	Mammogram, both breasts	0.87	1.60	NA	0.09	2.56	NA	XXX
76091	26	A	Mammogram, both breasts	0.87	0.30	0.30	0.03	1.20	1.20	XXX
76091	TC	A	Mammogram, both breasts	0.00	1.30	NA	0.06	1.36	NA	XXX
76092		A	Mammogram, screening	0.70	1.46	NA	0.09	2.25	NA	XXX
76092	26	A	Mammogram, screening	0.70	0.25	0.25	0.03	0.98	0.98	XXX
76092	TC	A	Mammogram, screening	0.00	1.21	NA	0.06	1.27	NA	XXX
76093		A	Magnetic image, breast	1.63	18.11	NA	0.83	20.57	NA	XXX
76093	26	A	Magnetic image, breast	1.63	0.56	0.56	0.07	2.26	2.26	XXX
76093	TC	A	Magnetic image, breast	0.00	17.55	NA	0.76	18.31	NA	XXX
76094		A	Magnetic image, both breasts	1.63	24.35	NA	1.10	27.08	NA	XXX
76094	26	A	Magnetic image, both breasts	1.63	0.55	0.55	0.07	2.25	2.25	XXX
76094	TC	A	Magnetic image, both breasts	0.00	23.80	NA	1.03	24.83	NA	XXX
76095		A	Stereotactic breast biopsy	1.59	7.67	NA	0.40	9.66	NA	XXX
76095	26	A	Stereotactic breast biopsy	1.59	0.54	0.54	0.09	2.22	2.22	XXX
76095	TC	A	Stereotactic breast biopsy	0.00	7.13	NA	0.31	7.44	NA	XXX
76096		A	X-ray of needle wire, breast	0.56	1.49	NA	0.09	2.14	NA	XXX
76096	26	A	X-ray of needle wire, breast	0.56	0.19	0.19	0.03	0.78	0.78	XXX
76096	TC	A	X-ray of needle wire, breast	0.00	1.30	NA	0.06	1.36	NA	XXX
76098		A	X-ray exam, breast specimen	0.16	0.48	NA	0.03	0.67	NA	XXX
76098	26	A	X-ray exam, breast specimen	0.16	0.06	0.06	0.01	0.23	0.23	XXX
76098	TC	A	X-ray exam, breast specimen	0.00	0.42	NA	0.02	0.44	NA	XXX
76100		A	X-ray exam of body section	0.58	1.44	NA	0.09	2.11	NA	XXX
76100	26	A	X-ray exam of body section	0.58	0.20	0.20	0.03	0.81	0.81	XXX
76100	TC	A	X-ray exam of body section	0.00	1.24	NA	0.06	1.30	NA	XXX
76101		A	Complex body section x-ray	0.58	1.61	NA	0.10	2.29	NA	XXX
76101	26	A	Complex body section x-ray	0.58	0.20	0.20	0.03	0.81	0.81	XXX
76101	TC	A	Complex body section x-ray	0.00	1.41	NA	0.07	1.48	NA	XXX
76102		A	Complex body section x-rays	0.58	1.92	NA	0.12	2.62	NA	XXX
76102	26	A	Complex body section x-rays	0.58	0.20	0.20	0.03	0.81	0.81	XXX
76102	TC	A	Complex body section x-rays	0.00	1.72	NA	0.09	1.81	NA	XXX
76120		A	Cine/video x-rays	0.38	1.17	NA	0.07	1.62	NA	XXX
76120	26	A	Cine/video x-rays	0.38	0.13	0.13	0.02	0.53	0.53	XXX
76120	TC	A	Cine/video x-rays	0.00	1.04	NA	0.05	1.09	NA	XXX
76125		A	Cine/video x-rays add-on	0.27	0.88	NA	0.05	1.20	NA	ZZZ
76125	26	A	Cine/video x-rays add-on	0.27	0.10	0.10	0.01	0.38	0.38	ZZZ
76125	TC	A	Cine/video x-rays add-on	0.00	0.78	NA	0.04	0.82	NA	ZZZ
76140		I	X-ray consultation	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76150		A	X-ray exam, dry process	0.00	0.42	NA	0.02	0.44	NA	XXX
76350		C	Special x-ray contrast study	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76355		A	CAT scan for localization	1.21	8.64	NA	0.41	10.26	NA	XXX
76355	26	A	CAT scan for localization	1.21	0.42	0.42	0.06	1.69	1.69	XXX
76355	TC	A	CAT scan for localization	0.00	8.22	NA	0.35	8.57	NA	XXX
76360		A	CAT scan for needle biopsy	1.16	8.61	NA	0.40	10.17	NA	XXX
76360	26	A	CAT scan for needle biopsy	1.16	0.39	0.39	0.05	1.60	1.60	XXX
76360	TC	A	CAT scan for needle biopsy	0.00	8.22	NA	0.35	8.57	NA	XXX
76362		A	Cat scan for tissue ablation	4.00	9.57	NA	1.39	14.96	NA	XXX
76362	26	A	Cat scan for tissue ablation	4.00	1.35	1.35	0.18	5.53	5.53	XXX
76362	TC	A	Cat scan for tissue ablation	0.00	8.22	NA	1.21	9.43	NA	XXX
76370		A	CAT scan for therapy guide	0.85	3.23	NA	0.17	4.25	NA	XXX
76370	26	A	CAT scan for therapy guide	0.85	0.29	0.29	0.04	1.18	1.18	XXX
76370	TC	A	CAT scan for therapy guide	0.00	2.94	NA	0.13	3.07	NA	XXX
76375		A	3d/holograph reconstr add-on	0.16	3.57	NA	0.16	3.89	NA	XXX
76375	26	A	3d/holograph reconstr add-on	0.16	0.05	0.05	0.01	0.22	0.22	XXX
76375	TC	A	3d/holograph reconstr add-on	0.00	3.52	NA	0.15	3.67	NA	XXX
76380		A	CAT scan follow-up study	0.98	3.81	NA	0.19	4.98	NA	XXX
76380	26	A	CAT scan follow-up study	0.98	0.33	0.33	0.04	1.35	1.35	XXX
76380	TC	A	CAT scan follow-up study	0.00	3.48	NA	0.15	3.63	NA	XXX
76390		N	Mr spectroscopy	+1.40	11.64	NA	0.55	13.59	NA	XXX
76390	26	N	Mr spectroscopy	+1.40	0.48	0.48	0.06	1.94	1.94	XXX
76390	TC	N	Mr spectroscopy	+0.00	11.16	NA	0.49	11.65	NA	XXX
76393		A	Mr guidance for needle place	1.50	11.68	NA	0.53	13.71	NA	XXX
76393	26	A	Mr guidance for needle place	1.50	0.52	0.52	0.07	2.09	2.09	XXX
76393	TC	A	Mr guidance for needle place	0.00	11.16	NA	0.46	11.62	NA	XXX
76394		A	Mri for tissue ablation	4.25	12.60	NA	1.48	18.33	NA	XXX
76394	26	A	Mri for tissue ablation	4.25	1.44	1.44	0.19	5.88	5.88	XXX
76394	TC	A	Mri for tissue ablation	0.00	11.16	NA	1.29	12.45	NA	XXX
76400		A	Magnetic image, bone marrow	1.60	11.70	NA	0.56	13.86	NA	XXX
76400	26	A	Magnetic image, bone marrow	1.60	0.54	0.54	0.07	2.21	2.21	XXX
76400	TC	A	Magnetic image, bone marrow	0.00	11.16	NA	0.49	11.65	NA	XXX
76490		A	Us for tissue ablation	4.00	2.85	NA	0.35	7.20	NA	XXX
76490	26	A	Us for tissue ablation	4.00	1.34	1.34	0.11	5.45	5.45	XXX
76490	TC	A	Us for tissue ablation	0.00	1.51	NA	0.24	1.75	NA	XXX
76496		C	Fluoroscopic procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76496	26	C	Fluoroscopic procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76496	TC	C	Fluoroscopic procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76497		C	Ct procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76497	26	C	Ct procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76497	TC	C	Ct procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76498		C	Mri procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76498	26	C	Mri procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76498	TC	C	Mri procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76499		C	Radiographic procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76499	26	C	Radiographic procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76499	TC	C	Radiographic procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76506		A	Echo exam of head	0.63	1.66	NA	0.10	2.39	NA	XXX
76506	26	A	Echo exam of head	0.63	0.25	0.25	0.03	0.91	0.91	XXX
76506	TC	A	Echo exam of head	0.00	1.41	NA	0.07	1.48	NA	XXX
76511		A	Echo exam of eye	0.94	2.59	NA	0.08	3.61	NA	XXX
76511	26	A	Echo exam of eye	0.94	0.41	0.41	0.02	1.37	1.37	XXX
76511	TC	A	Echo exam of eye	0.00	2.18	NA	0.06	2.24	NA	XXX
76512		A	Echo exam of eye	0.66	2.54	NA	0.09	3.29	NA	XXX
76512	26	A	Echo exam of eye	0.66	0.30	0.30	0.01	0.97	0.97	XXX
76512	TC	A	Echo exam of eye	0.00	2.24	NA	0.08	2.32	NA	XXX
76513		A	Echo exam of eye, water bath	0.66	2.80	NA	0.09	3.55	NA	XXX
76513	26	A	Echo exam of eye, water bath	0.66	0.30	0.30	0.01	0.97	0.97	XXX
76513	TC	A	Echo exam of eye, water bath	0.00	2.50	NA	0.08	2.58	NA	XXX
76516		A	Echo exam of eye	0.54	2.13	NA	0.07	2.74	NA	XXX
76516	26	A	Echo exam of eye	0.54	0.25	0.25	0.01	0.80	0.80	XXX
76516	TC	A	Echo exam of eye	0.00	1.88	NA	0.06	1.94	NA	XXX
76519		A	Echo exam of eye	0.54	1.86	NA	0.07	2.47	NA	XXX
76519	26	A	Echo exam of eye	0.54	0.25	0.25	0.01	0.80	0.80	XXX
76519	TC	A	Echo exam of eye	0.00	1.61	NA	0.06	1.67	NA	XXX
76529		A	Echo exam of eye	0.57	2.42	NA	0.08	3.07	NA	XXX
76529	26	A	Echo exam of eye	0.57	0.25	0.25	0.01	0.83	0.83	XXX
76529	TC	A	Echo exam of eye	0.00	2.17	NA	0.07	2.24	NA	XXX
76536		A	Us exam of head and neck	0.56	1.60	NA	0.09	2.25	NA	XXX
76536	26	A	Us exam of head and neck	0.56	0.19	0.19	0.02	0.77	0.77	XXX
76536	TC	A	Us exam of head and neck	0.00	1.41	NA	0.07	1.48	NA	XXX
76604		A	Us exam, chest, b-scan	0.55	1.49	NA	0.08	2.12	NA	XXX
76604	26	A	Us exam, chest, b-scan	0.55	0.19	0.19	0.02	0.76	0.76	XXX
76604	TC	A	Us exam, chest, b-scan	0.00	1.30	NA	0.06	1.36	NA	XXX
76645		A	Us exam, breast(s)	0.54	1.22	NA	0.08	1.84	NA	XXX
76645	26	A	Us exam, breast(s)	0.54	0.18	0.18	0.03	0.75	0.75	XXX
76645	TC	A	Us exam, breast(s)	0.00	1.04	NA	0.05	1.09	NA	XXX
76700		A	Us exam, abdom, complete	0.81	2.24	NA	0.13	3.18	NA	XXX
76700	26	A	Us exam, abdom, complete	0.81	0.28	0.28	0.04	1.13	1.13	XXX
76700	TC	A	Us exam, abdom, complete	0.00	1.96	NA	0.09	2.05	NA	XXX
76705		A	Echo exam of abdomen	0.59	1.61	NA	0.10	2.30	NA	XXX
76705	26	A	Echo exam of abdomen	0.59	0.20	0.20	0.03	0.82	0.82	XXX
76705	TC	A	Echo exam of abdomen	0.00	1.41	NA	0.07	1.48	NA	XXX
76770		A	Us exam abdo back wall, comp	0.74	2.21	NA	0.12	3.07	NA	XXX
76770	26	A	Us exam abdo back wall, comp	0.74	0.25	0.25	0.03	1.02	1.02	XXX
76770	TC	A	Us exam abdo back wall, comp	0.00	1.96	NA	0.09	2.05	NA	XXX
76775		A	Us eam abdo back wall, lim	0.58	1.61	NA	0.10	2.29	NA	XXX
76775	26	A	Us eam abdo back wall, lim	0.58	0.20	0.20	0.03	0.81	0.81	XXX
76775	TC	A	Us eam abdo back wall, lim	0.00	1.41	NA	0.07	1.48	NA	XXX
76778		A	Us exam kidney transplant	0.74	2.21	NA	0.12	3.07	NA	XXX
76778	26	A	Us exam kidney transplant	0.74	0.25	0.25	0.03	1.02	1.02	XXX
76778	TC	A	Us exam kidney transplant	0.00	1.96	NA	0.09	2.05	NA	XXX
76800		A	Us exam, spinal canal	1.13	1.76	NA	0.11	3.00	NA	XXX
76800	26	A	Us exam, spinal canal	1.13	0.35	0.35	0.04	1.52	1.52	XXX
76800	TC	A	Us exam, spinal canal	0.00	1.41	NA	0.07	1.48	NA	XXX
76801		A	Ob us < 14 wks, single fetus	0.99	1.40	NA	0.14	2.53	NA	XXX
76801	26	A	Ob us < 14 wks, single fetus	0.99	0.36	0.36	0.04	1.39	1.39	XXX
76801	TC	A	Ob us < 14 wks, single fetus	0.00	1.04	NA	0.10	1.14	NA	XXX
76802		A	Ob us < 14 wks, addl fetus	0.83	1.01	NA	0.14	1.98	NA	ZZZ
76802	26	A	Ob us < 14 wks, addl fetus	0.83	0.30	0.30	0.04	1.17	1.17	ZZZ
76802	TC	A	Ob us < 14 wks, addl fetus	0.00	0.71	NA	0.10	0.81	NA	ZZZ
76805		A	Ob us >/= 14 wks, sngl fetus	0.99	2.44	NA	0.14	3.57	NA	XXX
76805	26	A	Ob us >/= 14 wks, sngl fetus	0.99	0.35	0.35	0.04	1.38	1.38	XXX
76805	TC	A	Ob us >/= 14 wks, sngl fetus	0.00	2.09	NA	0.10	2.19	NA	XXX
76810		A	Ob us >/= 14 wks, addl fetus	0.98	1.40	NA	0.25	2.63	NA	ZZZ
76810	26	A	Ob us >/= 14 wks, addl fetus	0.98	0.36	0.36	0.07	1.41	1.41	ZZZ
76810	TC	A	Ob us >/= 14 wks, addl fetus	0.00	1.04	NA	0.18	1.22	NA	ZZZ
76811		A	Ob us, detailed, sngl fetus	1.90	4.19	NA	0.51	6.60	NA	XXX
76811	26	A	Ob us, detailed, sngl fetus	1.90	0.68	0.68	0.15	2.73	2.73	XXX
76811	TC	A	Ob us, detailed, sngl fetus	0.00	3.51	NA	0.36	3.87	NA	XXX
76812		A	Ob us, detailed, addl fetus	1.78	1.69	NA	0.46	3.93	NA	ZZZ
76812	26	A	Ob us, detailed, addl fetus	1.78	0.65	0.65	0.12	2.55	2.55	ZZZ
76812	TC	A	Ob us, detailed, addl fetus	0.00	1.04	NA	0.34	1.38	NA	ZZZ
76815		A	Ob us, limited, fetus(s)	0.65	1.65	NA	0.09	2.39	NA	XXX
76815	26	A	Ob us, limited, fetus(s)	0.65	0.24	0.24	0.02	0.91	0.91	XXX
76815	TC	A	Ob us, limited, fetus(s)	0.00	1.41	NA	0.07	1.48	NA	XXX
76816		A	Ob us, follow-up, per fetus	0.85	1.43	NA	0.07	2.35	NA	XXX
76816	26	A	Ob us, follow-up, per fetus	0.85	0.33	0.33	0.02	1.20	1.20	XXX
76816	TC	A	Ob us, follow-up, per fetus	0.00	1.10	NA	0.05	1.15	NA	XXX
76817		A	Transvaginal us, obstetric	0.75	1.79	NA	0.07	2.61	NA	XXX
76817	26	A	Transvaginal us, obstetric	0.75	0.28	0.28	0.02	1.05	1.05	XXX
76817	TC	A	Transvaginal us, obstetric	0.00	1.51	NA	0.05	1.56	NA	XXX
76818		A	Fetal biophys profile w/nst	1.05	2.01	NA	0.12	3.18	NA	XXX
76818	26	A	Fetal biophys profile w/nst	1.05	0.40	0.40	0.04	1.49	1.49	XXX
76818	TC	A	Fetal biophys profile w/nst	0.00	1.61	NA	0.08	1.69	NA	XXX
76819		A	Fetal biophys profil w/o nst	0.77	1.90	NA	0.10	2.77	NA	XXX
76819	26	A	Fetal biophys profil w/o nst	0.77	0.29	0.29	0.02	1.08	1.08	XXX
76819	TC	A	Fetal biophys profil w/o nst	0.00	1.61	NA	0.08	1.69	NA	XXX
76825		A	Echo exam of fetal heart	1.67	2.58	NA	0.15	4.40	NA	XXX
76825	26	A	Echo exam of fetal heart	1.67	0.62	0.62	0.06	2.35	2.35	XXX
76825	TC	A	Echo exam of fetal heart	0.00	1.96	NA	0.09	2.05	NA	XXX
76826		A	Echo exam of fetal heart	0.83	1.01	NA	0.07	1.91	NA	XXX
76826	26	A	Echo exam of fetal heart	0.83	0.30	0.30	0.03	1.16	1.16	XXX
76826	TC	A	Echo exam of fetal heart	0.00	0.71	NA	0.04	0.75	NA	XXX
76827		A	Echo exam of fetal heart	0.58	1.93	NA	0.12	2.63	NA	XXX
76827	26	A	Echo exam of fetal heart	0.58	0.22	0.22	0.02	0.82	0.82	XXX
76827	TC	A	Echo exam of fetal heart	0.00	1.71	NA	0.10	1.81	NA	XXX
76828		A	Echo exam of fetal heart	0.56	1.32	NA	0.09	1.97	NA	XXX
76828	26	A	Echo exam of fetal heart	0.56	0.22	0.22	0.02	0.80	0.80	XXX
76828	TC	A	Echo exam of fetal heart	0.00	1.10	NA	0.07	1.17	NA	XXX
76830		A	Transvaginal us, non-ob	0.69	1.75	NA	0.11	2.55	NA	XXX
76830	26	A	Transvaginal us, non-ob	0.69	0.24	0.24	0.03	0.96	0.96	XXX
76830	TC	A	Transvaginal us, non-ob	0.00	1.51	NA	0.08	1.59	NA	XXX
76831		A	Echo exam, uterus	0.72	1.77	NA	0.10	2.59	NA	XXX
76831	26	A	Echo exam, uterus	0.72	0.26	0.26	0.02	1.00	1.00	XXX
76831	TC	A	Echo exam, uterus	0.00	1.51	NA	0.08	1.59	NA	XXX
76856		A	Us exam, pelvic, complete	0.69	1.75	NA	0.11	2.55	NA	XXX
76856	26	A	Us exam, pelvic, complete	0.69	0.24	0.24	0.03	0.96	0.96	XXX
76856	TC	A	Us exam, pelvic, complete	0.00	1.51	NA	0.08	1.59	NA	XXX
76857		A	Us exam, pelvic, limited	0.38	2.09	NA	0.07	2.54	NA	XXX
76857	26	A	Us exam, pelvic, limited	0.38	0.13	0.13	0.02	0.53	0.53	XXX
76857	TC	A	Us exam, pelvic, limited	0.00	1.96	NA	0.05	2.01	NA	XXX
76870		A	Us exam, scrotum	0.64	1.73	NA	0.11	2.48	NA	XXX
76870	26	A	Us exam, scrotum	0.64	0.22	0.22	0.03	0.89	0.89	XXX
76870	TC	A	Us exam, scrotum	0.00	1.51	NA	0.08	1.59	NA	XXX
76872		A	Echo exam, transrectal	0.69	1.81	NA	0.12	2.62	NA	XXX
76872	26	A	Echo exam, transrectal	0.69	0.23	0.23	0.04	0.96	0.96	XXX
76872	TC	A	Echo exam, transrectal	0.00	1.58	NA	0.08	1.66	NA	XXX
76873		A	Echograp trans r, pros study	1.55	2.61	NA	0.21	4.37	NA	XXX
76873	26	A	Echograp trans r, pros study	1.55	0.52	0.52	0.08	2.15	2.15	XXX
76873	TC	A	Echograp trans r, pros study	0.00	2.09	NA	0.13	2.22	NA	XXX
76880		A	Us exam, extremity	0.59	1.61	NA	0.10	2.30	NA	XXX
76880	26	A	Us exam, extremity	0.59	0.20	0.20	0.03	0.82	0.82	XXX
76880	TC	A	Us exam, extremity	0.00	1.41	NA	0.07	1.48	NA	XXX
76885		A	Us exam infant hips, dynamic	0.74	1.76	NA	0.11	2.61	NA	XXX
76885	26	A	Us exam infant hips, dynamic	0.74	0.25	0.25	0.03	1.02	1.02	XXX
76885	TC	A	Us exam infant hips, dynamic	0.00	1.51	NA	0.08	1.59	NA	XXX
76886		A	Us exam infant hips, static	0.62	1.62	NA	0.10	2.34	NA	XXX
76886	26	A	Us exam infant hips, static	0.62	0.21	0.21	0.03	0.86	0.86	XXX
76886	TC	A	Us exam infant hips, static	0.00	1.41	NA	0.07	1.48	NA	XXX
76930		A	Echo guide, cardiocentesis	0.67	1.77	NA	0.10	2.54	NA	XXX
76930	26	A	Echo guide, cardiocentesis	0.67	0.26	0.26	0.02	0.95	0.95	XXX
76930	TC	A	Echo guide, cardiocentesis	0.00	1.51	NA	0.08	1.59	NA	XXX
76932		A	Echo guide for heart biopsy	0.67	1.77	NA	0.10	2.54	NA	XXX
76932	26	A	Echo guide for heart biopsy	0.67	0.26	0.26	0.02	0.95	0.95	XXX
76932	TC	A	Echo guide for heart biopsy	0.00	1.51	NA	0.08	1.59	NA	XXX
76936		A	Echo guide for artery repair	1.99	6.95	NA	0.39	9.33	NA	XXX
76936	26	A	Echo guide for artery repair	1.99	0.68	0.68	0.11	2.78	2.78	XXX
76936	TC	A	Echo guide for artery repair	0.00	6.27	NA	0.28	6.55	NA	XXX
76941		A	Echo guide for transfusion	1.34	2.01	NA	0.13	3.48	NA	XXX
76941	26	A	Echo guide for transfusion	1.34	0.49	0.49	0.06	1.89	1.89	XXX
76941	TC	A	Echo guide for transfusion	0.00	1.52	NA	0.07	1.59	NA	XXX
76942		A	Echo guide for biopsy	0.67	3.18	NA	0.12	3.97	NA	XXX
76942	26	A	Echo guide for biopsy	0.67	0.23	0.23	0.04	0.94	0.94	XXX
76942	TC	A	Echo guide for biopsy	0.00	2.95	NA	0.08	3.03	NA	XXX
76945		A	Echo guide, villus sampling	0.67	1.75	NA	0.10	2.52	NA	XXX
76945	26	A	Echo guide, villus sampling	0.67	0.23	0.23	0.03	0.93	0.93	XXX
76945	TC	A	Echo guide, villus sampling	0.00	1.52	NA	0.07	1.59	NA	XXX
76946		A	Echo guide for amniocentesis	0.38	1.65	NA	0.09	2.12	NA	XXX
76946	26	A	Echo guide for amniocentesis	0.38	0.14	0.14	0.01	0.53	0.53	XXX
76946	TC	A	Echo guide for amniocentesis	0.00	1.51	NA	0.08	1.59	NA	XXX
76948		A	Echo guide, ova aspiration	0.38	1.64	NA	0.10	2.12	NA	XXX
76948	26	A	Echo guide, ova aspiration	0.38	0.13	0.13	0.02	0.53	0.53	XXX
76948	TC	A	Echo guide, ova aspiration	0.00	1.51	NA	0.08	1.59	NA	XXX
76950		A	Echo guidance radiotherapy	0.58	1.50	NA	0.09	2.17	NA	XXX
76950	26	A	Echo guidance radiotherapy	0.58	0.20	0.20	0.03	0.81	0.81	XXX
76950	TC	A	Echo guidance radiotherapy	0.00	1.30	NA	0.06	1.36	NA	XXX
76965		A	Echo guidance radiotherapy	1.34	5.99	NA	0.31	7.64	NA	XXX
76965	26	A	Echo guidance radiotherapy	1.34	0.45	0.45	0.07	1.86	1.86	XXX
76965	TC	A	Echo guidance radiotherapy	0.00	5.54	NA	0.24	5.78	NA	XXX
76970		A	Ultrasound exam follow-up	0.40	1.18	NA	0.07	1.65	NA	XXX
76970	26	A	Ultrasound exam follow-up	0.40	0.14	0.14	0.02	0.56	0.56	XXX
76970	TC	A	Ultrasound exam follow-up	0.00	1.04	NA	0.05	1.09	NA	XXX
76975		A	GI endoscopic ultrasound	0.81	1.80	NA	0.11	2.72	NA	XXX
76975	26	A	GI endoscopic ultrasound	0.81	0.29	0.29	0.03	1.13	1.13	XXX
76975	TC	A	GI endoscopic ultrasound	0.00	1.51	NA	0.08	1.59	NA	XXX
76977		A	Us bone density measure	0.05	0.84	NA	0.05	0.94	NA	XXX
76977	26	A	Us bone density measure	0.05	0.02	0.02	0.01	0.08	0.08	XXX
76977	TC	A	Us bone density measure	0.00	0.82	NA	0.04	0.86	NA	XXX
76986		A	Ultrasound guide intraoper	1.20	3.02	NA	0.19	4.41	NA	XXX
76986	26	A	Ultrasound guide intraoper	1.20	0.41	0.41	0.07	1.68	1.68	XXX
76986	TC	A	Ultrasound guide intraoper	0.00	2.61	NA	0.12	2.73	NA	XXX
76999		C	Echo examination procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76999	26	C	Echo examination procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
76999	TC	C	Echo examination procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77261		A	Radiation therapy planning	1.39	0.54	0.54	0.06	1.99	1.99	XXX
77262		A	Radiation therapy planning	2.11	0.80	0.80	0.09	3.00	3.00	XXX
77263		A	Radiation therapy planning	3.14	1.17	1.17	0.13	4.44	4.44	XXX
77280		A	Set radiation therapy field	0.70	3.69	NA	0.18	4.57	NA	XXX
77280	26	A	Set radiation therapy field	0.70	0.24	0.24	0.03	0.97	0.97	XXX
77280	TC	A	Set radiation therapy field	0.00	3.45	NA	0.15	3.60	NA	XXX
77285		A	Set radiation therapy field	1.05	5.90	NA	0.29	7.24	NA	XXX
77285	26	A	Set radiation therapy field	1.05	0.36	0.36	0.04	1.45	1.45	XXX
77285	TC	A	Set radiation therapy field	0.00	5.54	NA	0.25	5.79	NA	XXX
77290		A	Set radiation therapy field	1.56	7.01	NA	0.35	8.92	NA	XXX
77290	26	A	Set radiation therapy field	1.56	0.53	0.53	0.06	2.15	2.15	XXX
77290	TC	A	Set radiation therapy field	0.00	6.48	NA	0.29	6.77	NA	XXX
77295		A	Set radiation therapy field	4.57	29.35	NA	1.41	35.33	NA	XXX
77295	26	A	Set radiation therapy field	4.57	1.54	1.54	0.18	6.29	6.29	XXX
77295	TC	A	Set radiation therapy field	0.00	27.81	NA	1.23	29.04	NA	XXX
77299		C	Radiation therapy planning	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77299	26	C	Radiation therapy planning	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77299	TC	C	Radiation therapy planning	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77300		A	Radiation therapy dose plan	0.62	1.54	NA	0.09	2.25	NA	XXX
77300	26	A	Radiation therapy dose plan	0.62	0.21	0.21	0.03	0.86	0.86	XXX
77300	TC	A	Radiation therapy dose plan	0.00	1.33	NA	0.06	1.39	NA	XXX
77301		A	Radiotherapy dose plan, imrt	8.00	30.92	NA	1.41	40.33	NA	XXX
77301	26	A	Radiotherapy dose plan, imrt	8.00	3.11	3.11	0.18	11.29	11.29	XXX
77301	TC	A	Radiotherapy dose plan, imrt	0.00	27.81	NA	1.23	29.04	NA	XXX
77305		A	Teletx isodose plan simple	0.70	2.09	NA	0.12	2.91	NA	XXX
77305	26	A	Teletx isodose plan simple	0.70	0.24	0.24	0.03	0.97	0.97	XXX
77305	TC	A	Teletx isodose plan simple	0.00	1.85	NA	0.09	1.94	NA	XXX
77310		A	Teletx isodose plan intermed	1.05	2.68	NA	0.15	3.88	NA	XXX
77310	26	A	Teletx isodose plan intermed	1.05	0.36	0.36	0.04	1.45	1.45	XXX
77310	TC	A	Teletx isodose plan intermed	0.00	2.32	NA	0.11	2.43	NA	XXX
77315		A	Teletx isodose plan complex	1.56	3.18	NA	0.18	4.92	NA	XXX
77315	26	A	Teletx isodose plan complex	1.56	0.53	0.53	0.06	2.15	2.15	XXX
77315	TC	A	Teletx isodose plan complex	0.00	2.65	NA	0.12	2.77	NA	XXX
77321		A	Special teletx port plan	0.95	4.34	NA	0.21	5.50	NA	XXX
77321	26	A	Special teletx port plan	0.95	0.32	0.32	0.04	1.31	1.31	XXX
77321	TC	A	Special teletx port plan	0.00	4.02	NA	0.17	4.19	NA	XXX
77326		A	Brachytx isodose calc simp	0.93	2.66	NA	0.15	3.74	NA	XXX
77326	26	A	Brachytx isodose calc simp	0.93	0.31	0.31	0.04	1.28	1.28	XXX
77326	TC	A	Brachytx isodose calc simp	0.00	2.35	NA	0.11	2.46	NA	XXX
77327		A	Brachytx isodose calc interm	1.39	3.92	NA	0.21	5.52	NA	XXX
77327	26	A	Brachytx isodose calc interm	1.39	0.47	0.47	0.06	1.92	1.92	XXX
77327	TC	A	Brachytx isodose calc interm	0.00	3.45	NA	0.15	3.60	NA	XXX
77328		A	Brachytx isodose plan compl	2.09	5.65	NA	0.30	8.04	NA	XXX
77328	26	A	Brachytx isodose plan compl	2.09	0.71	0.71	0.09	2.89	2.89	XXX
77328	TC	A	Brachytx isodose plan compl	0.00	4.94	NA	0.21	5.15	NA	XXX
77331		A	Special radiation dosimetry	0.87	0.80	NA	0.06	1.73	NA	XXX
77331	26	A	Special radiation dosimetry	0.87	0.30	0.30	0.04	1.21	1.21	XXX
77331	TC	A	Special radiation dosimetry	0.00	0.50	NA	0.02	0.52	NA	XXX
77332		A	Radiation treatment aid(s)	0.54	1.51	NA	0.08	2.13	NA	XXX
77332	26	A	Radiation treatment aid(s)	0.54	0.18	0.18	0.02	0.74	0.74	XXX
77332	TC	A	Radiation treatment aid(s)	0.00	1.33	NA	0.06	1.39	NA	XXX
77333		A	Radiation treatment aid(s)	0.84	2.18	NA	0.13	3.15	NA	XXX
77333	26	A	Radiation treatment aid(s)	0.84	0.29	0.29	0.04	1.17	1.17	XXX
77333	TC	A	Radiation treatment aid(s)	0.00	1.89	NA	0.09	1.98	NA	XXX
77334		A	Radiation treatment aid(s)	1.24	3.65	NA	0.19	5.08	NA	XXX
77334	26	A	Radiation treatment aid(s)	1.24	0.42	0.42	0.05	1.71	1.71	XXX
77334	TC	A	Radiation treatment aid(s)	0.00	3.23	NA	0.14	3.37	NA	XXX
77336		A	Radiation physics consult	0.00	2.97	NA	0.13	3.10	NA	XXX
77370		A	Radiation physics consult	0.00	3.47	NA	0.15	3.62	NA	XXX
77399		C	External radiation dosimetry	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77399	26	C	External radiation dosimetry	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77399	TC	C	External radiation dosimetry	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77401		A	Radiation treatment delivery	0.00	1.76	NA	0.09	1.85	NA	XXX
77402		A	Radiation treatment delivery	0.00	1.76	NA	0.09	1.85	NA	XXX
77403		A	Radiation treatment delivery	0.00	1.76	NA	0.09	1.85	NA	XXX
77404		A	Radiation treatment delivery	0.00	1.76	NA	0.09	1.85	NA	XXX
77406		A	Radiation treatment delivery	0.00	1.76	NA	0.09	1.85	NA	XXX
77407		A	Radiation treatment delivery	0.00	2.08	NA	0.10	2.18	NA	XXX
77408		A	Radiation treatment delivery	0.00	2.08	NA	0.10	2.18	NA	XXX
77409		A	Radiation treatment delivery	0.00	2.08	NA	0.10	2.18	NA	XXX
77411		A	Radiation treatment delivery	0.00	2.08	NA	0.10	2.18	NA	XXX
77412		A	Radiation treatment delivery	0.00	2.32	NA	0.11	2.43	NA	XXX
77413		A	Radiation treatment delivery	0.00	2.32	NA	0.11	2.43	NA	XXX
77414		A	Radiation treatment delivery	0.00	2.32	NA	0.11	2.43	NA	XXX
77416		A	Radiation treatment delivery	0.00	2.32	NA	0.11	2.43	NA	XXX
77417		A	Radiology port film(s)	0.00	0.59	NA	0.03	0.62	NA	XXX
77418		A	Radiation tx delivery, imrt	0.00	17.97	NA	0.11	18.08	NA	XXX
77427		A	Radiation tx management, x5	3.31	1.12	1.12	0.14	4.57	4.57	XXX
77431		A	Radiation therapy management	1.81	0.71	0.71	0.07	2.59	2.59	XXX
77432		A	Stereotactic radiation trmt	7.93	3.06	3.06	0.33	11.32	11.32	XXX
77470		A	Special radiation treatment	2.09	11.81	NA	0.58	14.48	NA	XXX
77470	26	A	Special radiation treatment	2.09	0.71	0.71	0.09	2.89	2.89	XXX
77470	TC	A	Special radiation treatment	0.00	11.10	NA	0.49	11.59	NA	XXX
77499		C	Radiation therapy management	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77499	26	C	Radiation therapy management	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77499	TC	C	Radiation therapy management	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77520		C	Proton trmt, simple w/o comp	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77522		C	Proton trmt, simple w/comp	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77523		C	Proton trmt, intermediate	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77525		C	Proton treatment, complex	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77600		R	Hyperthermia treatment	1.56	3.57	NA	0.21	5.34	NA	XXX
77600	26	R	Hyperthermia treatment	1.56	0.53	0.53	0.08	2.17	2.17	XXX
77600	TC	R	Hyperthermia treatment	0.00	3.04	NA	0.13	3.17	NA	XXX
77605		R	Hyperthermia treatment	2.09	4.75	NA	0.31	7.15	NA	XXX
77605	26	R	Hyperthermia treatment	2.09	0.71	0.71	0.13	2.93	2.93	XXX
77605	TC	R	Hyperthermia treatment	0.00	4.04	NA	0.18	4.22	NA	XXX
77610		R	Hyperthermia treatment	1.56	3.57	NA	0.20	5.33	NA	XXX
77610	26	R	Hyperthermia treatment	1.56	0.53	0.53	0.07	2.16	2.16	XXX
77610	TC	R	Hyperthermia treatment	0.00	3.04	NA	0.13	3.17	NA	XXX
77615		R	Hyperthermia treatment	2.09	4.75	NA	0.27	7.11	NA	XXX
77615	26	R	Hyperthermia treatment	2.09	0.71	0.71	0.09	2.89	2.89	XXX
77615	TC	R	Hyperthermia treatment	0.00	4.04	NA	0.18	4.22	NA	XXX
77620		R	Hyperthermia treatment	1.56	3.58	NA	0.19	5.33	NA	XXX
77620	26	R	Hyperthermia treatment	1.56	0.54	0.54	0.06	2.16	2.16	XXX
77620	TC	R	Hyperthermia treatment	0.00	3.04	NA	0.13	3.17	NA	XXX
77750		A	Infuse radioactive materials	4.91	3.00	NA	0.23	8.14	NA	090
77750	26	A	Infuse radioactive materials	4.91	1.67	1.67	0.17	6.75	6.75	090
77750	TC	A	Infuse radioactive materials	0.00	1.33	NA	0.06	1.39	NA	090
77761		A	Apply intrcav radiat simple	3.81	3.64	NA	0.28	7.73	NA	090
77761	26	A	Apply intrcav radiat simple	3.81	1.14	1.14	0.16	5.11	5.11	090
77761	TC	A	Apply intrcav radiat simple	0.00	2.50	NA	0.12	2.62	NA	090
77762		A	Apply intrcav radiat interm	5.72	5.51	NA	0.38	11.61	NA	090
77762	26	A	Apply intrcav radiat interm	5.72	1.92	1.92	0.22	7.86	7.86	090
77762	TC	A	Apply intrcav radiat interm	0.00	3.59	NA	0.16	3.75	NA	090
77763		A	Apply intrcav radiat compl	8.57	7.35	NA	0.53	16.45	NA	090
77763	26	A	Apply intrcav radiat compl	8.57	2.88	2.88	0.34	11.79	11.79	090
77763	TC	A	Apply intrcav radiat compl	0.00	4.47	NA	0.19	4.66	NA	090
77776		A	Apply interstit radiat simpl	4.66	3.15	NA	0.35	8.16	NA	090
77776	26	A	Apply interstit radiat simpl	4.66	0.98	0.98	0.24	5.88	5.88	090
77776	TC	A	Apply interstit radiat simpl	0.00	2.17	NA	0.11	2.28	NA	090
77777		A	Apply interstit radiat inter	7.48	6.70	NA	0.50	14.68	NA	090
77777	26	A	Apply interstit radiat inter	7.48	2.48	2.48	0.32	10.28	10.28	090
77777	TC	A	Apply interstit radiat inter	0.00	4.22	NA	0.18	4.40	NA	090
77778		A	Apply interstit radiat compl	11.19	8.88	NA	0.69	20.76	NA	090
77778	26	A	Apply interstit radiat compl	11.19	3.77	3.77	0.47	15.43	15.43	090
77778	TC	A	Apply interstit radiat compl	0.00	5.11	NA	0.22	5.33	NA	090
77781		A	High intensity brachytherapy	1.66	20.79	NA	0.95	23.40	NA	090
77781	26	A	High intensity brachytherapy	1.66	0.57	0.57	0.07	2.30	2.30	090
77781	TC	A	High intensity brachytherapy	0.00	20.22	NA	0.88	21.10	NA	090
77782		A	High intensity brachytherapy	2.49	21.07	NA	0.98	24.54	NA	090
77782	26	A	High intensity brachytherapy	2.49	0.85	0.85	0.10	3.44	3.44	090
77782	TC	A	High intensity brachytherapy	0.00	20.22	NA	0.88	21.10	NA	090
77783		A	High intensity brachytherapy	3.73	21.48	NA	1.03	26.24	NA	090
77783	26	A	High intensity brachytherapy	3.73	1.26	1.26	0.15	5.14	5.14	090
77783	TC	A	High intensity brachytherapy	0.00	20.22	NA	0.88	21.10	NA	090
77784		A	High intensity brachytherapy	5.61	22.11	NA	1.10	28.82	NA	090
77784	26	A	High intensity brachytherapy	5.61	1.89	1.89	0.22	7.72	7.72	090
77784	TC	A	High intensity brachytherapy	0.00	20.22	NA	0.88	21.10	NA	090
77789		A	Apply surface radiation	1.12	0.84	NA	0.05	2.01	NA	090
77789	26	A	Apply surface radiation	1.12	0.39	0.39	0.03	1.54	1.54	090
77789	TC	A	Apply surface radiation	0.00	0.45	NA	0.02	0.47	NA	090
77790		A	Radiation handling	1.05	0.86	NA	0.06	1.97	NA	XXX
77790	26	A	Radiation handling	1.05	0.36	0.36	0.04	1.45	1.45	XXX
77790	TC	A	Radiation handling	0.00	0.50	NA	0.02	0.52	NA	XXX
77799		C	Radium/radioisotope therapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77799	26	C	Radium/radioisotope therapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
77799	TC	C	Radium/radioisotope therapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78000		A	Thyroid, single uptake	0.19	1.04	NA	0.06	1.29	NA	XXX
78000	26	A	Thyroid, single uptake	0.19	0.07	0.07	0.01	0.27	0.27	XXX
78000	TC	A	Thyroid, single uptake	0.00	0.97	NA	0.05	1.02	NA	XXX
78001		A	Thyroid, multiple uptakes	0.26	1.39	NA	0.07	1.72	NA	XXX
78001	26	A	Thyroid, multiple uptakes	0.26	0.09	0.09	0.01	0.36	0.36	XXX
78001	TC	A	Thyroid, multiple uptakes	0.00	1.30	NA	0.06	1.36	NA	XXX
78003		A	Thyroid suppress/stimul	0.33	1.08	NA	0.06	1.47	NA	XXX
78003	26	A	Thyroid suppress/stimul	0.33	0.11	0.11	0.01	0.45	0.45	XXX
78003	TC	A	Thyroid suppress/stimul	0.00	0.97	NA	0.05	1.02	NA	XXX
78006		A	Thyroid imaging with uptake	0.49	2.54	NA	0.13	3.16	NA	XXX
78006	26	A	Thyroid imaging with uptake	0.49	0.17	0.17	0.02	0.68	0.68	XXX
78006	TC	A	Thyroid imaging with uptake	0.00	2.37	NA	0.11	2.48	NA	XXX
78007		A	Thyroid image, mult uptakes	0.50	2.73	NA	0.14	3.37	NA	XXX
78007	26	A	Thyroid image, mult uptakes	0.50	0.17	0.17	0.02	0.69	0.69	XXX
78007	TC	A	Thyroid image, mult uptakes	0.00	2.56	NA	0.12	2.68	NA	XXX
78010		A	Thyroid imaging	0.39	1.95	NA	0.11	2.45	NA	XXX
78010	26	A	Thyroid imaging	0.39	0.14	0.14	0.02	0.55	0.55	XXX
78010	TC	A	Thyroid imaging	0.00	1.81	NA	0.09	1.90	NA	XXX
78011		A	Thyroid imaging with flow	0.45	2.56	NA	0.13	3.14	NA	XXX
78011	26	A	Thyroid imaging with flow	0.45	0.16	0.16	0.02	0.63	0.63	XXX
78011	TC	A	Thyroid imaging with flow	0.00	2.40	NA	0.11	2.51	NA	XXX
78015		A	Thyroid met imaging	0.67	2.79	NA	0.15	3.61	NA	XXX
78015	26	A	Thyroid met imaging	0.67	0.23	0.23	0.03	0.93	0.93	XXX
78015	TC	A	Thyroid met imaging	0.00	2.56	NA	0.12	2.68	NA	XXX
78016		A	Thyroid met imaging/studies	0.82	3.76	NA	0.18	4.76	NA	XXX
78016	26	A	Thyroid met imaging/studies	0.82	0.30	0.30	0.03	1.15	1.15	XXX
78016	TC	A	Thyroid met imaging/studies	0.00	3.46	NA	0.15	3.61	NA	XXX
78018		A	Thyroid met imaging, body	0.86	5.71	NA	0.27	6.84	NA	XXX
78018	26	A	Thyroid met imaging, body	0.86	0.31	0.31	0.03	1.20	1.20	XXX
78018	TC	A	Thyroid met imaging, body	0.00	5.40	NA	0.24	5.64	NA	XXX
78020		A	Thyroid met uptake	0.60	1.52	NA	0.14	2.26	NA	ZZZ
78020	26	A	Thyroid met uptake	0.60	0.22	0.22	0.02	0.84	0.84	ZZZ
78020	TC	A	Thyroid met uptake	0.00	1.30	NA	0.12	1.42	NA	ZZZ
78070		A	Parathyroid nuclear imaging	0.82	2.10	NA	0.12	3.04	NA	XXX
78070	26	A	Parathyroid nuclear imaging	0.82	0.29	0.29	0.03	1.14	1.14	XXX
78070	TC	A	Parathyroid nuclear imaging	0.00	1.81	NA	0.09	1.90	NA	XXX
78075		A	Adrenal nuclear imaging	0.74	5.67	NA	0.27	6.68	NA	XXX
78075	26	A	Adrenal nuclear imaging	0.74	0.27	0.27	0.03	1.04	1.04	XXX
78075	TC	A	Adrenal nuclear imaging	0.00	5.40	NA	0.24	5.64	NA	XXX
78099		C	Endocrine nuclear procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78099	26	C	Endocrine nuclear procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78099	TC	C	Endocrine nuclear procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78102		A	Bone marrow imaging, ltd	0.55	2.23	NA	0.12	2.90	NA	XXX
78102	26	A	Bone marrow imaging, ltd	0.55	0.20	0.20	0.02	0.77	0.77	XXX
78102	TC	A	Bone marrow imaging, ltd	0.00	2.03	NA	0.10	2.13	NA	XXX
78103		A	Bone marrow imaging, mult	0.75	3.42	NA	0.17	4.34	NA	XXX
78103	26	A	Bone marrow imaging, mult	0.75	0.27	0.27	0.03	1.05	1.05	XXX
78103	TC	A	Bone marrow imaging, mult	0.00	3.15	NA	0.14	3.29	NA	XXX
78104		A	Bone marrow imaging, body	0.80	4.33	NA	0.21	5.34	NA	XXX
78104	26	A	Bone marrow imaging, body	0.80	0.28	0.28	0.03	1.11	1.11	XXX
78104	TC	A	Bone marrow imaging, body	0.00	4.05	NA	0.18	4.23	NA	XXX
78110		A	Plasma volume, single	0.19	1.02	NA	0.06	1.27	NA	XXX
78110	26	A	Plasma volume, single	0.19	0.07	0.07	0.01	0.27	0.27	XXX
78110	TC	A	Plasma volume, single	0.00	0.95	NA	0.05	1.00	NA	XXX
78111		A	Plasma volume, multiple	0.22	2.64	NA	0.13	2.99	NA	XXX
78111	26	A	Plasma volume, multiple	0.22	0.08	0.08	0.01	0.31	0.31	XXX
78111	TC	A	Plasma volume, multiple	0.00	2.56	NA	0.12	2.68	NA	XXX
78120		A	Red cell mass, single	0.23	1.80	NA	0.10	2.13	NA	XXX
78120	26	A	Red cell mass, single	0.23	0.08	0.08	0.01	0.32	0.32	XXX
78120	TC	A	Red cell mass, single	0.00	1.72	NA	0.09	1.81	NA	XXX
78121		A	Red cell mass, multiple	0.32	3.02	NA	0.13	3.47	NA	XXX
78121	26	A	Red cell mass, multiple	0.32	0.12	0.12	0.01	0.45	0.45	XXX
78121	TC	A	Red cell mass, multiple	0.00	2.90	NA	0.12	3.02	NA	XXX
78122		A	Blood volume	0.45	4.74	NA	0.22	5.41	NA	XXX
78122	26	A	Blood volume	0.45	0.16	0.16	0.02	0.63	0.63	XXX
78122	TC	A	Blood volume	0.00	4.58	NA	0.20	4.78	NA	XXX
78130		A	Red cell survival study	0.61	3.06	NA	0.15	3.82	NA	XXX
78130	26	A	Red cell survival study	0.61	0.22	0.22	0.03	0.86	0.86	XXX
78130	TC	A	Red cell survival study	0.00	2.84	NA	0.12	2.96	NA	XXX
78135		A	Red cell survival kinetics	0.64	5.09	NA	0.24	5.97	NA	XXX
78135	26	A	Red cell survival kinetics	0.64	0.23	0.23	0.03	0.90	0.90	XXX
78135	TC	A	Red cell survival kinetics	0.00	4.86	NA	0.21	5.07	NA	XXX
78140		A	Red cell sequestration	0.61	4.13	NA	0.20	4.94	NA	XXX
78140	26	A	Red cell sequestration	0.61	0.21	0.21	0.03	0.85	0.85	XXX
78140	TC	A	Red cell sequestration	0.00	3.92	NA	0.17	4.09	NA	XXX
78160		A	Plasma iron turnover	0.33	3.77	NA	0.19	4.29	NA	XXX
78160	26	A	Plasma iron turnover	0.33	0.12	0.12	0.03	0.48	0.48	XXX
78160	TC	A	Plasma iron turnover	0.00	3.65	NA	0.16	3.81	NA	XXX
78162		A	Radioiron absorption exam	0.45	3.37	NA	0.15	3.97	NA	XXX
78162	26	A	Radioiron absorption exam	0.45	0.19	0.19	0.01	0.65	0.65	XXX
78162	TC	A	Radioiron absorption exam	0.00	3.18	NA	0.14	3.32	NA	XXX
78170		A	Red cell iron utilization	0.41	5.42	NA	0.27	6.10	NA	XXX
78170	26	A	Red cell iron utilization	0.41	0.14	0.14	0.04	0.59	0.59	XXX
78170	TC	A	Red cell iron utilization	0.00	5.28	NA	0.23	5.51	NA	XXX
78172		C	Total body iron estimation	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78172	26	A	Total body iron estimation	0.53	0.18	0.18	0.02	0.73	0.73	XXX
78172	TC	C	Total body iron estimation	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78185		A	Spleen imaging	0.40	2.49	NA	0.13	3.02	NA	XXX
78185	26	A	Spleen imaging	0.40	0.14	0.14	0.02	0.56	0.56	XXX
78185	TC	A	Spleen imaging	0.00	2.35	NA	0.11	2.46	NA	XXX
78190		A	Platelet survival, kinetics	1.09	6.09	NA	0.31	7.49	NA	XXX
78190	26	A	Platelet survival, kinetics	1.09	0.40	0.40	0.06	1.55	1.55	XXX
78190	TC	A	Platelet survival, kinetics	0.00	5.69	NA	0.25	5.94	NA	XXX
78191		A	Platelet survival	0.61	7.51	NA	0.34	8.46	NA	XXX
78191	26	A	Platelet survival	0.61	0.21	0.21	0.03	0.85	0.85	XXX
78191	TC	A	Platelet survival	0.00	7.30	NA	0.31	7.61	NA	XXX
78195		A	Lymph system imaging	1.20	4.48	NA	0.23	5.91	NA	XXX
78195	26	A	Lymph system imaging	1.20	0.43	0.43	0.05	1.68	1.68	XXX
78195	TC	A	Lymph system imaging	0.00	4.05	NA	0.18	4.23	NA	XXX
78199		C	Blood/lymph nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78199	26	C	Blood/lymph nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78199	TC	C	Blood/lymph nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78201		A	Liver imaging	0.44	2.50	NA	0.13	3.07	NA	XXX
78201	26	A	Liver imaging	0.44	0.15	0.15	0.02	0.61	0.61	XXX
78201	TC	A	Liver imaging	0.00	2.35	NA	0.11	2.46	NA	XXX
78202		A	Liver imaging with flow	0.51	3.05	NA	0.14	3.70	NA	XXX
78202	26	A	Liver imaging with flow	0.51	0.18	0.18	0.02	0.71	0.71	XXX
78202	TC	A	Liver imaging with flow	0.00	2.87	NA	0.12	2.99	NA	XXX
78205		A	Liver imaging (3D)	0.71	6.13	NA	0.29	7.13	NA	XXX
78205	26	A	Liver imaging (3D)	0.71	0.25	0.25	0.03	0.99	0.99	XXX
78205	TC	A	Liver imaging (3D)	0.00	5.88	NA	0.26	6.14	NA	XXX
78206		A	Liver image (3d) with flow	0.96	6.22	NA	0.13	7.31	NA	XXX
78206	26	A	Liver image (3d) with flow	0.96	0.34	0.34	0.04	1.34	1.34	XXX
78206	TC	A	Liver image (3d) with flow	0.00	5.88	NA	0.09	5.97	NA	XXX
78215		A	Liver and spleen imaging	0.49	3.10	NA	0.14	3.73	NA	XXX
78215	26	A	Liver and spleen imaging	0.49	0.17	0.17	0.02	0.68	0.68	XXX
78215	TC	A	Liver and spleen imaging	0.00	2.93	NA	0.12	3.05	NA	XXX
78216		A	Liver & spleen image/flow	0.57	3.66	NA	0.17	4.40	NA	XXX
78216	26	A	Liver & spleen image/flow	0.57	0.20	0.20	0.02	0.79	0.79	XXX
78216	TC	A	Liver & spleen image/flow	0.00	3.46	NA	0.15	3.61	NA	XXX
78220		A	Liver function study	0.49	3.87	NA	0.18	4.54	NA	XXX
78220	26	A	Liver function study	0.49	0.17	0.17	0.02	0.68	0.68	XXX
78220	TC	A	Liver function study	0.00	3.70	NA	0.16	3.86	NA	XXX
78223		A	Hepatobiliary imaging	0.84	3.94	NA	0.20	4.98	NA	XXX
78223	26	A	Hepatobiliary imaging	0.84	0.29	0.29	0.04	1.17	1.17	XXX
78223	TC	A	Hepatobiliary imaging	0.00	3.65	NA	0.16	3.81	NA	XXX
78230		A	Salivary gland imaging	0.45	2.32	NA	0.13	2.90	NA	XXX
78230	26	A	Salivary gland imaging	0.45	0.15	0.15	0.02	0.62	0.62	XXX
78230	TC	A	Salivary gland imaging	0.00	2.17	NA	0.11	2.28	NA	XXX
78231		A	Serial salivary imaging	0.52	3.34	NA	0.16	4.02	NA	XXX
78231	26	A	Serial salivary imaging	0.52	0.19	0.19	0.02	0.73	0.73	XXX
78231	TC	A	Serial salivary imaging	0.00	3.15	NA	0.14	3.29	NA	XXX
78232		A	Salivary gland function exam	0.47	3.69	NA	0.16	4.32	NA	XXX
78232	26	A	Salivary gland function exam	0.47	0.17	0.17	0.01	0.65	0.65	XXX
78232	TC	A	Salivary gland function exam	0.00	3.52	NA	0.15	3.67	NA	XXX
78258		A	Esophageal motility study	0.74	3.13	NA	0.15	4.02	NA	XXX
78258	26	A	Esophageal motility study	0.74	0.26	0.26	0.03	1.03	1.03	XXX
78258	TC	A	Esophageal motility study	0.00	2.87	NA	0.12	2.99	NA	XXX
78261		A	Gastric mucosa imaging	0.69	4.33	NA	0.21	5.23	NA	XXX
78261	26	A	Gastric mucosa imaging	0.69	0.25	0.25	0.03	0.97	0.97	XXX
78261	TC	A	Gastric mucosa imaging	0.00	4.08	NA	0.18	4.26	NA	XXX
78262		A	Gastroesophageal reflux exam	0.68	4.48	NA	0.21	5.37	NA	XXX
78262	26	A	Gastroesophageal reflux exam	0.68	0.24	0.24	0.03	0.95	0.95	XXX
78262	TC	A	Gastroesophageal reflux exam	0.00	4.24	NA	0.18	4.42	NA	XXX
78264		A	Gastric emptying study	0.78	4.38	NA	0.21	5.37	NA	XXX
78264	26	A	Gastric emptying study	0.78	0.27	0.27	0.03	1.08	1.08	XXX
78264	TC	A	Gastric emptying study	0.00	4.11	NA	0.18	4.29	NA	XXX
78267		X	Breath tst attain/anal c-14	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78268		X	Breath test analysis, c-14	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78270		A	Vit B-12 absorption exam	0.20	1.61	NA	0.09	1.90	NA	XXX
78270	26	A	Vit B-12 absorption exam	0.20	0.07	0.07	0.01	0.28	0.28	XXX
78270	TC	A	Vit B-12 absorption exam	0.00	1.54	NA	0.08	1.62	NA	XXX
78271		A	Vit b-12 absrp exam, int fac	0.20	1.70	NA	0.09	1.99	NA	XXX
78271	26	A	Vit b-12 absrp exam, int fac	0.20	0.07	0.07	0.01	0.28	0.28	XXX
78271	TC	A	Vit b-12 absrp exam, int fac	0.00	1.63	NA	0.08	1.71	NA	XXX
78272		A	Vit B-12 absorp, combined	0.27	2.41	NA	0.12	2.80	NA	XXX
78272	26	A	Vit B-12 absorp, combined	0.27	0.10	0.10	0.01	0.38	0.38	XXX
78272	TC	A	Vit B-12 absorp, combined	0.00	2.31	NA	0.11	2.42	NA	XXX
78278		A	Acute GI blood loss imaging	0.99	5.20	NA	0.25	6.44	NA	XXX
78278	26	A	Acute GI blood loss imaging	0.99	0.34	0.34	0.04	1.37	1.37	XXX
78278	TC	A	Acute GI blood loss imaging	0.00	4.86	NA	0.21	5.07	NA	XXX
78282		C	GI protein loss exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78282	26	A	GI protein loss exam	0.38	0.14	0.14	0.02	0.54	0.54	XXX
78282	TC	C	GI protein loss exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78290		A	Meckel's divert exam	0.68	3.28	NA	0.16	4.12	NA	XXX
78290	26	A	Meckel's divert exam	0.68	0.24	0.24	0.03	0.95	0.95	XXX
78290	TC	A	Meckel's divert exam	0.00	3.04	NA	0.13	3.17	NA	XXX
78291		A	Leveen/shunt patency exam	0.88	3.36	NA	0.17	4.41	NA	XXX
78291	26	A	Leveen/shunt patency exam	0.88	0.31	0.31	0.04	1.23	1.23	XXX
78291	TC	A	Leveen/shunt patency exam	0.00	3.05	NA	0.13	3.18	NA	XXX
78299		C	GI nuclear procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78299	26	C	GI nuclear procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78299	TC	C	GI nuclear procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78300		A	Bone imaging, limited area	0.62	2.69	NA	0.15	3.46	NA	XXX
78300	26	A	Bone imaging, limited area	0.62	0.21	0.21	0.03	0.86	0.86	XXX
78300	TC	A	Bone imaging, limited area	0.00	2.48	NA	0.12	2.60	NA	XXX
78305		A	Bone imaging, multiple areas	0.83	3.94	NA	0.19	4.96	NA	XXX
78305	26	A	Bone imaging, multiple areas	0.83	0.29	0.29	0.03	1.15	1.15	XXX
78305	TC	A	Bone imaging, multiple areas	0.00	3.65	NA	0.16	3.81	NA	XXX
78306		A	Bone imaging, whole body	0.86	4.56	NA	0.22	5.64	NA	XXX
78306	26	A	Bone imaging, whole body	0.86	0.30	0.30	0.04	1.20	1.20	XXX
78306	TC	A	Bone imaging, whole body	0.00	4.26	NA	0.18	4.44	NA	XXX
78315		A	Bone imaging, 3 phase	1.02	5.12	NA	0.25	6.39	NA	XXX
78315	26	A	Bone imaging, 3 phase	1.02	0.36	0.36	0.04	1.42	1.42	XXX
78315	TC	A	Bone imaging, 3 phase	0.00	4.76	NA	0.21	4.97	NA	XXX
78320		A	Bone imaging (3D)	1.04	6.25	NA	0.30	7.59	NA	XXX
78320	26	A	Bone imaging (3D)	1.04	0.37	0.37	0.04	1.45	1.45	XXX
78320	TC	A	Bone imaging (3D)	0.00	5.88	NA	0.26	6.14	NA	XXX
78350		A	Bone mineral, single photon	0.22	0.83	NA	0.05	1.10	NA	XXX
78350	26	A	Bone mineral, single photon	0.22	0.08	0.08	0.01	0.31	0.31	XXX
78350	TC	A	Bone mineral, single photon	0.00	0.75	NA	0.04	0.79	NA	XXX
78351		N	Bone mineral, dual photon	+0.30	1.74	0.12	0.01	2.05	0.43	XXX
78399		C	Musculoskeletal nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78399	26	C	Musculoskeletal nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78399	TC	C	Musculoskeletal nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78414		C	Non-imaging heart function	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78414	26	A	Non-imaging heart function	0.45	0.16	0.16	0.02	0.63	0.63	XXX
78414	TC	C	Non-imaging heart function	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78428		A	Cardiac shunt imaging	0.78	2.54	NA	0.14	3.46	NA	XXX
78428	26	A	Cardiac shunt imaging	0.78	0.30	0.30	0.03	1.11	1.11	XXX
78428	TC	A	Cardiac shunt imaging	0.00	2.24	NA	0.11	2.35	NA	XXX
78445		A	Vascular flow imaging	0.49	2.03	NA	0.11	2.63	NA	XXX
78445	26	A	Vascular flow imaging	0.49	0.18	0.18	0.02	0.69	0.69	XXX
78445	TC	A	Vascular flow imaging	0.00	1.85	NA	0.09	1.94	NA	XXX
78455		A	Venous thrombosis study	0.73	4.23	NA	0.20	5.16	NA	XXX
78455	26	A	Venous thrombosis study	0.73	0.26	0.26	0.03	1.02	1.02	XXX
78455	TC	A	Venous thrombosis study	0.00	3.97	NA	0.17	4.14	NA	XXX
78456		A	Acute venous thrombus image	1.00	4.33	NA	0.28	5.61	NA	XXX
78456	26	A	Acute venous thrombus image	1.00	0.36	0.36	0.04	1.40	1.40	XXX
78456	TC	A	Acute venous thrombus image	0.00	3.97	NA	0.24	4.21	NA	XXX
78457		A	Venous thrombosis imaging	0.77	2.92	NA	0.15	3.84	NA	XXX
78457	26	A	Venous thrombosis imaging	0.77	0.27	0.27	0.03	1.07	1.07	XXX
78457	TC	A	Venous thrombosis imaging	0.00	2.65	NA	0.12	2.77	NA	XXX
78458		A	Ven thrombosis images, bilat	0.90	4.33	NA	0.20	5.43	NA	XXX
78458	26	A	Ven thrombosis images, bilat	0.90	0.33	0.33	0.03	1.26	1.26	XXX
78458	TC	A	Ven thrombosis images, bilat	0.00	4.00	NA	0.17	4.17	NA	XXX
78459		C	Heart muscle imaging (PET)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78459	26	R	Heart muscle imaging (PET)	1.50	0.59	0.59	0.04	2.13	2.13	XXX
78459	TC	C	Heart muscle imaging (PET)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78460		A	Heart muscle blood, single	0.86	2.65	NA	0.14	3.65	NA	XXX
78460	26	A	Heart muscle blood, single	0.86	0.30	0.30	0.03	1.19	1.19	XXX
78460	TC	A	Heart muscle blood, single	0.00	2.35	NA	0.11	2.46	NA	XXX
78461		A	Heart muscle blood, multiple	1.23	5.15	NA	0.26	6.64	NA	XXX
78461	26	A	Heart muscle blood, multiple	1.23	0.45	0.45	0.05	1.73	1.73	XXX
78461	TC	A	Heart muscle blood, multiple	0.00	4.70	NA	0.21	4.91	NA	XXX
78464		A	Heart image (3d), single	1.09	7.43	NA	0.35	8.87	NA	XXX
78464	26	A	Heart image (3d), single	1.09	0.39	0.39	0.04	1.52	1.52	XXX
78464	TC	A	Heart image (3d), single	0.00	7.04	NA	0.31	7.35	NA	XXX
78465		A	Heart image (3d), multiple	1.46	12.28	NA	0.56	14.30	NA	XXX
78465	26	A	Heart image (3d), multiple	1.46	0.54	0.54	0.05	2.05	2.05	XXX
78465	TC	A	Heart image (3d), multiple	0.00	11.74	NA	0.51	12.25	NA	XXX
78466		A	Heart infarct image	0.69	2.86	NA	0.15	3.70	NA	XXX
78466	26	A	Heart infarct image	0.69	0.25	0.25	0.03	0.97	0.97	XXX
78466	TC	A	Heart infarct image	0.00	2.61	NA	0.12	2.73	NA	XXX
78468		A	Heart infarct image (ef)	0.80	3.93	NA	0.19	4.92	NA	XXX
78468	26	A	Heart infarct image (ef)	0.80	0.28	0.28	0.03	1.11	1.11	XXX
78468	TC	A	Heart infarct image (ef)	0.00	3.65	NA	0.16	3.81	NA	XXX
78469		A	Heart infarct image (3D)	0.92	5.51	NA	0.26	6.69	NA	XXX
78469	26	A	Heart infarct image (3D)	0.92	0.32	0.32	0.03	1.27	1.27	XXX
78469	TC	A	Heart infarct image (3D)	0.00	5.19	NA	0.23	5.42	NA	XXX
78472		A	Gated heart, planar, single	0.98	5.83	NA	0.29	7.10	NA	XXX
78472	26	A	Gated heart, planar, single	0.98	0.35	0.35	0.04	1.37	1.37	XXX
78472	TC	A	Gated heart, planar, single	0.00	5.48	NA	0.25	5.73	NA	XXX
78473		A	Gated heart, multiple	1.47	8.75	NA	0.40	10.62	NA	XXX
78473	26	A	Gated heart, multiple	1.47	0.53	0.53	0.05	2.05	2.05	XXX
78473	TC	A	Gated heart, multiple	0.00	8.22	NA	0.35	8.57	NA	XXX
78478		A	Heart wall motion add-on	0.62	1.78	NA	0.10	2.50	NA	XXX
78478	26	A	Heart wall motion add-on	0.62	0.23	0.23	0.02	0.87	0.87	XXX
78478	TC	A	Heart wall motion add-on	0.00	1.55	NA	0.08	1.63	NA	XXX
78480		A	Heart function add-on	0.62	1.78	NA	0.10	2.50	NA	XXX
78480	26	A	Heart function add-on	0.62	0.23	0.23	0.02	0.87	0.87	XXX
78480	TC	A	Heart function add-on	0.00	1.55	NA	0.08	1.63	NA	XXX
78481		A	Heart first pass, single	0.98	5.56	NA	0.26	6.80	NA	XXX
78481	26	A	Heart first pass, single	0.98	0.37	0.37	0.03	1.38	1.38	XXX
78481	TC	A	Heart first pass, single	0.00	5.19	NA	0.23	5.42	NA	XXX
78483		A	Heart first pass, multiple	1.47	8.39	NA	0.39	10.25	NA	XXX
78483	26	A	Heart first pass, multiple	1.47	0.56	0.56	0.05	2.08	2.08	XXX
78483	TC	A	Heart first pass, multiple	0.00	7.83	NA	0.34	8.17	NA	XXX
78491		I	Heart image (pet), single	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78491	26	I	Heart image (pet), single	+1.50	0.60	0.60	0.05	2.15	2.15	XXX
78491	TC	I	Heart image (pet), single	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78492		I	Heart image (pet), multiple	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78492	26	I	Heart image (pet), multiple	+1.87	0.75	0.75	0.06	2.68	2.68	XXX
78492	TC	I	Heart image (pet), multiple	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78494		A	Heart image, spect	1.19	7.47	NA	0.29	8.95	NA	XXX
78494	26	A	Heart image, spect	1.19	0.43	0.43	0.04	1.66	1.66	XXX
78494	TC	A	Heart image, spect	0.00	7.04	NA	0.25	7.29	NA	XXX
78496		A	Heart first pass add-on	0.50	7.23	NA	0.27	8.00	NA	ZZZ
78496	26	A	Heart first pass add-on	0.50	0.19	0.19	0.02	0.71	0.71	ZZZ
78496	TC	A	Heart first pass add-on	0.00	7.04	NA	0.25	7.29	NA	ZZZ
78499		C	Cardiovascular nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78499	26	C	Cardiovascular nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78499	TC	C	Cardiovascular nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78580		A	Lung perfusion imaging	0.74	3.67	NA	0.18	4.59	NA	XXX
78580	26	A	Lung perfusion imaging	0.74	0.26	0.26	0.03	1.03	1.03	XXX
78580	TC	A	Lung perfusion imaging	0.00	3.41	NA	0.15	3.56	NA	XXX
78584		A	Lung V/Q image single breath	0.99	3.52	NA	0.18	4.69	NA	XXX
78584	26	A	Lung V/Q image single breath	0.99	0.34	0.34	0.04	1.37	1.37	XXX
78584	TC	A	Lung V/Q image single breath	0.00	3.18	NA	0.14	3.32	NA	XXX
78585		A	Lung V/Q imaging	1.09	5.99	NA	0.30	7.38	NA	XXX
78585	26	A	Lung V/Q imaging	1.09	0.38	0.38	0.05	1.52	1.52	XXX
78585	TC	A	Lung V/Q imaging	0.00	5.61	NA	0.25	5.86	NA	XXX
78586		A	Aerosol lung image, single	0.40	2.72	NA	0.14	3.26	NA	XXX
78586	26	A	Aerosol lung image, single	0.40	0.14	0.14	0.02	0.56	0.56	XXX
78586	TC	A	Aerosol lung image, single	0.00	2.58	NA	0.12	2.70	NA	XXX
78587		A	Aerosol lung image, multiple	0.49	2.97	NA	0.14	3.60	NA	XXX
78587	26	A	Aerosol lung image, multiple	0.49	0.17	0.17	0.02	0.68	0.68	XXX
78587	TC	A	Aerosol lung image, multiple	0.00	2.80	NA	0.12	2.92	NA	XXX
78588		A	Perfusion lung image	1.09	3.56	NA	0.20	4.85	NA	XXX
78588	26	A	Perfusion lung image	1.09	0.38	0.38	0.05	1.52	1.52	XXX
78588	TC	A	Perfusion lung image	0.00	3.18	NA	0.15	3.33	NA	XXX
78591		A	Vent image, 1 breath, 1 proj	0.40	2.98	NA	0.14	3.52	NA	XXX
78591	26	A	Vent image, 1 breath, 1 proj	0.40	0.14	0.14	0.02	0.56	0.56	XXX
78591	TC	A	Vent image, 1 breath, 1 proj	0.00	2.84	NA	0.12	2.96	NA	XXX
78593		A	Vent image, 1 proj, gas	0.49	3.60	NA	0.17	4.26	NA	XXX
78593	26	A	Vent image, 1 proj, gas	0.49	0.17	0.17	0.02	0.68	0.68	XXX
78593	TC	A	Vent image, 1 proj, gas	0.00	3.43	NA	0.15	3.58	NA	XXX
78594		A	Vent image, mult proj, gas	0.53	5.15	NA	0.23	5.91	NA	XXX
78594	26	A	Vent image, mult proj, gas	0.53	0.19	0.19	0.02	0.74	0.74	XXX
78594	TC	A	Vent image, mult proj, gas	0.00	4.96	NA	0.21	5.17	NA	XXX
78596		A	Lung differential function	1.27	7.48	NA	0.36	9.11	NA	XXX
78596	26	A	Lung differential function	1.27	0.44	0.44	0.05	1.76	1.76	XXX
78596	TC	A	Lung differential function	0.00	7.04	NA	0.31	7.35	NA	XXX
78599		C	Respiratory nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78599	26	C	Respiratory nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78599	TC	C	Respiratory nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78600		A	Brain imaging, ltd static	0.44	3.03	NA	0.14	3.61	NA	XXX
78600	26	A	Brain imaging, ltd static	0.44	0.16	0.16	0.02	0.62	0.62	XXX
78600	TC	A	Brain imaging, ltd static	0.00	2.87	NA	0.12	2.99	NA	XXX
78601		A	Brain imaging, ltd w/ flow	0.51	3.57	NA	0.17	4.25	NA	XXX
78601	26	A	Brain imaging, ltd w/ flow	0.51	0.18	0.18	0.02	0.71	0.71	XXX
78601	TC	A	Brain imaging, ltd w/ flow	0.00	3.39	NA	0.15	3.54	NA	XXX
78605		A	Brain imaging, complete	0.53	3.58	NA	0.17	4.28	NA	XXX
78605	26	A	Brain imaging, complete	0.53	0.19	0.19	0.02	0.74	0.74	XXX
78605	TC	A	Brain imaging, complete	0.00	3.39	NA	0.15	3.54	NA	XXX
78606		A	Brain imaging, compl w/flow	0.64	4.07	NA	0.20	4.91	NA	XXX
78606	26	A	Brain imaging, compl w/flow	0.64	0.22	0.22	0.03	0.89	0.89	XXX
78606	TC	A	Brain imaging, compl w/flow	0.00	3.85	NA	0.17	4.02	NA	XXX
78607		A	Brain imaging (3D)	1.23	6.98	NA	0.34	8.55	NA	XXX
78607	26	A	Brain imaging (3D)	1.23	0.45	0.45	0.05	1.73	1.73	XXX
78607	TC	A	Brain imaging (3D)	0.00	6.53	NA	0.29	6.82	NA	XXX
78608		N	Brain imaging (PET)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78609		N	Brain imaging (PET)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78610		A	Brain flow imaging only	0.30	1.68	NA	0.09	2.07	NA	XXX
78610	26	A	Brain flow imaging only	0.30	0.11	0.11	0.01	0.42	0.42	XXX
78610	TC	A	Brain flow imaging only	0.00	1.57	NA	0.08	1.65	NA	XXX
78615		A	Cerebral vascular flow image	0.42	3.99	NA	0.19	4.60	NA	XXX
78615	26	A	Cerebral vascular flow image	0.42	0.16	0.16	0.02	0.60	0.60	XXX
78615	TC	A	Cerebral vascular flow image	0.00	3.83	NA	0.17	4.00	NA	XXX
78630		A	Cerebrospinal fluid scan	0.68	5.26	NA	0.25	6.19	NA	XXX
78630	26	A	Cerebrospinal fluid scan	0.68	0.24	0.24	0.03	0.95	0.95	XXX
78630	TC	A	Cerebrospinal fluid scan	0.00	5.02	NA	0.22	5.24	NA	XXX
78635		A	CSF ventriculography	0.61	2.77	NA	0.14	3.52	NA	XXX
78635	26	A	CSF ventriculography	0.61	0.24	0.24	0.02	0.87	0.87	XXX
78635	TC	A	CSF ventriculography	0.00	2.53	NA	0.12	2.65	NA	XXX
78645		A	CSF shunt evaluation	0.57	3.61	NA	0.17	4.35	NA	XXX
78645	26	A	CSF shunt evaluation	0.57	0.20	0.20	0.02	0.79	0.79	XXX
78645	TC	A	CSF shunt evaluation	0.00	3.41	NA	0.15	3.56	NA	XXX
78647		A	Cerebrospinal fluid scan	0.90	6.21	NA	0.29	7.40	NA	XXX
78647	26	A	Cerebrospinal fluid scan	0.90	0.33	0.33	0.03	1.26	1.26	XXX
78647	TC	A	Cerebrospinal fluid scan	0.00	5.88	NA	0.26	6.14	NA	XXX
78650		A	CSF leakage imaging	0.61	4.84	NA	0.22	5.67	NA	XXX
78650	26	A	CSF leakage imaging	0.61	0.22	0.22	0.02	0.85	0.85	XXX
78650	TC	A	CSF leakage imaging	0.00	4.62	NA	0.20	4.82	NA	XXX
78660		A	Nuclear exam of tear flow	0.53	2.30	NA	0.12	2.95	NA	XXX
78660	26	A	Nuclear exam of tear flow	0.53	0.19	0.19	0.02	0.74	0.74	XXX
78660	TC	A	Nuclear exam of tear flow	0.00	2.11	NA	0.10	2.21	NA	XXX
78699		C	Nervous system nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78699	26	C	Nervous system nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78699	TC	C	Nervous system nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78700		A	Kidney imaging, static	0.45	3.20	NA	0.15	3.80	NA	XXX
78700	26	A	Kidney imaging, static	0.45	0.16	0.16	0.02	0.63	0.63	XXX
78700	TC	A	Kidney imaging, static	0.00	3.04	NA	0.13	3.17	NA	XXX
78701		A	Kidney imaging with flow	0.49	3.71	NA	0.17	4.37	NA	XXX
78701	26	A	Kidney imaging with flow	0.49	0.17	0.17	0.02	0.68	0.68	XXX
78701	TC	A	Kidney imaging with flow	0.00	3.54	NA	0.15	3.69	NA	XXX
78704		A	Imaging renogram	0.74	4.20	NA	0.20	5.14	NA	XXX
78704	26	A	Imaging renogram	0.74	0.26	0.26	0.03	1.03	1.03	XXX
78704	TC	A	Imaging renogram	0.00	3.94	NA	0.17	4.11	NA	XXX
78707		A	Kidney flow/function image	0.96	4.79	NA	0.23	5.98	NA	XXX
78707	26	A	Kidney flow/function image	0.96	0.34	0.34	0.04	1.34	1.34	XXX
78707	TC	A	Kidney flow/function image	0.00	4.45	NA	0.19	4.64	NA	XXX
78708		A	Kidney flow/function image	1.21	4.88	NA	0.24	6.33	NA	XXX
78708	26	A	Kidney flow/function image	1.21	0.43	0.43	0.05	1.69	1.69	XXX
78708	TC	A	Kidney flow/function image	0.00	4.45	NA	0.19	4.64	NA	XXX
78709		A	Kidney flow/function image	1.41	4.94	NA	0.25	6.60	NA	XXX
78709	26	A	Kidney flow/function image	1.41	0.49	0.49	0.06	1.96	1.96	XXX
78709	TC	A	Kidney flow/function image	0.00	4.45	NA	0.19	4.64	NA	XXX
78710		A	Kidney imaging (3D)	0.66	6.11	NA	0.29	7.06	NA	XXX
78710	26	A	Kidney imaging (3D)	0.66	0.23	0.23	0.03	0.92	0.92	XXX
78710	TC	A	Kidney imaging (3D)	0.00	5.88	NA	0.26	6.14	NA	XXX
78715		A	Renal vascular flow exam	0.30	1.68	NA	0.09	2.07	NA	XXX
78715	26	A	Renal vascular flow exam	0.30	0.11	0.11	0.01	0.42	0.42	XXX
78715	TC	A	Renal vascular flow exam	0.00	1.57	NA	0.08	1.65	NA	XXX
78725		A	Kidney function study	0.38	1.90	NA	0.10	2.38	NA	XXX
78725	26	A	Kidney function study	0.38	0.13	0.13	0.01	0.52	0.52	XXX
78725	TC	A	Kidney function study	0.00	1.77	NA	0.09	1.86	NA	XXX
78730		A	Urinary bladder retention	0.36	1.58	NA	0.09	2.03	NA	XXX
78730	26	A	Urinary bladder retention	0.36	0.13	0.13	0.02	0.51	0.51	XXX
78730	TC	A	Urinary bladder retention	0.00	1.45	NA	0.07	1.52	NA	XXX
78740		A	Ureteral reflux study	0.57	2.30	NA	0.12	2.99	NA	XXX
78740	26	A	Ureteral reflux study	0.57	0.19	0.19	0.02	0.78	0.78	XXX
78740	TC	A	Ureteral reflux study	0.00	2.11	NA	0.10	2.21	NA	XXX
78760		A	Testicular imaging	0.66	2.90	NA	0.15	3.71	NA	XXX
78760	26	A	Testicular imaging	0.66	0.23	0.23	0.03	0.92	0.92	XXX
78760	TC	A	Testicular imaging	0.00	2.67	NA	0.12	2.79	NA	XXX
78761		A	Testicular imaging/flow	0.71	3.43	NA	0.17	4.31	NA	XXX
78761	26	A	Testicular imaging/flow	0.71	0.25	0.25	0.03	0.99	0.99	XXX
78761	TC	A	Testicular imaging/flow	0.00	3.18	NA	0.14	3.32	NA	XXX
78799		C	Genitourinary nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78799	26	C	Genitourinary nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78799	TC	C	Genitourinary nuclear exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78800		A	Tumor imaging, limited area	0.66	3.62	NA	0.18	4.46	NA	XXX
78800	26	A	Tumor imaging, limited area	0.66	0.23	0.23	0.03	0.92	0.92	XXX
78800	TC	A	Tumor imaging, limited area	0.00	3.39	NA	0.15	3.54	NA	XXX
78801		A	Tumor imaging, mult areas	0.79	4.49	NA	0.21	5.49	NA	XXX
78801	26	A	Tumor imaging, mult areas	0.79	0.28	0.28	0.03	1.10	1.10	XXX
78801	TC	A	Tumor imaging, mult areas	0.00	4.21	NA	0.18	4.39	NA	XXX
78802		A	Tumor imaging, whole body	0.86	5.81	NA	0.28	6.95	NA	XXX
78802	26	A	Tumor imaging, whole body	0.86	0.31	0.31	0.03	1.20	1.20	XXX
78802	TC	A	Tumor imaging, whole body	0.00	5.50	NA	0.25	5.75	NA	XXX
78803		A	Tumor imaging (3D)	1.09	6.93	NA	0.33	8.35	NA	XXX
78803	26	A	Tumor imaging (3D)	1.09	0.40	0.40	0.04	1.53	1.53	XXX
78803	TC	A	Tumor imaging (3D)	0.00	6.53	NA	0.29	6.82	NA	XXX
78805		A	Abscess imaging, ltd area	0.73	3.65	NA	0.18	4.56	NA	XXX
78805	26	A	Abscess imaging, ltd area	0.73	0.26	0.26	0.03	1.02	1.02	XXX
78805	TC	A	Abscess imaging, ltd area	0.00	3.39	NA	0.15	3.54	NA	XXX
78806		A	Abscess imaging, whole body	0.86	6.71	NA	0.32	7.89	NA	XXX
78806	26	A	Abscess imaging, whole body	0.86	0.31	0.31	0.03	1.20	1.20	XXX
78806	TC	A	Abscess imaging, whole body	0.00	6.40	NA	0.29	6.69	NA	XXX
78807		A	Nuclear localization/abscess	1.09	6.94	NA	0.33	8.36	NA	XXX
78807	26	A	Nuclear localization/abscess	1.09	0.41	0.41	0.04	1.54	1.54	XXX
78807	TC	A	Nuclear localization/abscess	0.00	6.53	NA	0.29	6.82	NA	XXX
78810		N	Tumor imaging (PET)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78810	26	N	Tumor imaging (PET)	+1.93	0.75	0.75	0.09	2.77	2.77	XXX
78810	TC	N	Tumor imaging (PET)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78890		B	Nuclear medicine data proc	+0.05	1.32	NA	0.06	1.43	NA	XXX
78890	26	B	Nuclear medicine data proc	+0.05	0.02	0.02	0.01	0.08	0.08	XXX
78890	TC	B	Nuclear medicine data proc	+0.00	1.30	NA	0.05	1.35	NA	XXX
78891		B	Nuclear med data proc	+0.10	2.65	NA	0.12	2.87	NA	XXX
78891	26	B	Nuclear med data proc	+0.10	0.04	0.04	0.01	0.15	0.15	XXX
78891	TC	B	Nuclear med data proc	+0.00	2.61	NA	0.11	2.72	NA	XXX
78990		I	Provide diag radionuclide(s)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78999		C	Nuclear diagnostic exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78999	26	C	Nuclear diagnostic exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
78999	TC	C	Nuclear diagnostic exam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
79000		A	Init hyperthyroid therapy	1.80	3.24	NA	0.19	5.23	NA	XXX
79000	26	A	Init hyperthyroid therapy	1.80	0.63	0.63	0.07	2.50	2.50	XXX
79000	TC	A	Init hyperthyroid therapy	0.00	2.61	NA	0.12	2.73	NA	XXX
79001		A	Repeat hyperthyroid therapy	1.05	1.67	NA	0.10	2.82	NA	XXX
79001	26	A	Repeat hyperthyroid therapy	1.05	0.37	0.37	0.04	1.46	1.46	XXX
79001	TC	A	Repeat hyperthyroid therapy	0.00	1.30	NA	0.06	1.36	NA	XXX
79020		A	Thyroid ablation	1.81	3.23	NA	0.19	5.23	NA	XXX
79020	26	A	Thyroid ablation	1.81	0.62	0.62	0.07	2.50	2.50	XXX
79020	TC	A	Thyroid ablation	0.00	2.61	NA	0.12	2.73	NA	XXX
79030		A	Thyroid ablation, carcinoma	2.10	3.35	NA	0.20	5.65	NA	XXX
79030	26	A	Thyroid ablation, carcinoma	2.10	0.74	0.74	0.08	2.92	2.92	XXX
79030	TC	A	Thyroid ablation, carcinoma	0.00	2.61	NA	0.12	2.73	NA	XXX
79035		A	Thyroid metastatic therapy	2.52	3.52	NA	0.21	6.25	NA	XXX
79035	26	A	Thyroid metastatic therapy	2.52	0.91	0.91	0.09	3.52	3.52	XXX
79035	TC	A	Thyroid metastatic therapy	0.00	2.61	NA	0.12	2.73	NA	XXX
79100		A	Hematopoetic nuclear therapy	1.32	3.09	NA	0.17	4.58	NA	XXX
79100	26	A	Hematopoetic nuclear therapy	1.32	0.48	0.48	0.05	1.85	1.85	XXX
79100	TC	A	Hematopoetic nuclear therapy	0.00	2.61	NA	0.12	2.73	NA	XXX
79200		A	Intracavitary nuclear trmt	1.99	3.33	NA	0.19	5.51	NA	XXX
79200	26	A	Intracavitary nuclear trmt	1.99	0.72	0.72	0.07	2.78	2.78	XXX
79200	TC	A	Intracavitary nuclear trmt	0.00	2.61	NA	0.12	2.73	NA	XXX
79300		C	Interstitial nuclear therapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
79300	26	A	Interstitial nuclear therapy	1.60	0.59	0.59	0.07	2.26	2.26	XXX
79300	TC	C	Interstitial nuclear therapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
79400		A	Nonhemato nuclear therapy	1.96	3.31	NA	0.20	5.47	NA	XXX
79400	26	A	Nonhemato nuclear therapy	1.96	0.70	0.70	0.08	2.74	2.74	XXX
79400	TC	A	Nonhemato nuclear therapy	0.00	2.61	NA	0.12	2.73	NA	XXX
79420		C	Intravascular nuclear ther	0.00	0.00	0.00	0.00	0.00	0.00	XXX
79420	26	A	Intravascular nuclear ther	1.51	0.52	0.52	0.06	2.09	2.09	XXX
79420	TC	C	Intravascular nuclear ther	0.00	0.00	0.00	0.00	0.00	0.00	XXX
79440		A	Nuclear joint therapy	1.99	3.36	NA	0.20	5.55	NA	XXX
79440	26	A	Nuclear joint therapy	1.99	0.75	0.75	0.08	2.82	2.82	XXX
79440	TC	A	Nuclear joint therapy	0.00	2.61	NA	0.12	2.73	NA	XXX
79900		C	Provide ther radiopharm(s)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
79999		C	Nuclear medicine therapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
79999	26	C	Nuclear medicine therapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
79999	TC	C	Nuclear medicine therapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
80500		A	Lab pathology consultation	0.37	0.22	0.17	0.01	0.60	0.55	XXX
80502		A	Lab pathology consultation	1.33	0.65	0.60	0.05	2.03	1.98	XXX
83020	26	A	Hemoglobin electrophoresis	0.37	0.16	0.16	0.01	0.54	0.54	XXX
83912	26	A	Genetic examination	0.37	0.15	0.15	0.01	0.53	0.53	XXX
84165	26	A	Assay of serum proteins	0.37	0.16	0.16	0.01	0.54	0.54	XXX
84181	26	A	Western blot test	0.37	0.14	0.14	0.01	0.52	0.52	XXX
84182	26	A	Protein, western blot test	0.37	0.17	0.17	0.01	0.55	0.55	XXX
85060		A	Blood smear interpretation	0.45	0.19	0.19	0.02	0.66	0.66	XXX
85097		A	Bone marrow interpretation	0.94	1.81	0.41	0.03	2.78	1.38	XXX
85390	26	A	Fibrinolysins screen	0.37	0.13	0.13	0.01	0.51	0.51	XXX
85576	26	A	Blood platelet aggregation	0.37	0.16	0.16	0.01	0.54	0.54	XXX
86077		A	Physician blood bank service	0.94	0.47	0.42	0.03	1.44	1.39	XXX
86078		A	Physician blood bank service	0.94	0.51	0.42	0.03	1.48	1.39	XXX
86079		A	Physician blood bank service	0.94	0.50	0.42	0.03	1.47	1.39	XXX
86255	26	A	Fluorescent antibody, screen	0.37	0.17	0.17	0.01	0.55	0.55	XXX
86256	26	A	Fluorescent antibody, titer	0.37	0.16	0.16	0.01	0.54	0.54	XXX
86320	26	A	Serum immunoelectrophoresis	0.37	0.17	0.16	0.01	0.55	0.54	XXX
86325	26	A	Other immunoelectrophoresis	0.37	0.16	0.16	0.01	0.54	0.54	XXX
86327	26	A	Immunoelectrophoresis assay	0.42	0.19	0.19	0.01	0.62	0.62	XXX
86334	26	A	Immunofixation procedure	0.37	0.16	0.16	0.01	0.54	0.54	XXX
86485		C	Skin test, candida	0.00	0.00	0.00	0.00	0.00	0.00	XXX
86490		A	Coccidioidomycosis skin test	0.00	0.29	NA	0.02	0.31	NA	XXX
86510		A	Histoplasmosis skin test	0.00	0.32	NA	0.02	0.34	NA	XXX
86580		A	TB intradermal test	0.00	0.25	NA	0.02	0.27	NA	XXX
86585		A	TB tine test	0.00	0.20	NA	0.01	0.21	NA	XXX
86586		C	Skin test, unlisted	0.00	0.00	0.00	0.00	0.00	0.00	XXX
87164	26	A	Dark field examination	0.37	0.12	0.12	0.01	0.50	0.50	XXX
87207	26	A	Smear, special stain	0.37	0.17	0.17	0.01	0.55	0.55	XXX
88104		A	Cytopathology, fluids	0.56	0.79	NA	0.04	1.39	NA	XXX
88104	26	A	Cytopathology, fluids	0.56	0.25	0.25	0.02	0.83	0.83	XXX
88104	TC	A	Cytopathology, fluids	0.00	0.54	NA	0.02	0.56	NA	XXX
88106		A	Cytopathology, fluids	0.56	0.62	NA	0.04	1.22	NA	XXX
88106	26	A	Cytopathology, fluids	0.56	0.25	0.25	0.02	0.83	0.83	XXX
88106	TC	A	Cytopathology, fluids	0.00	0.37	NA	0.02	0.39	NA	XXX
88107		A	Cytopathology, fluids	0.76	1.00	NA	0.05	1.81	NA	XXX
88107	26	A	Cytopathology, fluids	0.76	0.34	0.34	0.03	1.13	1.13	XXX
88107	TC	A	Cytopathology, fluids	0.00	0.66	NA	0.02	0.68	NA	XXX
88108		A	Cytopath, concentrate tech	0.56	0.83	NA	0.04	1.43	NA	XXX
88108	26	A	Cytopath, concentrate tech	0.56	0.25	0.25	0.02	0.83	0.83	XXX
88108	TC	A	Cytopath, concentrate tech	0.00	0.58	NA	0.02	0.60	NA	XXX
88125		A	Forensic cytopathology	0.26	0.30	NA	0.02	0.58	NA	XXX
88125	26	A	Forensic cytopathology	0.26	0.12	0.12	0.01	0.39	0.39	XXX
88125	TC	A	Forensic cytopathology	0.00	0.18	NA	0.01	0.19	NA	XXX
88141		A	Cytopath, c/v, interpret	0.42	0.99	0.99	0.01	1.42	1.42	XXX
88160		A	Cytopath smear, other source	0.50	0.98	NA	0.04	1.52	NA	XXX
88160	26	A	Cytopath smear, other source	0.50	0.22	0.22	0.02	0.74	0.74	XXX
88160	TC	A	Cytopath smear, other source	0.00	0.76	NA	0.02	0.78	NA	XXX
88161		A	Cytopath smear, other source	0.50	0.93	NA	0.04	1.47	NA	XXX
88161	26	A	Cytopath smear, other source	0.50	0.22	0.22	0.02	0.74	0.74	XXX
88161	TC	A	Cytopath smear, other source	0.00	0.71	NA	0.02	0.73	NA	XXX
88162		A	Cytopath smear, other source	0.76	0.71	NA	0.05	1.52	NA	XXX
88162	26	A	Cytopath smear, other source	0.76	0.34	0.34	0.03	1.13	1.13	XXX
88162	TC	A	Cytopath smear, other source	0.00	0.37	NA	0.02	0.39	NA	XXX
88172		A	Cytopathology eval of fna	0.60	0.69	NA	0.04	1.33	NA	XXX
88172	26	A	Cytopathology eval of fna	0.60	0.27	0.27	0.02	0.89	0.89	XXX
88172	TC	A	Cytopathology eval of fna	0.00	0.42	NA	0.02	0.44	NA	XXX
88173		A	Cytopath eval, fna, report	1.39	1.83	NA	0.07	3.29	NA	XXX
88173	26	A	Cytopath eval, fna, report	1.39	0.62	0.62	0.05	2.06	2.06	XXX
88173	TC	A	Cytopath eval, fna, report	0.00	1.21	NA	0.02	1.23	NA	XXX
88180		A	Cell marker study	0.36	1.20	NA	0.03	1.59	NA	XXX
88180	26	A	Cell marker study	0.36	0.16	0.16	0.01	0.53	0.53	XXX
88180	TC	A	Cell marker study	0.00	1.04	NA	0.02	1.06	NA	XXX
88182		A	Cell marker study	0.77	1.56	NA	0.06	2.39	NA	XXX
88182	26	A	Cell marker study	0.77	0.35	0.35	0.03	1.15	1.15	XXX
88182	TC	A	Cell marker study	0.00	1.21	NA	0.03	1.24	NA	XXX
88199		C	Cytopathology procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
88199	26	C	Cytopathology procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
88199	TC	C	Cytopathology procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
88291		A	Cyto/molecular report	0.52	0.30	0.30	0.02	0.84	0.84	XXX
88299		C	Cytogenetic study	0.00	0.00	0.00	0.00	0.00	0.00	XXX
88300		A	Surgical path, gross	0.08	0.30	NA	0.02	0.40	NA	XXX
88300	26	A	Surgical path, gross	0.08	0.04	0.04	0.01	0.13	0.13	XXX
88300	TC	A	Surgical path, gross	0.00	0.26	NA	0.01	0.27	NA	XXX
88302		A	Tissue exam by pathologist	0.13	0.73	NA	0.03	0.89	NA	XXX
88302	26	A	Tissue exam by pathologist	0.13	0.06	0.06	0.01	0.20	0.20	XXX
88302	TC	A	Tissue exam by pathologist	0.00	0.67	NA	0.02	0.69	NA	XXX
88304		A	Tissue exam by pathologist	0.22	0.90	NA	0.03	1.15	NA	XXX
88304	26	A	Tissue exam by pathologist	0.22	0.10	0.10	0.01	0.33	0.33	XXX
88304	TC	A	Tissue exam by pathologist	0.00	0.80	NA	0.02	0.82	NA	XXX
88305		A	Tissue exam by pathologist	0.75	1.77	NA	0.05	2.57	NA	XXX
88305	26	A	Tissue exam by pathologist	0.75	0.34	0.34	0.02	1.11	1.11	XXX
88305	TC	A	Tissue exam by pathologist	0.00	1.43	NA	0.03	1.46	NA	XXX
88307		A	Tissue exam by pathologist	1.59	2.72	NA	0.11	4.42	NA	XXX
88307	26	A	Tissue exam by pathologist	1.59	0.71	0.71	0.06	2.36	2.36	XXX
88307	TC	A	Tissue exam by pathologist	0.00	2.01	NA	0.05	2.06	NA	XXX
88309		A	Tissue exam by pathologist	2.28	3.33	NA	0.13	5.74	NA	XXX
88309	26	A	Tissue exam by pathologist	2.28	1.02	1.02	0.08	3.38	3.38	XXX
88309	TC	A	Tissue exam by pathologist	0.00	2.31	NA	0.05	2.36	NA	XXX
88311		A	Decalcify tissue	0.24	0.20	NA	0.02	0.46	NA	XXX
88311	26	A	Decalcify tissue	0.24	0.11	0.11	0.01	0.36	0.36	XXX
88311	TC	A	Decalcify tissue	0.00	0.09	NA	0.01	0.10	NA	XXX
88312		A	Special stains	0.54	1.61	NA	0.03	2.18	NA	XXX
88312	26	A	Special stains	0.54	0.24	0.24	0.02	0.80	0.80	XXX
88312	TC	A	Special stains	0.00	1.37	NA	0.01	1.38	NA	XXX
88313		A	Special stains	0.24	1.19	NA	0.02	1.45	NA	XXX
88313	26	A	Special stains	0.24	0.11	0.11	0.01	0.36	0.36	XXX
88313	TC	A	Special stains	0.00	1.08	NA	0.01	1.09	NA	XXX
88314		A	Histochemical stain	0.45	0.84	NA	0.04	1.33	NA	XXX
88314	26	A	Histochemical stain	0.45	0.20	0.20	0.02	0.67	0.67	XXX
88314	TC	A	Histochemical stain	0.00	0.64	NA	0.02	0.66	NA	XXX
88318		A	Chemical histochemistry	0.42	0.74	NA	0.02	1.18	NA	XXX
88318	26	A	Chemical histochemistry	0.42	0.19	0.19	0.01	0.62	0.62	XXX
88318	TC	A	Chemical histochemistry	0.00	0.55	NA	0.01	0.56	NA	XXX
88319		A	Enzyme histochemistry	0.53	2.18	NA	0.04	2.75	NA	XXX
88319	26	A	Enzyme histochemistry	0.53	0.24	0.24	0.02	0.79	0.79	XXX
88319	TC	A	Enzyme histochemistry	0.00	1.94	NA	0.02	1.96	NA	XXX
88321		A	Microslide consultation	1.30	0.83	0.58	0.04	2.17	1.92	XXX
88323		A	Microslide consultation	1.35	1.42	NA	0.07	2.84	NA	XXX
88323	26	A	Microslide consultation	1.35	0.61	0.61	0.05	2.01	2.01	XXX
88323	TC	A	Microslide consultation	0.00	0.81	NA	0.02	0.83	NA	XXX
88325		A	Comprehensive review of data	2.22	2.93	0.99	0.08	5.23	3.29	XXX
88329		A	Path consult introp	0.67	0.66	0.30	0.02	1.35	0.99	XXX
88331		A	Path consult intraop, 1 bloc	1.19	1.03	NA	0.07	2.29	NA	XXX
88331	26	A	Path consult intraop, 1 bloc	1.19	0.54	0.54	0.04	1.77	1.77	XXX
88331	TC	A	Path consult intraop, 1 bloc	0.00	0.49	NA	0.03	0.52	NA	XXX
88332		A	Path consult intraop, addl	0.59	0.52	NA	0.04	1.15	NA	XXX
88332	26	A	Path consult intraop, addl	0.59	0.27	0.27	0.02	0.88	0.88	XXX
88332	TC	A	Path consult intraop, addl	0.00	0.25	NA	0.02	0.27	NA	XXX
88342		A	Immunocytochemistry	0.85	1.31	NA	0.05	2.21	NA	XXX
88342	26	A	Immunocytochemistry	0.85	0.38	0.38	0.03	1.26	1.26	XXX
88342	TC	A	Immunocytochemistry	0.00	0.93	NA	0.02	0.95	NA	XXX
88346		A	Immunofluorescent study	0.86	1.46	NA	0.05	2.37	NA	XXX
88346	26	A	Immunofluorescent study	0.86	0.38	0.38	0.03	1.27	1.27	XXX
88346	TC	A	Immunofluorescent study	0.00	1.08	NA	0.02	1.10	NA	XXX
88347		A	Immunofluorescent study	0.86	1.86	NA	0.05	2.77	NA	XXX
88347	26	A	Immunofluorescent study	0.86	0.36	0.36	0.03	1.25	1.25	XXX
88347	TC	A	Immunofluorescent study	0.00	1.50	NA	0.02	1.52	NA	XXX
88348		A	Electron microscopy	1.51	8.09	NA	0.11	9.71	NA	XXX
88348	26	A	Electron microscopy	1.51	0.67	0.67	0.05	2.23	2.23	XXX
88348	TC	A	Electron microscopy	0.00	7.42	NA	0.06	7.48	NA	XXX
88349		A	Scanning electron microscopy	0.76	9.38	NA	0.08	10.22	NA	XXX
88349	26	A	Scanning electron microscopy	0.76	0.34	0.34	0.03	1.13	1.13	XXX
88349	TC	A	Scanning electron microscopy	0.00	9.04	NA	0.05	9.09	NA	XXX
88355		A	Analysis, skeletal muscle	1.85	2.55	NA	0.12	4.52	NA	XXX
88355	26	A	Analysis, skeletal muscle	1.85	0.83	0.83	0.07	2.75	2.75	XXX
88355	TC	A	Analysis, skeletal muscle	0.00	1.72	NA	0.05	1.77	NA	XXX
88356		A	Analysis, nerve	3.02	2.83	NA	0.16	6.01	NA	XXX
88356	26	A	Analysis, nerve	3.02	1.30	1.30	0.10	4.42	4.42	XXX
88356	TC	A	Analysis, nerve	0.00	1.53	NA	0.06	1.59	NA	XXX
88358		A	Analysis, tumor	2.82	1.72	NA	0.16	4.70	NA	XXX
88358	26	A	Analysis, tumor	2.82	1.25	1.25	0.10	4.17	4.17	XXX
88358	TC	A	Analysis, tumor	0.00	0.47	NA	0.06	0.53	NA	XXX
88362		A	Nerve teasing preparations	2.17	4.54	NA	0.12	6.83	NA	XXX
88362	26	A	Nerve teasing preparations	2.17	0.95	0.95	0.07	3.19	3.19	XXX
88362	TC	A	Nerve teasing preparations	0.00	3.59	NA	0.05	3.64	NA	XXX
88365		A	Tissue hybridization	0.93	2.03	NA	0.05	3.01	NA	XXX
88365	26	A	Tissue hybridization	0.93	0.41	0.41	0.03	1.37	1.37	XXX
88365	TC	A	Tissue hybridization	0.00	1.62	NA	0.02	1.64	NA	XXX
88371	26	A	Protein, western blot tissue	0.37	0.13	0.13	0.01	0.51	0.51	XXX
88372	26	A	Protein analysis w/probe	0.37	0.17	0.17	0.01	0.55	0.55	XXX
88380		C	Microdissection	0.00	0.00	0.00	0.00	0.00	0.00	XXX
88380	26	C	Microdissection	0.00	0.00	0.00	0.00	0.00	0.00	XXX
88380	TC	C	Microdissection	0.00	0.00	0.00	0.00	0.00	0.00	XXX
88399		C	Surgical pathology procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
88399	26	C	Surgical pathology procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
88399	TC	C	Surgical pathology procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
89060	26	A	Exam,synovial fluid crystals	0.37	0.17	0.17	0.01	0.55	0.55	XXX
89100		A	Sample intestinal contents	0.60	1.72	0.22	0.02	2.34	0.84	XXX
89105		A	Sample intestinal contents	0.50	2.28	0.18	0.02	2.80	0.70	XXX
89130		A	Sample stomach contents	0.45	1.97	0.13	0.02	2.44	0.60	XXX
89132		A	Sample stomach contents	0.19	1.76	0.07	0.01	1.96	0.27	XXX
89135		A	Sample stomach contents	0.79	1.75	0.26	0.03	2.57	1.08	XXX
89136		A	Sample stomach contents	0.21	1.77	0.08	0.01	1.99	0.30	XXX
89140		A	Sample stomach contents	0.94	2.22	0.28	0.03	3.19	1.25	XXX
89141		A	Sample stomach contents	0.85	2.80	0.35	0.03	3.68	1.23	XXX
89350		A	Sputum specimen collection	0.00	0.41	NA	0.02	0.43	NA	XXX
89360		A	Collect sweat for test	0.00	0.45	NA	0.02	0.47	NA	XXX
89399		C	Pathology lab procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
89399	26	C	Pathology lab procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
89399	TC	C	Pathology lab procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90281		I	Human ig, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90283		I	Human ig, iv	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90287		I	Botulinum antitoxin	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90288		I	Botulism ig, iv	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90291		I	Cmv ig, iv	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90296		E	Diphtheria antitoxin	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90371		E	Hep b ig, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90375		E	Rabies ig, im/sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90376		E	Rabies ig, heat treated	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90378		X	Rsv ig, im, 50mg	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90379		I	Rsv ig, iv	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90384		I	Rh ig, full-dose, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90385		E	Rh ig, minidose, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90386		I	Rh ig, iv	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90389		I	Tetanus ig, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90393		E	Vaccina ig, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90396		E	Varicella-zoster ig, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90399		I	Immune globulin	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90471		A	Immunization admin	0.00	0.20	NA	0.01	0.21	NA	XXX
90472		A	Immunization admin, each add	0.00	0.14	NA	0.01	0.15	NA	ZZZ
90473		N	Immune admin oral/nasal	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90474		N	Immune admin oral/nasal addl	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
90476		E	Adenovirus vaccine, type 4	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90477		E	Adenovirus vaccine, type 7	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90581		E	Anthrax vaccine, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90585		E	Bcg vaccine, percut	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90586		E	Bcg vaccine, intravesical	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90632		E	Hep a vaccine, adult im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90633		E	Hep a vacc, ped/adol, 2 dose	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90634		E	Hep a vacc, ped/adol, 3 dose	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90636		E	Hep a/hep b vacc, adult im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90645		E	Hib vaccine, hboc, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90646		E	Hib vaccine, prp-d, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90647		E	Hib vaccine, prp-omp, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90648		E	Hib vaccine, prp-t, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90657		X	Flu vaccine, 6-35 mo, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90658		X	Flu vaccine, 3 yrs, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90659		X	Flu vaccine, whole, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90660		X	Flu vaccine, nasal	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90665		E	Lyme disease vaccine, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90669		N	Pneumococcal vacc, ped <5	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90675		E	Rabies vaccine, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90676		E	Rabies vaccine, id	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90680		E	Rotovirus vaccine, oral	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90690		E	Typhoid vaccine, oral	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90691		E	Typhoid vaccine, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90692		E	Typhoid vaccine, h-p, sc/id	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90693		E	Typhoid vaccine, akd, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90700		E	Dtap vaccine, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90701		E	Dtp vaccine, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90702		E	Dt vaccine < 7, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90703		E	Tetanus vaccine, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90704		E	Mumps vaccine, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90705		E	Measles vaccine, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90706		E	Rubella vaccine, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90707		E	Mmr vaccine, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90708		E	Measles-rubella vaccine, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90709		D	Rubella & mumps vaccine, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90710		E	Mmrv vaccine, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90712		E	Oral poliovirus vaccine	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90713		E	Poliovirus, ipv, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90716		E	Chicken pox vaccine, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90717		E	Yellow fever vaccine, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90718		E	Td vaccine > 7, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90719		E	Diphtheria vaccine, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90720		E	Dtp/hib vaccine, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90721		E	Dtap/hib vaccine, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90723		X	Dtap-hep b-ipv vaccine, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90725		E	Cholera vaccine, injectable	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90727		E	Plague vaccine, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90732		X	Pneumococcal vaccine	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90733		E	Meningococcal vaccine, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90735		E	Encephalitis vaccine, sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90740		I	Hepb vacc, ill pat 3 dose im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90743		I	Hep b vacc, adol, 2 dose, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90744		I	Hepb vacc ped/adol 3 dose im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90746		I	Hep b vaccine, adult, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90747		I	Hepb vacc, ill pat 4 dose im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90748		E	Hep b/hib vaccine, im	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90749		E	Vaccine toxoid	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90780		A	IV infusion therapy, 1 hour	0.00	1.10	NA	0.06	1.16	NA	XXX
90781		A	IV infusion, additional hour	0.00	0.56	NA	0.03	0.59	NA	ZZZ
90782		T	Injection, sc/im	0.00	0.11	NA	0.01	0.12	NA	XXX
90783		T	Injection, ia	0.00	0.41	NA	0.02	0.43	NA	XXX
90784		T	Injection, iv	0.00	0.47	NA	0.03	0.50	NA	XXX
90788		T	Injection of antibiotic	0.00	0.12	NA	0.01	0.13	NA	XXX
90799		C	Ther/prophylactic/dx inject	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90801		A	Psy dx interview	2.80	1.19	0.96	0.06	4.05	3.82	XXX
90802		A	Intac psy dx interview	3.01	1.23	1.01	0.07	4.31	4.09	XXX
90804		A	Psytx, office, 20-30 min	1.21	0.51	0.39	0.03	1.75	1.63	XXX
90805		A	Psytx, off, 20-30 min w/e&m	1.37	0.52	0.44	0.03	1.92	1.84	XXX
90806		A	Psytx, off, 45-50 min	1.86	0.72	0.62	0.04	2.62	2.52	XXX
90807		A	Psytx, off, 45-50 min w/e&m	2.02	0.72	0.65	0.05	2.79	2.72	XXX
90808		A	Psytx, office, 75-80 min	2.79	1.05	0.93	0.07	3.91	3.79	XXX
90809		A	Psytx, off, 75-80, w/e&m	2.95	1.02	0.95	0.07	4.04	3.97	XXX
90810		A	Intac psytx, off, 20-30 min	1.32	0.53	0.43	0.03	1.88	1.78	XXX
90811		A	Intac psytx, 20-30, w/e&m	1.48	0.59	0.48	0.03	2.10	1.99	XXX
90812		A	Intac psytx, off, 45-50 min	1.97	0.82	0.66	0.05	2.84	2.68	XXX
90813		A	Intac psytx, 45-50 min w/e&m	2.13	0.79	0.69	0.05	2.97	2.87	XXX
90814		A	Intac psytx, off, 75-80 min	2.90	1.13	1.01	0.07	4.10	3.98	XXX
90815		A	Intac psytx, 75-80 w/e&m	3.06	1.08	0.98	0.07	4.21	4.11	XXX
90816		A	Psytx, hosp, 20-30 min	1.25	NA	0.48	0.03	NA	1.76	XXX
90817		A	Psytx, hosp, 20-30 min w/e&m	1.41	NA	0.47	0.03	NA	1.91	XXX
90818		A	Psytx, hosp, 45-50 min	1.89	NA	0.71	0.04	NA	2.64	XXX
90819		A	Psytx, hosp, 45-50 min w/e&m	2.05	NA	0.67	0.05	NA	2.77	XXX
90821		A	Psytx, hosp, 75-80 min	2.83	NA	1.03	0.06	NA	3.92	XXX
90822		A	Psytx, hosp, 75-80 min w/e&m	2.99	NA	0.97	0.07	NA	4.03	XXX
90823		A	Intac psytx, hosp, 20-30 min	1.36	NA	0.49	0.03	NA	1.88	XXX
90824		A	Intac psytx, hsp 20-30 w/e&m	1.52	NA	0.51	0.03	NA	2.06	XXX
90826		A	Intac psytx, hosp, 45-50 min	2.01	NA	0.75	0.04	NA	2.80	XXX
90827		A	Intac psytx, hsp 45-50 w/e&m	2.16	NA	0.71	0.05	NA	2.92	XXX
90828		A	Intac psytx, hosp, 75-80 min	2.94	NA	1.09	0.07	NA	4.10	XXX
90829		A	Intac psytx, hsp 75-80 w/e&m	3.10	NA	1.01	0.07	NA	4.18	XXX
90845		A	Psychoanalysis	1.79	0.60	0.57	0.04	2.43	2.40	XXX
90846		R	Family psytx w/o patient	1.83	0.67	0.66	0.04	2.54	2.53	XXX
90847		R	Family psytx w/patient	2.21	0.84	0.78	0.05	3.10	3.04	XXX
90849		R	Multiple family group psytx	0.59	0.28	0.25	0.01	0.88	0.85	XXX
90853		A	Group psychotherapy	0.59	0.26	0.24	0.01	0.86	0.84	XXX
90857		A	Intac group psytx	0.63	0.31	0.26	0.02	0.96	0.91	XXX
90862		A	Medication management	0.95	0.41	0.33	0.02	1.38	1.30	XXX
90865		A	Narcosynthesis	2.84	1.62	0.91	0.07	4.53	3.82	XXX
90870		A	Electroconvulsive therapy	1.88	0.81	0.81	0.04	2.73	2.73	000
90871		A	Electroconvulsive therapy	2.72	NA	1.08	0.06	NA	3.86	000
90875		N	Psychophysiological therapy	+1.20	0.91	0.47	0.03	2.14	1.70	XXX
90876		N	Psychophysiological therapy	+1.90	1.18	0.74	0.04	3.12	2.68	XXX
90880		A	Hypnotherapy	2.19	1.06	0.71	0.05	3.30	2.95	XXX
90882		N	Environmental manipulation	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90885		B	Psy evaluation of records	+0.97	0.38	0.38	0.02	1.37	1.37	XXX
90887		B	Consultation with family	+1.48	0.83	0.58	0.03	2.34	2.09	XXX
90889		B	Preparation of report	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90899		C	Psychiatric service/therapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90901		A	Biofeedback train, any meth	0.41	0.86	0.19	0.02	1.29	0.62	000
90911		A	Biofeedback peri/uro/rectal	0.89	0.88	0.36	0.04	1.81	1.29	000
90918		A	ESRD related services, month	11.18	7.56	7.56	0.30	19.04	19.04	XXX
90919		A	ESRD related services, month	8.54	4.18	4.18	0.24	12.96	12.96	XXX
90920		A	ESRD related services, month	7.27	3.92	3.92	0.19	11.38	11.38	XXX
90921		A	ESRD related services, month	4.47	2.54	2.54	0.12	7.13	7.13	XXX
90922		A	ESRD related services, day	0.37	0.22	0.22	0.01	0.60	0.60	XXX
90923		A	Esrd related services, day	0.28	0.13	0.13	0.01	0.42	0.42	XXX
90924		A	Esrd related services, day	0.24	0.12	0.12	0.01	0.37	0.37	XXX
90925		A	Esrd related services, day	0.15	0.08	0.08	0.01	0.24	0.24	XXX
90935		A	Hemodialysis, one evaluation	1.22	NA	0.69	0.03	NA	1.94	000
90937		A	Hemodialysis, repeated eval	2.11	NA	1.00	0.06	NA	3.17	000
90939		X	Hemodialysis study, transcut	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90940		X	Hemodialysis access study	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90945		A	Dialysis, one evaluation	1.28	NA	0.72	0.04	NA	2.04	000
90947		A	Dialysis, repeated eval	2.16	NA	1.02	0.06	NA	3.24	000
90989		X	Dialysis training, complete	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90993		X	Dialysis training, incompl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
90997		A	Hemoperfusion	1.84	NA	1.43	0.05	NA	3.32	000
90999		C	Dialysis procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
91000		A	Esophageal intubation	0.73	0.33	NA	0.04	1.10	NA	000
91000	26	A	Esophageal intubation	0.73	0.25	0.25	0.03	1.01	1.01	000
91000	TC	A	Esophageal intubation	0.00	0.08	NA	0.01	0.09	NA	000
91010		A	Esophagus motility study	1.25	2.75	NA	0.10	4.10	NA	000
91010	26	A	Esophagus motility study	1.25	0.45	0.45	0.05	1.75	1.75	000
91010	TC	A	Esophagus motility study	0.00	2.30	NA	0.05	2.35	NA	000
91011		A	Esophagus motility study	1.50	3.18	NA	0.10	4.78	NA	000
91011	26	A	Esophagus motility study	1.50	0.54	0.54	0.05	2.09	2.09	000
91011	TC	A	Esophagus motility study	0.00	2.64	NA	0.05	2.69	NA	000
91012		A	Esophagus motility study	1.46	3.31	NA	0.12	4.89	NA	000
91012	26	A	Esophagus motility study	1.46	0.53	0.53	0.06	2.05	2.05	000
91012	TC	A	Esophagus motility study	0.00	2.78	NA	0.06	2.84	NA	000
91020		A	Gastric motility	1.44	3.05	NA	0.11	4.60	NA	000
91020	26	A	Gastric motility	1.44	0.50	0.50	0.06	2.00	2.00	000
91020	TC	A	Gastric motility	0.00	2.55	NA	0.05	2.60	NA	000
91030		A	Acid perfusion of esophagus	0.91	2.57	NA	0.05	3.53	NA	000
91030	26	A	Acid perfusion of esophagus	0.91	0.33	0.33	0.03	1.27	1.27	000
91030	TC	A	Acid perfusion of esophagus	0.00	2.24	NA	0.02	2.26	NA	000
91032		A	Esophagus, acid reflux test	1.21	2.43	NA	0.10	3.74	NA	000
91032	26	A	Esophagus, acid reflux test	1.21	0.43	0.43	0.05	1.69	1.69	000
91032	TC	A	Esophagus, acid reflux test	0.00	2.00	NA	0.05	2.05	NA	000
91033		A	Prolonged acid reflux test	1.30	2.64	NA	0.14	4.08	NA	000
91033	26	A	Prolonged acid reflux test	1.30	0.47	0.47	0.05	1.82	1.82	000
91033	TC	A	Prolonged acid reflux test	0.00	2.17	NA	0.09	2.26	NA	000
91052		A	Gastric analysis test	0.79	2.38	NA	0.05	3.22	NA	000
91052	26	A	Gastric analysis test	0.79	0.28	0.28	0.03	1.10	1.10	000
91052	TC	A	Gastric analysis test	0.00	2.10	NA	0.02	2.12	NA	000
91055		A	Gastric intubation for smear	0.94	2.17	NA	0.06	3.17	NA	000
91055	26	A	Gastric intubation for smear	0.94	0.27	0.27	0.04	1.25	1.25	000
91055	TC	A	Gastric intubation for smear	0.00	1.90	NA	0.02	1.92	NA	000
91060		A	Gastric saline load test	0.45	0.30	NA	0.04	0.79	NA	000
91060	26	A	Gastric saline load test	0.45	0.14	0.14	0.02	0.61	0.61	000
91060	TC	A	Gastric saline load test	0.00	0.16	NA	0.02	0.18	NA	000
91065		A	Breath hydrogen test	0.20	3.88	NA	0.03	4.11	NA	000
91065	26	A	Breath hydrogen test	0.20	0.07	0.07	0.01	0.28	0.28	000
91065	TC	A	Breath hydrogen test	0.00	3.81	NA	0.02	3.83	NA	000
91100		A	Pass intestine bleeding tube	1.08	NA	0.29	0.06	NA	1.43	000
91105		A	Gastric intubation treatment	0.37	NA	0.10	0.02	NA	0.49	000
91122		A	Anal pressure record	1.77	3.85	NA	0.17	5.79	NA	000
91122	26	A	Anal pressure record	1.77	0.62	0.62	0.10	2.49	2.49	000
91122	TC	A	Anal pressure record	0.00	3.23	NA	0.07	3.30	NA	000
91123		B	Irrigate fecal impaction	0.00	0.00	0.00	0.00	0.00	0.00	XXX
91132		C	Electrogastrography	0.00	0.00	0.00	0.00	0.00	0.00	XXX
91132	26	A	Electrogastrography	0.52	0.19	NA	0.03	0.74	NA	XXX
91132	TC	C	Electrogastrography	0.00	0.00	0.00	0.00	0.00	0.00	XXX
91133		C	Electrogastrography w/test	0.00	0.00	0.00	0.00	0.00	0.00	XXX
91133	26	A	Electrogastrography w/test	0.66	0.24	NA	0.03	0.93	NA	XXX
91133	TC	C	Electrogastrography w/test	0.00	0.00	0.00	0.00	0.00	0.00	XXX
91299		C	Gastroenterology procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
91299	26	C	Gastroenterology procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
91299	TC	C	Gastroenterology procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92002		A	Eye exam, new patient	0.88	0.94	0.35	0.02	1.84	1.25	XXX
92004		A	Eye exam, new patient	1.67	1.66	0.70	0.03	3.36	2.40	XXX
92012		A	Eye exam established pat	0.67	0.99	0.30	0.01	1.67	0.98	XXX
92014		A	Eye exam & treatment	1.10	1.35	0.48	0.02	2.47	1.60	XXX
92015		N	Refraction	+0.38	1.51	0.15	0.01	1.90	0.54	XXX
92018		A	New eye exam & treatment	2.50	NA	1.10	0.03	NA	3.63	XXX
92019		A	Eye exam & treatment	1.31	NA	0.58	0.03	NA	1.92	XXX
92020		A	Special eye evaluation	0.37	0.92	0.16	0.01	1.30	0.54	XXX
92060		A	Special eye evaluation	0.69	0.74	NA	0.02	1.45	NA	XXX
92060	26	A	Special eye evaluation	0.69	0.30	0.30	0.01	1.00	1.00	XXX
92060	TC	A	Special eye evaluation	0.00	0.44	NA	0.01	0.45	NA	XXX
92065		A	Orthoptic/pleoptic training	0.37	0.56	NA	0.02	0.95	NA	XXX
92065	26	A	Orthoptic/pleoptic training	0.37	0.16	0.16	0.01	0.54	0.54	XXX
92065	TC	A	Orthoptic/pleoptic training	0.00	0.40	NA	0.01	0.41	NA	XXX
92070		A	Fitting of contact lens	0.70	1.04	0.33	0.01	1.75	1.04	XXX
92081		A	Visual field examination(s)	0.36	2.04	NA	0.02	2.42	NA	XXX
92081	26	A	Visual field examination(s)	0.36	0.16	0.16	0.01	0.53	0.53	XXX
92081	TC	A	Visual field examination(s)	0.00	1.88	NA	0.01	1.89	NA	XXX
92082		A	Visual field examination(s)	0.44	1.06	NA	0.02	1.52	NA	XXX
92082	26	A	Visual field examination(s)	0.44	0.19	0.19	0.01	0.64	0.64	XXX
92082	TC	A	Visual field examination(s)	0.00	0.87	NA	0.01	0.88	NA	XXX
92083		A	Visual field examination(s)	0.50	1.59	NA	0.02	2.11	NA	XXX
92083	26	A	Visual field examination(s)	0.50	0.23	0.23	0.01	0.74	0.74	XXX
92083	TC	A	Visual field examination(s)	0.00	1.36	NA	0.01	1.37	NA	XXX
92100		A	Serial tonometry exam(s)	0.92	0.73	0.38	0.02	1.67	1.32	XXX
92120		A	Tonography & eye evaluation	0.81	0.80	0.33	0.02	1.63	1.16	XXX
92130		A	Water provocation tonography	0.81	0.91	0.38	0.02	1.74	1.21	XXX
92135		A	Opthalmic dx imaging	0.35	1.54	NA	0.02	1.91	NA	XXX
92135	26	A	Opthalmic dx imaging	0.35	0.16	0.16	0.01	0.52	0.52	XXX
92135	TC	A	Opthalmic dx imaging	0.00	1.38	NA	0.01	1.39	NA	XXX
92136		A	Ophthalmic biometry	0.54	1.88	NA	0.07	2.49	NA	XXX
92136	26	A	Ophthalmic biometry	0.54	0.25	0.25	0.01	0.80	0.80	XXX
92136	TC	A	Ophthalmic biometry	0.00	1.63	NA	0.06	1.69	NA	XXX
92140		A	Glaucoma provocative tests	0.50	0.99	0.22	0.01	1.50	0.73	XXX
92225		A	Special eye exam, initial	0.38	0.22	0.16	0.01	0.61	0.55	XXX
92226		A	Special eye exam, subsequent	0.33	0.21	0.15	0.01	0.55	0.49	XXX
92230		A	Eye exam with photos	0.60	1.69	0.20	0.02	2.31	0.82	XXX
92235		A	Eye exam with photos	0.81	2.61	NA	0.07	3.49	NA	XXX
92235	26	A	Eye exam with photos	0.81	0.38	0.38	0.02	1.21	1.21	XXX
92235	TC	A	Eye exam with photos	0.00	2.23	NA	0.05	2.28	NA	XXX
92240		A	Icg angiography	1.10	5.09	NA	0.07	6.26	NA	XXX
92240	26	A	Icg angiography	1.10	0.51	0.51	0.02	1.63	1.63	XXX
92240	TC	A	Icg angiography	0.00	4.58	NA	0.05	4.63	NA	XXX
92250		A	Eye exam with photos	0.44	1.49	NA	0.02	1.95	NA	XXX
92250	26	A	Eye exam with photos	0.44	0.20	0.20	0.01	0.65	0.65	XXX
92250	TC	A	Eye exam with photos	0.00	1.29	NA	0.01	1.30	NA	XXX
92260		A	Ophthalmoscopy/dynamometry	0.20	0.24	0.09	0.01	0.45	0.30	XXX
92265		A	Eye muscle evaluation	0.81	1.89	NA	0.04	2.74	NA	XXX
92265	26	A	Eye muscle evaluation	0.81	0.29	0.29	0.02	1.12	1.12	XXX
92265	TC	A	Eye muscle evaluation	0.00	1.60	NA	0.02	1.62	NA	XXX
92270		A	Electro-oculography	0.81	1.76	NA	0.05	2.62	NA	XXX
92270	26	A	Electro-oculography	0.81	0.35	0.35	0.03	1.19	1.19	XXX
92270	TC	A	Electro-oculography	0.00	1.41	NA	0.02	1.43	NA	XXX
92275		A	Electroretinography	1.01	1.98	NA	0.04	3.03	NA	XXX
92275	26	A	Electroretinography	1.01	0.44	0.44	0.02	1.47	1.47	XXX
92275	TC	A	Electroretinography	0.00	1.54	NA	0.02	1.56	NA	XXX
92283		A	Color vision examination	0.17	0.86	NA	0.02	1.05	NA	XXX
92283	26	A	Color vision examination	0.17	0.07	0.07	0.01	0.25	0.25	XXX
92283	TC	A	Color vision examination	0.00	0.79	NA	0.01	0.80	NA	XXX
92284		A	Dark adaptation eye exam	0.24	2.28	NA	0.02	2.54	NA	XXX
92284	26	A	Dark adaptation eye exam	0.24	0.09	0.09	0.01	0.34	0.34	XXX
92284	TC	A	Dark adaptation eye exam	0.00	2.19	NA	0.01	2.20	NA	XXX
92285		A	Eye photography	0.20	0.85	NA	0.02	1.07	NA	XXX
92285	26	A	Eye photography	0.20	0.09	0.09	0.01	0.30	0.30	XXX
92285	TC	A	Eye photography	0.00	0.76	NA	0.01	0.77	NA	XXX
92286		A	Internal eye photography	0.66	2.86	NA	0.03	3.55	NA	XXX
92286	26	A	Internal eye photography	0.66	0.30	0.30	0.01	0.97	0.97	XXX
92286	TC	A	Internal eye photography	0.00	2.56	NA	0.02	2.58	NA	XXX
92287		A	Internal eye photography	0.81	2.70	0.32	0.02	3.53	1.15	XXX
92310		N	Contact lens fitting	+1.17	1.13	0.46	0.03	2.33	1.66	XXX
92311		A	Contact lens fitting	1.08	1.14	0.36	0.03	2.25	1.47	XXX
92312		A	Contact lens fitting	1.26	1.13	0.51	0.03	2.42	1.80	XXX
92313		A	Contact lens fitting	0.92	1.11	0.29	0.02	2.05	1.23	XXX
92314		N	Prescription of contact lens	+0.69	0.95	0.27	0.01	1.65	0.97	XXX
92315		A	Prescription of contact lens	0.45	0.90	0.17	0.01	1.36	0.63	XXX
92316		A	Prescription of contact lens	0.68	0.96	0.30	0.01	1.65	0.99	XXX
92317		A	Prescription of contact lens	0.45	0.99	0.14	0.01	1.45	0.60	XXX
92325		A	Modification of contact lens	0.00	0.40	NA	0.01	0.41	NA	XXX
92326		A	Replacement of contact lens	0.00	1.62	NA	0.05	1.67	NA	XXX
92330		A	Fitting of artificial eye	1.08	1.03	0.33	0.04	2.15	1.45	XXX
92335		A	Fitting of artificial eye	0.45	0.96	0.17	0.01	1.42	0.63	XXX
92340		N	Fitting of spectacles	+0.37	0.71	0.14	0.01	1.09	0.52	XXX
92341		N	Fitting of spectacles	+0.47	0.75	0.18	0.01	1.23	0.66	XXX
92342		N	Fitting of spectacles	+0.53	0.77	0.21	0.01	1.31	0.75	XXX
92352		B	Special spectacles fitting	+0.37	0.71	0.14	0.01	1.09	0.52	XXX
92353		B	Special spectacles fitting	+0.50	0.76	0.20	0.02	1.28	0.72	XXX
92354		B	Special spectacles fitting	+0.00	8.82	NA	0.08	8.90	NA	XXX
92355		B	Special spectacles fitting	+0.00	4.31	NA	0.01	4.32	NA	XXX
92358		B	Eye prosthesis service	+0.00	0.97	NA	0.04	1.01	NA	XXX
92370		N	Repair & adjust spectacles	+0.32	0.56	0.13	0.02	0.90	0.47	XXX
92371		B	Repair & adjust spectacles	+0.00	0.62	NA	0.02	0.64	NA	XXX
92390		N	Supply of spectacles	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92391		N	Supply of contact lenses	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92392		I	Supply of low vision aids	+0.00	3.84	3.84	0.02	3.86	3.86	XXX
92393		I	Supply of artificial eye	+0.00	11.92	11.92	0.47	12.39	12.39	XXX
92395		I	Supply of spectacles	+0.00	1.30	1.30	0.08	1.38	1.38	XXX
92396		I	Supply of contact lenses	+0.00	2.19	2.19	0.06	2.25	2.25	XXX
92499		C	Eye service or procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92499	26	C	Eye service or procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92499	TC	C	Eye service or procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92502		A	Ear and throat examination	1.51	NA	1.24	0.06	NA	2.81	000
92504		A	Ear microscopy examination	0.18	0.51	0.09	0.01	0.70	0.28	XXX
92506		A	Speech/hearing evaluation	0.86	1.63	0.41	0.04	2.53	1.31	XXX
92507		A	Speech/hearing therapy	0.52	1.56	0.24	0.02	2.10	0.78	XXX
92508		A	Speech/hearing therapy	0.26	1.45	0.12	0.01	1.72	0.39	XXX
92510		I	Rehab for ear implant	+1.50	2.11	0.83	0.06	3.67	2.39	XXX
92511		A	Nasopharyngoscopy	0.84	1.38	0.42	0.03	2.25	1.29	000
92512		A	Nasal function studies	0.55	1.10	0.18	0.02	1.67	0.75	XXX
92516		A	Facial nerve function test	0.43	0.97	0.22	0.02	1.42	0.67	XXX
92520		A	Laryngeal function studies	0.76	0.55	0.40	0.03	1.34	1.19	XXX
92525		F	Oral function evaluation	+0.00	0.00	0.00	0.00	0.00	0.00	XXX
92526		A	Oral function therapy	0.55	1.62	0.21	0.02	2.19	0.78	XXX
92531		B	Spontaneous nystagmus study	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92532		B	Positional nystagmus test	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92533		B	Caloric vestibular test	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92534		B	Optokinetic nystagmus test	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92541		A	Spontaneous nystagmus test	0.40	1.11	NA	0.04	1.55	NA	XXX
92541	26	A	Spontaneous nystagmus test	0.40	0.20	0.20	0.02	0.62	0.62	XXX
92541	TC	A	Spontaneous nystagmus test	0.00	0.91	NA	0.02	0.93	NA	XXX
92542		A	Positional nystagmus test	0.33	1.20	NA	0.03	1.56	NA	XXX
92542	26	A	Positional nystagmus test	0.33	0.16	0.16	0.01	0.50	0.50	XXX
92542	TC	A	Positional nystagmus test	0.00	1.04	NA	0.02	1.06	NA	XXX
92543		A	Caloric vestibular test	0.10	0.63	NA	0.02	0.75	NA	XXX
92543	26	A	Caloric vestibular test	0.10	0.05	0.05	0.01	0.16	0.16	XXX
92543	TC	A	Caloric vestibular test	0.00	0.58	NA	0.01	0.59	NA	XXX
92544		A	Optokinetic nystagmus test	0.26	0.97	NA	0.03	1.26	NA	XXX
92544	26	A	Optokinetic nystagmus test	0.26	0.13	0.13	0.01	0.40	0.40	XXX
92544	TC	A	Optokinetic nystagmus test	0.00	0.84	NA	0.02	0.86	NA	XXX
92545		A	Oscillating tracking test	0.23	0.90	NA	0.03	1.16	NA	XXX
92545	26	A	Oscillating tracking test	0.23	0.11	0.11	0.01	0.35	0.35	XXX
92545	TC	A	Oscillating tracking test	0.00	0.79	NA	0.02	0.81	NA	XXX
92546		A	Sinusoidal rotational test	0.29	2.25	NA	0.03	2.57	NA	XXX
92546	26	A	Sinusoidal rotational test	0.29	0.14	0.14	0.01	0.44	0.44	XXX
92546	TC	A	Sinusoidal rotational test	0.00	2.11	NA	0.02	2.13	NA	XXX
92547		A	Supplemental electrical test	0.00	1.34	NA	0.05	1.39	NA	ZZZ
92548		A	Posturography	0.50	3.98	NA	0.13	4.61	NA	XXX
92548	26	A	Posturography	0.50	0.27	0.27	0.02	0.79	0.79	XXX
92548	TC	A	Posturography	0.00	3.71	NA	0.11	3.82	NA	XXX
92551		N	Pure tone hearing test, air	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92552		A	Pure tone audiometry, air	0.00	0.45	NA	0.03	0.48	NA	XXX
92553		A	Audiometry, air & bone	0.00	0.66	NA	0.05	0.71	NA	XXX
92555		A	Speech threshold audiometry	0.00	0.38	NA	0.03	0.41	NA	XXX
92556		A	Speech audiometry, complete	0.00	0.57	NA	0.05	0.62	NA	XXX
92557		A	Comprehensive hearing test	0.00	1.18	NA	0.10	1.28	NA	XXX
92559		N	Group audiometric testing	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92560		N	Bekesy audiometry, screen	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92561		A	Bekesy audiometry, diagnosis	0.00	0.72	NA	0.05	0.77	NA	XXX
92562		A	Loudness balance test	0.00	0.41	NA	0.03	0.44	NA	XXX
92563		A	Tone decay hearing test	0.00	0.38	NA	0.03	0.41	NA	XXX
92564		A	Sisi hearing test	0.00	0.47	NA	0.04	0.51	NA	XXX
92565		A	Stenger test, pure tone	0.00	0.40	NA	0.03	0.43	NA	XXX
92567		A	Tympanometry	0.00	0.52	NA	0.05	0.57	NA	XXX
92568		A	Acoustic reflex testing	0.00	0.38	NA	0.03	0.41	NA	XXX
92569		A	Acoustic reflex decay test	0.00	0.41	NA	0.03	0.44	NA	XXX
92571		A	Filtered speech hearing test	0.00	0.39	NA	0.03	0.42	NA	XXX
92572		A	Staggered spondaic word test	0.00	0.09	NA	0.01	0.10	NA	XXX
92573		A	Lombard test	0.00	0.35	NA	0.03	0.38	NA	XXX
92575		A	Sensorineural acuity test	0.00	0.30	NA	0.02	0.32	NA	XXX
92576		A	Synthetic sentence test	0.00	0.45	NA	0.04	0.49	NA	XXX
92577		A	Stenger test, speech	0.00	0.72	NA	0.06	0.78	NA	XXX
92579		A	Visual audiometry (vra)	0.00	0.73	NA	0.05	0.78	NA	XXX
92582		A	Conditioning play audiometry	0.00	0.73	NA	0.05	0.78	NA	XXX
92583		A	Select picture audiometry	0.00	0.89	NA	0.07	0.96	NA	XXX
92584		A	Electrocochleography	0.00	2.47	NA	0.17	2.64	NA	XXX
92585		A	Auditor evoke potent, compre	0.50	2.06	NA	0.14	2.70	NA	XXX
92585	26	A	Auditor evoke potent, compre	0.50	0.22	0.22	0.02	0.74	0.74	XXX
92585	TC	A	Auditor evoke potent, compre	0.00	1.84	NA	0.12	1.96	NA	XXX
92586		A	Auditor evoke potent, limit	0.00	1.84	NA	0.12	1.96	NA	XXX
92587		A	Evoked auditory test	0.13	1.37	NA	0.10	1.60	NA	XXX
92587	26	A	Evoked auditory test	0.13	0.07	0.07	0.01	0.21	0.21	XXX
92587	TC	A	Evoked auditory test	0.00	1.30	NA	0.09	1.39	NA	XXX
92588		A	Evoked auditory test	0.36	1.63	NA	0.12	2.11	NA	XXX
92588	26	A	Evoked auditory test	0.36	0.17	0.17	0.01	0.54	0.54	XXX
92588	TC	A	Evoked auditory test	0.00	1.46	NA	0.11	1.57	NA	XXX
92589		A	Auditory function test(s)	0.00	0.53	NA	0.05	0.58	NA	XXX
92590		N	Hearing aid exam, one ear	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92591		N	Hearing aid exam, both ears	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92592		N	Hearing aid check, one ear	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92593		N	Hearing aid check, both ears	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92594		N	Electro hearng aid test, one	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92595		N	Electro hearng aid tst, both	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92596		A	Ear protector evaluation	0.00	0.59	NA	0.05	0.64	NA	XXX
92597		I	Oral speech device eval	+1.35	1.49	0.54	0.05	2.89	1.94	XXX
92598		F	Modify oral speech device	+0.00	0.00	0.00	0.00	0.00	0.00	XXX
92599		D	ENT procedure/service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92599	26	D	ENT procedure/service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92599	TC	D	ENT procedure/service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92601		A	Cochlear implt f/up exam < 7	0.00	3.50	NA	0.06	3.56	NA	XXX
92602		A	Reprogram cochlear implt < 7	0.00	2.44	NA	0.06	2.50	NA	XXX
92603		A	Cochlear implt f/up exam 7 >	0.00	2.34	NA	0.06	2.40	NA	XXX
92604		A	Reprogram cochlear implt 7 >	0.00	1.58	NA	0.06	1.64	NA	XXX
92605		B	Eval for nonspeech device rx	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92606		B	Non-speech device service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92607		A	Ex for speech device rx, 1hr	0.00	2.93	NA	0.04	2.97	NA	XXX
92608		A	Ex for speech device rx addl	0.00	0.55	NA	0.04	0.59	NA	XXX
92609		A	Use of speech device service	0.00	1.58	NA	0.03	1.61	NA	XXX
92610		A	Evaluate swallowing function	0.00	1.08	NA	0.07	1.15	NA	XXX
92611		A	Motion fluoroscopy/swallow	0.00	1.18	NA	0.07	1.25	NA	XXX
92612		A	Endoscopy swallow tst (fees)	1.27	3.36	0.50	0.07	4.70	1.84	XXX
92613		B	Endoscopy swallow tst (fees)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92614		A	Laryngoscopic sensory test	1.27	2.29	0.50	0.07	3.63	1.84	XXX
92615		B	Eval laryngoscopy sense tst	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92616		A	Fees w/laryngeal sense test	1.88	3.02	0.73	0.07	4.97	2.68	XXX
92617		B	Interprt fees/laryngeal test	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92700		C	Ent procedure/service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92950		A	Heart/lung resuscitation cpr	3.80	NA	1.01	0.21	NA	5.02	000
92953		A	Temporary external pacing	0.23	NA	0.23	0.01	NA	0.47	000
92960		A	Cardioversion electric, ext	2.25	2.28	0.86	0.08	4.61	3.19	000
92961		A	Cardioversion, electric, int	4.60	NA	1.77	0.17	NA	6.54	000
92970		A	Cardioassist, internal	3.52	NA	1.08	0.17	NA	4.77	000
92971		A	Cardioassist, external	1.77	NA	0.88	0.06	NA	2.71	000
92973		A	Percut coronary thrombectomy	3.28	NA	1.32	0.12	NA	4.72	ZZZ
92974		A	Cath place, cardio brachytx	3.00	NA	1.20	0.14	NA	4.34	ZZZ
92975		A	Dissolve clot, heart vessel	7.25	NA	2.88	0.22	NA	10.35	000
92977		A	Dissolve clot, heart vessel	0.00	8.02	NA	0.38	8.40	NA	XXX
92978		A	Intravasc us, heart add-on	1.80	5.28	NA	0.26	7.34	NA	ZZZ
92978	26	A	Intravasc us, heart add-on	1.80	0.73	0.73	0.06	2.59	2.59	ZZZ
92978	TC	A	Intravasc us, heart add-on	0.00	4.55	NA	0.20	4.75	NA	ZZZ
92979		A	Intravasc us, heart add-on	1.44	2.86	NA	0.15	4.45	NA	ZZZ
92979	26	A	Intravasc us, heart add-on	1.44	0.58	0.58	0.04	2.06	2.06	ZZZ
92979	TC	A	Intravasc us, heart add-on	0.00	2.28	NA	0.11	2.39	NA	ZZZ
92980		A	Insert intracoronary stent	14.84	NA	6.21	0.71	NA	21.76	000
92981		A	Insert intracoronary stent	4.17	NA	1.68	0.20	NA	6.05	ZZZ
92982		A	Coronary artery dilation	10.98	NA	4.66	0.52	NA	16.16	000
92984		A	Coronary artery dilation	2.97	NA	1.19	0.14	NA	4.30	ZZZ
92986		A	Revision of aortic valve	21.80	NA	10.27	1.14	NA	33.21	090
92987		A	Revision of mitral valve	22.70	NA	10.66	1.18	NA	34.54	090
92990		A	Revision of pulmonary valve	17.34	NA	8.24	0.90	NA	26.48	090
92992		C	Revision of heart chamber	0.00	0.00	0.00	0.00	0.00	0.00	090
92993		C	Revision of heart chamber	0.00	0.00	0.00	0.00	0.00	0.00	090
92995		A	Coronary atherectomy	12.09	NA	5.10	0.58	NA	17.77	000
92996		A	Coronary atherectomy add-on	3.26	NA	1.30	0.16	NA	4.72	ZZZ
92997		A	Pul art balloon repr, percut	12.00	NA	4.96	0.63	NA	17.59	000
92998		A	Pul art balloon repr, percut	6.00	NA	2.26	0.31	NA	8.57	ZZZ
93000		A	Electrocardiogram, complete	0.17	0.51	NA	0.03	0.71	NA	XXX
93005		A	Electrocardiogram, tracing	0.00	0.45	NA	0.02	0.47	NA	XXX
93010		A	Electrocardiogram report	0.17	0.06	0.06	0.01	0.24	0.24	XXX
93012		A	Transmission of ecg	0.00	2.35	NA	0.15	2.50	NA	XXX
93014		A	Report on transmitted ecg	0.52	0.19	0.19	0.02	0.73	0.73	XXX
93015		A	Cardiovascular stress test	0.75	1.97	NA	0.11	2.83	NA	XXX
93016		A	Cardiovascular stress test	0.45	0.18	0.18	0.01	0.64	0.64	XXX
93017		A	Cardiovascular stress test	0.00	1.67	NA	0.09	1.76	NA	XXX
93018		A	Cardiovascular stress test	0.30	0.12	0.12	0.01	0.43	0.43	XXX
93024		A	Cardiac drug stress test	1.17	1.57	NA	0.11	2.85	NA	XXX
93024	26	A	Cardiac drug stress test	1.17	0.46	0.46	0.04	1.67	1.67	XXX
93024	TC	A	Cardiac drug stress test	0.00	1.11	NA	0.07	1.18	NA	XXX
93025		A	Microvolt t-wave assess	0.75	10.73	NA	0.11	11.59	NA	XXX
93025	26	A	Microvolt t-wave assess	0.75	0.31	0.31	0.02	1.08	1.08	XXX
93025	TC	A	Microvolt t-wave assess	0.00	10.42	NA	0.09	10.51	NA	XXX
93040		A	Rhythm ECG with report	0.16	0.20	NA	0.02	0.38	NA	XXX
93041		A	Rhythm ECG, tracing	0.00	0.15	NA	0.01	0.16	NA	XXX
93042		A	Rhythm ECG, report	0.16	0.05	0.05	0.01	0.22	0.22	XXX
93224		A	ECG monitor/report, 24 hrs	0.52	3.61	NA	0.21	4.34	NA	XXX
93225		A	ECG monitor/record, 24 hrs	0.00	1.23	NA	0.07	1.30	NA	XXX
93226		A	ECG monitor/report, 24 hrs	0.00	2.18	NA	0.12	2.30	NA	XXX
93227		A	ECG monitor/review, 24 hrs	0.52	0.20	0.20	0.02	0.74	0.74	XXX
93230		A	ECG monitor/report, 24 hrs	0.52	3.88	NA	0.22	4.62	NA	XXX
93231		A	Ecg monitor/record, 24 hrs	0.00	1.51	NA	0.09	1.60	NA	XXX
93232		A	ECG monitor/report, 24 hrs	0.00	2.17	NA	0.11	2.28	NA	XXX
93233		A	ECG monitor/review, 24 hrs	0.52	0.20	0.20	0.02	0.74	0.74	XXX
93235		A	ECG monitor/report, 24 hrs	0.45	2.78	NA	0.13	3.36	NA	XXX
93236		A	ECG monitor/report, 24 hrs	0.00	2.61	NA	0.12	2.73	NA	XXX
93237		A	ECG monitor/review, 24 hrs	0.45	0.17	0.17	0.01	0.63	0.63	XXX
93268		A	ECG record/review	0.52	7.41	NA	0.24	8.17	NA	XXX
93270		A	ECG recording	0.00	1.23	NA	0.07	1.30	NA	XXX
93271		A	Ecg/monitoring and analysis	0.00	5.99	NA	0.15	6.14	NA	XXX
93272		A	Ecg/review, interpret only	0.52	0.19	0.19	0.02	0.73	0.73	XXX
93278		A	ECG/signal-averaged	0.25	1.24	NA	0.10	1.59	NA	XXX
93278	26	A	ECG/signal-averaged	0.25	0.10	0.10	0.01	0.36	0.36	XXX
93278	TC	A	ECG/signal-averaged	0.00	1.14	NA	0.09	1.23	NA	XXX
93303		A	Echo transthoracic	1.30	4.33	NA	0.23	5.86	NA	XXX
93303	26	A	Echo transthoracic	1.30	0.49	0.49	0.04	1.83	1.83	XXX
93303	TC	A	Echo transthoracic	0.00	3.84	NA	0.19	4.03	NA	XXX
93304		A	Echo transthoracic	0.75	2.22	NA	0.13	3.10	NA	XXX
93304	26	A	Echo transthoracic	0.75	0.29	0.29	0.02	1.06	1.06	XXX
93304	TC	A	Echo transthoracic	0.00	1.93	NA	0.11	2.04	NA	XXX
93307		A	Echo exam of heart	0.92	4.20	NA	0.22	5.34	NA	XXX
93307	26	A	Echo exam of heart	0.92	0.36	0.36	0.03	1.31	1.31	XXX
93307	TC	A	Echo exam of heart	0.00	3.84	NA	0.19	4.03	NA	XXX
93308		A	Echo exam of heart	0.53	2.14	NA	0.13	2.80	NA	XXX
93308	26	A	Echo exam of heart	0.53	0.21	0.21	0.02	0.76	0.76	XXX
93308	TC	A	Echo exam of heart	0.00	1.93	NA	0.11	2.04	NA	XXX
93312		A	Echo transesophageal	2.20	4.57	NA	0.32	7.09	NA	XXX
93312	26	A	Echo transesophageal	2.20	0.81	0.81	0.08	3.09	3.09	XXX
93312	TC	A	Echo transesophageal	0.00	3.76	NA	0.24	4.00	NA	XXX
93313		A	Echo transesophageal	0.95	0.22	0.21	0.05	1.22	1.21	XXX
93314		A	Echo transesophageal	1.25	4.24	NA	0.28	5.77	NA	XXX
93314	26	A	Echo transesophageal	1.25	0.48	0.48	0.04	1.77	1.77	XXX
93314	TC	A	Echo transesophageal	0.00	3.76	NA	0.24	4.00	NA	XXX
93315		A	Echo transesophageal	2.78	4.79	NA	0.34	7.91	NA	XXX
93315	26	A	Echo transesophageal	2.78	1.03	1.03	0.10	3.91	3.91	XXX
93315	TC	A	Echo transesophageal	0.00	3.76	NA	0.24	4.00	NA	XXX
93316		A	Echo transesophageal	0.95	NA	0.24	0.05	NA	1.24	XXX
93317		A	Echo transesophageal	1.83	4.45	NA	0.30	6.58	NA	XXX
93317	26	A	Echo transesophageal	1.83	0.69	0.69	0.06	2.58	2.58	XXX
93317	TC	A	Echo transesophageal	0.00	3.76	NA	0.24	4.00	NA	XXX
93318		C	Echo transesophageal intraop	0.00	0.00	0.00	0.00	0.00	0.00	XXX
93318	26	A	Echo transesophageal intraop	2.20	0.49	NA	0.06	2.75	NA	XXX
93318	TC	C	Echo transesophageal intraop	0.00	0.00	0.00	0.00	0.00	0.00	XXX
93320		A	Doppler echo exam, heart	0.38	1.85	NA	0.11	2.34	NA	ZZZ
93320	26	A	Doppler echo exam, heart	0.38	0.15	0.15	0.01	0.54	0.54	ZZZ
93320	TC	A	Doppler echo exam, heart	0.00	1.70	NA	0.10	1.80	NA	ZZZ
93321		A	Doppler echo exam, heart	0.15	1.16	NA	0.08	1.39	NA	ZZZ
93321	26	A	Doppler echo exam, heart	0.15	0.06	0.06	0.01	0.22	0.22	ZZZ
93321	TC	A	Doppler echo exam, heart	0.00	1.10	NA	0.07	1.17	NA	ZZZ
93325		A	Doppler color flow add-on	0.07	2.92	NA	0.18	3.17	NA	ZZZ
93325	26	A	Doppler color flow add-on	0.07	0.03	0.03	0.01	0.11	0.11	ZZZ
93325	TC	A	Doppler color flow add-on	0.00	2.89	NA	0.17	3.06	NA	ZZZ
93350		A	Echo transthoracic	1.48	2.33	NA	0.13	3.94	NA	XXX
93350	26	A	Echo transthoracic	1.48	0.58	0.58	0.02	2.08	2.08	XXX
93350	TC	A	Echo transthoracic	0.00	1.75	NA	0.11	1.86	NA	XXX
93501		A	Right heart catheterization	3.02	18.01	NA	1.03	22.06	NA	000
93501	26	A	Right heart catheterization	3.02	1.18	1.18	0.16	4.36	4.36	000
93501	TC	A	Right heart catheterization	0.00	16.83	NA	0.87	17.70	NA	000
93503		A	Insert/place heart catheter	2.91	NA	0.69	0.16	NA	3.76	000
93505		A	Biopsy of heart lining	4.38	3.69	NA	0.36	8.43	NA	000
93505	26	A	Biopsy of heart lining	4.38	1.72	1.72	0.23	6.33	6.33	000
93505	TC	A	Biopsy of heart lining	0.00	1.97	NA	0.13	2.10	NA	000
93508		A	Cath placement, angiography	4.10	14.19	NA	0.75	19.04	NA	000
93508	26	A	Cath placement, angiography	4.10	1.64	1.64	0.21	5.95	5.95	000
93508	TC	A	Cath placement, angiography	0.00	12.55	NA	0.54	13.09	NA	000
93510		A	Left heart catheterization	4.33	38.53	NA	2.13	44.99	NA	000
93510	26	A	Left heart catheterization	4.33	1.74	1.74	0.22	6.29	6.29	000
93510	TC	A	Left heart catheterization	0.00	36.79	NA	1.91	38.70	NA	000
93511		A	Left heart catheterization	5.03	37.84	NA	2.11	44.98	NA	000
93511	26	A	Left heart catheterization	5.03	2.02	2.02	0.26	7.31	7.31	000
93511	TC	A	Left heart catheterization	0.00	35.82	NA	1.85	37.67	NA	000
93514		A	Left heart catheterization	7.05	38.58	NA	2.22	47.85	NA	000
93514	26	A	Left heart catheterization	7.05	2.76	2.76	0.37	10.18	10.18	000
93514	TC	A	Left heart catheterization	0.00	35.82	NA	1.85	37.67	NA	000
93524		A	Left heart catheterization	6.95	49.57	NA	2.79	59.31	NA	000
93524	26	A	Left heart catheterization	6.95	2.77	2.77	0.36	10.08	10.08	000
93524	TC	A	Left heart catheterization	0.00	46.80	NA	2.43	49.23	NA	000
93526		A	Rt & Lt heart catheters	5.99	50.48	NA	2.81	59.28	NA	000
93526	26	A	Rt & Lt heart catheters	5.99	2.40	2.40	0.31	8.70	8.70	000
93526	TC	A	Rt & Lt heart catheters	0.00	48.08	NA	2.50	50.58	NA	000
93527		A	Rt & Lt heart catheters	7.28	49.72	NA	2.81	59.81	NA	000
93527	26	A	Rt & Lt heart catheters	7.28	2.92	2.92	0.38	10.58	10.58	000
93527	TC	A	Rt & Lt heart catheters	0.00	46.80	NA	2.43	49.23	NA	000
93528		A	Rt & Lt heart catheters	9.00	50.44	NA	2.90	62.34	NA	000
93528	26	A	Rt & Lt heart catheters	9.00	3.64	3.64	0.47	13.11	13.11	000
93528	TC	A	Rt & Lt heart catheters	0.00	46.80	NA	2.43	49.23	NA	000
93529		A	Rt, lt heart catheterization	4.80	48.67	NA	2.68	56.15	NA	000
93529	26	A	Rt, lt heart catheterization	4.80	1.87	1.87	0.25	6.92	6.92	000
93529	TC	A	Rt, lt heart catheterization	0.00	46.80	NA	2.43	49.23	NA	000
93530		A	Rt heart cath, congenital	4.23	18.37	NA	1.11	23.71	NA	000
93530	26	A	Rt heart cath, congenital	4.23	1.54	1.54	0.24	6.01	6.01	000
93530	TC	A	Rt heart cath, congenital	0.00	16.83	NA	0.87	17.70	NA	000
93531		A	R & l heart cath, congenital	8.35	51.30	NA	2.96	62.61	NA	000
93531	26	A	R & l heart cath, congenital	8.35	3.22	3.22	0.46	12.03	12.03	000
93531	TC	A	R & l heart cath, congenital	0.00	48.08	NA	2.50	50.58	NA	000
93532		A	R & l heart cath, congenital	10.00	50.70	NA	2.95	63.65	NA	000
93532	26	A	R & l heart cath, congenital	10.00	3.90	3.90	0.52	14.42	14.42	000
93532	TC	A	R & l heart cath, congenital	0.00	46.80	NA	2.43	49.23	NA	000
93533		A	R & l heart cath, congenital	6.70	49.24	NA	2.86	58.80	NA	000
93533	26	A	R & l heart cath, congenital	6.70	2.44	2.44	0.43	9.57	9.57	000
93533	TC	A	R & l heart cath, congenital	0.00	46.80	NA	2.43	49.23	NA	000
93539		A	Injection, cardiac cath	0.40	0.16	0.16	0.01	0.57	0.57	000
93540		A	Injection, cardiac cath	0.43	0.17	0.17	0.01	0.61	0.61	000
93541		A	Injection for lung angiogram	0.29	NA	0.12	0.01	NA	0.42	000
93542		A	Injection for heart x-rays	0.29	NA	0.12	0.01	NA	0.42	000
93543		A	Injection for heart x-rays	0.29	0.12	0.12	0.01	0.42	0.42	000
93544		A	Injection for aortography	0.25	0.10	0.10	0.01	0.36	0.36	000
93545		A	Inject for coronary x-rays	0.40	0.16	0.16	0.01	0.57	0.57	000
93555		A	Imaging, cardiac cath	0.81	6.58	NA	0.31	7.70	NA	XXX
93555	26	A	Imaging, cardiac cath	0.81	0.33	0.33	0.03	1.17	1.17	XXX
93555	TC	A	Imaging, cardiac cath	0.00	6.25	NA	0.28	6.53	NA	XXX
93556		A	Imaging, cardiac cath	0.83	10.18	NA	0.45	11.46	NA	XXX
93556	26	A	Imaging, cardiac cath	0.83	0.33	0.33	0.03	1.19	1.19	XXX
93556	TC	A	Imaging, cardiac cath	0.00	9.85	NA	0.42	10.27	NA	XXX
93561		A	Cardiac output measurement	0.50	0.68	NA	0.07	1.25	NA	000
93561	26	A	Cardiac output measurement	0.50	0.16	0.16	0.02	0.68	0.68	000
93561	TC	A	Cardiac output measurement	0.00	0.52	NA	0.05	0.57	NA	000
93562		A	Cardiac output measurement	0.16	0.37	NA	0.04	0.57	NA	000
93562	26	A	Cardiac output measurement	0.16	0.05	0.05	0.01	0.22	0.22	000
93562	TC	A	Cardiac output measurement	0.00	0.32	NA	0.03	0.35	NA	000
93571		A	Heart flow reserve measure	1.80	5.25	NA	0.31	7.36	NA	ZZZ
93571	26	A	Heart flow reserve measure	1.80	0.70	0.70	0.11	2.61	2.61	ZZZ
93571	TC	A	Heart flow reserve measure	0.00	4.55	NA	0.20	4.75	NA	ZZZ
93572		A	Heart flow reserve measure	1.44	2.78	NA	0.28	4.50	NA	ZZZ
93572	26	A	Heart flow reserve measure	1.44	0.50	0.50	0.17	2.11	2.11	ZZZ
93572	TC	A	Heart flow reserve measure	0.00	2.28	NA	0.11	2.39	NA	ZZZ
93580		A	Transcath closure of asd	18.00	NA	7.34	1.14	NA	26.48	000
93581		A	Transcath closure of vsd	24.43	NA	9.84	1.14	NA	35.41	000
93600		A	Bundle of His recording	2.12	2.79	NA	0.22	5.13	NA	000
93600	26	A	Bundle of His recording	2.12	0.85	0.85	0.11	3.08	3.08	000
93600	TC	A	Bundle of His recording	0.00	1.94	NA	0.11	2.05	NA	000
93602		A	Intra-atrial recording	2.12	1.94	NA	0.18	4.24	NA	000
93602	26	A	Intra-atrial recording	2.12	0.84	0.84	0.12	3.08	3.08	000
93602	TC	A	Intra-atrial recording	0.00	1.10	NA	0.06	1.16	NA	000
93603		A	Right ventricular recording	2.12	2.51	NA	0.20	4.83	NA	000
93603	26	A	Right ventricular recording	2.12	0.84	0.84	0.11	3.07	3.07	000
93603	TC	A	Right ventricular recording	0.00	1.67	NA	0.09	1.76	NA	000
93609		A	Map tachycardia, add-on	5.00	4.71	NA	0.66	10.37	NA	ZZZ
93609	26	A	Map tachycardia, add-on	5.00	2.00	2.00	0.52	7.52	7.52	ZZZ
93609	TC	A	Map tachycardia, add-on	0.00	2.71	NA	0.14	2.85	NA	ZZZ
93610		A	Intra-atrial pacing	3.02	2.52	NA	0.25	5.79	NA	000
93610	26	A	Intra-atrial pacing	3.02	1.18	1.18	0.17	4.37	4.37	000
93610	TC	A	Intra-atrial pacing	0.00	1.34	NA	0.08	1.42	NA	000
93612		A	Intraventricular pacing	3.02	2.79	NA	0.26	6.07	NA	000
93612	26	A	Intraventricular pacing	3.02	1.18	1.18	0.17	4.37	4.37	000
93612	TC	A	Intraventricular pacing	0.00	1.61	NA	0.09	1.70	NA	000
93613		A	Electrophys map 3d, add-on	7.00	2.72	2.72	0.52	10.24	10.24	ZZZ
93615		A	Esophageal recording	0.99	0.59	NA	0.05	1.63	NA	000
93615	26	A	Esophageal recording	0.99	0.27	0.27	0.03	1.29	1.29	000
93615	TC	A	Esophageal recording	0.00	0.32	NA	0.02	0.34	NA	000
93616		A	Esophageal recording	1.49	0.76	NA	0.08	2.33	NA	000
93616	26	A	Esophageal recording	1.49	0.44	0.44	0.06	1.99	1.99	000
93616	TC	A	Esophageal recording	0.00	0.32	NA	0.02	0.34	NA	000
93618		A	Heart rhythm pacing	4.26	5.66	NA	0.42	10.34	NA	000
93618	26	A	Heart rhythm pacing	4.26	1.71	1.71	0.22	6.19	6.19	000
93618	TC	A	Heart rhythm pacing	0.00	3.95	NA	0.20	4.15	NA	000
93619		A	Electrophysiology evaluation	7.32	10.59	NA	0.77	18.68	NA	000
93619	26	A	Electrophysiology evaluation	7.32	2.92	2.92	0.38	10.62	10.62	000
93619	TC	A	Electrophysiology evaluation	0.00	7.67	NA	0.39	8.06	NA	000
93620		C	Electrophysiology evaluation	+0.00	0.00	NA	0.00	0.00	NA	000
93620	26	A	Electrophysiology evaluation	11.59	4.62	4.62	0.60	16.81	16.81	000
93620	TC	C	Electrophysiology evaluation	+0.00	0.00	NA	0.00	0.00	NA	000
93621		C	Electrophysiology evaluation	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
93621	26	A	Electrophysiology evaluation	2.10	0.84	0.84	0.15	3.09	3.09	ZZZ
93621	TC	C	Electrophysiology evaluation	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
93622		C	Electrophysiology evaluation	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
93622	26	A	Electrophysiology evaluation	3.10	1.23	1.23	0.67	5.00	5.00	ZZZ
93622	TC	C	Electrophysiology evaluation	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
93623		C	Stimulation, pacing heart	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
93623	26	A	Stimulation, pacing heart	2.85	1.13	1.13	0.15	4.13	4.13	ZZZ
93623	TC	C	Stimulation, pacing heart	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
93624		A	Electrophysiologic study	4.81	3.88	NA	0.36	9.05	NA	000
93624	26	A	Electrophysiologic study	4.81	1.91	1.91	0.25	6.97	6.97	000
93624	TC	A	Electrophysiologic study	0.00	1.97	NA	0.11	2.08	NA	000
93631		A	Heart pacing, mapping	7.60	8.93	NA	1.17	17.70	NA	000
93631	26	A	Heart pacing, mapping	7.60	2.81	2.81	0.66	11.07	11.07	000
93631	TC	A	Heart pacing, mapping	0.00	6.12	NA	0.51	6.63	NA	000
93640		A	Evaluation heart device	3.52	8.53	NA	0.53	12.58	NA	000
93640	26	A	Evaluation heart device	3.52	1.39	1.39	0.18	5.09	5.09	000
93640	TC	A	Evaluation heart device	0.00	7.14	NA	0.35	7.49	NA	000
93641		A	Electrophysiology evaluation	5.93	9.51	NA	0.66	16.10	NA	000
93641	26	A	Electrophysiology evaluation	5.93	2.37	2.37	0.31	8.61	8.61	000
93641	TC	A	Electrophysiology evaluation	0.00	7.14	NA	0.35	7.49	NA	000
93642		A	Electrophysiology evaluation	4.89	9.07	NA	0.51	14.47	NA	000
93642	26	A	Electrophysiology evaluation	4.89	1.93	1.93	0.16	6.98	6.98	000
93642	TC	A	Electrophysiology evaluation	0.00	7.14	NA	0.35	7.49	NA	000
93650		A	Ablate heart dysrhythm focus	10.51	NA	4.19	0.55	NA	15.25	000
93651		A	Ablate heart dysrhythm focus	16.25	NA	6.49	0.85	NA	23.59	000
93652		A	Ablate heart dysrhythm focus	17.68	NA	7.07	0.92	NA	25.67	000
93660		A	Tilt table evaluation	1.89	2.43	NA	0.08	4.40	NA	000
93660	26	A	Tilt table evaluation	1.89	0.76	0.76	0.06	2.71	2.71	000
93660	TC	A	Tilt table evaluation	0.00	1.67	NA	0.02	1.69	NA	000
93662		C	Intracardiac ecg (ice)	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
93662	26	A	Intracardiac ecg (ice)	2.80	1.08	1.08	0.41	4.29	4.29	ZZZ
93662	TC	C	Intracardiac ecg (ice)	0.00	0.00	NA	0.00	0.00	NA	ZZZ
93668		N	Peripheral vascular rehab	0.00	0.00	0.00	0.00	0.00	0.00	XXX
93701		A	Bioimpedance, thoracic	0.17	1.14	NA	0.02	1.33	NA	XXX
93701	26	A	Bioimpedance, thoracic	0.17	0.07	0.07	0.01	0.25	0.25	XXX
93701	TC	A	Bioimpedance, thoracic	0.00	1.07	NA	0.01	1.08	NA	XXX
93720		A	Total body plethysmography	0.17	0.76	NA	0.06	0.99	NA	XXX
93721		A	Plethysmography tracing	0.00	0.71	NA	0.05	0.76	NA	XXX
93722		A	Plethysmography report	0.17	0.05	0.05	0.01	0.23	0.23	XXX
93724		A	Analyze pacemaker system	4.89	5.91	NA	0.38	11.18	NA	000
93724	26	A	Analyze pacemaker system	4.89	1.96	1.96	0.18	7.03	7.03	000
93724	TC	A	Analyze pacemaker system	0.00	3.95	NA	0.20	4.15	NA	000
93727		A	Analyze ilr system	0.52	0.20	0.20	0.05	0.77	0.77	XXX
93731		A	Analyze pacemaker system	0.45	0.67	NA	0.05	1.17	NA	XXX
93731	26	A	Analyze pacemaker system	0.45	0.18	0.18	0.02	0.65	0.65	XXX
93731	TC	A	Analyze pacemaker system	0.00	0.49	NA	0.03	0.52	NA	XXX
93732		A	Analyze pacemaker system	0.92	0.87	NA	0.06	1.85	NA	XXX
93732	26	A	Analyze pacemaker system	0.92	0.36	0.36	0.03	1.31	1.31	XXX
93732	TC	A	Analyze pacemaker system	0.00	0.51	NA	0.03	0.54	NA	XXX
93733		A	Telephone analy, pacemaker	0.17	0.80	NA	0.06	1.03	NA	XXX
93733	26	A	Telephone analy, pacemaker	0.17	0.07	0.07	0.01	0.25	0.25	XXX
93733	TC	A	Telephone analy, pacemaker	0.00	0.73	NA	0.05	0.78	NA	XXX
93734		A	Analyze pacemaker system	0.38	0.50	NA	0.03	0.91	NA	XXX
93734	26	A	Analyze pacemaker system	0.38	0.15	0.15	0.01	0.54	0.54	XXX
93734	TC	A	Analyze pacemaker system	0.00	0.35	NA	0.02	0.37	NA	XXX
93735		A	Analyze pacemaker system	0.74	0.74	NA	0.06	1.54	NA	XXX
93735	26	A	Analyze pacemaker system	0.74	0.29	0.29	0.03	1.06	1.06	XXX
93735	TC	A	Analyze pacemaker system	0.00	0.45	NA	0.03	0.48	NA	XXX
93736		A	Telephone analy, pacemaker	0.15	0.69	NA	0.06	0.90	NA	XXX
93736	26	A	Telephone analy, pacemaker	0.15	0.06	0.06	0.01	0.22	0.22	XXX
93736	TC	A	Telephone analy, pacemaker	0.00	0.63	NA	0.05	0.68	NA	XXX
93740		B	Temperature gradient studies	+0.16	0.19	NA	0.02	0.37	NA	XXX
93740	26	B	Temperature gradient studies	+0.16	0.04	0.04	0.01	0.21	0.21	XXX
93740	TC	B	Temperature gradient studies	+0.00	0.15	NA	0.01	0.16	NA	XXX
93741		A	Analyze ht pace device sngl	0.80	0.99	NA	0.05	1.84	NA	XXX
93741	26	A	Analyze ht pace device sngl	0.80	0.32	0.32	0.02	1.14	1.14	XXX
93741	TC	A	Analyze ht pace device sngl	0.00	0.67	NA	0.03	0.70	NA	XXX
93742		A	Analyze ht pace device sngl	0.91	1.04	NA	0.05	2.00	NA	XXX
93742	26	A	Analyze ht pace device sngl	0.91	0.37	0.37	0.02	1.30	1.30	XXX
93742	TC	A	Analyze ht pace device sngl	0.00	0.67	NA	0.03	0.70	NA	XXX
93743		A	Analyze ht pace device dual	1.03	1.15	NA	0.06	2.24	NA	XXX
93743	26	A	Analyze ht pace device dual	1.03	0.41	0.41	0.03	1.47	1.47	XXX
93743	TC	A	Analyze ht pace device dual	0.00	0.74	NA	0.03	0.77	NA	XXX
93744		A	Analyze ht pace device dual	1.18	1.14	NA	0.06	2.38	NA	XXX
93744	26	A	Analyze ht pace device dual	1.18	0.47	0.47	0.03	1.68	1.68	XXX
93744	TC	A	Analyze ht pace device dual	0.00	0.67	NA	0.03	0.70	NA	XXX
93760		N	Cephalic thermogram	0.00	0.00	0.00	0.00	0.00	0.00	XXX
93762		N	Peripheral thermogram	0.00	0.00	0.00	0.00	0.00	0.00	XXX
93770		B	Measure venous pressure	+0.16	0.08	NA	0.02	0.26	NA	XXX
93770	26	B	Measure venous pressure	+0.16	0.05	0.05	0.01	0.22	0.22	XXX
93770	TC	B	Measure venous pressure	+0.00	0.03	NA	0.01	0.04	NA	XXX
93784		A	Ambulatory BP monitoring	0.17	0.98	NA	0.02	1.17	NA	XXX
93786		A	Ambulatory BP recording	0.00	0.91	NA	0.01	0.92	NA	XXX
93788		N	Ambulatory BP analysis	0.00	0.00	0.00	0.00	0.00	0.00	XXX
93790		A	Review/report BP recording	0.17	0.07	0.07	0.01	0.25	0.25	XXX
93797		A	Cardiac rehab	0.18	0.39	0.07	0.01	0.58	0.26	000
93798		A	Cardiac rehab/monitor	0.28	0.50	0.11	0.01	0.79	0.40	000
93799		C	Cardiovascular procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
93799	26	C	Cardiovascular procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
93799	TC	C	Cardiovascular procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
93875		A	Extracranial study	0.22	1.65	NA	0.10	1.97	NA	XXX
93875	26	A	Extracranial study	0.22	0.08	0.08	0.01	0.31	0.31	XXX
93875	TC	A	Extracranial study	0.00	1.57	NA	0.09	1.66	NA	XXX
93880		A	Extracranial study	0.60	4.30	NA	0.33	5.23	NA	XXX
93880	26	A	Extracranial study	0.60	0.21	0.21	0.04	0.85	0.85	XXX
93880	TC	A	Extracranial study	0.00	4.09	NA	0.29	4.38	NA	XXX
93882		A	Extracranial study	0.40	2.95	NA	0.22	3.57	NA	XXX
93882	26	A	Extracranial study	0.40	0.14	0.14	0.04	0.58	0.58	XXX
93882	TC	A	Extracranial study	0.00	2.81	NA	0.18	2.99	NA	XXX
93886		A	Intracranial study	0.94	4.73	NA	0.37	6.04	NA	XXX
93886	26	A	Intracranial study	0.94	0.38	0.38	0.05	1.37	1.37	XXX
93886	TC	A	Intracranial study	0.00	4.35	NA	0.32	4.67	NA	XXX
93888		A	Intracranial study	0.62	3.14	NA	0.26	4.02	NA	XXX
93888	26	A	Intracranial study	0.62	0.23	0.23	0.04	0.89	0.89	XXX
93888	TC	A	Intracranial study	0.00	2.91	NA	0.22	3.13	NA	XXX
93922		A	Extremity study	0.25	1.88	NA	0.13	2.26	NA	XXX
93922	26	A	Extremity study	0.25	0.09	0.09	0.02	0.36	0.36	XXX
93922	TC	A	Extremity study	0.00	1.79	NA	0.11	1.90	NA	XXX
93923		A	Extremity study	0.45	2.95	NA	0.22	3.62	NA	XXX
93923	26	A	Extremity study	0.45	0.16	0.16	0.04	0.65	0.65	XXX
93923	TC	A	Extremity study	0.00	2.79	NA	0.18	2.97	NA	XXX
93924		A	Extremity study	0.50	3.67	NA	0.26	4.43	NA	XXX
93924	26	A	Extremity study	0.50	0.17	0.17	0.05	0.72	0.72	XXX
93924	TC	A	Extremity study	0.00	3.50	NA	0.21	3.71	NA	XXX
93925		A	Lower extremity study	0.58	4.95	NA	0.33	5.86	NA	XXX
93925	26	A	Lower extremity study	0.58	0.20	0.20	0.04	0.82	0.82	XXX
93925	TC	A	Lower extremity study	0.00	4.75	NA	0.29	5.04	NA	XXX
93926		A	Lower extremity study	0.39	3.39	NA	0.22	4.00	NA	XXX
93926	26	A	Lower extremity study	0.39	0.13	0.13	0.03	0.55	0.55	XXX
93926	TC	A	Lower extremity study	0.00	3.26	NA	0.19	3.45	NA	XXX
93930		A	Upper extremity study	0.46	3.94	NA	0.34	4.74	NA	XXX
93930	26	A	Upper extremity study	0.46	0.16	0.16	0.03	0.65	0.65	XXX
93930	TC	A	Upper extremity study	0.00	3.78	NA	0.31	4.09	NA	XXX
93931		A	Upper extremity study	0.31	2.83	NA	0.22	3.36	NA	XXX
93931	26	A	Upper extremity study	0.31	0.11	0.11	0.02	0.44	0.44	XXX
93931	TC	A	Upper extremity study	0.00	2.72	NA	0.20	2.92	NA	XXX
93965		A	Extremity study	0.35	1.85	NA	0.12	2.32	NA	XXX
93965	26	A	Extremity study	0.35	0.12	0.12	0.02	0.49	0.49	XXX
93965	TC	A	Extremity study	0.00	1.73	NA	0.10	1.83	NA	XXX
93970		A	Extremity study	0.68	4.05	NA	0.38	5.11	NA	XXX
93970	26	A	Extremity study	0.68	0.24	0.24	0.05	0.97	0.97	XXX
93970	TC	A	Extremity study	0.00	3.81	NA	0.33	4.14	NA	XXX
93971		A	Extremity study	0.45	2.87	NA	0.25	3.57	NA	XXX
93971	26	A	Extremity study	0.45	0.15	0.15	0.03	0.63	0.63	XXX
93971	TC	A	Extremity study	0.00	2.72	NA	0.22	2.94	NA	XXX
93975		A	Vascular study	1.80	5.92	NA	0.47	8.19	NA	XXX
93975	26	A	Vascular study	1.80	0.62	0.62	0.11	2.53	2.53	XXX
93975	TC	A	Vascular study	0.00	5.30	NA	0.36	5.66	NA	XXX
93976		A	Vascular study	1.21	3.49	NA	0.31	5.01	NA	XXX
93976	26	A	Vascular study	1.21	0.41	0.41	0.06	1.68	1.68	XXX
93976	TC	A	Vascular study	0.00	3.08	NA	0.25	3.33	NA	XXX
93978		A	Vascular study	0.65	3.63	NA	0.36	4.64	NA	XXX
93978	26	A	Vascular study	0.65	0.23	0.23	0.05	0.93	0.93	XXX
93978	TC	A	Vascular study	0.00	3.40	NA	0.31	3.71	NA	XXX
93979		A	Vascular study	0.44	2.63	NA	0.24	3.31	NA	XXX
93979	26	A	Vascular study	0.44	0.16	0.16	0.04	0.64	0.64	XXX
93979	TC	A	Vascular study	0.00	2.47	NA	0.20	2.67	NA	XXX
93980		A	Penile vascular study	1.25	4.50	NA	0.35	6.10	NA	XXX
93980	26	A	Penile vascular study	1.25	0.42	0.42	0.07	1.74	1.74	XXX
93980	TC	A	Penile vascular study	0.00	4.08	NA	0.28	4.36	NA	XXX
93981		A	Penile vascular study	0.44	4.82	NA	0.28	5.54	NA	XXX
93981	26	A	Penile vascular study	0.44	0.15	0.15	0.02	0.61	0.61	XXX
93981	TC	A	Penile vascular study	0.00	4.67	NA	0.26	4.93	NA	XXX
93990		A	Doppler flow testing	0.25	3.35	NA	0.21	3.81	NA	XXX
93990	26	A	Doppler flow testing	0.25	0.09	0.09	0.02	0.36	0.36	XXX
93990	TC	A	Doppler flow testing	0.00	3.26	NA	0.19	3.45	NA	XXX
94010		A	Breathing capacity test	0.17	0.88	NA	0.03	1.08	NA	XXX
94010	26	A	Breathing capacity test	0.17	0.05	0.05	0.01	0.23	0.23	XXX
94010	TC	A	Breathing capacity test	0.00	0.83	NA	0.02	0.85	NA	XXX
94014		A	Patient recorded spirometry	0.52	0.46	NA	0.03	1.01	NA	XXX
94015		A	Patient recorded spirometry	0.00	0.29	NA	0.01	0.30	NA	XXX
94016		A	Review patient spirometry	0.52	0.17	0.17	0.02	0.71	0.71	XXX
94060		A	Evaluation of wheezing	0.31	1.52	NA	0.06	1.89	NA	XXX
94060	26	A	Evaluation of wheezing	0.31	0.10	0.10	0.01	0.42	0.42	XXX
94060	TC	A	Evaluation of wheezing	0.00	1.42	NA	0.05	1.47	NA	XXX
94070		A	Evaluation of wheezing	0.60	4.34	NA	0.10	5.04	NA	XXX
94070	26	A	Evaluation of wheezing	0.60	0.19	0.19	0.02	0.81	0.81	XXX
94070	TC	A	Evaluation of wheezing	0.00	4.15	NA	0.08	4.23	NA	XXX
94150		B	Vital capacity test	+0.07	0.66	NA	0.02	0.75	NA	XXX
94150	26	B	Vital capacity test	+0.07	0.03	0.03	0.01	0.11	0.11	XXX
94150	TC	B	Vital capacity test	+0.00	0.63	NA	0.01	0.64	NA	XXX
94200		A	Lung function test (MBC/MVV)	0.11	0.63	NA	0.03	0.77	NA	XXX
94200	26	A	Lung function test (MBC/MVV)	0.11	0.03	0.03	0.01	0.15	0.15	XXX
94200	TC	A	Lung function test (MBC/MVV)	0.00	0.60	NA	0.02	0.62	NA	XXX
94240		A	Residual lung capacity	0.26	1.89	NA	0.05	2.20	NA	XXX
94240	26	A	Residual lung capacity	0.26	0.08	0.08	0.01	0.35	0.35	XXX
94240	TC	A	Residual lung capacity	0.00	1.81	NA	0.04	1.85	NA	XXX
94250		A	Expired gas collection	0.11	0.70	NA	0.02	0.83	NA	XXX
94250	26	A	Expired gas collection	0.11	0.03	0.03	0.01	0.15	0.15	XXX
94250	TC	A	Expired gas collection	0.00	0.67	NA	0.01	0.68	NA	XXX
94260		A	Thoracic gas volume	0.13	0.55	NA	0.04	0.72	NA	XXX
94260	26	A	Thoracic gas volume	0.13	0.04	0.04	0.01	0.18	0.18	XXX
94260	TC	A	Thoracic gas volume	0.00	0.51	NA	0.03	0.54	NA	XXX
94350		A	Lung nitrogen washout curve	0.26	1.96	NA	0.04	2.26	NA	XXX
94350	26	A	Lung nitrogen washout curve	0.26	0.08	0.08	0.01	0.35	0.35	XXX
94350	TC	A	Lung nitrogen washout curve	0.00	1.88	NA	0.03	1.91	NA	XXX
94360		A	Measure airflow resistance	0.26	0.57	NA	0.06	0.89	NA	XXX
94360	26	A	Measure airflow resistance	0.26	0.08	0.08	0.01	0.35	0.35	XXX
94360	TC	A	Measure airflow resistance	0.00	0.49	NA	0.05	0.54	NA	XXX
94370		A	Breath airway closing volume	0.26	1.96	NA	0.03	2.25	NA	XXX
94370	26	A	Breath airway closing volume	0.26	0.08	0.08	0.01	0.35	0.35	XXX
94370	TC	A	Breath airway closing volume	0.00	1.88	NA	0.02	1.90	NA	XXX
94375		A	Respiratory flow volume loop	0.31	0.67	NA	0.03	1.01	NA	XXX
94375	26	A	Respiratory flow volume loop	0.31	0.10	0.10	0.01	0.42	0.42	XXX
94375	TC	A	Respiratory flow volume loop	0.00	0.57	NA	0.02	0.59	NA	XXX
94400		A	CO2 breathing response curve	0.40	0.89	NA	0.06	1.35	NA	XXX
94400	26	A	CO2 breathing response curve	0.40	0.13	0.13	0.01	0.54	0.54	XXX
94400	TC	A	CO2 breathing response curve	0.00	0.76	NA	0.05	0.81	NA	XXX
94450		A	Hypoxia response curve	0.40	0.68	NA	0.04	1.12	NA	XXX
94450	26	A	Hypoxia response curve	0.40	0.12	0.12	0.02	0.54	0.54	XXX
94450	TC	A	Hypoxia response curve	0.00	0.56	NA	0.02	0.58	NA	XXX
94620		A	Pulmonary stress test/simple	0.64	2.47	NA	0.10	3.21	NA	XXX
94620	26	A	Pulmonary stress test/simple	0.64	0.20	0.20	0.02	0.86	0.86	XXX
94620	TC	A	Pulmonary stress test/simple	0.00	2.27	NA	0.08	2.35	NA	XXX
94621		A	Pulm stress test/complex	1.42	2.12	NA	0.13	3.67	NA	XXX
94621	26	A	Pulm stress test/complex	1.42	0.45	0.45	0.05	1.92	1.92	XXX
94621	TC	A	Pulm stress test/complex	0.00	1.67	NA	0.08	1.75	NA	XXX
94640		A	Airway inhalation treatment	0.00	0.70	NA	0.02	0.72	NA	XXX
94642		C	Aerosol inhalation treatment	0.00	0.00	0.00	0.00	0.00	0.00	XXX
94650		D	Pressure breathing (IPPB)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
94651		D	Pressure breathing (IPPB)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
94652		D	Pressure breathing (IPPB)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
94656		A	Initial ventilator mgmt	1.22	NA	0.32	0.06	NA	1.60	XXX
94657		A	Continued ventilator mgmt	0.83	NA	0.26	0.03	NA	1.12	XXX
94660		A	Pos airway pressure, CPAP	0.76	0.68	0.24	0.03	1.47	1.03	XXX
94662		A	Neg press ventilation, cnp	0.76	NA	0.24	0.02	NA	1.02	XXX
94664		A	Evaluate pt use of inhaler	0.00	0.52	NA	0.03	0.55	NA	XXX
94665		D	Aerosol or vapor inhalations	0.00	0.00	0.00	0.00	0.00	0.00	XXX
94667		A	Chest wall manipulation	0.00	0.81	NA	0.04	0.85	NA	XXX
94668		A	Chest wall manipulation	0.00	0.71	NA	0.02	0.73	NA	XXX
94680		A	Exhaled air analysis, o2	0.26	1.91	NA	0.06	2.23	NA	XXX
94680	26	A	Exhaled air analysis, o2	0.26	0.09	0.09	0.01	0.36	0.36	XXX
94680	TC	A	Exhaled air analysis, o2	0.00	1.82	NA	0.05	1.87	NA	XXX
94681		A	Exhaled air analysis, o2/co2	0.20	2.80	NA	0.11	3.11	NA	XXX
94681	26	A	Exhaled air analysis, o2/co2	0.20	0.07	0.07	0.01	0.28	0.28	XXX
94681	TC	A	Exhaled air analysis, o2/co2	0.00	2.73	NA	0.10	2.83	NA	XXX
94690		A	Exhaled air analysis	0.07	2.13	NA	0.04	2.24	NA	XXX
94690	26	A	Exhaled air analysis	0.07	0.02	0.02	0.01	0.10	0.10	XXX
94690	TC	A	Exhaled air analysis	0.00	2.11	NA	0.03	2.14	NA	XXX
94720		A	Monoxide diffusing capacity	0.26	1.55	NA	0.06	1.87	NA	XXX
94720	26	A	Monoxide diffusing capacity	0.26	0.08	0.08	0.01	0.35	0.35	XXX
94720	TC	A	Monoxide diffusing capacity	0.00	1.47	NA	0.05	1.52	NA	XXX
94725		A	Membrane diffusion capacity	0.26	2.56	NA	0.11	2.93	NA	XXX
94725	26	A	Membrane diffusion capacity	0.26	0.08	0.08	0.01	0.35	0.35	XXX
94725	TC	A	Membrane diffusion capacity	0.00	2.48	NA	0.10	2.58	NA	XXX
94750		A	Pulmonary compliance study	0.23	2.07	NA	0.04	2.34	NA	XXX
94750	26	A	Pulmonary compliance study	0.23	0.07	0.07	0.01	0.31	0.31	XXX
94750	TC	A	Pulmonary compliance study	0.00	2.00	NA	0.03	2.03	NA	XXX
94760		T	Measure blood oxygen level	0.00	0.09	NA	0.02	0.11	NA	XXX
94761		T	Measure blood oxygen level	0.00	0.17	NA	0.05	0.22	NA	XXX
94762		A	Measure blood oxygen level	0.00	0.74	NA	0.08	0.82	NA	XXX
94770		A	Exhaled carbon dioxide test	0.15	1.68	NA	0.07	1.90	NA	XXX
94770	26	A	Exhaled carbon dioxide test	0.15	0.04	0.04	0.01	0.20	0.20	XXX
94770	TC	A	Exhaled carbon dioxide test	0.00	1.64	NA	0.06	1.70	NA	XXX
94772		C	Breath recording, infant	0.00	0.00	0.00	0.00	0.00	0.00	XXX
94772	26	C	Breath recording, infant	0.00	0.00	0.00	0.00	0.00	0.00	XXX
94772	TC	C	Breath recording, infant	0.00	0.00	0.00	0.00	0.00	0.00	XXX
94799		C	Pulmonary service/procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
94799	26	C	Pulmonary service/procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
94799	TC	C	Pulmonary service/procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95004		A	Percut allergy skin tests	0.00	0.10	NA	0.01	0.11	NA	XXX
95010		A	Percut allergy titrate test	0.15	0.44	0.06	0.01	0.60	0.22	XXX
95015		A	Id allergy titrate-drug/bug	0.15	0.38	0.06	0.01	0.54	0.22	XXX
95024		A	Id allergy test, drug/bug	0.00	0.15	NA	0.01	0.16	NA	XXX
95027		A	Id allergy titrate-airborne	0.00	0.15	NA	0.01	0.16	NA	XXX
95028		A	Id allergy test-delayed type	0.00	0.23	NA	0.01	0.24	NA	XXX
95044		A	Allergy patch tests	0.00	0.20	NA	0.01	0.21	NA	XXX
95052		A	Photo patch test	0.00	0.25	NA	0.01	0.26	NA	XXX
95056		A	Photosensitivity tests	0.00	0.17	NA	0.01	0.18	NA	XXX
95060		A	Eye allergy tests	0.00	0.35	NA	0.02	0.37	NA	XXX
95065		A	Nose allergy test	0.00	0.20	NA	0.01	0.21	NA	XXX
95070		A	Bronchial allergy tests	0.00	2.27	NA	0.02	2.29	NA	XXX
95071		A	Bronchial allergy tests	0.00	2.91	NA	0.02	2.93	NA	XXX
95075		A	Ingestion challenge test	0.95	0.84	0.40	0.03	1.82	1.38	XXX
95078		A	Provocative testing	0.00	0.25	NA	0.02	0.27	NA	XXX
95115		A	Immunotherapy, one injection	0.00	0.39	NA	0.02	0.41	NA	000
95117		A	Immunotherapy injections	0.00	0.50	NA	0.02	0.52	NA	000
95120		I	Immunotherapy, one injection	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95125		I	Immunotherapy, many antigens	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95130		I	Immunotherapy, insect venom	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95131		I	Immunotherapy, insect venoms	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95132		I	Immunotherapy, insect venoms	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95133		I	Immunotherapy, insect venoms	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95134		I	Immunotherapy, insect venoms	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95144		A	Antigen therapy services	0.06	0.25	0.02	0.01	0.32	0.09	000
95145		A	Antigen therapy services	0.06	0.49	0.02	0.01	0.56	0.09	000
95146		A	Antigen therapy services	0.06	0.61	0.03	0.01	0.68	0.10	000
95147		A	Antigen therapy services	0.06	0.83	0.02	0.01	0.90	0.09	000
95148		A	Antigen therapy services	0.06	0.81	0.03	0.01	0.88	0.10	000
95149		A	Antigen therapy services	0.06	1.02	0.03	0.01	1.09	0.10	000
95165		A	Antigen therapy services	0.06	0.20	0.02	0.01	0.27	0.09	000
95170		A	Antigen therapy services	0.06	0.26	0.02	0.01	0.33	0.09	000
95180		A	Rapid desensitization	2.01	1.60	0.84	0.04	3.65	2.89	000
95199		C	Allergy immunology services	0.00	0.00	0.00	0.00	0.00	0.00	000
95250		A	Glucose monitoring, cont	0.00	3.22	NA	0.01	3.23	NA	XXX
95805		A	Multiple sleep latency test	1.88	17.11	NA	0.34	19.33	NA	XXX
95805	26	A	Multiple sleep latency test	1.88	0.68	0.68	0.06	2.62	2.62	XXX
95805	TC	A	Multiple sleep latency test	0.00	16.43	NA	0.28	16.71	NA	XXX
95806		A	Sleep study, unattended	1.66	4.10	NA	0.32	6.08	NA	XXX
95806	26	A	Sleep study, unattended	1.66	0.55	0.55	0.06	2.27	2.27	XXX
95806	TC	A	Sleep study, unattended	0.00	3.55	NA	0.26	3.81	NA	XXX
95807		A	Sleep study, attended	1.66	12.00	NA	0.40	14.06	NA	XXX
95807	26	A	Sleep study, attended	1.66	0.54	0.54	0.05	2.25	2.25	XXX
95807	TC	A	Sleep study, attended	0.00	11.46	NA	0.35	11.81	NA	XXX
95808		A	Polysomnography, 1-3	2.65	13.10	NA	0.44	16.19	NA	XXX
95808	26	A	Polysomnography, 1-3	2.65	0.95	0.95	0.09	3.69	3.69	XXX
95808	TC	A	Polysomnography, 1-3	0.00	12.15	NA	0.35	12.50	NA	XXX
95810		A	Polysomnography, 4 or more	3.53	17.29	NA	0.47	21.29	NA	XXX
95810	26	A	Polysomnography, 4 or more	3.53	1.21	1.21	0.12	4.86	4.86	XXX
95810	TC	A	Polysomnography, 4 or more	0.00	16.08	NA	0.35	16.43	NA	XXX
95811		A	Polysomnography w/cpap	3.80	17.67	NA	0.49	21.96	NA	XXX
95811	26	A	Polysomnography w/cpap	3.80	1.30	1.30	0.13	5.23	5.23	XXX
95811	TC	A	Polysomnography w/cpap	0.00	16.37	NA	0.36	16.73	NA	XXX
95812		A	Eeg, 41-60 minutes	1.08	4.72	NA	0.13	5.93	NA	XXX
95812	26	A	Eeg, 41-60 minutes	1.08	0.46	0.46	0.04	1.58	1.58	XXX
95812	TC	A	Eeg, 41-60 minutes	0.00	4.26	NA	0.09	4.35	NA	XXX
95813		A	Eeg, over 1 hour	1.73	5.80	NA	0.15	7.68	NA	XXX
95813	26	A	Eeg, over 1 hour	1.73	0.72	0.72	0.06	2.51	2.51	XXX
95813	TC	A	Eeg, over 1 hour	0.00	5.08	NA	0.09	5.17	NA	XXX
95816		A	Eeg, awake and drowsy	1.08	3.67	NA	0.12	4.87	NA	XXX
95816	26	A	Eeg, awake and drowsy	1.08	0.47	0.47	0.04	1.59	1.59	XXX
95816	TC	A	Eeg, awake and drowsy	0.00	3.20	NA	0.08	3.28	NA	XXX
95819		A	Eeg, awake and asleep	1.08	4.31	NA	0.12	5.51	NA	XXX
95819	26	A	Eeg, awake and asleep	1.08	0.47	0.47	0.04	1.59	1.59	XXX
95819	TC	A	Eeg, awake and asleep	0.00	3.84	NA	0.08	3.92	NA	XXX
95822		A	Eeg, coma or sleep only	1.08	5.11	NA	0.15	6.34	NA	XXX
95822	26	A	Eeg, coma or sleep only	1.08	0.47	0.47	0.04	1.59	1.59	XXX
95822	TC	A	Eeg, coma or sleep only	0.00	4.64	NA	0.11	4.75	NA	XXX
95824		C	Eeg, cerebral death only	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95824	26	A	Eeg, cerebral death only	0.74	0.32	0.32	0.05	1.11	1.11	XXX
95824	TC	C	Eeg, cerebral death only	0.00	0.00	NA	0.00	0.00	NA	XXX
95827		A	Eeg, all night recording	1.08	2.70	NA	0.15	3.93	NA	XXX
95827	26	A	Eeg, all night recording	1.08	0.42	0.42	0.03	1.53	1.53	XXX
95827	TC	A	Eeg, all night recording	0.00	2.28	NA	0.12	2.40	NA	XXX
95829		A	Surgery electrocorticogram	6.21	40.12	NA	0.33	46.66	NA	XXX
95829	26	A	Surgery electrocorticogram	6.21	2.38	2.38	0.31	8.90	8.90	XXX
95829	TC	A	Surgery electrocorticogram	0.00	37.74	NA	0.02	37.76	NA	XXX
95830		A	Insert electrodes for EEG	1.70	3.55	0.75	0.07	5.32	2.52	XXX
95831		A	Limb muscle testing, manual	0.28	0.53	0.13	0.01	0.82	0.42	XXX
95832		A	Hand muscle testing, manual	0.29	0.45	0.12	0.01	0.75	0.42	XXX
95833		A	Body muscle testing, manual	0.47	0.61	0.23	0.01	1.09	0.71	XXX
95834		A	Body muscle testing, manual	0.60	0.58	0.28	0.02	1.20	0.90	XXX
95851		A	Range of motion measurements	0.16	0.57	0.08	0.01	0.74	0.25	XXX
95852		A	Range of motion measurements	0.11	0.47	0.05	0.01	0.59	0.17	XXX
95857		A	Tensilon test	0.53	0.65	0.23	0.02	1.20	0.78	XXX
95858		A	Tensilon test & myogram	1.56	1.09	NA	0.07	2.72	NA	XXX
95858	26	A	Tensilon test & myogram	1.56	0.69	0.69	0.04	2.29	2.29	XXX
95858	TC	A	Tensilon test & myogram	0.00	0.40	NA	0.03	0.43	NA	XXX
95860		A	Muscle test, one limb	0.96	1.62	NA	0.05	2.63	NA	XXX
95860	26	A	Muscle test, one limb	0.96	0.43	0.43	0.03	1.42	1.42	XXX
95860	TC	A	Muscle test, one limb	0.00	1.19	NA	0.02	1.21	NA	XXX
95861		A	Muscle test, 2 limbs	1.54	1.44	NA	0.10	3.08	NA	XXX
95861	26	A	Muscle test, 2 limbs	1.54	0.70	0.70	0.05	2.29	2.29	XXX
95861	TC	A	Muscle test, 2 limbs	0.00	0.74	NA	0.05	0.79	NA	XXX
95863		A	Muscle test, 3 limbs	1.87	1.77	NA	0.11	3.75	NA	XXX
95863	26	A	Muscle test, 3 limbs	1.87	0.83	0.83	0.06	2.76	2.76	XXX
95863	TC	A	Muscle test, 3 limbs	0.00	0.94	NA	0.05	0.99	NA	XXX
95864		A	Muscle test, 4 limbs	1.99	2.66	NA	0.16	4.81	NA	XXX
95864	26	A	Muscle test, 4 limbs	1.99	0.89	0.89	0.06	2.94	2.94	XXX
95864	TC	A	Muscle test, 4 limbs	0.00	1.77	NA	0.10	1.87	NA	XXX
95867		A	Muscle test cran nerv unilat	0.79	0.94	NA	0.06	1.79	NA	XXX
95867	26	A	Muscle test cran nerv unilat	0.79	0.36	0.36	0.03	1.18	1.18	XXX
95867	TC	A	Muscle test cran nerv unilat	0.00	0.58	NA	0.03	0.61	NA	XXX
95868		A	Muscle test cran nerve bilat	1.18	1.23	NA	0.08	2.49	NA	XXX
95868	26	A	Muscle test cran nerve bilat	1.18	0.53	0.53	0.04	1.75	1.75	XXX
95868	TC	A	Muscle test cran nerve bilat	0.00	0.70	NA	0.04	0.74	NA	XXX
95869		A	Muscle test, thor paraspinal	0.37	0.38	NA	0.03	0.78	NA	XXX
95869	26	A	Muscle test, thor paraspinal	0.37	0.17	0.17	0.01	0.55	0.55	XXX
95869	TC	A	Muscle test, thor paraspinal	0.00	0.21	NA	0.02	0.23	NA	XXX
95870		A	Muscle test, nonparaspinal	0.37	0.37	NA	0.03	0.77	NA	XXX
95870	26	A	Muscle test, nonparaspinal	0.37	0.16	0.16	0.01	0.54	0.54	XXX
95870	TC	A	Muscle test, nonparaspinal	0.00	0.21	NA	0.02	0.23	NA	XXX
95872		A	Muscle test, one fiber	1.50	1.25	NA	0.08	2.83	NA	XXX
95872	26	A	Muscle test, one fiber	1.50	0.65	0.65	0.04	2.19	2.19	XXX
95872	TC	A	Muscle test, one fiber	0.00	0.60	NA	0.04	0.64	NA	XXX
95875		A	Limb exercise test	1.10	1.72	NA	0.09	2.91	NA	XXX
95875	26	A	Limb exercise test	1.10	0.48	0.48	0.04	1.62	1.62	XXX
95875	TC	A	Limb exercise test	0.00	1.24	NA	0.05	1.29	NA	XXX
95900		A	Motor nerve conduction test	0.42	1.12	NA	0.03	1.57	NA	XXX
95900	26	A	Motor nerve conduction test	0.42	0.19	0.19	0.01	0.62	0.62	XXX
95900	TC	A	Motor nerve conduction test	0.00	0.93	NA	0.02	0.95	NA	XXX
95903		A	Motor nerve conduction test	0.60	1.07	NA	0.04	1.71	NA	XXX
95903	26	A	Motor nerve conduction test	0.60	0.27	0.27	0.02	0.89	0.89	XXX
95903	TC	A	Motor nerve conduction test	0.00	0.80	NA	0.02	0.82	NA	XXX
95904		A	Sense nerve conduction test	0.34	0.95	NA	0.03	1.32	NA	XXX
95904	26	A	Sense nerve conduction test	0.34	0.15	0.15	0.01	0.50	0.50	XXX
95904	TC	A	Sense nerve conduction test	0.00	0.80	NA	0.02	0.82	NA	XXX
95920		A	Intraop nerve test add-on	2.11	2.26	NA	0.20	4.57	NA	ZZZ
95920	26	A	Intraop nerve test add-on	2.11	0.96	0.96	0.14	3.21	3.21	ZZZ
95920	TC	A	Intraop nerve test add-on	0.00	1.30	NA	0.06	1.36	NA	ZZZ
95921		A	Autonomic nerv function test	0.90	0.72	NA	0.05	1.67	NA	XXX
95921	26	A	Autonomic nerv function test	0.90	0.34	0.34	0.03	1.27	1.27	XXX
95921	TC	A	Autonomic nerv function test	0.00	0.38	NA	0.02	0.40	NA	XXX
95922		A	Autonomic nerv function test	0.96	0.79	NA	0.05	1.80	NA	XXX
95922	26	A	Autonomic nerv function test	0.96	0.41	0.41	0.03	1.40	1.40	XXX
95922	TC	A	Autonomic nerv function test	0.00	0.38	NA	0.02	0.40	NA	XXX
95923		A	Autonomic nerv function test	0.90	2.92	NA	0.05	3.87	NA	XXX
95923	26	A	Autonomic nerv function test	0.90	0.39	0.39	0.03	1.32	1.32	XXX
95923	TC	A	Autonomic nerv function test	0.00	2.53	NA	0.02	2.55	NA	XXX
95925		A	Somatosensory testing	0.54	1.14	NA	0.07	1.75	NA	XXX
95925	26	A	Somatosensory testing	0.54	0.23	0.23	0.02	0.79	0.79	XXX
95925	TC	A	Somatosensory testing	0.00	0.91	NA	0.05	0.96	NA	XXX
95926		A	Somatosensory testing	0.54	1.15	NA	0.07	1.76	NA	XXX
95926	26	A	Somatosensory testing	0.54	0.24	0.24	0.02	0.80	0.80	XXX
95926	TC	A	Somatosensory testing	0.00	0.91	NA	0.05	0.96	NA	XXX
95927		A	Somatosensory testing	0.54	1.17	NA	0.08	1.79	NA	XXX
95927	26	A	Somatosensory testing	0.54	0.26	0.26	0.03	0.83	0.83	XXX
95927	TC	A	Somatosensory testing	0.00	0.91	NA	0.05	0.96	NA	XXX
95930		A	Visual evoked potential test	0.35	1.18	NA	0.02	1.55	NA	XXX
95930	26	A	Visual evoked potential test	0.35	0.15	0.15	0.01	0.51	0.51	XXX
95930	TC	A	Visual evoked potential test	0.00	1.03	NA	0.01	1.04	NA	XXX
95933		A	Blink reflex test	0.59	1.03	NA	0.07	1.69	NA	XXX
95933	26	A	Blink reflex test	0.59	0.25	0.25	0.02	0.86	0.86	XXX
95933	TC	A	Blink reflex test	0.00	0.78	NA	0.05	0.83	NA	XXX
95934		A	H-reflex test	0.51	0.44	NA	0.04	0.99	NA	XXX
95934	26	A	H-reflex test	0.51	0.23	0.23	0.02	0.76	0.76	XXX
95934	TC	A	H-reflex test	0.00	0.21	NA	0.02	0.23	NA	XXX
95936		A	H-reflex test	0.55	0.46	NA	0.04	1.05	NA	XXX
95936	26	A	H-reflex test	0.55	0.25	0.25	0.02	0.82	0.82	XXX
95936	TC	A	H-reflex test	0.00	0.21	NA	0.02	0.23	NA	XXX
95937		A	Neuromuscular junction test	0.65	0.61	NA	0.04	1.30	NA	XXX
95937	26	A	Neuromuscular junction test	0.65	0.27	0.27	0.02	0.94	0.94	XXX
95937	TC	A	Neuromuscular junction test	0.00	0.34	NA	0.02	0.36	NA	XXX
95950		A	Ambulatory eeg monitoring	1.51	6.79	NA	0.44	8.74	NA	XXX
95950	26	A	Ambulatory eeg monitoring	1.51	0.65	0.65	0.08	2.24	2.24	XXX
95950	TC	A	Ambulatory eeg monitoring	0.00	6.14	NA	0.36	6.50	NA	XXX
95951		A	EEG monitoring/videorecord	6.00	2.63	NA	0.58	9.21	NA	XXX
95951	26	A	EEG monitoring/videorecord	6.00	2.62	2.62	0.20	8.82	8.82	XXX
95951	TC	A	EEG monitoring/videorecord	0.00	0.01	NA	0.38	0.39	NA	XXX
95953		A	EEG monitoring/computer	3.08	7.63	NA	0.46	11.17	NA	XXX
95953	26	A	EEG monitoring/computer	3.08	1.32	1.32	0.10	4.50	4.50	XXX
95953	TC	A	EEG monitoring/computer	0.00	6.31	NA	0.36	6.67	NA	XXX
95954		A	EEG monitoring/giving drugs	2.45	5.04	NA	0.15	7.64	NA	XXX
95954	26	A	EEG monitoring/giving drugs	2.45	1.06	1.06	0.10	3.61	3.61	XXX
95954	TC	A	EEG monitoring/giving drugs	0.00	3.98	NA	0.05	4.03	NA	XXX
95955		A	EEG during surgery	1.01	2.32	NA	0.19	3.52	NA	XXX
95955	26	A	EEG during surgery	1.01	0.37	0.37	0.05	1.43	1.43	XXX
95955	TC	A	EEG during surgery	0.00	1.95	NA	0.14	2.09	NA	XXX
95956		A	Eeg monitoring, cable/radio	3.08	15.69	NA	0.47	19.24	NA	XXX
95956	26	A	Eeg monitoring, cable/radio	3.08	1.33	1.33	0.11	4.52	4.52	XXX
95956	TC	A	Eeg monitoring, cable/radio	0.00	14.36	NA	0.36	14.72	NA	XXX
95957		A	EEG digital analysis	1.98	2.56	NA	0.17	4.71	NA	XXX
95957	26	A	EEG digital analysis	1.98	0.87	0.87	0.07	2.92	2.92	XXX
95957	TC	A	EEG digital analysis	0.00	1.69	NA	0.10	1.79	NA	XXX
95958		A	EEG monitoring/function test	4.25	3.51	NA	0.29	8.05	NA	XXX
95958	26	A	EEG monitoring/function test	4.25	1.78	1.78	0.18	6.21	6.21	XXX
95958	TC	A	EEG monitoring/function test	0.00	1.73	NA	0.11	1.84	NA	XXX
95961		A	Electrode stimulation, brain	2.97	2.65	NA	0.24	5.86	NA	XXX
95961	26	A	Electrode stimulation, brain	2.97	1.35	1.35	0.18	4.50	4.50	XXX
95961	TC	A	Electrode stimulation, brain	0.00	1.30	NA	0.06	1.36	NA	XXX
95962		A	Electrode stim, brain add-on	3.21	2.72	NA	0.23	6.16	NA	ZZZ
95962	26	A	Electrode stim, brain add-on	3.21	1.42	1.42	0.17	4.80	4.80	ZZZ
95962	TC	A	Electrode stim, brain add-on	0.00	1.30	NA	0.06	1.36	NA	ZZZ
95965		C	Meg, spontaneous	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95965	26	A	Meg, spontaneous	8.00	3.11	3.11	0.31	11.42	11.42	XXX
95965	TC	C	Meg, spontaneous	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95966		C	Meg, evoked, single	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95966	26	A	Meg, evoked, single	4.00	1.55	1.55	0.15	5.70	5.70	XXX
95966	TC	C	Meg, evoked, single	0.00	0.00	0.00	0.00	0.00	0.00	XXX
95967		C	Meg, evoked, each addl	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
95967	26	A	Meg, evoked, each addl	3.50	1.36	1.36	0.13	4.99	4.99	ZZZ
95967	TC	C	Meg, evoked, each addl	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
95970		A	Analyze neurostim, no prog	0.45	0.17	0.15	0.03	0.65	0.63	XXX
95971		A	Analyze neurostim, simple	0.78	0.28	0.23	0.06	1.12	1.07	XXX
95972		A	Analyze neurostim, complex	1.50	0.61	0.51	0.17	2.28	2.18	XXX
95973		A	Analyze neurostim, complex	0.92	0.41	0.35	0.07	1.40	1.34	ZZZ
95974		A	Cranial neurostim, complex	3.00	1.32	1.32	0.15	4.47	4.47	XXX
95975		A	Cranial neurostim, complex	1.70	0.75	0.75	0.07	2.52	2.52	ZZZ
95990		A	Spin/brain pump refil & main	0.00	1.49	NA	0.05	1.54	NA	XXX
95999		C	Neurological procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
96000		A	Motion analysis, video/3d	1.80	NA	0.70	0.02	NA	2.52	XXX
96001		A	Motion test w/ft press meas	2.15	NA	0.84	0.02	NA	3.01	XXX
96002		A	Dynamic surface emg	0.41	NA	0.16	0.02	NA	0.59	XXX
96003		A	Dynamic fine wire emg	0.37	NA	0.14	0.03	NA	0.54	XXX
96004		A	Phys review of motion tests	2.14	0.84	0.84	0.08	3.06	3.06	XXX
96100		A	Psychological testing	0.00	1.75	NA	0.15	1.90	NA	XXX
96105		A	Assessment of aphasia	0.00	1.75	NA	0.15	1.90	NA	XXX
96110		C	Developmental test, lim	0.00	0.00	0.00	0.00	0.00	0.00	XXX
96111		A	Developmental test, extend	0.00	1.75	NA	0.15	1.90	NA	XXX
96115		A	Neurobehavior status exam	0.00	1.75	NA	0.15	1.90	NA	XXX
96117		A	Neuropsych test battery	0.00	1.75	NA	0.15	1.90	NA	XXX
96150		A	Assess lth/behave, init	0.50	0.21	0.20	0.02	0.73	0.72	XXX
96151		A	Assess hlth/behave, subseq	0.48	0.20	0.19	0.02	0.70	0.69	XXX
96152		A	Intervene hlth/behave, indiv	0.46	0.19	0.18	0.02	0.67	0.66	XXX
96153		A	Intervene hlth/behave, group	0.10	0.04	0.04	0.01	0.15	0.15	XXX
96154		A	Interv hlth/behav, fam w/pt	0.45	0.19	0.18	0.02	0.66	0.65	XXX
96155		A	Interv hlth/behav fam no pt	0.44	0.18	0.17	0.02	0.64	0.63	XXX
96400		A	Chemotherapy, sc/im	0.00	1.01	NA	0.01	1.02	NA	XXX
96405		A	Intralesional chemo admin	0.52	1.68	0.23	0.02	2.22	0.77	000
96406		A	Intralesional chemo admin	0.80	2.54	0.30	0.02	3.36	1.12	000
96408		A	Chemotherapy, push technique	0.00	0.97	NA	0.05	1.02	NA	XXX
96410		A	Chemotherapy,infusion method	0.00	1.54	NA	0.07	1.61	NA	XXX
96412		A	Chemo, infuse method add-on	0.00	1.14	NA	0.06	1.20	NA	ZZZ
96414		A	Chemo, infuse method add-on	0.00	1.33	NA	0.07	1.40	NA	XXX
96420		A	Chemotherapy, push technique	0.00	1.24	NA	0.07	1.31	NA	XXX
96422		A	Chemotherapy,infusion method	0.00	1.22	NA	0.07	1.29	NA	XXX
96423		A	Chemo, infuse method add-on	0.00	0.48	NA	0.02	0.50	NA	ZZZ
96425		A	Chemotherapy,infusion method	0.00	1.42	NA	0.07	1.49	NA	XXX
96440		A	Chemotherapy, intracavitary	2.37	7.92	1.04	0.12	10.41	3.53	000
96445		A	Chemotherapy, intracavitary	2.20	7.97	1.02	0.07	10.24	3.29	000
96450		A	Chemotherapy, into CNS	1.89	6.30	0.93	0.06	8.25	2.88	000
96520		A	Port pump refill & main	0.00	0.89	NA	0.05	0.94	NA	XXX
96530		A	Syst pump refill & main	0.00	1.05	NA	0.05	1.10	NA	XXX
96542		A	Chemotherapy injection	1.42	3.99	0.55	0.05	5.46	2.02	XXX
96545		B	Provide chemotherapy agent	0.00	0.00	0.00	0.00	0.00	0.00	XXX
96549		C	Chemotherapy, unspecified	0.00	0.00	0.00	0.00	0.00	0.00	XXX
96567		A	Photodynamic tx, skin	0.00	5.10	NA	0.03	5.13	NA	XXX
96570		A	Photodynamic tx, 30 min	1.10	0.38	0.37	0.04	1.52	1.51	ZZZ
96571		A	Photodynamic tx, addl 15 min	0.55	0.21	0.20	0.02	0.78	0.77	ZZZ
96900		A	Ultraviolet light therapy	0.00	0.49	NA	0.02	0.51	NA	XXX
96902		B	Trichogram	+0.41	0.25	0.16	0.01	0.67	0.58	XXX
96910		A	Photochemotherapy with UV-B	0.00	1.57	NA	0.03	1.60	NA	XXX
96912		A	Photochemotherapy with UV-A	0.00	1.80	NA	0.04	1.84	NA	XXX
96913		A	Photochemotherapy, UV-A or B	0.00	2.71	NA	0.08	2.79	NA	XXX
96920		A	Laser tx, skin < 250 sq cm	1.15	2.88	0.45	0.09	4.12	1.69	000
96921		A	Laser tx, skin 250-500 sq cm	1.17	2.96	0.46	0.09	4.22	1.72	000
96922		A	Laser tx, skin > 500 sq cm	2.10	3.56	0.82	0.16	5.82	3.08	000
96999		C	Dermatological procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
97001		A	Pt evaluation	1.20	0.74	0.46	0.05	1.99	1.71	XXX
97002		A	Pt re-evaluation	0.60	0.45	0.24	0.02	1.07	0.86	XXX
97003		A	Ot evaluation	1.20	0.87	0.41	0.05	2.12	1.66	XXX
97004		A	Ot re-evaluation	0.60	0.68	0.20	0.02	1.30	0.82	XXX
97005		I	Athletic train eval	0.00	0.00	0.00	0.00	0.00	0.00	XXX
97006		I	Athletic train reeval	0.00	0.00	0.00	0.00	0.00	0.00	XXX
97010		B	Hot or cold packs therapy	+0.06	0.05	NA	0.01	0.12	NA	XXX
97012		A	Mechanical traction therapy	0.25	0.14	NA	0.01	0.40	NA	XXX
97014		I	Electric stimulation therapy	+0.18	0.19	0.19	0.01	0.38	0.38	XXX
97016		A	Vasopneumatic device therapy	0.18	0.19	NA	0.01	0.38	NA	XXX
97018		A	Paraffin bath therapy	0.06	0.11	NA	0.01	0.18	NA	XXX
97020		A	Microwave therapy	0.06	0.06	NA	0.01	0.13	NA	XXX
97022		A	Whirlpool therapy	0.17	0.22	NA	0.01	0.40	NA	XXX
97024		A	Diathermy treatment	0.06	0.06	NA	0.01	0.13	NA	XXX
97026		A	Infrared therapy	0.06	0.06	NA	0.01	0.13	NA	XXX
97028		A	Ultraviolet therapy	0.08	0.07	NA	0.01	0.16	NA	XXX
97032		A	Electrical stimulation	0.25	0.18	NA	0.01	0.44	NA	XXX
97033		A	Electric current therapy	0.26	0.27	NA	0.02	0.55	NA	XXX
97034		A	Contrast bath therapy	0.21	0.16	NA	0.01	0.38	NA	XXX
97035		A	Ultrasound therapy	0.21	0.11	NA	0.01	0.33	NA	XXX
97036		A	Hydrotherapy	0.28	0.33	NA	0.01	0.62	NA	XXX
97039		A	Physical therapy treatment	0.20	0.11	NA	0.01	0.32	NA	XXX
97110		A	Therapeutic exercises	0.45	0.28	NA	0.03	0.76	NA	XXX
97112		A	Neuromuscular reeducation	0.45	0.31	NA	0.02	0.78	NA	XXX
97113		A	Aquatic therapy/exercises	0.44	0.34	NA	0.03	0.81	NA	XXX
97116		A	Gait training therapy	0.40	0.25	NA	0.02	0.67	NA	XXX
97124		A	Massage therapy	0.35	0.24	NA	0.01	0.60	NA	XXX
97139		A	Physical medicine procedure	0.21	0.21	NA	0.01	0.43	NA	XXX
97140		A	Manual therapy	0.43	0.27	NA	0.02	0.72	NA	XXX
97150		A	Group therapeutic procedures	0.27	0.21	NA	0.02	0.50	NA	XXX
97504		A	Orthotic training	0.45	0.29	NA	0.03	0.77	NA	XXX
97520		A	Prosthetic training	0.45	0.28	NA	0.02	0.75	NA	XXX
97530		A	Therapeutic activities	0.44	0.31	NA	0.02	0.77	NA	XXX
97532		A	Cognitive skills development	0.44	0.20	NA	0.01	0.65	NA	XXX
97533		A	Sensory integration	0.44	0.24	NA	0.01	0.69	NA	XXX
97535		A	Self care mngment training	0.45	0.36	NA	0.02	0.83	NA	XXX
97537		A	Community/work reintegration	0.45	0.27	NA	0.01	0.73	NA	XXX
97542		A	Wheelchair mngment training	0.45	0.29	NA	0.01	0.75	NA	XXX
97545		R	Work hardening	0.00	0.00	0.00	0.00	0.00	0.00	XXX
97546		R	Work hardening add-on	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
97601		A	Wound(s) care, selective	0.50	0.53	NA	0.04	1.07	NA	XXX
97602		B	Wound(s) care non-selective	0.00	0.00	0.00	0.00	0.00	0.00	XXX
97703		A	Prosthetic checkout	0.25	0.33	NA	0.02	0.60	NA	XXX
97750		A	Physical performance test	0.45	0.31	NA	0.02	0.78	NA	XXX
97780		N	Acupuncture w/o stimul	0.00	0.00	0.00	0.00	0.00	0.00	XXX
97781		N	Acupuncture w/stimul	0.00	0.00	0.00	0.00	0.00	0.00	XXX
97799		C	Physical medicine procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
97802		A	Medical nutrition, indiv, in	0.00	0.47	NA	0.01	0.48	NA	XXX
97803		A	Med nutrition, indiv, subseq	0.00	0.47	NA	0.01	0.48	NA	XXX
97804		A	Medical nutrition, group	0.00	0.18	NA	0.01	0.19	NA	XXX
98925		A	Osteopathic manipulation	0.45	0.37	0.15	0.01	0.83	0.61	000
98926		A	Osteopathic manipulation	0.65	0.44	0.26	0.02	1.11	0.93	000
98927		A	Osteopathic manipulation	0.87	0.51	0.30	0.03	1.41	1.20	000
98928		A	Osteopathic manipulation	1.03	0.59	0.35	0.03	1.65	1.41	000
98929		A	Osteopathic manipulation	1.19	0.65	0.38	0.04	1.88	1.61	000
98940		A	Chiropractic manipulation	0.45	0.24	0.13	0.01	0.70	0.59	000
98941		A	Chiropractic manipulation	0.65	0.30	0.18	0.02	0.97	0.85	000
98942		A	Chiropractic manipulation	0.87	0.37	0.24	0.03	1.27	1.14	000
98943		N	Chiropractic manipulation	+0.40	0.24	0.16	0.01	0.65	0.57	XXX
99000		B	Specimen handling	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99001		B	Specimen handling	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99002		B	Device handling	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99024		B	Postop follow-up visit	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99025		B	Initial surgical evaluation	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99026		I	In-hospital on call service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99027		I	Out-of-hosp on call service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99050		B	Medical services after hrs	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99052		B	Medical services at night	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99054		B	Medical servcs, unusual hrs	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99056		B	Non-office medical services	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99058		B	Office emergency care	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99070		B	Special supplies	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99071		B	Patient education materials	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99075		N	Medical testimony	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99078		B	Group health education	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99080		B	Special reports or forms	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99082		C	Unusual physician travel	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99090		B	Computer data analysis	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99091		B	Collect/review data from pt	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99100		B	Special anesthesia service	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
99116		B	Anesthesia with hypothermia	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
99135		B	Special anesthesia procedure	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
99140		B	Emergency anesthesia	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
99141		B	Sedation, iv/im or inhalant	+0.80	2.15	0.39	0.04	2.99	1.23	XXX
99142		B	Sedation, oral/rectal/nasal	+0.60	1.25	0.31	0.03	1.88	0.94	XXX
99170		A	Anogenital exam, child	1.75	2.07	0.53	0.07	3.89	2.35	000
99172		N	Ocular function screen	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99173		N	Visual acuity screen	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99175		A	Induction of vomiting	0.00	1.38	NA	0.08	1.46	NA	XXX
99183		A	Hyperbaric oxygen therapy	2.34	NA	0.75	0.12	NA	3.21	XXX
99185		A	Regional hypothermia	0.00	0.64	NA	0.03	0.67	NA	XXX
99186		A	Total body hypothermia	0.00	1.77	NA	0.37	2.14	NA	XXX
99190		X	Special pump services	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99191		X	Special pump services	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99192		X	Special pump services	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99195		A	Phlebotomy	0.00	0.45	NA	0.02	0.47	NA	XXX
99199		C	Special service/proc/report	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99201		A	Office/outpatient visit, new	0.45	0.48	0.16	0.02	0.95	0.63	XXX
99202		A	Office/outpatient visit, new	0.88	0.77	0.32	0.05	1.70	1.25	XXX
99203		A	Office/outpatient visit, new	1.34	1.10	0.49	0.08	2.52	1.91	XXX
99204		A	Office/outpatient visit, new	2.00	1.49	0.72	0.10	3.59	2.82	XXX
99205		A	Office/outpatient visit, new	2.67	1.79	0.95	0.12	4.58	3.74	XXX
99211		A	Office/outpatient visit, est	0.17	0.38	0.06	0.01	0.56	0.24	XXX
99212		A	Office/outpatient visit, est	0.45	0.52	0.16	0.02	0.99	0.63	XXX
99213		A	Office/outpatient visit, est	0.67	0.69	0.24	0.03	1.39	0.94	XXX
99214		A	Office/outpatient visit, est	1.10	1.03	0.40	0.04	2.17	1.54	XXX
99215		A	Office/outpatient visit, est	1.77	1.34	0.64	0.07	3.18	2.48	XXX
99217		A	Observation care discharge	1.28	NA	0.44	0.05	NA	1.77	XXX
99218		A	Observation care	1.28	NA	0.44	0.05	NA	1.77	XXX
99219		A	Observation care	2.14	NA	0.73	0.08	NA	2.95	XXX
99220		A	Observation care	2.99	NA	1.03	0.11	NA	4.13	XXX
99221		A	Initial hospital care	1.28	NA	0.46	0.05	NA	1.79	XXX
99222		A	Initial hospital care	2.14	NA	0.75	0.08	NA	2.97	XXX
99223		A	Initial hospital care	2.99	NA	1.04	0.10	NA	4.13	XXX
99231		A	Subsequent hospital care	0.64	NA	0.23	0.02	NA	0.89	XXX
99232		A	Subsequent hospital care	1.06	NA	0.38	0.03	NA	1.47	XXX
99233		A	Subsequent hospital care	1.51	NA	0.53	0.05	NA	2.09	XXX
99234		A	Observ/hosp same date	2.56	NA	0.89	0.11	NA	3.56	XXX
99235		A	Observ/hosp same date	3.42	NA	1.16	0.13	NA	4.71	XXX
99236		A	Observ/hosp same date	4.27	NA	1.45	0.17	NA	5.89	XXX
99238		A	Hospital discharge day	1.28	NA	0.56	0.04	NA	1.88	XXX
99239		A	Hospital discharge day	1.75	NA	0.75	0.05	NA	2.55	XXX
99241		A	Office consultation	0.64	0.61	0.22	0.04	1.29	0.90	XXX
99242		A	Office consultation	1.29	1.02	0.47	0.09	2.40	1.85	XXX
99243		A	Office consultation	1.72	1.35	0.64	0.10	3.17	2.46	XXX
99244		A	Office consultation	2.58	1.80	0.94	0.13	4.51	3.65	XXX
99245		A	Office consultation	3.43	2.26	1.24	0.16	5.85	4.83	XXX
99251		A	Initial inpatient consult	0.66	NA	0.25	0.04	NA	0.95	XXX
99252		A	Initial inpatient consult	1.32	NA	0.51	0.08	NA	1.91	XXX
99253		A	Initial inpatient consult	1.82	NA	0.70	0.09	NA	2.61	XXX
99254		A	Initial inpatient consult	2.64	NA	1.00	0.11	NA	3.75	XXX
99255		A	Initial inpatient consult	3.65	NA	1.36	0.15	NA	5.16	XXX
99261		A	Follow-up inpatient consult	0.42	NA	0.16	0.02	NA	0.60	XXX
99262		A	Follow-up inpatient consult	0.85	NA	0.31	0.03	NA	1.19	XXX
99263		A	Follow-up inpatient consult	1.27	NA	0.46	0.04	NA	1.77	XXX
99271		A	Confirmatory consultation	0.45	0.66	0.16	0.03	1.14	0.64	XXX
99272		A	Confirmatory consultation	0.84	0.89	0.32	0.06	1.79	1.22	XXX
99273		A	Confirmatory consultation	1.19	1.09	0.45	0.07	2.35	1.71	XXX
99274		A	Confirmatory consultation	1.73	1.39	0.65	0.09	3.21	2.47	XXX
99275		A	Confirmatory consultation	2.31	1.64	0.84	0.10	4.05	3.25	XXX
99281		A	Emergency dept visit	0.33	NA	0.09	0.02	NA	0.44	XXX
99282		A	Emergency dept visit	0.55	NA	0.15	0.03	NA	0.73	XXX
99283		A	Emergency dept visit	1.24	NA	0.32	0.08	NA	1.64	XXX
99284		A	Emergency dept visit	1.95	NA	0.49	0.12	NA	2.56	XXX
99285		A	Emergency dept visit	3.06	NA	0.74	0.19	NA	3.99	XXX
99288		B	Direct advanced life support	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99289		A	Ped crit care transport	4.80	NA	1.87	0.14	NA	6.81	XXX
99290		A	Ped crit care transport addl	2.40	NA	0.94	0.07	NA	3.41	ZZZ
99291		A	Critical care, first hour	4.00	1.57	1.30	0.14	5.71	5.44	XXX
99292		A	Critical care, addl 30 min	2.00	0.86	0.65	0.07	2.93	2.72	ZZZ
99293		A	Ped critical care, initial	16.00	NA	5.13	0.70	NA	21.83	XXX
99294		A	Ped critical care, subseq	8.00	NA	2.57	0.23	NA	10.80	XXX
99295		A	Neonate crit care, initial	18.49	NA	5.48	0.70	NA	24.67	XXX
99296		A	Neonate critical care subseq	8.00	NA	2.61	0.23	NA	10.84	XXX
99297		D	Neonatal critical care	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99298		A	Ic for lbw infant < 1500 gm	2.75	NA	0.96	0.10	NA	3.81	XXX
99299		A	Ic, lbw infant 1500-2500 gm	2.50	NA	0.98	0.10	NA	3.58	XXX
99301		A	Nursing facility care	1.20	0.69	0.42	0.04	1.93	1.66	XXX
99302		A	Nursing facility care	1.61	0.97	0.55	0.05	2.63	2.21	XXX
99303		A	Nursing facility care	2.01	1.19	0.68	0.06	3.26	2.75	XXX
99311		A	Nursing fac care, subseq	0.60	0.49	0.21	0.02	1.11	0.83	XXX
99312		A	Nursing fac care, subseq	1.00	0.67	0.34	0.03	1.70	1.37	XXX
99313		A	Nursing fac care, subseq	1.42	0.87	0.49	0.04	2.33	1.95	XXX
99315		A	Nursing fac discharge day	1.13	0.73	0.38	0.04	1.90	1.55	XXX
99316		A	Nursing fac discharge day	1.50	0.93	0.52	0.05	2.48	2.07	XXX
99321		A	Rest home visit, new patient	0.71	0.45	NA	0.02	1.18	NA	XXX
99322		A	Rest home visit, new patient	1.01	0.70	NA	0.03	1.74	NA	XXX
99323		A	Rest home visit, new patient	1.28	0.92	NA	0.04	2.24	NA	XXX
99331		A	Rest home visit, est pat	0.60	0.47	NA	0.02	1.09	NA	XXX
99332		A	Rest home visit, est pat	0.80	0.58	NA	0.03	1.41	NA	XXX
99333		A	Rest home visit, est pat	1.00	0.71	NA	0.03	1.74	NA	XXX
99341		A	Home visit, new patient	1.01	0.55	NA	0.05	1.61	NA	XXX
99342		A	Home visit, new patient	1.52	0.85	NA	0.05	2.42	NA	XXX
99343		A	Home visit, new patient	2.27	1.26	NA	0.07	3.60	NA	XXX
99344		A	Home visit, new patient	3.03	1.55	NA	0.10	4.68	NA	XXX
99345		A	Home visit, new patient	3.79	1.81	NA	0.12	5.72	NA	XXX
99347		A	Home visit, est patient	0.76	0.48	NA	0.03	1.27	NA	XXX
99348		A	Home visit, est patient	1.26	0.72	NA	0.04	2.02	NA	XXX
99349		A	Home visit, est patient	2.02	1.05	NA	0.06	3.13	NA	XXX
99350		A	Home visit, est patient	3.03	1.43	NA	0.10	4.56	NA	XXX
99354		A	Prolonged service, office	1.77	1.46	0.61	0.06	3.29	2.44	ZZZ
99355		A	Prolonged service, office	1.77	1.24	0.59	0.06	3.07	2.42	ZZZ
99356		A	Prolonged service, inpatient	1.71	NA	0.60	0.06	NA	2.37	ZZZ
99357		A	Prolonged service, inpatient	1.71	NA	0.61	0.06	NA	2.38	ZZZ
99358		B	Prolonged serv, w/o contact	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
99359		B	Prolonged serv, w/o contact	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
99360		X	Physician standby services	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99361		B	Physician/team conference	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99362		B	Physician/team conference	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99371		B	Physician phone consultation	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99372		B	Physician phone consultation	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99373		B	Physician phone consultation	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99374		B	Home health care supervision	+1.10	1.49	0.43	0.04	2.63	1.57	XXX
99375		I	Home health care supervision	+1.73	1.57	1.57	0.06	3.36	3.36	XXX
99377		B	Hospice care supervision	+1.10	1.49	0.43	0.04	2.63	1.57	XXX
99378		I	Hospice care supervision	+1.73	1.97	1.97	0.06	3.76	3.76	XXX
99379		B	Nursing fac care supervision	+1.10	1.49	0.43	0.03	2.62	1.56	XXX
99380		B	Nursing fac care supervision	+1.73	1.74	0.68	0.05	3.52	2.46	XXX
99381		N	Prev visit, new, infant	+1.19	1.52	0.46	0.04	2.75	1.69	XXX
99382		N	Prev visit, new, age 1-4	+1.36	1.56	0.53	0.04	2.96	1.93	XXX
99383		N	Prev visit, new, age 5-11	+1.36	1.50	0.53	0.04	2.90	1.93	XXX
99384		N	Prev visit, new, age 12-17	+1.53	1.57	0.60	0.05	3.15	2.18	XXX
99385		N	Prev visit, new, age 18-39	+1.53	1.57	0.60	0.05	3.15	2.18	XXX
99386		N	Prev visit, new, age 40-64	+1.88	1.76	0.73	0.06	3.70	2.67	XXX
99387		N	Prev visit, new, 65 & over	+2.06	1.89	0.80	0.06	4.01	2.92	XXX
99391		N	Prev visit, est, infant	+1.02	1.03	0.40	0.03	2.08	1.45	XXX
99392		N	Prev visit, est, age 1-4	+1.19	1.10	0.46	0.04	2.33	1.69	XXX
99393		N	Prev visit, est, age 5-11	+1.19	1.07	0.46	0.04	2.30	1.69	XXX
99394		N	Prev visit, est, age 12-17	+1.36	1.15	0.53	0.04	2.55	1.93	XXX
99395		N	Prev visit, est, age 18-39	+1.36	1.18	0.53	0.04	2.58	1.93	XXX
99396		N	Prev visit, est, age 40-64	+1.53	1.27	0.60	0.05	2.85	2.18	XXX
99397		N	Prev visit, est, 65 & over	+1.71	1.38	0.67	0.05	3.14	2.43	XXX
99401		N	Preventive counseling, indiv	+0.48	0.63	0.19	0.01	1.12	0.68	XXX
99402		N	Preventive counseling, indiv	+0.98	0.88	0.38	0.02	1.88	1.38	XXX
99403		N	Preventive counseling, indiv	+1.46	1.10	0.57	0.03	2.59	2.06	XXX
99404		N	Preventive counseling, indiv	+1.95	1.34	0.76	0.04	3.33	2.75	XXX
99411		N	Preventive counseling, group	+0.15	0.18	0.06	0.01	0.34	0.22	XXX
99412		N	Preventive counseling, group	+0.25	0.25	0.10	0.01	0.51	0.36	XXX
99420		N	Health risk assessment test	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99429		N	Unlisted preventive service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99431		A	Initial care, normal newborn	1.17	NA	0.39	0.04	NA	1.60	XXX
99432		A	Newborn care, not in hosp	1.26	0.84	0.41	0.06	2.16	1.73	XXX
99433		A	Normal newborn care/hospital	0.62	NA	0.20	0.02	NA	0.84	XXX
99435		A	Newborn discharge day hosp	1.50	NA	0.51	0.05	NA	2.06	XXX
99436		A	Attendance, birth	1.50	0.49	0.48	0.05	2.04	2.03	XXX
99440		A	Newborn resuscitation	2.93	NA	0.95	0.11	NA	3.99	XXX
99450		N	Life/disability evaluation	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99455		R	Disability examination	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99456		R	Disability examination	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99499		C	Unlisted e&m service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99500		I	Home visit, prenatal	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99501		I	Home visit, postnatal	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99502		I	Home visit, nb care	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99503		I	Home visit, resp therapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99504		I	Home visit mech ventilator	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99505		I	Home visit, stoma care	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99506		I	Home visit, im injection	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99507		I	Home visit, cath maintain	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99508		F	Home visit, sleep studies	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99509		I	Home visit day life activity	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99510		I	Home visit, sing/m/fam couns	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99511		I	Home visit, fecal/enema mgmt	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99512		I	Home visit, hemodialysis	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99539		F	Home visit, nos	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99551		I	Home infus, pain mgmt, iv/sc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99552		I	Hm infus pain mgmt, epid/ith	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99553		I	Home infuse, tocolytic tx	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99554		I	Home infus, hormone/platelet	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99555		I	Home infuse, chemotheraphy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99556		I	Home infus, antibio/fung/vir	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99557		I	Home infuse, anticoagulant	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99558		I	Home infuse, immunotherapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99559		I	Home infus, periton dialysis	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99560		I	Home infus, entero nutrition	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99561		I	Home infuse, hydration tx	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99562		I	Home infus, parent nutrition	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99563		I	Home admin, pentamidine	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99564		I	Hme infus, antihemophil agnt	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99565		I	Home infus, proteinase inhib	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99566		I	Home infuse, iv therapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99567		I	Home infuse, sympath agent	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99568		I	Home infus, misc drug, daily	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99569		I	Home infuse, each addl tx	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99600		I	Home visit nos	0.00	0.00	0.00	0.00	0.00	0.00	XXX
A4890		R	Repair/maint cont hemo equip	0.00	0.00	0.00	0.00	0.00	0.00	XXX
D0150		R	Comprehensve oral evaluation	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D0240		R	Intraoral occlusal film	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D0250		R	Extraoral first film	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D0260		R	Extraoral ea additional film	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D0270		R	Dental bitewing single film	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D0272		R	Dental bitewings two films	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D0274		R	Dental bitewings four films	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D0277		R	Vert bitewings-sev to eight	0.00	0.00	0.00	0.00	0.00	0.00	XXX
D0460		R	Pulp vitality test	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D0472		R	Gross exam, prep & report	0.00	0.00	0.00	0.00	0.00	0.00	XXX
D0473		R	Micro exam, prep & report	0.00	0.00	0.00	0.00	0.00	0.00	XXX
D0474		R	Micro w exam of surg margins	0.00	0.00	0.00	0.00	0.00	0.00	XXX
D0480		R	Cytopath smear prep & report	0.00	0.00	0.00	0.00	0.00	0.00	XXX
D0502		R	Other oral pathology procedu	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D0999		R	Unspecified diagnostic proce	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D1510		R	Space maintainer fxd unilat	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D1515		R	Fixed bilat space maintainer	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D1520		R	Remove unilat space maintain	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D1525		R	Remove bilat space maintain	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D1550		R	Recement space maintainer	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D2970		R	Temporary- fractured tooth	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D2999		R	Dental unspec restorative pr	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D3460		R	Endodontic endosseous implan	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D3999		R	Endodontic procedure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D4260		R	Osseous surgery per quadrant	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D4263		R	Bone replce graft first site	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D4264		R	Bone replce graft each add	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D4268		R	Surgical revision procedure	0.00	0.00	0.00	0.00	0.00	0.00	XXX
D4270		R	Pedicle soft tissue graft pr	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D4271		R	Free soft tissue graft proc	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D4273		R	Subepithelial tissue graft	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D4355		R	Full mouth debridement	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D4381		R	Localized chemo delivery	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D5911		R	Facial moulage sectional	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D5912		R	Facial moulage complete	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D5951		R	Feeding aid	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D5983		R	Radiation applicator	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D5984		R	Radiation shield	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D5985		R	Radiation cone locator	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D5987		R	Commissure splint	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D6920		R	Dental connector bar	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D7111		R	Coronal remnants deciduous t	0.00	0.00	0.00	0.00	0.00	0.00	XXX
D7140		R	Extraction erupted tooth/exr	0.00	0.00	0.00	0.00	0.00	0.00	XXX
D7210		R	Rem imp tooth w mucoper flp	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D7220		R	Impact tooth remov soft tiss	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D7230		R	Impact tooth remov part bony	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D7240		R	Impact tooth remov comp bony	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D7241		R	Impact tooth rem bony w/comp	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D7250		R	Tooth root removal	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D7260		R	Oral antral fistula closure	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D7261		R	Primary closure sinus perf	0.00	0.00	0.00	0.00	0.00	0.00	XXX
D7291		R	Transseptal fiberotomy	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D7940		R	Reshaping bone orthognathic	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D9110		R	Tx dental pain minor proc	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D9230		R	Analgesia	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D9248		R	Sedation (non-iv)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
D9630		R	Other drugs/medicaments	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D9930		R	Treatment of complications	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D9940		R	Dental occlusal guard	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D9950		R	Occlusion analysis	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D9951		R	Limited occlusal adjustment	0.00	0.00	0.00	0.00	0.00	0.00	YYY
D9952		R	Complete occlusal adjustment	0.00	0.00	0.00	0.00	0.00	0.00	YYY
G0001		X	Drawing blood for specimen	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0002		D	Temporary urinary catheter	0.00	0.00	0.00	0.00	0.00	0.00	000
G0004		D	ECG transm phys review & int	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0005		D	ECG 24 hour recording	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0006		D	ECG transmission & analysis	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0007		D	ECG phy review & interpret	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0008		X	Admin influenza virus vac	0.00	0.00	NA	0.00	0.00	NA	XXX
G0009		X	Admin pneumococcal vaccine	0.00	0.00	NA	0.00	0.00	NA	XXX
G0010		X	Admin hepatitis b vaccine	0.00	0.00	NA	0.00	0.00	NA	XXX
G0015		D	Post symptom ECG tracing	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0025		B	Collagen skin test kit	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0026		D	Fecal leukocyte examination	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0027		D	Semen analysis	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0030		C	PET imaging prev PET single	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0030	26	A	PET imaging prev PET single	1.50	0.52	0.52	0.04	2.06	2.06	XXX
G0030	TC	C	PET imaging prev PET single	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0031		C	PET imaging prev PET multple	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0031	26	A	PET imaging prev PET multple	1.87	0.70	0.70	0.06	2.63	2.63	XXX
G0031	TC	C	PET imaging prev PET multple	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0032		C	PET follow SPECT 78464 singl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0032	26	A	PET follow SPECT 78464 singl	1.50	0.52	0.52	0.05	2.07	2.07	XXX
G0032	TC	C	PET follow SPECT 78464 singl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0033		C	PET follow SPECT 78464 mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0033	26	A	PET follow SPECT 78464 mult	1.87	0.70	0.70	0.06	2.63	2.63	XXX
G0033	TC	C	PET follow SPECT 78464 mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0034		C	PET follow SPECT 76865 singl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0034	26	A	PET follow SPECT 76865 singl	1.50	0.52	0.52	0.05	2.07	2.07	XXX
G0034	TC	C	PET follow SPECT 76865 singl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0035		C	PET follow SPECT 78465 mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0035	26	A	PET follow SPECT 78465 mult	1.87	0.70	0.70	0.06	2.63	2.63	XXX
G0035	TC	C	PET follow SPECT 78465 mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0036		C	PET follow cornry angio sing	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0036	26	A	PET follow cornry angio sing	1.50	0.52	0.52	0.04	2.06	2.06	XXX
G0036	TC	C	PET follow cornry angio sing	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0037		C	PET follow cornry angio mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0037	26	A	PET follow cornry angio mult	1.87	0.70	0.70	0.06	2.63	2.63	XXX
G0037	TC	C	PET follow cornry angio mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0038		C	PET follow myocard perf sing	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0038	26	A	PET follow myocard perf sing	1.50	0.52	0.52	0.04	2.06	2.06	XXX
G0038	TC	C	PET follow myocard perf sing	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0039		C	PET follow myocard perf mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0039	26	A	PET follow myocard perf mult	1.87	0.70	0.70	0.07	2.64	2.64	XXX
G0039	TC	C	PET follow myocard perf mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0040		C	PET follow stress echo singl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0040	26	A	PET follow stress echo singl	1.50	0.52	0.52	0.04	2.06	2.06	XXX
G0040	TC	C	PET follow stress echo singl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0041		C	PET follow stress echo mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0041	26	A	PET follow stress echo mult	1.87	0.70	0.70	0.05	2.62	2.62	XXX
G0041	TC	C	PET follow stress echo mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0042		C	PET follow ventriculogm sing	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0042	26	A	PET follow ventriculogm sing	1.50	0.52	0.52	0.04	2.06	2.06	XXX
G0042	TC	C	PET follow ventriculogm sing	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0043		C	PET follow ventriculogm mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0043	26	A	PET follow ventriculogm mult	1.87	0.70	0.70	0.06	2.63	2.63	XXX
G0043	TC	C	PET follow ventriculogm mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0044		C	PET following rest ECG singl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0044	26	A	PET following rest ECG singl	1.50	0.52	0.52	0.04	2.06	2.06	XXX
G0044	TC	C	PET following rest ECG singl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0045		C	PET following rest ECG mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0045	26	A	PET following rest ECG mult	1.87	0.70	0.70	0.06	2.63	2.63	XXX
G0045	TC	C	PET following rest ECG mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0046		C	PET follow stress ECG singl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0046	26	A	PET follow stress ECG singl	1.50	0.52	0.52	0.04	2.06	2.06	XXX
G0046	TC	C	PET follow stress ECG singl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0047		C	PET follow stress ECG mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0047	26	A	PET follow stress ECG mult	1.87	0.70	0.70	0.06	2.63	2.63	XXX
G0047	TC	C	PET follow stress ECG mult	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0050		D	Residual urine by ultrasound	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0101		A	CA screen;pelvic/breast exam	0.45	0.51	0.17	0.01	0.97	0.63	XXX
G0102		A	Prostate ca screening; dre	0.17	0.38	0.06	0.01	0.56	0.24	XXX
G0103		X	Psa, total screening	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0104		A	CA screen;flexi sigmoidscope	0.96	1.82	0.52	0.05	2.83	1.53	000
G0105		A	Colorectal scrn; hi risk ind	3.70	8.03	1.72	0.20	11.93	5.62	000
G0106		A	Colon CA screen;barium enema	0.99	2.56	NA	0.15	3.70	NA	XXX
G0106	26	A	Colon CA screen;barium enema	0.99	0.34	0.34	0.04	1.37	1.37	XXX
G0106	TC	A	Colon CA screen;barium enema	0.00	2.22	NA	0.11	2.33	NA	XXX
G0107		X	CA screen; fecal blood test	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0108		A	Diab manage trn per indiv	0.00	0.82	NA	0.01	0.83	NA	XXX
G0109		A	Diab manage trn ind/group	0.00	0.48	NA	0.01	0.49	NA	XXX
G0110		R	Nett pulm-rehab educ; ind	0.90	0.71	0.30	0.03	1.64	1.23	XXX
G0111		R	Nett pulm-rehab educ; group	0.27	0.29	0.14	0.01	0.57	0.42	XXX
G0112		R	Nett;nutrition guid, initial	1.72	1.22	0.67	0.05	2.99	2.44	XXX
G0113		R	Nett;nutrition guid,subseqnt	1.29	0.84	0.42	0.04	2.17	1.75	XXX
G0114		R	Nett; psychosocial consult	1.20	0.50	0.38	0.03	1.73	1.61	XXX
G0115		R	Nett; psychological testing	1.20	0.65	0.38	0.04	1.89	1.62	XXX
G0116		R	Nett; psychosocial counsel	1.11	1.02	0.34	0.04	2.17	1.49	XXX
G0117		T	Glaucoma scrn hgh risk direc	0.45	0.94	0.21	0.02	1.41	0.68	XXX
G0118		T	Glaucoma scrn hgh risk direc	0.17	0.81	0.08	0.01	0.99	0.26	XXX
G0120		A	Colon ca scrn; barium enema	0.99	2.56	NA	0.15	3.70	NA	XXX
G0120	26	A	Colon ca scrn; barium enema	0.99	0.34	0.34	0.04	1.37	1.37	XXX
G0120	TC	A	Colon ca scrn; barium enema	0.00	2.22	NA	0.11	2.33	NA	XXX
G0121		A	Colon ca scrn not hi rsk ind	3.70	8.03	1.72	0.20	11.93	5.62	000
G0122		N	Colon ca scrn; barium enema	+0.99	2.61	NA	0.15	3.75	NA	XXX
G0122	26	N	Colon ca scrn; barium enema	+0.99	0.39	0.39	0.04	1.42	1.42	XXX
G0122	TC	N	Colon ca scrn; barium enema	+0.00	2.22	NA	0.11	2.33	NA	XXX
G0123		X	Screen cerv/vag thin layer	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0124		A	Screen c/v thin layer by MD	0.42	0.99	0.99	0.01	1.42	1.42	XXX
G0125		A	PET image pulmonary nodule	1.50	55.83	NA	2.00	59.33	NA	XXX
G0125	26	A	PET image pulmonary nodule	1.50	0.52	0.52	0.05	2.07	2.07	XXX
G0125	TC	A	PET image pulmonary nodule	0.00	55.31	NA	1.95	57.26	NA	XXX
G0127		R	Trim nail(s)	0.17	0.26	0.07	0.01	0.44	0.25	000
G0128		R	CORF skilled nursing service	0.08	0.03	0.03	0.01	0.12	0.12	XXX
G0130		A	Single energy x-ray study	0.22	0.90	NA	0.05	1.17	NA	XXX
G0130	26	A	Single energy x-ray study	0.22	0.11	0.11	0.01	0.34	0.34	XXX
G0130	TC	A	Single energy x-ray study	0.00	0.79	NA	0.04	0.83	NA	XXX
G0131		D	CT scan, bone density study	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0131	26	D	CT scan, bone density study	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0131	TC	D	CT scan, bone density study	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0132		D	CT scan, bone density study	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0132	26	D	CT scan, bone density study	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0132	TC	D	CT scan, bone density study	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0141		A	Scr c/v cyto,autosys and md	0.42	0.99	0.99	0.01	1.42	1.42	XXX
G0143		X	Scr c/v cyto,thinlayer,rescr	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0144		X	Scr c/v cyto,thinlayer,rescr	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0145		X	Scr c/v cyto,thinlayer,rescr	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0147		X	Scr c/v cyto, automated sys	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0148		X	Scr c/v cyto, autosys, rescr	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0166		A	Extrnl counterpulse, per tx	0.07	5.57	0.03	0.01	5.65	0.11	XXX
G0167		C	Hyperbaric oz tx;no md reqrd	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0168		A	Wound closure by adhesive	0.45	2.24	0.18	0.01	2.70	0.64	000
G0173		X	Stereo radoisurgery,complete	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0175		X	OPPS Service,sched team conf	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0176		X	OPPS/PHP;activity therapy	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0177		X	OPPS/PHP; train & educ serv	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0179		A	MD recertification HHA PT	0.45	1.09	NA	0.01	1.55	NA	XXX
G0180		A	MD certification HHA patient	0.67	1.31	NA	0.02	2.00	NA	XXX
G0181		A	Home health care supervision	1.73	1.56	NA	0.06	3.35	NA	XXX
G0182		A	Hospice care supervision	1.73	1.75	NA	0.06	3.54	NA	XXX
G0185		D	Transpuppillary thermotx	0.00	0.00	0.00	0.00	0.00	0.00	YYY
G0186		C	Dstry eye lesn,fdr vssl tech	0.00	0.00	0.00	0.00	0.00	0.00	YYY
G0187		D	Dstry mclr drusen,photocoag	0.00	0.00	0.00	0.00	0.00	0.00	YYY
G0192		F	Immunization oral/intranasal	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0193		D	Endoscopicstudyswallowfunctn	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0194		D	Sensorytestingendoscopicstud	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0195		D	Clinicalevalswallowingfunct	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0196		D	Evalofswallowingwithradioopa	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0197		D	Evalofptforprescipspeechdevi	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0198		D	Patientadapation&trainforspe	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0199		D	Reevaluationofpatientusespec	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0200		D	Evalofpatientprescipofvoicep	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0201		D	Modifortraininginusevoicepro	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0202		A	Screeningmammographydigital	0.70	2.80	NA	0.09	3.59	NA	XXX
G0202	26	A	Screeningmammographydigital	0.70	0.27	0.27	0.03	1.00	1.00	XXX
G0202	TC	A	Screeningmammographydigital	0.00	2.53	NA	0.06	2.59	NA	XXX
G0204		A	Diagnosticmammographydigital	0.87	2.84	NA	0.10	3.81	NA	XXX
G0204	26	A	Diagnosticmammographydigital	0.87	0.34	0.34	0.04	1.25	1.25	XXX
G0204	TC	A	Diagnosticmammographydigital	0.00	2.50	NA	0.06	2.56	NA	XXX
G0206		A	Diagnosticmammographydigital	0.70	2.28	NA	0.09	3.07	NA	XXX
G0206	26	A	Diagnosticmammographydigital	0.70	0.27	0.27	0.04	1.01	1.01	XXX
G0206	TC	A	Diagnosticmammographydigital	0.00	2.01	NA	0.05	2.06	NA	XXX
G0210		C	PET img wholebody dxlung	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0210	26	A	PET img wholebody dxlung	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0210	TC	C	PET img wholebody dxlung	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0211		C	PET img wholbody init lung	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0211	26	A	PET img wholbody init lung	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0211	TC	C	PET img wholbody init lung	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0212		C	PET img wholebod restag lung	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0212	26	A	PET img wholebod restag lung	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0212	TC	C	PET img wholebod restag lung	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0213		C	PET img wholbody dx	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0213	26	A	PET img wholbody dx	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0213	TC	C	PET img wholbody dx	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0214		C	PET img wholebod init	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0214	26	A	PET img wholebod init	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0214	TC	C	PET img wholebod init	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0215		C	PETimg wholebod restag	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0215	26	A	PETimg wholebod restag	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0215	TC	C	PETimg wholebod restag	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0216		C	PET img wholebod dx melanoma	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0216	26	A	PET img wholebod dx melanoma	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0216	TC	C	PET img wholebod dx melanoma	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0217		C	PET img wholebod init melan	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0217	26	A	PET img wholebod init melan	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0217	TC	C	PET img wholebod init melan	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0218		C	PET img wholebod restag mela	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0218	26	A	PET img wholebod restag mela	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0218	TC	C	PET img wholebod restag mela	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0219		N	PET img wholbod melano nonco	+1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0219	26	N	PET img wholbod melano nonco	+1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0219	TC	N	PET img wholbod melano nonco	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0220		C	PET img wholebod dx lymphoma	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0220	26	A	PET img wholebod dx lymphoma	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0220	TC	C	PET img wholebod dx lymphoma	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0221		C	PET imag wholbod init lympho	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0221	26	A	PET imag wholbod init lympho	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0221	TC	C	PET imag wholbod init lympho	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0222		C	PET imag wholbod resta lymph	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0222	26	A	PET imag wholbod resta lymph	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0222	TC	C	PET imag wholbod resta lymph	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0223		C	PET imag wholbod reg dx head	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0223	26	A	PET imag wholbod reg dx head	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0223	TC	C	PET imag wholbod reg dx head	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0224		C	PET imag wholbod reg ini hea	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0224	26	A	PET imag wholbod reg ini hea	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0224	TC	C	PET imag wholbod reg ini hea	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0225		C	PET whol restag headneckonly	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0225	26	A	PET whol restag headneckonly	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0225	TC	C	PET whol restag headneckonly	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0226		C	PET img wholbody dx esophagl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0226	26	A	PET img wholbody dx esophagl	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0226	TC	C	PET img wholbody dx esophagl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0227		C	PET img wholbod ini esophage	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0227	26	A	PET img wholbod ini esophage	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0227	TC	C	PET img wholbod ini esophage	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0228		C	PET img wholbod restg esopha	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0228	26	A	PET img wholbod restg esopha	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0228	TC	C	PET img wholbod restg esopha	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0229		C	PET img metaboloc brain pres	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0229	26	A	PET img metaboloc brain pres	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0229	TC	C	PET img metaboloc brain pres	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0230		C	PET myocard viability post	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0230	26	A	PET myocard viability post	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0230	TC	C	PET myocard viability post	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0231		C	PET WhBD colorec; gamma cam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0231	26	A	PET WhBD colorec; gamma cam	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0231	TC	C	PET WhBD colorec; gamma cam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0232		C	PET whbd lymphoma; gamma cam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0232	26	A	PET whbd lymphoma; gamma cam	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0232	TC	C	PET whbd lymphoma; gamma cam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0233		C	PET whbd melanoma; gamma cam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0233	26	A	PET whbd melanoma; gamma cam	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0233	TC	C	PET whbd melanoma; gamma cam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0234		C	PET WhBD pulm nod; gamma cam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0234	26	A	PET WhBD pulm nod; gamma cam	1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0234	TC	C	PET WhBD pulm nod; gamma cam	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0236		A	Digital film convert diag ma	0.06	0.44	NA	0.02	0.52	NA	ZZZ
G0236	26	A	Digital film convert diag ma	0.06	0.02	0.02	0.01	0.09	0.09	ZZZ
G0236	TC	A	Digital film convert diag ma	0.00	0.42	NA	0.01	0.43	NA	ZZZ
G0237		A	Therapeutic procd strg endur	0.00	0.47	NA	0.02	0.49	NA	XXX
G0238		C	Oth resp proc, indiv	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0239		C	Oth resp proc, group	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0240		D	Critic care by MD transport	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0241		D	Each additional 30 minutes	0.00	0.00	0.00	0.00	0.00	0.00	ZZZ
G0242		X	Multisource photon ster plan	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0243		X	Multisour photon stero treat	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0244		E	Observ care by facility topt	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0245		R	Initial foot exam pt lops	0.88	0.77	0.32	0.05	1.70	1.25	XXX
G0246		R	Followup eval of foot pt lop	0.45	0.52	0.16	0.02	0.99	0.63	XXX
G0247		R	Routine footcare pt w lops	0.50	0.52	0.21	0.05	1.07	0.76	ZZZ
G0248		R	Demonstrate use home inr mon	0.00	4.30	NA	0.01	4.31	NA	XXX
G0249		R	Provide test material,equipm	0.00	3.35	NA	0.01	3.36	NA	XXX
G0250		R	MD review interpret of test	0.18	0.07	0.07	0.01	0.26	0.26	XXX
G0251		E	Linear acc based stero radio	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0252		N	PET imaging initial dx	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0252	26	N	PET imaging initial dx	+1.50	0.60	0.60	0.04	2.14	2.14	XXX
G0252	TC	N	PET imaging initial dx	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0253		C	PET image brst dection recur	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0253	26	A	PET image brst dection recur	1.87	0.73	0.73	0.07	2.67	2.67	XXX
G0253	TC	C	PET image brst dection recur	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0254		C	PET image brst eval to tx	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0254	26	A	PET image brst eval to tx	1.87	0.73	0.73	0.07	2.67	2.67	XXX
G0254	TC	C	PET image brst eval to tx	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0255		N	Current percep threshold tst	+1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0255	26	N	Current percep threshold tst	+1.50	0.59	0.59	0.04	2.13	2.13	XXX
G0255	TC	N	Current percep threshold tst	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0256		E	Prostate brachy w palladium	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0257		E	Unsched dialysis ESRD pt hos	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0258		E	IV infusion during obs stay	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0259		E	Inject for sacroiliac joint	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0260		E	Inj for sacroiliac jt anesth	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0261		E	Prostate brachy w iodine see	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0262		A	Sm intestinal image capsule	2.12	18.67	NA	0.08	20.87	NA	XXX
G0262	26	A	Sm intestinal image capsule	2.12	0.83	0.83	0.02	2.97	2.97	XXX
G0262	TC	A	Sm intestinal image capsule	0.00	17.84	NA	0.06	17.90	NA	XXX
G0263		E	Adm with CHF, CP, asthma	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0264		E	Assmt otr CHF, CP, asthma	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0265		X	Cryopresevation Freeze+stora	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0266		X	Thawing + expansion froz cel	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0267		X	Bone marrow or psc harvest	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0268		A	Removal of impacted wax md	0.61	0.57	0.24	0.04	1.22	0.89	000
G0269		B	Occlusive device in vein art	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0270		A	MNT subs tx for change dx	0.00	0.47	NA	0.01	0.48	NA	XXX
G0271		A	Group MNT 2 or more 30 mins	0.00	0.18	NA	0.01	0.19	NA	XXX
G0272		A	Naso/oro gastric tube pl MD	0.32	0.13	NA	0.02	0.47	NA	000
G0273		A	Pretx planning, non-Hodgkins	0.86	11.36	NA	0.28	12.50	NA	XXX
G0273	26	A	Pretx planning, non-Hodgkins	0.86	0.34	0.34	0.03	1.23	1.23	XXX
G0273	TC	A	Pretx planning, non-Hodgkins	0.00	11.02	NA	0.25	11.27	NA	XXX
G0274		A	Radiopharm tx, non-Hodgkins	2.07	3.42	NA	0.20	5.69	NA	XXX
G0274	26	A	Radiopharm tx, non-Hodgkins	2.07	0.81	0.81	0.08	2.96	2.96	XXX
G0274	TC	A	Radiopharm tx, non-Hodgkins	0.00	2.61	NA	0.12	2.73	NA	XXX
G0275		A	Renal angio, cardiac cath	0.25	0.10	NA	0.01	0.36	NA	ZZZ
G0278		A	Iliac art angio,cardiac cath	0.25	0.10	NA	0.01	0.36	NA	ZZZ
G0279		A	Excorp shock tx, elbow epi	0.06	1.46	NA	0.01	1.53	NA	XXX
G0280		A	Excorp shock tx other than	0.06	1.46	NA	0.01	1.53	NA	XXX
G0281		A	Elec stim unattend for press	0.18	0.35	0.07	0.01	0.54	0.26	XXX
G0282		N	Elect stim wound care not pd	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0283		A	Elec stim other than wound	0.18	0.35	0.07	0.01	0.54	0.26	XXX
G0288		A	Recon, CTA for surg plan	0.00	10.57	NA	0.15	10.72	NA	XXX
G0289		A	Arthro, loose body + chondro	1.48	0.58	NA	0.27	2.33	NA	ZZZ
G0290		E	Drug-eluting stents, single	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0291		E	Drug-eluting stents,each add	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0292		E	Adm exp drugs,clinical trial	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0293		E	Non-cov surg proc,clin trial	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0294		E	Non-cov proc, clinical trial	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0295		N	Electromagnetic therapy onc	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9001		X	MCCD, initial rate	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9002		X	MCCD,maintenance rate	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9003		X	MCCD, risk adj hi, initial	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9004		X	MCCD, risk adj lo, initial	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9005		X	MCCD, risk adj, maintenance	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9006		X	MCCD, Home monitoring	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9007		X	MCCD, sch team conf	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9008		X	Mccd,phys coor-care ovrsght	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9009		X	MCCD, risk adj, level 3	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9010		X	MCCD, risk adj, level 4	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9011		X	MCCD, risk adj, level 5	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9012		X	Other Specified Case Mgmt	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G9016		N	Demo-smoking cessation coun	0.00	0.00	0.00	0.00	0.00	0.00	XXX
J3370		R	Vancomycin hcl injection	0.00	0.00	0.00	0.00	0.00	0.00	XXX
M0064		A	Visit for drug monitoring	0.37	0.35	0.12	0.01	0.73	0.50	XXX
P3001		A	Screening pap smear by phys	0.42	0.99	0.99	0.01	1.42	1.42	XXX
Q0035		A	Cardiokymography	0.17	0.46	NA	0.03	0.66	NA	XXX
Q0035	26	A	Cardiokymography	0.17	0.07	0.07	0.01	0.25	0.25	XXX
Q0035	TC	A	Cardiokymography	0.00	0.39	NA	0.02	0.41	NA	XXX
Q0091		A	Obtaining screen pap smear	0.37	0.68	0.14	0.01	1.06	0.52	XXX
Q0092		A	Set up port xray equipment	0.00	0.32	NA	0.01	0.33	NA	XXX
Q3014		X	Telehealth facility fee	0.00	0.00	0.00	0.00	0.00	0.00	XXX
R0070		C	Transport portable x-ray	0.00	0.00	0.00	0.00	0.00	0.00	XXX
R0075		C	Transport port x-ray multipl	0.00	0.00	0.00	0.00	0.00	0.00	XXX
R0076		B	Transport portable EKG	0.00	0.00	0.00	0.00	0.00	0.00	XXX
V5299		R	Hearing service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
V5362		R	Speech screening	0.00	0.00	0.00	0.00	0.00	0.00	XXX
V5363		R	Language screening	0.00	0.00	0.00	0.00	0.00	0.00	XXX
V5364		R	Dysphagia screening	0.00	0.00	0.00	0.00	0.00	0.00	XXX
1 CPT codes and descriptions only are copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2002 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

       

 

—————————— ¹ CPT codes and descriptions only are copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply. ² Copyright 2002 American Dental Association. All rights reserved. ³ + Indicates RVUs are not used for Medicare payment.

Addendum C.—CODES WITH INTERIM RVUs

CPT 1 /HCPCS 2	MOD	Status	Description	Physician Work RVUs3	Non- Facility PE RVUs	Facility PE RVUs	Mal- Practice RVUs	Non- Facility Total	Facility Total	Global
11400		A	Exc tr-ext b9+marg 0.5 < cm	0.85	2.08	0.96	0.06	2.99	1.87	010
11401		A	Exc tr-ext b9+marg 0.6-1 cm	1.23	2.12	1.08	0.09	3.44	2.40	010
11402		A	Exc tr-ext b9+marg 1.1-2 cm	1.51	2.28	1.14	0.12	3.91	2.77	010
11403		A	Exc tr-ext b9+marg 2.1-3 cm	1.79	2.50	1.35	0.16	4.45	3.30	010
11404		A	Exc tr-ext b9+marg 3.1-4 cm	2.06	2.84	1.42	0.18	5.08	3.66	010
11406		A	Exc tr-ext b9+marg > 4.0 cm	2.76	3.24	1.68	0.25	6.25	4.69	010
11420		A	Exc h-f-nk-sp b9+marg 0.5 <	0.98	1.81	1.00	0.08	2.87	2.06	010
11421		A	Exc h-f-nk-sp b9+marg 0.6-1	1.42	2.12	1.18	0.11	3.65	2.71	010
11422		A	Exc h-f-nk-sp b9+marg 1.1-2	1.63	2.30	1.38	0.14	4.07	3.15	010
11423		A	Exc h-f-nk-sp b9+marg 2.1-3	2.01	2.66	1.49	0.17	4.84	3.67	010
11424		A	Exc h-f-nk-sp b9+marg 3.1-4	2.43	2.93	1.64	0.21	5.57	4.28	010
11426		A	Exc h-f-nk-sp b9+marg > 4 cm	3.78	3.75	2.15	0.34	7.87	6.27	010
11440		A	Exc face-mm b9+marg 0.5 < cm	1.06	2.27	1.41	0.08	3.41	2.55	010
11441		A	Exc face-mm b9+marg 0.6-1 cm	1.48	2.40	1.59	0.11	3.99	3.18	010
11442		A	Exc face-mm b9+marg 1.1-2 cm	1.72	2.66	1.66	0.14	4.52	3.52	010
11443		A	Exc face-mm b9+marg 2.1-3 cm	2.29	3.04	1.90	0.18	5.51	4.37	010
11444		A	Exc face-mm b9+marg 3.1-4 cm	3.14	3.64	2.28	0.25	7.03	5.67	010
11446		A	Exc face-mm b9+marg > 4 cm	4.49	4.26	2.88	0.30	9.05	7.67	010
11600		A	Exc tr-ext mlg+marg 0.5 < cm	1.31	2.53	0.99	0.09	3.93	2.39	010
11601		A	Exc tr-ext mlg+marg 0.6-1 cm	1.80	2.60	1.24	0.12	4.52	3.16	010
11602		A	Exc tr-ext mlg+marg 1.1-2 cm	1.95	2.73	1.29	0.13	4.81	3.37	010
11603		A	Exc tr-ext mlg+marg 2.1-3 cm	2.19	2.96	1.35	0.16	5.31	3.70	010
11604		A	Exc tr-ext mlg+marg 3.1-4 cm	2.40	3.27	1.41	0.18	5.85	3.99	010
11606		A	Exc tr-ext mlg+marg > 4 cm	3.43	3.96	1.76	0.28	7.67	5.47	010
11620		A	Exc h-f-nk-sp mlg+marg 0.5 <	1.19	2.49	0.97	0.09	3.77	2.25	010
11621		A	Exc h-f-nk-sp mlg+marg 0.6-1	1.76	2.60	1.27	0.12	4.48	3.15	010
11622		A	Exc h-f-nk-sp mlg+marg 1.1-2	2.09	2.87	1.42	0.15	5.11	3.66	010
11623		A	Exc h-f-nk-sp mlg+marg 2.1-3	2.61	3.22	1.62	0.20	6.03	4.43	010
11624		A	Exc h-f-nk-sp mlg+marg 3.1-4	3.06	3.61	1.81	0.25	6.92	5.12	010
11626		A	Exc h-f-nk-sp mlg+mar > 4 cm	4.30	4.56	2.44	0.35	9.21	7.09	010
11640		A	Exc face-mm malig+marg 0.5 <	1.35	2.54	1.14	0.10	3.99	2.59	010
11641		A	Exc face-mm malig+marg 0.6-1	2.16	2.92	1.57	0.15	5.23	3.88	010
11642		A	Exc face-mm malig+marg 1.1-2	2.59	3.30	1.77	0.18	6.07	4.54	010
11643		A	Exc face-mm malig+marg 2.1-3	3.10	3.70	2.01	0.24	7.04	5.35	010
11644		A	Exc face-mm malig+marg 3.1-4	4.03	4.63	2.56	0.33	8.99	6.92	010
11646		A	Exc face-mm mlg+marg > 4 cm	5.95	5.73	3.60	0.46	12.14	10.01	010
11981		A	Insert drug implant device	1.48	1.59	0.58	0.14	3.21	2.20	XXX
11982		A	Remove drug implant device	1.78	1.71	0.70	0.17	3.66	2.65	XXX
11983		A	Remove/insert drug implant	3.30	2.30	1.28	0.31	5.91	4.89	XXX
17304		A	1 stage mohs, up to 5 spec	7.60	8.09	3.66	0.31	16.00	11.57	000
17305		A	2 stage mohs, up to 5 spec	2.85	3.81	1.37	0.12	6.78	4.34	000
17306		A	3 stage mohs, up to 5 spec	2.85	3.81	1.38	0.12	6.78	4.35	000
17307		A	Mohs addl stage up to 5 spec	2.85	3.82	1.40	0.12	6.79	4.37	000
17310		A	Mohs any stage > 5 spec each	0.62	1.48	0.31	0.05	2.15	0.98	ZZZ
20526		A	Ther injection, carp tunnel	0.94	0.77	0.41	0.06	1.77	1.41	000
20550		A	Inj tendon sheath/ligament	0.75	0.76	0.24	0.06	1.57	1.05	000
20551		A	Inject tendon origin/insert	0.75	0.70	0.34	0.06	1.51	1.15	000
20552		A	Inject trigger point, 1 or 2	0.66	0.66	0.30	0.06	1.38	1.02	000
20553		A	Inject trigger points, =/> 3	0.75	0.75	0.34	0.06	1.56	1.15	000
20600		A	Drain/inject, joint/bursa	0.66	0.66	0.36	0.06	1.38	1.08	000
20605		A	Drain/inject, joint/bursa	0.68	0.78	0.37	0.06	1.52	1.11	000
20612		A	Aspirate/inj ganglion cyst	0.70	0.77	0.28	0.06	1.53	1.04	000
21030		A	Excise max/zygoma b9 tumor	3.89	4.36	3.64	0.60	8.85	8.13	090
21034		A	Excise max/zygoma mlg tumor	16.17	10.67	10.64	1.37	28.21	28.18	090
21040		A	Excise mandible lesion	3.89	3.76	2.58	0.19	7.84	6.66	090
21046		A	Remove mandible cyst complex	13.00	NA	10.42	1.01	NA	24.43	090
21047		A	Excise lwr jaw cyst w/repair	18.75	NA	9.87	1.53	NA	30.15	090
21048		A	Remove maxilla cyst complex	13.50	NA	10.63	1.01	NA	25.14	090
21049		A	Excis uppr jaw cyst w/repair	18.00	NA	9.55	1.01	NA	28.56	090
21740		A	Reconstruction of sternum	16.50	NA	12.48	2.03	NA	31.01	090
21742		C	Repair stern/nuss w/o scope	0.00	0.00	0.00	0.00	0.00	0.00	090
21743		C	Repair sternum/nuss w/scope	0.00	0.00	0.00	0.00	0.00	0.00	090
23410		A	Repair rotator cuff, acute	12.45	NA	12.81	1.72	NA	26.98	090
23412		A	Repair rotator cuff, chronic	13.31	NA	13.32	1.86	NA	28.49	090
24344		A	Reconstruct elbow lat ligmnt	14.00	NA	11.18	1.83	NA	27.01	090
24346		A	Reconstruct elbow med ligmnt	14.00	NA	11.18	1.83	NA	27.01	090
25320		A	Repair/revise wrist joint	10.77	NA	11.50	1.32	NA	23.59	090
27425		A	Lat retinacular release open	5.22	NA	7.58	0.73	NA	13.53	090
27730		A	Repair of tibia epiphysis	7.41	21.22	10.17	0.75	29.38	18.33	090
27732		A	Repair of fibula epiphysis	5.32	14.21	8.71	0.63	20.16	14.66	090
27734		A	Repair lower leg epiphyses	8.48	NA	9.91	0.85	NA	19.24	090
27870		A	Fusion of ankle joint, open	13.91	NA	14.08	1.95	NA	29.94	090
29806		A	Shoulder arthroscopy/surgery	14.37	NA	11.17	2.00	NA	27.54	090
29827		A	Arthroscop rotator cuff repr	15.36	NA	11.55	1.86	NA	28.77	090
29873		A	Knee arthroscopy/surgery	6.00	NA	6.56	0.73	NA	13.29	090
29899		A	Ankle arthroscopy/surgery	13.91	NA	10.58	1.95	NA	26.44	090
33215		A	Reposition pacing-defib lead	4.76	NA	3.15	0.36	NA	8.27	090
33216		A	Insert lead pace-defib, one	5.78	NA	5.32	0.36	NA	11.46	090
33217		A	Insert lead pace-defib, dual	5.75	NA	5.58	0.36	NA	11.69	090
33224		A	Insert pacing lead & connect	9.05	NA	3.92	0.36	NA	13.33	090
33225		A	L ventric pacing lead add-on	8.34	NA	3.11	0.36	NA	11.81	ZZZ
33226		A	Reposition l ventric lead	8.69	NA	3.79	0.36	NA	12.84	000
33508		A	Endoscopic vein harvest	0.31	NA	0.11	0.03	NA	0.45	ZZZ
33979		A	Insert intracorporeal device	46.00	17.88	17.88	3.98	67.86	67.86	XXX
33980		A	Remove intracorporeal device	56.25	NA	26.47	4.60	NA	87.32	090
34812		A	Xpose for endoprosth, femorl	6.75	NA	2.29	0.49	NA	9.53	000
34825		A	Endovasc extend prosth, init	12.00	NA	5.95	0.86	NA	18.81	090
34826		A	Endovasc exten prosth, addl	4.13	NA	1.41	0.29	NA	5.83	ZZZ
34833		A	Xpose for endoprosth, iliac	12.00	NA	4.98	0.70	NA	17.68	000
34834		A	Xpose, endoprosth, brachial	5.35	NA	2.48	0.49	NA	8.32	000
34900		A	Endovasc iliac repr w/graft	16.38	NA	8.24	1.49	NA	26.11	090
35572		A	Harvest femoropopliteal vein	6.82	NA	2.57	0.63	NA	10.02	ZZZ
36415		I	Routine venipuncture	0.00	0.00	0.00	0.00	0.00	0.00	XXX
36416		I	Capillary blood draw	0.00	0.00	0.00	0.00	0.00	0.00	XXX
36511		A	Apheresis wbc	1.74	NA	0.70	0.06	NA	2.50	000
36512		A	Apheresis rbc	1.74	NA	0.70	0.06	NA	2.50	000
36513		A	Apheresis platelets	1.74	NA	0.70	0.06	NA	2.50	000
36514		A	Apheresis plasma	1.74	NA	0.70	0.06	NA	2.50	000
36515		A	Apheresis, adsorp/reinfuse	1.74	NA	0.70	0.06	NA	2.50	000
36516		A	Apheresis, selective	1.74	NA	0.70	0.06	NA	2.50	000
36536		A	Remove cva device obstruct	3.60	33.54	1.47	0.23	37.37	5.30	000
36537		A	Remove cva lumen obstruct	0.75	7.69	0.49	0.04	8.48	1.28	000
36540		B	Collect blood venous device	0.00	0.00	0.00	0.00	0.00	0.00	XXX
37182		A	Insert hepatic shunt (tips)	17.00	NA	6.37	1.49	NA	24.86	000
37183		A	Remove hepatic shunt (tips)	8.00	NA	3.12	0.43	NA	11.55	000
37500		A	Endoscopy ligate perf veins	11.00	NA	8.70	0.40	NA	20.10	090
37760		A	Ligation, leg veins, open	10.47	NA	5.63	1.11	NA	17.21	090
38204		B	Bl donor search management	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38205		R	Harvest allogenic stem cells	1.50	NA	0.61	0.05	NA	2.16	000
38206		R	Harvest auto stem cells	1.50	NA	0.61	0.05	NA	2.16	000
38207		I	Cryopreserve stem cells	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38208		I	Thaw preserved stem cells	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38209		I	Wash harvest stem cells	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38210		I	T-cell depletion of harvest	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38211		I	Tumor cell deplete of harvst	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38212		I	Rbc depletion of harvest	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38213		I	Platelet deplete of harvest	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38214		I	Volume deplete of harvest	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38215		I	Harvest stem cell concentrte	0.00	0.00	0.00	0.00	0.00	0.00	XXX
38242		A	Lymphocyte infuse transplant	1.71	NA	0.70	0.05	NA	2.46	000
43201		A	Esoph scope w/submucous inj	2.09	4.44	1.27	0.12	6.65	3.48	000
43219		A	Esophagus endoscopy	2.80	NA	1.40	0.16	NA	4.36	000
43236		A	Uppr gi scope w/submuc inj	2.92	4.70	1.26	0.14	7.76	4.32	000
43245		A	Uppr gi scope dilate strictr	3.18	13.87	1.34	0.18	17.23	4.70	000
43256		A	Uppr gi endoscopy w stent	4.35	NA	1.77	0.23	NA	6.35	000
44206		A	Lap part colectomy w/stoma	27.00	NA	11.22	2.02	NA	40.24	090
44207		A	L colectomy/coloproctostomy	30.00	NA	11.82	2.22	NA	44.04	090
44208		A	L colectomy/coloproctostomy	32.00	NA	13.42	2.20	NA	47.62	090
44210		A	Laparo total proctocolectomy	28.00	NA	12.11	2.05	NA	42.16	090
44211		A	Laparo total proctocolectomy	35.00	NA	15.02	2.33	NA	52.35	090
44212		A	Laparo total proctocolectomy	32.50	NA	14.16	2.26	NA	48.92	090
44383		A	Ileoscopy w/stent	2.94	NA	1.42	0.13	NA	4.49	000
44701		A	Intraop colon lavage add-on	3.10	NA	1.07	0.21	NA	4.38	ZZZ
45335		A	Sigmoidoscope w/submuc inj	1.36	2.48	0.65	0.07	3.91	2.08	000
45340		A	Sig w/balloon dilation	1.66	7.19	0.76	0.07	8.92	2.49	000
45381		A	Colonoscope, submucous inj	4.20	6.15	1.70	0.21	10.56	6.11	000
45386		A	Colonoscope dilate stricture	4.58	15.29	1.84	0.21	20.08	6.63	000
46706		A	Repr of anal fistula w/glue	2.39	NA	1.24	0.17	NA	3.80	010
47370		A	Laparo ablate liver tumor rf	19.69	NA	9.72	0.85	NA	30.26	090
47371		A	Laparo ablate liver cryosurg	19.69	NA	9.72	0.85	NA	30.26	090
47380		A	Open ablate liver tumor rf	23.00	NA	11.01	0.85	NA	34.86	090
47381		A	Open ablate liver tumor cryo	23.27	NA	11.12	0.85	NA	35.24	090
47382		A	Percut ablate liver rf	15.19	NA	6.25	1.14	NA	22.58	010
49419		A	Insrt abdom cath for chemotx	6.65	NA	3.81	0.55	NA	11.01	090
49904		A	Omental flap, extra-abdom	20.00	NA	15.98	1.91	NA	37.89	090
49905		A	Omental flap, intra-abdom	6.55	NA	2.34	0.61	NA	9.50	ZZZ
50542		A	Laparo ablate renal mass	20.00	NA	8.34	1.36	NA	29.70	090
50543		A	Laparo partial nephrectomy	25.50	NA	10.48	1.36	NA	37.34	090
50562		A	Renal scope w/tumor resect	10.92	NA	4.02	0.84	NA	15.78	090
51701		A	Insert bladder catheter	0.50	1.06	0.20	0.03	1.59	0.73	000
51702		A	Insert temp bladder cath	0.50	1.97	0.27	0.03	2.50	0.80	000
51703		A	Insert bladder cath, complex	1.47	1.91	0.59	0.09	3.47	2.15	000
51798		A	Us urine capacity measure	0.00	0.48	NA	0.07	0.55	NA	XXX
52001		A	Cystoscopy, removal of clots	5.45	7.89	2.33	0.32	13.66	8.10	000
53440		A	Male sling procedure	13.62	NA	6.33	0.73	NA	20.68	090
53442		A	Remove/revise male sling	11.57	NA	5.93	0.55	NA	18.05	090
55866		A	Laparo radical prostatectomy	30.74	NA	11.79	1.37	NA	43.90	090
56820		A	Exam of vulva w/scope	1.50	1.64	0.65	0.10	3.24	2.25	000
56821		A	Exam/biopsy of vulva w/scope	2.05	2.02	0.92	0.13	4.20	3.10	000
57420		A	Exam of vagina w/scope	1.60	1.68	0.69	0.10	3.38	2.39	000
57421		A	Exam/biopsy of vag w/scope	2.20	2.08	0.98	0.13	4.41	3.31	000
57452		A	Exam of cervix w/scope	1.50	1.70	0.65	0.10	3.30	2.25	000
57454		A	Bx/curett of cervix w/scope	2.33	2.05	1.02	0.13	4.51	3.48	000
57455		A	Biopsy of cervix w/scope	1.99	1.94	0.89	0.13	4.06	3.01	000
57456		A	Endocerv curettage w/scope	1.85	1.86	0.84	0.13	3.84	2.82	000
57460		A	Bx of cervix w/scope, leep	2.83	5.01	1.25	0.28	8.12	4.36	000
57461		A	Conz of cervix w/scope, leep	3.44	5.32	1.50	0.28	9.04	5.22	000
58140		A	Myomectomy abdom method	14.60	NA	7.01	1.46	NA	23.07	090
58145		A	Myomectomy vag method	8.04	NA	4.84	0.80	NA	13.68	090
58146		A	Myomectomy abdom complex	19.00	NA	9.15	1.46	NA	29.61	090
58260		A	Vaginal hysterectomy	12.98	NA	6.68	1.23	NA	20.89	090
58262		A	Vag hyst including t/o	14.77	NA	7.43	1.42	NA	23.62	090
58263		A	Vag hyst w/t/o & vag repair	16.06	NA	7.95	1.55	NA	25.56	090
58267		A	Vag hyst w/urinary repair	17.04	NA	8.52	1.51	NA	27.07	090
58270		A	Vag hyst w/enterocele repair	14.26	NA	7.19	1.37	NA	22.82	090
58290		A	Vag hyst complex	19.00	NA	9.37	1.23	NA	29.60	090
58291		A	Vag hyst incl t/o, complex	20.79	NA	10.34	1.42	NA	32.55	090
58292		A	Vag hyst t/o & repair, compl	22.08	NA	10.85	1.55	NA	34.48	090
58293		A	Vag hyst w/uro repair, compl	23.06	NA	11.25	1.51	NA	35.82	090
58294		A	Vag hyst w/enterocele, compl	20.28	NA	10.10	1.37	NA	31.75	090
58545		A	Laparoscopic myomectomy	14.60	NA	7.76	1.45	NA	23.81	090
58546		A	Laparo-myomectomy, complex	19.00	NA	9.55	1.45	NA	30.00	090
58550		A	Laparo-asst vag hysterectomy	14.19	NA	7.21	1.44	NA	22.84	010
58552		A	Laparo-vag hyst incl t/o	14.19	NA	7.56	1.44	NA	23.19	090
58553		A	Laparo-vag hyst, complex	19.00	NA	9.57	1.23	NA	29.80	090
58554		A	Laparo-vag hyst w/t/o, compl	19.00	NA	9.26	1.23	NA	29.49	090
61316		A	Implt cran bone flap to abdo	1.39	NA	0.57	0.43	NA	2.39	ZZZ
61322		A	Decompressive craniotomy	29.50	NA	13.88	4.99	NA	48.37	090
61323		A	Decompressive lobectomy	31.00	NA	14.08	4.99	NA	50.07	090
61340		A	Subtemporal decompression	18.66	NA	11.41	3.66	NA	33.73	090
61517		A	Implt brain chemotx add-on	1.38	NA	0.56	0.08	NA	2.02	ZZZ
61623		A	Endovasc tempory vessel occl	9.96	NA	4.23	0.50	NA	14.69	000
61624		A	Transcath occlusion, cns	20.15	NA	7.13	1.15	NA	28.43	000
62148		A	Retr bone flap to fix skull	2.00	NA	0.82	0.43	NA	3.25	ZZZ
62160		A	Neuroendoscopy add-on	3.00	NA	1.16	0.52	NA	4.68	ZZZ
62161		A	Dissect brain w/scope	20.00	NA	9.71	3.70	NA	33.41	090
62162		A	Remove colloid cyst w/scope	25.25	NA	11.89	5.77	NA	42.91	090
62163		A	Neuroendoscopy w/fb removal	15.50	NA	7.97	3.70	NA	27.17	090
62164		A	Remove brain tumor w/scope	27.50	NA	13.12	5.77	NA	46.39	090
62165		A	Remove pituit tumor w/scope	22.00	NA	10.68	3.63	NA	36.31	090
62201		A	Brain cavity shunt w/scope	14.86	NA	9.77	2.52	NA	27.15	090
62263		A	Epidural lysis mult sessions	6.14	13.45	2.43	0.42	20.01	8.99	010
62264		A	Epidural lysis on single day	4.43	11.38	1.32	0.30	16.11	6.05	010
64415		A	N block inj, brachial plexus	1.48	3.05	0.39	0.08	4.61	1.95	000
64416		A	N block cont infuse, b plex	3.50	NA	0.75	0.08	NA	4.33	010
64445		A	N block inj, sciatic, sng	1.48	2.78	0.38	0.08	4.34	1.94	000
64446		A	N blk inj, sciatic, cont inf	3.25	NA	1.15	0.08	NA	4.48	010
64447		A	N block inj fem, single	1.50	NA	0.52	0.08	NA	2.10	000
64448		A	N block inj fem, cont inf	3.00	NA	1.04	0.08	NA	4.12	010
64450		A	N block, other peripheral	1.27	1.30	0.42	0.08	2.65	1.77	000
66990		A	Ophthalmic endoscope add-on	1.51	NA	0.70	0.06	NA	2.27	ZZZ
75901	26	A	Remove cva device obstruct	0.49	0.17	0.17	0.02	0.68	0.68	XXX
75902	26	A	Remove cva lumen obstruct	0.39	0.13	0.13	0.02	0.54	0.54	XXX
75953	26	A	Abdom aneurysm endovas rpr	1.36	0.53	0.53	0.68	2.57	2.57	XXX
75954	26	A	Iliac aneurysm endovas rpr	1.36	0.48	0.48	0.68	2.52	2.52	XXX
76070	26	A	Ct bone density, axial	0.25	0.08	0.08	0.01	0.34	0.34	XXX
76071	26	A	Ct bone density, peripheral	0.22	0.07	0.07	0.01	0.30	0.30	XXX
76085	26	A	Computer mammogram add-on	0.06	0.02	0.02	0.01	0.09	0.09	ZZZ
76362	26	A	Cat scan for tissue ablation	4.00	1.35	1.35	0.18	5.53	5.53	XXX
76394	26	A	Mri for tissue ablation	4.25	1.44	1.44	0.19	5.88	5.88	XXX
76490	26	A	Us for tissue ablation	4.00	1.34	1.34	0.11	5.45	5.45	XXX
76801	26	A	Ob us < 14 wks, single fetus	0.99	0.36	0.36	0.04	1.39	1.39	XXX
76802	26	A	Ob us < 14 wks, addl fetus	0.83	0.30	0.30	0.04	1.17	1.17	XXX
76805	26	A	Ob us >/= 14 wks, sngl fetus	0.99	0.35	0.35	0.04	1.38	1.38	XXX
76810	26	A	Ob us >/= 14 wks, addl fetus	0.98	0.36	0.36	0.07	1.41	1.41	ZZZ
76811	26	A	Ob us, detailed, sngl fetus	1.90	0.68	0.68	0.15	2.73	2.73	XXX
76812	26	A	Ob us, detailed, addl fetus	1.78	0.65	0.65	0.12	2.55	2.55	ZZZ
76815	26	A	Ob us, limited, fetus(s)	0.65	0.24	0.24	0.02	0.91	0.91	XXX
76816	26	A	Ob us, follow-up, per fetus	0.85	0.33	0.33	0.02	1.20	1.20	XXX
76817	26	A	Transvaginal us, obstetric	0.75	0.28	0.28	0.02	1.05	1.05	XXX
92601		A	Cochlear implt f/up exam < 7	0.00	3.50	NA	0.06	3.56	NA	XXX
92602		A	Reprogram cochlear implt < 7	0.00	2.44	NA	0.06	2.50	NA	XXX
92603		A	Cochlear implt f/up exam 7 >	0.00	2.34	NA	0.06	2.40	NA	XXX
92604		A	Reprogram cochlear implt 7 >	0.00	1.58	NA	0.06	1.64	NA	XXX
92605		B	Eval for nonspeech device rx	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92606		B	Non-speech device service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92607		A	Ex for speech device rx, 1hr	0.00	2.93	NA	0.04	2.97	NA	XXX
92608		A	Ex for speech device rx addl	0.00	0.55	NA	0.04	0.59	NA	XXX
92609		A	Use of speech device service	0.00	1.58	NA	0.03	1.61	NA	XXX
92610		A	Evaluate swallowing function	0.00	1.08	NA	0.07	1.15	NA	XXX
92611		A	Motion fluoroscopy/swallow	0.00	1.18	NA	0.07	1.25	NA	XXX
92612		A	Endoscopy swallow tst (fees)	1.27	3.36	0.50	0.07	4.70	1.84	XXX
92613		B	Endoscopy swallow tst (fees)	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92614		A	Laryngoscopic sensory test	1.27	2.29	0.50	0.07	3.63	1.84	XXX
92615		B	Eval laryngoscopy sense tst	0.00	0.00	0.00	0.00	0.00	0.00	XXX
92616		A	Fees w/laryngeal sense test	1.88	3.02	0.73	0.07	4.97	2.68	XXX
92617		B	Interprt fees/laryngeal test	0.00	0.00	0.00	0.00	0.00	0.00	XXX
93580		A	Transcath closure of asd	18.00	NA	7.34	1.14	NA	26.48	000
93581		A	Transcath closure of vsd	24.43	NA	9.84	1.14	NA	35.41	000
93609	26	A	Map tachycardia, add-on	5.00	2.00	2.00	0.52	7.52	7.52	ZZZ
93613		A	Electrophys map 3d, add-on	7.00	2.72	2.72	0.52	10.24	10.24	ZZZ
93619	26	A	Electrophysiology evaluation	7.32	2.92	2.92	0.38	10.62	10.62	000
93620	26	A	Electrophysiology evaluation	11.59	4.62	4.62	0.60	16.81	16.81	000
93621	26	A	Electrophysiology evaluation	2.10	0.84	0.84	0.15	3.09	3.09	ZZZ
93622	26	A	Electrophysiology evaluation	3.10	1.23	1.23	0.67	5.00	5.00	ZZZ
95990		A	Spin/brain pump refil & main	0.00	1.49	NA	0.05	1.54	NA	XXX
96000		A	Motion analysis, video/3d	1.80	NA	0.70	0.02	NA	2.52	XXX
96001		A	Motion test w/ft press meas	2.15	NA	0.84	0.02	NA	3.01	XXX
96002		A	Dynamic surface emg	0.41	NA	0.16	0.02	NA	0.59	XXX
96003		A	Dynamic fine wire emg	0.37	NA	0.14	0.03	NA	0.54	XXX
96004		A	Phys review of motion tests	2.14	0.84	0.84	0.08	3.06	3.06	XXX
96530		A	Syst pump refill & main	0.00	1.05	NA	0.05	1.10	NA	XXX
96920		A	Laser tx, skin < 250 sq cm	1.15	2.88	0.45	0.09	4.12	1.69	000
96921		A	Laser tx, skin 250-500 sq cm	1.17	2.96	0.46	0.09	4.22	1.72	000
96922		A	Laser tx, skin > 500 sq cm	2.10	3.56	0.82	0.16	5.82	3.08	000
99026		I	In-hospital on call service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99027		I	Out-of-hosp on call service	0.00	0.00	0.00	0.00	0.00	0.00	XXX
99289		A	Ped crit care transport	4.80	NA	1.87	0.14	NA	6.81	XXX
99290		A	Ped crit care transport addl	2.40	NA	0.94	0.07	NA	3.41	ZZZ
99293		A	Ped critical care, initial	16.00	NA	5.13	0.70	NA	21.83	XXX
99294		A	Ped critical care, subseq	8.00	NA	2.57	0.23	NA	10.80	XXX
99295		A	Neonate crit care, initial	18.49	NA	5.48	0.70	NA	24.67	XXX
99296		A	Neonate critical care subseq	8.00	NA	2.61	0.23	NA	10.84	XXX
99298		A	Ic for lbw infant < 1500 gm	2.75	NA	0.96	0.10	NA	3.81	XXX
99299		A	Ic, lbw infant 1500-2500 gm	2.50	NA	0.98	0.10	NA	3.58	XXX
G0262	26	A	Sm intestinal image capsule	2.12	0.83	0.83	0.02	2.97	2.97	XXX
G0268		A	Removal of impacted wax md	0.61	0.57	0.24	0.04	1.22	0.89	000
G0269		B	Occlusive device in vein art	0.00	0.00	0.00	0.00	0.00	0.00	XXX
G0270		A	MNT subs tx for change dx	0.00	0.47	NA	0.01	0.48	NA	XXX
G0271		A	Group MNT 2 or more 30 mins	0.00	0.18	NA	0.01	0.19	NA	XXX
G0272		A	Naso/oro gastric tube pl MD	0.32	0.13	NA	0.02	0.47	NA	000
G0273	26	A	Pretx planning, non-Hodgkins	0.86	0.34	0.34	0.03	1.23	1.23	XXX
G0274	26	A	Radiopharm tx, non-Hodgkins	2.07	0.81	0.81	0.08	2.96	2.96	XXX
G0275		A	Renal angio, cardiac cath	0.25	0.10	NA	0.01	0.36	NA	ZZZ
G0278		A	Iliac art angio,cardiac cath	0.25	0.10	NA	0.01	0.36	NA	ZZZ
G0279		A	Excorp shock tx, elbow epi	0.06	1.46	NA	0.01	1.53	NA	XXX
G0280		A	Excorp shock tx other than	0.06	1.46	NA	0.01	1.53	NA	XXX
G0281		A	Elec stim unattend for press	0.18	0.35	0.07	0.01	0.54	0.26	XXX
G0283		A	Elec stim other than wound	0.18	0.35	0.07	0.01	0.54	0.26	XXX
G0288		A	Recon, CTA for surg plan	0.00	10.57	NA	0.15	10.72	NA	XXX
G0289		A	Arthro, loose body + chondro	1.48	0.58	NA	0.27	2.33	NA	ZZZ
1 CPT codes and descriptions only are copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2002 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

       

 

Addendum D.—2002/2003 Geographic Practice Cost Indices by Medicare Carrier and Locality

Carrier No.	Locality No. -	Locality name	Work	Practice expense	Mal- practice
00510	00	ALABAMA	0.978	0.870	0.807
00831	01	ALASKA	1.064	1.172	1.223
00832	00	ARIZONA	0.994	0.978	1.111
00520	13	ARKANSAS	0.953	0.847	0.340
31146	26	ANAHEIM/SANTA ANA, CA	1.037	1.184	0.955
31146	18	LOS ANGELES, CA	1.056	1.139	0.955
31140	03	MARIN/NAPA/SOLANO, CA	1.015	1.248	0.687
31140	07	OAKLAND/BERKELEY, CA	1.041	1.235	0.687
31140	05	SAN FRANCISCO, CA	1.068	1.458	0.687
31140	06	SAN MATEO, CA	1.048	1.432	0.687
31140	09	SANTA CLARA, CA	1.063	1.380	0.639
31146	17	VENTURA, CA	1.028	1.125	0.783
31146	99	REST OF CALIFORNIA*	1.007	1.034	0.748
31140	99	REST OF CALIFORNIA*	1.007	1.034	0.748
00824	01	COLORADO	0.985	0.992	0.840
00591	00	CONNECTICUT	1.050	1.156	0.966
00902	01	DELAWARE	1.019	1.035	0.712
00903	01	DC + MD/VA SUBURBS	1.050	1.166	0.909
00590	03	FORT LAUDERDALE, FL	0.996	1.018	1.877
00590	04	MIAMI, FL	1.015	1.052	2.528
00590	99	REST OF FLORIDA	0.975	0.946	1.265
00511	01	ATLANTA, GA	1.006	1.059	0.935
00511	99	REST OF GEORGIA	0.970	0.892	0.935
00833	01	HAWAII/GUAM	0.997	1.124	0.834
05130	00	IDAHO	0.960	0.881	0.497
00952	16	CHICAGO, IL	1.028	1.092	1.797
00952	12	EAST ST. LOUIS, IL	0.988	0.924	1.691
00952	15	SUBURBAN CHICAGO, IL	1.006	1.071	1.645
00952	99	REST OF ILLINOIS	0.964	0.889	1.157
00630	00	INDIANA	0.981	0.922	0.481
00826	00	IOWA	0.959	0.876	0.596
00650	00	KANSAS*	0.963	0.895	0.756
00740	04	KANSAS*	0.963	0.895	0.756
00660	00	KENTUCKY	0.970	0.866	0.877
00528	01	NEW ORLEANS, LA	0.998	0.945	1.283
00528	99	REST OF LOUISIANA	0.968	0.870	1.073
31142	03	SOUTHERN MAINE	0.979	0.999	0.666
31142	99	REST OF MAINE	0.961	0.910	0.666
00901	01	BALTIMORE/SURR. CNTYS, MD	1.021	1.038	0.916
00901	99	REST OF MARYLAND	0.984	0.972	0.774
31143	01	METROPOLITAN BOSTON	1.041	1.239	0.784
31143	99	REST OF MASSACHUSETTS	1.010	1.129	0.784
00953	01	DETROIT, MI	1.043	1.038	2.738
00953	99	REST OF MICHIGAN	0.997	0.938	1.571
00954	00	MINNESOTA	0.990	0.974	0.452
00512	00	MISSISSIPPI	0.957	0.837	0.779
00740	02	METROPOLITAN KANSAS CITY, MO	0.988	0.967	0.846
00523	01	METROPOLITAN ST. LOUIS, MO	0.994	0.938	0.846
00740	99	REST OF MISSOURI*	0.946	0.825	0.793
00523	99	REST OF MISSOURI*	0.946	0.825	0.793
00751	01	MONTANA	0.950	0.876	0.727
00655	00	NEBRASKA	0.948	0.877	0.430
00834	00	NEVADA	1.005	1.039	1.209
31144	40	NEW HAMPSHIRE	0.986	1.030	0.825
00805	01	NORTHERN NJ	1.058	1.193	0.860
00805	99	REST OF NEW JERSEY	1.029	1.110	0.860
00521	05	NEW MEXICO	0.973	0.900	0.902
00803	01	MANHATTAN, NY	1.094	1.351	1.668
00803	02	NYC SUBURBS/LONG I., NY	1.068	1.251	1.952
00803	03	POUGHKPSIE/N NYC SUBURBS, NY	1.011	1.075	1.275
14330	04	QUEENS, NY	1.058	1.228	1.871
00801	99	REST OF NEW YORK	0.998	0.944	0.764
05535	00	NORTH CAROLINA	0.970	0.931	0.595
00820	01	NORTH DAKOTA	0.950	0.880	0.657
16360	00	OHIO	0.988	0.944	0.957
00522	00	OKLAHOMA	0.968	0.876	0.444
00835	01	PORTLAND, OR	0.996	1.049	0.436
00835	99	REST OF OREGON	0.961	0.933	0.436
00865	01	METROPOLITAN PHILADELPHIA, PA	1.023	1.092	1.413
00865	99	REST OF PENNSYLVANIA	0.989	0.929	0.774
00973	20	PUERTO RICO	0.881	0.712	0.275
00870	01	RHODE ISLAND	1.017	1.065	0.883
00880	01	SOUTH CAROLINA	0.974	0.904	0.279
00820	02	SOUTH DAKOTA	0.935	0.878	0.406
05440	35	TENNESSEE	0.975	0.900	0.592
00900	31	AUSTIN, TX	0.986	0.996	0.859
00900	20	BEAUMONT, TX	0.992	0.890	1.338
00900	09	BRAZORIA, TX	0.992	0.978	1.338
00900	11	DALLAS, TX	1.010	1.065	0.931
00900	28	FORT WORTH, TX	0.987	0.981	0.931
00900	15	GALVESTON, TX	0.988	0.969	1.338
00900	18	HOUSTON, TX	1.020	1.007	1.336
00900	99	REST OF TEXAS	0.966	0.880	0.956
00910	09	UTAH	0.976	0.941	0.644
31145	50	VERMONT	0.973	0.986	0.539
00973	50	VIRGIN ISLANDS	0.965	1.023	1.002
00904	00	VIRGINIA	0.984	0.938	0.500
00836	02	SEATTLE (KING CNTY), WA	1.005	1.100	0.788
00836	99	REST OF WASHINGTON	0.981	0.972	0.788
16510	16	WEST VIRGINIA	0.963	0.850	1.378
00951	00	WISCONSIN	0.981	0.929	0.939
00825	21	WYOMING	0.967	0.895	1.005
*Payment locality is serviced by two carriers.
Note: Work GPCI is the 1/4 work GPCI required by Section 1848(e)(1)(A)(iii) of the Social Security Act. GPCIs rescaled by the following factors for budget netrality: Work = 0.99699; Practice Expense = 0.99235; Malpractice Expense = 1.00215.

Addendum E.—Updated List of CPT1/HCPCS Codes Used To Describe Certain Designated Health Services Under the Physician Referral Provisions

[Section 1877 of the Social Security Act—Effective January 1, 2003]

CLINICAL LABORATORY SERVICES
INCLUDE CPT codes for all clinical laboratory services in the 80000 series, except EXCLUDE CPT codes for the following blood component collection services:
86890	Autologous blood process
86891	Autologous blood, op salvage
86927	Plasma, fresh frozen
86930	Frozen blood prep
86931	Frozen blood thaw
86932	Frozen blood freeze/thaw
86945	Blood product/irradiation
86950	Leukacyte transfusion
86965	Pooling blood platelets
86985	Split blood or products
INCLUDE the following CPT and HCPCS level 2 codes for other clinical laboratory services:
0010T	TB test,gamma interferon-
0023T	Phenotype drug test, hiv 1
0026T	Measure remnant lipoproteins
0030T	Antiprothrombin antibody
0041T	Detect ur infect agent w/cpas
0043T	Co expired gas analysis
G0001	Drawing blood for specimen
G0103	Psa, total screening
G0107	CA screen; fecal blood test
G0123	Screen cerv/vag thin layer
G0124	Screen c/v thin layer by MD
G0141	Scr c/v cyto,autosys and md
G0143	Scr c/v cyto,thinlayer,rescr
G0144	Scr c/v cyto,thinlayer,rescr
G0145	Scr c/v cyto,thinlayer,rescr
G0147	Scr c/v cyto, automated sys
G0148	Scr c/v cyto, autosys, rescr
P2028	Cephalin floculation test
P2029	Congo red blood test
P2031	Hair analysis
P2033	Blood thymol turbidity
P2038	Blood mucoprotein
P3000	Screen pap by tech w md supv
P3001	Screening pap smear by phys
P7001	Culture bacterial urine
P9612	Catheterize for urine spec
P9615	Urine specimen collect mult
Q0111	Wet mounts/ w preparations
Q0112	Potassium hydroxide preps
Q0113	Pinworm examinations
Q0114	Fern test
Q0115	Post-coital mucous exam
PHYSICAL THERAPY, OCCUPATIONAL THERAPY, AND SPEECH-LANGUAGE PATHOLOGY
INCLUDE the following CPT codes for the physical therapy/occupational therapy/speech-language pathology services in the 97000 series:
97001	Pt evaluation
97002	Pt re-evaluation
97003	Ot evaluation
97004	Ot re-evaluation
97010	Hot or cold packs therapy
97012	Mechanical traction therapy
97016	Vasopneumatic device therapy
97018	Paraffin bath therapy
97020	Microwave therapy
97022	Whirlpool therapy
97024	Diathermy treatment
97026	Infrared therapy
97028	Ultraviolet therapy
97032	Electrical stimulation
97033	Electric current therapy
97034	Contrast bath therapy
97035	Ultrasound therapy
97036	Hydrotherapy
97039	Physical therapy treatment
97110	Therapeutic exercises
97112	Neuromuscular reeducation
97113	Aquatic therapy/exercises
97116	Gait training therapy
97124	Massage therapy
97139	Physical medicine procedure
97140	Manual therapy
97150	Group therapeutic procedures
97504	Orthotic training
97520	Prosthetic training
97530	Therapeutic activities
97532	Cognitive skills development
97533	Sensory integration
97535	Self care mngment training
97537	Community/work reintegration
97542	Wheelchair mngment training
97545	Work hardening
97546	Work hardening add-on
97703	Prosthetic checkout
97750	Physical performance test
97799	Physical medicine procedure
INCLUDE CPT codes for physical therapy/occupational therapy/speech-language pathology services not in the 97000 series:
64550	Apply neurostimulator
90901	Biofeedback train, any meth
90911	Biofeedback peri/uro/rectal
92506	Speech/hearing evaluation
92507	Speech/hearing therapy
92508	Speech/hearing therapy-
92526	Oral function therapy
92601	Cochlear implt f/up exam < 7
92602	Reprogram cochlear implt < 7
92603	Cochlear implt f/up exam 7 >
92604	Reprogram cochlear implt 7 >-
92607	Ex for speech device rx, 1hr
92608	Ex for speech device rx addl
92609	Use of speech device service
92610	Evaluate swallowing function
92611	Motion fluoroscopy/swallow
92612	Endoscopy swallow tst (fees)
92614	Laryngoscopic sensory test
92616	Fees w/laryngeal sense test
93797	Cardiac rehab
93798	Cardiac rehab/monitor
94667	Chest wall manipulation
94668	Chest wall manipulation
94762	Measure blood oxygen level
95831	Limb muscle testing, manual
95832	Hand muscle testing, manual
95833	Body muscle testing, manual
95834	Body muscle testing, manual
95851	Range of motion measurements
95852	Range of motion measurements
96000	Motion analysis, video/3d
96001	Motion test w/ft press meas
96002	Dynamic surface emg
96003	Dynamic fine wire emg
96105	Assessment of aphasia
96110	Developmental test, lim
96111	Developmental test, extend
96115	Neurobehavior status exam
0019T	Extracorp shock wave tx, ms-
0020T	Extracorp shock wave tx, ft
0029T	Magnetic tx for incontinence
INCLUDE HCPCS level 2 codes for the following physical therapy/occupational therapy/speech-language pathology service:
G0279	Excorp shock tx, elbow epi
G0280	Excorp shock tx other than
G0281	Elec stim unattend for press
G0283	Elec stim other than wound
Q0086	Physical therapy evaluation/
RADIOLOGY AND CERTAIN OTHER IMAGING SERVICES
INCLUDE the following codes in the CPT 70000 series:
70100	X-ray exam of jaw
70110	X-ray exam of jaw
70120	X-ray exam of mastoids
70130	X-ray exam of mastoids
70134	X-ray exam of middle ear
70140	X-ray exam of facial bones
70150	X-ray exam of facial bones
70160	X-ray exam of nasal bones
70190	X-ray exam of eye sockets
70200	X-ray exam of eye sockets
70210	X-ray exam of sinuses
70220	X-ray exam of sinuses
70240	X-ray exam, pituitary saddle
70250	X-ray exam of skull
70260	X-ray exam of skull
70300	X-ray exam of teeth
70310	X-ray exam of teeth
70320	Full mouth x-ray of teeth
70328	X-ray exam of jaw joint
70330	X-ray exam of jaw joints
70336	Magnetic image, jaw joint
70350	X-ray head for orthodontia
70355	Panoramic x-ray of jaws
70360	X-ray exam of neck
70370	Throat x-ray & fluoroscopy
70371	Speech evaluation, complex
70380	X-ray exam of salivary gland
70450	Ct head/brain w/o dye
70460	Ct head/brain w/dye
70470	Ct head/brain w/o&w dye
70480	Ct orbit/ear/fossa w/o dye
70481	Ct orbit/ear/fossa w/dye
70482	Ct orbit/ear/fossa w/o&w dye
70486	Ct maxillofacial w/o dye
70487	Ct maxillofacial w/dye
70488	Ct maxillofacial w/o&w dye
70490	Ct soft tissue neck w/o dye
70491	Ct soft tissue neck w/dye
70492	Ct sft tsue nck w/o & w/dye
70496	Ct angiography, head
70498	Ct angiography, neck
70540	Mri orbit/face/neck w/o dye
70542	Mri orbit/face/neck w/dye
70543	Mri orbt/fac/nck w/o&w dye
70544	Mr angiography head w/o dye
70545	Mr angiography head w/dye
70546	Mr angiograph head w/o&w dye
70547	Mr angiography neck w/o dye
70548	Mr angiography neck w/dye
70549	Mr angiograph neck w/o&w dye
70551	Mri brain w/o dye
70552	Mri brain w/dye
70553	Mri brain w/o&w dye
71010	Chest x-ray
71015	Chest x-ray
71020	Chest x-ray
71021	Chest x-ray
71022	Chest x-ray
71023	Chest x-ray and fluoroscopy
71030	Chest x-ray
71034	Chest x-ray and fluoroscopy
71035	Chest x-ray-
71100	X-ray exam of ribs
71101	X-ray exam of ribs/chest
71110	X-ray exam of ribs
71111	X-ray exam of ribs/ chest
71120	X-ray exam of breastbone
71130	X-ray exam of breastbone
71250	Ct thorax w/o dye
71260	Ct thorax w/dye
71270	Ct thorax w/o&w dye
71275	Ct angiography, chest
71550	Mri chest w/o dye
71551	Mri chest w/dye
71552	Mri chest w/o&w/dye
71555	Mri angio chest w or w/o dye
72010	X-ray exam of spine
72020	X-ray exam of spine
72040	X-ray exam of neck spine
72050	X-ray exam of neck spine
72052	X-ray exam of neck spine
72069	X-ray exam of trunk spine
72070	X-ray exam of thoracic spine
72072	X-ray exam of thoracic spine
72074	X-ray exam of thoracic spine
72080	X-ray exam of trunk spine
72090	X-ray exam of trunk spine
72100	X-ray exam of lower spine
72110	X-ray exam of lower spine
72114	X-ray exam of lower spine
72120	X-ray exam of lower spine
72125	Ct neck spine w/o dye
72126	Ct neck spine w/dye
72127	Ct neck spine w/o&w/dye
72128	Ct chest spine w/o dye
72129	Ct chest spine w/dye
72130	Ct chest spine w/o&w/dye
72131	Ct lumbar spine w/o dye
72132	Ct lumbar spine w/dye
72133	Ct lumbar spine w/o&w/dye
72141	Mri neck spine w/o dye
72142	Mri neck spine w/dye
72146	Mri chest spine w/o dye
72147	Mri chest spine w/dye
72148	Mri lumbar spine w/o dye
72149	Mri lumbar spine w/dye
72156	Mri neck spine w/o&w/dye
72157	Mri chest spine w/o&w/dye
72158	Mri lumbar spine w/o&w/dye
72170	X-ray exam of pelvis
72190	X-ray exam of pelvis
72191	Ct angiograph pelv w/o&w/dye
72192	Ct pelvis w/o dye
72193	Ct pelvis w/dye
72194	Ct pelvis w/o&w/dye
72195	Mri pelvis w/o dye
72196	Mri pelvis w/dye
72197	Mri pelvis w/o & w dye
72200	X-ray exam sacroiliac joints
72202	X-ray exam sacroiliac joints
72220	X-ray exam of tailbone
73000	X-ray exam of collar bone
73010	X-ray exam of shoulder blade
73020	X-ray exam of shoulder
73030	X-ray exam of shoulder
73050	X-ray exam of shoulders
73060	X-ray exam of humerus
73070	X-ray exam of elbow
73080	X-ray exam of elbow
73090	X-ray exam of forearm
73092	X-ray exam of arm, infant
73100	X-ray exam of wrist
73110	X-ray exam of wrist
73120	X-ray exam of hand
73130	X-ray exam of hand
73140	X-ray exam of finger(s)
73200	Ct upper extremity w/o dye
73201	Ct upper extremity w/dye
73202	Ct uppr extremity w/o&w/dye
73206	Ct angio upr extrm w/o&w/dye
73218	Mri upper extremity w/o dye
73219	Mri upper extremity w/dye
73220	Mri uppr extremity w/o&w/dye
73221	Mri joint upr extrem w/o dye
73222	Mri joint upr extrem w/dye
73223	Mri joint upr extr w/o&w/dye
73500	X-ray exam of hip
73510	X-ray exam of hip
73520	X-ray exam of hips
73540	X-ray exam of pelvis & hips
73550	X-ray exam of thigh
73560	X-ray exam of knee, 1 or 2
73562	X-ray exam of knee, 3
73564	X-ray exam, knee, 4 or more
73565	X-ray exam of knees
73590	X-ray exam of lower leg
73592	X-ray exam of leg, infant
73600	X-ray exam of ankle
73610	X-ray exam of ankle
73620	X-ray exam of foot
73630	X-ray exam of foot
73650	X-ray exam of heel
73660	X-ray exam of toe(s)
73700	Ct lower extremity w/o dye
73701	Ct lower extremity w/dye
73702	Ct lwr extremity w/o&w/dye
73706	Ct angio lwr extr w/o&w/dye
73718	Mri lower extremity w/o dye
73719	Mri lower extremity w/dye
73720	Mri lwr extremity w/o&w/dye
73721	Mri jnt of lwr extre w/o dye
73722	Mri joint of lwr extr w/dye
73723	Mri joint lwr extr w/o&w/dye
73725	Mr ang lwr ext w or w/o dye
74000	X-ray exam of abdomen
74010	X-ray exam of abdomen
74020	X-ray exam of abdomen
74022	X-ray exam series, abdomen
74150	Ct abdomen w/o dye
74160	Ct abdomen w/dye
74170	Ct abdomen w/o&w/dye
74175	Ct angio abdom w/o&w/dye
74181	Mri abdomen w/o dye
74182	Mri abdomen w/dye
74183	Mri abdomen w/o&w/dye
74185	Mri angio, abdom w or w/o dy
74210	Contrst x-ray exam of throat
74220	Contrast x-ray, esophagus
74230	Cine/vid x-ray, throat/esoph
74240	X-ray exam, upper gi tract
74241	X-ray exam, upper gi tract
74245	X-ray exam, upper gi tract
74246	Contrst x-ray uppr gi tract
74247	Contrst x-ray uppr gi tract
74249	Contrst x-ray uppr gi tract
74250	X-ray exam of small bowel
74290	Contrast x-ray, gallbladder
74291	Contrast x-rays, gallbladder
74710	X-ray measurement of pelvis
75552	Heart mri for morph w/o dye
75553	Heart mri for morph w/dye
75554	Cardiac MRI/function
75555	Cardiac MRI/limited study
75635	Ct angio abdominal arteries
76000	Fluoroscope examination
76006	X-ray stress view
76010	X-ray, nose to rectum
76020	X-rays for bone age
76040	X-rays, bone evaluation
76061	X-rays, bone survey
76062	X-rays, bone survey
76065	X-rays, bone evaluation
76066	Joint survey, single view
76070	Ct bone density, axial
76071	Ct bone density, peripheral
76085	Computer mammogram add-on
76090	Mammogram, one breast
76091	Mammogram, both breasts
76092	Mammogram, screening
76093	Magnetic image, breast
76094	Magnetic image, both breasts
76100	X-ray exam of body section
76101	Complex body section x-ray
76102	Complex body section x-rays
76120	Cine/video x-rays
76125	Cine/video x-rays add-on
76150	X-ray exam, dry process
76370	CAT scan for therapy guide
76375	3d/holograph reconstr add-on
76380	CAT scan follow-up study
76400	Magnetic image, bone marrow
76499	Radiographic procedure
76506	Echo exam of head
76511	Echo exam of eye
76512	Echo exam of eye
76513	Echo exam of eye, water bath
76516	Echo exam of eye
76519	Echo exam of eye
76536	Us exam of head and neck
76604	Us exam, chest, b-scan
76645	Us exam, breast(s)
76700	Us exam, abdom, complete
76705	Echo exam of abdomen
76770	Us exam abdo back wall, comp
76775	Us eam abdo back wall,lim
76778	Us exam kidney transplant
76800	Us exam, spinal canal
76801	Ob us < 14 wks, single fetus-
76802	Ob us < 14 wks, addl fetus
76805	Ob us >/= 14 wks, sngl fetus
76810	Ob us >/= 14 wks, addl fetus
76811	Ob us, detailed, sngl fetus
76812	Ob us, detailed, addl fetus
76815	Ob us, limited, fetus(s)
76816	Ob us, follow-up, per fetus
76818	Fetal biophys profile w/nst
76819	Fetal biophys profil w/o nst
76825	Echo exam of fetal heart
76826	Echo exam of fetal heart
76827	Echo exam of fetal heart
76828	Echo exam of fetal heart
76831	Echo exam, uterus
76856	Us exam, pelvic, complete
76857	Us exam, pelvic, limited
76870	Us exam, scrotum
76880	Us exam, extremity
76885	Us exam infant hips, dynamic
76886	Us exam infant hips, static
76970	Ultrasound exam follow-up
76977	Us bone density measure
76999	Echo examination procedure
INCLUDE the following CPT codes for echocardiography and vascular ultrasound:
93303	Echo transthoracic
93304	Echo transthoracic
93307	Echo exam of heart
93308	Echo exam of heart
93320	Doppler echo exam, heart [if used in conjunction with 9330393308]
93321	Doppler echo exam, heart [if used in conjunction with 9330393308]
93325	Doppler color flow add-on [if used in conjunction with 9330393308]
93875	Extracranial study
93880	Extracranial study
93882	Extracranial study
93886	Intracranial study
93888	Intracranial study
93922	Extremity study
93923	Extremity study
93924	Extremity study
93925	Lower extremity study
93926	Lower extremity study
93930	Upper extremity study
93931	Upper extremity study
93965	Extremity study
93970	Extremity study
93971	Extremity study
93975	Vascular study
93976	Vascular study
93978	Vascular study
93979	Vascular study
93980	Penile vascular study
93981	Penile vascular study
93990	Doppler flow testing
INCLUDE the following CPT and HCPCS level 2 codes:
51798	Us urine capacity measure
0028T	Dexa body composition study
0042T	Ct perfusion w/contrast, cbf
G0202	Screeningmammographydigital
G0204	Diagnosticmammographydigital
G0206	Diagnosticmammographydigital
G0236	digital film convert diag ma
G0262	Sm intestinal image capsule
G0288	Recon, CTA for surg plan
R0070	Transport portable x-ray
R0075	Transport port x-ray multipl
RADIATION THERAPY SERVICES AND SUPPLIES
INCLUDE the following codes in the CPT 70000 series:
77261	Radiation therapy planning
77262	Radiation therapy planning
77263	Radiation therapy planning
77280	Set radiation therapy field
77285	Set radiation therapy field
77290	Set radiation therapy field
77295	Set radiation therapy field
77299	Radiation therapy planning
77300	Radiation therapy dose plan
77301	Radiotherapy dose plan, imrt
77305	Teletx isodose plan simple
77310	Teletx isodose plan intermed
77315	Teletx isodose plan complex
77321	Special teletx port plan
77326	Brachytx isodose calc simp
77327	Brachytx isodose calc interm
77328	Brachytx isodose plan compl
77331	Special radiation dosimetry
77332	Radiation treatment aid(s)
77333	Radiation treatment aid(s)
77334	Radiation treatment aid(s)
77336	Radiation physics consult
77370	Radiation physics consult
77399	External radiation dosimetry
77401	Radiation treatment delivery
77402	Radiation treatment delivery
77403	Radiation treatment delivery
77404	Radiation treatment delivery
77406	Radiation treatment delivery
77407	Radiation treatment delivery
77408	Radiation treatment delivery-
77409	Radiation treatment delivery
77411	Radiation treatment delivery
77412	Radiation treatment delivery
77413	Radiation treatment delivery
77414	Radiation treatment delivery
77416	Radiation treatment delivery
77417	Radiology port film(s)
77418	Radiation tx delivery, imrt
77427	Radiation tx management, x5
77431	Radiation therapy management
77432	Stereotactic radiation trmt
77470	Special radiation treatment
77499	Radiation therapy management
77520	Proton trmt, simple w/o comp
77522	Proton trmt, simple w/comp
77523	Proton trmt, intermediate
77525	Proton treatment, complex
77600	Hyperthermia treatment
77605	Hyperthermia treatment
77610	Hyperthermia treatment
77615	Hyperthermia treatment
77620	Hyperthermia treatment
77750	Infuse radioactive materials
77761	Apply intrcav radiat simple
77762	Apply intrcav radiat interm
77763	Apply intrcav radiat compl
77776	Apply interstit radiat simpl
77777	Apply interstit radiat inter
77778	Apply interstit radiat compl
77781	High intensity brachytherapy
77782	High intensity brachytherapy
77783	High intensity brachytherapy
77784	High intensity brachytherapy
77789	Apply surface radiation
77790	Radiation handling
77799	Radium/radioisotope therapy
INCLUDE the following CPT and HCPCS level 2 codes classified elsewhere:
31643	Diag bronchoscope/catheter
50559	Renal endoscopy/radiotracer
55859	Percut/needle insert, pros
61770	Incise skull for treatment
61793	Focus radiation beam
92974	Cath place, cardio brachytx
G0242	Multisource photon ster plan-
G0243	Multisour photon stero treat
G0256	Prostate brachy w palladium
G0261	Prostate brachytherapy w/rad
G0274	Radiopharm tx, non-Hodgkins
PREVENTIVE SCREENING TESTS, IMMUNIZATIONS AND VACCINES
The physician self-referral prohibition does not apply to the following tests if they are performed for screening purposes and satisfy the conditions in § 411.355(h):
76085	Computer mammogram add-on [when used in conjunction with 76092]
76092	Mammogram, screening
76977	Us bone density measure
G0103	Psa, total screening
G0107	CA screen; fecal blood test
G0123	Screen cerv/vag thin layer
G0124	Screen c/v thin layer by MD
G0141	Scr c/v cyto,autosys and md
G0143	Scr c/v cyto,thinlayer,rescr
G0144	Scr c/v cyto,thinlayer,rescr
G0145	Scr c/v cyto,thinlayer,rescr
G0147	Scr c/v cyto, automated sys
G0148	Scr c/v cyto, autosys, rescr
G0202	Screeningmammographydigital
P3000	Screen pap by tech w md supv
P3001	Screening pap smear by phys
The physician self-referral prohibition does not apply to the following immunization and vaccine codes if they satisfy the conditions in § 411.355(h):
90657	Flu vaccine, 635 mo, im
90658	Flu vaccine, 3 yrs, im
90659	Flu vacine, whole, im
90732	Pneumococcal vaccine
90748	Hep b/hib vaccine, im
Q3021	Ped hepatitis b vaccine inj
Q3022	Hepatitis b vaccine adult ds
Q3023	Injection hepatitis Bvaccine
DRUGS USED BY PATIENTS UNDERGOING DIALYSIS
The physician self-referral prohibition does not apply to the following EPO and other dialysis-related outpatient prescription drugs furnished in or by an ESRD facility if the conditions in § 411.355(g) are satisfied:
J0636	Inj calcitriol per 0.1 mcg
J0895	Deferoxamine mesylate inj
J1270	Injection, doxercalciferol
J1750	Iron dextran
J1756	Iron sucrose injection
J2501	Paricalcitol
J2916	Na ferric gluconate complex
J2997	Alteplase recombinant
Q9920	Epoetin with hct <=20
Q9921	Epoetin with hct = 21
Q9922	Epoetin with hct = 22
Q9923	Epoetin with hct = 23
Q9924	Epoetin with hct = 24
Q9925	Epoetin with hct = 25
Q9926	Epoetin with hct = 26
Q9927	Epoetin with hct = 27
Q9928	Epoetin with hct = 28
Q9929	Epoetin with hct = 29
Q9930	Epoetin with hct = 30
Q9931	Epoetin with hct = 31
Q9932	Epoetin with hct = 32
Q9933	Epoetin with hct = 33
Q9934	Epoetin with hct = 34
Q9935	Epoetin with hct = 35
Q9936	Epoetin with hct = 36
Q9937	Epoetin with hct = 37
Q9938	Epoetin with hct = 38
Q9939	Epoetin with hct = 39
Q9940	Epoetin with hct >= 40
1 CPT codes and descriptions only are copyright 2002 American Medical Association. All rights are reserved and applicable FARS/DFARS clauses apply.

Addendum F.—Codes Reviewed by PEAC

[Codes Refined by the Practice Expense Advisory Committee (PEAC)

CPT code	Short descriptors	CPT code	Short descriptors
11043	DEBRIDE TISSUE/MUSCLE	15736	MUSCLE-SKIN GRAFT, ARM
11044	DEBRIDE TISSUE/MUSCLE/BONE	15738	MUSCLE-SKIN GRAFT, LEG
11100	BIOPSY OF SKIN LESION	15820	REVISION OF LOWER EYELID
11101	BIOPSY, SKIN ADD-ON	15821	REVISION OF LOWER EYELID
11300	SHAVE SKIN LESION	15822	REVISION OF UPPER EYELID
11301	SHAVE SKIN LESION	15823	REVISION OF UPPER EYELID
11302	SHAVE SKIN LESION	17000	DETROY BENIGN/PREMLG LESION
11303	SHAVE SKIN LESION	17003	DESTROY LESIONS, 2-14
11305	SHAVE SKIN LESION	17004	DESTROY LESIONS, 15 OR MORE
11306	SHAVE SKIN LESION	17106	DESTRUCTION OF SKIN LESIONS
11307	SHAVE SKIN LESION	17107	DESTRUCTION OF SKIN LESIONS
11308	SHAVE SKIN LESION	17108	DESTRUCTION OF SKIN LESIONS
11310	SHAVE SKIN LESION	17110	DESTRUCT LESION, 1-14
11311	SHAVE SKIN LESION	17111	DESTRUCT LESION, 15 OR MORE
11312	SHAVE SKIN LESION	17250	CHEMICAL CAUTERY, TISSUE
11313	SHAVE SKIN LESION	17260	DESTRUCTION OF SKIN LESIONS
11400	EXC TR -EXT B9+MARG 0.5 < CM	17261	DESTRUCTION OF SKIN LESIONS
11401	EXC TR -EXT B9+MARG 0.6-1 CM	17262	DESTRUCTION OF SKIN LESIONS
11402	EXC TR -EXT B9+MARG 1.1-2 CM	17263	DESTRUCTION OF SKIN LESIONS
11403	EXC TR -EXT B9+MARG 2.1-3 CM	17264	DESTRUCTION OF SKIN LESIONS
11404	EXC TR - EXT B9+MARG 3.1-4 CM	17266	DESTRUCTION OF SKIN LESIONS
11406	EXC TR —EXT B9=MARG > 4.0 CM	17270	DESTRUCTION OF SKIN LESIONS
11420	EXC H-F-NK-SP B9+MARG 0.5 <	17271	DESTRUCTION OF SKIN LESIONS
11421	EXC H-F-NK-SP B9+MARG 0.6-1	17272	DESTRUCTION OF SKIN LESIONS
11422	EXC H-F-NK-SP B9+MARG 1.1-2	17273	DESTRUCTION OF SKIN LESIONS
11423	EXC H-F-NK-SP B9+MARG 2.1-3	17274	DESTRUCTION OF SKIN LESIONS
11424	EXC H-F-NK-SP B9+MARG 3.1-4	17276	DESTRUCTION OF SKIN LESIONS
11426	EXC H-F-NK-SP B9+MARG > 4 CM	17280	DESTRUCTION OF SKIN LESIONS
11440	EXC FACE-MM B9+MARG 0.5 < CM	17281	DESTRUCTION OF SKIN LESIONS
11441	EXC FACE-MM B9+MARG 0.6-1 CM	17282	DESTRUCTION OF SKIN LESIONS
11442	EXC FACE-MM B9+MARG 1.1-2 CM	17283	DESTRUCTION OF SKIN LESIONS
11443	EXC FACE-MM B9+MARG 2.1-3 CM	17284	DESTRUCTION OF SKIN LESIONS
11444	EXC FACE-MM B9+MARG 3.1-4 CM	17286	DESTRUCTION OF SKIN LESIONS
11446	EXC FACE-MM B9+MARG > 4 CM	19318	REDUCTION OF LARGE BREAST
11900	INJECTION INTO SKIN LESIONS	19357	BREAST RECONSTRUCTION
11901	ADDED SKIN LESIONS INJECTIONS	19361	BREAST RECONSTRUCTION
14040	SKIN TISSUE REARRANGEMENT	19364	BREAST RECONSTRUCTION
14041	SKIN TISSUE REARRANGEMENT	19366	BREAST RECONSTRUCTION
14060	SKIN TISSUE REARRANGEMENT	19367	BREAST RECONSTRUCTION
14061	SKIN TISSUE REARRANGEMENT	19368	BREAST RECONSTRUCTION
14300	SKIN TISSUE REARRANGEMENT	19369	BREAST RECONSTRUCTION
15000	SKIN GRAFT	22548	NECK SPINE FUSION
15001	SKIN GRAFT ADD-ON	22554	NECK SPINE FUSION
15100	SKIN SPLIT GRAFT	22556	THORAX SPINE FUSION
15101	SKIN SPLIT GRAFT ADD-ON	22558	LUMBAR SPINE FUSION
15120	SKIN SPLIT GRAFT	22590	SPINE & SKULL SPINAL FUSION
15121	SKIN SPLIT GRAFT ADD-ON	22595	NECK SPINAL FUSION
15260	SKIN FULL GRAFT	22600	NECK SPINE FUSION
15261	SKIN FULL GRAFT ADD-ON	22610	THORAX SPINE FUSION
15732	MUSCLE-SKIN GRAFT, HEAD/NECK	22612	LUMBAR SPINE FUSION
15734	MUSCLE-SKIN GRAFT, TRUNK	22630	LUMBAR SPINE FUSION
*PEAC refined in office inputs only.
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved.

Addendum F.—Codes Reviewed by PEAC—Continued

CPT code	Short descriptors	CPT code	Short descriptors
22800	FUSION OF SPINE	26121	RELEASE PALM CONTRACTURE
22802	FUSION OF SPINE	26123	RELEASE PALM CONTRACTURE
22804	FUSION OF SPINE	26130	REMOVE WRIST JOINT LINING
22808	FUSION OF SPINE	26135	REVISE FINGER JOINT, EACH
22810	FUSION OF SPINE	26140	REVISE FINGER JOINT, EACH
22812	FUSION OF SPINE	26145	TENDON EXCISION, PALM/FINGER
22818	KYPHECTOMY, 1-2 SEGMENTS	26160	REMOVE TENDON SHEATH LESION
22819	KYPHECTOMY, 3 OR MORE	26170	REMOVAL OF PALM TENDON, EACH
22830	EXPLORATION OF SPINAL FUSION	26180	REMOVAL OF FINGER TENDON
23470	RECONSTRUCT SHOULDER JOINT	26185	REMOVE FINGER BONE
23472	RECONSTRUCT SHOULDER JOINT	26200	REMOVE HAND BONE LESION
24160	REMOVE ELBOW JOINT IMPLANT	26205	REMOVE/GRAFT BONE LESION
24164	REMOVE RADIUS HEAD IMPLANT	26210	REMOVAL OF FINGER LESION
24360	RECONSTRUCT ELBOW JOINT	26215	REMOVE/GRAFT FINGER LESION
24361	RECONSTRUCT ELBOW JOINT	26230	PARTIAL REMOVAL OF HAND BONE
24362	RECONSTRUCT ELBOW JOINT	26235	PARTIAL REMOVAL, FINGER BONE
24363	REPLACE ELBOW JOINT	26236	PARTIAL REMOVAL, FINGER BONE
24365	RECONSTRUCT HEAD OF RADIUS	26250	EXTENSIVE HAND SURGERY
24366	RECONSTRUCT HEAD OF RADIUS	26255	EXTENSIVE HAND SURGERY
25250	REMOVAL OF WRIST PROSTHESIS	26260	EXTENSIVE FINGER SURGERY
25251	REMOVAL OF WRIST PROSTHESIS	26261	EXTENSIVE FINGER SURGERY
25332	REVISE WRIST JOINT	26262	PARTIAL REMOVAL OF FINGER
25441	RECONSTRUCT WRIST JOINT	26320	REMOVAL OF IMPLANT FROM HAND
25442	RECONSTRUCT WRIST JOINT	26530	REVISE KNUCKLE JOINT
25443	RECONSTRUCT WRIST JOINT	26531	REVISE KNUCKLE WITH IMPLANT
25444	RECONSTRUCT WRIST JOINT	26535	REVISE FINGER JOINT
25445	RECONSTRUCT WRIST JOINT	26536	REVISE/IMPLANT FINGER JOINT
25446	WRIST REPLACEMENT	27090	REMOVAL OF HIP PROSTHESIS
25447	REPAIR WRIST JOINT(S)	27091	REMOVAL OF HIP PROSTHESIS
25449	REMOVE WRIST JOINT IMPLANT	27120	RECONSTRUCTION OF HIP SOCKET
26010	DRAINAGE OF FINGER ABSCESS	27122	RECONSTRUCTION OF HIP SOCKET
26011	DRAINAGE OF FINGER ABSCESS	27125	PARTIAL HIP REPLACEMENT
26020	DRAIN HAND TENDON SHEATH	27130	TOTAL HIP ARTHROPLASTY
26025	DRAINAGE OF PALM BURSA	27132	TOTAL HIP ARTHROPLASTY
26030	DRAINAGE OF PALM BURSA(S)	27134	REVISE HIP JOINT REPLACEMENT
26034	TREAT HAND BONE LESION	27137	REVISE HIP JOINT REPLACEMENT
26035	DECOMPRESS FINGERS/HAND	27138	REVISE HIP JOINT REPLACEMENT
26037	DECOMPRESS FINGERS/HAND	27236	TREAT THIGH FRACTURE
26040	RELEASE PALM CONTRACTURE	27437	REVISE KNEECAP
26045	RELEASE PALM CONTRACTURE	27438	REVISE KNEECAP WITH IMPLANT
26055	INCISE FINGER TENDON SHEATH	27440	REVISION OF KNEE JOINT
26060	INCISION OF FINGER TENDON	27441	REVISION OF KNEE JOINT
26070	EXPLORE/TREAT HAND JOINT	27442	REVISION OF KNEE JOINT
26075	EXPLORE/TREAT FINGER JOINT	27443	REVISION OF KNEE JOINT
26080	EXPLORE/TREAT FINGER JOINT	27445	REVISION OF KNEE JOINT
26100	BIOPSY HAND JOINT LINING	27446	REVISION OF KNEE JOINT
26105	BIOPSY FINGER JOINT LINING	27447	TOTAL KNEE ARTHROPLASTY
26110	BIOPSY FINGER JOINT LINING	27486	REVISE/REPLACE KNEE JOINT
26115	REMOVEL HAND LESION SUBCUT	27487	REVISE/REPLACE KNEE JOINT
26116	REMOVEL HAND LESION, DEEP	27488	REMOVAL OF KNEE PROSTHESIS
26117	REMOVE TUMOR, HAND/FINGER	27700	REVISION OF ANKLE JOINT
*PEAC refined in office inputs only.
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved.

Addendum F.—Codes Reviewed by PEAC—Continued

CPT code	Short descriptors	CPT code	Short descriptors
27702	RECONSTRUCT ANKLE JOINT	29889	KNEE ARTHROSCOPY/SURGERY
27703	RECONSTRUCTION, ANKLE JOINT	29891	ANKLE ARTHROSCOPY/SURGERY
27704	REMOVAL OF ANKLE IMPLANT	29892	ANKLE ARTHROSCOPY/SURGERY
28293	CORRECTION OF BUNION	29894	ANKLE ARTHROSCOPY/SURGERY
29800	JAW ARTHROSCOPY/SURGERY	29895	ANKLE ARTHROSCOPY/SURGERY
29804	JAW ARTHROSCOPY/SURGERY	29897	ANKLE ARTHROSCOPY/SURGERY
29819	SHOULDER ARTHROSCOPY/SURGERY	29898	ANKLE ARTHROSCOPY/SURGERY
29820	SHOULDER ARTHROSCOPY/SURGERY	31505	DIAGNOSTIC LARYNGOSCOPY
29821	SHOULDER ARTHROSCOPY/SURGERY	32440	REMOVAL OF LUNG
29822	SHOULDER ARTHROSCOPY/SURGERY	32442	SLEEVE PNEUMONECTOMY
29823	SHOULDER ARTHROSCOPY/SURGERY	32445	REMOVAL OF LUNG
29825	SHOULDER ARTHROSCOPY/SURGERY	32480	PARTIAL REMOVAL OF LUNG
29826	SHOULDER ARTHROSCOPY/SURGERY	32482	BILOBECTOMY
29830	ELBOW ARTHROSCOPY	32484	SEGMENTECTOMY
29834	ELBOW ARTHROSCOPY/SURGERY	32486	SLEEVE LOBECTOMY
29835	ELBOW ARTHROSCOPY/SURGERY	32488	COMPLETION PNEUMONECTOMY
29836	ELBOW ARTHROSCOPY/SURGERY	32491	LUNG VOLUME REDUCTION
29837	ELBOW ARTHROSCOPY/SURGERY	32500	PARTIAL REMOVAL OF LUNG
29838	ELBOW ARTHROSCOPY/SURGERY	32501	REPAIR BRONCHUS ADD-ON
29840	WRIST ARTHROSCOPY	32520	REMOVE LUNG & REVISE CHEST
29843	WRIST ARTHROSCOPY/SURGERY	32522	REMOVE LUNG & REVISE CHEST
29844	WRIST ARTHROSCOPY/SURGERY	32525	REMOVE LUNG & REVISE CHEST
29845	WRIST ARTHROSCOPY/SURGERY	32540	REMOVAL OF LUNG LESION
29846	WRIST ARTHROSCOPY/SURGERY	32650	THORACOSCOPY, SURGICAL
29847	WRIST ARTHROSCOPY/SURGERY	32651	THORACOSCOPY, SURGICAL
29848	WRIST ENDOSCOPY/SURGERY	32652	THORACOSCOPY, SURGICAL
29850	KNEE ARTHROSCOPY/SURGERY	32653	THORACOSCOPY, SURGICAL
29851	KNEE ARTHROSCOPY/SURGERY	32654	THORACOSCOPY, SURGICAL
29855	TIBIAL ARTHROSCOPY/SURGERY	32655	THORACOSCOPY, SURGICAL
29856	TIBIAL ARTHROSCOPY/SURGERY	32656	THORACOSCOPY, SURGICAL
29860	HIP ARTHROSCOPY, DX	32657	THORACOSCOPY, SURGICAL
29861	HIP ARTHROSCOPY/SURGERY	32658	THORACOSCOPY, SURGICAL
29862	HIP ARTHROSCOPY/SURGERY	32659	THORACOSCOPY, SURGICAL
29863	HIP ARTHROSCOPY/SURGERY	32660	THORACOSCOPY, SURGICAL
29870	KNEE ARTHROSCOPY, DX	32661	THORACOSCOPY, SURGICAL
29871	KNEE ARTHROSCOPY/DRAINAGE	32662	THORACOSCOPY, SURGICAL
29874	KNEE ARTHROSCOPY/SURGERY	32663	THORACOSCOPY, SURGICAL
29875	KNEE ARTHROSCOPY/SURGERY	32664	THORACOSCOPY, SURGICAL
29876	KNEE ARTHROSCOPY/SURGERY	32665	THORACOSCOPY, SURGICAL
29877	KNEE ARTHROSCOPY/SURGERY	33400	REPAIR OF AORTIC VALVE
29879	KNEE ARTHROSCOPY/SURGERY	33401	VALVULOPLASTY, OPEN
29880	KNEE ARTHROSCOPY/SURGERY	33403	VALVULOPLASTY, W/CP BYPASS
29881	KNEE ARTHROSCOPY/SURGERY	33404	PREPARE HEART-AORTA CONDUIT
29882	KNEE ARTHROSCOPY/SURGERY	33405	REPLACEMENT OF AORTIC VALVE
29883	KNEE ARTHROSCOPY/SURGERY	33406	REPLACEMENT OF AORTIC VALVE
29884	KNEE ARTHROSCOPY/SURGERY	33410	REPLACEMENT OF AORTIC VALVE
29885	KNEE ARTHROSCOPY/SURGERY	33411	REPLACEMENT OF AORTIC VALVE
29886	KNEE ARTHROSCOPY/SURGERY	33412	REPLACEMENT OF AORTIC VALVE
29887	KNEE ARTHROSCOPY/SURGERY	33413	REPLACEMENT OF AORTIC VALVE
29888	KNEE ARTHROSCOPY/SURGERY	33420	REVISION OF MITRAL VALVE
*PEAC refined in office inputs only.
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved.

Addendum F.—Codes Reviewed by PEAC—Continued

CPT code	Short descriptors	CPT code	Short descriptors
33422	REVISION OF MITRAL VALVE	43239	UPPER GI ENDOSCOPY, BIOPSY*
33425	REPAIR OF MITRAL VALVE	43240	ESOPH ENDOSCOPE W/DRAIN CYST*
33426	REPAIR OF MITRAL VALVE	43241	UPPER GI ENDOSCOPY WITH TUBE*
33427	REPAIR OF MITRAL VALVE	43242	UPPR GI ENDOSCOPY W/US FN BX*
33430	REPLACEMENT OF MITRAL VALVE	43243	UPPER GI ENDOSCOPY & INJECT*
33510	CABG, VEIN, SINGLE	43244	UPPER GI ENSOSCOPY/LIGATION*
33511	CABG, VEIN, TWO	43245	UPPR GI SCOPY DILATE STRICTR*
33512	CABG, VEIN, THREE	43246	PLACE GASTROSTOMY TUBE*
33513	CABG, VEIN, FOUR	43247	OPERATIVE UPPER GI ENDOSCOPY*
33514	CABG, VEIN, FIVE	43248	UPPR GI ENDOSCOPY/GUIDE WIRE*
33516	CABG, VEIN, SIX OR MORE	43249	ESOPH ENDOSCOPY, DILATION*
33533	CABG, ARTERIAL, SINGLE	43250	UPPER GI ENDOSCOPY/TUMOR*
33534	CABG, ARTERIAL, TWO	43251	OPERATIVE UPPER GI ENDOSCOPY*
33535	CABG, ARTERIAL, THREE	43255	OPERATIVE UPPER GI ENDOSCOPY*
33536	CABG, ARTERIAL, FOUR OR MORE	43256	UPPR GI ENDOSCOPY W STENT*
35474	REPAIR ARTERIAL BLOCKAGE	43258	OPERATIVE UPPER GI ENDOSCOPY*
36400	BL DRAW < 3 YRS FEM/JUGULAR	43259	ENDOSCOPIC ULTRASOUND EXAM*
36405	BL DRAW < 3 YRS SCALP VEIN	43752	NASAL/OROGASTRIC W/STENT
36406	BL DRAW < 3 YRS OTHER VEIN	44140	PARTIAL REMOVAL OF COLON
36410	NON-ROUTINE BL DRAW > 3 YRS	44141	PARTIAL REMOVAL OF COLON
36415	ROUTINE VENIPUNCTURE	44143	PARTIAL REMOVAL OF COLON
36416	CAPILLARY BLOOD DRAW	44144	PARTIAL REMOVAL OF COLON
36420	VEIN ACCESS CUTDOWN < 1 YR	44145	PARTIAL REMOVAL OF COLON
36425	VEIN ACCESS CUTDOWN > 1 YR	44146	PARTIAL REMOVAL OF COLON
36540	COLLECT BLOOD VENOUS DEVICE	44147	PARTIAL REMOVAL OF COLON
36660	INSERTION CATHETER, ARTERY	44150	REMOVAL OF COLON
39010	EXPLORATION OF CHEST	44151	REMOVAL OF COLON/ILEOSTOMY
39200	REMOVAL CHEST LESION	44152	REMOVAL OF COLON/ILEOSTOMY
39220	REMOVAL CHEST LESION	44153	REMOVAL OF COLON/ILEOSTOMY
39400	VISUALIZATION OF CHEST	44155	REMOVAL OF COLON/ILEOSTOMY
40800	DRAINAGE OF MOUTH LESION	44156	REMOVAL OF COLON/ILEOSTOMY
40801	DRAINAGE OF MOUTH LESION	44160	REMOVAL OF COLON
40804	REMOVAL, FOREIGN BODY, MOUTH	44200	LAPAROSCOPY, ENTEROLYSIS
40805	REMOVAL, FOREIGN BODY, MOUTH	44201	LAPAROSCOPY, JEJUNOSTOMY
40808	BIOPSY OF MOUTH LESION	44202	LAP RESECT S/INTESTINE SINGL
40810	EXCISION OF MOUTH LESION	44300	OPEN BOWEL TO SKIN
40812	EXCISE/REPAIR MOUTH LESION	44310	ILEOSTOMY/JEJUNOSTOMY
40814	EXCISE/REPAIR MOUTH LESION	44312	REVISION OF ILEOSTOMY
40816	EXCISION OF MOUTH LESION	44314	REVISION OF ILEOSTOMY
41100	BIOPSY OF TONGUE	44316	DEVISE BOWEL POUCH
41105	BIOPSY OF TONGUE	44320	COLOSTOMY
41108	BIOPSY OF FLOOR OF MOUTH	44322	COLOSTOMY WITH BIOPSIES
41110	EXCISION OF TONGUE LESION	44340	REVISION OF COLOSTOMY
41112	EXCISION OF TONGUE LESION	44345	REVISION OF COLOSTOMY
41113	EXCISION OF TONGUE LESION	44346	REVISION OF COLOSTOMY
41114	EXCISION OF TONGUE LESION	44602	SUTURE, SMALL INTESTINE
43107	REMOVAL OF ESOPHAGUS	44603	SUTURE, SMALL INTESTINE
43112	REMOVAL OF ESOPHAGUS	44604	SUTURE, LARGE INTESTINE
43117	PARTIAL REMOVAL OF ESOPHAGUS	44605	REPAIR OF BOWEL LESION
43121	PARTIAL REMOVAL OF ESOPHAGUS	44615	INTESTINAL STRICTUROPLASTY
43122	PARTIAL REMOVAL OF ESOPHAGUS	44620	REPAIR BOWEL OPENING
43235	UPPR GI ENDOSCOPY, DIAGNOSIS*
*PEAC refined in office inputs only.
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved.

Addendum F.—Codes Reviewed by PEAC—Continued

CPT code	Short descriptors	CPT code	Short descriptors
44625	REPAIR BOWEL OPENING	52007	CYSTOSCOPY AND BIOPSY
44626	REPAIR BOWEL OPENING	52010	CYSTOSCOPY & DUCT CATHETER
44640	REPAIR BOWEL-SKIN FISTULA	52204	CYSTOSCOPY
44650	REPAIR BOWEL FISTULA	52214	CYSTOSCOPY AND TREATMENT
44660	REPAIR BOWEL-BLADDER FISTULA	52224	CYSTOSCOPY AND TREATMENT
44661	REPAIR BOWEL-BLADDER FISTULA	52234	CYSTOSCOPY AND TREATMENT
44680	SURGICAL REVISION, INTESTINE	52235	CYSTOSCOPY AND TREATMENT
44700	SUSPEND BOWEL W/PROSTHESIS	52240	CYSTOSCOPY AND TREATMENT
44800	EXCISION OF BOWEL POUCH	52250	CYSTOSCOPY AND RADIOTRACER
44820	EXCISION OF MESENTERY LESION	52260	CYSTOSCOPY AND TREATMENT
44850	REPAIR OF MESENTERY	52265	CYSTOSCOPY AND TREATMENT
44900	DRAIN APP ABSCESS, OPEN	52270	CYSTOSCOPY & REVISE URETHRA
44950	APPENDECTOMY	52275	CYSTOSCOPY & REVISE URETHRA
44955	APPENDECTOMY ADD-ON	52276	CYSTOSCOPY AND TREATMENT
44960	APPENDECTOMY	52277	CYSTOSCOPY AND TREATMENT
44970	LAPAROSCOPY, APPENDECTOMY	52281	CYSTOSCOPY AND TREATMENT
45000	DRAINAGE OF PELVIC ABSCESS	52282	CYSTOSCOPY, IMPLANT STENT
45020	DRAINAGE OF RECTAL ABSCESS	52283	CYSTOSCOPY AND TREATMENT
45100	BIOPSY OF RECTUM	52285	CYSTOSCOPY AND TREATMENT
45108	REMOVAL OF ANORECTAL LESION	52290	CYSTOSCOPY AND TREATMENT
45110	REMOVAL OF RECTUM	52300	CYSTOSCOPY AND TREATMENT
45111	PARTIAL REMOVAL OF RECTUM	52301	CYSTOSCOPY AND TREATMENT
45112	REMOVAL OF RECTUM	52305	CYSTOSCOPY AND TREATMENT
45113	PARTIAL PROCTECTOMY	52310	CYSTOSCOPY AND TREATMENT
45114	PARTIAL REMOVAL OF RECTUM	52315	CYSTOSCOPY AND TREATMENT
45116	PARTIAL REMOVAL OF RECTUM	52317	REMOVE BLADDER STONE
45119	REMOVE RECTUM W/RESERVOIR	52318	REMOVE BLADDER STONE
45120	REMOVAL OF RECTUM	52320	CYSTOSCOPY AND TREATMENT
45121	REMOVAL OF RECTUM AND COLON	52325	CYSTOSCOPY, STONE REMOVAL
45123	PARTIAL PROCTECTOMY	52327	CYSTOSCOPY, INJECT MATERIAL
45126	PELVIC EXENTERATION	52330	CYSTOSCOPY AND TREATMENT
45130	EXCISION OF RECTAL PROLAPSE	52332	CYSTOSCOPY AND TREATMENT
45135	EXCISION OF RECTAL PROLAPSE	52334	CREATE PASSAGE TO KIDNEY
45150	EXCISION OF RECTAL STRICTURE	52341	CYSTO W/URETER STRICTURE TX
45160	EXCISION OF RECTAL LESION	52342	CYSTO W/UP STRICTURE TX
45170	EXCISION OF RECTAL LESION	52343	CYSTO W/RENAL STRICTURE TX
45190	DESTRUCTION, RECTAL TUMOR	52344	CYSTO/URETERO, STONE REMOVE
47510	INSERT CATHETER, BILE DUCT	52345	CYSTO/URETERO W/UP STRICTURE
51725	SIMPLE CYSTOMETROGRAM	52346	CYSTOURETERO W/RENAL STRICT
51726	COMPLEX CYSTOMETROGRAM	52351	CYSTOURETRO & OR PYELOSCOPE
51736	URINE FLOW MEASUREMENT	52352	CYSTOURETRO W/STONE REMOVE
51741	ELECTRO-UROFLOWMETRY, FIRST	52353	CYSTOURETERO W/LITHOTRIPSY
51772	URETHRA PRESSURE PROFILE	52354	CYSTOURETERO W/BIOPSY
51784	ANAL/URINARY MUSCLE STUDY	52355	CYSTOURETERO W/EXCISE TUMOR
51785	ANAL/URINARY MUSCLE STUDY	52400	CYSTOURETERO W/CONGEN REPR
51792	URINARY REFLEX STUDY	52450	INCISION OF PROSTATE
51795	URINE VOIDING PRESSURE STUDY	52500	REVISION OF BLADDER NECK
51797	INTRAABDOMINAL PRESSURE TEST	52510	DILATION PROSTATIC URETHRA
52000	CYSTOSCOPY	52601	PROSTATECTOMY (TURP)
52001	CYSTOSCOPY, REMOVAL OF CLOTS	52606	CONTROL POSTOP BLEEDING
52005	CYSTOSCOPY & URETER CATHETER	52612	PROSTATECTOMY, FIRST STAGE
*PEAC refined in office inputs only.
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved.

Addendum F.—Codes Reviewed by PEAC—Continued

CPT code	Short descriptors	CPT code	Short descriptors
52614	PROSTATECTOMY, SECOND	58555	HYSTEROSCOPY, DX, SEP PROC
52620	REMOVE RESIDUAL PROSTATE	58558	HYSTEROSCOPY, BIOPSY
52630	REMOVE PROSTATE REGROWTH	58559	HYSTEROSCOPY, LYSIS
52640	RELIEVE BLADDER CONTRACTURE	58560	HYSTEROSCOPY, RESECT SPECTUM
52647	LASER SURGERY OF PROSTATE	58561	HYSTEROSCOPY, REMOVE MYOMA
52648	LASER SURGERY OF PROSTATE	58563	HYSTEROSCOPY, ABLATION
52700	DRAINAGE OF PROSTATE ABSCESS	59400	OBSTETRICAL CARE
56605	BIOPSY OF VULVA/PERINEUM	59409	OBSTETRICAL CARE
56606	BIOPSY OF VULVA/PERINEUM	59410	OBSTETRICAL CARE
56700	PARTIAL REMOVAL OF HYMEN	59412	ANTEPARTUM MANIPULATION
56720	INCISION OF HYMEN	59414	DELIVER PLACENTA
56740	REMOVE VAGINA GLAND LESION	59425	ANTEPARTUM CARE ONLY
57100	BIOPSY OF VAGINA	59426	ANTEPARTUM CARE ONLY
57105	BIOPSY OF VAGINA	59430	CARE AFTER DELIVERY
57200	REPAIR OF VAGINA	59510	CESAREAN DELIVERY
57210	REPAIR VAGINA/PERINEUM	59514	CESAREAN DELIVERY ONLY
57220	REVISION OF URETHRA	59515	CESAREAN DELIVERY
57230	REPAIR OF URETHRAL LESION	59525	REMOVE UTERUS AFTER CESAREAN
57240	REPAIR BLADDER & VAGINA	59610	VBAC DELIVERY
57250	REPAIR RECTUM & VAGINA	59612	VBAC DELIVERY ONLY
57260	REPAIR OF VAGINA	59614	VBAC CARE AFTER DELIVERY
57265	EXTENSIVE REPAIR OF VAGINA	59618	ATTEMPTED VBAC DELIVERY
57268	REPAIR OF BOWEL BULGE	59620	ATTEMPTED VBAC DELIVERY ONLY
57270	REPAIR OF BOWEL POUCH	59622	ATTEMPTED VBAC AFTER CARE
57280	SUSPENSION OF VAGINA	60100	BIOPSY OF THYROID
57282	REPAIR OF VAGINAL PROLAPSE	61000	REMOVE CRANIAL CAVITY FLUID
57284	REPAIR PARAVAGINAL DEFECT	61001	REMOVE CRANIAL CAVITY FLUID
57287	REVISE/REMOVE SLING REPAIR	61020	REMOVE BRAIN CAVITY FLUID
57288	REPAIR BLADDER DEFECT	61026	INJECTION INTO BRAIN CANAL
57289	REPAIR BLADDER & VAGINA	61050	REMOVE BRAIN CANAL FLUID
57291	CONSTRUCTION OF VAGINA	61055	INJECTION INTO BRAIN CANAL
57292	CONSTRUCT VAGINA WITH GRAFT	61070	BRAIN CANAL SHUNT PROCEDURE
57300	REPAIR RECTUM-VAGINA FISTULA	61105	TWIST DRILL HOLE
57305	REPAIR RECTUM-VAGINA FISTULA	61108	DRILL SKULL FOR DRAINAGE
57307	FISTULA REPAIR & COLOSTOMY	61120	BURR HOLE FOR PUNCTURE
57308	FISTULA REPAIR, TRANSPERINE	61140	PIERCE SKULL FOR BIOPSY
57310	REPAIR URETHROVAGINAL LESION	61150	PIERCE SKULL FOR DRAINAGE
57311	REPAIR URETHROVAGINAL LESION	61151	PIERCE SKULL FOR DRAINAGE
57320	REPAIR BLADDER-VAGINA LESION	61154	PIERCE SKULL & REMOVE CLOT
57330	REPAIR BLADDER-VAGINA LESION	61156	PIERCE SKULL FOR DRAINAGE
57335	REPAIR VAGINA	61215	INSERT BRAIN-FLUID DEVICE
57460	BX OF CERVIX W/SCOPE, LEEP	61250	PIERCE SKULL & EXPLORE
57800	DILATION OF CERVICAL CANAL	61253	PIERCE SKULL & EXPLORE
57820	D & C OF RESIDUAL CERVIX	61304	OPEN SKULL FOR EXPLORATION
58120	DILATION AND CURETTAGE	61305	OPEN SKULL FOR EXPLORATION
58150	TOTAL HYSTERECTOMY	61312	OPEN SKULL FOR DRAINAGE
58152	TOTAL HYSTERECTOMY	61313	OPEN SKULL FOR DRAINAGE
58180	PARTIAL HYSTERECTOMY	61314	OPEN SKULL FOR DRAINAGE
58200	EXTENSIVE HYSTERECTOMY	61315	OPEN SKULL FOR DRAINAGE
58210	EXTENSIVE HYSTERECTOMY	61320	OPEN SKULL FOR DRAINAGE
58240	REMOVAL OF PELVIS CONTENTS	61321	OPEN SKULL FOR DRAINAGE
*PEAC refined in office inputs only.
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved.

Addendum F.—Codes Reviewed by PEAC—Continued

CPT code	Short descriptors	CPT code	Short descriptors
61330	DECOMPRESS EYE SOCKET	64418	N BLOCK INJ, SUPRASCAPULAR
61332	EXPLORE/BIOPSY EYE SOCKET	64420	N BLOCK INJ, INTERCOST, SNG
61333	EXPLORE ORBIT/REMOVE LESION	64421	N BLOCK INJ, INTERCOST, MLT
61334	EXPLORE ORBIT/REMOVE OBJECT	64425	N BLOCK INJ ILIO-ING/HYPOGI
61340	SUBTEMPORAL DECOMPRESSION	64430	N BLOCK INJ, PUDENDAL
62270	SPINAL FLUID TAP, DIAGNOSTIC	64435	N BLOCK INJ, PARACERVICAL
62272	DRAIN CEREBRO SPINAL FLUID	64445	N BLOCK INJ, SCIATIC, SNG
62273	TREAT EPIDURAL SPINE LESION	64450	N BLOCK, OTHER PERIPHERAL
62280	TREAT SPINAL CORD LESION	64470	INJ PARAVERTEBRAL C/T
62281	TREAT SPINAL CORD LESION	64472	INJ PARAVERTEBRAL C/T ADD-ON
62282	TREAT SPINAL CANAL LESION	64475	INJ PARAVERTEBRAL L/S
62284	INJECTION FOR MYELOGRAM	64476	INJ PARAVERTEBRAL L/S ADD-ON
62290	INJECT FOR SPINE DISK X-RAY	64479	INJ FORAMEN EPIDURAL C/T
62291	INJECT FOR SPINE DISK X-RAY	64480	INJ FORAMEN EPIDURAL ADD-ON
62310	INJECT SPINE C/T	64483	INJ FORAMEN EPIDURAL L/S
62311	INJECT SPINE L/S (CD)	64484	INJ FORAMEN EPIDURAL ADD-ON
62318	INJECT SPINE W/CATH, C/T	64505	N BLOCK, SPENOPALATINE GANGL
62319	INJECT SPINE W/CATH L/S (CD)	64508	N BLOCK, CAROTID SINUS S/P
63001	REMOVAL OF SPINAL LAMINA	64510	N BLOCK, STELLATE GANGLION
63003	REMOVAL OF SPINAL LAMINA	64520	N BLOCK, LUMBAR/THORACIC
63005	REMOVAL OF SPINAL LAMINA	64530	N BLOCK INJ, CELIAC PELUS
63011	REMOVAL OF SPINAL LAMINA	64600	INJECTION TREATMENT OF NERVE
63012	REMOVAL OF SPINAL LAMINA	64605	INJECTION TREATMENT OF NERVE
63015	REMOVAL OF SPINAL LAMINA	64610	INJECTION TREATMENT OF NERVE
63016	REMOVAL OF SPINAL LAMINA	64612	DESTROY NERVE, FACE MUSCLE
63017	REMOVAL OF SPINAL LAMINA	64613	DESTROY NERVE, SPINE MUSCLE
63020	NECK SPINE DISK SURGERY	64614	DESTROY NERVE, EXTREM MUSC
63030	LOW BACK DISK SURGERY	64620	INJECTION TREATMENT OF NERVE
63040	LAMINOTOMY, SINGLE CERVICAL	64622	DESTR PARAVERTEBRL NERVE L/S
63042	LAMINOTOMY, SINGLE LUMBAR	64623	DESTR PARAVERTEBRAL N ADD-ON
63045	REMOVAL OF SPINAL LAMINA	64626	DESTR PARAVERTEBRL NERVE C/T
63046	REMOVAL OF SPINAL LAMINA	64627	DESTR PARAVERTEBRAL N ADD-ON
63047	REMOVAL OF SPINAL LAMINA	64630	INJECTION TREATMENT OF NERVE
63055	DECOMPRESS SPINAL CORD	64640	INJECTION TREATMENT OF NERVE
63056	DECOMPRESS SPINAL CORD	64680	INJECTION TREATMENT OF NERVE
63064	DECOMPRESS SPINAL CORD	66700	DESTRUCTION, CILIARY BODY
63075	NECK SPINE DISK SURGERY	66710	DESTRUCTION, CILIARY BODY
63077	SPINE DISK SURGERY, THORAX	66720	DESTRUCTION, CILIARY BODY
63081	REMOVAL OF VERTEBRAL BODY	66740	DESTRUCTION, CILIARY BODY
63085	REMOVAL OF VERTEBRAL BODY	66761	REVISION OF IRIS
63087	REMOVAL OF VERTEBRAL BODY	66762	REVISION OF IRIS
63090	REMOVAL OF VERTEBRAL BODY	66770	REMOVAL OF INNER EYE LESION
64400	N BLOCK INJ, TRIGEMINAL	70336	MAGNETIC IMAGE, JAW JOINT
64402	N BLOCK INJ, FACIAL	70540	MRI ORBIT/FACE/NECK W/O DYE
64405	N BLOCK INJ, OCCIPITAL	70551	MRI BRAIN W/O DYE
64408	N BLOCK INJ, VAGUS	71550	MRI CHEST W/O DYE
64410	N BLOCK INJ, PHRENIC	72141	MRI NECK SPINE W/O DYE
64412	N BLOCK INJ, SPINAL ACCESSOR	72146	MRI CHEST SPINE W/O DYE
64413	N BLOCK INJ, CERVICAL PLEXUS	72148	MRI LUMBAR SPINE W/O DYE
64415	N BLOCK INJ, BRACHIAL PLEXUS	72195	MRI PELVIS W/O DYE
64417	N BLOCK INJ, AXILLARY	73218	MRI UPPER EXTREMITY W/O
*PEAC refined in office inputs only.
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved.

Addendum F.—Codes Reviewed by PEAC—Continued

CPT code	Short descriptors	CPT code	Short descriptors
73221	MRI JOINT UPR EXTREM W/O DYE	88332	PATH CONSULT INTRAOP, ADDL
73718	MRI LOWER EXTREMITY W/O DYE	88342	IMMUNOCYTOCHEMISTRY
73721	MRI JOINT OF LWR EXTRE W/O DYE	88346	IMMUNOFLUORESCENT STUDY
74181	MRI ABDOMEN W/O DYE	88347	IMMUNOFLUORESCENT STUDY
75552	HEART MRI FOR MORPH W/O DYE	88362	NERVE TEASING PREPARATIONS
75554	CARDIAC MRI/FUNCTION	90471	IMMUNIZATION ADMIN
75555	CARDIAC MRI/LIMITED STUDY	90472	IMMUNIZATION ADMIN, EACH ADD
76075	DEXA, AXIAL SKELETON STUDY	90780	IV INFUSION THERAPY, 1 HOUR
76076	DEXA, PERIPHERAL STUDY	90781	IV INFUSION, ADDITIONAL HOUR
76400	MAGNETIC IMAGE, BONE MARROW	90782	INJECTION, SC/IM
76506	ECHO EXAM OF HEAD	90783	INJECTION, IA
76536	US EXAM OF HEAD AND NECK	90784	INJECTION, IV
76700	US EXAM, ABDOM, COMPLETE	90788	INJECTION OF ANTIBIOTIC
76770	US EXAM ABDO BACK WALL, COMP	90801	PSY DX INTERVIEW
76778	US EXAM KIDNEY TRANSPLANT	90802	INTAC PSY DX INTERVIEW
76818	FETAL BIOPHYS PROFILE W/NST	90804	PSYTX, OFFICE, 20-30 MIN
76819	FETAL BIOPHYS PROFIL W/O NST	90805	PSYTX, OFF, 20-30 MIN W/E&M
76825	ECHO EXAM OF FETAL HEART	90806	PSYTX, OFF, 45-50 MIN
76826	ECHO EXAM OF FETAL HEART	90807	PSYTX, OFF, 45-50 MIN W/E&M
76827	ECHO EXAM OF FETAL HEART	90808	PSYTX, OFFICE, 75-80 MIN
76828	ECHO EXAM OF FETAL HEART	90809	PSYTX, OFF, 75-80, W/E&M
76830	TRANSVAGINAL US, NON-OB	90810	INTAC PSYTX, OFF, 20-30 MIN
76831	ECHO EXAM, UTERUS	90811	INTAC PSYTX, 20-30, W/E&M
76856	US EXAM, PELVIC, COMPLETE	90812	INTAC PSYTX, OFF, 45-50 MIN
76857	US EXAM, PELVIC, LIMITED	90813	INTAC PSYTX, 45-50 MIN W/E&M
76870	US EXAM, SCROTUM	90814	INTAC PSYTX, OFF, 75-80 MIN
76872	ECHO EXAM, TRANSRECTAL	90815	INTAC PSYTX, 75-80 W/E&M
76873	ECHOGRAP TRANS R, PROS STUDY	90816	PSYTX, HOSP, 20-30 MIN
76880	US EXAM, EXTREMITY	90817	PSYTX, HOSP, 20-30 MIN W/E&M
76885	US EXAM INFANT HIPS, DYNAMIC	90818	PSYTX, HOSP, 45-50 MIN
76942	ECHO GUIDE FOR BIOPSY	90819	PSYTX, HOSP, 45-50 MIN W/E&M
77789	APPLY SURFACE RADIATION	90821	PSYTX, HOSP, 75-80 MIN
78070	PARATHYROID NUCLEAR IMAGING	90822	PSYTX, HOSP, 75-80 MIN W/E&M
78306	BONE IMAGING, WHOLE BODY	90823	INTAC PSYTX, HOSP, 20-30 MIN
78315	BONE IMAGING, 3 PHASE	90824	INTAC PSYTX, HSP 20-30 W/E&M
78460	HEART MUSCLE BLOOD, SINGLE	90826	INTAC PSYTX, HOSP, 45-50 MIN
78461	HEART MUSCLE BLOOD, MULTIPLE	90827	INTAC PSYTX, HSP 45-50 W/E&M
78464	HEART IMAGE (3D), SINGLE	90828	INTAC PSYTX, HOSP, 75-80 MIN
78465	HEART IMAGE (3D), MULTIPLE	90829	INTAC PSYTX, HSP 75-80 W/E&M
78478	HEART WALL MOTION ADD-ON	90845	PSYCHOANALYSIS
78480	HEART FUNCTION ADD-ON	90846	FAMILY PSYTX W/O PATIENT
78580	LUNG PERFUSION IMAGING	90847	FAMILY PSYTX W/PATIENT
88180	CELL MARKER STUDY	90849	MULTIPLE FAMILY GROUP PSYTX
88182	CELL MARKER STUDY	90853	GROUP PSYCHOTHERAPY
88291	CYTO/MOLECULAR REPORT	90857	INTAC GROUP PSYTX
88321	MICROSLIDE CONSULTATION	90862	MEDICATION MANAGEMENT
88323	MICROSLIDE CONSULTATION	90918	ESRD RELATED SERVICES, MONTH
88325	COMPREHENSIVE REVIEW OF DATA	90919	ESRD RELATED SERVICES, MONTH
88329	PATH CONSULT INTROP	90920	ESRD RELATED SERVICES, MONTH
88331	PATH CONSULT INTRAOP, 1 BLOC	90921	ESRD RELATED SERVICES, MONTH
*PEAC refined in office inputs only.
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved.

Addendum F.—Codes Reviewed by PEAC—Continued

CPT code	Short descriptors	CPT code	Short descriptors
90922	ESRD RELATED SERVICES, DAY	93314	ECHO TRANSESOPHAGEAL
90923	ESRD RELATED SERVICES, DAY	93315	ECHO TRANSESOPHAGEAL
90924	ESRD RELATED SERVICES, DAY	93317	ECHO TRANSESOPHAGEAL
90925	ESRD RELATED SERVICES, DAY	93320	DOPPLER ECHO EXAM, HEART
90935	HEMODIALYSIS, ONE EVALUATION	93321	DOPPLER ECHO EXAM, HEART
90937	HEMODIALYSIS, REPEATED EVAL	93325	DOPPLER COLOR FLOW ADD-ON
90945	DIALYSIS, ONE EVALUATION	93350	ECHO TRANSTHORACIC
90947	DIALYSIS, REPEATED EVAL	93508	CATH PLACEMENT, ANGIOGRAPHY
91100	PASS INTESTINE BLEEDING TUBE	93510	LEFT HEART CATHETERIZATION
91105	GASTRIC INTUBATION TREATMENT	93511	LEFT HEART CATHETERIZATION
92065	ORTHOPTIC/PLEOPTIC TRAINING	93514	LEFT HEART CATHETERIZATION
92070	FITTING OF CONTACT LENS	93524	LEFT HEART CATHETERIZATION
92283	COLOR VISION EXAMINATION	93526	RT & LT HEART CATHETERS
92504	EAR MICROSCOPY EXAMINATION	93527	RT & LT HEART CATHETERS
92541	SPONTANEOUS NYSTAGMUS TEST	93528	RT & LT HEART CATHETERS
92542	POSITIONAL NYSTAGMUS TEST	93529	RT & LT HEART CATHETERIZATION
92543	CALORIC VESTIBULAR TEST	93530	RT HEART CATH, CONGENITAL
92544	OPTOKINETIC NYSTAGMUS TEST	93531	R & L HEART CATH, CONGENITAL
92545	OSCILLATING TRACKING TEST	93532	R & L HEART CATH, CONGENITAL
92546	SINUSOIDAL ROTATIONAL TEST	93533	R & L HEART CATH, CONGENITAL
92552	PURE TONE AUDIOMETRY, AIR	93539	INJECTION, CARDIAC CATH
92553	AUDIOMETRY, AIR & BONE	93540	INJECTION, CARDIAC CATH
92555	SPEECH THRESHOLD AUDIOMETRY	93541	INJECTION FOR LUNG ANGIOGRAM
92556	SPEECH AUDIOMETRY, COMPLETE	93542	INJECTION FOR HEART X-RAYS
92557	COMPREHENSIVE HEARING TEST	93543	INJECTION FOR HEART X-RAYS
92567	TYMPANOMETRY	93544	INJECTION FOR AORTOGRAPHY
92568	ACOUSTIC REFLEX TESTING	93545	INJECT FOR CORONARY X-RAYS
92569	ACOUSTIC REFLEX DECAY TEST	93555	IMAGING, CARDIAC CATH
92980	INSERT INTRACORONARY STENT	93556	IMAGING, CARDIAC CATH
92981	INSERT INTRACORONARY STENT	93733	TELEPHONE ANALY, PACEMAKER
92982	CORONARY ARTERY DILATION	93736	TELEPHONE ANALY, PACEMAKER
92984	CORONARY ARTERY DILATION	93740	TEMPERATURE GRADIENT STUDIES
92995	CORONARY ATHERECTOMY	93770	MEASURE VENOUS PRESSURE
92996	CORONARY ATHERECTOMY ADD-ON	93875 TC	EXTRACRANIAL STUDY
92997	PUL ART BALLOON REPR, PERCUT	93880 TC	EXTRACRANIAL STUDY
92998	PUL ART BALLOON REPR, PERCUT	93882 TC	EXTRACRANIAL STUDY
93000	ELECTROCARDIOGRAM, COMPLETE	93886 TC	INTRACRANIAL STUDY
93005	ELECTROCARDIOGRAM, TRACING	93888 TC	INTRACRANIAL STUDY
93010	ELECTROCARDIOGRAM REPORT	93922 TC	EXTREMITY STUDY
93015	CARDIOVASCULAR STRESS TEST	93923 TC	EXTREMITY STUDY
93016	CARDIOVASCULAR STRESS TEST	93924 TC	EXTREMITY STUDY
93017	CARDIOVASCULAR STRESS TEST	93925 TC	LOWER EXTREMITY STUDY
93018	CARDIOVASCULAR STRESS TEST	93926 TC	LOWER EXTREMITY STUDY
93040	RHYTHM ECG WITH REPORT	93930 TC	UPPER EXTREMITY STUDY
93041	RHYTHM ECG, TRACING	93931 TC	UPPER EXTREMITY STUDY
93042	RHYTHM ECG, REPORT	93965 TC	EXTREMITY STUDY
93303	ECHO TRANSTHORACIC	93970 TC	EXTREMITY STUDY
93304	ECHO TRANSTHORACIC	93971 TC	EXTREMITY STUDY
93307	ECHO EXAM OF HEART	93975 TC	VASCULAR STUDY
93308	ECHO EXAM OF HEART	93976 TC	VASCULAR STUDY
93312	ECHO TRANSESOPHAGEAL	93978 TC	VASCULAR STUDY
*PEAC refined in office inputs only.
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved.

Addendum F.—Codes Reviewed by PEAC—Continued

CPT code	Short descriptors	CPT code	Short descriptors
93979 TC	VASCULAR STUDY
93990 TC	DOPPLER FLOW TESTING
95807	SLEEP STUDY, ATTENDED
95808	POLYSOMNOGRAPHY, 1-3
95810	POLYSOMNOGRAPHY, 4 OR MORE
95811	POLYSOMNOGRAPHY W/CPAP
95951	EEG MONITORING/VIDEORECORD
96400	CHEMOTHERAPY, SC/IM
96408	CHEMOTHERAPY, PUSH TECHNIQUE
96410	CHEMOTHERAPY, INFUSION METHOD
96412	CHEMO, INFUSE METHOD ADD-ON
96414	CHEMO, INFUSE METHOD ADD-ON
96420	CHEMOTHERAPY, PUSH TECHNIQUE
96422	CHEMOTHERAPY, INFUSION METHOD
96423	CHEMO, INFUSE METHOD ADD-ON
96425	CHEMOTHERAPY, INFUSION METHOD
96520	PORT PUMP REFILL & MAIN
96530	SYST PUMP REFILL & MAIN
98940	CHIROPRACTIC MANIPULATION
98941	CHIROPRACTIC MANIPULATION
98942	CHIROPRACTIC MANIPULATION
98943	CHIROPRACTIC MANIPULATION
99183	HYPERBARIC OXYGEN THERAPY
99195	PHLEBOTOMY
99199	SPECIAL SERVICE/PROC/REPORT
99431	INITIAL CARE, NORMAL NEWBORN
99432	NEWBORN CARE, NOT IN HOSP
99433	NORMAL NEWBORN CARE/HOSPITAL
99435	NEWBORN DISCHARGE DAY HOSP
99436	ATTENDANCE, BIRTH
99440	NEWBORN RESUSCITATION
*PEAC refined in office inputs only.
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved.